data_1qjo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qjo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 123.968 1.842 . . . . 0.0 115.926 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.629 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 6.1 mmmt -139.83 149.93 44.07 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.863 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -96.27 154.97 16.96 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.561 HG23 ' CE1' ' A' ' 74' ' ' PHE . 43.3 t -116.52 117.27 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.586 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.2 p-10 -108.5 169.4 8.67 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.154 1.454 . . . . 0.0 109.767 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.476 HG23 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -94.94 115.0 64.94 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 112.546 -2.115 . . . . 0.0 106.468 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.506 2.235 0 C-N-CA 122.513 2.142 . . . . 0.0 113.471 -175.553 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.502 2.146 0 CA-C-O 122.693 1.235 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 2.5 pt-20 -120.58 170.32 9.52 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.43 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 t -97.62 120.75 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 12.2 t -96.47 -46.17 6.47 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.68 98.51 4.51 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 122.437 1.113 . . . . 0.0 113.362 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.62 68.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 124.599 2.142 . . . . 0.0 108.498 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -32.49 -56.15 0.34 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.729 2.862 . . . . 0.0 118.729 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.2 m -87.71 164.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.547 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 16.3 mmtp -131.79 -166.38 1.71 Allowed 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 124.25 1.976 . . . . 0.0 115.91 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.7 t -74.42 86.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-N 113.294 -1.775 . . . . 0.0 113.654 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.62 -11.49 7.07 Favored Glycine 1 N--CA 1.517 4.065 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.097 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -54.97 163.94 0.92 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD2' HG13 ' A' ' 53' ' ' VAL . 8.4 mmmm -100.2 102.29 13.54 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 112.263 -2.244 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.79 148.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 CA-C-O 124.217 1.96 . . . . 0.0 114.804 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.04 154.67 46.09 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.548 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -55.03 163.85 0.96 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 60.49 -16.54 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -88.81 106.97 18.72 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 4.0 t -36.57 138.44 0.23 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -102.14 -59.43 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.8 pt -140.26 130.89 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.198 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.488 HG22 ' HG2' ' A' ' 45' ' ' GLU . 6.7 m -83.55 123.06 29.38 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.8 m -115.66 141.59 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.512 2.666 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 N--CA 1.508 2.464 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 32.6 mtt -121.97 164.86 16.89 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.64 -1.288 . . . . 0.0 112.117 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HG2' HG22 ' A' ' 36' ' ' THR . 36.7 mt-10 -129.81 153.49 48.19 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.44 1.114 . . . . 0.0 112.361 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 t -124.74 112.97 27.16 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.698 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.56 177.52 5.6 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.741 1.627 . . . . 0.0 113.214 178.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -69.27 114.75 25.98 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -46.79 -27.71 5.94 Favored 'Trans proline' 0 N--CA 1.512 2.609 0 C-N-CA 122.371 2.048 . . . . 0.0 112.609 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.629 ' CZ ' ' HE3' ' A' ' 3' ' ' LYS . 47.0 p90 -167.13 -175.28 2.92 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.26 164.12 12.61 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.85 -144.65 15.53 Favored Glycine 1 N--CA 1.52 4.293 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.545 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 27' ' ' LYS . 3.4 m -121.87 166.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.062 0.934 . . . . 0.0 112.318 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' CE1' ' A' ' 74' ' ' PHE . 13.8 t -98.33 142.08 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.487 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 75' ' ' GLU . 69.2 tttt -115.93 -63.88 1.39 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.645 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -135.82 158.5 44.24 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -155.97 115.8 3.63 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.077 -1.639 . . . . 0.0 113.203 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -90.65 52.54 2.21 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.237 -1.539 . . . . 0.0 109.466 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.18 149.09 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -122.67 172.02 8.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 124.355 2.026 . . . . 0.0 116.123 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -95.06 111.41 25.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 100.992 -3.707 . . . . 0.0 100.992 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.03 8.71 11.38 Favored Glycine 1 N--CA 1.518 4.15 1 CA-C-N 107.741 -4.3 . . . . 0.0 108.855 -179.218 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -94.82 177.49 5.89 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.611 -1.295 . . . . 0.0 110.264 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -108.73 144.46 36.5 Favored 'General case' 0 N--CA 1.511 2.595 1 N-CA-C 123.369 4.581 . . . . 0.0 123.369 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -142.26 150.22 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.757 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -161.74 162.52 29.71 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.412 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 16.6 p -41.49 113.75 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.99 -35.88 4.78 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 111.641 -2.527 . . . . 0.0 115.314 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.6 t -38.31 132.92 1.02 Allowed 'General case' 0 N--CA 1.53 3.567 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.59 56.96 0.18 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.481 ' CG2' ' SD ' ' A' ' 72' ' ' MET . 3.1 mt -23.12 -63.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CG2' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -159.23 171.94 18.95 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 112.529 -2.123 . . . . 0.0 114.123 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.77 120.51 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 123.635 1.683 . . . . 0.0 110.842 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.561 ' CE1' HG23 ' A' ' 5' ' ' VAL . 6.8 m-30 -99.05 176.01 5.71 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 112.083 -2.326 . . . . 0.0 109.136 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 55' ' ' LYS 0.264 26.5 tt0 -156.39 115.87 3.52 Favored 'General case' 0 C--N 1.285 -2.23 1 N-CA-C 98.965 -4.457 . . . . 0.0 98.965 178.712 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.783 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.513 2.692 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -112.19 127.12 55.86 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -66.84 142.86 57.19 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.717 1.246 . . . . 0.0 110.732 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 74' ' ' PHE . 26.2 t -116.49 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.9 p-10 -101.61 168.78 9.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.748 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.87 140.06 21.7 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.721 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 N--CA 1.496 1.674 0 C-N-CA 123.327 2.684 . . . . 0.0 114.803 -179.239 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.502 2.159 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 14.4 pm0 -113.13 164.96 12.85 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.488 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 t -101.48 117.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.221 -0.924 . . . . 0.0 110.118 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.61 -50.57 4.44 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.285 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.3 mt-10 -128.69 95.28 4.07 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 123.555 1.645 . . . . 0.0 111.305 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.5 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.8 p -70.23 66.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.5 mtt -30.24 -57.35 0.19 Allowed 'General case' 0 N--CA 1.512 2.631 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 18.8 m -87.16 171.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -134.33 169.37 17.31 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.63 110.26 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.704 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 10.91 21.62 Favored Glycine 0 N--CA 1.508 3.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.694 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.38 159.34 16.46 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 123.731 1.729 . . . . 0.0 110.045 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -78.58 122.74 26.29 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 125.151 2.405 . . . . 0.0 113.49 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG12 ' CE2' ' A' ' 74' ' ' PHE . 92.7 t -125.25 97.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 110.455 -3.066 . . . . 0.0 114.56 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -107.44 160.01 15.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -57.45 173.83 0.24 Allowed 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.454 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 62.79 -18.67 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 30' ' ' ALA . 1.6 pp0? -94.97 139.51 31.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.132 -1.605 . . . . 0.0 107.789 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t -63.48 128.48 36.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.498 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -92.77 -64.52 1.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.8 pt -138.61 140.04 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 113.424 -1.717 . . . . 0.0 112.306 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 3.4 m -93.35 130.13 39.23 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.985 -3.339 . . . . 0.0 101.985 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.49 164.8 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.197 0.936 . . . . 0.0 112.473 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 11.6 tt0 . . . . . 0 N--CA 1.505 2.293 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.253 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.505 2.302 0 CA-C-O 121.992 0.901 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.39 124.72 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.842 -1.526 . . . . 0.0 107.413 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 22.7 mp0 -95.65 142.55 27.83 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 123.825 1.774 . . . . 0.0 113.557 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 t -113.48 118.47 43.45 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.582 -1.644 . . . . 0.0 115.092 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -82.14 178.11 6.65 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.875 1.717 . . . . 0.0 112.356 174.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -67.51 103.1 0.44 Allowed Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 118.793 2.886 . . . . 0.0 118.793 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -42.93 -29.59 1.56 Allowed 'Trans proline' 0 N--CA 1.508 2.349 0 C-N-CA 122.416 2.077 . . . . 0.0 114.105 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -159.2 -179.44 7.99 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.24 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -99.86 156.53 17.08 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 120.097 3.369 . . . . 0.0 120.097 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.37 -147.82 18.56 Favored Glycine 1 N--CA 1.519 4.221 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.98 160.89 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.93 83.74 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -67.47 -42.48 82.94 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.562 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 36.4 tt0 -163.84 130.19 3.16 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 1.9 pt? -126.95 151.27 48.73 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 119.78 -1.825 . . . . 0.0 108.362 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.562 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 12.9 mptt -121.05 45.08 2.35 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.899 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 p -141.11 154.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.953 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -124.26 171.78 9.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -87.0 114.76 26.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 100.9 -3.741 . . . . 0.0 100.9 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.35 -0.77 16.41 Favored Glycine 0 N--CA 1.503 3.147 0 CA-C-N 110.145 -3.207 . . . . 0.0 109.216 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.8 170.48 9.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.334 0.667 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -118.68 145.73 45.26 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 121.13 3.752 . . . . 0.0 121.13 -179.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 HG11 ' CD1' ' A' ' 71' ' ' ILE . 17.1 m -130.62 164.79 32.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.218 -1.81 . . . . 0.0 113.557 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 140.82 18.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 t -43.72 120.42 2.0 Allowed 'General case' 0 N--CA 1.514 2.773 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.242 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.13 -23.72 10.46 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 117.285 1.674 . . . . 0.0 117.285 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.4 t -79.25 143.26 35.46 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 118.664 -1.214 . . . . 0.0 112.602 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.99 62.49 6.87 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 124.369 2.033 . . . . 0.0 113.338 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.451 ' CD1' HG11 ' A' ' 65' ' ' VAL . 12.9 mm -44.65 -45.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -133.85 -177.47 4.58 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.743 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -138.63 117.29 13.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.604 ' CD1' HG22 ' A' ' 5' ' ' VAL . 22.6 m-30 -109.75 159.51 17.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.273 3.1 tt0 -126.02 150.9 47.76 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 -179.472 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.513 2.682 0 N-CA-C 121.218 3.784 . . . . 0.0 121.218 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.563 ' HZ1' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.13 158.77 15.44 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 113.011 -1.904 . . . . 0.0 114.131 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.474 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 4.5 mp0 -100.27 149.79 23.23 Favored 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.478 HG23 ' CE1' ' A' ' 74' ' ' PHE . 85.2 t -130.89 91.54 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.092 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -104.93 174.28 5.94 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 67' ' ' THR . 56.4 t -90.81 126.23 56.45 Favored Pre-proline 0 N--CA 1.504 2.255 0 C-N-CA 117.128 -1.829 . . . . 0.0 106.527 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 N--CA 1.51 2.5 0 N-CA-C 120.606 3.272 . . . . 0.0 120.606 175.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.511 2.607 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.1 pt-20 -120.36 171.08 8.78 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -101.52 120.93 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.181 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 p -97.8 -52.84 3.6 Favored 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.837 -1.529 . . . . 0.0 111.279 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -123.27 104.98 9.47 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 122.978 1.37 . . . . 0.0 113.882 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.63 93.29 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.175 -1.578 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -38.23 90.12 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 26' ' ' ASP . 3.4 t -126.49 160.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -134.51 -175.63 3.94 Favored 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.37 91.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 113.83 -1.532 . . . . 0.0 112.114 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.36 -4.23 13.61 Favored Glycine 1 N--CA 1.52 4.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.326 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HB2' HG13 ' A' ' 22' ' ' VAL . 23.8 m-20 -93.07 143.32 26.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.242 1.02 . . . . 0.0 111.697 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -76.4 122.9 25.15 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 124.71 2.195 . . . . 0.0 115.935 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.48 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 59.1 t -110.81 125.26 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.593 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -132.23 150.7 52.1 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 111.925 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -44.05 157.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.49 -20.05 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' ALA . 30.0 tt0 -74.42 148.11 41.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -84.89 124.14 31.28 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.483 1.135 . . . . 0.0 108.592 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.434 HD11 ' HA ' ' A' ' 48' ' ' ALA . 2.9 mt -85.35 -57.57 3.02 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 122.652 1.215 . . . . 0.0 110.191 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -143.98 151.61 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -102.4 138.94 38.67 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.3 m -129.96 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 N--CA 1.512 2.669 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 N--CA 1.515 2.799 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.17 148.26 33.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.039 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 14.0 mp0 -114.64 151.57 33.33 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 123.511 1.624 . . . . 0.0 114.457 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.0 t -112.7 105.88 55.72 Favored Pre-proline 0 N--CA 1.506 2.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -86.33 179.81 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.87 1.529 . . . . 0.0 112.276 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -71.31 107.36 2.62 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -49.52 -26.4 12.36 Favored 'Trans proline' 0 N--CA 1.514 2.697 0 C-N-CA 122.22 1.947 . . . . 0.0 113.757 -176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -164.97 -175.7 3.85 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 163.97 12.4 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.2 -144.83 15.78 Favored Glycine 1 N--CA 1.528 4.778 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.879 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.03 169.76 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 CA-C-N 118.879 1.339 . . . . 0.0 111.389 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 27.0 t -88.2 133.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.4 -53.8 3.63 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.032 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.29 159.42 19.9 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 124.672 1.233 . . . . 0.0 110.726 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -155.31 130.3 9.41 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -100.76 29.97 4.25 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.935 -1.103 . . . . 0.0 109.768 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.421 ' C ' HD21 ' A' ' 60' ' ' ASN . 29.4 m -119.4 157.33 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 112.71 -2.041 . . . . 0.0 114.005 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.421 HD21 ' C ' ' A' ' 59' ' ' VAL . 1.6 m-80 -131.94 -178.42 4.88 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.5 t -90.19 106.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 1 N-CA-C 99.059 -4.423 . . . . 0.0 99.059 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.22 28.59 2.15 Favored Glycine 0 N--CA 1.515 3.919 0 CA-C-N 108.991 -3.731 . . . . 0.0 110.591 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -119.71 164.9 15.23 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -106.08 141.31 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 119.857 3.28 . . . . 0.0 119.857 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.19 -179.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.92 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.2 pttt 149.94 154.59 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.923 0 C-N-CA 125.715 1.606 . . . . 0.0 111.656 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.1 p -25.09 103.59 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 118.515 2.784 . . . . 0.0 118.515 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.14 -47.8 1.0 Allowed Glycine 0 N--CA 1.507 3.415 0 CA-C-N 111.711 -2.495 . . . . 0.0 112.491 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.1 t -50.12 123.9 9.19 Favored 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.953 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.56 67.39 0.76 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mt -22.75 -58.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 8.8 ptp -169.66 -173.67 1.69 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.414 -2.176 . . . . 0.0 115.488 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.52 133.51 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.501 1.143 . . . . 0.0 110.731 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 5' ' ' VAL . 12.1 m-30 -112.64 176.2 5.12 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.271 7.3 tp10 -144.37 99.54 3.39 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 CA--C 1.569 1.693 1 N-CA-C 126.853 5.872 . . . . 0.0 126.853 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 124.03 1.872 . . . . 0.0 114.091 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -118.74 122.62 42.89 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.778 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -68.4 155.65 39.4 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.977 0.894 . . . . 0.0 110.267 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 74' ' ' PHE . 36.9 t -122.87 100.18 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.45 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -98.24 96.56 8.16 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.421 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.6 t -20.75 122.71 0.1 Allowed Pre-proline 0 N--CA 1.511 2.58 0 CA-C-N 113.093 -1.867 . . . . 0.0 114.858 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.504 2.127 0 C-N-CA 122.262 1.975 . . . . 0.0 116.346 -178.227 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.512 2.672 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.9 pt-20 -107.32 166.52 10.58 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 t -94.86 116.29 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.226 1.012 . . . . 0.0 112.456 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -94.65 -32.23 13.48 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 113.78 -1.555 . . . . 0.0 111.726 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.4 OUTLIER -138.54 107.64 6.05 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.828 0.705 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.3 p -86.74 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 118.43 -2.669 . . . . 0.0 117.088 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.3 mmt -20.3 -51.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG22 HE22 ' A' ' 32' ' ' GLN . 2.9 t -111.97 151.54 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 23.4 mtmt -134.07 -177.62 4.66 Favored 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.24 94.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.246 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.9 -7.1 17.36 Favored Glycine 1 N--CA 1.516 4.021 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -92.48 142.54 27.3 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.251 1.024 . . . . 0.0 110.477 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -69.82 127.25 32.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.653 2.644 . . . . 0.0 117.193 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 48' ' ' ALA . 1.5 t -112.66 98.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 109.86 -3.336 . . . . 0.0 113.906 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.85 146.96 37.97 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.75 -1.219 . . . . 0.0 112.42 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.02 124.16 20.04 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 118.89 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 128.358 3.536 . . . . 0.0 110.62 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.478 HE22 HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.09 147.38 22.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.417 -1.427 . . . . 0.0 108.997 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 2.2 t -80.48 80.94 6.85 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 48' ' ' ALA . 2.0 mt -29.99 -57.25 0.18 Allowed 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.8 pt -149.41 156.76 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 112.591 -2.095 . . . . 0.0 110.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 87.2 m -106.15 131.75 53.03 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 23.0 m -129.96 154.88 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 N--CA 1.505 2.29 0 CA-C-O 123.721 1.725 . . . . 0.0 113.372 179.464 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.513 2.682 0 CA-C-O 121.13 0.49 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.3 mtm -106.34 165.81 10.98 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -102.12 145.28 29.58 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.54 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.5 t -117.81 97.2 50.55 Favored Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.861 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 7.1 Cg_endo -73.95 175.02 11.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-O 125.154 2.064 . . . . 0.0 111.584 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -77.04 109.06 7.9 Favored Pre-proline 0 C--N 1.284 -2.276 0 CA-C-N 111.527 -2.578 . . . . 0.0 117.262 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -47.08 -32.03 12.67 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.794 2.329 . . . . 0.0 111.707 -170.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -155.73 -178.35 7.23 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 111.932 -2.395 . . . . 0.0 107.318 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.97 159.68 14.78 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.51 -147.68 19.39 Favored Glycine 1 N--CA 1.531 4.971 0 C-N-CA 123.828 0.728 . . . . 0.0 112.663 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 162.16 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 CA-C-N 119.029 1.415 . . . . 0.0 109.521 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 24.9 t -82.25 102.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.844 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -76.79 -47.8 20.51 Favored 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.482 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 5.4 tt0 -161.33 152.58 18.71 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -149.69 150.67 32.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.592 -1.942 . . . . 0.0 108.489 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 6.0 mttp -115.34 47.28 1.33 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 121.785 0.802 . . . . 0.0 111.246 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -139.49 140.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 113.688 -1.597 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -125.45 -170.44 2.18 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.132 1.444 . . . . 0.0 110.49 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.43 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.78 9.05 4.98 Favored Glycine 1 N--CA 1.517 4.097 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.577 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -101.57 157.3 16.92 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -111.45 146.49 37.12 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.49 168.15 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 113.01 -1.905 . . . . 0.0 113.908 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.31 147.34 22.16 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 t -47.37 122.6 4.79 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.936 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.06 16.94 24.16 Favored Glycine 0 N--CA 1.514 3.835 0 O-C-N 121.353 -0.842 . . . . 0.0 114.96 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -107.02 97.03 6.86 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.796 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.22 87.64 7.19 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 123.592 1.663 . . . . 0.0 112.575 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.465 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -112.4 -26.54 3.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.952 -1.931 . . . . 0.0 116.046 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 5' ' ' VAL . 11.3 ttp -100.56 153.99 18.93 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.605 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.2 126.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 124.957 2.313 . . . . 0.0 115.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.47 ' CD1' HG22 ' A' ' 5' ' ' VAL . 17.8 m-30 -114.5 158.52 21.5 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.475 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -140.4 135.75 32.4 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.298 -1.65 0 CA-C-O 122.074 0.94 . . . . 0.0 113.199 -179.581 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 80.4 t . . . . . 0 N--CA 1.518 2.928 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -129.91 162.14 29.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.973 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 2.4 pm0 -105.12 153.34 21.64 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 74' ' ' PHE . 46.6 t -133.18 97.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.951 1.358 . . . . 0.0 113.716 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.7 p-10 -103.51 177.46 4.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.453 HG22 ' CG2' ' A' ' 65' ' ' VAL . 79.0 t -104.29 142.02 23.73 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.493 1.493 0 C-N-CA 123.114 2.543 . . . . 0.0 113.633 176.752 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.505 2.296 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 64' ' ' LYS 0.342 89.9 mt-10 -87.21 -179.43 6.43 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 179.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.69 115.73 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -46.15 9.53 Favored 'General case' 0 N--CA 1.522 3.161 0 CA-C-N 120.343 1.428 . . . . 0.0 110.24 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 45.8 mt-10 -134.68 100.72 4.71 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.058 1.409 . . . . 0.0 113.516 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 61' ' ' VAL . 13.8 p -82.14 58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 122.234 1.016 . . . . 0.0 111.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.1 mmt -22.08 -52.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.09 171.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 120.663 3.579 . . . . 0.0 120.663 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -134.28 -162.17 1.22 Allowed 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 120.541 3.534 . . . . 0.0 120.541 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.12 92.96 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.984 0 O-C-N 119.938 -1.726 . . . . 0.0 113.898 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.39 12.37 13.56 Favored Glycine 1 N--CA 1.517 4.038 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.93 178.08 7.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.016 -1.592 . . . . 0.0 115.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -95.72 142.77 27.62 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG13 ' CD2' ' A' ' 74' ' ' PHE . 1.8 t -145.93 113.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.706 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -132.24 151.92 51.59 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.98 79.12 0.22 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 124.035 1.874 . . . . 0.0 114.945 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CD ' ' N ' ' A' ' 32' ' ' GLN . 2.9 pp20? 166.77 -35.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 109.443 -3.526 . . . . 0.0 108.962 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 4.4 tt0 -58.99 80.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.254 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -31.66 70.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -24.27 -67.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.6 pt -151.43 141.87 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.292 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 20.5 m -99.09 139.94 33.99 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.79 146.08 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.578 ' CD ' ' HG ' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.514 2.765 0 N-CA-C 118.678 2.844 . . . . 0.0 118.678 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.578 ' HG ' ' CD ' ' A' ' 38' ' ' GLU . 1.2 m . . . . . 0 N--CA 1.516 2.874 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.8 mmt -125.76 150.6 47.61 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 122.363 0.265 . . . . 0.0 111.663 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -125.15 152.06 44.96 Favored 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -134.7 124.21 16.69 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.267 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -88.43 176.95 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.966 1.777 . . . . 0.0 111.592 171.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -53.31 117.35 11.52 Favored Pre-proline 0 CA--C 1.584 2.285 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -48.85 -21.43 3.71 Favored 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 122.391 2.061 . . . . 0.0 114.235 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -169.92 -174.23 1.76 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.586 -2.097 . . . . 0.0 109.871 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.6 163.82 12.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.18 -152.13 19.89 Favored Glycine 0 N--CA 1.512 3.754 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.042 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.86 164.13 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' CE1' ' A' ' 74' ' ' PHE . 44.9 t -94.56 145.79 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.836 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.469 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 19.0 tttp -112.83 -73.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.58 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 47.7 tt0 -142.42 128.73 19.95 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.8 pt? -122.31 124.81 44.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.58 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.7 mptt -104.86 43.33 1.11 Allowed 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.21 157.41 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-N 114.095 -1.411 . . . . 0.0 114.453 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -144.45 171.44 14.35 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 20' ' ' VAL . 33.5 t -88.74 103.63 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 101.782 -3.414 . . . . 0.0 101.782 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.98 12.91 2.81 Favored Glycine 1 N--CA 1.519 4.18 0 CA-C-N 108.657 -3.883 . . . . 0.0 111.958 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 26.1 t70 -120.39 163.49 17.8 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 111.682 -2.259 . . . . 0.0 107.283 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.22 152.67 22.57 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -136.39 170.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 110.632 -2.985 . . . . 0.0 110.029 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 67' ' ' THR . 15.4 ptmt -171.63 160.55 5.82 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.432 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 9.2 t -56.53 127.46 31.33 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 114.724 -2.79 . . . . 0.0 110.897 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.33 -41.22 2.27 Favored Glycine 0 N--CA 1.509 3.519 0 N-CA-C 117.439 1.736 . . . . 0.0 117.439 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 58.8 m -60.02 127.73 33.34 Favored 'General case' 0 N--CA 1.524 3.228 0 CA-C-N 119.627 1.713 . . . . 0.0 114.225 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.459 ' N ' HD13 ' A' ' 70' ' ' LEU . 8.4 mp -79.13 65.13 4.22 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-O 122.645 1.212 . . . . 0.0 111.649 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.53 HG23 ' SD ' ' A' ' 72' ' ' MET . 40.0 mm -33.49 -54.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.53 ' SD ' HG23 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -148.6 175.91 10.78 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.52 134.05 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.685 0.755 . . . . 0.0 110.665 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.546 ' CD2' HG13 ' A' ' 28' ' ' VAL . 14.6 m-30 -113.48 165.97 11.96 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.894 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.469 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 16.9 tp10 -130.81 80.91 1.97 Allowed 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 123.964 1.84 . . . . 0.0 109.426 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 118.029 2.604 . . . . 0.0 118.029 179.354 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HZ1' ' CD ' ' A' ' 4' ' ' GLU . 2.3 mmtt -114.65 161.88 17.52 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.988 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 3' ' ' LYS . 1.2 pm0 -107.31 156.21 19.13 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 123.362 1.553 . . . . 0.0 114.257 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.5 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 74.6 t -137.5 111.64 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 124.655 2.169 . . . . 0.0 113.275 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.4 p-10 -97.53 166.16 11.64 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 111.981 -2.372 . . . . 0.0 106.28 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.16 135.95 29.32 Favored Pre-proline 0 C--N 1.29 -1.99 0 C-N-CA 117.607 -1.637 . . . . 0.0 109.413 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.488 ' C ' ' HG1' ' A' ' 67' ' ' THR . 9.4 Cg_endo . . . . . 0 C--N 1.312 -1.346 0 C-N-CA 121.903 1.736 . . . . 0.0 110.961 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG21 HG21 ' A' ' 65' ' ' VAL . 2.5 m . . . . . 0 N--CA 1.509 2.482 0 CA-C-O 120.976 0.417 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -120.98 172.1 8.17 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.306 -0.871 . . . . 0.0 109.212 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.12 140.75 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.067 0 CA-C-O 123.195 1.474 . . . . 0.0 112.529 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 76.1 p -116.96 -45.94 2.75 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.97 112.94 15.84 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.919 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.8 65.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 124.193 1.949 . . . . 0.0 110.874 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.1 mmt -26.92 -44.85 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.379 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.35 162.94 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -128.63 -165.59 1.52 Allowed 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.8 t -70.23 111.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 O-C-N 120.75 -1.219 . . . . 0.0 108.998 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.32 -0.41 35.05 Favored Glycine 1 N--CA 1.52 4.298 0 O-C-N 124.113 0.883 . . . . 0.0 113.0 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.75 145.42 24.42 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.67 114.11 10.44 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.409 HG12 ' CE2' ' A' ' 74' ' ' PHE . 6.6 t -107.82 110.4 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.072 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.424 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.673 -1.267 . . . . 0.0 110.954 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -41.77 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.319 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.924 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -18.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 30' ' ' ALA . 1.2 tm0? -84.71 108.76 17.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 p -40.13 118.21 0.87 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 120.182 3.401 . . . . 0.0 120.182 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 4.8 mt -86.01 -60.98 1.86 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.5 pt -145.82 150.2 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.2 m -102.05 131.22 48.63 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.4 m -121.66 137.31 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 122.09 0.947 . . . . 0.0 112.262 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.516 2.833 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.1 mtt -145.12 152.66 40.41 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -112.14 138.7 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.969 1.842 . . . . 0.0 113.865 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.5 t -112.28 112.57 52.0 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -86.24 177.06 4.69 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 122.08 1.854 . . . . 0.0 110.167 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -62.85 98.25 0.14 Allowed Pre-proline 0 C--N 1.286 -2.162 1 N-CA-C 123.17 4.507 . . . . 0.0 123.17 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -34.51 -42.04 0.28 Allowed 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.827 2.351 . . . . 0.0 113.388 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -146.36 -173.9 4.31 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 109.916 -3.311 . . . . 0.0 111.389 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.8 154.44 19.58 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.5 -174.02 22.22 Favored Glycine 1 N--CA 1.523 4.451 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.734 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.96 162.01 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 CA-C-N 121.29 2.545 . . . . 0.0 113.307 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.58 121.07 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.24 -49.82 5.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.682 0.674 . . . . 0.0 111.722 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.462 ' OE2' ' CE ' ' A' ' 58' ' ' LYS . 45.9 tt0 -153.69 162.78 40.94 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.211 0.529 . . . . 0.0 112.086 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 57' ' ' LEU . 1.8 pt? -171.44 146.64 2.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.074 -1.016 . . . . 0.0 109.783 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' CE ' ' OE2' ' A' ' 56' ' ' GLU . 83.4 mttt -123.46 52.59 1.4 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 p -121.33 164.47 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.317 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -137.54 163.32 31.47 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -95.11 73.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-O 126.833 3.206 . . . . 0.0 109.519 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.92 39.16 0.12 Allowed Glycine 0 N--CA 1.509 3.508 1 CA-C-N 106.196 -5.002 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -120.31 174.39 6.55 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -114.19 136.74 52.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 -179.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 71' ' ' ILE . 1.3 m -117.61 165.81 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.682 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -147.94 139.32 23.61 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 116.66 -1.638 . . . . 0.0 107.095 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.488 ' HG1' ' C ' ' A' ' 8' ' ' PRO . 8.9 t -53.98 125.89 20.45 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.637 -2.425 . . . . 0.0 110.279 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.7 -39.54 2.76 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 112.962 -1.926 . . . . 0.0 114.142 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.4 t -52.03 120.73 5.69 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.08 64.22 1.35 Allowed 'General case' 0 N--CA 1.525 3.294 0 CA-C-O 124.161 1.934 . . . . 0.0 111.975 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.475 ' CD1' HG11 ' A' ' 65' ' ' VAL . 18.8 mm -46.37 -44.55 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 120.858 3.651 . . . . 0.0 120.858 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.6 ptm -141.21 157.71 44.88 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.808 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.36 129.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 122.275 1.036 . . . . 0.0 110.882 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.5 ' CZ ' HG22 ' A' ' 5' ' ' VAL . 13.1 m-30 -97.61 -171.44 2.19 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -157.04 80.77 0.92 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.556 1.179 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.238 179.734 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.505 2.312 0 N-CA-C 120.274 3.435 . . . . 0.0 120.274 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -126.39 107.17 10.04 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.332 -2.213 . . . . 0.0 109.988 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.89 148.13 40.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.316 -0.865 . . . . 0.0 111.068 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG23 ' CD1' ' A' ' 74' ' ' PHE . 20.4 t -110.73 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 CA-C-O 123.014 1.387 . . . . 0.0 113.918 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -89.83 161.76 15.83 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.955 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.454 HG22 ' CG2' ' A' ' 65' ' ' VAL . 89.9 t -97.9 128.91 32.47 Favored Pre-proline 0 C--N 1.292 -1.909 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.792 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.404 ' C ' ' HG1' ' A' ' 67' ' ' THR . 53.1 Cg_exo . . . . . 0 N--CA 1.501 1.957 0 C-N-CA 121.203 1.269 . . . . 0.0 115.131 169.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.505 2.324 0 CA-C-O 120.837 0.351 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.649 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 11.9 pt-20 -123.36 166.86 14.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.5 t -89.75 128.78 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 55.5 p -102.03 -44.59 5.43 Favored 'General case' 0 N--CA 1.512 2.656 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.786 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -134.84 103.53 5.65 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.515 HG12 ' HZ3' ' A' ' 23' ' ' LYS . 9.0 p -82.4 79.59 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 124.172 1.939 . . . . 0.0 110.46 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 mmt -43.9 -45.42 7.58 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 111.708 -2.496 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.24 158.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.515 ' HZ3' HG12 ' A' ' 20' ' ' VAL . 8.8 mptt -130.91 -177.79 4.53 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-O 125.106 2.384 . . . . 0.0 117.434 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.77 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 112.708 -2.042 . . . . 0.0 114.341 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.49 17.18 5.3 Favored Glycine 1 N--CA 1.52 4.248 0 CA-C-N 114.701 -1.136 . . . . 0.0 114.635 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -96.97 141.48 30.09 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 122.656 1.217 . . . . 0.0 113.799 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 53' ' ' VAL . 52.6 mmtt -71.35 97.62 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.122 1.439 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.466 HG12 ' CE2' ' A' ' 74' ' ' PHE . 65.1 t -102.18 107.23 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 113.62 -1.627 . . . . 0.0 115.335 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.49 163.39 18.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.048 -1.033 . . . . 0.0 110.32 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.96 166.24 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.967 0.792 . . . . 0.0 112.795 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 62.17 -26.27 0.06 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -74.5 96.8 2.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.231 -1.543 . . . . 0.0 110.132 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 t -40.7 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -27.13 -67.61 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.0 pt -147.57 143.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 111.902 -2.408 . . . . 0.0 112.526 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.1 m -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.53 158.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.524 3.23 0 CA-C-O 122.599 1.19 . . . . 0.0 110.51 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 N--CA 1.519 2.977 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -116.39 160.18 20.91 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 122.629 0.372 . . . . 0.0 110.537 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -125.31 152.92 44.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.242 -0.912 . . . . 0.0 113.03 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 39.5 t -122.25 113.66 30.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -85.53 177.0 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.249 1.299 . . . . 0.0 112.499 170.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.47 95.53 0.06 OUTLIER Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -38.52 -35.29 0.45 Allowed 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 122.512 2.141 . . . . 0.0 114.073 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -154.76 -174.93 5.18 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 112.117 -2.31 . . . . 0.0 108.758 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.2 155.1 19.0 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.5 -138.61 7.29 Favored Glycine 0 N--CA 1.511 3.638 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.289 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.455 HG12 ' HD3' ' A' ' 27' ' ' LYS . 1.9 t -140.55 165.14 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.535 HG21 ' CE1' ' A' ' 74' ' ' PHE . 14.4 t -90.93 137.26 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 118.83 -1.148 . . . . 0.0 107.934 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 19.7 tptt -108.12 -59.6 1.83 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.605 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 27.3 tt0 -149.66 160.85 43.18 Favored 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.605 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -163.21 156.34 19.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.181 -0.95 . . . . 0.0 108.448 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.3 48.75 1.98 Allowed 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.985 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.22 152.35 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.044 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.23 -175.38 3.84 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 124.745 2.212 . . . . 0.0 116.277 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -86.72 114.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 113.07 4.95 23.82 Favored Glycine 0 N--CA 1.511 3.699 0 CA-C-N 108.721 -3.854 . . . . 0.0 110.028 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -79.78 177.55 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.824 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.649 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 28.2 mmtm -114.15 132.92 55.91 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 118.576 2.806 . . . . 0.0 118.576 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.454 ' CG2' HG22 ' A' ' 7' ' ' VAL . 1.3 p -132.86 169.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' N ' ' CG2' ' A' ' 65' ' ' VAL . 6.4 ptpp? -173.99 134.99 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.434 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 8' ' ' PRO . 11.3 t -33.42 116.34 0.25 Allowed 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 124.741 2.21 . . . . 0.0 113.646 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.87 -35.47 4.68 Favored Glycine 0 N--CA 1.507 3.409 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.941 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.6 m -64.86 136.76 57.22 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.61 72.23 10.7 Favored 'General case' 0 N--CA 1.522 3.138 0 CA-C-O 122.209 1.004 . . . . 0.0 109.621 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.604 HD13 ' SD ' ' A' ' 72' ' ' MET . 1.6 pp -58.11 -46.12 88.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.604 ' SD ' HD13 ' A' ' 71' ' ' ILE . 11.4 ptm -132.83 171.89 13.31 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 118.617 -1.233 . . . . 0.0 114.116 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.24 123.58 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.594 -1.316 . . . . 0.0 112.595 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CD1' HG23 ' A' ' 5' ' ' VAL . 14.8 m-30 -111.96 167.68 10.19 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.292 1.52 . . . . 0.0 113.726 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.428 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 32.7 tt0 -145.89 155.85 43.15 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.296 -1.735 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 -179.587 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.59 152.98 44.39 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -109.92 149.46 29.87 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.642 1.687 . . . . 0.0 114.731 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.516 HG23 ' CE1' ' A' ' 74' ' ' PHE . 70.2 t -122.86 114.29 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.565 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -109.9 -178.41 3.52 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.438 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 65' ' ' VAL . 59.5 t -102.19 128.63 28.0 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.016 -1.074 . . . . 0.0 113.486 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.99 179.387 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 23.0 m . . . . . 0 N--CA 1.514 2.733 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 29.3 mt-10 -93.29 163.28 13.67 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.033 1.458 . . . . 0.0 112.302 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.06 112.61 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.2 t -98.71 -37.41 9.5 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -129.92 127.65 40.55 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.55 65.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 124.526 2.108 . . . . 0.0 113.359 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.4 mmt -24.49 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 110.925 -2.852 . . . . 0.0 117.839 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.445 ' CG2' HE22 ' A' ' 32' ' ' GLN . 2.9 t -122.67 155.82 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.1 tttt -127.51 178.66 5.95 Favored 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 120.797 3.629 . . . . 0.0 120.797 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.21 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 113.716 -1.584 . . . . 0.0 113.576 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.63 1.39 19.79 Favored Glycine 1 N--CA 1.517 4.037 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.891 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -90.32 150.54 21.87 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.651 1.215 . . . . 0.0 113.092 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -75.94 112.6 12.52 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.892 0.853 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -106.61 101.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.437 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -105.89 151.13 24.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.306 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.19 157.85 0.42 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.564 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 69.5 -26.24 0.15 Allowed 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 122.658 1.218 . . . . 0.0 112.961 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.445 HE22 ' CG2' ' A' ' 22' ' ' VAL . 4.5 tm0? -80.15 102.13 9.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.223 -1.548 . . . . 0.0 109.471 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.2 t -33.25 124.99 0.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 HD11 ' HA ' ' A' ' 48' ' ' ALA . 3.8 mt -93.6 -52.71 4.35 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 110.711 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 pt -144.26 134.69 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.9 m -92.1 120.68 32.94 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 102.789 -3.041 . . . . 0.0 102.789 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.1 m -109.02 147.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 N--CA 1.512 2.637 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -179.724 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.513 2.709 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ttm -143.22 171.04 14.63 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -130.32 153.02 49.1 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.45 105.31 15.97 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.48 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -81.73 178.73 6.28 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 CA-C-O 123.612 1.421 . . . . 0.0 112.276 177.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -66.0 117.08 38.97 Favored Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -49.63 -22.31 6.5 Favored 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 123.186 2.591 . . . . 0.0 114.968 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -171.52 -174.06 1.33 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 113.232 -1.804 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.56 119.1 38.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 -165.37 32.62 Favored Glycine 0 N--CA 1.513 3.769 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.44 154.37 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 CA-C-N 118.205 1.003 . . . . 0.0 109.204 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 24.3 t -78.8 121.18 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -97.37 -56.72 2.45 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.754 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 31.0 tt0 -149.08 150.53 32.9 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.997 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -146.23 163.77 34.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.075 -1.641 . . . . 0.0 108.869 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.465 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 8.4 mmtp -133.89 42.6 2.92 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.24 154.02 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-N 113.969 -1.468 . . . . 0.0 114.071 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -130.78 -175.93 3.83 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-O 125.542 2.592 . . . . 0.0 116.089 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.14 109.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 1 N-CA-C 99.135 -4.394 . . . . 0.0 99.135 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.47 -27.26 3.12 Favored Glycine 0 N--CA 1.508 3.443 0 CA-C-N 111.518 -2.583 . . . . 0.0 107.532 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -72.95 159.18 34.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.341 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -115.27 143.65 44.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -131.62 161.7 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -156.02 158.27 37.55 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -27.72 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.19 -42.14 1.96 Allowed Glycine 0 N--CA 1.515 3.943 0 CA-C-N 112.944 -1.934 . . . . 0.0 114.923 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.7 m -36.0 118.39 0.51 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 mp -67.72 64.95 0.08 Allowed 'General case' 0 N--CA 1.513 2.699 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.9 mt -23.6 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.449 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptp -167.93 -176.85 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 111.361 -2.654 . . . . 0.0 115.586 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.26 122.67 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 123.495 1.617 . . . . 0.0 114.829 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CE1' HG23 ' A' ' 5' ' ' VAL . 10.7 m-30 -102.76 175.74 5.39 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 113.435 -1.711 . . . . 0.0 109.543 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.28 22.3 tp10 -144.97 109.71 5.01 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 121.398 3.851 . . . . 0.0 121.398 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.491 ' CG1' ' HZ1' ' A' ' 55' ' ' LYS . 20.4 m . . . . . 0 N--CA 1.501 2.118 1 N-CA-C 122.858 4.392 . . . . 0.0 122.858 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -127.61 160.38 31.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.428 -2.623 . . . . 0.0 106.449 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -105.29 169.16 8.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.476 1.131 . . . . 0.0 110.437 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.505 HG23 ' CD1' ' A' ' 74' ' ' PHE . 73.2 t -125.82 102.27 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 114.343 -1.298 . . . . 0.0 113.804 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.7 p-10 -99.43 163.52 12.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.1 t -75.4 138.09 71.3 Favored Pre-proline 0 N--CA 1.502 2.127 0 C-N-CA 116.862 -1.935 . . . . 0.0 110.503 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.493 1.464 0 C-N-CA 122.098 1.866 . . . . 0.0 112.675 177.21 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.507 2.399 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.0 pt-20 -113.56 167.46 10.58 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 t -84.42 119.43 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 t -100.77 -36.76 8.98 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.81 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.03 117.5 16.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.41 59.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.0 mmt -18.98 -45.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.8 155.77 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 22.3 mttt -140.72 -169.34 2.78 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 121.666 3.95 . . . . 0.0 121.666 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -51.49 84.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.08 -0.25 14.69 Favored Glycine 1 N--CA 1.519 4.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -89.1 139.83 30.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.883 1.801 . . . . 0.0 113.018 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -62.77 74.22 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 112.534 -2.121 . . . . 0.0 116.459 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -74.0 97.77 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.73 156.88 17.23 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.337 -1.477 . . . . 0.0 108.958 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -58.27 168.81 0.97 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.999 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.71 -24.66 0.08 Allowed 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 30' ' ' ALA . 3.7 tm0? -82.42 109.07 16.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 123.231 1.491 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 10.1 m -35.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 120.927 3.677 . . . . 0.0 120.927 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.419 HD11 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -24.77 -58.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 pt -146.14 150.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.92 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 96.7 m -102.52 124.93 48.96 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.4 m -110.8 154.0 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.51 2.572 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.511 2.583 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 mtm -132.81 164.33 27.08 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -122.19 148.73 44.58 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.062 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.0 t -122.76 116.21 29.18 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.16 172.32 13.97 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 CA-C-O 124.455 1.773 . . . . 0.0 110.347 176.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -76.34 117.05 61.59 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 111.84 -2.436 . . . . 0.0 115.377 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -39.34 -37.45 1.14 Allowed 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.008 2.472 . . . . 0.0 113.632 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.34 -174.16 4.55 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 110.963 -2.835 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.14 152.39 18.39 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.69 -150.14 22.33 Favored Glycine 1 N--CA 1.517 4.085 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.843 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.11 157.5 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 O-C-N 121.768 -0.842 . . . . 0.0 112.15 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 30.4 t -83.02 128.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 C-N-CA 118.091 -1.444 . . . . 0.0 107.662 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 81.1 tttt -106.26 -72.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 38.4 tt0 -127.36 123.28 35.86 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 123.368 1.556 . . . . 0.0 111.314 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.405 ' H ' HD22 ' A' ' 57' ' ' LEU . 2.0 pt? -129.07 146.49 51.01 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.548 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 87.8 mttt -127.95 53.16 1.81 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.82 137.58 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 110.204 -3.18 . . . . 0.0 111.051 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.555 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.3 m120 -120.37 -171.33 2.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.741 2.21 . . . . 0.0 114.683 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.65 87.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 125.978 2.799 . . . . 0.0 106.422 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.07 24.35 0.23 Allowed Glycine 0 N--CA 1.516 3.97 1 CA-C-N 106.715 -4.766 . . . . 0.0 112.809 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -106.22 152.15 23.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -102.6 145.27 29.89 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.15 163.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.989 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -166.0 145.89 6.32 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.037 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -36.74 116.14 0.41 Allowed 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.403 1.573 . . . . 0.0 112.426 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.28 -52.18 0.73 Allowed Glycine 0 N--CA 1.511 3.665 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.951 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 16.4 t -45.74 128.18 8.44 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.39 60.24 0.62 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.7 mt -18.94 -60.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 119.031 2.974 . . . . 0.0 119.031 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -167.42 -172.51 1.97 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 112.321 -2.218 . . . . 0.0 115.238 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.08 130.42 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 124.414 2.054 . . . . 0.0 112.691 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.505 ' CD1' HG23 ' A' ' 5' ' ' VAL . 13.2 m-30 -117.49 145.88 43.9 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 111.804 -2.453 . . . . 0.0 113.202 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.513 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 8.4 tt0 -124.2 162.58 23.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 119.733 3.234 . . . . 0.0 119.733 -179.273 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m . . . . . 0 N--CA 1.512 2.655 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.62 149.06 33.83 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 111.549 -2.569 . . . . 0.0 111.376 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -97.4 104.2 16.2 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.492 1.139 . . . . 0.0 113.773 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 77.1 t -71.22 99.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 CA-C-O 124.8 2.238 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 69' ' ' SER . 5.8 p30 -96.05 177.4 5.75 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.631 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 67' ' ' THR . 78.2 t -98.01 131.82 25.85 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 C--N 1.311 -1.41 0 C-N-CA 120.708 0.939 . . . . 0.0 114.048 179.266 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.533 3.712 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.9 pt-20 -111.3 169.55 8.72 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.17 114.11 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -93.67 -44.79 8.0 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 112.84 -1.982 . . . . 0.0 114.859 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' HG3' HG23 ' A' ' 18' ' ' THR . 36.0 mt-10 -131.16 102.77 6.14 Favored 'General case' 0 N--CA 1.52 3.036 0 CA-C-N 119.866 1.212 . . . . 0.0 111.452 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.28 72.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 O-C-N 119.284 -2.135 . . . . 0.0 113.498 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.465 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 57.1 mmm -34.65 -52.28 0.51 Allowed 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.65 150.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 CA-C-N 119.574 1.079 . . . . 0.0 113.55 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -123.33 169.28 11.48 Favored 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -54.59 87.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.292 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 127.32 9.62 4.03 Favored Glycine 1 N--CA 1.517 4.046 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -92.24 140.22 29.83 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.69 1.234 . . . . 0.0 111.91 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.66 86.2 2.71 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 126.839 2.056 . . . . 0.0 109.162 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.64 149.3 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -140.59 154.6 46.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' ALA . . . -69.11 99.19 1.08 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 139.81 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 127.784 3.177 . . . . 0.0 108.185 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -71.3 105.8 3.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 112.708 -2.042 . . . . 0.0 113.665 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 16.6 t -39.03 96.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 112.569 -2.105 . . . . 0.0 115.554 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' VAL . 4.2 mt -53.52 -62.8 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' H ' HG22 ' A' ' 46' ' ' VAL . 25.6 pt -147.91 128.8 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.906 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 19' ' ' GLU . 5.2 m -67.87 129.79 40.99 Favored 'General case' 0 N--CA 1.517 2.917 0 O-C-N 119.965 -1.709 . . . . 0.0 111.066 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.6 m -119.67 151.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.707 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 43' ' ' SER . 3.4 tt0 . . . . . 0 N--CA 1.515 2.781 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 92.7 p . . . . . 0 N--CA 1.51 2.554 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.0 mtm -139.55 164.71 29.17 Favored 'General case' 0 N--CA 1.516 2.872 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -120.3 168.52 11.18 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 123.148 1.451 . . . . 0.0 114.19 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -115.74 129.42 25.17 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.64 168.74 11.04 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-O 123.384 1.327 . . . . 0.0 109.935 168.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 30' ' ' ALA . . . -74.98 117.19 60.83 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 112.859 -1.973 . . . . 0.0 115.065 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -48.62 -25.75 8.33 Favored 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.011 1.807 . . . . 0.0 114.016 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.41 ' HA ' ' HB1' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -158.08 -173.37 4.31 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.896 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.71 165.86 10.83 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.1 -153.61 21.01 Favored Glycine 1 N--CA 1.522 4.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 113.538 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.07 153.51 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 41.3 t -77.14 84.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -61.83 -44.64 96.43 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.644 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.578 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 28.3 tt0 -176.46 159.23 1.91 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 124.005 0.815 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.509 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.7 pt? -154.76 159.77 40.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.323 -0.861 . . . . 0.0 109.703 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.578 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 29.8 mmtt -126.33 45.82 2.58 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.16 161.93 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.69 171.4 9.62 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 125.367 2.508 . . . . 0.0 116.952 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.86 100.15 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 1 N-CA-C 99.784 -4.154 . . . . 0.0 99.784 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.14 19.97 0.95 Allowed Glycine 0 N--CA 1.51 3.576 1 CA-C-N 107.305 -4.498 . . . . 0.0 111.84 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.18 170.43 8.1 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.482 0.713 . . . . 0.0 109.278 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -103.43 143.65 32.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.778 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 m -132.52 127.49 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 67' ' ' THR . 26.1 ttmt -139.98 151.54 45.59 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.471 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 7.6 t -42.21 118.5 1.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 117.271 -1.772 . . . . 0.0 111.495 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.23 -51.36 0.78 Allowed Glycine 0 N--CA 1.513 3.793 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m -39.51 119.55 0.96 Allowed 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.62 65.47 1.82 Allowed 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 123.065 1.412 . . . . 0.0 111.346 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 mm -48.78 -57.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 120.729 3.604 . . . . 0.0 120.729 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.9 ptp -135.49 166.89 22.15 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.346 -0.846 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -110.47 122.51 65.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.811 1.291 . . . . 0.0 112.253 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.51 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 7.5 m-30 -117.07 149.27 40.58 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.96 127.48 36.43 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.469 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.302 -1.483 1 N-CA-C 122.142 4.127 . . . . 0.0 122.142 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.509 2.485 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.498 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 3.1 mmmp? -134.17 166.5 22.62 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.129 1.443 . . . . 0.0 110.886 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' NZ ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -107.56 157.32 18.14 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.296 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.443 HG23 ' CD1' ' A' ' 74' ' ' PHE . 58.9 t -126.08 106.98 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 CA-C-O 121.883 0.849 . . . . 0.0 111.504 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -101.87 152.85 20.41 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' A' ' 65' ' ' VAL . 99.2 t -71.33 132.29 86.06 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 116.877 -1.929 . . . . 0.0 112.197 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 CA--C 1.557 1.643 0 C-N-CA 122.616 2.211 . . . . 0.0 115.329 172.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.504 2.235 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 34.5 mt-10 -96.31 164.19 12.76 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.747 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 t -103.4 116.25 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.099 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 2.1 t -96.8 -41.96 8.2 Favored 'General case' 0 N--CA 1.524 3.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.765 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -131.99 105.21 7.27 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.947 0.879 . . . . 0.0 110.855 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.45 63.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 O-C-N 119.087 -2.258 . . . . 0.0 115.261 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.6 mmm -23.17 -42.44 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 119.403 3.112 . . . . 0.0 119.403 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.74 155.26 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.6 tttm -131.46 175.33 9.24 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 120.551 3.537 . . . . 0.0 120.551 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.47 91.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.28 0.38 12.76 Favored Glycine 1 N--CA 1.516 4.03 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.775 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -93.27 143.65 26.07 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.58 1.181 . . . . 0.0 112.706 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -66.33 121.77 16.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.15 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.6 t -116.04 115.19 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.894 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -122.91 151.42 41.78 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.696 -0.628 . . . . 0.0 111.282 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -48.02 158.26 0.24 Allowed 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 69.51 -28.42 0.16 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 122.541 1.162 . . . . 0.0 112.753 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 30' ' ' ALA . 6.4 tt0 -77.35 105.13 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.316 -1.49 . . . . 0.0 111.575 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 19.8 t -37.92 120.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.469 HD11 ' HA ' ' A' ' 48' ' ' ALA . 2.8 mt -85.78 -51.03 6.69 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.1 pt -146.79 137.35 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.958 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -84.32 128.26 34.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 34.4 m -119.35 160.77 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 N--CA 1.513 2.708 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.8 mtt -129.74 174.29 9.85 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -124.81 153.81 41.93 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 122.115 0.96 . . . . 0.0 113.512 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.1 t -121.03 104.42 41.44 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.525 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.5 OUTLIER -80.18 177.63 8.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 CA-C-O 123.779 1.491 . . . . 0.0 111.087 179.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -71.89 111.49 10.79 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -46.11 -28.52 5.48 Favored 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 121.884 1.723 . . . . 0.0 113.049 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -163.05 -173.51 3.47 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.112 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.89 160.78 14.51 Favored 'General case' 0 CA--C 1.579 2.07 1 N-CA-C 121.879 4.029 . . . . 0.0 121.879 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.95 -124.26 3.06 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 114.577 -1.192 . . . . 0.0 114.096 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.48 159.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.206 0 O-C-N 121.996 -0.708 . . . . 0.0 111.305 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.549 HG11 ' SD ' ' A' ' 72' ' ' MET . 67.6 t -80.85 112.0 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 28.3 tttm -89.94 -64.55 1.12 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.431 -1.308 . . . . 0.0 110.045 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.507 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 42.4 tt0 -145.07 133.77 22.2 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.3 pt? -130.53 163.13 27.72 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.532 -1.98 . . . . 0.0 109.314 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.507 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 14.1 mmtp -133.64 42.02 3.0 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 p -132.26 159.61 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.942 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -126.19 177.65 6.27 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -94.03 108.81 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 1 N-CA-C 97.752 -4.907 . . . . 0.0 97.752 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.2 6.05 6.45 Favored Glycine 0 N--CA 1.515 3.908 0 CA-C-N 109.898 -3.319 . . . . 0.0 109.784 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.71 156.84 16.17 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.451 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.72 144.38 41.11 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 7' ' ' VAL . 14.2 m -138.4 172.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -178.0 156.63 1.07 Allowed 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.2 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -26.73 101.4 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 118.644 2.831 . . . . 0.0 118.644 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.79 -53.02 0.69 Allowed Glycine 0 N--CA 1.511 3.697 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.073 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.1 m -21.85 117.2 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.36 59.49 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.41 HG23 ' HG2' ' A' ' 72' ' ' MET . 4.3 mm -34.5 -58.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.549 ' SD ' HG11 ' A' ' 54' ' ' VAL . 5.1 ptp -174.43 -170.81 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.261 -1.79 . . . . 0.0 113.757 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -116.7 130.28 71.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-O 124.026 1.87 . . . . 0.0 107.883 178.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 8.9 m-30 -112.69 161.65 16.62 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.835 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -134.36 137.19 43.95 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 C--N 1.294 -1.822 0 CA-C-O 124.552 2.12 . . . . 0.0 116.047 -179.727 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.518 2.928 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.68 160.65 26.74 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 123.826 0.704 . . . . 0.0 110.008 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -108.4 169.32 8.72 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.522 HG23 ' CE1' ' A' ' 74' ' ' PHE . 39.5 t -134.91 117.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -106.33 166.67 10.37 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.412 ' CG2' HG12 ' A' ' 71' ' ' ILE . 48.1 t -85.73 140.53 35.6 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 121.38 1.387 . . . . 0.0 112.879 171.511 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.3 m . . . . . 0 N--CA 1.515 2.822 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -110.85 171.33 7.53 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 124.207 0.942 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 t -107.04 115.11 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.541 -0.724 . . . . 0.0 111.758 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 27.7 p -97.01 -50.38 4.64 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 124.065 0.946 . . . . 0.0 112.597 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 12.8 mp0 -121.63 105.22 10.23 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 123.594 1.664 . . . . 0.0 113.241 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.36 70.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 123.672 1.701 . . . . 0.0 114.367 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.9 mmt -30.36 -47.93 0.09 Allowed 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.458 ' CG2' HD22 ' A' ' 34' ' ' LEU . 15.8 m -128.71 154.35 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-O 122.853 1.311 . . . . 0.0 112.751 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.5 mtmt -129.3 -170.2 2.24 Favored 'General case' 0 N--CA 1.522 3.174 0 N-CA-C 119.066 2.987 . . . . 0.0 119.066 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.22 93.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.33 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.87 11.28 8.55 Favored Glycine 1 N--CA 1.516 4.003 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.553 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.5 m-20 -101.85 130.6 48.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 123.765 1.745 . . . . 0.0 112.649 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -57.0 91.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 111.648 -2.524 . . . . 0.0 111.642 179.156 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.45 120.98 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.75 155.69 50.14 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.7 -1.25 . . . . 0.0 112.561 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.33 156.25 4.48 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.464 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 81.37 -20.29 0.38 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.715 1.884 . . . . 0.0 111.251 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.487 ' HG2' ' N ' ' A' ' 33' ' ' SER . 3.6 tt0 -95.15 155.4 16.75 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.579 1.181 . . . . 0.0 109.425 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.487 ' N ' ' HG2' ' A' ' 32' ' ' GLN . 62.6 p -76.13 134.16 40.05 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.213 1.482 . . . . 0.0 112.57 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.487 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 4.2 mt -96.13 -58.77 1.99 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.921 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.74 148.38 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.576 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 64.9 m -94.81 135.34 36.42 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.1 m -125.98 147.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.512 2.651 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 122.488 1.137 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.1 mtp -133.04 168.64 18.11 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.529 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -129.64 156.09 44.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.1 t -119.15 114.36 35.03 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.299 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -81.91 177.77 7.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 CA-C-O 123.698 1.458 . . . . 0.0 111.873 171.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -75.09 103.52 0.99 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 119.447 3.129 . . . . 0.0 119.447 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -41.41 -34.36 1.89 Allowed 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.664 2.242 . . . . 0.0 113.908 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.56 -169.25 3.06 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 113.34 -1.754 . . . . 0.0 110.159 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.1 163.25 13.32 Favored 'General case' 0 CA--C 1.574 1.869 1 N-CA-C 123.135 4.494 . . . . 0.0 123.135 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.96 -142.93 14.51 Favored Glycine 1 N--CA 1.517 4.039 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.394 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.42 165.76 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 O-C-N 121.813 -0.816 . . . . 0.0 108.955 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 22.5 t -89.72 128.08 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.212 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -103.62 -58.75 1.83 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 22.4 tt0 -141.95 151.2 42.35 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.949 0.795 . . . . 0.0 111.825 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -148.92 154.01 38.82 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 119.499 -2.001 . . . . 0.0 110.397 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 76.9 mttt -131.87 49.26 2.34 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-O 125.224 2.44 . . . . 0.0 109.582 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.0 m -137.5 151.9 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 1 CA-C-N 108.345 -4.025 . . . . 0.0 108.537 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -134.14 176.9 8.17 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 122.94 1.352 . . . . 0.0 111.585 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 18' ' ' THR . 1.6 t -88.29 114.1 26.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 1 N-CA-C 95.713 -5.662 . . . . 0.0 95.713 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.52 7.88 6.65 Favored Glycine 0 N--CA 1.513 3.822 0 CA-C-N 109.271 -3.604 . . . . 0.0 110.785 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' CG ' ' HZ2' ' A' ' 64' ' ' LYS . 19.1 t70 -113.19 167.66 10.36 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.931 0.872 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.67 157.86 16.17 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.75 165.81 9.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 112.842 -1.981 . . . . 0.0 112.596 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -172.61 146.19 1.65 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 123.31 0.381 . . . . 0.0 110.951 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -42.12 113.32 0.42 Allowed 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 125.416 2.532 . . . . 0.0 115.952 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 -40.81 2.31 Favored Glycine 0 N--CA 1.515 3.932 0 CA-C-N 112.92 -1.945 . . . . 0.0 113.089 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.2 m -53.33 128.45 28.38 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.77 66.17 0.13 Allowed 'General case' 0 N--CA 1.521 3.097 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.551 ' HB ' ' SD ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -27.48 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.551 ' SD ' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -157.46 -173.23 4.31 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 110.773 -2.921 . . . . 0.0 115.147 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.75 132.25 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 123.229 1.49 . . . . 0.0 110.432 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.522 ' CE1' HG23 ' A' ' 5' ' ' VAL . 18.2 m-30 -114.12 169.17 9.21 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-N 113.734 -1.576 . . . . 0.0 115.23 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -138.46 127.08 23.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 123.467 1.603 . . . . 0.0 109.173 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--N 1.291 -1.965 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -179.727 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.506 2.37 0 N-CA-C 119.986 3.328 . . . . 0.0 119.986 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.545 ' HZ2' ' CD ' ' A' ' 4' ' ' GLU . 24.7 mmmt -119.8 158.71 26.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.366 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.545 ' CD ' ' HZ2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -96.18 145.92 25.12 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 123.424 1.583 . . . . 0.0 114.581 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.606 HG23 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -121.56 91.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-O 123.864 1.792 . . . . 0.0 111.223 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.5 p30 -101.91 -179.49 4.02 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 111.635 -2.529 . . . . 0.0 107.799 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.402 HG22 HG21 ' A' ' 65' ' ' VAL . 79.8 t -104.51 133.54 20.14 Favored Pre-proline 0 N--CA 1.503 2.213 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.501 1.944 0 C-N-CA 123.875 3.05 . . . . 0.0 111.458 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 1.7 pt-20 -119.67 170.3 9.32 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.756 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.95 130.48 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.896 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 11.8 t -108.91 -44.91 3.89 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.059 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 3.3 mm-40 -130.55 112.76 13.48 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.801 1.286 . . . . 0.0 108.517 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.419 ' O ' ' CE ' ' A' ' 23' ' ' LYS . 7.4 p -90.49 70.34 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 124.506 2.098 . . . . 0.0 114.083 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mmm -32.39 -60.87 0.28 Allowed 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 119.536 3.162 . . . . 0.0 119.536 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.553 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.3 t -103.81 150.22 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -129.56 -179.1 4.97 Favored 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 120.386 3.476 . . . . 0.0 120.386 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -53.07 115.5 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.226 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.09 10.88 31.11 Favored Glycine 1 N--CA 1.518 4.153 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.227 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.6 m-20 -114.45 131.85 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.622 ' CD ' ' H ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -58.41 75.72 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 108.696 -3.865 . . . . 0.0 110.614 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.5 151.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 CA-C-O 124.525 2.107 . . . . 0.0 114.049 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -152.26 153.41 33.7 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.953 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.54 163.43 0.28 Allowed 'General case' 0 N--CA 1.512 2.647 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.918 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 69.85 -27.79 0.16 Allowed 'General case' 0 N--CA 1.52 3.03 0 CA-C-O 122.018 0.913 . . . . 0.0 112.486 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -84.44 97.55 9.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.784 1.278 . . . . 0.0 112.261 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.0 m -31.86 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -70.98 -52.16 21.33 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 46' ' ' VAL . 30.4 pt -143.11 151.76 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.909 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 51.9 m -105.31 127.97 53.23 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 28.4 m -120.45 154.17 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 N--CA 1.507 2.423 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -179.275 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.509 2.495 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 35.8 tpp -134.83 158.61 43.76 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.458 0.646 . . . . 0.0 111.714 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.37 153.67 30.59 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.904 1.812 . . . . 0.0 114.247 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 35' ' ' ILE . 60.1 t -123.87 102.67 34.65 Favored Pre-proline 0 N--CA 1.495 1.824 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.413 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -79.01 169.37 19.41 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 CA-C-O 124.394 1.747 . . . . 0.0 109.743 173.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -61.26 115.48 14.72 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 111.441 -2.618 . . . . 0.0 117.528 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -46.85 -26.66 4.91 Favored 'Trans proline' 0 N--CA 1.509 2.436 0 C-N-CA 122.144 1.896 . . . . 0.0 113.295 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -171.73 -174.26 1.32 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.532 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -96.51 166.97 11.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.83 -172.17 21.44 Favored Glycine 0 N--CA 1.514 3.84 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.369 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 t -106.65 149.87 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 C-N-CA 117.549 -1.661 . . . . 0.0 113.14 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG12 ' SD ' ' A' ' 72' ' ' MET . 58.4 t -67.29 102.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.592 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -82.44 -62.81 1.51 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 1.5 tt0 -147.24 151.28 36.42 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.96 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -143.55 135.81 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.502 -0.749 . . . . 0.0 110.58 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 41.9 mttm -114.45 42.87 2.01 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.11 161.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.072 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -132.78 170.78 14.79 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 121.489 3.885 . . . . 0.0 121.489 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.6 t -96.11 101.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 101.17 -3.641 . . . . 0.0 101.17 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.92 32.4 1.56 Allowed Glycine 0 N--CA 1.502 3.04 1 CA-C-N 107.826 -4.261 . . . . 0.0 106.816 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -113.95 174.07 6.12 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HD2' ' HB3' ' A' ' 16' ' ' GLU . 29.6 mmmt -101.37 132.39 46.96 Favored 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 121.233 3.79 . . . . 0.0 121.233 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG21 HG22 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -130.57 165.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 113.35 -1.75 . . . . 0.0 111.146 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 167.72 150.66 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 124.59 1.156 . . . . 0.0 110.021 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.76 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.34 -41.98 1.99 Allowed Glycine 1 N--CA 1.518 4.104 0 N-CA-C 116.699 1.44 . . . . 0.0 116.699 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.4 t -35.48 139.25 0.12 Allowed 'General case' 0 N--CA 1.531 3.617 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.966 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.3 mt -94.55 63.51 2.94 Favored 'General case' 0 N--CA 1.52 3.053 0 CA-C-N 120.358 1.435 . . . . 0.0 113.189 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.8 mm -40.52 -58.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.615 ' SD ' HG12 ' A' ' 54' ' ' VAL . 4.6 ptp -155.9 -172.92 4.3 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.27 122.0 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 122.998 1.38 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.606 ' CD1' HG23 ' A' ' 5' ' ' VAL . 5.6 m-30 -98.89 156.95 16.63 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.817 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.524 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 17.4 tt0 -147.6 98.15 2.94 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 123.952 1.834 . . . . 0.0 111.444 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.565 1.548 0 CA-C-N 114.053 -1.43 . . . . 0.0 114.616 179.547 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 58.0 t . . . . . 0 N--CA 1.513 2.705 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 73.3 mmtt -136.73 154.22 50.65 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.769 -1.559 . . . . 0.0 113.013 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.8 152.23 20.75 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.933 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 74.1 t -118.24 107.9 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -107.82 141.26 39.67 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.037 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -51.37 121.86 17.99 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 113.019 -1.9 . . . . 0.0 113.162 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' O ' HG21 ' A' ' 67' ' ' THR . 83.0 Cg_endo . . . . . 0 N--CA 1.505 2.148 0 C-N-CA 123.182 2.588 . . . . 0.0 114.623 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.521 3.107 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 10.2 pt-20 -106.73 179.12 4.36 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.524 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.69 115.61 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p -96.86 -41.22 8.54 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.066 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.8 OUTLIER -123.2 126.02 46.18 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 119.679 1.127 . . . . 0.0 112.038 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.7 53.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 125.549 2.595 . . . . 0.0 116.547 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.7 mmm -20.05 -54.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 110.509 -3.042 . . . . 0.0 114.152 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.472 ' C ' ' NZ ' ' A' ' 23' ' ' LYS . 1.4 m -114.88 159.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 O-C-N 120.778 -1.201 . . . . 0.0 108.699 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' NZ ' ' C ' ' A' ' 22' ' ' VAL . 3.8 mtmm -143.37 -176.9 5.12 Favored 'General case' 0 N--CA 1.522 3.13 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -49.15 106.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.775 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.99 -48.94 0.91 Allowed Glycine 0 N--CA 1.508 3.496 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -36.51 130.0 0.73 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-O 123.987 1.851 . . . . 0.0 115.39 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -70.5 76.88 0.57 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.141 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.52 HG12 ' CE2' ' A' ' 74' ' ' PHE . 37.6 t -79.34 156.97 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 125.413 2.53 . . . . 0.0 116.981 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -164.81 154.93 13.85 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.833 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.48 166.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.332 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 65.05 -21.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -93.34 152.68 18.99 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.532 ' N ' ' NE2' ' A' ' 32' ' ' GLN . 8.6 p -68.34 146.66 53.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 123.223 1.487 . . . . 0.0 110.716 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 mt -109.08 -65.6 1.13 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 123.748 1.737 . . . . 0.0 109.032 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.8 pt -142.53 160.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 111.351 -2.659 . . . . 0.0 110.013 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.423 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 61.6 m -107.3 129.04 54.94 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.7 m -118.39 151.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 118.116 2.636 . . . . 0.0 118.116 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.7 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.0 p . . . . . 0 N--CA 1.515 2.785 0 CA-C-O 121.581 0.705 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 30.5 mtp -142.92 163.3 33.17 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.909 -0.495 . . . . 0.0 112.185 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.01 149.23 42.49 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.777 1.275 . . . . 0.0 113.911 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.05 127.38 26.39 Favored Pre-proline 0 N--CA 1.503 2.202 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.958 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -92.67 178.59 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.148 1.899 . . . . 0.0 114.295 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.7 110.44 5.42 Favored Pre-proline 0 CA--C 1.578 2.056 0 N-CA-C 117.595 2.443 . . . . 0.0 117.595 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -53.38 -21.41 17.88 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 122.905 2.404 . . . . 0.0 113.384 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -164.74 -169.65 1.78 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.401 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -108.82 158.77 17.34 Favored 'General case' 0 C--N 1.3 -1.56 1 N-CA-C 121.838 4.014 . . . . 0.0 121.838 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.91 179.85 16.68 Favored Glycine 1 N--CA 1.519 4.212 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.548 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.53 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.27 -1.723 . . . . 0.0 113.978 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 t -83.87 112.23 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.07 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 22.2 ttmm -93.16 -55.04 3.47 Favored 'General case' 0 N--CA 1.516 2.837 0 CA-C-N 120.42 1.464 . . . . 0.0 112.366 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 4.5 tt0 -147.91 162.08 40.0 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 121.135 0.493 . . . . 0.0 109.918 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.453 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.1 pt? -162.72 150.78 14.02 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.943 -1.098 . . . . 0.0 108.36 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 41.2 mtmt -125.16 53.01 1.55 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.896 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 m -138.35 157.3 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 126.183 2.177 . . . . 0.0 112.279 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.407 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 3.6 m120 -124.78 173.83 8.31 Favored 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.79 83.05 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 127.298 3.428 . . . . 0.0 104.458 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.25 41.9 0.08 OUTLIER Glycine 0 N--CA 1.505 3.273 1 CA-C-N 104.699 -5.682 . . . . 0.0 107.058 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 11.3 t0 -122.49 168.67 11.83 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -113.24 144.91 41.9 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 121.786 3.995 . . . . 0.0 121.786 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 m -125.44 130.49 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 118.251 2.685 . . . . 0.0 118.251 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -130.18 120.28 24.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 8' ' ' PRO . 24.5 p -28.47 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 124.571 2.129 . . . . 0.0 112.501 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.46 42.0 1.67 Allowed Glycine 0 N--CA 1.508 3.485 0 CA-C-N 109.983 -3.281 . . . . 0.0 113.635 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -115.51 131.88 56.8 Favored 'General case' 0 N--CA 1.529 3.493 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.504 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.08 63.99 0.71 Allowed 'General case' 0 N--CA 1.519 2.981 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.0 mm -53.68 -63.47 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.445 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 18.2 ptt? -138.81 168.82 18.98 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.43 119.79 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 123.365 1.555 . . . . 0.0 110.388 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 28' ' ' VAL . 8.8 m-30 -99.87 163.87 12.27 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.435 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 35.4 tt0 -144.34 106.14 4.3 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.851 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.494 1.742 1 N-CA-C 122.784 4.364 . . . . 0.0 122.784 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' ' 3' ' ' LYS . 3.5 t . . . . . 0 N--CA 1.516 2.833 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.489 ' H ' HG13 ' A' ' 2' ' ' VAL . 33.1 mmtm -141.79 131.51 24.17 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -88.25 151.1 22.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.698 -1.251 . . . . 0.0 109.236 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 79.7 t -108.14 115.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 CA-C-O 121.569 0.7 . . . . 0.0 111.851 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.6 p30 -106.18 -179.18 3.86 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 123.0 1.381 . . . . 0.0 111.383 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 67' ' ' THR . 34.7 t -101.19 117.86 61.39 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.907 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo . . . . . 0 N--CA 1.493 1.463 0 C-N-CA 121.643 1.562 . . . . 0.0 113.0 171.499 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.506 2.374 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.646 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 9.9 pt-20 -123.8 167.91 13.44 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -95.42 122.51 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 m -92.38 -52.02 4.86 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 126.424 1.89 . . . . 0.0 108.597 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -131.89 120.74 22.97 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.7 0.762 . . . . 0.0 111.407 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.5 p -95.29 61.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 123.573 1.654 . . . . 0.0 110.444 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 mtt -27.73 -32.77 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 118.584 2.809 . . . . 0.0 118.584 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 m -115.85 145.72 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -129.88 176.13 8.29 Favored 'General case' 0 N--CA 1.517 2.884 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.15 102.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.85 0 CA-C-N 114.174 -1.375 . . . . 0.0 114.406 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.02 -36.21 3.03 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.256 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -49.36 171.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HD3' HG13 ' A' ' 53' ' ' VAL . 74.3 mmtt -105.44 105.13 15.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 111.629 -2.532 . . . . 0.0 108.841 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.404 HG12 ' CE2' ' A' ' 74' ' ' PHE . 21.8 t -115.2 106.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -117.29 158.74 23.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.827 -1.171 . . . . 0.0 110.52 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -42.5 157.83 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.702 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.027 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 2.7 tm-20 79.55 -48.88 0.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.828 1.299 . . . . 0.0 107.845 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' LEU . 43.0 tt0 -47.37 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 m -32.19 61.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -19.45 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 pt -147.61 146.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 110.628 -2.987 . . . . 0.0 112.89 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 m -105.15 124.73 50.03 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.09 158.41 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 117.849 2.536 . . . . 0.0 117.849 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.621 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.794 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 N--CA 1.511 2.579 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' A' ' 44' ' ' MET . 2.1 mpp? -121.71 159.2 27.09 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -117.18 146.41 43.24 Favored 'General case' 0 N--CA 1.506 2.342 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.481 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.7 127.04 25.92 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.838 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.48 171.86 7.22 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.794 1.662 . . . . 0.0 111.326 174.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.62 103.86 0.39 Allowed Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -35.48 -40.17 0.31 Allowed 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 123.409 2.739 . . . . 0.0 113.199 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.05 -172.4 4.01 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 109.981 -3.281 . . . . 0.0 108.109 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -107.45 162.15 14.18 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.706 3.224 . . . . 0.0 119.706 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.3 -154.25 21.58 Favored Glycine 1 N--CA 1.519 4.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.473 HG13 ' HD3' ' A' ' 27' ' ' LYS . 17.6 m -114.66 174.82 2.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.321 1.534 . . . . 0.0 113.001 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG21 ' CE1' ' A' ' 74' ' ' PHE . 20.6 t -102.73 108.58 24.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.976 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 14.0 tttm -88.57 -45.42 9.9 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.179 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 60.3 tt0 -165.45 163.83 19.61 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.696 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.37 164.29 32.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.106 . . . . 0.0 110.447 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -130.88 51.07 2.16 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -143.7 155.35 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 125.633 1.833 . . . . 0.0 113.504 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -127.44 -177.36 4.05 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 125.521 2.581 . . . . 0.0 115.321 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.91 104.61 16.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 101.123 -3.658 . . . . 0.0 101.123 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 136.85 -10.72 3.95 Favored Glycine 0 N--CA 1.514 3.864 1 CA-C-N 107.783 -4.281 . . . . 0.0 110.188 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -69.73 174.01 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.959 0.904 . . . . 0.0 110.268 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.646 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 30.4 mmtm -115.85 142.18 47.12 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.8 164.65 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.14 0.576 . . . . 0.0 112.397 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.55 153.74 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 2.9 t -39.45 118.5 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 122.579 1.18 . . . . 0.0 113.426 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.45 -29.17 7.11 Favored Glycine 1 N--CA 1.518 4.127 0 CA-C-N 114.574 -1.194 . . . . 0.0 115.607 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 24.5 t -75.7 161.25 29.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 117.92 -1.512 . . . . 0.0 112.933 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.3 mt -97.91 64.79 1.75 Allowed 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 mt -21.82 -67.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.4 ptp -149.93 179.39 8.09 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.519 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.5 118.25 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 123.351 1.548 . . . . 0.0 111.835 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.472 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 10.5 m-30 -106.99 162.9 13.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 123.43 1.586 . . . . 0.0 112.086 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.4 tt0 -142.57 133.09 25.09 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.345 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.295 -1.767 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.664 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.498 1.945 0 CA-C-O 124.14 1.924 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -126.98 145.23 50.78 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.503 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -81.79 155.58 25.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.19 0.995 . . . . 0.0 110.809 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.583 HG23 ' CD1' ' A' ' 74' ' ' PHE . 48.2 t -122.71 91.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 123.73 1.729 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.32 146.5 24.68 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.23 137.84 81.52 Favored Pre-proline 0 N--CA 1.501 2.084 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.789 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.174 1.916 . . . . 0.0 112.699 -177.774 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.505 2.286 0 N-CA-C 110.87 -0.048 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 2.0 pm0 -118.64 179.03 4.25 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.73 1.252 . . . . 0.0 110.274 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -94.3 115.64 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.302 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 m -90.45 -34.98 15.4 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -143.62 134.74 25.66 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.19 64.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 124.73 2.205 . . . . 0.0 114.972 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.2 mmm -25.17 -48.74 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 109.875 -3.329 . . . . 0.0 118.019 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.82 164.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -130.52 -174.86 3.47 Favored 'General case' 0 N--CA 1.522 3.145 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.1 107.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.875 0 O-C-N 120.831 -1.168 . . . . 0.0 111.472 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.87 -25.83 9.82 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-O 122.172 0.873 . . . . 0.0 111.915 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.85 156.62 13.91 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -86.51 127.84 34.91 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.918 1.342 . . . . 0.0 110.65 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 t -127.41 93.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 112.369 -2.196 . . . . 0.0 113.599 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -99.79 158.7 15.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.726 -1.234 . . . . 0.0 108.617 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -54.08 163.68 0.75 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.142 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 75.55 -35.63 0.28 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.763 1.268 . . . . 0.0 110.562 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -67.31 127.22 31.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 123.146 1.45 . . . . 0.0 112.34 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.5 p -57.77 97.71 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -61.13 -63.31 1.34 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.81 150.17 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 112.187 -2.279 . . . . 0.0 110.038 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.481 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 87.2 m -97.77 114.95 27.09 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 14.4 m -111.74 148.57 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.511 2.596 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.4 ptp -148.98 174.59 12.12 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -122.88 157.95 31.4 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.9 t -121.54 126.18 26.56 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.582 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -88.94 171.84 4.64 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.485 1.369 . . . . 0.0 110.073 174.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -70.81 119.85 75.56 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 118.581 2.808 . . . . 0.0 118.581 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -50.1 -29.26 21.6 Favored 'Trans proline' 0 N--CA 1.511 2.544 0 C-N-CA 122.947 2.431 . . . . 0.0 112.953 -174.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.71 -175.19 5.01 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 112.214 -2.266 . . . . 0.0 108.536 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.47 161.53 13.64 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.76 -167.88 23.81 Favored Glycine 1 N--CA 1.524 4.516 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.102 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.69 165.03 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 118.613 1.206 . . . . 0.0 113.171 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 74' ' ' PHE . 25.0 t -89.84 120.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -103.98 -62.6 1.29 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 2.2 tp10 -130.62 137.19 49.5 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 118.326 0.512 . . . . 0.0 110.803 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.69 114.7 5.4 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 123.466 1.603 . . . . 0.0 108.425 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.437 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 93.3 mttt -94.48 50.74 1.37 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.28 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.11 143.36 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.431 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -130.94 -172.56 2.86 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.793 2.235 . . . . 0.0 113.58 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.54 108.27 19.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.37 -15.81 4.68 Favored Glycine 0 N--CA 1.513 3.798 0 CA-C-N 108.913 -3.767 . . . . 0.0 113.144 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -70.28 157.08 38.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 9.0 mmmt -91.56 136.69 32.94 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.98 152.3 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.999 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -162.98 148.29 11.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.4 t -55.32 120.59 7.32 Favored 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.241 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.14 6.42 39.43 Favored Glycine 1 N--CA 1.523 4.452 0 CA-C-N 114.408 -1.269 . . . . 0.0 114.985 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.84 112.69 24.58 Favored 'General case' 0 N--CA 1.517 2.919 0 O-C-N 120.95 -1.324 . . . . 0.0 111.491 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.94 56.59 0.01 OUTLIER 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mm -42.61 -51.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.418 ' O ' ' N ' ' A' ' 5' ' ' VAL . 4.9 ptp -151.18 -175.05 5.01 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.415 HD12 ' HG2' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -123.24 120.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 123.814 1.768 . . . . 0.0 114.494 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CD1' HG23 ' A' ' 5' ' ' VAL . 19.7 m-30 -108.82 164.61 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.313 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -138.13 131.03 29.84 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.29 -1.979 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -179.6 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.503 2.219 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 73' ' ' ILE . 4.1 mmmm -137.98 154.12 49.38 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -101.35 172.08 7.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.761 -0.587 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' A' ' 74' ' ' PHE . 58.4 t -133.53 97.53 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.142 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.0 p30 -94.56 168.66 10.71 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -98.73 125.44 42.4 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 118.104 -1.438 . . . . 0.0 111.346 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.435 ' O ' HG21 ' A' ' 67' ' ' THR . 60.5 Cg_endo . . . . . 0 N--CA 1.502 2.005 0 C-N-CA 123.619 2.879 . . . . 0.0 109.961 -163.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.513 2.692 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 47.3 mt-10 -82.72 165.3 20.05 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -112.53 120.08 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 118.944 -1.102 . . . . 0.0 108.578 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -94.9 -48.18 6.12 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.081 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.83 102.94 5.42 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 123.2 1.476 . . . . 0.0 113.283 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.96 64.64 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 O-C-N 119.83 -1.794 . . . . 0.0 113.441 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 mtt -32.78 -36.12 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 N-CA-C 121.253 3.797 . . . . 0.0 121.253 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.91 142.68 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 6.8 mtpm? -134.94 179.94 6.0 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 119.148 3.018 . . . . 0.0 119.148 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.8 t -45.04 91.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.456 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 2.63 12.51 Favored Glycine 1 N--CA 1.523 4.454 0 CA-C-O 121.91 0.728 . . . . 0.0 113.555 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -97.51 120.42 37.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 124.903 2.287 . . . . 0.0 113.731 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.608 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -65.52 95.24 0.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.649 -2.523 . . . . 0.0 110.933 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.413 HG12 HD22 ' A' ' 34' ' ' LEU . 7.3 t -91.15 157.56 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.734 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.21 167.77 2.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.321 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.33 162.09 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 O-C-N 124.582 1.176 . . . . 0.0 113.638 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.85 -10.37 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.655 1.217 . . . . 0.0 113.923 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 30' ' ' ALA . 34.7 tt0 -90.15 87.68 6.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.203 -1.561 . . . . 0.0 106.809 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 70.7 m -35.99 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.427 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -24.63 -66.4 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 pt -147.42 146.02 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 111.387 -2.642 . . . . 0.0 111.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -93.17 131.01 38.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 23.5 m -124.82 160.55 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.72 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.521 3.082 0 CA-C-O 120.778 0.323 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 45.2 mtm -109.72 161.28 15.56 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.832 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -122.14 158.59 28.99 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.05 121.45 19.76 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.51 171.28 2.43 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.28 1.32 . . . . 0.0 111.217 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . . . -45.28 96.7 0.12 Allowed Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -44.55 -28.39 2.69 Favored 'Trans proline' 0 N--CA 1.511 2.551 0 C-N-CA 121.968 1.779 . . . . 0.0 112.973 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -163.8 -179.35 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.322 -2.217 . . . . 0.0 107.016 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.16 156.54 18.71 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 120.035 3.346 . . . . 0.0 120.035 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.33 -173.65 22.14 Favored Glycine 1 N--CA 1.529 4.863 0 CA-C-N 112.772 -2.013 . . . . 0.0 114.185 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.8 167.83 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 CA-C-N 120.405 2.103 . . . . 0.0 112.209 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.465 HG21 ' CE1' ' A' ' 74' ' ' PHE . 11.7 t -91.9 126.82 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.115 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 9.6 tttp -99.64 -60.44 1.53 Allowed 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.615 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 12.4 tt0 -144.6 159.71 42.35 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.285 0.564 . . . . 0.0 112.471 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.6 pt? -154.7 161.34 41.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.48 -2.013 . . . . 0.0 110.417 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.615 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 1.9 mptt -133.1 45.79 2.68 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 122.369 1.081 . . . . 0.0 108.962 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.91 149.2 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -129.89 177.69 7.08 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 125.504 2.574 . . . . 0.0 113.446 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.43 109.71 20.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.53 -27.95 3.04 Favored Glycine 0 N--CA 1.511 3.659 0 CA-C-N 111.929 -2.396 . . . . 0.0 108.393 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.78 169.86 17.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -123.32 164.39 18.89 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.909 1.337 . . . . 0.0 108.799 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.52 168.2 18.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CB ' ' HZ1' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -150.01 156.2 41.28 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 119.186 -1.006 . . . . 0.0 113.161 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -34.13 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.3 -5.69 45.38 Favored Glycine 1 N--CA 1.517 4.075 0 CA-C-N 113.785 -1.552 . . . . 0.0 115.8 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 8.5 m -63.7 133.52 53.73 Favored 'General case' 0 N--CA 1.524 3.226 0 CA-C-O 117.621 -1.18 . . . . 0.0 112.879 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.72 59.17 0.21 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.47 HG13 HG21 ' A' ' 7' ' ' VAL . 6.0 mm -30.68 -64.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 124.847 2.26 . . . . 0.0 116.528 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.419 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -152.27 177.25 10.75 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 111.357 -2.656 . . . . 0.0 112.856 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -118.42 127.89 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 123.384 1.564 . . . . 0.0 107.019 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CD1' HG23 ' A' ' 5' ' ' VAL . 8.9 m-30 -105.51 160.76 14.91 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 113.316 -1.766 . . . . 0.0 115.005 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 14.0 tt0 -141.04 109.69 6.0 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 124.618 2.151 . . . . 0.0 111.362 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 CA--C 1.58 2.13 0 N-CA-C 121.362 3.838 . . . . 0.0 121.362 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.429 HG21 ' HZ2' ' A' ' 55' ' ' LYS . 2.0 t . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 118.572 2.804 . . . . 0.0 118.572 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.518 ' HA ' ' NZ ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -118.83 146.63 44.7 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 124.225 1.964 . . . . 0.0 112.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 4' ' ' GLU . 7.5 mp0 -91.15 132.17 36.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.438 -2.619 . . . . 0.0 114.258 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -104.26 111.75 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.726 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 69' ' ' SER . 16.3 p-10 -108.9 172.79 6.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.34 1.543 . . . . 0.0 112.273 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.549 HG21 ' CG1' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -101.39 117.82 61.26 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 112.832 -1.986 . . . . 0.0 113.65 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.506 2.257 0 C-N-CA 123.87 3.047 . . . . 0.0 112.724 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.517 2.904 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 1.6 pm0 -118.11 174.66 6.09 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.223 1.011 . . . . 0.0 113.315 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.43 127.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.221 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 81.4 p -98.82 -50.36 4.24 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -131.12 100.31 5.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 123.254 1.502 . . . . 0.0 112.9 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG23 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -73.89 65.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 O-C-N 120.295 -1.503 . . . . 0.0 114.06 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 34.3 mmm -30.39 -52.43 0.16 Allowed 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.9 m -89.01 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HZ3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -130.7 161.88 30.68 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.47 114.97 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.849 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.76 -29.15 6.16 Favored Glycine 0 N--CA 1.515 3.966 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.414 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.526 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 11.7 t70 -89.02 168.39 12.39 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HZ1' ' CG ' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -83.98 109.21 17.45 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' CG1' HD22 ' A' ' 34' ' ' LEU . 6.7 t -111.04 102.77 14.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.612 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.25 159.02 25.78 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.316 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -39.48 160.92 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 74.27 -40.16 0.44 Allowed 'General case' 0 N--CA 1.516 2.843 0 CA-C-O 121.963 0.887 . . . . 0.0 110.475 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 47.0 tp60 -58.39 83.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 50.4 m -28.86 70.15 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.094 2.998 . . . . 0.0 119.094 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -23.32 -67.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.29 155.44 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.525 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -99.16 136.63 38.84 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 25.0 m -124.85 148.71 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB2' ' CG2' ' A' ' 18' ' ' THR . 3.4 tt0 . . . . . 0 N--CA 1.508 2.461 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.517 2.916 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.0 mtt -132.27 168.23 18.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.483 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.85 152.69 49.06 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.5 t -129.79 125.86 22.35 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.0 173.37 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.414 1.409 . . . . 0.0 110.544 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . . . -54.36 98.81 0.18 Allowed Pre-proline 0 C--N 1.287 -2.145 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -44.31 -29.3 2.94 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 C-N-CA 122.402 2.068 . . . . 0.0 113.679 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -158.76 -175.3 5.22 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.093 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.57 155.93 19.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.16 -168.61 26.53 Favored Glycine 1 N--CA 1.518 4.153 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.95 154.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.435 -1.626 . . . . 0.0 112.268 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.56 108.9 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 1.9 tmtp? -94.24 -50.15 5.4 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.226 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.7 tt0 -155.88 162.89 40.35 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.429 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -167.85 156.77 9.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.085 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -131.76 53.27 2.01 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.39 153.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 126.079 2.112 . . . . 0.0 113.735 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -121.76 178.62 4.78 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 124.809 2.243 . . . . 0.0 115.576 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.37 108.9 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.96 -23.76 3.34 Favored Glycine 0 N--CA 1.507 3.378 1 CA-C-N 108.282 -4.054 . . . . 0.0 108.501 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.39 154.11 4.91 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.945 0.879 . . . . 0.0 111.58 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.6 mmmt -95.81 148.32 22.71 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.43 147.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.667 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -148.56 155.65 41.4 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.28 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.46 -32.5 5.53 Favored Glycine 0 N--CA 1.511 3.698 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.327 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 21.2 m -37.84 122.87 1.02 Allowed 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 70' ' ' LEU . 7.4 mp -70.39 58.96 0.19 Allowed 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.549 ' CG1' HG21 ' A' ' 7' ' ' VAL . 5.1 mt -20.07 -61.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.439 ' SD ' ' HE1' ' A' ' 74' ' ' PHE . 7.9 ptp -156.85 176.77 12.31 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 112.573 -2.103 . . . . 0.0 114.509 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 114.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 123.845 1.783 . . . . 0.0 112.42 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.439 ' HE1' ' SD ' ' A' ' 72' ' ' MET . 17.0 m-30 -106.96 154.88 20.43 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.632 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 2.5 tp10 -127.01 123.35 36.86 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 CA--C 1.582 2.189 1 N-CA-C 124.577 5.029 . . . . 0.0 124.577 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -128.54 84.0 2.2 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.227 2.677 . . . . 0.0 118.227 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.08 143.85 1.06 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG23 ' CD1' ' A' ' 74' ' ' PHE . 26.5 t -118.01 120.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.0 p-10 -117.48 172.78 7.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 t -101.95 137.3 19.47 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 118.299 -1.361 . . . . 0.0 109.563 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.438 ' O ' HG21 ' A' ' 67' ' ' THR . 42.4 Cg_endo . . . . . 0 N--CA 1.505 2.195 0 C-N-CA 123.605 2.87 . . . . 0.0 111.327 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.503 2.212 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 49.5 mt-10 -92.33 169.98 10.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.544 -0.723 . . . . 0.0 109.558 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG11 ' HB ' ' A' ' 35' ' ' ILE . 60.0 t -106.89 116.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -94.49 -43.43 8.35 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.633 1.173 . . . . 0.0 113.787 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -136.49 102.06 4.83 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.678 1.228 . . . . 0.0 110.342 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.7 p -75.18 63.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 O-C-N 119.562 -1.962 . . . . 0.0 116.1 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.9 mmm -29.57 -33.6 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 26' ' ' ASP . 2.1 t -125.57 154.32 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -134.41 -176.93 4.37 Favored 'General case' 0 N--CA 1.521 3.078 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.54 87.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.101 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.91 26.01 3.71 Favored Glycine 0 N--CA 1.514 3.869 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.576 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 1.3 m-20 -116.37 141.09 48.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -63.36 115.02 4.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.798 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.19 98.23 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -105.04 149.43 25.81 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.232 -1.543 . . . . 0.0 114.782 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.2 73.03 0.3 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 177.2 -24.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.001 -3.272 . . . . 0.0 110.131 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -89.87 119.08 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.877 -1.14 . . . . 0.0 112.74 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 29.5 t -48.78 123.87 7.6 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 HD11 ' HA ' ' A' ' 48' ' ' ALA . 1.5 mt -81.78 -55.46 4.61 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.477 1.132 . . . . 0.0 112.625 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.422 ' HB ' HG11 ' A' ' 17' ' ' VAL . 19.9 pt -146.7 129.75 8.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.481 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 m -73.17 137.68 45.23 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.1 m -124.77 154.54 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.518 2.928 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.505 2.308 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.0 mmm -116.79 166.72 11.82 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.064 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -130.81 156.93 44.17 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.25 105.83 14.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.311 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 1.4 Cg_endo -77.71 175.66 10.97 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.155 1.236 . . . . 0.0 110.212 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -72.3 107.49 3.07 Favored Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -38.3 -39.33 1.01 Allowed 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.42 2.747 . . . . 0.0 113.981 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -150.77 176.69 10.8 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.02 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.82 89.09 5.54 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.57 -164.46 10.18 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 114.48 -1.236 . . . . 0.0 113.603 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.47 156.5 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG21 ' CE1' ' A' ' 74' ' ' PHE . 2.7 t -87.11 135.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.372 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -110.97 -65.22 1.19 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.158 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.506 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 29.7 tt0 -137.85 148.86 45.8 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.637 0.732 . . . . 0.0 109.521 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.64 154.76 28.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.506 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 86.6 mttt -131.1 51.55 2.13 Favored 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.11 154.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 CA-C-N 111.82 -2.446 . . . . 0.0 114.195 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -145.55 -176.19 5.02 Favored 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.0 t -84.65 113.22 22.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 1 N-CA-C 99.688 -4.19 . . . . 0.0 99.688 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.93 10.15 12.7 Favored Glycine 0 N--CA 1.513 3.769 0 CA-C-N 112.293 -2.23 . . . . 0.0 108.952 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -103.68 159.58 15.5 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 150.12 35.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.02 166.04 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.336 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 67' ' ' THR . 4.5 tmmm? -159.72 160.54 34.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.076 -1.015 . . . . 0.0 109.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.512 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 6.5 p -43.4 112.93 0.43 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.8 -8.49 61.55 Favored Glycine 0 N--CA 1.515 3.964 0 CA-C-N 113.043 -1.89 . . . . 0.0 114.619 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 7.2 m -67.41 127.13 31.53 Favored 'General case' 0 N--CA 1.52 3.068 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.184 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.99 66.21 0.79 Allowed 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.409 HD13 ' C ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER -36.46 -61.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 119.549 3.166 . . . . 0.0 119.549 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 ptp -144.89 175.18 10.39 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 113.987 -1.46 . . . . 0.0 114.812 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -113.72 121.94 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.932 1.349 . . . . 0.0 111.677 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.515 ' CD1' HG23 ' A' ' 5' ' ' VAL . 15.2 m-30 -106.0 -177.36 3.34 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.168 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -153.44 165.55 35.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 120.224 3.416 . . . . 0.0 120.224 -179.463 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.513 2.713 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -125.15 155.09 40.49 Favored 'General case' 0 N--CA 1.515 2.781 0 CA-C-O 122.015 0.912 . . . . 0.0 112.477 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -107.35 149.35 27.94 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.298 1.523 . . . . 0.0 113.375 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 59.5 t -102.97 102.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-O 124.102 1.906 . . . . 0.0 112.074 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -95.94 130.12 43.0 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 111.094 -2.775 . . . . 0.0 105.563 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' THR . 69.7 t -55.64 132.51 71.79 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 C-N-CA 121.578 1.519 . . . . 0.0 114.119 176.209 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.517 2.892 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.6 pt-20 -100.27 167.73 10.23 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.245 -0.909 . . . . 0.0 109.818 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.35 113.44 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.394 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.3 p -90.5 -40.98 11.67 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 93.8 mt-10 -133.99 101.76 5.17 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 123.297 1.522 . . . . 0.0 111.682 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.37 73.64 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-O 125.981 2.801 . . . . 0.0 113.047 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.449 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 mtp -38.39 -45.66 1.04 Allowed 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' C ' ' HD3' ' A' ' 23' ' ' LYS . 10.4 m -103.31 153.44 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 CA-C-N 119.486 1.039 . . . . 0.0 113.349 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD3' ' C ' ' A' ' 22' ' ' VAL . 3.7 mppt? -129.58 175.16 9.02 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.0 107.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.745 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.87 -28.11 5.5 Favored Glycine 1 N--CA 1.519 4.176 0 N-CA-C 114.598 0.599 . . . . 0.0 114.598 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -59.66 157.54 11.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -107.85 103.32 12.55 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 123.513 1.625 . . . . 0.0 106.982 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.424 HG12 HD23 ' A' ' 34' ' ' LEU . 66.1 t -103.78 117.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 120.327 3.454 . . . . 0.0 120.327 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.86 154.32 26.5 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 119.803 -1.81 . . . . 0.0 113.897 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.79 92.66 2.52 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 160.59 -20.51 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 109.994 -3.275 . . . . 0.0 109.284 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.58 165.86 14.0 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.023 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.3 p -85.56 106.19 16.7 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.445 HD21 ' HE3' ' A' ' 72' ' ' MET . 3.4 mt -69.13 -63.78 1.0 Allowed 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.9 pt -143.11 157.88 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.128 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 9.9 m -104.7 134.26 48.15 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.7 m -127.12 165.62 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.094 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.518 2.959 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 mmt -139.02 168.42 19.87 Favored 'General case' 0 N--CA 1.513 2.72 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -111.3 151.89 27.84 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 122.177 0.989 . . . . 0.0 111.627 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.2 t -122.66 119.59 28.11 Favored Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.616 -0.677 . . . . 0.0 109.708 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -85.17 175.9 6.19 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 CA-C-O 122.581 0.992 . . . . 0.0 111.67 175.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.6 108.41 5.77 Favored Pre-proline 0 CA--C 1.58 2.111 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -48.62 -30.46 16.46 Favored 'Trans proline' 0 N--CA 1.512 2.584 0 C-N-CA 123.084 2.523 . . . . 0.0 114.122 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 178.38 10.15 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.498 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.29 20.85 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.04 -175.79 35.19 Favored Glycine 0 N--CA 1.507 3.413 0 CA-C-O 121.812 0.673 . . . . 0.0 111.985 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 3.8 m -117.6 151.12 19.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.199 -1.177 . . . . 0.0 111.379 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 10.7 t -74.69 80.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.633 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.496 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -68.54 -41.36 79.99 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.528 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.496 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 39.7 tt0 -167.74 166.32 13.8 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -166.56 159.34 14.19 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.046 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -132.24 49.14 2.34 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 122.715 1.245 . . . . 0.0 108.958 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.43 157.03 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 112.524 -2.125 . . . . 0.0 113.279 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -129.94 178.42 6.54 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 125.829 2.728 . . . . 0.0 115.065 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -90.24 112.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 100.536 -3.876 . . . . 0.0 100.536 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.02 -29.41 3.52 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 109.636 -3.438 . . . . 0.0 109.363 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -62.07 159.18 14.96 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.886 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -104.75 142.88 33.91 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 7' ' ' VAL . 28.6 m -123.71 158.19 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -153.03 145.7 24.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 118.088 -0.958 . . . . 0.0 108.934 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 14.3 t -47.78 121.74 4.35 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.851 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.98 35.06 Favored Glycine 0 N--CA 1.513 3.825 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.733 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.8 t -78.36 121.45 24.49 Favored 'General case' 0 N--CA 1.52 3.06 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.15 66.54 0.63 Allowed 'General case' 0 N--CA 1.516 2.827 0 CA-C-O 122.032 0.92 . . . . 0.0 113.158 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 72' ' ' MET . 35.9 pt -58.98 -45.78 91.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.445 ' HE3' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -137.24 165.11 26.92 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 112.888 -1.96 . . . . 0.0 115.974 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.06 125.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.943 1.354 . . . . 0.0 113.448 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.488 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 7.3 m-30 -117.14 150.35 38.85 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.24 160.11 30.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 -179.175 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.503 2.179 0 CA-C-O 121.437 0.637 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.451 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 2.3 mmtt -131.97 127.41 36.24 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.331 1.063 . . . . 0.0 112.961 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -68.97 122.68 19.17 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.892 -1.503 . . . . 0.0 110.595 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 74' ' ' PHE . 10.6 t -101.49 96.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 CA-C-O 124.573 2.13 . . . . 0.0 114.999 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -89.13 128.15 35.76 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 110.058 -3.246 . . . . 0.0 106.986 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.438 HG23 HG13 ' A' ' 65' ' ' VAL . 12.5 t -68.49 130.79 91.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.502 1.995 0 C-N-CA 122.951 2.434 . . . . 0.0 115.635 -172.064 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.522 3.143 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 2.8 pt-20 -102.48 176.14 5.27 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 120.584 1.538 . . . . 0.0 113.728 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 t -108.35 119.4 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-O 122.921 1.344 . . . . 0.0 113.251 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.1 m -93.04 -52.67 4.47 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.368 -1.742 . . . . 0.0 111.305 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 16.5 mm-40 -126.32 126.87 44.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.485 0.659 . . . . 0.0 109.499 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.62 ' CG2' ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -105.73 61.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 123.045 1.403 . . . . 0.0 111.646 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmt -21.22 -46.7 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 110.622 -2.99 . . . . 0.0 116.671 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.79 159.7 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' HZ3' ' CG2' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -133.7 178.42 6.95 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 179.851 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.6 99.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.782 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.69 13.51 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.679 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -75.76 147.22 39.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HD2' HG11 ' A' ' 53' ' ' VAL . 27.8 mmmt -73.84 108.61 6.77 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.705 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -109.29 124.16 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.956 0.884 . . . . 0.0 109.95 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -137.3 159.88 40.65 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -47.08 161.06 0.08 Allowed 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.25 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 56.93 -1.7 0.05 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.07 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.449 ' H ' ' C ' ' A' ' 30' ' ' ALA . 1.4 tm0? -96.07 107.67 20.0 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.5 m -48.33 121.72 4.66 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -88.23 -59.38 2.25 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -144.79 152.95 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.702 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 16.7 m -110.44 125.42 53.25 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 179.169 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.6 m -109.97 157.8 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.514 2.754 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.28 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.516 2.86 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.5 ttt -144.85 161.05 40.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.079 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.28 155.16 20.81 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 123.265 1.507 . . . . 0.0 114.493 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.88 126.07 23.75 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.48 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -91.18 177.83 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 CA-C-O 124.51 1.796 . . . . 0.0 113.367 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -70.25 103.71 0.66 Allowed Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 111.699 -2.501 . . . . 0.0 117.613 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -46.69 -26.21 4.28 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 121.718 1.612 . . . . 0.0 114.067 -177.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -162.14 -172.62 3.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.683 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.71 166.81 10.52 Favored 'General case' 0 CA--C 1.568 1.669 1 N-CA-C 122.747 4.351 . . . . 0.0 122.747 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.62 -134.68 7.26 Favored Glycine 1 N--CA 1.526 4.645 0 CA-C-N 113.173 -1.831 . . . . 0.0 113.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.493 HG11 ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -134.91 160.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 O-C-N 121.512 -0.993 . . . . 0.0 109.915 179.317 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 39.7 t -84.44 133.63 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 C-N-CA 117.604 -1.638 . . . . 0.0 106.912 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 45.5 tptt -102.73 -62.52 1.26 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 25.6 tt0 -150.53 158.79 44.55 Favored 'General case' 0 N--CA 1.511 2.624 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.471 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.1 pt? -166.02 149.66 7.71 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.03 50.06 1.8 Allowed 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.8 162.9 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 126.33 2.269 . . . . 0.0 113.967 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.27 -177.51 4.68 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 120.625 3.565 . . . . 0.0 120.625 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -94.4 67.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 127.458 3.504 . . . . 0.0 109.575 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.15 37.33 0.02 OUTLIER Glycine 0 N--CA 1.506 3.354 1 CA-C-N 105.395 -5.366 . . . . 0.0 109.602 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -121.53 173.9 7.11 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 111.568 -2.316 . . . . 0.0 104.912 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' C ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -121.79 160.67 24.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 120.356 3.465 . . . . 0.0 120.356 -179.517 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.471 ' CG1' HG23 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.27 147.8 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 119.992 3.33 . . . . 0.0 119.992 -179.213 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.95 163.23 40.0 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.724 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -50.58 106.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 123.358 1.551 . . . . 0.0 114.763 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.05 11.69 56.09 Favored Glycine 0 N--CA 1.513 3.767 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.671 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 t -76.12 116.9 17.27 Favored 'General case' 0 N--CA 1.507 2.423 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.551 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.45 77.09 9.87 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.81 1.767 . . . . 0.0 109.831 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.523 HD13 ' SD ' ' A' ' 72' ' ' MET . 1.7 pp -77.95 -44.13 28.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.164 -1.835 . . . . 0.0 112.915 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.523 ' SD ' HD13 ' A' ' 71' ' ' ILE . 9.3 ptm -130.36 175.34 9.04 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.674 -1.21 . . . . 0.0 113.259 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 mp -128.49 128.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.654 ' CD1' HG22 ' A' ' 5' ' ' VAL . 16.4 m-30 -109.8 164.05 12.93 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.489 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 38.0 tt0 -137.88 131.11 30.5 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.303 -1.417 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -179.558 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.03 150.38 51.33 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.262 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -95.07 160.11 14.71 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 74' ' ' PHE . 89.9 t -118.36 114.69 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.154 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.9 p-10 -105.79 173.67 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.412 ' CG2' HG12 ' A' ' 71' ' ' ILE . 38.4 t -95.18 131.04 30.8 Favored Pre-proline 0 N--CA 1.495 1.781 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.61 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.501 1.927 0 C-N-CA 121.343 1.362 . . . . 0.0 111.99 172.022 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.501 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 12.2 pt-20 -118.16 164.71 14.75 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.266 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 62' ' ' GLY . 10.2 t -83.6 123.91 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.418 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.1 t -102.39 -45.8 4.98 Favored 'General case' 0 N--CA 1.522 3.155 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.798 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 24.3 mt-10 -130.97 123.1 28.08 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.893 0.854 . . . . 0.0 109.594 178.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -102.99 71.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 125.957 2.789 . . . . 0.0 110.538 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 mtt -34.07 -59.45 0.43 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 110.59 -3.004 . . . . 0.0 115.101 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.502 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.8 t -100.63 151.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 CA-C-O 122.161 0.981 . . . . 0.0 112.809 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -138.54 177.18 8.08 Favored 'General case' 0 N--CA 1.518 2.962 0 N-CA-C 121.574 3.916 . . . . 0.0 121.574 -178.74 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -42.5 97.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.88 11.8 25.58 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.634 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 t0 -110.32 142.23 42.25 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -59.39 107.17 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.707 -2.042 . . . . 0.0 116.145 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 74' ' ' PHE . 94.6 t -114.97 118.22 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 122.271 1.034 . . . . 0.0 111.807 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.56 149.34 51.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.544 -1.348 . . . . 0.0 113.69 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.67 140.46 14.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 93.73 -21.28 0.07 Allowed 'General case' 0 N--CA 1.513 2.707 0 O-C-N 126.703 2.502 . . . . 0.0 110.405 -179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -88.1 140.27 29.66 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.782 -1.199 . . . . 0.0 109.573 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.6 m -73.69 128.23 34.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 112.257 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 48' ' ' ALA . 5.2 mt -95.38 -61.95 1.38 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 pt -137.66 146.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-O 122.551 1.167 . . . . 0.0 113.03 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.458 HG21 ' HG2' ' A' ' 45' ' ' GLU . 88.1 m -101.87 116.89 33.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.4 m -113.25 160.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.513 2.702 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.514 2.753 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -118.94 156.07 30.2 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.477 0.581 . . . . 0.0 111.465 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HG2' HG21 ' A' ' 36' ' ' THR . 47.6 mt-10 -111.64 158.48 19.21 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.14 123.09 22.42 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 112.644 -2.071 . . . . 0.0 112.164 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -84.52 -179.7 3.97 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 CA-C-O 123.55 1.396 . . . . 0.0 112.636 168.937 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -66.02 101.24 0.27 Allowed Pre-proline 0 C--N 1.282 -2.356 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -36.61 -35.98 0.22 Allowed 'Trans proline' 0 N--CA 1.51 2.476 0 C-N-CA 122.71 2.273 . . . . 0.0 113.986 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -154.24 -177.49 6.47 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 112.078 -2.328 . . . . 0.0 107.006 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.31 168.79 9.55 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.97 -147.53 19.29 Favored Glycine 1 N--CA 1.517 4.035 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.075 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.37 148.16 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 47.6 t -68.94 92.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.142 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 17.5 tttm -69.82 -58.9 3.33 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.954 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' CD ' ' NZ ' ' A' ' 55' ' ' LYS 0.319 37.3 tt0 -149.52 144.07 26.03 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.52 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -130.73 155.15 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -128.54 37.58 4.1 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.106 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.43 161.98 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-N 113.09 -1.868 . . . . 0.0 114.562 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -122.83 173.96 7.44 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 124.819 2.247 . . . . 0.0 115.677 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 18' ' ' THR . 3.4 t -98.97 100.69 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 101.305 -3.591 . . . . 0.0 101.305 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' VAL . . . 120.86 30.58 1.33 Allowed Glycine 0 N--CA 1.511 3.678 1 CA-C-N 106.973 -4.649 . . . . 0.0 107.8 -179.336 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -107.28 155.34 20.06 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 114.133 -1.034 . . . . 0.0 109.995 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 31.4 mmtm -89.22 140.15 29.76 Favored 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.27 166.75 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.97 0.891 . . . . 0.0 111.035 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -165.98 153.5 10.27 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 t -47.9 127.04 11.46 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 117.304 -1.758 . . . . 0.0 111.858 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.66 -40.5 2.41 Favored Glycine 0 N--CA 1.513 3.824 0 CA-C-N 114.902 -1.044 . . . . 0.0 114.464 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 32.3 t -57.0 146.25 27.69 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.289 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.99 63.89 7.56 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.682 1.23 . . . . 0.0 114.28 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.501 ' CG2' ' SD ' ' A' ' 72' ' ' MET . 1.4 mt -17.0 -57.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.501 ' SD ' ' CG2' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -168.84 -176.81 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 111.767 -2.469 . . . . 0.0 114.92 -179.596 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.96 125.45 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 124.092 1.901 . . . . 0.0 112.767 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 17.3 m-30 -112.9 156.23 23.33 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.885 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -130.46 139.61 50.55 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 103.571 -2.752 . . . . 0.0 103.571 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.294 -1.822 1 N-CA-C 123.075 4.472 . . . . 0.0 123.075 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.521 3.078 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HG3' HG11 ' A' ' 76' ' ' VAL . 70.7 mmtt -133.31 148.64 51.91 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.07 155.42 18.4 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.58 -1.325 . . . . 0.0 114.246 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.534 HG23 ' CD1' ' A' ' 74' ' ' PHE . 40.1 t -121.97 88.36 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 124.753 2.216 . . . . 0.0 113.852 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.8 p30 -95.05 170.36 9.47 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 111.291 -2.686 . . . . 0.0 105.802 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG23 HG12 ' A' ' 65' ' ' VAL . 96.0 t -104.6 136.02 19.23 Favored Pre-proline 0 N--CA 1.504 2.246 0 C-N-CA 118.135 -1.426 . . . . 0.0 113.39 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 N--CA 1.5 1.9 0 C-N-CA 122.842 2.361 . . . . 0.0 115.509 168.813 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.5 2.066 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' HB3' ' CD ' ' A' ' 64' ' ' LYS . 8.7 pt-20 -124.42 172.63 9.01 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.68 122.84 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.995 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 p -101.56 -42.56 6.19 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.48 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.87 109.32 11.17 Favored 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.4 p -92.09 72.9 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 125.361 2.505 . . . . 0.0 110.279 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.9 mtt -35.27 -56.87 0.61 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 111.694 -2.503 . . . . 0.0 112.951 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 10.3 p -105.67 164.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 CA-C-O 123.29 1.519 . . . . 0.0 114.145 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -145.96 174.69 11.04 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 119.409 3.114 . . . . 0.0 119.409 -179.424 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.2 t -47.62 111.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.13 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.69 -27.87 6.99 Favored Glycine 1 N--CA 1.516 4.027 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.117 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -81.93 173.17 12.47 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 124.256 1.979 . . . . 0.0 115.947 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.06 136.36 50.21 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.944 -1.934 . . . . 0.0 112.586 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.4 t -126.41 160.65 33.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.993 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -159.03 156.05 28.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.516 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.72 168.86 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 125.071 1.482 . . . . 0.0 111.171 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 5.9 mp0 55.17 -7.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.156 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -101.89 110.0 21.88 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.51 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -40.16 133.57 1.73 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 9.4 mt -100.86 -61.76 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.6 pt -141.85 151.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.243 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.9 m -101.84 138.27 39.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.9 m -129.67 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -179.303 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.516 2.851 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.6 ttm -167.81 164.09 14.13 Favored 'General case' 0 N--CA 1.517 2.883 0 CA-C-O 122.45 1.119 . . . . 0.0 112.927 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.6 mp0 -103.71 141.68 35.65 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 124.368 2.032 . . . . 0.0 114.659 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 22.7 t -121.56 98.97 45.58 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -81.94 -178.72 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 CA-C-O 124.25 1.688 . . . . 0.0 113.618 171.225 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -68.24 102.21 0.37 Allowed Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -41.11 -25.01 0.2 Allowed 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 121.945 1.763 . . . . 0.0 115.453 170.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.45 -167.09 0.75 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -106.37 163.9 12.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.96 -175.72 19.34 Favored Glycine 1 N--CA 1.522 4.428 0 CA-C-N 113.58 -1.645 . . . . 0.0 113.443 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.24 166.23 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.307 . . . . 0.0 114.287 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG21 ' CE1' ' A' ' 74' ' ' PHE . 20.0 t -89.43 106.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 113.983 -1.462 . . . . 0.0 112.047 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -64.18 1.09 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 13.8 tt0 -140.39 155.71 46.65 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 118.506 0.594 . . . . 0.0 111.825 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.484 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.0 pt? -161.61 153.69 19.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.545 -0.722 . . . . 0.0 110.114 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HD2' ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -129.05 55.87 1.71 Allowed 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.51 151.46 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 112.277 -2.238 . . . . 0.0 111.622 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -130.57 170.99 13.53 Favored 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.77 111.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 1 N-CA-C 98.202 -4.74 . . . . 0.0 98.202 179.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.36 21.64 5.1 Favored Glycine 0 N--CA 1.514 3.886 0 CA-C-N 109.667 -3.424 . . . . 0.0 111.716 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.297 36.1 t0 -114.56 175.27 5.56 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.648 1.179 . . . . 0.0 111.537 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' CD ' ' HB3' ' A' ' 16' ' ' GLU . 25.8 mmtp -98.56 149.55 22.63 Favored 'General case' 0 N--CA 1.526 3.351 1 N-CA-C 122.395 4.22 . . . . 0.0 122.395 -179.049 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 7' ' ' VAL . 4.4 t -144.77 168.36 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 67' ' ' THR . 10.4 ptmm? 174.93 139.0 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.6 t -31.51 122.55 0.26 Allowed 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.72 -24.77 26.17 Favored Glycine 0 N--CA 1.509 3.561 0 CA-C-N 114.285 -1.325 . . . . 0.0 114.624 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.1 m -75.21 123.22 24.89 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -75.46 72.32 2.46 Favored 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 125.338 1.455 . . . . 0.0 114.694 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.431 HD13 ' SD ' ' A' ' 72' ' ' MET . 1.7 pp -56.03 -52.49 49.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.445 ' SD ' ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -127.95 174.95 8.75 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -123.79 129.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.677 0.751 . . . . 0.0 110.602 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.534 ' CD1' HG23 ' A' ' 5' ' ' VAL . 13.7 m-30 -114.77 158.79 21.39 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.465 1.602 . . . . 0.0 111.732 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.355 11.6 tt0 -136.28 124.25 22.8 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG11 ' HG3' ' A' ' 3' ' ' LYS . 23.3 m . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 121.047 3.721 . . . . 0.0 121.047 -179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.511 2.575 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 3' ' ' LYS . 1.1 mmpt? -131.8 164.05 26.89 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' CD ' ' N ' ' A' ' 4' ' ' GLU . 2.2 mp0 -107.78 140.4 40.91 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -115.08 100.84 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 CA-C-O 122.907 1.337 . . . . 0.0 112.483 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' SER . 3.3 p30 -91.84 173.87 7.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.806 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -112.71 137.2 21.66 Favored Pre-proline 0 N--CA 1.499 2.006 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.687 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 CA--C 1.56 1.778 0 C-N-CA 122.161 1.907 . . . . 0.0 116.437 175.69 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.527 3.387 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.6 pt-20 -113.79 178.9 4.12 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.0 t -110.76 111.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.99 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.9 t -91.51 -42.97 9.96 Favored 'General case' 0 N--CA 1.526 3.349 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -130.67 100.39 5.29 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 123.597 1.665 . . . . 0.0 109.327 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.79 64.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 119.188 -2.195 . . . . 0.0 115.826 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -29.93 -27.4 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' A' ' 23' ' ' LYS . 13.0 p -112.02 170.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' N ' ' CG2' ' A' ' 22' ' ' VAL . 33.3 mmtp -139.02 164.46 29.69 Favored 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.434 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 59.0 t -72.38 115.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 O-C-N 121.597 -0.69 . . . . 0.0 111.331 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . 116.01 -29.13 7.28 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.546 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 2.0 m-20 -63.9 -176.32 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 25' ' ' GLY . 36.7 mmtm -109.93 123.14 49.1 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.826 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 48' ' ' ALA . 2.2 t -123.35 102.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -91.9 162.5 14.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.05 -1.656 . . . . 0.0 111.434 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -61.72 164.94 5.57 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.617 -1.233 . . . . 0.0 107.75 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 70.62 -22.04 0.18 Allowed 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 123.6 1.666 . . . . 0.0 111.158 -179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 30' ' ' ALA . 37.7 tt0 -80.34 110.77 16.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.765 -1.209 . . . . 0.0 109.069 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 27.7 t -47.91 139.88 7.32 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.332 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -103.61 -55.95 2.3 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.458 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.33 141.76 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.475 1.131 . . . . 0.0 111.947 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.6 m -86.37 122.75 30.78 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.97 152.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.507 2.405 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.949 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 53.2 m . . . . . 0 N--CA 1.514 2.767 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtp -122.02 176.05 6.01 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -125.8 157.98 36.14 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.41 110.71 17.82 Favored Pre-proline 0 N--CA 1.498 1.946 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.629 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -83.36 -179.36 4.24 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.44 1.426 . . . . 0.0 113.829 173.314 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -64.14 105.79 0.79 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 120.484 3.513 . . . . 0.0 120.484 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -29.09 -39.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.474 0 C-N-CA 122.165 1.91 . . . . 0.0 115.098 171.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.42 177.82 10.83 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.381 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -89.18 101.03 13.7 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.7 -178.9 29.5 Favored Glycine 1 N--CA 1.528 4.787 0 O-C-N 121.71 -0.619 . . . . 0.0 114.606 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 1.4 m -100.58 171.55 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.315 -1.697 . . . . 0.0 107.878 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.585 HG12 ' SD ' ' A' ' 72' ' ' MET . 96.3 t -94.04 121.99 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.237 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -86.05 -58.68 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.77 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 1.7 tp10 -167.2 150.79 6.53 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.843 1.964 . . . . 0.0 112.652 178.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -130.86 -178.61 4.88 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.194 -1.567 . . . . 0.0 110.856 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.77 ' HZ2' ' CG ' ' A' ' 56' ' ' GLU . 1.5 mptp? -150.57 32.34 0.64 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.912 -1.117 . . . . 0.0 108.673 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.22 156.29 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-N 114.267 -1.333 . . . . 0.0 114.031 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -127.37 176.64 7.28 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -92.83 105.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.97 29.05 2.48 Favored Glycine 0 N--CA 1.51 3.617 1 CA-C-N 108.392 -4.004 . . . . 0.0 107.992 -178.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -113.73 163.24 15.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.7 pptp? -115.43 143.26 45.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.42 171.61 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.401 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -165.53 151.29 9.36 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 117.93 -1.033 . . . . 0.0 108.68 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 t -42.06 116.39 0.81 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-O 121.975 0.893 . . . . 0.0 112.841 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.68 -30.0 9.68 Favored Glycine 0 N--CA 1.514 3.834 0 CA-C-N 114.925 -1.034 . . . . 0.0 114.021 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 1.8 t -52.13 162.03 0.54 Allowed 'General case' 0 N--CA 1.52 3.05 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -96.79 64.17 2.05 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG1' HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -30.54 -49.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 179.64 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.585 ' SD ' HG12 ' A' ' 54' ' ' VAL . 1.1 ptp 178.38 -179.25 0.3 Allowed 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -107.81 133.63 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 123.617 1.675 . . . . 0.0 108.548 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -101.88 168.3 9.51 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.403 -179.604 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.43 ' OE2' ' NZ ' ' A' ' 55' ' ' LYS . 18.7 tt0 -146.69 99.45 3.2 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 123.782 1.753 . . . . 0.0 107.729 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.572 1.788 1 N-CA-C 123.287 4.551 . . . . 0.0 123.287 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 9.5 p . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 119.854 3.279 . . . . 0.0 119.854 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.544 ' HZ1' ' CD ' ' A' ' 4' ' ' GLU . 45.5 mmtt -138.24 165.12 27.51 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 118.822 2.897 . . . . 0.0 118.822 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.544 ' CD ' ' HZ1' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -99.85 142.39 31.39 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 111.255 -2.702 . . . . 0.0 113.532 -179.39 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.571 HG22 ' CD1' ' A' ' 74' ' ' PHE . 43.4 t -118.79 98.43 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.168 0 O-C-N 121.212 -0.93 . . . . 0.0 112.447 179.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 69' ' ' SER . 23.6 p30 -110.82 174.89 5.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.381 1.086 . . . . 0.0 111.375 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 67' ' ' THR . 70.1 t -108.78 130.34 22.85 Favored Pre-proline 0 N--CA 1.5 2.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.644 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 N--CA 1.509 2.423 0 C-N-CA 123.654 2.903 . . . . 0.0 114.463 164.185 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.513 2.722 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 11.7 pt-20 -116.85 169.29 9.5 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 122.0 -0.438 . . . . 0.0 111.442 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.08 118.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 O-C-N 120.907 -1.12 . . . . 0.0 112.422 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 3.7 t -98.47 -34.8 10.48 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.204 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 43.5 mt-10 -134.58 105.48 6.54 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.581 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.44 89.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 126.084 2.849 . . . . 0.0 111.811 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -59.93 -54.34 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 111.311 -2.677 . . . . 0.0 114.771 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.45 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 34.5 m -66.58 149.78 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 N-CA-C 118.009 2.596 . . . . 0.0 118.009 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 22' ' ' VAL . 13.0 mmtp -131.65 171.86 12.96 Favored 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 121.366 0.603 . . . . 0.0 112.339 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -75.75 98.19 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.47 14.85 7.3 Favored Glycine 1 N--CA 1.52 4.263 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.703 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.11 136.69 36.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -76.48 111.54 12.05 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 125.042 2.353 . . . . 0.0 106.812 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.401 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 96.7 t -111.22 108.31 25.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 109.857 -3.338 . . . . 0.0 112.719 -179.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.49 158.56 28.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.978 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.23 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.953 1.408 . . . . 0.0 113.037 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 72.61 -41.22 0.5 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.755 0.788 . . . . 0.0 110.823 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 13.2 tt0 -57.8 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.853 -1.155 . . . . 0.0 112.078 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 49.0 m -40.6 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.518 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -18.06 -67.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -151.31 149.38 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.236 -2.711 . . . . 0.0 109.294 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 1.2 m -106.75 133.6 51.17 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 26.8 m -112.36 146.66 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 N-CA-C 118.578 2.806 . . . . 0.0 118.578 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.811 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.514 2.73 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.4 mmt -137.77 146.47 43.66 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 17.1 mp0 -118.77 159.62 23.37 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -129.39 124.89 22.3 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.792 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.06 172.43 2.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.958 1.772 . . . . 0.0 112.025 171.438 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.518 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . . . -53.17 100.55 0.23 Allowed Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.1 Cg_endo -42.44 -31.39 1.83 Allowed 'Trans proline' 0 N--CA 1.51 2.442 0 C-N-CA 122.816 2.344 . . . . 0.0 113.603 -178.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -160.0 -174.71 4.7 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.752 -2.476 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.25 159.87 16.03 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 120.509 3.522 . . . . 0.0 120.509 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.11 -144.87 15.9 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.395 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.44 161.97 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 CA-C-N 117.937 0.868 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 74' ' ' PHE . 31.3 t -85.96 116.6 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -90.58 -67.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.54 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 41.7 tt0 -143.43 152.1 41.15 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.335 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.94 146.18 30.95 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 30.6 mmtt -119.17 46.1 1.96 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.86 152.12 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -134.04 -178.73 5.16 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.971 2.32 . . . . 0.0 114.222 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -87.89 112.24 23.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.71 -19.28 5.59 Favored Glycine 0 N--CA 1.509 3.565 0 CA-C-N 109.893 -3.321 . . . . 0.0 110.779 -179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.12 168.91 12.97 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.573 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.66 145.21 33.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -179.69 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -126.85 176.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 112.876 -1.965 . . . . 0.0 111.249 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HG2' ' N ' ' A' ' 67' ' ' THR . 37.8 tttt 166.19 144.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.431 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 4.5 t -39.47 119.49 0.95 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.48 -32.58 5.99 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.725 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.0 t -56.92 128.65 37.91 Favored 'General case' 0 N--CA 1.512 2.656 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.59 64.21 7.96 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 124.842 2.258 . . . . 0.0 111.079 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.405 ' CG1' HG21 ' A' ' 7' ' ' VAL . 5.1 mm -24.26 -56.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 111.717 -2.492 . . . . 0.0 117.375 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.0 ptp -161.19 -174.17 4.21 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.033 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.15 123.97 72.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 124.504 2.097 . . . . 0.0 112.207 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CD1' HG22 ' A' ' 5' ' ' VAL . 13.0 m-30 -113.05 165.26 12.53 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.733 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 2' ' ' VAL . 2.0 tt0 -142.3 122.71 14.01 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 CA--C 1.568 1.662 0 CA-C-O 122.736 1.255 . . . . 0.0 113.631 179.793 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.535 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -142.98 154.38 43.96 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 124.233 1.968 . . . . 0.0 111.395 178.789 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.535 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 13.4 pm0 -112.96 149.94 32.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.82 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.536 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 87.8 t -120.14 113.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.598 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.734 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 15.9 p-10 -109.86 177.18 4.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.329 1.062 . . . . 0.0 109.533 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.35 130.59 29.13 Favored Pre-proline 0 C--N 1.291 -1.958 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.088 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.681 0 C-N-CA 122.331 2.021 . . . . 0.0 110.565 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.519 2.99 0 CA-C-O 120.326 0.108 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.9 pt-20 -110.24 174.15 6.0 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.591 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.04 123.39 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.845 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.81 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.478 HG21 ' HG3' ' A' ' 19' ' ' GLU . 11.5 t -101.31 -43.83 5.84 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HG3' HG21 ' A' ' 18' ' ' THR . 28.9 mt-10 -128.25 99.06 5.29 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.757 0.789 . . . . 0.0 112.685 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.423 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 7.4 p -75.65 70.59 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.091 -2.255 . . . . 0.0 114.281 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.4 mmm -33.83 -45.9 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.89 167.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 36.6 mmtm -137.43 175.5 9.55 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -74.6 99.2 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.777 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.71 -23.08 5.4 Favored Glycine 1 N--CA 1.518 4.15 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.309 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.53 168.32 16.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 123.482 1.61 . . . . 0.0 114.326 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -98.9 132.94 43.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.416 ' CG1' HD22 ' A' ' 34' ' ' LEU . 88.7 t -128.12 122.62 58.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.209 -179.399 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -128.59 152.66 48.07 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 112.908 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.96 68.74 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.776 0 CA-C-O 124.135 1.921 . . . . 0.0 115.131 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 32' ' ' GLN . 15.6 pt-20 -177.05 -37.66 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 110.124 -3.216 . . . . 0.0 111.565 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.515 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -71.58 110.49 6.2 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.945 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 7.2 p -51.26 67.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -14.03 -64.73 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 120.518 3.525 . . . . 0.0 120.518 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 pt -150.52 148.86 14.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.186 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.4 m -95.27 133.8 38.76 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 178.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.7 m -118.13 157.1 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.567 ' CD ' ' HG ' ' A' ' 43' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.041 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.567 ' HG ' ' CD ' ' A' ' 38' ' ' GLU . 3.9 m . . . . . 0 N--CA 1.511 2.607 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -131.69 162.69 29.84 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 123.638 0.586 . . . . 0.0 110.328 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -115.12 159.51 20.78 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.022 -1.674 . . . . 0.0 114.186 179.665 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.3 t -121.42 133.44 24.22 Favored Pre-proline 0 N--CA 1.503 2.208 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.84 171.79 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.683 1.589 . . . . 0.0 111.899 173.52 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -54.79 100.43 0.22 Allowed Pre-proline 0 C--N 1.286 -2.192 0 CA-C-N 112.316 -2.22 . . . . 0.0 116.332 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -39.89 -33.72 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 122.151 1.901 . . . . 0.0 113.582 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -156.1 176.98 11.95 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-N 112.692 -2.049 . . . . 0.0 108.466 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.1 159.57 15.26 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.63 -142.13 10.4 Favored Glycine 0 N--CA 1.51 3.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.94 169.62 21.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 124.762 1.225 . . . . 0.0 108.757 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 74' ' ' PHE . 38.5 t -95.61 127.7 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.439 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 44.8 tttp -102.72 -56.72 2.18 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.178 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -154.72 157.13 37.59 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 1.8 pt? -149.9 147.45 27.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 118.871 -2.393 . . . . 0.0 113.995 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 53.42 1.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.46 154.49 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.978 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 9.9 m-80 -131.83 -174.38 3.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 124.299 2.0 . . . . 0.0 115.227 179.141 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.01 88.94 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-O 126.262 2.934 . . . . 0.0 110.05 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.37 15.72 0.41 Allowed Glycine 0 N--CA 1.515 3.917 1 CA-C-N 105.702 -5.227 . . . . 0.0 111.192 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -95.01 152.69 18.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.465 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 2.2 pptp? -106.95 142.03 37.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.32 175.87 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 112.0 -2.363 . . . . 0.0 111.257 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.55 ' HD3' ' C ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 177.51 157.45 0.37 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.594 179.796 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -29.1 103.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 178.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . 109.74 -47.01 1.09 Allowed Glycine 1 N--CA 1.518 4.102 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.89 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 5.6 t -26.84 117.72 0.08 Allowed 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 61.18 0.2 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 mt -23.79 -68.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 124.748 2.214 . . . . 0.0 115.575 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.409 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 5.7 ptp -154.58 -175.41 5.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.523 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -113.62 122.83 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 124.359 2.028 . . . . 0.0 110.948 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 8.9 m-30 -107.97 174.65 5.79 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.571 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 21.0 tt0 -151.45 166.37 31.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -179.316 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.504 2.236 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HZ3' ' CD ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -129.51 139.82 51.44 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.714 179.18 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.423 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.57 155.92 20.96 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 119.242 -2.161 . . . . 0.0 113.651 179.374 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 74' ' ' PHE . 90.4 t -116.56 119.79 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.809 0 C-N-CA 124.602 1.161 . . . . 0.0 113.92 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -111.05 174.78 5.7 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.744 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' CG1' ' A' ' 71' ' ' ILE . 60.7 t -96.86 130.4 30.24 Favored Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' O ' HG21 ' A' ' 67' ' ' THR . 53.6 Cg_endo . . . . . 0 N--CA 1.508 2.348 0 C-N-CA 124.468 3.445 . . . . 0.0 120.913 -173.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 37' ' ' VAL . 1.4 m . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 121.806 0.812 . . . . 0.0 108.948 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.595 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 6.9 pt-20 -113.36 169.25 9.09 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 t -93.97 130.0 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.128 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -179.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.471 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 63.9 p -105.8 -47.15 3.95 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.801 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.422 ' HG3' ' C ' ' A' ' 18' ' ' THR . 2.8 mt-10 -130.49 106.04 8.26 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 123.126 1.441 . . . . 0.0 112.822 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.506 HG11 ' HZ3' ' A' ' 23' ' ' LYS . 8.0 p -83.88 70.49 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-O 123.709 1.718 . . . . 0.0 111.162 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -25.37 -52.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 111.786 -2.461 . . . . 0.0 116.982 179.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 m -102.59 179.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.787 0 N-CA-C 118.514 2.783 . . . . 0.0 118.514 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HZ3' HG11 ' A' ' 20' ' ' VAL . 40.3 mmtm -140.18 168.69 19.22 Favored 'General case' 0 N--CA 1.522 3.131 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.12 89.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.525 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.063 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.87 4.6 5.58 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.748 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.6 141.24 31.68 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.411 1.101 . . . . 0.0 113.474 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -64.99 135.32 55.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.983 179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.488 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 19.0 t -131.96 115.82 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -179.335 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.26 152.46 35.69 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.181 -1.575 . . . . 0.0 113.97 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.94 72.91 0.42 Allowed 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.494 1.616 . . . . 0.0 114.545 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 175.98 -22.44 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 110.315 -3.13 . . . . 0.0 110.299 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -92.94 117.04 29.61 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -179.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 14.7 m -48.27 126.8 11.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.331 1.063 . . . . 0.0 112.981 179.277 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -89.02 -55.26 3.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 125.003 1.321 . . . . 0.0 113.711 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.4 152.18 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.566 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -99.48 136.41 39.45 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 21.4 m -123.68 146.71 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' CG ' ' HB2' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.501 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.414 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 37.9 t . . . . . 0 N--CA 1.51 2.53 0 CA-C-O 121.008 0.432 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.0 mtm -132.22 172.31 12.58 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -122.88 156.69 34.13 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 122.178 0.989 . . . . 0.0 113.397 179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.2 122.24 19.04 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.753 179.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -85.86 178.7 4.13 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.008 1.805 . . . . 0.0 113.02 169.144 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -67.27 106.75 1.31 Allowed Pre-proline 0 C--N 1.287 -2.121 1 N-CA-C 122.188 4.144 . . . . 0.0 122.188 -179.903 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -29.7 -40.69 0.06 OUTLIER 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.665 2.243 . . . . 0.0 115.61 174.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -154.11 -176.42 5.85 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 112.8 -2.0 . . . . 0.0 111.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.22 116.66 31.92 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.7 -169.7 34.84 Favored Glycine 1 N--CA 1.526 4.636 0 CA-C-O 119.276 -0.735 . . . . 0.0 112.556 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 2.1 t -109.91 157.31 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.34 0 CA-C-N 119.804 1.802 . . . . 0.0 107.847 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 20.8 t -76.43 113.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -91.74 -41.81 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 51.2 tt0 -164.92 161.28 19.99 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.155 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -162.71 152.16 15.53 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.164 -1.585 . . . . 0.0 109.243 178.587 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 54.0 mttt -126.29 49.48 2.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.761 1.267 . . . . 0.0 109.164 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.03 137.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 111.828 -2.442 . . . . 0.0 112.707 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.82 177.75 4.59 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 124.619 2.152 . . . . 0.0 113.621 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -85.06 115.8 27.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 1 N-CA-C 99.967 -4.086 . . . . 0.0 99.967 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.55 -24.74 5.49 Favored Glycine 0 N--CA 1.514 3.882 0 CA-C-N 110.156 -3.202 . . . . 0.0 109.905 -179.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.06 174.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.595 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 25.2 mmtm -104.13 136.13 44.33 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 m -132.15 142.87 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 123.218 1.485 . . . . 0.0 110.107 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 67' ' ' THR . 11.9 ttmt -141.01 123.44 15.86 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.69 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 8' ' ' PRO . 1.4 m -22.72 103.64 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.32 -42.49 1.72 Allowed Glycine 0 N--CA 1.511 3.695 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.542 -179.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 13.8 t -38.45 140.22 0.34 Allowed 'General case' 0 N--CA 1.53 3.526 0 CA-C-O 118.028 -0.987 . . . . 0.0 113.611 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.7 tt -80.78 57.33 2.96 Favored 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 124.527 2.108 . . . . 0.0 115.871 -179.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG1' HG22 ' A' ' 7' ' ' VAL . 14.4 mm -30.05 -67.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 120.498 3.518 . . . . 0.0 120.498 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptm -143.26 172.15 13.14 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 111.784 -2.462 . . . . 0.0 113.397 -179.349 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.38 122.74 69.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 120.731 -1.231 . . . . 0.0 109.681 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.521 ' CE1' HG22 ' A' ' 5' ' ' VAL . 16.2 m-30 -105.02 144.69 31.47 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -120.73 99.2 6.39 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 124.551 2.12 . . . . 0.0 111.293 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.295 -1.761 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.598 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.514 2.736 1 N-CA-C 124.099 4.852 . . . . 0.0 124.099 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 74' ' ' PHE . 3.2 mttp -164.16 171.89 14.42 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.222 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.65 161.21 19.54 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.358 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 72' ' ' MET . 43.8 t -128.48 96.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 124.943 2.306 . . . . 0.0 108.143 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.9 p-10 -86.72 168.79 13.23 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.454 HG22 ' CG1' ' A' ' 65' ' ' VAL . 33.1 t -98.69 143.71 26.83 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 116.598 -2.041 . . . . 0.0 112.879 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.181 1.921 . . . . 0.0 114.633 177.555 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.508 2.471 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 28.8 mt-10 -112.19 128.67 56.3 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 61' ' ' VAL . 5.6 t -69.49 119.01 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.109 0 C-N-CA 115.71 -2.396 . . . . 0.0 109.835 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -94.11 -51.24 4.93 Favored 'General case' 0 N--CA 1.519 2.98 0 C-N-CA 123.755 0.822 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.13 119.05 20.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.61 1.195 . . . . 0.0 112.726 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -92.33 63.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 123.594 1.664 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.3 mmm -24.33 -46.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.75 160.34 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -153.96 0.57 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 120.606 3.558 . . . . 0.0 120.606 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 55' ' ' LYS . 65.4 t -73.92 97.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.898 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.78 6.18 26.8 Favored Glycine 0 N--CA 1.516 3.977 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.722 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -92.85 152.77 19.23 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -82.09 124.84 30.2 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.55 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 t -123.47 148.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.054 -179.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -147.39 151.12 35.96 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.384 -0.822 . . . . 0.0 109.018 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 48' ' ' ALA . . . -48.72 158.96 0.27 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 124.172 0.92 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 74.12 -41.54 0.48 Allowed 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 123.901 1.81 . . . . 0.0 112.007 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 119.565 -1.959 . . . . 0.0 114.656 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -34.0 82.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 179.154 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -50.79 -51.48 50.19 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.2 pt -142.1 144.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.001 179.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 m -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 24.7 m -130.82 162.4 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 . . . . . 0 N--CA 1.511 2.601 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.745 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.507 2.408 0 CA-C-O 122.044 0.926 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 30.7 mmt -124.1 152.58 42.57 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.601 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -124.41 152.94 42.63 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 t -121.76 112.75 32.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.911 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.97 171.12 14.54 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 CA-C-O 124.282 1.701 . . . . 0.0 108.933 172.439 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -64.27 106.83 1.06 Allowed Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.089 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -34.45 -37.04 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 121.808 1.672 . . . . 0.0 114.321 175.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -156.16 -175.74 5.59 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -96.61 164.83 12.43 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.49 -152.69 18.45 Favored Glycine 1 N--CA 1.524 4.567 0 O-C-N 121.415 -0.803 . . . . 0.0 114.78 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.38 165.46 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 121.429 0.633 . . . . 0.0 112.143 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 74' ' ' PHE . 15.3 t -96.09 145.33 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.103 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 18.8 tptt -107.65 -60.59 1.68 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.631 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.9 tt0 -161.17 169.79 21.6 Favored 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.585 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt? -164.61 155.97 15.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.655 -1.278 . . . . 0.0 109.645 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -131.11 51.55 2.13 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.387 1.089 . . . . 0.0 108.368 179.714 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.28 170.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 CA-C-N 114.121 -1.4 . . . . 0.0 114.719 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -138.65 165.95 25.62 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 120.692 3.59 . . . . 0.0 120.692 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 1.9 t -96.03 101.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 100.849 -3.76 . . . . 0.0 100.849 179.604 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.35 29.17 2.18 Favored Glycine 0 N--CA 1.508 3.481 0 CA-C-N 109.572 -3.467 . . . . 0.0 108.01 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.285 0.0 OUTLIER -112.12 178.79 4.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 179.44 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HE2' ' CD ' ' A' ' 16' ' ' GLU . 29.6 mmtp -109.77 130.35 55.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.454 ' CG1' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -113.01 147.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 113.492 -1.685 . . . . 0.0 112.918 -179.838 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -146.76 140.97 26.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 15.1 t -50.97 124.44 11.32 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.699 178.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.8 -47.11 1.05 Allowed Glycine 0 N--CA 1.508 3.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.659 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.9 t -36.32 118.78 0.56 Allowed 'General case' 0 N--CA 1.523 3.222 0 CA-C-O 117.316 -1.326 . . . . 0.0 113.606 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.92 62.15 1.09 Allowed 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 123.198 1.475 . . . . 0.0 110.527 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.2 mm -45.11 -58.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' VAL . 8.0 ptm -142.06 160.7 39.69 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.13 131.79 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 123.532 1.634 . . . . 0.0 112.54 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 3' ' ' LYS . 3.6 m-30 -110.35 165.27 11.91 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.956 -2.384 . . . . 0.0 116.919 -179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.43 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 21.6 tt0 -151.36 101.89 2.87 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 CA--C 1.566 1.588 0 C-N-CA 127.297 2.239 . . . . 0.0 116.245 179.467 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.543 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.421 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.568 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.568 ' HZ2' ' CG ' ' A' ' 56' ' ' GLU . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG1' HG22 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.518 ' SD ' HG11 ' A' ' 54' ' ' VAL . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE1' HG23 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.543 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.421 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.568 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.568 ' HZ2' ' CG ' ' A' ' 56' ' ' GLU . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG1' HG22 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.518 ' SD ' HG11 ' A' ' 54' ' ' VAL . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE1' HG23 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.517 2.913 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 m -56.17 158.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 123.968 1.842 . . . . 0.0 115.926 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.629 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 6.1 mmmt -139.83 149.93 44.07 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.863 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -96.27 154.97 16.96 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG23 ' CE1' ' A' ' 74' ' ' PHE . 43.3 t -116.52 117.27 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.586 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.2 p-10 -108.5 169.4 8.67 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.154 1.454 . . . . 0.0 109.767 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.476 HG23 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -94.94 115.0 64.94 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 112.546 -2.115 . . . . 0.0 106.468 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 52.8 Cg_endo -66.58 -90.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.513 2.142 . . . . 0.0 113.471 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.442 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 21.2 p-10 -123.82 116.54 23.13 Favored 'General case' 0 CA--C 1.578 2.027 0 CA-C-O 124.341 2.02 . . . . 0.0 113.875 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.473 HD11 ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -123.03 43.37 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.85 0 CA-C-O 124.416 2.055 . . . . 0.0 111.047 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.82 -64.25 0.03 OUTLIER Glycine 1 N--CA 1.518 4.129 0 CA-C-N 112.585 -2.098 . . . . 0.0 117.427 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.81 -163.07 9.64 Favored Glycine 1 N--CA 1.518 4.121 0 N-CA-C 118.016 1.966 . . . . 0.0 118.016 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -9.95 -106.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 120.572 3.545 . . . . 0.0 120.572 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.9 140.42 52.65 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-N 112.496 -2.138 . . . . 0.0 113.946 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 m -139.13 162.34 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 122.693 1.235 . . . . 0.0 110.586 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 2.5 pt-20 -120.58 170.32 9.52 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.43 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 t -97.62 120.75 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 12.2 t -96.47 -46.17 6.47 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.68 98.51 4.51 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 122.437 1.113 . . . . 0.0 113.362 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.62 68.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 124.599 2.142 . . . . 0.0 108.498 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -32.49 -56.15 0.34 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.729 2.862 . . . . 0.0 118.729 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.2 m -87.71 164.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.547 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 16.3 mmtp -131.79 -166.38 1.71 Allowed 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 124.25 1.976 . . . . 0.0 115.91 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.7 t -74.42 86.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-N 113.294 -1.775 . . . . 0.0 113.654 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.62 -11.49 7.07 Favored Glycine 1 N--CA 1.517 4.065 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.097 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -54.97 163.94 0.92 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD2' HG13 ' A' ' 53' ' ' VAL . 8.4 mmmm -100.2 102.29 13.54 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 112.263 -2.244 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.79 148.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 CA-C-O 124.217 1.96 . . . . 0.0 114.804 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.04 154.67 46.09 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.548 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -55.03 163.85 0.96 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 60.49 -16.54 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -88.81 106.97 18.72 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 4.0 t -36.57 138.44 0.23 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -102.14 -59.43 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.8 pt -140.26 130.89 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.198 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.488 HG22 ' HG2' ' A' ' 45' ' ' GLU . 6.7 m -83.55 123.06 29.38 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.8 m -115.66 141.59 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.64 -171.6 2.31 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.33 -39.1 0.59 Allowed Glycine 1 N--CA 1.524 4.502 0 N-CA-C 118.104 2.002 . . . . 0.0 118.104 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 10.6 p-10 -111.02 -106.25 0.37 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 124.296 1.998 . . . . 0.0 115.598 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 21.6 mmmt -117.78 -11.61 10.32 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 127.708 2.403 . . . . 0.0 108.401 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.09 168.08 10.0 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -116.63 124.71 50.43 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.565 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 32.6 mtt -121.97 164.86 16.89 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.64 -1.288 . . . . 0.0 112.117 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HG2' HG22 ' A' ' 36' ' ' THR . 36.7 mt-10 -129.81 153.49 48.19 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.44 1.114 . . . . 0.0 112.361 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.451 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 3.8 t -124.74 112.97 27.16 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.698 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.56 177.52 5.6 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.741 1.627 . . . . 0.0 113.214 178.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -69.27 114.75 25.98 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -46.79 -27.71 5.94 Favored 'Trans proline' 0 N--CA 1.512 2.609 0 C-N-CA 122.371 2.048 . . . . 0.0 112.609 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.629 ' CZ ' ' HE3' ' A' ' 3' ' ' LYS . 47.0 p90 -167.13 -175.28 2.92 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.26 164.12 12.61 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.85 -144.65 15.53 Favored Glycine 1 N--CA 1.52 4.293 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.545 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 27' ' ' LYS . 3.4 m -121.87 166.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.062 0.934 . . . . 0.0 112.318 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' CE1' ' A' ' 74' ' ' PHE . 13.8 t -98.33 142.08 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.487 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 75' ' ' GLU . 69.2 tttt -115.93 -63.88 1.39 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.645 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -135.82 158.5 44.24 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -155.97 115.8 3.63 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.077 -1.639 . . . . 0.0 113.203 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -90.65 52.54 2.21 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.237 -1.539 . . . . 0.0 109.466 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.18 149.09 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -122.67 172.02 8.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 124.355 2.026 . . . . 0.0 116.123 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -95.06 111.41 25.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 100.992 -3.707 . . . . 0.0 100.992 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.03 8.71 11.38 Favored Glycine 1 N--CA 1.518 4.15 1 CA-C-N 107.741 -4.3 . . . . 0.0 108.855 -179.218 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -94.82 177.49 5.89 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.611 -1.295 . . . . 0.0 110.264 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -108.73 144.46 36.5 Favored 'General case' 0 N--CA 1.511 2.595 1 N-CA-C 123.369 4.581 . . . . 0.0 123.369 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -142.26 150.22 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.757 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -161.74 162.52 29.71 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.412 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 16.6 p -41.49 113.75 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.99 -35.88 4.78 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 111.641 -2.527 . . . . 0.0 115.314 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.6 t -38.31 132.92 1.02 Allowed 'General case' 0 N--CA 1.53 3.567 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.59 56.96 0.18 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.481 ' CG2' ' SD ' ' A' ' 72' ' ' MET . 3.1 mt -23.12 -63.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CG2' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -159.23 171.94 18.95 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 112.529 -2.123 . . . . 0.0 114.123 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.77 120.51 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 123.635 1.683 . . . . 0.0 110.842 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.561 ' CE1' HG23 ' A' ' 5' ' ' VAL . 6.8 m-30 -99.05 176.01 5.71 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 112.083 -2.326 . . . . 0.0 109.136 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 55' ' ' LYS 0.264 26.5 tt0 -156.39 115.87 3.52 Favored 'General case' 0 C--N 1.285 -2.23 1 N-CA-C 98.965 -4.457 . . . . 0.0 98.965 178.712 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 21.8 m -60.3 73.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 5.7 mt-10 83.22 -155.3 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 125.686 1.866 . . . . 0.0 109.79 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.09 58.34 0.06 OUTLIER Glycine 0 N--CA 1.512 3.734 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 4.31 50.91 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.072 1 N-CA-C 122.997 4.443 . . . . 0.0 122.997 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 120.014 3.338 . . . . 0.0 120.014 179.338 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mmm . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 115.588 -2.148 . . . . 0.0 107.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m -48.91 161.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.692 0 CA-C-N 120.06 1.3 . . . . 0.0 108.177 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -112.19 127.12 55.86 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -66.84 142.86 57.19 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.717 1.246 . . . . 0.0 110.732 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 74' ' ' PHE . 26.2 t -116.49 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.9 p-10 -101.61 168.78 9.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.748 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.87 140.06 21.7 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.721 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -74.07 -171.31 0.86 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.327 2.684 . . . . 0.0 114.803 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.73 101.81 3.79 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 125.798 2.713 . . . . 0.0 113.355 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.58 HG23 ' CG2' ' A' ' 46' ' ' VAL . 2.1 pt -119.91 36.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.97 -145.55 17.03 Favored Glycine 1 N--CA 1.524 4.526 0 CA-C-N 114.255 -1.339 . . . . 0.0 116.217 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.19 -41.7 0.74 Allowed Glycine 1 N--CA 1.519 4.215 0 CA-C-N 114.574 -0.813 . . . . 0.0 111.253 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.495 ' OD2' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -72.25 173.61 8.39 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' OE2' ' NZ ' ' A' ' 64' ' ' LYS . 5.6 pt-20 -104.11 155.46 18.67 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 101.616 -3.476 . . . . 0.0 101.616 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 29.5 m -124.0 169.88 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 14.4 pm0 -113.13 164.96 12.85 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.488 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 t -101.48 117.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.221 -0.924 . . . . 0.0 110.118 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.61 -50.57 4.44 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.285 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.3 mt-10 -128.69 95.28 4.07 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 123.555 1.645 . . . . 0.0 111.305 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.5 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.8 p -70.23 66.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.5 mtt -30.24 -57.35 0.19 Allowed 'General case' 0 N--CA 1.512 2.631 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 18.8 m -87.16 171.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -134.33 169.37 17.31 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.63 110.26 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.704 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 10.91 21.62 Favored Glycine 0 N--CA 1.508 3.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.694 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.38 159.34 16.46 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 123.731 1.729 . . . . 0.0 110.045 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -78.58 122.74 26.29 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 125.151 2.405 . . . . 0.0 113.49 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG12 ' CE2' ' A' ' 74' ' ' PHE . 92.7 t -125.25 97.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 110.455 -3.066 . . . . 0.0 114.56 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -107.44 160.01 15.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -57.45 173.83 0.24 Allowed 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.454 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 62.79 -18.67 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 30' ' ' ALA . 1.6 pp0? -94.97 139.51 31.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.132 -1.605 . . . . 0.0 107.789 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t -63.48 128.48 36.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -92.77 -64.52 1.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.8 pt -138.61 140.04 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 113.424 -1.717 . . . . 0.0 112.306 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 3.4 m -93.35 130.13 39.23 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.985 -3.339 . . . . 0.0 101.985 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.49 164.8 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.197 0.936 . . . . 0.0 112.473 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 11.6 tt0 -131.49 -142.96 0.23 Allowed 'General case' 0 N--CA 1.505 2.293 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.253 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 41' ' ' LYS . . . 158.2 67.12 0.01 OUTLIER Glycine 0 N--CA 1.512 3.724 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' C ' ' HG3' ' A' ' 41' ' ' LYS . 30.9 t0 28.61 58.06 0.12 Allowed 'General case' 0 CA--C 1.586 2.336 0 O-C-N 128.258 2.975 . . . . 0.0 117.45 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.495 ' NZ ' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER 159.02 -6.39 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -179.27 140.73 0.16 Allowed 'General case' 0 N--CA 1.515 2.807 0 CA-C-N 120.431 1.469 . . . . 0.0 113.95 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.7 p -86.2 138.3 31.98 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.992 0.901 . . . . 0.0 112.953 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.39 124.72 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.842 -1.526 . . . . 0.0 107.413 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 22.7 mp0 -95.65 142.55 27.83 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 123.825 1.774 . . . . 0.0 113.557 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.58 ' CG2' HG23 ' A' ' 10' ' ' ILE . 7.1 t -113.48 118.47 43.45 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.582 -1.644 . . . . 0.0 115.092 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -82.14 178.11 6.65 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.875 1.717 . . . . 0.0 112.356 174.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -67.51 103.1 0.44 Allowed Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 118.793 2.886 . . . . 0.0 118.793 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -42.93 -29.59 1.56 Allowed 'Trans proline' 0 N--CA 1.508 2.349 0 C-N-CA 122.416 2.077 . . . . 0.0 114.105 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -159.2 -179.44 7.99 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.24 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -99.86 156.53 17.08 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 120.097 3.369 . . . . 0.0 120.097 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.37 -147.82 18.56 Favored Glycine 1 N--CA 1.519 4.221 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.98 160.89 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.93 83.74 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -67.47 -42.48 82.94 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.562 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 36.4 tt0 -163.84 130.19 3.16 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 1.9 pt? -126.95 151.27 48.73 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 119.78 -1.825 . . . . 0.0 108.362 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.562 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 12.9 mptt -121.05 45.08 2.35 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.899 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 p -141.11 154.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.953 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -124.26 171.78 9.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -87.0 114.76 26.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 100.9 -3.741 . . . . 0.0 100.9 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.35 -0.77 16.41 Favored Glycine 0 N--CA 1.503 3.147 0 CA-C-N 110.145 -3.207 . . . . 0.0 109.216 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.8 170.48 9.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.334 0.667 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' NZ ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -118.68 145.73 45.26 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 121.13 3.752 . . . . 0.0 121.13 -179.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 HG11 ' CD1' ' A' ' 71' ' ' ILE . 17.1 m -130.62 164.79 32.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.218 -1.81 . . . . 0.0 113.557 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 140.82 18.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 t -43.72 120.42 2.0 Allowed 'General case' 0 N--CA 1.514 2.773 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.242 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.13 -23.72 10.46 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 117.285 1.674 . . . . 0.0 117.285 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.4 t -79.25 143.26 35.46 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 118.664 -1.214 . . . . 0.0 112.602 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.99 62.49 6.87 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 124.369 2.033 . . . . 0.0 113.338 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.451 ' CD1' HG11 ' A' ' 65' ' ' VAL . 12.9 mm -44.65 -45.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -133.85 -177.47 4.58 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.743 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -138.63 117.29 13.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.604 ' CD1' HG22 ' A' ' 5' ' ' VAL . 22.6 m-30 -109.75 159.51 17.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.273 3.1 tt0 -126.02 150.9 47.76 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.23 71.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -58.19 82.25 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.7 -59.81 0.08 OUTLIER Glycine 0 N--CA 1.512 3.751 0 N-CA-C 106.053 -2.819 . . . . 0.0 106.053 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 114.16 153.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 1 CA-C-N 108.185 -4.007 . . . . 0.0 106.83 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.519 0 CA-C-O 116.52 -1.705 . . . . 0.0 108.858 -179.803 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 1.2 mtp . . . . . 0 N--CA 1.506 2.371 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 m 10.67 103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.682 0 N-CA-C 121.218 3.784 . . . . 0.0 121.218 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.563 ' HZ1' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.13 158.77 15.44 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 113.011 -1.904 . . . . 0.0 114.131 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 4.5 mp0 -100.27 149.79 23.23 Favored 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.478 HG23 ' CE1' ' A' ' 74' ' ' PHE . 85.2 t -130.89 91.54 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.092 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -104.93 174.28 5.94 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.46 HG11 ' CG1' ' A' ' 10' ' ' ILE . 56.4 t -90.81 126.23 56.45 Favored Pre-proline 0 N--CA 1.504 2.255 0 C-N-CA 117.128 -1.829 . . . . 0.0 106.527 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -86.61 -63.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.5 0 N-CA-C 120.606 3.272 . . . . 0.0 120.606 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -96.59 -42.88 7.83 Favored 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 126.207 1.803 . . . . 0.0 112.805 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.49 ' CD1' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -53.49 64.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 C-N-CA 129.718 3.207 . . . . 0.0 108.182 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . -108.62 -168.05 20.97 Favored Glycine 0 N--CA 1.504 3.184 0 CA-C-N 113.31 -1.768 . . . . 0.0 114.806 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.62 -157.52 15.2 Favored Glycine 0 N--CA 1.514 3.846 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.882 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.93 58.42 2.38 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 123.535 1.635 . . . . 0.0 112.518 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 4.5 mt-10 41.4 149.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 N-CA-C 119.11 3.004 . . . . 0.0 119.11 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.87 165.46 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 O-C-N 119.773 -1.83 . . . . 0.0 115.379 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.1 pt-20 -120.36 171.08 8.78 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -101.52 120.93 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.181 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 p -97.8 -52.84 3.6 Favored 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.837 -1.529 . . . . 0.0 111.279 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -123.27 104.98 9.47 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 122.978 1.37 . . . . 0.0 113.882 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.63 93.29 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.175 -1.578 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -38.23 90.12 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 26' ' ' ASP . 3.4 t -126.49 160.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -134.51 -175.63 3.94 Favored 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.37 91.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 113.83 -1.532 . . . . 0.0 112.114 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.36 -4.23 13.61 Favored Glycine 1 N--CA 1.52 4.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.326 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HB2' HG13 ' A' ' 22' ' ' VAL . 23.8 m-20 -93.07 143.32 26.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.242 1.02 . . . . 0.0 111.697 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 80' ' ' ALA . 45.8 pttt -76.4 122.9 25.15 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 124.71 2.195 . . . . 0.0 115.935 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.48 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 59.1 t -110.81 125.26 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.593 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -132.23 150.7 52.1 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 111.925 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -44.05 157.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.49 -20.05 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' ALA . 30.0 tt0 -74.42 148.11 41.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -84.89 124.14 31.28 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.483 1.135 . . . . 0.0 108.592 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.434 HD11 ' HA ' ' A' ' 48' ' ' ALA . 2.9 mt -85.35 -57.57 3.02 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 122.652 1.215 . . . . 0.0 110.191 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -143.98 151.61 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -102.4 138.94 38.67 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.3 m -129.96 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -134.72 -161.91 1.2 Allowed 'General case' 0 N--CA 1.512 2.669 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 172.95 -67.11 0.11 Allowed Glycine 1 N--CA 1.524 4.542 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -123.88 171.6 9.55 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -24.31 -6.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.442 1 N-CA-C 124.576 5.028 . . . . 0.0 124.576 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.18 116.44 17.68 Favored 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 120.171 1.35 . . . . 0.0 111.071 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.2 p -74.99 163.37 27.69 Favored 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.17 148.26 33.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.039 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 14.0 mp0 -114.64 151.57 33.33 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 123.511 1.624 . . . . 0.0 114.457 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.49 HG12 ' CD1' ' A' ' 10' ' ' ILE . 31.0 t -112.7 105.88 55.72 Favored Pre-proline 0 N--CA 1.506 2.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -86.33 179.81 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.87 1.529 . . . . 0.0 112.276 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -71.31 107.36 2.62 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -49.52 -26.4 12.36 Favored 'Trans proline' 0 N--CA 1.514 2.697 0 C-N-CA 122.22 1.947 . . . . 0.0 113.757 -176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -164.97 -175.7 3.85 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 163.97 12.4 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.2 -144.83 15.78 Favored Glycine 1 N--CA 1.528 4.778 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.879 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.03 169.76 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 CA-C-N 118.879 1.339 . . . . 0.0 111.389 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 27.0 t -88.2 133.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.4 -53.8 3.63 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.032 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.29 159.42 19.9 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 124.672 1.233 . . . . 0.0 110.726 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -155.31 130.3 9.41 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -100.76 29.97 4.25 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.935 -1.103 . . . . 0.0 109.768 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.421 ' C ' HD21 ' A' ' 60' ' ' ASN . 29.4 m -119.4 157.33 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 112.71 -2.041 . . . . 0.0 114.005 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.421 HD21 ' C ' ' A' ' 59' ' ' VAL . 1.6 m-80 -131.94 -178.42 4.88 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.5 t -90.19 106.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 1 N-CA-C 99.059 -4.423 . . . . 0.0 99.059 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.22 28.59 2.15 Favored Glycine 0 N--CA 1.515 3.919 0 CA-C-N 108.991 -3.731 . . . . 0.0 110.591 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -119.71 164.9 15.23 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -106.08 141.31 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 119.857 3.28 . . . . 0.0 119.857 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.19 -179.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.92 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' NZ ' ' OE2' ' A' ' 14' ' ' GLU . 7.2 pttt 149.94 154.59 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.923 0 C-N-CA 125.715 1.606 . . . . 0.0 111.656 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.1 p -25.09 103.59 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 118.515 2.784 . . . . 0.0 118.515 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.14 -47.8 1.0 Allowed Glycine 0 N--CA 1.507 3.415 0 CA-C-N 111.711 -2.495 . . . . 0.0 112.491 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.1 t -50.12 123.9 9.19 Favored 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.953 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.56 67.39 0.76 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mt -22.75 -58.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 8.8 ptp -169.66 -173.67 1.69 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.414 -2.176 . . . . 0.0 115.488 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.52 133.51 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.501 1.143 . . . . 0.0 110.731 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 5' ' ' VAL . 12.1 m-30 -112.64 176.2 5.12 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.564 ' OE2' ' N ' ' A' ' 1' ' ' MET 0.271 7.3 tp10 -144.37 99.54 3.39 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.39 33.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.693 1 N-CA-C 126.853 5.872 . . . . 0.0 126.853 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -134.88 -176.01 4.09 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 118.068 0.394 . . . . 0.0 111.956 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' H ' ' CD ' ' A' ' 77' ' ' GLU . . . 134.69 -32.32 2.63 Favored Glycine 1 N--CA 1.52 4.251 0 O-C-N 120.145 -1.597 . . . . 0.0 110.191 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 97.43 -90.41 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.152 0 CA-C-N 109.667 -3.267 . . . . 0.0 118.08 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.564 1.501 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 9.8 ttm . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.503 -0.761 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 t 85.48 119.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 126.713 2.508 . . . . 0.0 114.091 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -118.74 122.62 42.89 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.778 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -68.4 155.65 39.4 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.977 0.894 . . . . 0.0 110.267 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 74' ' ' PHE . 36.9 t -122.87 100.18 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.45 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -98.24 96.56 8.16 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.421 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.6 t -20.75 122.71 0.1 Allowed Pre-proline 0 N--CA 1.511 2.58 0 CA-C-N 113.093 -1.867 . . . . 0.0 114.858 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.36 -172.1 0.22 Allowed 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 122.262 1.975 . . . . 0.0 116.346 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -65.66 45.08 0.02 OUTLIER 'General case' 0 CA--C 1.585 2.294 0 C-N-CA 127.017 2.127 . . . . 0.0 115.837 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.405 HG23 HG21 ' A' ' 46' ' ' VAL . 30.8 pt -80.25 48.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 O-C-N 120.049 -1.657 . . . . 0.0 114.161 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.57 -162.84 12.83 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.739 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.54 -45.29 0.67 Allowed Glycine 1 N--CA 1.521 4.341 0 CA-C-O 122.042 0.801 . . . . 0.0 112.365 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.03 -176.96 4.78 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 112.686 -1.757 . . . . 0.0 110.545 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -96.2 139.78 31.86 Favored 'General case' 0 N--CA 1.509 2.511 0 CA-C-O 122.436 1.112 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.16 159.7 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.672 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.9 pt-20 -107.32 166.52 10.58 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 t -94.86 116.29 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.226 1.012 . . . . 0.0 112.456 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -94.65 -32.23 13.48 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 113.78 -1.555 . . . . 0.0 111.726 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.4 OUTLIER -138.54 107.64 6.05 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.828 0.705 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.3 p -86.74 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 118.43 -2.669 . . . . 0.0 117.088 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.3 mmt -20.3 -51.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG22 HE22 ' A' ' 32' ' ' GLN . 2.9 t -111.97 151.54 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 23.4 mtmt -134.07 -177.62 4.66 Favored 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.24 94.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.246 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.9 -7.1 17.36 Favored Glycine 1 N--CA 1.516 4.021 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -92.48 142.54 27.3 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.251 1.024 . . . . 0.0 110.477 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.453 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 15.5 mttp -69.82 127.25 32.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.653 2.644 . . . . 0.0 117.193 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 48' ' ' ALA . 1.5 t -112.66 98.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 109.86 -3.336 . . . . 0.0 113.906 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.85 146.96 37.97 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.75 -1.219 . . . . 0.0 112.42 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.02 124.16 20.04 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 118.89 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 128.358 3.536 . . . . 0.0 110.62 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.478 HE22 HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.09 147.38 22.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.417 -1.427 . . . . 0.0 108.997 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 2.2 t -80.48 80.94 6.85 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 48' ' ' ALA . 2.0 mt -29.99 -57.25 0.18 Allowed 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.8 pt -149.41 156.76 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 112.591 -2.095 . . . . 0.0 110.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 87.2 m -106.15 131.75 53.03 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 23.0 m -129.96 154.88 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 27.7 tt0 -130.18 169.58 15.18 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 123.721 1.725 . . . . 0.0 113.372 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.573 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . -171.79 174.78 45.26 Favored Glycine 0 N--CA 1.512 3.744 0 N-CA-C 105.011 -3.236 . . . . 0.0 105.011 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -3.94 59.78 0.0 OUTLIER 'General case' 0 CA--C 1.588 2.426 0 N-CA-C 121.176 3.769 . . . . 0.0 121.176 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' GLY . 33.3 mmtp 59.61 27.25 16.42 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.624 1.202 . . . . 0.0 113.145 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.45 76.78 1.65 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -66.34 107.47 2.02 Favored 'General case' 0 N--CA 1.513 2.682 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.961 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.3 mtm -106.34 165.81 10.98 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -102.12 145.28 29.58 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.54 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.405 HG21 HG23 ' A' ' 10' ' ' ILE . 90.5 t -117.81 97.2 50.55 Favored Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.861 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 7.1 Cg_endo -73.95 175.02 11.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-O 125.154 2.064 . . . . 0.0 111.584 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -77.04 109.06 7.9 Favored Pre-proline 0 C--N 1.284 -2.276 0 CA-C-N 111.527 -2.578 . . . . 0.0 117.262 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -47.08 -32.03 12.67 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.794 2.329 . . . . 0.0 111.707 -170.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -155.73 -178.35 7.23 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 111.932 -2.395 . . . . 0.0 107.318 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.97 159.68 14.78 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.51 -147.68 19.39 Favored Glycine 1 N--CA 1.531 4.971 0 C-N-CA 123.828 0.728 . . . . 0.0 112.663 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 162.16 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 CA-C-N 119.029 1.415 . . . . 0.0 109.521 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 24.9 t -82.25 102.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.844 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.603 ' HZ2' ' C ' ' A' ' 80' ' ' ALA . 11.8 tptm -76.79 -47.8 20.51 Favored 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.482 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 5.4 tt0 -161.33 152.58 18.71 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -149.69 150.67 32.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.592 -1.942 . . . . 0.0 108.489 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 6.0 mttp -115.34 47.28 1.33 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 121.785 0.802 . . . . 0.0 111.246 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -139.49 140.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 113.688 -1.597 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -125.45 -170.44 2.18 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.132 1.444 . . . . 0.0 110.49 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.43 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.78 9.05 4.98 Favored Glycine 1 N--CA 1.517 4.097 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.577 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -101.57 157.3 16.92 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -111.45 146.49 37.12 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.49 168.15 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 113.01 -1.905 . . . . 0.0 113.908 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.31 147.34 22.16 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 t -47.37 122.6 4.79 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.936 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.06 16.94 24.16 Favored Glycine 0 N--CA 1.514 3.835 0 O-C-N 121.353 -0.842 . . . . 0.0 114.96 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -107.02 97.03 6.86 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.796 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.22 87.64 7.19 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 123.592 1.663 . . . . 0.0 112.575 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.465 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -112.4 -26.54 3.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.952 -1.931 . . . . 0.0 116.046 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 5' ' ' VAL . 11.3 ttp -100.56 153.99 18.93 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.605 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.2 126.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 124.957 2.313 . . . . 0.0 115.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.47 ' CD1' HG22 ' A' ' 5' ' ' VAL . 17.8 m-30 -114.5 158.52 21.5 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.475 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' OE2' ' N ' ' A' ' 1' ' ' MET . 3.4 tp10 -140.4 135.75 32.4 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -91.15 56.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 122.074 0.94 . . . . 0.0 113.199 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.453 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER 66.26 -173.27 0.19 Allowed 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 113.486 -1.688 . . . . 0.0 110.324 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.59 -64.49 0.59 Allowed Glycine 0 N--CA 1.505 3.3 1 N-CA-C 102.25 -4.34 . . . . 0.0 102.25 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -156.73 -102.02 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.603 ' C ' ' HZ2' ' A' ' 55' ' ' LYS . . . . . . . . 0 CA--C 1.567 1.623 0 C-N-CA 125.139 1.376 . . . . 0.0 110.622 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.528 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 10.7 mmt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 80.4 t -11.73 123.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.928 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -129.91 162.14 29.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.973 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 2.4 pm0 -105.12 153.34 21.64 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 74' ' ' PHE . 46.6 t -133.18 97.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.951 1.358 . . . . 0.0 113.716 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.7 p-10 -103.51 177.46 4.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.453 HG22 ' CG2' ' A' ' 65' ' ' VAL . 79.0 t -104.29 142.02 23.73 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -79.04 -174.36 2.26 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.114 2.543 . . . . 0.0 113.633 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -69.2 53.77 0.1 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 112.574 -2.103 . . . . 0.0 114.228 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.455 HG22 ' CG2' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -70.87 21.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.104 0 O-C-N 119.776 -1.827 . . . . 0.0 115.805 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 86.61 169.57 46.04 Favored Glycine 0 N--CA 1.506 3.327 0 CA-C-N 112.785 -2.007 . . . . 0.0 113.86 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 38.29 -163.86 0.01 OUTLIER Glycine 1 N--CA 1.525 4.578 0 N-CA-C 120.968 3.147 . . . . 0.0 120.968 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.89 -74.02 0.28 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 112.096 -2.052 . . . . 0.0 112.302 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.68 163.8 28.95 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 123.241 1.496 . . . . 0.0 114.75 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m -152.22 154.57 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.868 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 64' ' ' LYS 0.342 89.9 mt-10 -87.21 -179.43 6.43 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 179.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.69 115.73 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -46.15 9.53 Favored 'General case' 0 N--CA 1.522 3.161 0 CA-C-N 120.343 1.428 . . . . 0.0 110.24 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 45.8 mt-10 -134.68 100.72 4.71 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.058 1.409 . . . . 0.0 113.516 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 61' ' ' VAL . 13.8 p -82.14 58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 122.234 1.016 . . . . 0.0 111.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.1 mmt -22.08 -52.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.09 171.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 120.663 3.579 . . . . 0.0 120.663 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -134.28 -162.17 1.22 Allowed 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 120.541 3.534 . . . . 0.0 120.541 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.12 92.96 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.984 0 O-C-N 119.938 -1.726 . . . . 0.0 113.898 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.39 12.37 13.56 Favored Glycine 1 N--CA 1.517 4.038 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.93 178.08 7.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.016 -1.592 . . . . 0.0 115.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -95.72 142.77 27.62 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG13 ' CD2' ' A' ' 74' ' ' PHE . 1.8 t -145.93 113.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.706 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -132.24 151.92 51.59 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.98 79.12 0.22 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 124.035 1.874 . . . . 0.0 114.945 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CD ' ' N ' ' A' ' 32' ' ' GLN . 2.9 pp20? 166.77 -35.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 109.443 -3.526 . . . . 0.0 108.962 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 4.4 tt0 -58.99 80.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.254 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -31.66 70.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -24.27 -67.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.6 pt -151.43 141.87 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.292 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 20.5 m -99.09 139.94 33.99 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.79 146.08 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.578 ' CD ' ' HG ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -128.6 -162.36 1.18 Allowed 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 118.678 2.844 . . . . 0.0 118.678 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.75 -89.95 0.12 Allowed Glycine 1 N--CA 1.524 4.528 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.974 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.45 -172.9 3.05 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.954 0.883 . . . . 0.0 111.745 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -43.14 7.16 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 121.692 3.96 . . . . 0.0 121.692 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.93 107.27 3.3 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 120.277 1.399 . . . . 0.0 114.145 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.578 ' HG ' ' CD ' ' A' ' 38' ' ' GLU . 1.2 m -65.85 152.59 44.07 Favored 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.8 mmt -125.76 150.6 47.61 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 122.363 0.265 . . . . 0.0 111.663 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -125.15 152.06 44.96 Favored 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.455 ' CG2' HG22 ' A' ' 10' ' ' ILE . 24.9 t -134.7 124.21 16.69 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.267 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -88.43 176.95 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.966 1.777 . . . . 0.0 111.592 171.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -53.31 117.35 11.52 Favored Pre-proline 0 CA--C 1.584 2.285 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -48.85 -21.43 3.71 Favored 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 122.391 2.061 . . . . 0.0 114.235 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -169.92 -174.23 1.76 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.586 -2.097 . . . . 0.0 109.871 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.6 163.82 12.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.18 -152.13 19.89 Favored Glycine 0 N--CA 1.512 3.754 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.042 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.86 164.13 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' CE1' ' A' ' 74' ' ' PHE . 44.9 t -94.56 145.79 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.836 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.469 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 19.0 tttp -112.83 -73.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.58 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 47.7 tt0 -142.42 128.73 19.95 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.8 pt? -122.31 124.81 44.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.58 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.7 mptt -104.86 43.33 1.11 Allowed 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.21 157.41 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-N 114.095 -1.411 . . . . 0.0 114.453 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -144.45 171.44 14.35 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 20' ' ' VAL . 33.5 t -88.74 103.63 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 101.782 -3.414 . . . . 0.0 101.782 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.98 12.91 2.81 Favored Glycine 1 N--CA 1.519 4.18 0 CA-C-N 108.657 -3.883 . . . . 0.0 111.958 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 26.1 t70 -120.39 163.49 17.8 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 111.682 -2.259 . . . . 0.0 107.283 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.22 152.67 22.57 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -136.39 170.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 110.632 -2.985 . . . . 0.0 110.029 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 67' ' ' THR . 15.4 ptmt -171.63 160.55 5.82 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.432 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 9.2 t -56.53 127.46 31.33 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 114.724 -2.79 . . . . 0.0 110.897 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.33 -41.22 2.27 Favored Glycine 0 N--CA 1.509 3.519 0 N-CA-C 117.439 1.736 . . . . 0.0 117.439 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 58.8 m -60.02 127.73 33.34 Favored 'General case' 0 N--CA 1.524 3.228 0 CA-C-N 119.627 1.713 . . . . 0.0 114.225 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.459 ' N ' HD13 ' A' ' 70' ' ' LEU . 8.4 mp -79.13 65.13 4.22 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-O 122.645 1.212 . . . . 0.0 111.649 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.53 HG23 ' SD ' ' A' ' 72' ' ' MET . 40.0 mm -33.49 -54.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.53 ' SD ' HG23 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -148.6 175.91 10.78 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.52 134.05 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.685 0.755 . . . . 0.0 110.665 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.546 ' CD2' HG13 ' A' ' 28' ' ' VAL . 14.6 m-30 -113.48 165.97 11.96 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.894 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 1' ' ' MET . 16.9 tp10 -130.81 80.91 1.97 Allowed 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 123.964 1.84 . . . . 0.0 109.426 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.4 m -34.82 61.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 118.029 2.604 . . . . 0.0 118.029 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -125.26 173.1 9.03 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 120.099 3.37 . . . . 0.0 120.099 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.81 -28.24 3.57 Favored Glycine 1 N--CA 1.517 4.085 0 N-CA-C 104.483 -3.447 . . . . 0.0 104.483 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 80.76 160.82 0.16 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 109.417 -3.391 . . . . 0.0 117.137 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.522 0 C-N-CA 128.998 2.919 . . . . 0.0 104.621 179.763 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' N ' ' OE1' ' A' ' 75' ' ' GLU . 9.5 mtt . . . . . 0 N--CA 1.505 2.291 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.5 t -53.67 118.72 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HZ1' ' CD ' ' A' ' 4' ' ' GLU . 2.3 mmtt -114.65 161.88 17.52 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.988 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 3' ' ' LYS . 1.2 pm0 -107.31 156.21 19.13 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 123.362 1.553 . . . . 0.0 114.257 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 74.6 t -137.5 111.64 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 124.655 2.169 . . . . 0.0 113.275 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.4 p-10 -97.53 166.16 11.64 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 111.981 -2.372 . . . . 0.0 106.28 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.16 135.95 29.32 Favored Pre-proline 0 C--N 1.29 -1.99 0 C-N-CA 117.607 -1.637 . . . . 0.0 109.413 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.488 ' C ' ' HG1' ' A' ' 67' ' ' THR . 9.4 Cg_endo -77.47 -169.2 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.903 1.736 . . . . 0.0 110.961 -172.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -70.28 56.07 0.15 Allowed 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 123.845 1.783 . . . . 0.0 113.458 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.98 42.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 O-C-N 119.672 -1.893 . . . . 0.0 113.511 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.18 -138.4 14.93 Favored Glycine 1 N--CA 1.52 4.296 0 CA-C-N 115.184 -0.916 . . . . 0.0 114.739 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.58 79.98 0.28 Allowed Glycine 1 N--CA 1.517 4.068 0 N-CA-C 105.973 -2.851 . . . . 0.0 105.973 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' CG ' ' HZ2' ' A' ' 66' ' ' LYS . 76.6 m-20 44.87 -129.12 1.03 Allowed 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 121.332 3.827 . . . . 0.0 121.332 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 64' ' ' LYS . 1.1 mm-40 -2.08 78.49 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 1 N-CA-C 122.686 4.328 . . . . 0.0 122.686 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG21 HG21 ' A' ' 65' ' ' VAL . 2.5 m -126.72 158.8 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-N 113.521 -1.672 . . . . 0.0 110.628 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -120.98 172.1 8.17 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.306 -0.871 . . . . 0.0 109.212 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.12 140.75 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.067 0 CA-C-O 123.195 1.474 . . . . 0.0 112.529 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 76.1 p -116.96 -45.94 2.75 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.97 112.94 15.84 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.919 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.8 65.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 124.193 1.949 . . . . 0.0 110.874 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.1 mmt -26.92 -44.85 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.379 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.35 162.94 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -128.63 -165.59 1.52 Allowed 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.8 t -70.23 111.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 O-C-N 120.75 -1.219 . . . . 0.0 108.998 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.32 -0.41 35.05 Favored Glycine 1 N--CA 1.52 4.298 0 O-C-N 124.113 0.883 . . . . 0.0 113.0 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.75 145.42 24.42 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.67 114.11 10.44 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.409 HG12 ' CE2' ' A' ' 74' ' ' PHE . 6.6 t -107.82 110.4 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.072 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.673 -1.267 . . . . 0.0 110.954 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -41.77 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.319 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.924 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -18.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 30' ' ' ALA . 1.2 tm0? -84.71 108.76 17.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 p -40.13 118.21 0.87 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 120.182 3.401 . . . . 0.0 120.182 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 4.8 mt -86.01 -60.98 1.86 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.5 pt -145.82 150.2 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.2 m -102.05 131.22 48.63 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.4 m -121.66 137.31 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.01 150.71 25.46 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 122.09 0.947 . . . . 0.0 112.262 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 40' ' ' ASP . . . -138.16 176.88 20.45 Favored Glycine 1 N--CA 1.524 4.513 0 CA-C-O 117.028 -1.985 . . . . 0.0 109.793 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' OD1' ' HE3' ' A' ' 41' ' ' LYS . 24.1 t0 -53.81 128.39 29.69 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-N 121.853 2.827 . . . . 0.0 106.888 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HE3' ' OD1' ' A' ' 40' ' ' ASP . 22.3 mmtp 41.77 3.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -120.27 140.16 51.64 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 119.748 1.158 . . . . 0.0 113.361 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 p -113.98 137.45 51.68 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 123.63 0.772 . . . . 0.0 110.112 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.1 mtt -145.12 152.66 40.41 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -112.14 138.7 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.969 1.842 . . . . 0.0 113.865 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.5 t -112.28 112.57 52.0 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -86.24 177.06 4.69 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 122.08 1.854 . . . . 0.0 110.167 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -62.85 98.25 0.14 Allowed Pre-proline 0 C--N 1.286 -2.162 1 N-CA-C 123.17 4.507 . . . . 0.0 123.17 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -34.51 -42.04 0.28 Allowed 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.827 2.351 . . . . 0.0 113.388 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -146.36 -173.9 4.31 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 109.916 -3.311 . . . . 0.0 111.389 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.8 154.44 19.58 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.5 -174.02 22.22 Favored Glycine 1 N--CA 1.523 4.451 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.734 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.96 162.01 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 CA-C-N 121.29 2.545 . . . . 0.0 113.307 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.58 121.07 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.24 -49.82 5.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.682 0.674 . . . . 0.0 111.722 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' OE2' ' CE ' ' A' ' 58' ' ' LYS . 45.9 tt0 -153.69 162.78 40.94 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.211 0.529 . . . . 0.0 112.086 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 57' ' ' LEU . 1.8 pt? -171.44 146.64 2.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.074 -1.016 . . . . 0.0 109.783 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' CE ' ' OE2' ' A' ' 56' ' ' GLU . 83.4 mttt -123.46 52.59 1.4 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 p -121.33 164.47 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.317 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -137.54 163.32 31.47 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -95.11 73.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-O 126.833 3.206 . . . . 0.0 109.519 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.92 39.16 0.12 Allowed Glycine 0 N--CA 1.509 3.508 1 CA-C-N 106.196 -5.002 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -120.31 174.39 6.55 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' NZ ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -114.19 136.74 52.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 -179.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 71' ' ' ILE . 1.3 m -117.61 165.81 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.682 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.541 ' HZ2' ' CG ' ' A' ' 13' ' ' ASP . 48.5 tttm -147.94 139.32 23.61 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 116.66 -1.638 . . . . 0.0 107.095 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.488 ' HG1' ' C ' ' A' ' 8' ' ' PRO . 8.9 t -53.98 125.89 20.45 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.637 -2.425 . . . . 0.0 110.279 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.7 -39.54 2.76 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 112.962 -1.926 . . . . 0.0 114.142 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.4 t -52.03 120.73 5.69 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.08 64.22 1.35 Allowed 'General case' 0 N--CA 1.525 3.294 0 CA-C-O 124.161 1.934 . . . . 0.0 111.975 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.475 ' CD1' HG11 ' A' ' 65' ' ' VAL . 18.8 mm -46.37 -44.55 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 120.858 3.651 . . . . 0.0 120.858 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.6 ptm -141.21 157.71 44.88 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.808 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.36 129.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 122.275 1.036 . . . . 0.0 110.882 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.5 ' CZ ' HG22 ' A' ' 5' ' ' VAL . 13.1 m-30 -97.61 -171.44 2.19 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 1' ' ' MET . 6.0 tp10 -157.04 80.77 0.92 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.7 m -38.42 90.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.238 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 35.7 67.03 0.31 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -115.72 -63.54 0.37 Allowed Glycine 1 N--CA 1.521 4.306 1 N-CA-C 99.777 -5.329 . . . . 0.0 99.777 178.931 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 99.81 165.7 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.079 1 N-CA-C 123.215 4.524 . . . . 0.0 123.215 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.071 0 C-N-CA 129.887 3.275 . . . . 0.0 107.65 179.85 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 N--CA 1.503 2.187 0 CA-C-O 114.229 -2.796 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.5 m 13.23 121.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 120.274 3.435 . . . . 0.0 120.274 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -126.39 107.17 10.04 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.332 -2.213 . . . . 0.0 109.988 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.89 148.13 40.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.316 -0.865 . . . . 0.0 111.068 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG23 ' CD1' ' A' ' 74' ' ' PHE . 20.4 t -110.73 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 CA-C-O 123.014 1.387 . . . . 0.0 113.918 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -89.83 161.76 15.83 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.955 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.454 HG22 ' CG2' ' A' ' 65' ' ' VAL . 89.9 t -97.9 128.91 32.47 Favored Pre-proline 0 C--N 1.292 -1.909 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.792 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' C ' ' HG1' ' A' ' 67' ' ' THR . 53.1 Cg_exo -59.88 -169.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.203 1.269 . . . . 0.0 115.131 169.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.39 40.84 0.01 OUTLIER 'General case' 0 CA--C 1.591 2.555 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.489 HG22 ' CG2' ' A' ' 46' ' ' VAL . 3.9 mp -85.3 61.92 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 119.03 -2.294 . . . . 0.0 115.658 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.83 -164.28 13.31 Favored Glycine 0 N--CA 1.495 2.622 0 CA-C-N 112.495 -2.139 . . . . 0.0 117.769 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.37 -158.0 11.62 Favored Glycine 1 N--CA 1.52 4.273 0 CA-C-N 113.782 -1.209 . . . . 0.0 113.016 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 10.4 -102.16 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 125.496 1.351 . . . . 0.0 113.939 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HB3' ' CE ' ' A' ' 66' ' ' LYS . 18.7 pt-20 -157.15 134.95 10.84 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 124.433 2.063 . . . . 0.0 112.339 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.45 175.06 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-N 112.876 -1.966 . . . . 0.0 110.888 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.649 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 11.9 pt-20 -123.36 166.86 14.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.5 t -89.75 128.78 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 55.5 p -102.03 -44.59 5.43 Favored 'General case' 0 N--CA 1.512 2.656 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.786 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -134.84 103.53 5.65 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.515 HG12 ' HZ3' ' A' ' 23' ' ' LYS . 9.0 p -82.4 79.59 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 124.172 1.939 . . . . 0.0 110.46 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 mmt -43.9 -45.42 7.58 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 111.708 -2.496 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.24 158.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' HZ3' HG12 ' A' ' 20' ' ' VAL . 8.8 mptt -130.91 -177.79 4.53 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-O 125.106 2.384 . . . . 0.0 117.434 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.77 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 112.708 -2.042 . . . . 0.0 114.341 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.49 17.18 5.3 Favored Glycine 1 N--CA 1.52 4.248 0 CA-C-N 114.701 -1.136 . . . . 0.0 114.635 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -96.97 141.48 30.09 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 122.656 1.217 . . . . 0.0 113.799 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 53' ' ' VAL . 52.6 mmtt -71.35 97.62 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.122 1.439 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.466 HG12 ' CE2' ' A' ' 74' ' ' PHE . 65.1 t -102.18 107.23 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 113.62 -1.627 . . . . 0.0 115.335 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.49 163.39 18.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.048 -1.033 . . . . 0.0 110.32 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.96 166.24 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.967 0.792 . . . . 0.0 112.795 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 62.17 -26.27 0.06 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -74.5 96.8 2.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.231 -1.543 . . . . 0.0 110.132 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 t -40.7 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -27.13 -67.61 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.0 pt -147.57 143.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 111.902 -2.408 . . . . 0.0 112.526 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.1 m -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.53 158.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.67 156.76 48.33 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-O 122.599 1.19 . . . . 0.0 110.51 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.71 -88.45 0.56 Allowed Glycine 1 N--CA 1.523 4.477 0 C-N-CA 126.907 2.194 . . . . 0.0 109.441 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' O ' ' HD2' ' A' ' 41' ' ' LYS . 1.3 p-10 -129.34 94.71 3.85 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 125.416 2.532 . . . . 0.0 107.391 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.511 ' HD2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER 51.42 25.41 2.61 Favored 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.794 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.18 83.1 2.13 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.237 2.68 . . . . 0.0 118.237 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 t -62.27 113.46 2.9 Favored 'General case' 0 N--CA 1.519 2.977 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -116.39 160.18 20.91 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 122.629 0.372 . . . . 0.0 110.537 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -125.31 152.92 44.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.242 -0.912 . . . . 0.0 113.03 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' CG2' HG22 ' A' ' 10' ' ' ILE . 39.5 t -122.25 113.66 30.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -85.53 177.0 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.249 1.299 . . . . 0.0 112.499 170.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.47 95.53 0.06 OUTLIER Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -38.52 -35.29 0.45 Allowed 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 122.512 2.141 . . . . 0.0 114.073 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -154.76 -174.93 5.18 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 112.117 -2.31 . . . . 0.0 108.758 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.2 155.1 19.0 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.5 -138.61 7.29 Favored Glycine 0 N--CA 1.511 3.638 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.289 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.455 HG12 ' HD3' ' A' ' 27' ' ' LYS . 1.9 t -140.55 165.14 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG21 ' CE1' ' A' ' 74' ' ' PHE . 14.4 t -90.93 137.26 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 118.83 -1.148 . . . . 0.0 107.934 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 19.7 tptt -108.12 -59.6 1.83 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.605 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 27.3 tt0 -149.66 160.85 43.18 Favored 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.605 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -163.21 156.34 19.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.181 -0.95 . . . . 0.0 108.448 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.3 48.75 1.98 Allowed 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.985 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.22 152.35 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.044 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.23 -175.38 3.84 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 124.745 2.212 . . . . 0.0 116.277 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -86.72 114.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 113.07 4.95 23.82 Favored Glycine 0 N--CA 1.511 3.699 0 CA-C-N 108.721 -3.854 . . . . 0.0 110.028 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -79.78 177.55 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.824 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.649 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 28.2 mmtm -114.15 132.92 55.91 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 118.576 2.806 . . . . 0.0 118.576 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.454 ' CG2' HG22 ' A' ' 7' ' ' VAL . 1.3 p -132.86 169.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' CE ' ' HB3' ' A' ' 14' ' ' GLU . 6.4 ptpp? -173.99 134.99 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.434 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 8' ' ' PRO . 11.3 t -33.42 116.34 0.25 Allowed 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 124.741 2.21 . . . . 0.0 113.646 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.87 -35.47 4.68 Favored Glycine 0 N--CA 1.507 3.409 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.941 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.6 m -64.86 136.76 57.22 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.61 72.23 10.7 Favored 'General case' 0 N--CA 1.522 3.138 0 CA-C-O 122.209 1.004 . . . . 0.0 109.621 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.604 HD13 ' SD ' ' A' ' 72' ' ' MET . 1.6 pp -58.11 -46.12 88.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.604 ' SD ' HD13 ' A' ' 71' ' ' ILE . 11.4 ptm -132.83 171.89 13.31 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 118.617 -1.233 . . . . 0.0 114.116 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.24 123.58 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.594 -1.316 . . . . 0.0 112.595 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CD1' HG23 ' A' ' 5' ' ' VAL . 14.8 m-30 -111.96 167.68 10.19 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.292 1.52 . . . . 0.0 113.726 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 32.7 tt0 -145.89 155.85 43.15 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.36 42.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -11.05 -61.23 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.517 0 CA-C-O 124.433 2.063 . . . . 0.0 115.486 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.59 101.55 0.2 Allowed Glycine 0 N--CA 1.499 2.885 1 N-CA-C 98.147 -5.981 . . . . 0.0 98.147 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.69 31.63 2.27 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 117.189 -1.805 . . . . 0.0 113.179 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.841 0 O-C-N 127.859 3.224 . . . . 0.0 106.152 -179.577 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.477 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 2.3 ttp . . . . . 0 N--CA 1.509 2.509 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t -22.02 120.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.59 152.98 44.39 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -109.92 149.46 29.87 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.642 1.687 . . . . 0.0 114.731 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.516 HG23 ' CE1' ' A' ' 74' ' ' PHE . 70.2 t -122.86 114.29 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.565 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -109.9 -178.41 3.52 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.438 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 65' ' ' VAL . 59.5 t -102.19 128.63 28.0 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.016 -1.074 . . . . 0.0 113.486 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -77.87 -164.11 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.99 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.27 64.61 2.7 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.48 HD11 ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -75.82 56.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.316 0 O-C-N 119.908 -1.745 . . . . 0.0 111.296 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.61 -54.69 1.07 Allowed Glycine 1 N--CA 1.519 4.184 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.21 -34.85 1.8 Allowed Glycine 0 N--CA 1.514 3.884 0 CA-C-N 112.406 -1.897 . . . . 0.0 113.791 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.72 -167.35 0.45 Allowed 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.58 ' CD ' ' NZ ' ' A' ' 64' ' ' LYS . 3.4 mt-10 -108.03 129.14 55.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 120.796 -1.19 . . . . 0.0 108.774 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 23.0 m -125.08 168.71 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 29.3 mt-10 -93.29 163.28 13.67 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.033 1.458 . . . . 0.0 112.302 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.06 112.61 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.2 t -98.71 -37.41 9.5 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -129.92 127.65 40.55 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.55 65.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 124.526 2.108 . . . . 0.0 113.359 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.4 mmt -24.49 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 110.925 -2.852 . . . . 0.0 117.839 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.445 ' CG2' HE22 ' A' ' 32' ' ' GLN . 2.9 t -122.67 155.82 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.1 tttt -127.51 178.66 5.95 Favored 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 120.797 3.629 . . . . 0.0 120.797 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.21 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 113.716 -1.584 . . . . 0.0 113.576 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.63 1.39 19.79 Favored Glycine 1 N--CA 1.517 4.037 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.891 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -90.32 150.54 21.87 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.651 1.215 . . . . 0.0 113.092 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -75.94 112.6 12.52 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.892 0.853 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -106.61 101.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.437 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -105.89 151.13 24.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.306 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.19 157.85 0.42 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.564 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 69.5 -26.24 0.15 Allowed 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 122.658 1.218 . . . . 0.0 112.961 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.445 HE22 ' CG2' ' A' ' 22' ' ' VAL . 4.5 tm0? -80.15 102.13 9.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.223 -1.548 . . . . 0.0 109.471 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.2 t -33.25 124.99 0.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 HD11 ' HA ' ' A' ' 48' ' ' ALA . 3.8 mt -93.6 -52.71 4.35 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 110.711 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 pt -144.26 134.69 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.9 m -92.1 120.68 32.94 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 102.789 -3.041 . . . . 0.0 102.789 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.1 m -109.02 147.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -127.52 -146.49 0.33 Allowed 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.73 -116.94 1.26 Allowed Glycine 1 N--CA 1.525 4.59 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -88.14 83.36 6.99 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 126.594 3.092 . . . . 0.0 116.393 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 68.36 -20.44 0.14 Allowed 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 111.97 -2.377 . . . . 0.0 115.292 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.21 139.8 32.65 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -116.84 141.25 48.46 Favored 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ttm -143.22 171.04 14.63 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -130.32 153.02 49.1 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.446 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 3.9 t -130.45 105.31 15.97 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.48 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -81.73 178.73 6.28 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 CA-C-O 123.612 1.421 . . . . 0.0 112.276 177.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -66.0 117.08 38.97 Favored Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -49.63 -22.31 6.5 Favored 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 123.186 2.591 . . . . 0.0 114.968 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -171.52 -174.06 1.33 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 113.232 -1.804 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.56 119.1 38.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 -165.37 32.62 Favored Glycine 0 N--CA 1.513 3.769 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.44 154.37 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 CA-C-N 118.205 1.003 . . . . 0.0 109.204 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 24.3 t -78.8 121.18 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -97.37 -56.72 2.45 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.754 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 31.0 tt0 -149.08 150.53 32.9 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.997 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -146.23 163.77 34.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.075 -1.641 . . . . 0.0 108.869 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.465 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 8.4 mmtp -133.89 42.6 2.92 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.24 154.02 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-N 113.969 -1.468 . . . . 0.0 114.071 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -130.78 -175.93 3.83 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-O 125.542 2.592 . . . . 0.0 116.089 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.14 109.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 1 N-CA-C 99.135 -4.394 . . . . 0.0 99.135 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.47 -27.26 3.12 Favored Glycine 0 N--CA 1.508 3.443 0 CA-C-N 111.518 -2.583 . . . . 0.0 107.532 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -72.95 159.18 34.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.341 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' NZ ' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -115.27 143.65 44.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -131.62 161.7 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HB3' ' CG ' ' A' ' 14' ' ' GLU . 1.2 pttp -156.02 158.27 37.55 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -27.72 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.19 -42.14 1.96 Allowed Glycine 0 N--CA 1.515 3.943 0 CA-C-N 112.944 -1.934 . . . . 0.0 114.923 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.7 m -36.0 118.39 0.51 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 mp -67.72 64.95 0.08 Allowed 'General case' 0 N--CA 1.513 2.699 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.9 mt -23.6 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.449 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptp -167.93 -176.85 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 111.361 -2.654 . . . . 0.0 115.586 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.26 122.67 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 123.495 1.617 . . . . 0.0 114.829 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CE1' HG23 ' A' ' 5' ' ' VAL . 10.7 m-30 -102.76 175.74 5.39 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 113.435 -1.711 . . . . 0.0 109.543 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' OE2' ' N ' ' A' ' 1' ' ' MET 0.28 22.3 tp10 -144.97 109.71 5.01 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.47 72.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 121.398 3.851 . . . . 0.0 121.398 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -121.6 149.73 42.72 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.4 -47.85 0.04 OUTLIER Glycine 1 N--CA 1.526 4.656 0 CA-C-O 122.01 0.783 . . . . 0.0 112.526 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 146.48 32.87 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.953 0 CA-C-N 109.2 -3.5 . . . . 0.0 109.495 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.572 1.826 3 N-CA-C 98.242 -4.725 . . . . 0.0 98.242 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.709 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.491 ' CG1' ' HZ1' ' A' ' 55' ' ' LYS . 20.4 m -15.03 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 1 N-CA-C 122.858 4.392 . . . . 0.0 122.858 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -127.61 160.38 31.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.428 -2.623 . . . . 0.0 106.449 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -105.29 169.16 8.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.476 1.131 . . . . 0.0 110.437 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.505 HG23 ' CD1' ' A' ' 74' ' ' PHE . 73.2 t -125.82 102.27 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 114.343 -1.298 . . . . 0.0 113.804 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.7 p-10 -99.43 163.52 12.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.1 t -75.4 138.09 71.3 Favored Pre-proline 0 N--CA 1.502 2.127 0 C-N-CA 116.862 -1.935 . . . . 0.0 110.503 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.3 -174.98 1.35 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.098 1.866 . . . . 0.0 112.675 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.73 49.07 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.404 HG22 HG21 ' A' ' 46' ' ' VAL . 37.8 pt -79.78 58.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 O-C-N 119.366 -2.084 . . . . 0.0 111.893 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -20.04 69.77 0.0 OUTLIER Glycine 1 N--CA 1.524 4.539 0 N-CA-C 122.975 3.95 . . . . 0.0 122.975 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.46 -155.95 9.23 Favored Glycine 1 N--CA 1.524 4.552 0 N-CA-C 118.845 2.298 . . . . 0.0 118.845 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -56.89 -120.18 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.626 0 CA-C-N 112.895 -1.653 . . . . 0.0 109.359 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.451 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 8.6 tt0 -151.61 122.12 7.38 Favored 'General case' 0 N--CA 1.497 1.889 1 N-CA-C 99.44 -4.282 . . . . 0.0 99.44 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.92 169.37 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.0 pt-20 -113.56 167.46 10.58 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 t -84.42 119.43 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 t -100.77 -36.76 8.98 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.81 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.03 117.5 16.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.41 59.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.0 mmt -18.98 -45.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.8 155.77 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 22.3 mttt -140.72 -169.34 2.78 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 121.666 3.95 . . . . 0.0 121.666 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -51.49 84.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.08 -0.25 14.69 Favored Glycine 1 N--CA 1.519 4.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -89.1 139.83 30.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.883 1.801 . . . . 0.0 113.018 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 49.8 mmtt -62.77 74.22 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 112.534 -2.121 . . . . 0.0 116.459 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -74.0 97.77 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.73 156.88 17.23 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.337 -1.477 . . . . 0.0 108.958 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -58.27 168.81 0.97 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.999 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.71 -24.66 0.08 Allowed 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 30' ' ' ALA . 3.7 tm0? -82.42 109.07 16.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 123.231 1.491 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 10.1 m -35.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 120.927 3.677 . . . . 0.0 120.927 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.419 HD11 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -24.77 -58.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 pt -146.14 150.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.92 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 96.7 m -102.52 124.93 48.96 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.4 m -110.8 154.0 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -140.73 -161.95 1.29 Allowed 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' A' ' 38' ' ' GLU . . . 148.87 -84.84 0.17 Allowed Glycine 1 N--CA 1.525 4.588 0 N-CA-C 115.673 1.029 . . . . 0.0 115.673 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 42' ' ' ALA . 1.8 m-20 -115.37 -131.36 0.32 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 123.175 1.464 . . . . 0.0 109.193 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' NZ ' ' OD2' ' A' ' 13' ' ' ASP . 27.5 pttt -8.84 -32.99 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 121.576 3.917 . . . . 0.0 121.576 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . 178.48 178.05 0.42 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.739 0.78 . . . . 0.0 110.935 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.7 t -99.97 150.26 22.6 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.472 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 mtm -132.81 164.33 27.08 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -122.19 148.73 44.58 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.062 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG21 HG22 ' A' ' 10' ' ' ILE . 76.0 t -122.76 116.21 29.18 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.16 172.32 13.97 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 CA-C-O 124.455 1.773 . . . . 0.0 110.347 176.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -76.34 117.05 61.59 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 111.84 -2.436 . . . . 0.0 115.377 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -39.34 -37.45 1.14 Allowed 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.008 2.472 . . . . 0.0 113.632 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.34 -174.16 4.55 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 110.963 -2.835 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.14 152.39 18.39 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.69 -150.14 22.33 Favored Glycine 1 N--CA 1.517 4.085 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.843 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.11 157.5 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 O-C-N 121.768 -0.842 . . . . 0.0 112.15 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 30.4 t -83.02 128.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 C-N-CA 118.091 -1.444 . . . . 0.0 107.662 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 81.1 tttt -106.26 -72.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 38.4 tt0 -127.36 123.28 35.86 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 123.368 1.556 . . . . 0.0 111.314 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.405 ' H ' HD22 ' A' ' 57' ' ' LEU . 2.0 pt? -129.07 146.49 51.01 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.548 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 87.8 mttt -127.95 53.16 1.81 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.82 137.58 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 110.204 -3.18 . . . . 0.0 111.051 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.555 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.3 m120 -120.37 -171.33 2.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.741 2.21 . . . . 0.0 114.683 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.65 87.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 125.978 2.799 . . . . 0.0 106.422 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.07 24.35 0.23 Allowed Glycine 0 N--CA 1.516 3.97 1 CA-C-N 106.715 -4.766 . . . . 0.0 112.809 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -106.22 152.15 23.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -102.6 145.27 29.89 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.15 163.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.989 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.519 ' NZ ' ' O ' ' A' ' 13' ' ' ASP . 53.4 tttt -166.0 145.89 6.32 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.037 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -36.74 116.14 0.41 Allowed 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.403 1.573 . . . . 0.0 112.426 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.28 -52.18 0.73 Allowed Glycine 0 N--CA 1.511 3.665 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.951 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 16.4 t -45.74 128.18 8.44 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.39 60.24 0.62 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.7 mt -18.94 -60.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 119.031 2.974 . . . . 0.0 119.031 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -167.42 -172.51 1.97 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 112.321 -2.218 . . . . 0.0 115.238 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.08 130.42 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 124.414 2.054 . . . . 0.0 112.691 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.505 ' CD1' HG23 ' A' ' 5' ' ' VAL . 13.2 m-30 -117.49 145.88 43.9 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 111.804 -2.453 . . . . 0.0 113.202 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.513 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 8.4 tt0 -124.2 162.58 23.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 78' ' ' GLY . 28.1 m -111.52 120.53 62.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 119.733 3.234 . . . . 0.0 119.733 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.455 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 58.7 mt-10 -65.35 76.31 0.06 Allowed 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 124.19 1.948 . . . . 0.0 109.685 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . 161.93 78.1 0.03 OUTLIER Glycine 0 N--CA 1.507 3.371 1 N-CA-C 99.505 -5.438 . . . . 0.0 99.505 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.99 62.09 4.8 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 C-N-CA 127.252 2.221 . . . . 0.0 108.88 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.534 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 5.8 ptp . . . . . 0 N--CA 1.506 2.374 0 CA-C-O 117.477 -1.249 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m -76.6 155.0 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -145.62 149.06 33.83 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 111.549 -2.569 . . . . 0.0 111.376 178.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -97.4 104.2 16.2 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.492 1.139 . . . . 0.0 113.773 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 77.1 t -71.22 99.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 CA-C-O 124.8 2.238 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 69' ' ' SER . 5.8 p30 -96.05 177.4 5.75 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.631 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 67' ' ' THR . 78.2 t -98.01 131.82 25.85 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.26 -176.29 1.58 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 120.708 0.939 . . . . 0.0 114.048 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -68.42 46.55 0.05 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 112.605 -2.089 . . . . 0.0 114.382 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.35 45.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 O-C-N 119.59 -1.944 . . . . 0.0 113.33 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.12 -163.93 12.16 Favored Glycine 0 N--CA 1.513 3.815 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.053 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.62 -35.65 1.53 Allowed Glycine 1 N--CA 1.522 4.423 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -41.43 162.55 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.934 0 CA-C-N 109.324 -3.438 . . . . 0.0 113.276 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 2.7 tp10 -117.7 112.29 20.27 Favored 'General case' 0 N--CA 1.52 3.063 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.99 177.29 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.712 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.9 pt-20 -111.3 169.55 8.72 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.17 114.11 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -93.67 -44.79 8.0 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 112.84 -1.982 . . . . 0.0 114.859 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' HG3' HG23 ' A' ' 18' ' ' THR . 36.0 mt-10 -131.16 102.77 6.14 Favored 'General case' 0 N--CA 1.52 3.036 0 CA-C-N 119.866 1.212 . . . . 0.0 111.452 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.28 72.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 O-C-N 119.284 -2.135 . . . . 0.0 113.498 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.465 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 57.1 mmm -34.65 -52.28 0.51 Allowed 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.65 150.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 CA-C-N 119.574 1.079 . . . . 0.0 113.55 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -123.33 169.28 11.48 Favored 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -54.59 87.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.292 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 127.32 9.62 4.03 Favored Glycine 1 N--CA 1.517 4.046 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -92.24 140.22 29.83 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.69 1.234 . . . . 0.0 111.91 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' NZ ' ' OXT' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -75.66 86.2 2.71 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 126.839 2.056 . . . . 0.0 109.162 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.64 149.3 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -140.59 154.6 46.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' ALA . . . -69.11 99.19 1.08 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 139.81 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 127.784 3.177 . . . . 0.0 108.185 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -71.3 105.8 3.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 112.708 -2.042 . . . . 0.0 113.665 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 16.6 t -39.03 96.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 112.569 -2.105 . . . . 0.0 115.554 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' VAL . 4.2 mt -53.52 -62.8 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' H ' HG22 ' A' ' 46' ' ' VAL . 25.6 pt -147.91 128.8 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.906 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 19' ' ' GLU . 5.2 m -67.87 129.79 40.99 Favored 'General case' 0 N--CA 1.517 2.917 0 O-C-N 119.965 -1.709 . . . . 0.0 111.066 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.6 m -119.67 151.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.707 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 43' ' ' SER . 3.4 tt0 -142.51 -152.04 0.39 Allowed 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.57 -69.93 0.31 Allowed Glycine 1 N--CA 1.526 4.65 0 C-N-CA 124.936 1.255 . . . . 0.0 112.759 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -116.09 -165.69 1.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 117.828 0.814 . . . . 0.0 110.795 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -56.36 25.96 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 121.474 3.879 . . . . 0.0 121.474 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.13 76.32 1.5 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 123.456 1.598 . . . . 0.0 114.831 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 92.7 p -59.52 127.86 34.16 Favored 'General case' 0 N--CA 1.51 2.554 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.99 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.0 mtm -139.55 164.71 29.17 Favored 'General case' 0 N--CA 1.516 2.872 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -120.3 168.52 11.18 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 123.148 1.451 . . . . 0.0 114.19 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -115.74 129.42 25.17 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.64 168.74 11.04 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-O 123.384 1.327 . . . . 0.0 109.935 168.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 30' ' ' ALA . . . -74.98 117.19 60.83 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 112.859 -1.973 . . . . 0.0 115.065 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -48.62 -25.75 8.33 Favored 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.011 1.807 . . . . 0.0 114.016 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.41 ' HA ' ' HB1' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -158.08 -173.37 4.31 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.896 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.71 165.86 10.83 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.1 -153.61 21.01 Favored Glycine 1 N--CA 1.522 4.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 113.538 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.07 153.51 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 41.3 t -77.14 84.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -61.83 -44.64 96.43 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.644 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.578 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 28.3 tt0 -176.46 159.23 1.91 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 124.005 0.815 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.509 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.7 pt? -154.76 159.77 40.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.323 -0.861 . . . . 0.0 109.703 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.578 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 29.8 mmtt -126.33 45.82 2.58 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.16 161.93 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.69 171.4 9.62 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 125.367 2.508 . . . . 0.0 116.952 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.86 100.15 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 1 N-CA-C 99.784 -4.154 . . . . 0.0 99.784 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.14 19.97 0.95 Allowed Glycine 0 N--CA 1.51 3.576 1 CA-C-N 107.305 -4.498 . . . . 0.0 111.84 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.18 170.43 8.1 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.482 0.713 . . . . 0.0 109.278 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -103.43 143.65 32.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.778 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 m -132.52 127.49 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 67' ' ' THR . 26.1 ttmt -139.98 151.54 45.59 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.471 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 7.6 t -42.21 118.5 1.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 117.271 -1.772 . . . . 0.0 111.495 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.23 -51.36 0.78 Allowed Glycine 0 N--CA 1.513 3.793 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m -39.51 119.55 0.96 Allowed 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.62 65.47 1.82 Allowed 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 123.065 1.412 . . . . 0.0 111.346 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 mm -48.78 -57.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 120.729 3.604 . . . . 0.0 120.729 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.9 ptp -135.49 166.89 22.15 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.346 -0.846 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -110.47 122.51 65.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.811 1.291 . . . . 0.0 112.253 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.51 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 7.5 m-30 -117.07 149.27 40.58 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.534 ' OE2' ' N ' ' A' ' 1' ' ' MET . 3.4 tt0 -131.96 127.48 36.43 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.469 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.8 m -68.82 49.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.483 1 N-CA-C 122.142 4.127 . . . . 0.0 122.142 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 3.82 -68.23 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 121.004 3.705 . . . . 0.0 121.004 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.74 43.07 0.23 Allowed Glycine 0 N--CA 1.516 3.981 0 CA-C-N 110.568 -3.015 . . . . 0.0 105.9 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 30.19 77.9 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 1 N-CA-C 121.844 4.016 . . . . 0.0 121.844 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.469 ' OXT' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.574 1.901 0 CA-C-N 111.685 -2.507 . . . . 0.0 113.765 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.674 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.244 -1.836 . . . . 0.0 107.168 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.2 t -21.28 136.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.498 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 3.1 mmmp? -134.17 166.5 22.62 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.129 1.443 . . . . 0.0 110.886 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' NZ ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -107.56 157.32 18.14 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.296 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG23 ' CD1' ' A' ' 74' ' ' PHE . 58.9 t -126.08 106.98 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 CA-C-O 121.883 0.849 . . . . 0.0 111.504 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -101.87 152.85 20.41 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' A' ' 65' ' ' VAL . 99.2 t -71.33 132.29 86.06 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 116.877 -1.929 . . . . 0.0 112.197 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -71.91 -175.17 1.56 Allowed 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 122.616 2.211 . . . . 0.0 115.329 172.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.34 46.52 0.02 OUTLIER 'General case' 0 CA--C 1.583 2.217 0 C-N-CA 127.452 2.301 . . . . 0.0 116.224 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.424 HG23 HG21 ' A' ' 46' ' ' VAL . 36.2 pt -75.23 53.66 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -23.58 92.41 0.01 OUTLIER Glycine 1 N--CA 1.53 4.905 0 N-CA-C 118.515 2.166 . . . . 0.0 118.515 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.26 37.32 0.02 OUTLIER Glycine 1 N--CA 1.535 5.255 0 CA-C-O 124.826 2.348 . . . . 0.0 111.782 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.282 30.2 m-20 -1.54 68.28 0.0 OUTLIER 'General case' 0 CA--C 1.597 2.772 2 N-CA-C 127.928 6.27 . . . . 0.0 127.928 -179.516 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' CD ' ' HZ2' ' A' ' 66' ' ' LYS . 4.0 tp10 109.64 78.54 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.848 0 C-N-CA 128.66 2.784 . . . . 0.0 108.113 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.0 m -106.58 156.12 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-N 113.348 -1.751 . . . . 0.0 115.358 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 34.5 mt-10 -96.31 164.19 12.76 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.747 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 t -103.4 116.25 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.099 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 2.1 t -96.8 -41.96 8.2 Favored 'General case' 0 N--CA 1.524 3.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.765 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -131.99 105.21 7.27 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.947 0.879 . . . . 0.0 110.855 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.45 63.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 O-C-N 119.087 -2.258 . . . . 0.0 115.261 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.6 mmm -23.17 -42.44 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 119.403 3.112 . . . . 0.0 119.403 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.74 155.26 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.6 tttm -131.46 175.33 9.24 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 120.551 3.537 . . . . 0.0 120.551 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.47 91.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.28 0.38 12.76 Favored Glycine 1 N--CA 1.516 4.03 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.775 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -93.27 143.65 26.07 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.58 1.181 . . . . 0.0 112.706 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HZ2' ' CD ' ' A' ' 77' ' ' GLU . 14.0 mmmm -66.33 121.77 16.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.15 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.6 t -116.04 115.19 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.894 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -122.91 151.42 41.78 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.696 -0.628 . . . . 0.0 111.282 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -48.02 158.26 0.24 Allowed 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 69.51 -28.42 0.16 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 122.541 1.162 . . . . 0.0 112.753 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 30' ' ' ALA . 6.4 tt0 -77.35 105.13 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.316 -1.49 . . . . 0.0 111.575 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 19.8 t -37.92 120.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.469 HD11 ' HA ' ' A' ' 48' ' ' ALA . 2.8 mt -85.78 -51.03 6.69 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.1 pt -146.79 137.35 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.958 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -84.32 128.26 34.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 34.4 m -119.35 160.77 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 1.7 tt0 -138.13 -143.02 0.16 Allowed 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . 145.48 -104.83 0.32 Allowed Glycine 1 N--CA 1.524 4.54 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' OD2' ' NZ ' ' A' ' 41' ' ' LYS 0.314 0.3 OUTLIER -90.45 -89.22 0.16 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 118.474 1.137 . . . . 0.0 113.651 -179.7 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.447 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -114.19 43.06 1.94 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.55 149.51 1.67 Allowed 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 93.5 p -106.02 126.94 52.8 Favored 'General case' 0 N--CA 1.513 2.708 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.95 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.8 mtt -129.74 174.29 9.85 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -124.81 153.81 41.93 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 122.115 0.96 . . . . 0.0 113.512 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 HG21 HG23 ' A' ' 10' ' ' ILE . 53.1 t -121.03 104.42 41.44 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.525 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.5 OUTLIER -80.18 177.63 8.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 CA-C-O 123.779 1.491 . . . . 0.0 111.087 179.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -71.89 111.49 10.79 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -46.11 -28.52 5.48 Favored 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 121.884 1.723 . . . . 0.0 113.049 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -163.05 -173.51 3.47 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.112 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.89 160.78 14.51 Favored 'General case' 0 CA--C 1.579 2.07 1 N-CA-C 121.879 4.029 . . . . 0.0 121.879 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.95 -124.26 3.06 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 114.577 -1.192 . . . . 0.0 114.096 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -141.48 159.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.206 0 O-C-N 121.996 -0.708 . . . . 0.0 111.305 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG11 ' SD ' ' A' ' 72' ' ' MET . 67.6 t -80.85 112.0 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 28.3 tttm -89.94 -64.55 1.12 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.431 -1.308 . . . . 0.0 110.045 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.507 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 42.4 tt0 -145.07 133.77 22.2 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.3 pt? -130.53 163.13 27.72 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.532 -1.98 . . . . 0.0 109.314 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.507 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 14.1 mmtp -133.64 42.02 3.0 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 p -132.26 159.61 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.942 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -126.19 177.65 6.27 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -94.03 108.81 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 1 N-CA-C 97.752 -4.907 . . . . 0.0 97.752 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.2 6.05 6.45 Favored Glycine 0 N--CA 1.515 3.908 0 CA-C-N 109.898 -3.319 . . . . 0.0 109.784 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.71 156.84 16.17 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.451 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.72 144.38 41.11 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 7' ' ' VAL . 14.2 m -138.4 172.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.551 ' HZ2' ' CD ' ' A' ' 14' ' ' GLU . 10.8 ptpt -178.0 156.63 1.07 Allowed 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.2 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -26.73 101.4 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 118.644 2.831 . . . . 0.0 118.644 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.79 -53.02 0.69 Allowed Glycine 0 N--CA 1.511 3.697 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.073 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.1 m -21.85 117.2 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.36 59.49 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.41 HG23 ' HG2' ' A' ' 72' ' ' MET . 4.3 mm -34.5 -58.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.549 ' SD ' HG11 ' A' ' 54' ' ' VAL . 5.1 ptp -174.43 -170.81 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.261 -1.79 . . . . 0.0 113.757 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -116.7 130.28 71.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-O 124.026 1.87 . . . . 0.0 107.883 178.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 8.9 m-30 -112.69 161.65 16.62 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.835 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -134.36 137.19 43.95 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 m -76.53 74.15 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 124.552 2.12 . . . . 0.0 116.047 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.484 ' CD ' ' HZ2' ' A' ' 27' ' ' LYS . 3.5 mt-10 76.13 -97.57 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 108.598 -3.91 . . . . 0.0 118.18 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.0 77.0 0.11 Allowed Glycine 0 N--CA 1.513 3.83 1 N-CA-C 100.97 -4.852 . . . . 0.0 100.97 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.44 34.79 0.64 Allowed 'General case' 0 CA--C 1.573 1.855 0 CA-C-N 112.83 -1.685 . . . . 0.0 114.577 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.721 0 C-N-CA 128.34 2.656 . . . . 0.0 106.978 -179.527 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mtp . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.927 -1.035 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.82 -178.89 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.928 0 CA-C-N 119.888 1.222 . . . . 0.0 109.911 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.68 160.65 26.74 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 123.826 0.704 . . . . 0.0 110.008 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -108.4 169.32 8.72 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.522 HG23 ' CE1' ' A' ' 74' ' ' PHE . 39.5 t -134.91 117.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -106.33 166.67 10.37 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.412 ' CG2' HG12 ' A' ' 71' ' ' ILE . 48.1 t -85.73 140.53 35.6 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.89 178.9 6.05 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.38 1.387 . . . . 0.0 112.879 171.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' GLY . 4.2 p-10 -64.48 56.18 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.459 HG23 HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -82.45 41.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.039 0 O-C-N 119.439 -2.038 . . . . 0.0 111.974 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 7.1 53.42 0.0 OUTLIER Glycine 1 N--CA 1.524 4.552 0 N-CA-C 119.957 2.743 . . . . 0.0 119.957 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.3 -28.26 0.24 Allowed Glycine 1 N--CA 1.522 4.387 0 CA-C-N 113.79 -1.205 . . . . 0.0 112.152 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.301 20.5 m-20 15.0 16.02 0.0 OUTLIER 'General case' 0 CA--C 1.586 2.351 2 N-CA-C 124.922 5.156 . . . . 0.0 124.922 -179.78 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -146.94 69.76 1.18 Allowed 'General case' 0 N--CA 1.501 2.114 1 N-CA-C 97.233 -5.099 . . . . 0.0 97.233 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 34.3 m -140.7 168.32 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.822 0 C-N-CA 117.497 -1.681 . . . . 0.0 115.034 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -110.85 171.33 7.53 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 124.207 0.942 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.2 t -107.04 115.11 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.541 -0.724 . . . . 0.0 111.758 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 27.7 p -97.01 -50.38 4.64 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 124.065 0.946 . . . . 0.0 112.597 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 12.8 mp0 -121.63 105.22 10.23 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 123.594 1.664 . . . . 0.0 113.241 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.36 70.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 123.672 1.701 . . . . 0.0 114.367 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 12.9 mmt -30.36 -47.93 0.09 Allowed 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.458 ' CG2' HD22 ' A' ' 34' ' ' LEU . 15.8 m -128.71 154.35 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-O 122.853 1.311 . . . . 0.0 112.751 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.5 mtmt -129.3 -170.2 2.24 Favored 'General case' 0 N--CA 1.522 3.174 0 N-CA-C 119.066 2.987 . . . . 0.0 119.066 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.22 93.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.33 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.87 11.28 8.55 Favored Glycine 1 N--CA 1.516 4.003 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.553 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.5 m-20 -101.85 130.6 48.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 123.765 1.745 . . . . 0.0 112.649 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -57.0 91.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 111.648 -2.524 . . . . 0.0 111.642 179.156 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.45 120.98 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.75 155.69 50.14 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.7 -1.25 . . . . 0.0 112.561 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.33 156.25 4.48 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.464 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 81.37 -20.29 0.38 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.715 1.884 . . . . 0.0 111.251 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.487 ' HG2' ' N ' ' A' ' 33' ' ' SER . 3.6 tt0 -95.15 155.4 16.75 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.579 1.181 . . . . 0.0 109.425 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.487 ' N ' ' HG2' ' A' ' 32' ' ' GLN . 62.6 p -76.13 134.16 40.05 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.213 1.482 . . . . 0.0 112.57 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.487 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 4.2 mt -96.13 -58.77 1.99 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.921 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.74 148.38 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.576 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 64.9 m -94.81 135.34 36.42 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.1 m -125.98 147.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.579 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -132.84 -165.6 1.63 Allowed 'General case' 0 N--CA 1.512 2.651 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.579 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . 163.14 -83.91 0.11 Allowed Glycine 1 N--CA 1.521 4.304 0 CA-C-N 114.46 -1.245 . . . . 0.0 115.316 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 25.0 t70 -120.86 -122.79 0.28 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 117.705 0.752 . . . . 0.0 111.422 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 65.3 mmtt -6.67 -46.23 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 119.768 3.248 . . . . 0.0 119.768 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -178.59 179.42 0.74 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 123.602 0.761 . . . . 0.0 112.016 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.7 145.01 26.85 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.049 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.1 mtp -133.04 168.64 18.11 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.529 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -129.64 156.09 44.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.459 HG21 HG23 ' A' ' 10' ' ' ILE . 71.1 t -119.15 114.36 35.03 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.299 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -81.91 177.77 7.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 CA-C-O 123.698 1.458 . . . . 0.0 111.873 171.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -75.09 103.52 0.99 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 119.447 3.129 . . . . 0.0 119.447 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -41.41 -34.36 1.89 Allowed 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.664 2.242 . . . . 0.0 113.908 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.56 -169.25 3.06 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 113.34 -1.754 . . . . 0.0 110.159 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.1 163.25 13.32 Favored 'General case' 0 CA--C 1.574 1.869 1 N-CA-C 123.135 4.494 . . . . 0.0 123.135 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.96 -142.93 14.51 Favored Glycine 1 N--CA 1.517 4.039 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.394 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.42 165.76 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 O-C-N 121.813 -0.816 . . . . 0.0 108.955 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 22.5 t -89.72 128.08 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.212 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -103.62 -58.75 1.83 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 22.4 tt0 -141.95 151.2 42.35 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.949 0.795 . . . . 0.0 111.825 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -148.92 154.01 38.82 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 119.499 -2.001 . . . . 0.0 110.397 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 76.9 mttt -131.87 49.26 2.34 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-O 125.224 2.44 . . . . 0.0 109.582 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.0 m -137.5 151.9 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 1 CA-C-N 108.345 -4.025 . . . . 0.0 108.537 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -134.14 176.9 8.17 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 122.94 1.352 . . . . 0.0 111.585 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 18' ' ' THR . 1.6 t -88.29 114.1 26.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 1 N-CA-C 95.713 -5.662 . . . . 0.0 95.713 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.52 7.88 6.65 Favored Glycine 0 N--CA 1.513 3.822 0 CA-C-N 109.271 -3.604 . . . . 0.0 110.785 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' CG ' ' HZ2' ' A' ' 64' ' ' LYS . 19.1 t70 -113.19 167.66 10.36 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.931 0.872 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.67 157.86 16.17 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.75 165.81 9.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 112.842 -1.981 . . . . 0.0 112.596 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -172.61 146.19 1.65 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 123.31 0.381 . . . . 0.0 110.951 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -42.12 113.32 0.42 Allowed 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 125.416 2.532 . . . . 0.0 115.952 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 -40.81 2.31 Favored Glycine 0 N--CA 1.515 3.932 0 CA-C-N 112.92 -1.945 . . . . 0.0 113.089 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.2 m -53.33 128.45 28.38 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.77 66.17 0.13 Allowed 'General case' 0 N--CA 1.521 3.097 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.551 ' HB ' ' SD ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -27.48 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.551 ' SD ' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -157.46 -173.23 4.31 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 110.773 -2.921 . . . . 0.0 115.147 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.75 132.25 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 123.229 1.49 . . . . 0.0 110.432 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.522 ' CE1' HG23 ' A' ' 5' ' ' VAL . 18.2 m-30 -114.12 169.17 9.21 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-N 113.734 -1.576 . . . . 0.0 115.23 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -138.46 127.08 23.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 123.467 1.603 . . . . 0.0 109.173 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.8 m -77.94 86.31 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -3.32 72.72 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 N-CA-C 121.552 3.908 . . . . 0.0 121.552 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -140.44 26.11 2.57 Favored Glycine 0 N--CA 1.507 3.402 0 N-CA-C 106.072 -2.811 . . . . 0.0 106.072 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -31.73 102.34 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 118.586 2.81 . . . . 0.0 118.586 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.61 0 O-C-N 124.655 1.222 . . . . 0.0 110.194 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mtp . . . . . 0 N--CA 1.51 2.56 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.9 m 0.17 119.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 N-CA-C 119.986 3.328 . . . . 0.0 119.986 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' HZ2' ' CD ' ' A' ' 4' ' ' GLU . 24.7 mmmt -119.8 158.71 26.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.366 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.545 ' CD ' ' HZ2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -96.18 145.92 25.12 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 123.424 1.583 . . . . 0.0 114.581 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG23 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -121.56 91.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-O 123.864 1.792 . . . . 0.0 111.223 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.5 p30 -101.91 -179.49 4.02 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 111.635 -2.529 . . . . 0.0 107.799 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.402 HG22 HG21 ' A' ' 65' ' ' VAL . 79.8 t -104.51 133.54 20.14 Favored Pre-proline 0 N--CA 1.503 2.213 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -82.77 -170.05 0.85 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 123.875 3.05 . . . . 0.0 111.458 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -72.98 66.97 0.82 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 124.764 2.221 . . . . 0.0 112.535 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.462 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -76.57 52.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.773 0 O-C-N 119.808 -1.807 . . . . 0.0 114.886 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.13 -37.38 0.11 Allowed Glycine 1 N--CA 1.522 4.381 0 N-CA-C 120.43 2.932 . . . . 0.0 120.43 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.51 179.8 16.19 Favored Glycine 1 N--CA 1.531 5.025 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 10.7 t70 -86.41 -72.73 0.49 Allowed 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 121.624 0.726 . . . . 0.0 111.559 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HB2' ' HZ2' ' A' ' 66' ' ' LYS . 3.1 tt0 -114.47 124.81 52.84 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 m -148.71 158.54 6.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.002 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 1.7 pt-20 -119.67 170.3 9.32 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.756 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.95 130.48 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.896 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 11.8 t -108.91 -44.91 3.89 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.059 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 3.3 mm-40 -130.55 112.76 13.48 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.801 1.286 . . . . 0.0 108.517 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.419 ' O ' ' CE ' ' A' ' 23' ' ' LYS . 7.4 p -90.49 70.34 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 124.506 2.098 . . . . 0.0 114.083 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mmm -32.39 -60.87 0.28 Allowed 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 119.536 3.162 . . . . 0.0 119.536 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.553 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.3 t -103.81 150.22 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -129.56 -179.1 4.97 Favored 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 120.386 3.476 . . . . 0.0 120.386 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -53.07 115.5 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.226 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.09 10.88 31.11 Favored Glycine 1 N--CA 1.518 4.153 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.227 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.6 m-20 -114.45 131.85 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.622 ' CD ' ' H ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -58.41 75.72 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 108.696 -3.865 . . . . 0.0 110.614 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.5 151.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 CA-C-O 124.525 2.107 . . . . 0.0 114.049 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -152.26 153.41 33.7 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.953 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.54 163.43 0.28 Allowed 'General case' 0 N--CA 1.512 2.647 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.918 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 69.85 -27.79 0.16 Allowed 'General case' 0 N--CA 1.52 3.03 0 CA-C-O 122.018 0.913 . . . . 0.0 112.486 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -84.44 97.55 9.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.784 1.278 . . . . 0.0 112.261 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.0 m -31.86 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -70.98 -52.16 21.33 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 46' ' ' VAL . 30.4 pt -143.11 151.76 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.909 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 51.9 m -105.31 127.97 53.23 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 28.4 m -120.45 154.17 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -125.0 172.65 9.25 Favored 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.57 -65.04 0.01 OUTLIER Glycine 1 N--CA 1.53 4.911 0 N-CA-C 122.663 3.825 . . . . 0.0 122.663 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.582 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 9.5 p-10 -112.56 -83.16 0.59 Allowed 'General case' 0 N--CA 1.522 3.154 0 N-CA-C 120.51 3.522 . . . . 0.0 120.51 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.582 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 66.3 mmtt -119.56 -28.18 5.36 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 129.664 3.186 . . . . 0.0 111.238 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.43 167.36 10.79 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.99 1.376 . . . . 0.0 112.786 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -111.78 156.39 22.02 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.957 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 35.8 tpp -134.83 158.61 43.76 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.458 0.646 . . . . 0.0 111.714 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.37 153.67 30.59 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.904 1.812 . . . . 0.0 114.247 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 35' ' ' ILE . 60.1 t -123.87 102.67 34.65 Favored Pre-proline 0 N--CA 1.495 1.824 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.413 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -79.01 169.37 19.41 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 CA-C-O 124.394 1.747 . . . . 0.0 109.743 173.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -61.26 115.48 14.72 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 111.441 -2.618 . . . . 0.0 117.528 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -46.85 -26.66 4.91 Favored 'Trans proline' 0 N--CA 1.509 2.436 0 C-N-CA 122.144 1.896 . . . . 0.0 113.295 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -171.73 -174.26 1.32 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.532 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -96.51 166.97 11.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.83 -172.17 21.44 Favored Glycine 0 N--CA 1.514 3.84 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.369 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 t -106.65 149.87 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 C-N-CA 117.549 -1.661 . . . . 0.0 113.14 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG12 ' SD ' ' A' ' 72' ' ' MET . 58.4 t -67.29 102.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.592 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -82.44 -62.81 1.51 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 1.5 tt0 -147.24 151.28 36.42 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.96 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -143.55 135.81 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.502 -0.749 . . . . 0.0 110.58 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 41.9 mttm -114.45 42.87 2.01 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.11 161.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.072 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -132.78 170.78 14.79 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 121.489 3.885 . . . . 0.0 121.489 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.6 t -96.11 101.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 101.17 -3.641 . . . . 0.0 101.17 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.92 32.4 1.56 Allowed Glycine 0 N--CA 1.502 3.04 1 CA-C-N 107.826 -4.261 . . . . 0.0 106.816 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -113.95 174.07 6.12 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HD2' ' HB3' ' A' ' 16' ' ' GLU . 29.6 mmmt -101.37 132.39 46.96 Favored 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 121.233 3.79 . . . . 0.0 121.233 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG21 HG22 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -130.57 165.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 113.35 -1.75 . . . . 0.0 111.146 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HZ2' ' HB2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER 167.72 150.66 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 124.59 1.156 . . . . 0.0 110.021 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.76 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.34 -41.98 1.99 Allowed Glycine 1 N--CA 1.518 4.104 0 N-CA-C 116.699 1.44 . . . . 0.0 116.699 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.4 t -35.48 139.25 0.12 Allowed 'General case' 0 N--CA 1.531 3.617 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.966 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.3 mt -94.55 63.51 2.94 Favored 'General case' 0 N--CA 1.52 3.053 0 CA-C-N 120.358 1.435 . . . . 0.0 113.189 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.8 mm -40.52 -58.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.615 ' SD ' HG12 ' A' ' 54' ' ' VAL . 4.6 ptp -155.9 -172.92 4.3 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.27 122.0 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 122.998 1.38 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.606 ' CD1' HG23 ' A' ' 5' ' ' VAL . 5.6 m-30 -98.89 156.95 16.63 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.817 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.524 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 17.4 tt0 -147.6 98.15 2.94 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 123.952 1.834 . . . . 0.0 111.444 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 78' ' ' GLY . 34.3 m -58.49 69.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-N 114.053 -1.43 . . . . 0.0 114.616 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 52.82 -69.83 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.87 0 CA-C-O 122.202 1.001 . . . . 0.0 112.816 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . 164.03 33.1 0.02 OUTLIER Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -22.5 -83.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.315 0 C-N-CA 130.683 3.593 . . . . 0.0 108.709 179.505 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttm . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 58.0 t -42.45 164.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 73.3 mmtt -136.73 154.22 50.65 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.769 -1.559 . . . . 0.0 113.013 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.8 152.23 20.75 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.933 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 74.1 t -118.24 107.9 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -107.82 141.26 39.67 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.037 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -51.37 121.86 17.99 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 113.019 -1.9 . . . . 0.0 113.162 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' O ' HG21 ' A' ' 67' ' ' THR . 83.0 Cg_endo -63.49 -168.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.505 2.148 0 C-N-CA 123.182 2.588 . . . . 0.0 114.623 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -70.01 48.88 0.1 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 124.377 2.037 . . . . 0.0 115.126 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' GLY . 29.8 pt -80.64 47.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.761 0 O-C-N 119.798 -1.814 . . . . 0.0 114.039 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -10.11 57.87 0.0 OUTLIER Glycine 1 N--CA 1.524 4.566 0 N-CA-C 120.505 2.962 . . . . 0.0 120.505 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -130.93 160.31 23.25 Favored Glycine 1 N--CA 1.519 4.196 0 N-CA-C 114.461 0.544 . . . . 0.0 114.461 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.23 58.8 4.19 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 124.787 1.235 . . . . 0.0 112.721 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 4.8 mm-40 65.19 97.25 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.221 0 CA-C-O 122.239 1.018 . . . . 0.0 112.249 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.69 169.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 10.2 pt-20 -106.73 179.12 4.36 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.524 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.69 115.61 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p -96.86 -41.22 8.54 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.066 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.8 OUTLIER -123.2 126.02 46.18 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 119.679 1.127 . . . . 0.0 112.038 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.7 53.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 125.549 2.595 . . . . 0.0 116.547 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.7 mmm -20.05 -54.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 110.509 -3.042 . . . . 0.0 114.152 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.472 ' C ' ' NZ ' ' A' ' 23' ' ' LYS . 1.4 m -114.88 159.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 O-C-N 120.778 -1.201 . . . . 0.0 108.699 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' NZ ' ' C ' ' A' ' 22' ' ' VAL . 3.8 mtmm -143.37 -176.9 5.12 Favored 'General case' 0 N--CA 1.522 3.13 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -49.15 106.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.775 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.99 -48.94 0.91 Allowed Glycine 0 N--CA 1.508 3.496 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -36.51 130.0 0.73 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-O 123.987 1.851 . . . . 0.0 115.39 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' NZ ' ' CD ' ' A' ' 77' ' ' GLU . 70.9 mmtt -70.5 76.88 0.57 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.141 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.52 HG12 ' CE2' ' A' ' 74' ' ' PHE . 37.6 t -79.34 156.97 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 125.413 2.53 . . . . 0.0 116.981 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -164.81 154.93 13.85 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.833 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.48 166.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.332 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 65.05 -21.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -93.34 152.68 18.99 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.532 ' N ' ' NE2' ' A' ' 32' ' ' GLN . 8.6 p -68.34 146.66 53.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 123.223 1.487 . . . . 0.0 110.716 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 mt -109.08 -65.6 1.13 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 123.748 1.737 . . . . 0.0 109.032 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.8 pt -142.53 160.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 111.351 -2.659 . . . . 0.0 110.013 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.423 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 61.6 m -107.3 129.04 54.94 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.7 m -118.39 151.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 118.116 2.636 . . . . 0.0 118.116 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.35 -167.25 1.89 Allowed 'General case' 0 N--CA 1.513 2.7 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.59 -101.84 0.24 Allowed Glycine 1 N--CA 1.527 4.714 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.495 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 42' ' ' ALA . 23.3 m-20 -90.81 -133.48 0.12 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 122.258 1.028 . . . . 0.0 112.89 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.564 ' NZ ' ' SD ' ' A' ' 44' ' ' MET . 10.8 ptmm? 4.14 -43.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.487 1 N-CA-C 122.811 4.375 . . . . 0.0 122.811 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . 167.03 163.96 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 O-C-N 124.778 1.299 . . . . 0.0 110.386 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.0 p -69.21 153.28 43.93 Favored 'General case' 0 N--CA 1.515 2.785 0 CA-C-O 121.581 0.705 . . . . 0.0 112.872 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.564 ' SD ' ' NZ ' ' A' ' 41' ' ' LYS . 30.5 mtp -142.92 163.3 33.17 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.909 -0.495 . . . . 0.0 112.185 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.01 149.23 42.49 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.777 1.275 . . . . 0.0 113.911 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.402 HG21 HG23 ' A' ' 10' ' ' ILE . 54.6 t -120.05 127.38 26.39 Favored Pre-proline 0 N--CA 1.503 2.202 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -92.67 178.59 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.148 1.899 . . . . 0.0 114.295 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.7 110.44 5.42 Favored Pre-proline 0 CA--C 1.578 2.056 0 N-CA-C 117.595 2.443 . . . . 0.0 117.595 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -53.38 -21.41 17.88 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 122.905 2.404 . . . . 0.0 113.384 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -164.74 -169.65 1.78 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.401 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -108.82 158.77 17.34 Favored 'General case' 0 C--N 1.3 -1.56 1 N-CA-C 121.838 4.014 . . . . 0.0 121.838 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.91 179.85 16.68 Favored Glycine 1 N--CA 1.519 4.212 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.548 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.53 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.27 -1.723 . . . . 0.0 113.978 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 t -83.87 112.23 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.07 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 22.2 ttmm -93.16 -55.04 3.47 Favored 'General case' 0 N--CA 1.516 2.837 0 CA-C-N 120.42 1.464 . . . . 0.0 112.366 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 4.5 tt0 -147.91 162.08 40.0 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 121.135 0.493 . . . . 0.0 109.918 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.453 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.1 pt? -162.72 150.78 14.02 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.943 -1.098 . . . . 0.0 108.36 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 41.2 mtmt -125.16 53.01 1.55 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.896 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 m -138.35 157.3 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 126.183 2.177 . . . . 0.0 112.279 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.407 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 3.6 m120 -124.78 173.83 8.31 Favored 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.79 83.05 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 127.298 3.428 . . . . 0.0 104.458 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.25 41.9 0.08 OUTLIER Glycine 0 N--CA 1.505 3.273 1 CA-C-N 104.699 -5.682 . . . . 0.0 107.058 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 11.3 t0 -122.49 168.67 11.83 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HZ3' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -113.24 144.91 41.9 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 121.786 3.995 . . . . 0.0 121.786 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 m -125.44 130.49 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 118.251 2.685 . . . . 0.0 118.251 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -130.18 120.28 24.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 8' ' ' PRO . 24.5 p -28.47 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 124.571 2.129 . . . . 0.0 112.501 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.46 42.0 1.67 Allowed Glycine 0 N--CA 1.508 3.485 0 CA-C-N 109.983 -3.281 . . . . 0.0 113.635 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -115.51 131.88 56.8 Favored 'General case' 0 N--CA 1.529 3.493 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.504 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.08 63.99 0.71 Allowed 'General case' 0 N--CA 1.519 2.981 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.0 mm -53.68 -63.47 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.445 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 18.2 ptt? -138.81 168.82 18.98 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.43 119.79 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 123.365 1.555 . . . . 0.0 110.388 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 28' ' ' VAL . 8.8 m-30 -99.87 163.87 12.27 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.435 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 35.4 tt0 -144.34 106.14 4.3 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.851 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.2 m -43.69 48.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 1 N-CA-C 122.784 4.364 . . . . 0.0 122.784 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.523 ' CD ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.52 104.4 16.42 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.98 -51.95 0.08 OUTLIER Glycine 1 N--CA 1.517 4.035 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 122.15 100.38 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 109.48 -3.36 . . . . 0.0 106.479 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.694 0 C-N-CA 127.82 2.448 . . . . 0.0 106.57 -179.587 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 117.199 -1.381 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' ' 3' ' ' LYS . 3.5 t 62.12 -178.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.833 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.489 ' H ' HG13 ' A' ' 2' ' ' VAL . 33.1 mmtm -141.79 131.51 24.17 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -88.25 151.1 22.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.698 -1.251 . . . . 0.0 109.236 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 79.7 t -108.14 115.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 CA-C-O 121.569 0.7 . . . . 0.0 111.851 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.6 p30 -106.18 -179.18 3.86 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 123.0 1.381 . . . . 0.0 111.383 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 67' ' ' THR . 34.7 t -101.19 117.86 61.39 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.907 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -61.92 -174.35 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.643 1.562 . . . . 0.0 113.0 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -68.75 51.66 0.08 Allowed 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 124.729 2.204 . . . . 0.0 114.171 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.6 pt -78.03 46.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 O-C-N 119.066 -2.271 . . . . 0.0 114.611 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.14 -66.42 0.35 Allowed Glycine 1 N--CA 1.519 4.224 0 N-CA-C 116.276 1.27 . . . . 0.0 116.276 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.13 -59.65 0.46 Allowed Glycine 1 N--CA 1.517 4.035 0 CA-C-N 113.698 -1.251 . . . . 0.0 110.015 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -27.09 143.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 117.886 2.551 . . . . 0.0 117.886 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.488 ' CD ' ' NZ ' ' A' ' 66' ' ' LYS . 3.2 mm-40 -85.56 87.47 7.4 Favored 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 101.775 -3.417 . . . . 0.0 101.775 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 m -95.67 175.56 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 114.295 -1.321 . . . . 0.0 114.226 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.646 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 9.9 pt-20 -123.8 167.91 13.44 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -95.42 122.51 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 m -92.38 -52.02 4.86 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 126.424 1.89 . . . . 0.0 108.597 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -131.89 120.74 22.97 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.7 0.762 . . . . 0.0 111.407 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.5 p -95.29 61.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 123.573 1.654 . . . . 0.0 110.444 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 mtt -27.73 -32.77 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 118.584 2.809 . . . . 0.0 118.584 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 m -115.85 145.72 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -129.88 176.13 8.29 Favored 'General case' 0 N--CA 1.517 2.884 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.15 102.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.85 0 CA-C-N 114.174 -1.375 . . . . 0.0 114.406 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.02 -36.21 3.03 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.256 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -49.36 171.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.569 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 74.3 mmtt -105.44 105.13 15.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 111.629 -2.532 . . . . 0.0 108.841 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.404 HG12 ' CE2' ' A' ' 74' ' ' PHE . 21.8 t -115.2 106.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -117.29 158.74 23.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.827 -1.171 . . . . 0.0 110.52 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -42.5 157.83 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.702 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.027 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 2.7 tm-20 79.55 -48.88 0.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.828 1.299 . . . . 0.0 107.845 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' LEU . 43.0 tt0 -47.37 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 m -32.19 61.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -19.45 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 pt -147.61 146.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 110.628 -2.987 . . . . 0.0 112.89 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 m -105.15 124.73 50.03 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.09 158.41 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 117.849 2.536 . . . . 0.0 117.849 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -128.05 -177.42 4.13 Favored 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.794 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' H ' ' CD ' ' A' ' 38' ' ' GLU . . . 168.09 -75.01 0.13 Allowed Glycine 0 N--CA 1.514 3.878 0 N-CA-C 118.833 2.293 . . . . 0.0 118.833 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.529 ' HB2' ' CE ' ' A' ' 41' ' ' LYS . 49.3 m-20 -127.79 -102.11 0.34 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 125.67 2.653 . . . . 0.0 115.793 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.529 ' CE ' ' HB2' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -33.2 -47.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 129.245 3.018 . . . . 0.0 115.907 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' O ' ' SD ' ' A' ' 44' ' ' MET . . . 179.01 173.26 0.77 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.1 p -90.78 148.86 22.26 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 123.525 0.516 . . . . 0.0 111.949 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 42' ' ' ALA . 2.1 mpp? -121.71 159.2 27.09 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -117.18 146.41 43.24 Favored 'General case' 0 N--CA 1.506 2.342 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.481 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.7 127.04 25.92 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.838 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.48 171.86 7.22 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.794 1.662 . . . . 0.0 111.326 174.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.62 103.86 0.39 Allowed Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -35.48 -40.17 0.31 Allowed 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 123.409 2.739 . . . . 0.0 113.199 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.05 -172.4 4.01 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 109.981 -3.281 . . . . 0.0 108.109 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -107.45 162.15 14.18 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.706 3.224 . . . . 0.0 119.706 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.3 -154.25 21.58 Favored Glycine 1 N--CA 1.519 4.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.473 HG13 ' HD3' ' A' ' 27' ' ' LYS . 17.6 m -114.66 174.82 2.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.321 1.534 . . . . 0.0 113.001 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG21 ' CE1' ' A' ' 74' ' ' PHE . 20.6 t -102.73 108.58 24.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.976 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 14.0 tttm -88.57 -45.42 9.9 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.179 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 60.3 tt0 -165.45 163.83 19.61 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.696 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.37 164.29 32.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.106 . . . . 0.0 110.447 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -130.88 51.07 2.16 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -143.7 155.35 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 125.633 1.833 . . . . 0.0 113.504 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -127.44 -177.36 4.05 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 125.521 2.581 . . . . 0.0 115.321 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.91 104.61 16.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 101.123 -3.658 . . . . 0.0 101.123 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 136.85 -10.72 3.95 Favored Glycine 0 N--CA 1.514 3.864 1 CA-C-N 107.783 -4.281 . . . . 0.0 110.188 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -69.73 174.01 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.959 0.904 . . . . 0.0 110.268 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.646 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 30.4 mmtm -115.85 142.18 47.12 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.8 164.65 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.14 0.576 . . . . 0.0 112.397 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' NZ ' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -175.55 153.74 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 2.9 t -39.45 118.5 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 122.579 1.18 . . . . 0.0 113.426 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.45 -29.17 7.11 Favored Glycine 1 N--CA 1.518 4.127 0 CA-C-N 114.574 -1.194 . . . . 0.0 115.607 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 24.5 t -75.7 161.25 29.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 117.92 -1.512 . . . . 0.0 112.933 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.3 mt -97.91 64.79 1.75 Allowed 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 mt -21.82 -67.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.4 ptp -149.93 179.39 8.09 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.519 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.5 118.25 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 123.351 1.548 . . . . 0.0 111.835 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.472 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 10.5 m-30 -106.99 162.9 13.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 123.43 1.586 . . . . 0.0 112.086 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.4 tt0 -142.57 133.09 25.09 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.345 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 78' ' ' GLY . 14.6 m -83.65 73.87 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.569 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 61.61 -17.67 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.144 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 76' ' ' VAL . . . 153.6 -54.75 0.44 Allowed Glycine 1 N--CA 1.524 4.536 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HB3' HG22 ' A' ' 76' ' ' VAL . . . 92.76 104.99 0.02 OUTLIER 'General case' 0 CA--C 1.582 2.181 0 CA-C-N 110.167 -3.017 . . . . 0.0 118.42 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 2.795 0 C-N-CA 128.565 2.746 . . . . 0.0 106.937 179.557 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 mtm . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 115.495 -2.193 . . . . 0.0 106.426 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t 63.48 136.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 124.14 1.924 . . . . 0.0 113.48 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -126.98 145.23 50.78 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.503 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -81.79 155.58 25.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.19 0.995 . . . . 0.0 110.809 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG23 ' CD1' ' A' ' 74' ' ' PHE . 48.2 t -122.71 91.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 123.73 1.729 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.32 146.5 24.68 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.23 137.84 81.52 Favored Pre-proline 0 N--CA 1.501 2.084 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.789 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -76.44 -175.33 2.51 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.174 1.916 . . . . 0.0 112.699 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.13 57.83 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 124.595 2.141 . . . . 0.0 115.631 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.435 HG23 HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -80.4 51.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.93 0 O-C-N 119.232 -2.167 . . . . 0.0 109.758 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.55 -60.39 0.67 Allowed Glycine 1 N--CA 1.518 4.152 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.771 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.79 -59.21 0.54 Allowed Glycine 0 N--CA 1.511 3.653 0 CA-C-N 113.059 -1.571 . . . . 0.0 110.213 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -22.87 176.25 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.0 1 N-CA-C 123.244 4.535 . . . . 0.0 123.244 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -99.38 88.02 3.78 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 112.045 -2.343 . . . . 0.0 113.694 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.8 m -118.63 161.99 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.87 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 2.0 pm0 -118.64 179.03 4.25 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.73 1.252 . . . . 0.0 110.274 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -94.3 115.64 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.302 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 m -90.45 -34.98 15.4 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -143.62 134.74 25.66 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.19 64.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 124.73 2.205 . . . . 0.0 114.972 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.2 mmm -25.17 -48.74 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 109.875 -3.329 . . . . 0.0 118.019 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.82 164.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -130.52 -174.86 3.47 Favored 'General case' 0 N--CA 1.522 3.145 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.1 107.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.875 0 O-C-N 120.831 -1.168 . . . . 0.0 111.472 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.87 -25.83 9.82 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-O 122.172 0.873 . . . . 0.0 111.915 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.85 156.62 13.91 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -86.51 127.84 34.91 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.918 1.342 . . . . 0.0 110.65 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 t -127.41 93.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 112.369 -2.196 . . . . 0.0 113.599 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -99.79 158.7 15.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.726 -1.234 . . . . 0.0 108.617 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -54.08 163.68 0.75 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.142 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 75.55 -35.63 0.28 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.763 1.268 . . . . 0.0 110.562 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -67.31 127.22 31.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 123.146 1.45 . . . . 0.0 112.34 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.5 p -57.77 97.71 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -61.13 -63.31 1.34 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.81 150.17 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 112.187 -2.279 . . . . 0.0 110.038 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.481 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 87.2 m -97.77 114.95 27.09 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 14.4 m -111.74 148.57 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -129.3 178.07 6.71 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.4 -72.02 0.02 OUTLIER Glycine 1 N--CA 1.519 4.217 0 N-CA-C 116.883 1.513 . . . . 0.0 116.883 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.67 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 10.9 p-10 -114.55 -73.21 0.66 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 123.038 1.399 . . . . 0.0 113.216 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.67 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -125.78 -14.34 6.22 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 126.864 2.065 . . . . 0.0 110.68 179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.89 132.79 53.83 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 t -102.57 143.22 32.55 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.717 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.4 ptp -148.98 174.59 12.12 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -122.88 157.95 31.4 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.435 HG21 HG23 ' A' ' 10' ' ' ILE . 74.9 t -121.54 126.18 26.56 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.582 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -88.94 171.84 4.64 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.485 1.369 . . . . 0.0 110.073 174.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -70.81 119.85 75.56 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 118.581 2.808 . . . . 0.0 118.581 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -50.1 -29.26 21.6 Favored 'Trans proline' 0 N--CA 1.511 2.544 0 C-N-CA 122.947 2.431 . . . . 0.0 112.953 -174.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.71 -175.19 5.01 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 112.214 -2.266 . . . . 0.0 108.536 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.47 161.53 13.64 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.76 -167.88 23.81 Favored Glycine 1 N--CA 1.524 4.516 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.102 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.69 165.03 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 118.613 1.206 . . . . 0.0 113.171 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 74' ' ' PHE . 25.0 t -89.84 120.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 80' ' ' ALA . 6.3 tttp -103.98 -62.6 1.29 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 2.2 tp10 -130.62 137.19 49.5 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 118.326 0.512 . . . . 0.0 110.803 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.69 114.7 5.4 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 123.466 1.603 . . . . 0.0 108.425 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 93.3 mttt -94.48 50.74 1.37 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.28 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.11 143.36 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.431 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -130.94 -172.56 2.86 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.793 2.235 . . . . 0.0 113.58 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.54 108.27 19.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.37 -15.81 4.68 Favored Glycine 0 N--CA 1.513 3.798 0 CA-C-N 108.913 -3.767 . . . . 0.0 113.144 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -70.28 157.08 38.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 9.0 mmmt -91.56 136.69 32.94 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.98 152.3 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.999 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -162.98 148.29 11.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.4 t -55.32 120.59 7.32 Favored 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.241 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.14 6.42 39.43 Favored Glycine 1 N--CA 1.523 4.452 0 CA-C-N 114.408 -1.269 . . . . 0.0 114.985 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.84 112.69 24.58 Favored 'General case' 0 N--CA 1.517 2.919 0 O-C-N 120.95 -1.324 . . . . 0.0 111.491 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.94 56.59 0.01 OUTLIER 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mm -42.61 -51.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.418 ' O ' ' N ' ' A' ' 5' ' ' VAL . 4.9 ptp -151.18 -175.05 5.01 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.415 HD12 ' HG2' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -123.24 120.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 123.814 1.768 . . . . 0.0 114.494 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CD1' HG23 ' A' ' 5' ' ' VAL . 19.7 m-30 -108.82 164.61 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.313 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -138.13 131.03 29.84 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.93 59.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 68.51 101.76 0.05 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-O 123.71 1.719 . . . . 0.0 112.972 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.18 45.52 0.8 Allowed Glycine 1 N--CA 1.522 4.4 0 N-CA-C 107.334 -2.306 . . . . 0.0 107.334 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 37.02 50.27 0.88 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 110.531 -2.834 . . . . 0.0 115.528 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.463 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.663 0 C-N-CA 129.926 3.29 . . . . 0.0 107.264 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.41 0 CA-C-O 120.669 0.271 . . . . 0.0 111.506 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 m -88.68 146.15 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 73' ' ' ILE . 4.1 mmmm -137.98 154.12 49.38 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -101.35 172.08 7.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.761 -0.587 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' A' ' 74' ' ' PHE . 58.4 t -133.53 97.53 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.142 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.0 p30 -94.56 168.66 10.71 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -98.73 125.44 42.4 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 118.104 -1.438 . . . . 0.0 111.346 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 60.5 Cg_endo -67.74 -91.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 123.619 2.879 . . . . 0.0 109.961 -163.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 4.6 p-10 -130.53 147.43 52.21 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.463 HD11 ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -151.49 37.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.553 0 CA-C-O 123.831 1.777 . . . . 0.0 109.554 179.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.45 -55.61 3.7 Favored Glycine 1 N--CA 1.52 4.275 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.791 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -125.58 -144.74 6.3 Favored Glycine 0 N--CA 1.506 3.313 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.609 ' CG ' ' HZ3' ' A' ' 66' ' ' LYS . 0.6 OUTLIER -105.33 -75.38 0.63 Allowed 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.584 ' CG ' ' HZ2' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -73.17 102.87 3.72 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 119.376 3.102 . . . . 0.0 119.376 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.88 141.93 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.692 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 47.3 mt-10 -82.72 165.3 20.05 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -112.53 120.08 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 118.944 -1.102 . . . . 0.0 108.578 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -94.9 -48.18 6.12 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.081 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.83 102.94 5.42 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 123.2 1.476 . . . . 0.0 113.283 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.96 64.64 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 O-C-N 119.83 -1.794 . . . . 0.0 113.441 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 mtt -32.78 -36.12 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 N-CA-C 121.253 3.797 . . . . 0.0 121.253 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.91 142.68 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 6.8 mtpm? -134.94 179.94 6.0 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 119.148 3.018 . . . . 0.0 119.148 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.8 t -45.04 91.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.456 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 2.63 12.51 Favored Glycine 1 N--CA 1.523 4.454 0 CA-C-O 121.91 0.728 . . . . 0.0 113.555 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -97.51 120.42 37.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 124.903 2.287 . . . . 0.0 113.731 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.608 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -65.52 95.24 0.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.649 -2.523 . . . . 0.0 110.933 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.413 HG12 HD22 ' A' ' 34' ' ' LEU . 7.3 t -91.15 157.56 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.734 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.21 167.77 2.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.321 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.33 162.09 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 O-C-N 124.582 1.176 . . . . 0.0 113.638 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.85 -10.37 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.655 1.217 . . . . 0.0 113.923 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 30' ' ' ALA . 34.7 tt0 -90.15 87.68 6.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.203 -1.561 . . . . 0.0 106.809 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 70.7 m -35.99 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.427 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -24.63 -66.4 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 pt -147.42 146.02 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 111.387 -2.642 . . . . 0.0 111.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -93.17 131.01 38.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 23.5 m -124.82 160.55 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -128.5 -157.89 0.85 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 129.7 172.28 13.12 Favored Glycine 0 N--CA 1.51 3.597 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.539 ' CG ' ' HZ1' ' A' ' 41' ' ' LYS . 11.9 t70 54.05 -83.42 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 CA-C-O 122.989 1.375 . . . . 0.0 113.095 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HZ1' ' CG ' ' A' ' 40' ' ' ASP . 1.5 pptp? 170.69 35.71 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 128.615 2.766 . . . . 0.0 108.615 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.11 104.57 5.97 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.114 -1.403 . . . . 0.0 114.561 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t -70.52 109.07 4.62 Favored 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.529 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 45.2 mtm -109.72 161.28 15.56 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.832 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -122.14 158.59 28.99 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 37.3 t -130.05 121.45 19.76 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.51 171.28 2.43 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.28 1.32 . . . . 0.0 111.217 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . . . -45.28 96.7 0.12 Allowed Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -44.55 -28.39 2.69 Favored 'Trans proline' 0 N--CA 1.511 2.551 0 C-N-CA 121.968 1.779 . . . . 0.0 112.973 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -163.8 -179.35 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.322 -2.217 . . . . 0.0 107.016 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.16 156.54 18.71 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 120.035 3.346 . . . . 0.0 120.035 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.33 -173.65 22.14 Favored Glycine 1 N--CA 1.529 4.863 0 CA-C-N 112.772 -2.013 . . . . 0.0 114.185 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.8 167.83 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 CA-C-N 120.405 2.103 . . . . 0.0 112.209 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.465 HG21 ' CE1' ' A' ' 74' ' ' PHE . 11.7 t -91.9 126.82 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.115 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 9.6 tttp -99.64 -60.44 1.53 Allowed 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.615 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 12.4 tt0 -144.6 159.71 42.35 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.285 0.564 . . . . 0.0 112.471 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.6 pt? -154.7 161.34 41.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.48 -2.013 . . . . 0.0 110.417 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.615 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 1.9 mptt -133.1 45.79 2.68 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 122.369 1.081 . . . . 0.0 108.962 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.91 149.2 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -129.89 177.69 7.08 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 125.504 2.574 . . . . 0.0 113.446 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.43 109.71 20.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.53 -27.95 3.04 Favored Glycine 0 N--CA 1.511 3.659 0 CA-C-N 111.929 -2.396 . . . . 0.0 108.393 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.78 169.86 17.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HZ2' ' CG ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -123.32 164.39 18.89 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.909 1.337 . . . . 0.0 108.799 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.52 168.2 18.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.609 ' HZ3' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -150.01 156.2 41.28 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 119.186 -1.006 . . . . 0.0 113.161 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -34.13 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.3 -5.69 45.38 Favored Glycine 1 N--CA 1.517 4.075 0 CA-C-N 113.785 -1.552 . . . . 0.0 115.8 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 8.5 m -63.7 133.52 53.73 Favored 'General case' 0 N--CA 1.524 3.226 0 CA-C-O 117.621 -1.18 . . . . 0.0 112.879 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.72 59.17 0.21 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.47 HG13 HG21 ' A' ' 7' ' ' VAL . 6.0 mm -30.68 -64.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 124.847 2.26 . . . . 0.0 116.528 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.419 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -152.27 177.25 10.75 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 111.357 -2.656 . . . . 0.0 112.856 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -118.42 127.89 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 123.384 1.564 . . . . 0.0 107.019 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CD1' HG23 ' A' ' 5' ' ' VAL . 8.9 m-30 -105.51 160.76 14.91 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 113.316 -1.766 . . . . 0.0 115.005 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 14.0 tt0 -141.04 109.69 6.0 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 124.618 2.151 . . . . 0.0 111.362 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 m -53.5 44.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.13 0 N-CA-C 121.362 3.838 . . . . 0.0 121.362 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 22.42 -94.69 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -140.41 40.42 1.38 Allowed Glycine 1 N--CA 1.52 4.283 0 N-CA-C 105.031 -3.228 . . . . 0.0 105.031 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 17.9 58.65 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 110.114 -3.043 . . . . 0.0 119.009 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 1.732 0 CA-C-N 111.363 -2.653 . . . . 0.0 105.613 179.769 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 3.3 mpp? . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.429 HG21 ' HZ2' ' A' ' 55' ' ' LYS . 2.0 t -9.53 130.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 118.572 2.804 . . . . 0.0 118.572 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.518 ' HA ' ' NZ ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -118.83 146.63 44.7 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 124.225 1.964 . . . . 0.0 112.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 4' ' ' GLU . 7.5 mp0 -91.15 132.17 36.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.438 -2.619 . . . . 0.0 114.258 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -104.26 111.75 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.726 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 69' ' ' SER . 16.3 p-10 -108.9 172.79 6.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.34 1.543 . . . . 0.0 112.273 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.549 HG21 ' CG1' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -101.39 117.82 61.26 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 112.832 -1.986 . . . . 0.0 113.65 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -85.24 172.31 8.47 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 123.87 3.047 . . . . 0.0 112.724 172.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -1.5 37.74 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.604 1 N-CA-C 123.346 4.572 . . . . 0.0 123.346 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.57 ' H ' HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -76.8 61.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 O-C-N 119.226 -2.171 . . . . 0.0 114.496 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -41.12 141.28 1.08 Allowed Glycine 0 N--CA 1.515 3.905 0 CA-C-N 112.868 -1.969 . . . . 0.0 114.165 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.2 -45.88 1.13 Allowed Glycine 1 N--CA 1.521 4.318 0 N-CA-C 106.453 -2.659 . . . . 0.0 106.453 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.532 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 1.0 OUTLIER 75.46 163.88 0.26 Allowed 'General case' 0 CA--C 1.573 1.863 0 O-C-N 128.418 3.07 . . . . 0.0 114.545 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 0.2 OUTLIER 36.37 52.98 0.97 Allowed 'General case' 0 N--CA 1.51 2.554 0 CA-C-O 122.534 1.159 . . . . 0.0 110.589 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.4 m -97.41 160.92 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.783 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 1.6 pm0 -118.11 174.66 6.09 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.223 1.011 . . . . 0.0 113.315 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.43 127.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.221 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 81.4 p -98.82 -50.36 4.24 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -131.12 100.31 5.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 123.254 1.502 . . . . 0.0 112.9 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG23 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -73.89 65.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 O-C-N 120.295 -1.503 . . . . 0.0 114.06 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 34.3 mmm -30.39 -52.43 0.16 Allowed 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.9 m -89.01 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HZ3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -130.7 161.88 30.68 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.47 114.97 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.849 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.76 -29.15 6.16 Favored Glycine 0 N--CA 1.515 3.966 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.414 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 11.7 t70 -89.02 168.39 12.39 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HZ1' ' CG ' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -83.98 109.21 17.45 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' CG1' HD22 ' A' ' 34' ' ' LEU . 6.7 t -111.04 102.77 14.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.612 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.25 159.02 25.78 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.316 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -39.48 160.92 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 74.27 -40.16 0.44 Allowed 'General case' 0 N--CA 1.516 2.843 0 CA-C-O 121.963 0.887 . . . . 0.0 110.475 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 47.0 tp60 -58.39 83.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 50.4 m -28.86 70.15 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.094 2.998 . . . . 0.0 119.094 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -23.32 -67.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.29 155.44 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.525 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -99.16 136.63 38.84 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 25.0 m -124.85 148.71 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' HB2' ' CG2' ' A' ' 18' ' ' THR . 3.4 tt0 -118.98 174.25 6.41 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.14 -68.96 0.07 OUTLIER Glycine 1 N--CA 1.518 4.135 0 CA-C-N 114.792 -1.095 . . . . 0.0 113.28 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.92 -177.73 3.73 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.896 1.331 . . . . 0.0 110.936 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.515 ' CB ' ' HZ1' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -39.51 -15.02 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.36 150.69 48.95 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.211 0.529 . . . . 0.0 111.764 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -89.68 164.17 14.82 Favored 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.0 mtt -132.27 168.23 18.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.483 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.85 152.69 49.06 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.44 HG22 ' CG2' ' A' ' 10' ' ' ILE . 43.5 t -129.79 125.86 22.35 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.0 173.37 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.414 1.409 . . . . 0.0 110.544 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . . . -54.36 98.81 0.18 Allowed Pre-proline 0 C--N 1.287 -2.145 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -44.31 -29.3 2.94 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 C-N-CA 122.402 2.068 . . . . 0.0 113.679 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -158.76 -175.3 5.22 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.093 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.57 155.93 19.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.16 -168.61 26.53 Favored Glycine 1 N--CA 1.518 4.153 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.95 154.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.435 -1.626 . . . . 0.0 112.268 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.56 108.9 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 1.9 tmtp? -94.24 -50.15 5.4 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.226 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.7 tt0 -155.88 162.89 40.35 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.429 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -167.85 156.77 9.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.085 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -131.76 53.27 2.01 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.39 153.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 126.079 2.112 . . . . 0.0 113.735 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -121.76 178.62 4.78 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 124.809 2.243 . . . . 0.0 115.576 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.37 108.9 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.96 -23.76 3.34 Favored Glycine 0 N--CA 1.507 3.378 1 CA-C-N 108.282 -4.054 . . . . 0.0 108.501 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.39 154.11 4.91 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.945 0.879 . . . . 0.0 111.58 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.6 mmmt -95.81 148.32 22.71 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.43 147.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.667 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HZ2' ' HB3' ' A' ' 13' ' ' ASP . 20.2 tttp -148.56 155.65 41.4 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.418 ' N ' HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -30.28 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.052 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.46 -32.5 5.53 Favored Glycine 0 N--CA 1.511 3.698 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.327 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 21.2 m -37.84 122.87 1.02 Allowed 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 70' ' ' LEU . 7.4 mp -70.39 58.96 0.19 Allowed 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.549 ' CG1' HG21 ' A' ' 7' ' ' VAL . 5.1 mt -20.07 -61.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.439 ' SD ' ' HE1' ' A' ' 74' ' ' PHE . 7.9 ptp -156.85 176.77 12.31 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 112.573 -2.103 . . . . 0.0 114.509 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 114.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 123.845 1.783 . . . . 0.0 112.42 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.439 ' HE1' ' SD ' ' A' ' 72' ' ' MET . 17.0 m-30 -106.96 154.88 20.43 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.632 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.496 ' OE2' ' N ' ' A' ' 1' ' ' MET . 2.5 tp10 -127.01 123.35 36.86 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.3 m -51.9 33.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.582 2.189 1 N-CA-C 124.577 5.029 . . . . 0.0 124.577 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -90.82 63.89 5.4 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 123.604 1.669 . . . . 0.0 112.891 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.23 67.88 0.03 OUTLIER Glycine 0 N--CA 1.506 3.348 0 N-CA-C 104.971 -3.251 . . . . 0.0 104.971 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.28 138.39 36.76 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 112.268 -1.966 . . . . 0.0 109.143 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 O-C-N 126.658 2.474 . . . . 0.0 115.868 -179.844 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 9.0 ttt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 100.847 -3.76 . . . . 0.0 100.847 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' H ' ' HG2' ' A' ' 1' ' ' MET . 7.2 p -163.9 134.79 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -128.54 84.0 2.2 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.227 2.677 . . . . 0.0 118.227 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.08 143.85 1.06 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG23 ' CD1' ' A' ' 74' ' ' PHE . 26.5 t -118.01 120.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.0 p-10 -117.48 172.78 7.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.458 ' CG1' HD11 ' A' ' 10' ' ' ILE . 5.8 t -101.95 137.3 19.47 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 118.299 -1.361 . . . . 0.0 109.563 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 42.4 Cg_endo -70.39 -92.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.195 0 C-N-CA 123.605 2.87 . . . . 0.0 111.327 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 10.1 p-10 -116.97 145.09 43.87 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 123.654 1.692 . . . . 0.0 109.491 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -155.93 48.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 CA-C-O 123.292 1.52 . . . . 0.0 111.496 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.24 -63.27 3.43 Favored Glycine 1 N--CA 1.522 4.406 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.342 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.81 -49.54 0.52 Allowed Glycine 1 N--CA 1.526 4.694 0 O-C-N 123.902 0.413 . . . . 0.0 112.154 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.572 ' CG ' ' HZ2' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -73.29 -174.11 1.52 Allowed 'General case' 0 CA--C 1.585 2.321 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.445 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 8.3 pt-20 -102.29 151.89 21.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 119.387 -2.071 . . . . 0.0 107.239 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.83 158.43 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 49.5 mt-10 -92.33 169.98 10.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.544 -0.723 . . . . 0.0 109.558 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG11 ' HB ' ' A' ' 35' ' ' ILE . 60.0 t -106.89 116.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -94.49 -43.43 8.35 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.633 1.173 . . . . 0.0 113.787 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -136.49 102.06 4.83 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.678 1.228 . . . . 0.0 110.342 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.7 p -75.18 63.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 O-C-N 119.562 -1.962 . . . . 0.0 116.1 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.9 mmm -29.57 -33.6 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 26' ' ' ASP . 2.1 t -125.57 154.32 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -134.41 -176.93 4.37 Favored 'General case' 0 N--CA 1.521 3.078 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.54 87.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.101 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.91 26.01 3.71 Favored Glycine 0 N--CA 1.514 3.869 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.576 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 1.3 m-20 -116.37 141.09 48.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -63.36 115.02 4.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.798 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.19 98.23 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -105.04 149.43 25.81 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.232 -1.543 . . . . 0.0 114.782 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.2 73.03 0.3 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 177.2 -24.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.001 -3.272 . . . . 0.0 110.131 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -89.87 119.08 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.877 -1.14 . . . . 0.0 112.74 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 29.5 t -48.78 123.87 7.6 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 HD11 ' HA ' ' A' ' 48' ' ' ALA . 1.5 mt -81.78 -55.46 4.61 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.477 1.132 . . . . 0.0 112.625 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.422 ' HB ' HG11 ' A' ' 17' ' ' VAL . 19.9 pt -146.7 129.75 8.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.481 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 m -73.17 137.68 45.23 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.1 m -124.77 154.54 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.42 -164.41 1.71 Allowed 'General case' 0 N--CA 1.518 2.928 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.7 -51.26 0.49 Allowed Glycine 0 N--CA 1.513 3.809 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 45.0 t0 -155.51 -118.12 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.636 0.732 . . . . 0.0 112.341 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HZ2' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -10.76 -44.2 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.888 2.922 . . . . 0.0 118.888 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . 171.92 157.15 0.09 Allowed 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 123.637 0.775 . . . . 0.0 111.571 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.7 m -58.81 127.64 33.23 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.0 mmm -116.79 166.72 11.82 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.064 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -130.81 156.93 44.17 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.467 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 6.1 t -131.25 105.83 14.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.311 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 1.4 Cg_endo -77.71 175.66 10.97 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.155 1.236 . . . . 0.0 110.212 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -72.3 107.49 3.07 Favored Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -38.3 -39.33 1.01 Allowed 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.42 2.747 . . . . 0.0 113.981 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -150.77 176.69 10.8 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.02 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.82 89.09 5.54 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.57 -164.46 10.18 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 114.48 -1.236 . . . . 0.0 113.603 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.47 156.5 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG21 ' CE1' ' A' ' 74' ' ' PHE . 2.7 t -87.11 135.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.372 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 10.2 tptt -110.97 -65.22 1.19 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.158 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.506 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 29.7 tt0 -137.85 148.86 45.8 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.637 0.732 . . . . 0.0 109.521 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.64 154.76 28.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 86.6 mttt -131.1 51.55 2.13 Favored 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.11 154.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 CA-C-N 111.82 -2.446 . . . . 0.0 114.195 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -145.55 -176.19 5.02 Favored 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.0 t -84.65 113.22 22.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 1 N-CA-C 99.688 -4.19 . . . . 0.0 99.688 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.93 10.15 12.7 Favored Glycine 0 N--CA 1.513 3.769 0 CA-C-N 112.293 -2.23 . . . . 0.0 108.952 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -103.68 159.58 15.5 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HZ3' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -114.51 150.12 35.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -179.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.02 166.04 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.336 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 67' ' ' THR . 4.5 tmmm? -159.72 160.54 34.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.076 -1.015 . . . . 0.0 109.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.512 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 6.5 p -43.4 112.93 0.43 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.8 -8.49 61.55 Favored Glycine 0 N--CA 1.515 3.964 0 CA-C-N 113.043 -1.89 . . . . 0.0 114.619 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 7.2 m -67.41 127.13 31.53 Favored 'General case' 0 N--CA 1.52 3.068 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.184 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.99 66.21 0.79 Allowed 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.409 HD13 ' C ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER -36.46 -61.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 119.549 3.166 . . . . 0.0 119.549 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 ptp -144.89 175.18 10.39 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 113.987 -1.46 . . . . 0.0 114.812 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -113.72 121.94 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.932 1.349 . . . . 0.0 111.677 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.515 ' CD1' HG23 ' A' ' 5' ' ' VAL . 15.2 m-30 -106.0 -177.36 3.34 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.168 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.458 ' OE2' ' N ' ' A' ' 1' ' ' MET . 3.1 tp10 -153.44 165.55 35.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m -115.57 70.04 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 120.224 3.416 . . . . 0.0 120.224 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.496 ' OE2' ' NZ ' ' A' ' 55' ' ' LYS . 52.2 mt-10 -61.0 -71.62 0.14 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 119.116 3.006 . . . . 0.0 119.116 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.81 9.27 0.87 Allowed Glycine 1 N--CA 1.533 5.142 0 O-C-N 119.924 -1.735 . . . . 0.0 114.491 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.5 31.29 3.95 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 112.319 -1.941 . . . . 0.0 115.451 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.62 0 C-N-CA 127.874 2.469 . . . . 0.0 104.972 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.339 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 m -55.92 -174.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -125.15 155.09 40.49 Favored 'General case' 0 N--CA 1.515 2.781 0 CA-C-O 122.015 0.912 . . . . 0.0 112.477 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -107.35 149.35 27.94 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.298 1.523 . . . . 0.0 113.375 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 59.5 t -102.97 102.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-O 124.102 1.906 . . . . 0.0 112.074 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -95.94 130.12 43.0 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 111.094 -2.775 . . . . 0.0 105.563 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' THR . 69.7 t -55.64 132.51 71.79 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -69.36 -176.41 1.36 Allowed 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.578 1.519 . . . . 0.0 114.119 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -62.02 46.57 0.01 OUTLIER 'General case' 0 CA--C 1.58 2.101 0 C-N-CA 127.905 2.482 . . . . 0.0 115.912 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 46' ' ' VAL . 40.3 pt -79.11 59.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 O-C-N 119.79 -1.819 . . . . 0.0 113.017 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -33.13 140.16 0.08 OUTLIER Glycine 1 N--CA 1.521 4.362 0 CA-C-N 113.635 -1.621 . . . . 0.0 116.261 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.97 88.58 0.66 Allowed Glycine 1 N--CA 1.52 4.238 0 CA-C-O 121.881 0.712 . . . . 0.0 112.042 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.255 17.9 m-20 -2.36 60.39 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 121.086 3.736 . . . . 0.0 121.086 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' CD ' ' HZ2' ' A' ' 64' ' ' LYS . 27.1 mm-40 69.07 118.36 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.032 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.846 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 m -119.5 158.83 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.892 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.6 pt-20 -100.27 167.73 10.23 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.245 -0.909 . . . . 0.0 109.818 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.35 113.44 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.394 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.3 p -90.5 -40.98 11.67 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 93.8 mt-10 -133.99 101.76 5.17 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 123.297 1.522 . . . . 0.0 111.682 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.37 73.64 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-O 125.981 2.801 . . . . 0.0 113.047 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.449 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 mtp -38.39 -45.66 1.04 Allowed 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' C ' ' HD3' ' A' ' 23' ' ' LYS . 10.4 m -103.31 153.44 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 CA-C-N 119.486 1.039 . . . . 0.0 113.349 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD3' ' C ' ' A' ' 22' ' ' VAL . 3.7 mppt? -129.58 175.16 9.02 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.0 107.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.745 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.87 -28.11 5.5 Favored Glycine 1 N--CA 1.519 4.176 0 N-CA-C 114.598 0.599 . . . . 0.0 114.598 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -59.66 157.54 11.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 17.6 mmtp -107.85 103.32 12.55 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 123.513 1.625 . . . . 0.0 106.982 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.424 HG12 HD23 ' A' ' 34' ' ' LEU . 66.1 t -103.78 117.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 120.327 3.454 . . . . 0.0 120.327 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.86 154.32 26.5 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 119.803 -1.81 . . . . 0.0 113.897 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.79 92.66 2.52 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 160.59 -20.51 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 109.994 -3.275 . . . . 0.0 109.284 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.58 165.86 14.0 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.023 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.3 p -85.56 106.19 16.7 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.445 HD21 ' HE3' ' A' ' 72' ' ' MET . 3.4 mt -69.13 -63.78 1.0 Allowed 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.9 pt -143.11 157.88 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.128 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 9.9 m -104.7 134.26 48.15 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.7 m -127.12 165.62 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.63 151.13 51.86 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.82 -161.41 9.22 Favored Glycine 0 N--CA 1.511 3.646 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 25.3 t70 -63.38 96.15 0.11 Allowed 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 117.634 -1.626 . . . . 0.0 109.104 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER 46.57 39.61 7.11 Favored 'General case' 0 N--CA 1.511 2.616 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.374 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.82 65.72 1.34 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 t -51.82 131.38 30.64 Favored 'General case' 0 N--CA 1.518 2.959 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 mmt -139.02 168.42 19.87 Favored 'General case' 0 N--CA 1.513 2.72 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -111.3 151.89 27.84 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 122.177 0.989 . . . . 0.0 111.627 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG21 HG23 ' A' ' 10' ' ' ILE . 70.2 t -122.66 119.59 28.11 Favored Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.616 -0.677 . . . . 0.0 109.708 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -85.17 175.9 6.19 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 CA-C-O 122.581 0.992 . . . . 0.0 111.67 175.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.6 108.41 5.77 Favored Pre-proline 0 CA--C 1.58 2.111 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -48.62 -30.46 16.46 Favored 'Trans proline' 0 N--CA 1.512 2.584 0 C-N-CA 123.084 2.523 . . . . 0.0 114.122 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 178.38 10.15 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.498 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.29 20.85 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.04 -175.79 35.19 Favored Glycine 0 N--CA 1.507 3.413 0 CA-C-O 121.812 0.673 . . . . 0.0 111.985 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 3.8 m -117.6 151.12 19.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.199 -1.177 . . . . 0.0 111.379 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 10.7 t -74.69 80.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.633 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -68.54 -41.36 79.99 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.528 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.496 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 39.7 tt0 -167.74 166.32 13.8 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -166.56 159.34 14.19 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.046 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -132.24 49.14 2.34 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 122.715 1.245 . . . . 0.0 108.958 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.43 157.03 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 112.524 -2.125 . . . . 0.0 113.279 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -129.94 178.42 6.54 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 125.829 2.728 . . . . 0.0 115.065 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -90.24 112.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 100.536 -3.876 . . . . 0.0 100.536 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.02 -29.41 3.52 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 109.636 -3.438 . . . . 0.0 109.363 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -62.07 159.18 14.96 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.886 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.541 ' HZ2' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -104.75 142.88 33.91 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 7' ' ' VAL . 28.6 m -123.71 158.19 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -153.03 145.7 24.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 118.088 -0.958 . . . . 0.0 108.934 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 14.3 t -47.78 121.74 4.35 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.851 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.98 35.06 Favored Glycine 0 N--CA 1.513 3.825 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.733 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.8 t -78.36 121.45 24.49 Favored 'General case' 0 N--CA 1.52 3.06 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.15 66.54 0.63 Allowed 'General case' 0 N--CA 1.516 2.827 0 CA-C-O 122.032 0.92 . . . . 0.0 113.158 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 72' ' ' MET . 35.9 pt -58.98 -45.78 91.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.445 ' HE3' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -137.24 165.11 26.92 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 112.888 -1.96 . . . . 0.0 115.974 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.06 125.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.943 1.354 . . . . 0.0 113.448 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.488 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 7.3 m-30 -117.14 150.35 38.85 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.24 160.11 30.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 78' ' ' GLY . 27.2 m -106.07 67.7 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 2.2 mm-40 -13.59 62.61 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.785 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . -177.24 91.41 0.08 OUTLIER Glycine 0 N--CA 1.505 3.297 1 N-CA-C 99.87 -5.292 . . . . 0.0 99.87 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.29 55.9 1.31 Allowed 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 C-N-CA 127.173 2.189 . . . . 0.0 107.701 -179.967 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 117.232 -1.366 . . . . 0.0 107.792 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 m -87.74 -177.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 124.813 1.321 . . . . 0.0 110.361 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 2.3 mmtt -131.97 127.41 36.24 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.331 1.063 . . . . 0.0 112.961 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -68.97 122.68 19.17 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.892 -1.503 . . . . 0.0 110.595 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 74' ' ' PHE . 10.6 t -101.49 96.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 CA-C-O 124.573 2.13 . . . . 0.0 114.999 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -89.13 128.15 35.76 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 110.058 -3.246 . . . . 0.0 106.986 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.438 HG23 HG13 ' A' ' 65' ' ' VAL . 12.5 t -68.49 130.79 91.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 28.2 Cg_endo -72.28 -92.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.951 2.434 . . . . 0.0 115.635 -172.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 9.8 p-10 -108.58 106.57 16.69 Favored 'General case' 0 CA--C 1.577 1.983 0 CA-C-O 125.865 2.745 . . . . 0.0 114.487 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.45 HD11 ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -124.43 50.13 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.254 -1.529 . . . . 0.0 111.156 179.836 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.33 -59.17 4.67 Favored Glycine 1 N--CA 1.519 4.211 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.897 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.33 -53.83 0.32 Allowed Glycine 1 N--CA 1.523 4.494 0 CA-C-N 114.272 -0.964 . . . . 0.0 114.084 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.46 -149.33 0.14 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 124.1 0.96 . . . . 0.0 110.591 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -120.19 145.45 46.96 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.392 -1.443 . . . . 0.0 110.307 179.253 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.59 177.59 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -178.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 2.8 pt-20 -102.48 176.14 5.27 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 120.584 1.538 . . . . 0.0 113.728 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 t -108.35 119.4 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-O 122.921 1.344 . . . . 0.0 113.251 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.1 m -93.04 -52.67 4.47 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.368 -1.742 . . . . 0.0 111.305 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 16.5 mm-40 -126.32 126.87 44.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.485 0.659 . . . . 0.0 109.499 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.62 ' CG2' ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -105.73 61.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 123.045 1.403 . . . . 0.0 111.646 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmt -21.22 -46.7 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 110.622 -2.99 . . . . 0.0 116.671 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.79 159.7 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' HZ3' ' CG2' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -133.7 178.42 6.95 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 179.851 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.6 99.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.782 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.69 13.51 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.679 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -75.76 147.22 39.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HD2' HG11 ' A' ' 53' ' ' VAL . 27.8 mmmt -73.84 108.61 6.77 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.705 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -109.29 124.16 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.956 0.884 . . . . 0.0 109.95 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -137.3 159.88 40.65 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -47.08 161.06 0.08 Allowed 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.25 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 56.93 -1.7 0.05 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.07 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.449 ' H ' ' C ' ' A' ' 30' ' ' ALA . 1.4 tm0? -96.07 107.67 20.0 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.5 m -48.33 121.72 4.66 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -88.23 -59.38 2.25 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -144.79 152.95 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.702 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 16.7 m -110.44 125.42 53.25 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 179.169 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.6 m -109.97 157.8 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.76 -175.01 3.82 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.28 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.4 -72.1 0.28 Allowed Glycine 1 N--CA 1.521 4.363 0 CA-C-O 119.181 -0.788 . . . . 0.0 114.925 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -118.63 -121.76 0.29 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 124.242 1.972 . . . . 0.0 114.421 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -19.57 -40.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 119.842 3.275 . . . . 0.0 119.842 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 167.91 164.55 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 O-C-N 126.682 2.488 . . . . 0.0 111.906 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -74.71 152.8 39.07 Favored 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.94 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.5 ttt -144.85 161.05 40.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.079 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.28 155.16 20.81 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 123.265 1.507 . . . . 0.0 114.493 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.45 HG22 ' CG2' ' A' ' 10' ' ' ILE . 21.0 t -127.88 126.07 23.75 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.48 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -91.18 177.83 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 CA-C-O 124.51 1.796 . . . . 0.0 113.367 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -70.25 103.71 0.66 Allowed Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 111.699 -2.501 . . . . 0.0 117.613 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -46.69 -26.21 4.28 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 121.718 1.612 . . . . 0.0 114.067 -177.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -162.14 -172.62 3.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.683 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.71 166.81 10.52 Favored 'General case' 0 CA--C 1.568 1.669 1 N-CA-C 122.747 4.351 . . . . 0.0 122.747 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.62 -134.68 7.26 Favored Glycine 1 N--CA 1.526 4.645 0 CA-C-N 113.173 -1.831 . . . . 0.0 113.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.493 HG11 ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -134.91 160.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 O-C-N 121.512 -0.993 . . . . 0.0 109.915 179.317 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 39.7 t -84.44 133.63 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 C-N-CA 117.604 -1.638 . . . . 0.0 106.912 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 45.5 tptt -102.73 -62.52 1.26 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 25.6 tt0 -150.53 158.79 44.55 Favored 'General case' 0 N--CA 1.511 2.624 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.471 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.1 pt? -166.02 149.66 7.71 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.03 50.06 1.8 Allowed 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.8 162.9 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 126.33 2.269 . . . . 0.0 113.967 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.27 -177.51 4.68 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 120.625 3.565 . . . . 0.0 120.625 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -94.4 67.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 127.458 3.504 . . . . 0.0 109.575 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.15 37.33 0.02 OUTLIER Glycine 0 N--CA 1.506 3.354 1 CA-C-N 105.395 -5.366 . . . . 0.0 109.602 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -121.53 173.9 7.11 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 111.568 -2.316 . . . . 0.0 104.912 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HZ1' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -121.79 160.67 24.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 120.356 3.465 . . . . 0.0 120.356 -179.517 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.471 ' CG1' HG23 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.27 147.8 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 119.992 3.33 . . . . 0.0 119.992 -179.213 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -155.95 163.23 40.0 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.724 179.733 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -50.58 106.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 123.358 1.551 . . . . 0.0 114.763 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.05 11.69 56.09 Favored Glycine 0 N--CA 1.513 3.767 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.671 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 t -76.12 116.9 17.27 Favored 'General case' 0 N--CA 1.507 2.423 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.551 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.45 77.09 9.87 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.81 1.767 . . . . 0.0 109.831 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.523 HD13 ' SD ' ' A' ' 72' ' ' MET . 1.7 pp -77.95 -44.13 28.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.164 -1.835 . . . . 0.0 112.915 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.523 ' SD ' HD13 ' A' ' 71' ' ' ILE . 9.3 ptm -130.36 175.34 9.04 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.674 -1.21 . . . . 0.0 113.259 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 mp -128.49 128.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.654 ' CD1' HG22 ' A' ' 5' ' ' VAL . 16.4 m-30 -109.8 164.05 12.93 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.489 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 38.0 tt0 -137.88 131.11 30.5 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.39 56.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -102.53 147.52 26.67 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 118.928 2.936 . . . . 0.0 118.928 -179.8 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 164.83 73.64 0.03 OUTLIER Glycine 0 N--CA 1.506 3.327 1 N-CA-C 101.876 -4.49 . . . . 0.0 101.876 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.94 48.56 0.72 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.932 0 C-N-CA 128.764 2.826 . . . . 0.0 107.848 -179.825 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.546 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 18.6 mtp . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.6 m -51.95 138.8 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.03 150.38 51.33 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.262 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -95.07 160.11 14.71 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 74' ' ' PHE . 89.9 t -118.36 114.69 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.154 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.9 p-10 -105.79 173.67 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.412 ' CG2' HG12 ' A' ' 71' ' ' ILE . 38.4 t -95.18 131.04 30.8 Favored Pre-proline 0 N--CA 1.495 1.781 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.61 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -64.1 -176.38 0.37 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.343 1.362 . . . . 0.0 111.99 172.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -57.77 39.46 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 119.76 3.244 . . . . 0.0 119.76 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.598 HG23 ' CG2' ' A' ' 46' ' ' VAL . 27.6 pt -81.02 69.34 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 119.066 -2.271 . . . . 0.0 111.973 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.06 168.45 1.55 Allowed Glycine 1 N--CA 1.52 4.268 0 CA-C-N 112.663 -2.062 . . . . 0.0 112.562 179.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.34 170.4 12.74 Favored Glycine 1 N--CA 1.526 4.636 0 CA-C-O 121.482 0.49 . . . . 0.0 113.406 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.8 67.59 4.56 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 123.709 1.719 . . . . 0.0 114.194 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 68.82 100.61 0.06 Allowed 'General case' 0 N--CA 1.513 2.701 0 CA-C-N 111.859 -2.428 . . . . 0.0 111.039 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.0 m -96.35 141.7 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 117.302 -1.759 . . . . 0.0 106.843 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.501 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 12.2 pt-20 -118.16 164.71 14.75 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.266 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 62' ' ' GLY . 10.2 t -83.6 123.91 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.418 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.1 t -102.39 -45.8 4.98 Favored 'General case' 0 N--CA 1.522 3.155 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.798 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 24.3 mt-10 -130.97 123.1 28.08 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.893 0.854 . . . . 0.0 109.594 178.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -102.99 71.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 125.957 2.789 . . . . 0.0 110.538 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 mtt -34.07 -59.45 0.43 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 110.59 -3.004 . . . . 0.0 115.101 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.502 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.8 t -100.63 151.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 CA-C-O 122.161 0.981 . . . . 0.0 112.809 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -138.54 177.18 8.08 Favored 'General case' 0 N--CA 1.518 2.962 0 N-CA-C 121.574 3.916 . . . . 0.0 121.574 -178.74 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -42.5 97.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.88 11.8 25.58 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.634 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 t0 -110.32 142.23 42.25 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -59.39 107.17 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.707 -2.042 . . . . 0.0 116.145 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 74' ' ' PHE . 94.6 t -114.97 118.22 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 122.271 1.034 . . . . 0.0 111.807 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.56 149.34 51.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.544 -1.348 . . . . 0.0 113.69 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.67 140.46 14.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 93.73 -21.28 0.07 Allowed 'General case' 0 N--CA 1.513 2.707 0 O-C-N 126.703 2.502 . . . . 0.0 110.405 -179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -88.1 140.27 29.66 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.782 -1.199 . . . . 0.0 109.573 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.6 m -73.69 128.23 34.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 112.257 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 48' ' ' ALA . 5.2 mt -95.38 -61.95 1.38 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 pt -137.66 146.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-O 122.551 1.167 . . . . 0.0 113.03 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.458 HG21 ' HG2' ' A' ' 45' ' ' GLU . 88.1 m -101.87 116.89 33.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.4 m -113.25 160.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.08 -165.31 1.45 Allowed 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.14 -53.89 0.78 Allowed Glycine 1 N--CA 1.529 4.881 0 CA-C-N 119.052 0.842 . . . . 0.0 114.355 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -86.33 179.67 6.85 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.162 0.982 . . . . 0.0 109.709 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -46.0 -7.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -154.58 162.11 41.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.2 t -83.13 138.65 33.59 Favored 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.98 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -118.94 156.07 30.2 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.477 0.581 . . . . 0.0 111.465 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HG2' HG21 ' A' ' 36' ' ' THR . 47.6 mt-10 -111.64 158.48 19.21 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.598 ' CG2' HG23 ' A' ' 10' ' ' ILE . 2.9 t -128.14 123.09 22.42 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 112.644 -2.071 . . . . 0.0 112.164 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -84.52 -179.7 3.97 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 CA-C-O 123.55 1.396 . . . . 0.0 112.636 168.937 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -66.02 101.24 0.27 Allowed Pre-proline 0 C--N 1.282 -2.356 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -36.61 -35.98 0.22 Allowed 'Trans proline' 0 N--CA 1.51 2.476 0 C-N-CA 122.71 2.273 . . . . 0.0 113.986 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -154.24 -177.49 6.47 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 112.078 -2.328 . . . . 0.0 107.006 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.31 168.79 9.55 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.97 -147.53 19.29 Favored Glycine 1 N--CA 1.517 4.035 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.075 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.37 148.16 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 47.6 t -68.94 92.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.142 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 17.5 tttm -69.82 -58.9 3.33 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.954 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' CD ' ' NZ ' ' A' ' 55' ' ' LYS 0.319 37.3 tt0 -149.52 144.07 26.03 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.52 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -130.73 155.15 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -128.54 37.58 4.1 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.106 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.43 161.98 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-N 113.09 -1.868 . . . . 0.0 114.562 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -122.83 173.96 7.44 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 124.819 2.247 . . . . 0.0 115.677 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 18' ' ' THR . 3.4 t -98.97 100.69 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 101.305 -3.591 . . . . 0.0 101.305 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' VAL . . . 120.86 30.58 1.33 Allowed Glycine 0 N--CA 1.511 3.678 1 CA-C-N 106.973 -4.649 . . . . 0.0 107.8 -179.336 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -107.28 155.34 20.06 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 114.133 -1.034 . . . . 0.0 109.995 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 31.4 mmtm -89.22 140.15 29.76 Favored 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.27 166.75 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.97 0.891 . . . . 0.0 111.035 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -165.98 153.5 10.27 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 t -47.9 127.04 11.46 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 117.304 -1.758 . . . . 0.0 111.858 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.66 -40.5 2.41 Favored Glycine 0 N--CA 1.513 3.824 0 CA-C-N 114.902 -1.044 . . . . 0.0 114.464 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 32.3 t -57.0 146.25 27.69 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.289 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.99 63.89 7.56 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.682 1.23 . . . . 0.0 114.28 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.501 ' CG2' ' SD ' ' A' ' 72' ' ' MET . 1.4 mt -17.0 -57.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.501 ' SD ' ' CG2' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -168.84 -176.81 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 111.767 -2.469 . . . . 0.0 114.92 -179.596 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.96 125.45 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 124.092 1.901 . . . . 0.0 112.767 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 17.3 m-30 -112.9 156.23 23.33 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.885 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.546 ' OE2' ' N ' ' A' ' 1' ' ' MET . 6.1 tp10 -130.46 139.61 50.55 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 103.571 -2.752 . . . . 0.0 103.571 179.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 77' ' ' GLU . 16.2 m -86.26 23.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 1 N-CA-C 123.075 4.472 . . . . 0.0 123.075 -179.187 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 76' ' ' VAL . 17.4 mm-40 6.78 -86.06 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.98 51.8 0.63 Allowed Glycine 0 N--CA 1.509 3.534 0 N-CA-C 103.287 -3.925 . . . . 0.0 103.287 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.49 82.68 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -179.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.565 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.12 179.63 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.631 ' H3 ' ' CA ' ' A' ' 80' ' ' ALA . 3.6 tmm? . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 101.886 -3.376 . . . . 0.0 101.886 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m -126.56 159.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.078 0 CA-C-N 123.694 2.952 . . . . 0.0 113.467 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HG3' HG11 ' A' ' 76' ' ' VAL . 70.7 mmtt -133.31 148.64 51.91 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.07 155.42 18.4 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.58 -1.325 . . . . 0.0 114.246 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.534 HG23 ' CD1' ' A' ' 74' ' ' PHE . 40.1 t -121.97 88.36 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 124.753 2.216 . . . . 0.0 113.852 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.8 p30 -95.05 170.36 9.47 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 111.291 -2.686 . . . . 0.0 105.802 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG23 HG12 ' A' ' 65' ' ' VAL . 96.0 t -104.6 136.02 19.23 Favored Pre-proline 0 N--CA 1.504 2.246 0 C-N-CA 118.135 -1.426 . . . . 0.0 113.39 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.41 -166.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.842 2.361 . . . . 0.0 115.509 168.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.23 32.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.531 HG22 ' CG2' ' A' ' 46' ' ' VAL . 3.4 mp -83.75 64.31 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 CA-C-O 126.198 2.904 . . . . 0.0 111.982 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.51 -113.28 4.38 Favored Glycine 0 C--N 1.292 -1.87 0 CA-C-N 109.863 -3.335 . . . . 0.0 110.859 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.99 -31.55 1.97 Allowed Glycine 0 N--CA 1.514 3.846 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.98 84.07 0.22 Allowed 'General case' 0 CA--C 1.58 2.123 0 CA-C-N 111.754 -2.223 . . . . 0.0 105.339 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.646 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 12.9 tt0 -2.67 86.27 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.106 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -179.381 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -99.23 168.92 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.651 -179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' HB3' ' CD ' ' A' ' 64' ' ' LYS . 8.7 pt-20 -124.42 172.63 9.01 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.68 122.84 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.995 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 p -101.56 -42.56 6.19 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.48 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.87 109.32 11.17 Favored 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.4 p -92.09 72.9 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 125.361 2.505 . . . . 0.0 110.279 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.9 mtt -35.27 -56.87 0.61 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 111.694 -2.503 . . . . 0.0 112.951 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 10.3 p -105.67 164.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 CA-C-O 123.29 1.519 . . . . 0.0 114.145 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -145.96 174.69 11.04 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 119.409 3.114 . . . . 0.0 119.409 -179.424 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.2 t -47.62 111.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.13 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.69 -27.87 6.99 Favored Glycine 1 N--CA 1.516 4.027 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.117 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -81.93 173.17 12.47 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 124.256 1.979 . . . . 0.0 115.947 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.06 136.36 50.21 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.944 -1.934 . . . . 0.0 112.586 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.4 t -126.41 160.65 33.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.993 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -159.03 156.05 28.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.516 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.72 168.86 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 125.071 1.482 . . . . 0.0 111.171 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 5.9 mp0 55.17 -7.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.156 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -101.89 110.0 21.88 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.51 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -40.16 133.57 1.73 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 9.4 mt -100.86 -61.76 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.6 pt -141.85 151.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.243 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.9 m -101.84 138.27 39.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.9 m -129.67 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -123.01 162.74 21.78 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.04 148.06 19.49 Favored Glycine 1 N--CA 1.516 4.029 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.616 ' CB ' ' HD3' ' A' ' 41' ' ' LYS . 11.8 m-20 6.69 -67.16 0.0 OUTLIER 'General case' 0 CA--C 1.59 2.482 0 N-CA-C 120.533 3.531 . . . . 0.0 120.533 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.616 ' HD3' ' CB ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -136.29 35.94 2.75 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 126.605 1.962 . . . . 0.0 113.324 -179.515 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.65 136.7 4.52 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.7 t -108.74 169.01 8.93 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.991 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 10' ' ' ILE . 51.6 ttm -167.81 164.09 14.13 Favored 'General case' 0 N--CA 1.517 2.883 0 CA-C-O 122.45 1.119 . . . . 0.0 112.927 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.6 mp0 -103.71 141.68 35.65 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 124.368 2.032 . . . . 0.0 114.659 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' A' ' 10' ' ' ILE . 22.7 t -121.56 98.97 45.58 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -81.94 -178.72 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 CA-C-O 124.25 1.688 . . . . 0.0 113.618 171.225 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -68.24 102.21 0.37 Allowed Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -41.11 -25.01 0.2 Allowed 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 121.945 1.763 . . . . 0.0 115.453 170.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.45 -167.09 0.75 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -106.37 163.9 12.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.96 -175.72 19.34 Favored Glycine 1 N--CA 1.522 4.428 0 CA-C-N 113.58 -1.645 . . . . 0.0 113.443 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.24 166.23 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.307 . . . . 0.0 114.287 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG21 ' CE1' ' A' ' 74' ' ' PHE . 20.0 t -89.43 106.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 113.983 -1.462 . . . . 0.0 112.047 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -64.18 1.09 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 13.8 tt0 -140.39 155.71 46.65 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 118.506 0.594 . . . . 0.0 111.825 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.484 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.0 pt? -161.61 153.69 19.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.545 -0.722 . . . . 0.0 110.114 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HD2' ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -129.05 55.87 1.71 Allowed 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.51 151.46 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 112.277 -2.238 . . . . 0.0 111.622 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -130.57 170.99 13.53 Favored 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.77 111.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 1 N-CA-C 98.202 -4.74 . . . . 0.0 98.202 179.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.36 21.64 5.1 Favored Glycine 0 N--CA 1.514 3.886 0 CA-C-N 109.667 -3.424 . . . . 0.0 111.716 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.297 36.1 t0 -114.56 175.27 5.56 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.648 1.179 . . . . 0.0 111.537 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.646 ' HZ1' ' CD ' ' A' ' 14' ' ' GLU . 25.8 mmtp -98.56 149.55 22.63 Favored 'General case' 0 N--CA 1.526 3.351 1 N-CA-C 122.395 4.22 . . . . 0.0 122.395 -179.049 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 7' ' ' VAL . 4.4 t -144.77 168.36 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 67' ' ' THR . 10.4 ptmm? 174.93 139.0 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.6 t -31.51 122.55 0.26 Allowed 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.72 -24.77 26.17 Favored Glycine 0 N--CA 1.509 3.561 0 CA-C-N 114.285 -1.325 . . . . 0.0 114.624 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.1 m -75.21 123.22 24.89 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -75.46 72.32 2.46 Favored 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 125.338 1.455 . . . . 0.0 114.694 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.431 HD13 ' SD ' ' A' ' 72' ' ' MET . 1.7 pp -56.03 -52.49 49.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.445 ' SD ' ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -127.95 174.95 8.75 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -123.79 129.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.677 0.751 . . . . 0.0 110.602 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.534 ' CD1' HG23 ' A' ' 5' ' ' VAL . 13.7 m-30 -114.77 158.79 21.39 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.465 1.602 . . . . 0.0 111.732 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.355 11.6 tt0 -136.28 124.25 22.8 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 78' ' ' GLY . 23.3 m -68.56 54.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 121.047 3.721 . . . . 0.0 121.047 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -13.81 74.1 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.287 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . -138.62 -63.22 0.04 OUTLIER Glycine 0 N--CA 1.508 3.494 0 N-CA-C 104.751 -3.34 . . . . 0.0 104.751 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' A' ' 80' ' ' ALA . . . 176.88 29.73 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.631 ' CA ' ' H3 ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 114.709 -2.567 . . . . 0.0 111.66 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.514 2.733 0 CA-C-O 116.07 -1.919 . . . . 0.0 106.107 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.5 t -122.02 175.37 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.575 0 O-C-N 124.544 1.153 . . . . 0.0 112.419 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 3' ' ' LYS . 1.1 mmpt? -131.8 164.05 26.89 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' CD ' ' N ' ' A' ' 4' ' ' GLU . 2.2 mp0 -107.78 140.4 40.91 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -115.08 100.84 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 CA-C-O 122.907 1.337 . . . . 0.0 112.483 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' SER . 3.3 p30 -91.84 173.87 7.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.806 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -112.71 137.2 21.66 Favored Pre-proline 0 N--CA 1.499 2.006 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.687 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.91 -173.25 0.57 Allowed 'Trans proline' 0 CA--C 1.56 1.778 0 C-N-CA 122.161 1.907 . . . . 0.0 116.437 175.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -57.96 42.74 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 119.282 3.067 . . . . 0.0 119.282 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.546 HG23 ' CG2' ' A' ' 46' ' ' VAL . 10.8 pt -80.42 48.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 O-C-N 119.639 -1.913 . . . . 0.0 113.746 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.86 173.33 20.61 Favored Glycine 1 N--CA 1.524 4.54 0 N-CA-C 116.699 1.44 . . . . 0.0 116.699 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . -105.98 -25.33 6.52 Favored Glycine 1 N--CA 1.525 4.617 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.922 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -82.35 -137.4 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 129.555 3.142 . . . . 0.0 107.714 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.58 ' CD ' ' HD3' ' A' ' 64' ' ' LYS . 19.6 tt0 -133.54 148.31 51.63 Favored 'General case' 0 N--CA 1.522 3.157 0 CA-C-N 119.052 0.842 . . . . 0.0 112.302 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 m -142.67 163.24 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 O-C-N 120.709 -1.244 . . . . 0.0 113.123 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.6 pt-20 -113.79 178.9 4.12 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.0 t -110.76 111.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.99 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.9 t -91.51 -42.97 9.96 Favored 'General case' 0 N--CA 1.526 3.349 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -130.67 100.39 5.29 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 123.597 1.665 . . . . 0.0 109.327 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.79 64.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 119.188 -2.195 . . . . 0.0 115.826 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -29.93 -27.4 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' A' ' 23' ' ' LYS . 13.0 p -112.02 170.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' N ' ' CG2' ' A' ' 22' ' ' VAL . 33.3 mmtp -139.02 164.46 29.69 Favored 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.434 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 59.0 t -72.38 115.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 O-C-N 121.597 -0.69 . . . . 0.0 111.331 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . 116.01 -29.13 7.28 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.546 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 2.0 m-20 -63.9 -176.32 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 25' ' ' GLY . 36.7 mmtm -109.93 123.14 49.1 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.826 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 48' ' ' ALA . 2.2 t -123.35 102.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -91.9 162.5 14.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.05 -1.656 . . . . 0.0 111.434 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -61.72 164.94 5.57 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.617 -1.233 . . . . 0.0 107.75 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 70.62 -22.04 0.18 Allowed 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 123.6 1.666 . . . . 0.0 111.158 -179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 30' ' ' ALA . 37.7 tt0 -80.34 110.77 16.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.765 -1.209 . . . . 0.0 109.069 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 27.7 t -47.91 139.88 7.32 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.332 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -103.61 -55.95 2.3 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.458 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.33 141.76 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.475 1.131 . . . . 0.0 111.947 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.6 m -86.37 122.75 30.78 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.97 152.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -137.15 148.66 46.77 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.949 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.73 3.46 8.64 Favored Glycine 1 N--CA 1.526 4.692 0 O-C-N 120.839 -1.163 . . . . 0.0 110.412 179.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' CG ' ' HZ1' ' A' ' 41' ' ' LYS . 47.1 t0 105.86 132.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 131.377 3.871 . . . . 0.0 104.257 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HZ1' ' CG ' ' A' ' 40' ' ' ASP . 18.2 mmtm 48.39 17.24 0.12 Allowed 'General case' 0 N--CA 1.52 3.066 0 O-C-N 121.488 -0.757 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -128.56 53.18 1.86 Allowed 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 -179.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 53.2 m -54.44 86.01 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtp -122.02 176.05 6.01 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -125.8 157.98 36.14 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.546 ' CG2' HG23 ' A' ' 10' ' ' ILE . 6.2 t -129.41 110.71 17.82 Favored Pre-proline 0 N--CA 1.498 1.946 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.629 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -83.36 -179.36 4.24 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.44 1.426 . . . . 0.0 113.829 173.314 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . . . -64.14 105.79 0.79 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 120.484 3.513 . . . . 0.0 120.484 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -29.09 -39.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.474 0 C-N-CA 122.165 1.91 . . . . 0.0 115.098 171.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.42 177.82 10.83 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.381 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -89.18 101.03 13.7 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.7 -178.9 29.5 Favored Glycine 1 N--CA 1.528 4.787 0 O-C-N 121.71 -0.619 . . . . 0.0 114.606 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 1.4 m -100.58 171.55 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.315 -1.697 . . . . 0.0 107.878 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.585 HG12 ' SD ' ' A' ' 72' ' ' MET . 96.3 t -94.04 121.99 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.237 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -86.05 -58.68 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.77 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 1.7 tp10 -167.2 150.79 6.53 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.843 1.964 . . . . 0.0 112.652 178.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -130.86 -178.61 4.88 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.194 -1.567 . . . . 0.0 110.856 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.77 ' HZ2' ' CG ' ' A' ' 56' ' ' GLU . 1.5 mptp? -150.57 32.34 0.64 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.912 -1.117 . . . . 0.0 108.673 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.22 156.29 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-N 114.267 -1.333 . . . . 0.0 114.031 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -127.37 176.64 7.28 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -92.83 105.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.97 29.05 2.48 Favored Glycine 0 N--CA 1.51 3.617 1 CA-C-N 108.392 -4.004 . . . . 0.0 107.992 -178.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -113.73 163.24 15.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 1.7 pptp? -115.43 143.26 45.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.42 171.61 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.401 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 13' ' ' ASP . 1.6 tmtp? -165.53 151.29 9.36 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 117.93 -1.033 . . . . 0.0 108.68 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 t -42.06 116.39 0.81 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-O 121.975 0.893 . . . . 0.0 112.841 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.68 -30.0 9.68 Favored Glycine 0 N--CA 1.514 3.834 0 CA-C-N 114.925 -1.034 . . . . 0.0 114.021 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 1.8 t -52.13 162.03 0.54 Allowed 'General case' 0 N--CA 1.52 3.05 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -96.79 64.17 2.05 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG1' HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -30.54 -49.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 179.64 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.585 ' SD ' HG12 ' A' ' 54' ' ' VAL . 1.1 ptp 178.38 -179.25 0.3 Allowed 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -107.81 133.63 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 123.617 1.675 . . . . 0.0 108.548 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -101.88 168.3 9.51 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.403 -179.604 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.43 ' OE2' ' NZ ' ' A' ' 55' ' ' LYS . 18.7 tt0 -146.69 99.45 3.2 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 123.782 1.753 . . . . 0.0 107.729 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m -54.64 49.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.788 1 N-CA-C 123.287 4.551 . . . . 0.0 123.287 -179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.63 -173.93 2.85 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 123.636 1.684 . . . . 0.0 111.773 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.17 -52.44 0.04 OUTLIER Glycine 0 N--CA 1.503 3.144 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 126.72 -43.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 O-C-N 129.491 3.701 . . . . 0.0 109.182 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.306 0 C-N-CA 129.861 3.265 . . . . 0.0 107.596 179.688 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 8.6 tpt . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 9.5 p -19.13 137.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 119.854 3.279 . . . . 0.0 119.854 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.544 ' HZ1' ' CD ' ' A' ' 4' ' ' GLU . 45.5 mmtt -138.24 165.12 27.51 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 118.822 2.897 . . . . 0.0 118.822 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.544 ' CD ' ' HZ1' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -99.85 142.39 31.39 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 111.255 -2.702 . . . . 0.0 113.532 -179.39 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.571 HG22 ' CD1' ' A' ' 74' ' ' PHE . 43.4 t -118.79 98.43 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.168 0 O-C-N 121.212 -0.93 . . . . 0.0 112.447 179.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 69' ' ' SER . 23.6 p30 -110.82 174.89 5.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.381 1.086 . . . . 0.0 111.375 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 67' ' ' THR . 70.1 t -108.78 130.34 22.85 Favored Pre-proline 0 N--CA 1.5 2.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.644 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.01 -169.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.423 0 C-N-CA 123.654 2.903 . . . . 0.0 114.463 164.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -43.58 7.53 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.533 0 N-CA-C 120.377 3.473 . . . . 0.0 120.377 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 10' ' ' ILE . 4.3 mp -73.21 73.67 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 125.245 2.45 . . . . 0.0 113.411 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.93 103.36 1.27 Allowed Glycine 0 N--CA 1.5 2.902 0 N-CA-C 121.095 3.198 . . . . 0.0 121.095 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.11 -48.41 39.71 Favored Glycine 1 N--CA 1.523 4.454 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.96 -91.53 0.19 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 110.935 -2.633 . . . . 0.0 106.869 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -160.7 169.36 22.98 Favored 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.64 166.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.478 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 11.7 pt-20 -116.85 169.29 9.5 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 122.0 -0.438 . . . . 0.0 111.442 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.08 118.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 O-C-N 120.907 -1.12 . . . . 0.0 112.422 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 3.7 t -98.47 -34.8 10.48 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.204 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 43.5 mt-10 -134.58 105.48 6.54 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.581 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.44 89.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 126.084 2.849 . . . . 0.0 111.811 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -59.93 -54.34 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 111.311 -2.677 . . . . 0.0 114.771 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.45 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 34.5 m -66.58 149.78 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 N-CA-C 118.009 2.596 . . . . 0.0 118.009 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 22' ' ' VAL . 13.0 mmtp -131.65 171.86 12.96 Favored 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 121.366 0.603 . . . . 0.0 112.339 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -75.75 98.19 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.47 14.85 7.3 Favored Glycine 1 N--CA 1.52 4.263 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.703 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.11 136.69 36.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -76.48 111.54 12.05 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 125.042 2.353 . . . . 0.0 106.812 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.401 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 96.7 t -111.22 108.31 25.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 109.857 -3.338 . . . . 0.0 112.719 -179.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.49 158.56 28.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.978 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.23 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.953 1.408 . . . . 0.0 113.037 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 72.61 -41.22 0.5 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.755 0.788 . . . . 0.0 110.823 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 13.2 tt0 -57.8 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.853 -1.155 . . . . 0.0 112.078 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 49.0 m -40.6 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -18.06 -67.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -151.31 149.38 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.236 -2.711 . . . . 0.0 109.294 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 1.2 m -106.75 133.6 51.17 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 26.8 m -112.36 146.66 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 N-CA-C 118.578 2.806 . . . . 0.0 118.578 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -136.4 -153.39 0.5 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.35 -63.82 0.55 Allowed Glycine 1 N--CA 1.519 4.226 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.966 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.39 -171.16 2.02 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 123.775 1.75 . . . . 0.0 113.919 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -73.81 40.87 0.12 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.423 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.06 103.6 1.85 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.466 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.3 p -74.16 142.54 45.46 Favored 'General case' 0 N--CA 1.514 2.73 0 O-C-N 121.922 -0.486 . . . . 0.0 111.701 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.4 mmt -137.77 146.47 43.66 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 17.1 mp0 -118.77 159.62 23.37 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 10' ' ' ILE . 12.3 t -129.39 124.89 22.3 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.792 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.06 172.43 2.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.958 1.772 . . . . 0.0 112.025 171.438 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.518 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . . . -53.17 100.55 0.23 Allowed Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.1 Cg_endo -42.44 -31.39 1.83 Allowed 'Trans proline' 0 N--CA 1.51 2.442 0 C-N-CA 122.816 2.344 . . . . 0.0 113.603 -178.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -160.0 -174.71 4.7 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.752 -2.476 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.25 159.87 16.03 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 120.509 3.522 . . . . 0.0 120.509 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.11 -144.87 15.9 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.395 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.44 161.97 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 CA-C-N 117.937 0.868 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 74' ' ' PHE . 31.3 t -85.96 116.6 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -90.58 -67.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.54 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 41.7 tt0 -143.43 152.1 41.15 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.335 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.94 146.18 30.95 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 30.6 mmtt -119.17 46.1 1.96 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.86 152.12 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -134.04 -178.73 5.16 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.971 2.32 . . . . 0.0 114.222 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -87.89 112.24 23.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.71 -19.28 5.59 Favored Glycine 0 N--CA 1.509 3.565 0 CA-C-N 109.893 -3.321 . . . . 0.0 110.779 -179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.12 168.91 12.97 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.573 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.66 145.21 33.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -179.69 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -126.85 176.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 112.876 -1.965 . . . . 0.0 111.249 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HG2' ' N ' ' A' ' 67' ' ' THR . 37.8 tttt 166.19 144.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.431 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 4.5 t -39.47 119.49 0.95 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.48 -32.58 5.99 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.725 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.0 t -56.92 128.65 37.91 Favored 'General case' 0 N--CA 1.512 2.656 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.59 64.21 7.96 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 124.842 2.258 . . . . 0.0 111.079 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.405 ' CG1' HG21 ' A' ' 7' ' ' VAL . 5.1 mm -24.26 -56.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 111.717 -2.492 . . . . 0.0 117.375 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.0 ptp -161.19 -174.17 4.21 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.033 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.15 123.97 72.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 124.504 2.097 . . . . 0.0 112.207 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CD1' HG22 ' A' ' 5' ' ' VAL . 13.0 m-30 -113.05 165.26 12.53 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.733 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 1' ' ' MET . 2.0 tt0 -142.3 122.71 14.01 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.32 87.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 CA-C-O 122.736 1.255 . . . . 0.0 113.631 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 73.1 -87.86 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 111.889 -2.414 . . . . 0.0 114.061 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.13 -73.1 0.45 Allowed Glycine 1 N--CA 1.516 4.009 1 N-CA-C 99.674 -5.37 . . . . 0.0 99.674 179.761 . . . . . . . . 3 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -167.07 31.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 178.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.839 0 C-N-CA 128.86 2.864 . . . . 0.0 108.57 179.918 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.8 mtp . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m -161.96 169.27 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 124.962 1.414 . . . . 0.0 108.735 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -142.98 154.38 43.96 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 124.233 1.968 . . . . 0.0 111.395 178.789 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.535 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 13.4 pm0 -112.96 149.94 32.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.82 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.536 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 87.8 t -120.14 113.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.598 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.734 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 15.9 p-10 -109.86 177.18 4.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.329 1.062 . . . . 0.0 109.533 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -97.35 130.59 29.13 Favored Pre-proline 0 C--N 1.291 -1.958 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.088 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -83.93 -157.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.331 2.021 . . . . 0.0 110.565 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -84.05 65.65 8.82 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 124.556 2.122 . . . . 0.0 109.871 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.438 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -74.88 54.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 CA-C-O 123.238 1.494 . . . . 0.0 114.622 -179.894 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 32.19 39.83 0.07 OUTLIER Glycine 1 N--CA 1.524 4.534 0 N-CA-C 117.11 1.604 . . . . 0.0 117.11 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.49 173.73 46.49 Favored Glycine 0 N--CA 1.506 3.342 0 CA-C-N 113.516 -1.342 . . . . 0.0 111.727 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.299 16.9 m-20 -93.33 -84.15 0.3 Allowed 'General case' 0 CA--C 1.577 1.984 0 CA-C-O 116.429 -1.748 . . . . 0.0 111.12 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -110.03 135.93 50.08 Favored 'General case' 0 N--CA 1.517 2.903 0 CA-C-N 123.123 2.692 . . . . 0.0 112.722 179.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 m -142.06 160.99 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.99 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.776 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.9 pt-20 -110.24 174.15 6.0 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.591 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.04 123.39 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.845 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.81 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.478 HG21 ' HG3' ' A' ' 19' ' ' GLU . 11.5 t -101.31 -43.83 5.84 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HG3' HG21 ' A' ' 18' ' ' THR . 28.9 mt-10 -128.25 99.06 5.29 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.757 0.789 . . . . 0.0 112.685 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.423 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 7.4 p -75.65 70.59 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.091 -2.255 . . . . 0.0 114.281 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.4 mmm -33.83 -45.9 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.89 167.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 36.6 mmtm -137.43 175.5 9.55 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -74.6 99.2 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.777 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.71 -23.08 5.4 Favored Glycine 1 N--CA 1.518 4.15 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.309 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.53 168.32 16.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 123.482 1.61 . . . . 0.0 114.326 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -98.9 132.94 43.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.416 ' CG1' HD22 ' A' ' 34' ' ' LEU . 88.7 t -128.12 122.62 58.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.209 -179.399 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -128.59 152.66 48.07 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 112.908 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.96 68.74 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.776 0 CA-C-O 124.135 1.921 . . . . 0.0 115.131 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 32' ' ' GLN . 15.6 pt-20 -177.05 -37.66 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 110.124 -3.216 . . . . 0.0 111.565 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.515 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -71.58 110.49 6.2 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.945 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 7.2 p -51.26 67.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -14.03 -64.73 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 120.518 3.525 . . . . 0.0 120.518 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 pt -150.52 148.86 14.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.186 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.4 m -95.27 133.8 38.76 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 178.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.7 m -118.13 157.1 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.567 ' CD ' ' HG ' ' A' ' 43' ' ' SER . 0.4 OUTLIER -122.97 167.44 13.59 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.79 94.98 0.16 Allowed Glycine 0 N--CA 1.511 3.653 0 CA-C-N 111.944 -2.389 . . . . 0.0 114.668 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.493 ' HB2' ' CE ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER 60.18 -68.8 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.666 0 CA-C-O 124.093 1.902 . . . . 0.0 115.492 179.696 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' CE ' ' HB2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -144.8 23.88 1.54 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 112.331 -2.213 . . . . 0.0 111.158 -179.82 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.56 122.87 19.41 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.567 ' HG ' ' CD ' ' A' ' 38' ' ' GLU . 3.9 m -105.87 124.66 49.93 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.351 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -131.69 162.69 29.84 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 123.638 0.586 . . . . 0.0 110.328 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -115.12 159.51 20.78 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.022 -1.674 . . . . 0.0 114.186 179.665 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.3 t -121.42 133.44 24.22 Favored Pre-proline 0 N--CA 1.503 2.208 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.84 171.79 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.683 1.589 . . . . 0.0 111.899 173.52 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -54.79 100.43 0.22 Allowed Pre-proline 0 C--N 1.286 -2.192 0 CA-C-N 112.316 -2.22 . . . . 0.0 116.332 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -39.89 -33.72 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 122.151 1.901 . . . . 0.0 113.582 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -156.1 176.98 11.95 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-N 112.692 -2.049 . . . . 0.0 108.466 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.1 159.57 15.26 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.63 -142.13 10.4 Favored Glycine 0 N--CA 1.51 3.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.94 169.62 21.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 124.762 1.225 . . . . 0.0 108.757 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 74' ' ' PHE . 38.5 t -95.61 127.7 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.439 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 44.8 tttp -102.72 -56.72 2.18 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.178 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -154.72 157.13 37.59 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 1.8 pt? -149.9 147.45 27.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 118.871 -2.393 . . . . 0.0 113.995 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 53.42 1.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.46 154.49 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.978 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 9.9 m-80 -131.83 -174.38 3.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 124.299 2.0 . . . . 0.0 115.227 179.141 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.01 88.94 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-O 126.262 2.934 . . . . 0.0 110.05 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.37 15.72 0.41 Allowed Glycine 0 N--CA 1.515 3.917 1 CA-C-N 105.702 -5.227 . . . . 0.0 111.192 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -95.01 152.69 18.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.465 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 2.2 pptp? -106.95 142.03 37.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.32 175.87 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 112.0 -2.363 . . . . 0.0 111.257 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.55 ' HD3' ' C ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 177.51 157.45 0.37 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.594 179.796 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -29.1 103.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 178.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . 109.74 -47.01 1.09 Allowed Glycine 1 N--CA 1.518 4.102 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.89 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 5.6 t -26.84 117.72 0.08 Allowed 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 61.18 0.2 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 mt -23.79 -68.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 124.748 2.214 . . . . 0.0 115.575 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.409 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 5.7 ptp -154.58 -175.41 5.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.523 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -113.62 122.83 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 124.359 2.028 . . . . 0.0 110.948 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 8.9 m-30 -107.97 174.65 5.79 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.571 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 21.0 tt0 -151.45 166.37 31.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.35 56.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -179.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -64.1 -72.75 0.13 Allowed 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.52 50.01 0.07 OUTLIER Glycine 1 N--CA 1.521 4.344 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 17.37 64.32 0.02 OUTLIER 'General case' 0 CA--C 1.579 2.061 0 N-CA-C 119.797 3.258 . . . . 0.0 119.797 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.619 0 C-N-CA 128.074 2.55 . . . . 0.0 105.905 179.831 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 5.5 ttp . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.32 121.03 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HZ3' ' CD ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -129.51 139.82 51.44 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.714 179.18 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.423 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -85.57 155.92 20.96 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 119.242 -2.161 . . . . 0.0 113.651 179.374 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 74' ' ' PHE . 90.4 t -116.56 119.79 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.809 0 C-N-CA 124.602 1.161 . . . . 0.0 113.92 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -111.05 174.78 5.7 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.744 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' CG1' ' A' ' 71' ' ' ILE . 60.7 t -96.86 130.4 30.24 Favored Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' O ' HG21 ' A' ' 67' ' ' THR . 53.6 Cg_endo -64.33 -100.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.348 0 C-N-CA 124.468 3.445 . . . . 0.0 120.913 -173.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 p30 -123.86 39.72 3.9 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 116.458 2.022 . . . . 0.0 116.458 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.53 HG23 ' CG2' ' A' ' 46' ' ' VAL . 5.6 pt -84.92 58.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 CA-C-O 124.859 2.266 . . . . 0.0 114.754 -179.536 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.72 111.1 0.97 Allowed Glycine 1 N--CA 1.516 4.001 0 CA-C-N 111.454 -2.612 . . . . 0.0 114.089 179.235 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 14' ' ' GLU . . . 160.51 82.83 0.04 OUTLIER Glycine 0 N--CA 1.508 3.496 0 O-C-N 121.676 -0.896 . . . . 0.0 112.187 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.287 4.5 m-20 13.11 23.38 0.0 OUTLIER 'General case' 0 CA--C 1.594 2.635 0 C-N-CA 131.572 3.949 . . . . 0.0 121.643 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' GLY . 42.5 tt0 118.52 137.5 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.878 0 C-N-CA 130.381 3.472 . . . . 0.0 112.368 179.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 37' ' ' VAL . 1.4 m -137.41 146.12 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.948 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.595 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 6.9 pt-20 -113.36 169.25 9.09 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 t -93.97 130.0 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.128 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -179.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.471 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 63.9 p -105.8 -47.15 3.95 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.801 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.422 ' HG3' ' C ' ' A' ' 18' ' ' THR . 2.8 mt-10 -130.49 106.04 8.26 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 123.126 1.441 . . . . 0.0 112.822 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.506 HG11 ' HZ3' ' A' ' 23' ' ' LYS . 8.0 p -83.88 70.49 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-O 123.709 1.718 . . . . 0.0 111.162 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -25.37 -52.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 111.786 -2.461 . . . . 0.0 116.982 179.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 m -102.59 179.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.787 0 N-CA-C 118.514 2.783 . . . . 0.0 118.514 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HZ3' HG11 ' A' ' 20' ' ' VAL . 40.3 mmtm -140.18 168.69 19.22 Favored 'General case' 0 N--CA 1.522 3.131 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.12 89.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.525 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.063 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.87 4.6 5.58 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.748 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.6 141.24 31.68 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.411 1.101 . . . . 0.0 113.474 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HZ3' ' CD ' ' A' ' 77' ' ' GLU . 28.4 mttp -64.99 135.32 55.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.983 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.488 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 19.0 t -131.96 115.82 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -179.335 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.26 152.46 35.69 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.181 -1.575 . . . . 0.0 113.97 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.94 72.91 0.42 Allowed 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.494 1.616 . . . . 0.0 114.545 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 175.98 -22.44 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 110.315 -3.13 . . . . 0.0 110.299 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -92.94 117.04 29.61 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -179.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 14.7 m -48.27 126.8 11.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.331 1.063 . . . . 0.0 112.981 179.277 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -89.02 -55.26 3.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 125.003 1.321 . . . . 0.0 113.711 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.4 152.18 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.566 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -99.48 136.41 39.45 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 21.4 m -123.68 146.71 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' CG ' ' HB2' ' A' ' 43' ' ' SER . 0.0 OUTLIER -124.84 -173.69 2.86 Favored 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 179.8 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.23 145.36 4.93 Favored Glycine 1 N--CA 1.519 4.177 0 O-C-N 124.419 1.074 . . . . 0.0 113.061 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 1.0 -73.0 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -35.65 -54.68 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 160.84 172.13 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.294 0 O-C-N 126.109 2.131 . . . . 0.0 107.851 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.414 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 37.9 t -89.79 141.41 28.65 Favored 'General case' 0 N--CA 1.51 2.53 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.679 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.0 mtm -132.22 172.31 12.58 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -122.88 156.69 34.13 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 122.178 0.989 . . . . 0.0 113.397 179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.53 ' CG2' HG23 ' A' ' 10' ' ' ILE . 5.8 t -131.2 122.24 19.04 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.753 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -85.86 178.7 4.13 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.008 1.805 . . . . 0.0 113.02 169.144 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -67.27 106.75 1.31 Allowed Pre-proline 0 C--N 1.287 -2.121 1 N-CA-C 122.188 4.144 . . . . 0.0 122.188 -179.903 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -29.7 -40.69 0.06 OUTLIER 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.665 2.243 . . . . 0.0 115.61 174.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -154.11 -176.42 5.85 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 112.8 -2.0 . . . . 0.0 111.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.22 116.66 31.92 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.7 -169.7 34.84 Favored Glycine 1 N--CA 1.526 4.636 0 CA-C-O 119.276 -0.735 . . . . 0.0 112.556 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.43 ' CG2' ' HG3' ' A' ' 77' ' ' GLU . 2.1 t -109.91 157.31 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.34 0 CA-C-N 119.804 1.802 . . . . 0.0 107.847 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 20.8 t -76.43 113.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -91.74 -41.81 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 51.2 tt0 -164.92 161.28 19.99 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.155 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -162.71 152.16 15.53 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.164 -1.585 . . . . 0.0 109.243 178.587 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 54.0 mttt -126.29 49.48 2.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.761 1.267 . . . . 0.0 109.164 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.03 137.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 111.828 -2.442 . . . . 0.0 112.707 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.82 177.75 4.59 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 124.619 2.152 . . . . 0.0 113.621 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -85.06 115.8 27.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 1 N-CA-C 99.967 -4.086 . . . . 0.0 99.967 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.55 -24.74 5.49 Favored Glycine 0 N--CA 1.514 3.882 0 CA-C-N 110.156 -3.202 . . . . 0.0 109.905 -179.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.06 174.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.595 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 25.2 mmtm -104.13 136.13 44.33 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 m -132.15 142.87 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 123.218 1.485 . . . . 0.0 110.107 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 67' ' ' THR . 11.9 ttmt -141.01 123.44 15.86 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.69 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 8' ' ' PRO . 1.4 m -22.72 103.64 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.32 -42.49 1.72 Allowed Glycine 0 N--CA 1.511 3.695 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.542 -179.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 13.8 t -38.45 140.22 0.34 Allowed 'General case' 0 N--CA 1.53 3.526 0 CA-C-O 118.028 -0.987 . . . . 0.0 113.611 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.7 tt -80.78 57.33 2.96 Favored 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 124.527 2.108 . . . . 0.0 115.871 -179.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG1' HG22 ' A' ' 7' ' ' VAL . 14.4 mm -30.05 -67.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 120.498 3.518 . . . . 0.0 120.498 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptm -143.26 172.15 13.14 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 111.784 -2.462 . . . . 0.0 113.397 -179.349 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.38 122.74 69.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 120.731 -1.231 . . . . 0.0 109.681 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.521 ' CE1' HG22 ' A' ' 5' ' ' VAL . 16.2 m-30 -105.02 144.69 31.47 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' OE2' ' N ' ' A' ' 1' ' ' MET . 1.2 tp10 -120.73 99.2 6.39 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 124.551 2.12 . . . . 0.0 111.293 179.578 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 m -49.26 90.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' CD ' ' HZ3' ' A' ' 27' ' ' LYS . 83.4 mt-10 -26.77 -50.01 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.853 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.91 -67.76 0.16 Allowed Glycine 0 N--CA 1.516 3.967 0 N-CA-C 103.171 -3.972 . . . . 0.0 103.171 179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 175.88 33.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 111.15 -2.525 . . . . 0.0 109.111 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.807 3 N-CA-C 97.479 -5.008 . . . . 0.0 97.479 -179.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' H1 ' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.587 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 . . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.2 m -19.36 154.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 1 N-CA-C 124.099 4.852 . . . . 0.0 124.099 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 74' ' ' PHE . 3.2 mttp -164.16 171.89 14.42 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.222 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.65 161.21 19.54 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.358 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 72' ' ' MET . 43.8 t -128.48 96.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 124.943 2.306 . . . . 0.0 108.143 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.9 p-10 -86.72 168.79 13.23 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.454 HG22 ' CG1' ' A' ' 65' ' ' VAL . 33.1 t -98.69 143.71 26.83 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 116.598 -2.041 . . . . 0.0 112.879 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -72.05 -178.98 3.51 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.181 1.921 . . . . 0.0 114.633 177.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -53.99 40.82 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 118.757 2.873 . . . . 0.0 118.757 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.577 HG23 ' CG2' ' A' ' 46' ' ' VAL . 9.6 pt -79.53 46.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 O-C-N 118.842 -2.411 . . . . 0.0 116.368 -179.406 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.0 175.74 18.58 Favored Glycine 1 N--CA 1.526 4.664 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.75 -29.31 7.8 Favored Glycine 1 N--CA 1.525 4.569 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' O ' ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -89.35 -167.87 2.0 Allowed 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 131.263 3.825 . . . . 0.0 110.54 -179.885 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -112.03 149.76 31.59 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 122.554 1.169 . . . . 0.0 112.041 179.782 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.47 167.22 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.275 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 28.8 mt-10 -112.19 128.67 56.3 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 61' ' ' VAL . 5.6 t -69.49 119.01 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.109 0 C-N-CA 115.71 -2.396 . . . . 0.0 109.835 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -94.11 -51.24 4.93 Favored 'General case' 0 N--CA 1.519 2.98 0 C-N-CA 123.755 0.822 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.13 119.05 20.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.61 1.195 . . . . 0.0 112.726 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -92.33 63.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 123.594 1.664 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.3 mmm -24.33 -46.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.75 160.34 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -153.96 0.57 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 120.606 3.558 . . . . 0.0 120.606 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 55' ' ' LYS . 65.4 t -73.92 97.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.898 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.78 6.18 26.8 Favored Glycine 0 N--CA 1.516 3.977 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.722 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -92.85 152.77 19.23 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -82.09 124.84 30.2 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.55 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 t -123.47 148.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.054 -179.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' HB1' ' A' ' 48' ' ' ALA . . . -147.39 151.12 35.96 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.384 -0.822 . . . . 0.0 109.018 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 48' ' ' ALA . . . -48.72 158.96 0.27 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 124.172 0.92 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 74.12 -41.54 0.48 Allowed 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 123.901 1.81 . . . . 0.0 112.007 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 119.565 -1.959 . . . . 0.0 114.656 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -34.0 82.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 179.154 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -50.79 -51.48 50.19 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.2 pt -142.1 144.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.001 179.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 m -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 24.7 m -130.82 162.4 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 17.7 tt0 -121.57 -144.61 0.35 Allowed 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.469 ' H ' ' HG2' ' A' ' 38' ' ' GLU . . . 129.67 -141.21 12.38 Favored Glycine 1 N--CA 1.517 4.096 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.224 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -48.26 86.19 0.0 OUTLIER 'General case' 0 CA--C 1.6 2.872 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 0.3 OUTLIER 33.49 32.1 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.149 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -179.532 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.58 150.34 38.69 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.823 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.5 p -106.46 130.22 54.3 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 122.044 0.926 . . . . 0.0 111.63 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 30.7 mmt -124.1 152.58 42.57 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.601 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -124.41 152.94 42.63 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.577 ' CG2' HG23 ' A' ' 10' ' ' ILE . 5.4 t -121.76 112.75 32.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.911 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.97 171.12 14.54 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 CA-C-O 124.282 1.701 . . . . 0.0 108.933 172.439 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HD11 ' A' ' 34' ' ' LEU . . . -64.27 106.83 1.06 Allowed Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.089 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -34.45 -37.04 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 121.808 1.672 . . . . 0.0 114.321 175.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -156.16 -175.74 5.59 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -96.61 164.83 12.43 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.49 -152.69 18.45 Favored Glycine 1 N--CA 1.524 4.567 0 O-C-N 121.415 -0.803 . . . . 0.0 114.78 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.38 165.46 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 121.429 0.633 . . . . 0.0 112.143 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.459 HG21 ' CE1' ' A' ' 74' ' ' PHE . 15.3 t -96.09 145.33 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.103 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 18.8 tptt -107.65 -60.59 1.68 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.631 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.9 tt0 -161.17 169.79 21.6 Favored 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.585 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt? -164.61 155.97 15.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.655 -1.278 . . . . 0.0 109.645 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -131.11 51.55 2.13 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.387 1.089 . . . . 0.0 108.368 179.714 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.28 170.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 CA-C-N 114.121 -1.4 . . . . 0.0 114.719 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -138.65 165.95 25.62 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 120.692 3.59 . . . . 0.0 120.692 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 1.9 t -96.03 101.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 100.849 -3.76 . . . . 0.0 100.849 179.604 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.35 29.17 2.18 Favored Glycine 0 N--CA 1.508 3.481 0 CA-C-N 109.572 -3.467 . . . . 0.0 108.01 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.285 0.0 OUTLIER -112.12 178.79 4.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 179.44 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HE2' ' CD ' ' A' ' 16' ' ' GLU . 29.6 mmtp -109.77 130.35 55.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.454 ' CG1' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -113.01 147.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 113.492 -1.685 . . . . 0.0 112.918 -179.838 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' CE ' ' O ' ' A' ' 13' ' ' ASP . 4.3 tptm -146.76 140.97 26.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 15.1 t -50.97 124.44 11.32 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.699 178.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.8 -47.11 1.05 Allowed Glycine 0 N--CA 1.508 3.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.659 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.9 t -36.32 118.78 0.56 Allowed 'General case' 0 N--CA 1.523 3.222 0 CA-C-O 117.316 -1.326 . . . . 0.0 113.606 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.92 62.15 1.09 Allowed 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 123.198 1.475 . . . . 0.0 110.527 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.2 mm -45.11 -58.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' VAL . 8.0 ptm -142.06 160.7 39.69 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.13 131.79 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 123.532 1.634 . . . . 0.0 112.54 179.549 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 3' ' ' LYS . 3.6 m-30 -110.35 165.27 11.91 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.956 -2.384 . . . . 0.0 116.919 -179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.516 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 21.6 tt0 -151.36 101.89 2.87 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.1 m -48.66 60.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 C-N-CA 127.297 2.239 . . . . 0.0 116.245 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 85.94 144.9 0.06 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 -179.189 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.56 9.52 4.63 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 2.89 -80.03 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.697 0 O-C-N 127.668 2.628 . . . . 0.0 115.393 -179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.209 0 O-C-N 127.652 3.095 . . . . 0.0 113.785 179.61 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' HG23 ' A' ' 76' ' ' VAL . 57.2 mtm . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -34.35 137.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -76.12 177.37 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 11' ' ' GLY . 10.1 p30 -70.63 60.52 0.22 Allowed 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 125.264 2.459 . . . . 0.0 114.778 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.445 HG23 ' CG1' ' A' ' 46' ' ' VAL . 10.8 pt -79.22 39.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 CA-C-O 123.687 1.708 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 46.48 -79.99 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.89 95.47 0.01 OUTLIER Glycine 1 N--CA 1.52 4.242 0 N-CA-C 117.869 1.907 . . . . 0.0 117.869 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -17.68 -66.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.17 139.01 35.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.466 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.79 155.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.543 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.86 -166.74 1.66 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.6 174.3 16.73 Favored Glycine 0 N--CA 1.514 3.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -14.07 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt 66.98 -3.9 0.88 Allowed 'General case' 0 N--CA 1.518 2.942 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.27 118.14 34.44 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -103.44 125.75 50.21 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' CG1' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.568 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.568 ' HZ2' ' CG ' ' A' ' 56' ' ' GLU . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 9' ' ' ASP . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG1' HG22 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.518 ' SD ' HG11 ' A' ' 54' ' ' VAL . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE1' HG23 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 1' ' ' MET . 27.5 m -62.96 74.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.47 146.64 40.41 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.384 179.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.16 -36.53 2.38 Favored Glycine 0 N--CA 1.511 3.676 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 158.35 -170.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 110.981 -2.609 . . . . 0.0 111.923 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.699 0 C-N-CA 125.611 1.564 . . . . 0.0 108.714 179.926 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' HG23 ' A' ' 76' ' ' VAL . 57.2 mtm . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -34.35 137.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -76.12 177.37 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 11' ' ' GLY . 10.1 p30 -70.63 60.52 0.22 Allowed 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 125.264 2.459 . . . . 0.0 114.778 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.445 HG23 ' CG1' ' A' ' 46' ' ' VAL . 10.8 pt -79.22 39.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 CA-C-O 123.687 1.708 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 46.48 -79.99 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.89 95.47 0.01 OUTLIER Glycine 1 N--CA 1.52 4.242 0 N-CA-C 117.869 1.907 . . . . 0.0 117.869 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -17.68 -66.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 179.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.17 139.01 35.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.79 155.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.543 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.86 -166.74 1.66 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.6 174.3 16.73 Favored Glycine 0 N--CA 1.514 3.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -14.07 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt 66.98 -3.9 0.88 Allowed 'General case' 0 N--CA 1.518 2.942 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.27 118.14 34.44 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -103.44 125.75 50.21 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' CG1' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.568 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.568 ' HZ2' ' CG ' ' A' ' 56' ' ' GLU . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 9' ' ' ASP . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG1' HG22 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.518 ' SD ' HG11 ' A' ' 54' ' ' VAL . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE1' HG23 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 1' ' ' MET . 27.5 m -62.96 74.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.47 146.64 40.41 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.384 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.16 -36.53 2.38 Favored Glycine 0 N--CA 1.511 3.676 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 158.35 -170.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 110.981 -2.609 . . . . 0.0 111.923 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.699 0 C-N-CA 125.611 1.564 . . . . 0.0 108.714 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 123.968 1.842 . . . . 0.0 115.926 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.643 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 6.1 mmmt -139.83 149.93 44.07 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.863 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -96.27 154.97 16.96 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 74' ' ' PHE . 43.3 t -116.52 117.27 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.586 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.2 p-10 -108.5 169.4 8.67 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.154 1.454 . . . . 0.0 109.767 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.509 HG22 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -94.94 115.0 64.94 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 112.546 -2.115 . . . . 0.0 106.468 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.413 ' O ' HG22 ' A' ' 67' ' ' THR . 52.8 Cg_endo . . . . . 0 N--CA 1.506 2.235 0 C-N-CA 122.513 2.142 . . . . 0.0 113.471 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 65' ' ' VAL . 24.7 m . . . . . 0 N--CA 1.502 2.146 0 CA-C-O 122.693 1.235 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 2.5 pt-20 -120.58 170.32 9.52 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.43 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 t -97.62 120.75 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' HB ' ' A' ' 36' ' ' THR . 12.2 t -96.47 -46.17 6.47 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.68 98.51 4.51 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 122.437 1.113 . . . . 0.0 113.362 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.8 p -81.62 68.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 124.599 2.142 . . . . 0.0 108.498 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -32.49 -56.15 0.34 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.729 2.862 . . . . 0.0 118.729 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.2 m -87.71 164.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.617 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 16.3 mmtp -131.79 -166.38 1.71 Allowed 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 124.25 1.976 . . . . 0.0 115.91 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.7 t -74.42 86.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-N 113.294 -1.775 . . . . 0.0 113.654 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.62 -11.49 7.07 Favored Glycine 1 N--CA 1.517 4.065 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.097 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -54.97 163.94 0.92 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD2' HG12 ' A' ' 53' ' ' VAL . 8.4 mmmm -100.2 102.29 13.54 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 112.263 -2.244 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.79 148.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 CA-C-O 124.217 1.96 . . . . 0.0 114.804 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -141.04 154.67 46.09 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.548 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -55.03 163.85 0.96 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 60.49 -16.54 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 30' ' ' ALA . 3.4 tm0? -88.81 106.97 18.72 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 4.0 t -36.57 138.44 0.23 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.3 mt -102.14 -59.43 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.8 pt -140.26 130.89 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.198 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 45' ' ' GLU . 6.7 m -83.55 123.06 29.38 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.8 m -115.66 141.59 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.512 2.666 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 N--CA 1.508 2.464 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 32.6 mtt -121.97 164.86 16.89 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.64 -1.288 . . . . 0.0 112.117 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' HG2' HG23 ' A' ' 36' ' ' THR . 36.7 mt-10 -129.81 153.49 48.19 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.44 1.114 . . . . 0.0 112.361 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.8 t -124.74 112.97 27.16 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.698 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.56 177.52 5.6 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.741 1.627 . . . . 0.0 113.214 178.357 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -69.27 114.75 25.98 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 29.2 Cg_endo -46.79 -27.71 5.94 Favored 'Trans proline' 0 N--CA 1.512 2.609 0 C-N-CA 122.371 2.048 . . . . 0.0 112.609 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.643 ' CZ ' ' HE3' ' A' ' 3' ' ' LYS . 47.0 p90 -167.13 -175.28 2.92 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.26 164.12 12.61 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.85 -144.65 15.53 Favored Glycine 1 N--CA 1.52 4.293 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.545 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG12 ' HD2' ' A' ' 27' ' ' LYS . 3.4 m -121.87 166.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.062 0.934 . . . . 0.0 112.318 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' CE1' ' A' ' 74' ' ' PHE . 13.8 t -98.33 142.08 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.487 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 69.2 tttt -115.93 -63.88 1.39 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.645 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -135.82 158.5 44.24 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -155.97 115.8 3.63 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.077 -1.639 . . . . 0.0 113.203 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -90.65 52.54 2.21 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.237 -1.539 . . . . 0.0 109.466 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.18 149.09 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -122.67 172.02 8.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 124.355 2.026 . . . . 0.0 116.123 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -95.06 111.41 25.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 100.992 -3.707 . . . . 0.0 100.992 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.03 8.71 11.38 Favored Glycine 1 N--CA 1.518 4.15 1 CA-C-N 107.741 -4.3 . . . . 0.0 108.855 -179.218 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' A' ' 64' ' ' LYS . 43.9 t0 -94.82 177.49 5.89 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.611 -1.295 . . . . 0.0 110.264 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' CE ' ' HB3' ' A' ' 16' ' ' GLU . 2.6 mmtp -108.73 144.46 36.5 Favored 'General case' 0 N--CA 1.511 2.595 1 N-CA-C 123.369 4.581 . . . . 0.0 123.369 -179.174 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 15' ' ' VAL . 2.8 m -142.26 150.22 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.757 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -161.74 162.52 29.71 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 16.6 p -41.49 113.75 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.99 -35.88 4.78 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 111.641 -2.527 . . . . 0.0 115.314 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.6 t -38.31 132.92 1.02 Allowed 'General case' 0 N--CA 1.53 3.567 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.59 56.96 0.18 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.509 ' CG1' HG22 ' A' ' 7' ' ' VAL . 3.1 mt -23.12 -63.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CG2' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -159.23 171.94 18.95 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 112.529 -2.123 . . . . 0.0 114.123 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.77 120.51 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 123.635 1.683 . . . . 0.0 110.842 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' HG21 ' A' ' 5' ' ' VAL . 6.8 m-30 -99.05 176.01 5.71 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 112.083 -2.326 . . . . 0.0 109.136 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS 0.264 26.5 tt0 -156.39 115.87 3.52 Favored 'General case' 0 C--N 1.285 -2.23 1 N-CA-C 98.965 -4.457 . . . . 0.0 98.965 178.712 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.783 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.513 2.692 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.498 ' HE3' ' OE2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -112.19 127.12 55.86 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -66.84 142.86 57.19 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.717 1.246 . . . . 0.0 110.732 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 74' ' ' PHE . 26.2 t -116.49 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.9 p-10 -101.61 168.78 9.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.748 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.87 140.06 21.7 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.721 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 N--CA 1.496 1.674 0 C-N-CA 123.327 2.684 . . . . 0.0 114.803 -179.239 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.502 2.159 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 pm0 -113.13 164.96 12.85 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.488 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 t -101.48 117.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.221 -0.924 . . . . 0.0 110.118 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.61 -50.57 4.44 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.285 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.3 mt-10 -128.69 95.28 4.07 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 123.555 1.645 . . . . 0.0 111.305 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.5 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.8 p -70.23 66.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.5 mtt -30.24 -57.35 0.19 Allowed 'General case' 0 N--CA 1.512 2.631 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.422 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 18.8 m -87.16 171.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -134.33 169.37 17.31 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.63 110.26 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.704 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 10.91 21.62 Favored Glycine 0 N--CA 1.508 3.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.694 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.38 159.34 16.46 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 123.731 1.729 . . . . 0.0 110.045 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -78.58 122.74 26.29 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 125.151 2.405 . . . . 0.0 113.49 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 74' ' ' PHE . 92.7 t -125.25 97.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 110.455 -3.066 . . . . 0.0 114.56 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -107.44 160.01 15.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 173.83 0.24 Allowed 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.454 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 62.79 -18.67 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -94.97 139.51 31.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.132 -1.605 . . . . 0.0 107.789 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t -63.48 128.48 36.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -92.77 -64.52 1.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.8 pt -138.61 140.04 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 113.424 -1.717 . . . . 0.0 112.306 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 3.4 m -93.35 130.13 39.23 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.985 -3.339 . . . . 0.0 101.985 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.49 164.8 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.197 0.936 . . . . 0.0 112.473 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 11.6 tt0 . . . . . 0 N--CA 1.505 2.293 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.253 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.505 2.302 0 CA-C-O 121.992 0.901 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.39 124.72 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.842 -1.526 . . . . 0.0 107.413 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 22.7 mp0 -95.65 142.55 27.83 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 123.825 1.774 . . . . 0.0 113.557 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 t -113.48 118.47 43.45 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.582 -1.644 . . . . 0.0 115.092 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -82.14 178.11 6.65 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.875 1.717 . . . . 0.0 112.356 174.167 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -67.51 103.1 0.44 Allowed Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 118.793 2.886 . . . . 0.0 118.793 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.8 Cg_endo -42.93 -29.59 1.56 Allowed 'Trans proline' 0 N--CA 1.508 2.349 0 C-N-CA 122.416 2.077 . . . . 0.0 114.105 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -159.2 -179.44 7.99 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.24 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.53 17.08 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 120.097 3.369 . . . . 0.0 120.097 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.37 -147.82 18.56 Favored Glycine 1 N--CA 1.519 4.221 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.98 160.89 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.93 83.74 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -67.47 -42.48 82.94 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -163.84 130.19 3.16 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 1.9 pt? -126.95 151.27 48.73 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 119.78 -1.825 . . . . 0.0 108.362 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -121.05 45.08 2.35 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.899 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 p -141.11 154.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.953 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -124.26 171.78 9.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -87.0 114.76 26.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 100.9 -3.741 . . . . 0.0 100.9 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.35 -0.77 16.41 Favored Glycine 0 N--CA 1.503 3.147 0 CA-C-N 110.145 -3.207 . . . . 0.0 109.216 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.8 170.48 9.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.334 0.667 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -118.68 145.73 45.26 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 121.13 3.752 . . . . 0.0 121.13 -179.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.471 HG12 ' CD1' ' A' ' 71' ' ' ILE . 17.1 m -130.62 164.79 32.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.218 -1.81 . . . . 0.0 113.557 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 140.82 18.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 t -43.72 120.42 2.0 Allowed 'General case' 0 N--CA 1.514 2.773 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.242 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.13 -23.72 10.46 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 117.285 1.674 . . . . 0.0 117.285 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.4 t -79.25 143.26 35.46 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 118.664 -1.214 . . . . 0.0 112.602 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 70' ' ' LEU . 9.3 mp -87.99 62.49 6.87 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 124.369 2.033 . . . . 0.0 113.338 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CD1' HG12 ' A' ' 65' ' ' VAL . 12.9 mm -44.65 -45.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -133.85 -177.47 4.58 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.743 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -138.63 117.29 13.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 5' ' ' VAL . 22.6 m-30 -109.75 159.51 17.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.273 3.1 tt0 -126.02 150.9 47.76 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 -179.472 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.513 2.682 0 N-CA-C 121.218 3.784 . . . . 0.0 121.218 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.606 ' HZ2' ' CD ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -99.13 158.77 15.44 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 113.011 -1.904 . . . . 0.0 114.131 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.606 ' CD ' ' HZ2' ' A' ' 3' ' ' LYS . 4.5 mp0 -100.27 149.79 23.23 Favored 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 74' ' ' PHE . 85.2 t -130.89 91.54 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.092 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 15.3 p-10 -104.93 174.28 5.94 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.508 HG22 HD11 ' A' ' 71' ' ' ILE . 56.4 t -90.81 126.23 56.45 Favored Pre-proline 0 N--CA 1.504 2.255 0 C-N-CA 117.128 -1.829 . . . . 0.0 106.527 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 N--CA 1.51 2.5 0 N-CA-C 120.606 3.272 . . . . 0.0 120.606 175.989 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.511 2.607 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.1 pt-20 -120.36 171.08 8.78 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -101.52 120.93 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.181 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 p -97.8 -52.84 3.6 Favored 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.837 -1.529 . . . . 0.0 111.279 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -123.27 104.98 9.47 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 122.978 1.37 . . . . 0.0 113.882 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.63 93.29 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.175 -1.578 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -38.23 90.12 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 26' ' ' ASP . 3.4 t -126.49 160.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -134.51 -175.63 3.94 Favored 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.37 91.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 113.83 -1.532 . . . . 0.0 112.114 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.36 -4.23 13.61 Favored Glycine 1 N--CA 1.52 4.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.326 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.548 ' HB2' HG12 ' A' ' 22' ' ' VAL . 23.8 m-20 -93.07 143.32 26.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.242 1.02 . . . . 0.0 111.697 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -76.4 122.9 25.15 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 124.71 2.195 . . . . 0.0 115.935 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 59.1 t -110.81 125.26 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.593 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -132.23 150.7 52.1 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 111.925 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -44.05 157.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.49 -20.05 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.529 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 30.0 tt0 -74.42 148.11 41.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -84.89 124.14 31.28 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.483 1.135 . . . . 0.0 108.592 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.9 mt -85.35 -57.57 3.02 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 122.652 1.215 . . . . 0.0 110.191 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -143.98 151.61 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -102.4 138.94 38.67 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.3 m -129.96 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 N--CA 1.512 2.669 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 N--CA 1.515 2.799 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.17 148.26 33.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.039 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 14.0 mp0 -114.64 151.57 33.33 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 123.511 1.624 . . . . 0.0 114.457 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.0 t -112.7 105.88 55.72 Favored Pre-proline 0 N--CA 1.506 2.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -86.33 179.81 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.87 1.529 . . . . 0.0 112.276 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -71.31 107.36 2.62 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 42.2 Cg_endo -49.52 -26.4 12.36 Favored 'Trans proline' 0 N--CA 1.514 2.697 0 C-N-CA 122.22 1.947 . . . . 0.0 113.757 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -164.97 -175.7 3.85 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 163.97 12.4 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 129.2 -144.83 15.78 Favored Glycine 1 N--CA 1.528 4.778 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.879 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.03 169.76 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 CA-C-N 118.879 1.339 . . . . 0.0 111.389 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 27.0 t -88.2 133.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.4 -53.8 3.63 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.032 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.29 159.42 19.9 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 124.672 1.233 . . . . 0.0 110.726 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -155.31 130.3 9.41 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -100.76 29.97 4.25 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.935 -1.103 . . . . 0.0 109.768 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -119.4 157.33 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 112.71 -2.041 . . . . 0.0 114.005 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.94 -178.42 4.88 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.5 t -90.19 106.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 1 N-CA-C 99.059 -4.423 . . . . 0.0 99.059 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.22 28.59 2.15 Favored Glycine 0 N--CA 1.515 3.919 0 CA-C-N 108.991 -3.731 . . . . 0.0 110.591 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 67.3 t0 -119.71 164.9 15.23 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -106.08 141.31 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 119.857 3.28 . . . . 0.0 119.857 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -139.19 -179.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.92 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 65' ' ' VAL . 7.2 pttt 149.94 154.59 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.923 0 C-N-CA 125.715 1.606 . . . . 0.0 111.656 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.1 p -25.09 103.59 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 118.515 2.784 . . . . 0.0 118.515 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.14 -47.8 1.0 Allowed Glycine 0 N--CA 1.507 3.415 0 CA-C-N 111.711 -2.495 . . . . 0.0 112.491 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.1 t -50.12 123.9 9.19 Favored 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.953 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 25.7 mt -72.56 67.39 0.76 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 7' ' ' VAL . 2.0 mt -22.75 -58.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 8.8 ptp -169.66 -173.67 1.69 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.414 -2.176 . . . . 0.0 115.488 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.52 133.51 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.501 1.143 . . . . 0.0 110.731 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 5' ' ' VAL . 12.1 m-30 -112.64 176.2 5.12 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.271 7.3 tp10 -144.37 99.54 3.39 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 29.8 m . . . . . 0 CA--C 1.569 1.693 1 N-CA-C 126.853 5.872 . . . . 0.0 126.853 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 124.03 1.872 . . . . 0.0 114.091 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -118.74 122.62 42.89 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.778 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -68.4 155.65 39.4 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.977 0.894 . . . . 0.0 110.267 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 74' ' ' PHE . 36.9 t -122.87 100.18 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.45 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 10.9 p-10 -98.24 96.56 8.16 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.421 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' THR . 89.6 t -20.75 122.71 0.1 Allowed Pre-proline 0 N--CA 1.511 2.58 0 CA-C-N 113.093 -1.867 . . . . 0.0 114.858 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.504 2.127 0 C-N-CA 122.262 1.975 . . . . 0.0 116.346 -178.227 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.512 2.672 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.9 pt-20 -107.32 166.52 10.58 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 t -94.86 116.29 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.226 1.012 . . . . 0.0 112.456 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -94.65 -32.23 13.48 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 113.78 -1.555 . . . . 0.0 111.726 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 0.4 OUTLIER -138.54 107.64 6.05 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.828 0.705 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.3 p -86.74 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 118.43 -2.669 . . . . 0.0 117.088 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.3 mmt -20.3 -51.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.55 HG21 HE22 ' A' ' 32' ' ' GLN . 2.9 t -111.97 151.54 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 23' ' ' LYS . 23.4 mtmt -134.07 -177.62 4.66 Favored 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.24 94.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.246 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.9 -7.1 17.36 Favored Glycine 1 N--CA 1.516 4.021 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -92.48 142.54 27.3 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.251 1.024 . . . . 0.0 110.477 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -69.82 127.25 32.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.653 2.644 . . . . 0.0 117.193 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 1.5 t -112.66 98.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 109.86 -3.336 . . . . 0.0 113.906 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.473 ' H ' ' HG2' ' A' ' 32' ' ' GLN . . . -112.85 146.96 37.97 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.75 -1.219 . . . . 0.0 112.42 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.02 124.16 20.04 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 118.89 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 128.358 3.536 . . . . 0.0 110.62 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.55 HE22 HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.09 147.38 22.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.417 -1.427 . . . . 0.0 108.997 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 2.2 t -80.48 80.94 6.85 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.0 mt -29.99 -57.25 0.18 Allowed 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.8 pt -149.41 156.76 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 112.591 -2.095 . . . . 0.0 110.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 87.2 m -106.15 131.75 53.03 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.96 154.88 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 N--CA 1.505 2.29 0 CA-C-O 123.721 1.725 . . . . 0.0 113.372 179.464 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.513 2.682 0 CA-C-O 121.13 0.49 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.3 mtm -106.34 165.81 10.98 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -102.12 145.28 29.58 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.54 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.5 t -117.81 97.2 50.55 Favored Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.861 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 7.1 Cg_endo -73.95 175.02 11.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-O 125.154 2.064 . . . . 0.0 111.584 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.633 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -77.04 109.06 7.9 Favored Pre-proline 0 C--N 1.284 -2.276 0 CA-C-N 111.527 -2.578 . . . . 0.0 117.262 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 27.6 Cg_endo -47.08 -32.03 12.67 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.794 2.329 . . . . 0.0 111.707 -170.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -155.73 -178.35 7.23 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 111.932 -2.395 . . . . 0.0 107.318 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -97.97 159.68 14.78 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.51 -147.68 19.39 Favored Glycine 1 N--CA 1.531 4.971 0 C-N-CA 123.828 0.728 . . . . 0.0 112.663 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 162.16 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 CA-C-N 119.029 1.415 . . . . 0.0 109.521 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 24.9 t -82.25 102.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.844 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -76.79 -47.8 20.51 Favored 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.482 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 5.4 tt0 -161.33 152.58 18.71 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.7 pt? -149.69 150.67 32.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.592 -1.942 . . . . 0.0 108.489 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 6.0 mttp -115.34 47.28 1.33 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 121.785 0.802 . . . . 0.0 111.246 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -139.49 140.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 113.688 -1.597 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -125.45 -170.44 2.18 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.132 1.444 . . . . 0.0 110.49 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.43 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.78 9.05 4.98 Favored Glycine 1 N--CA 1.517 4.097 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.577 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -101.57 157.3 16.92 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -111.45 146.49 37.12 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HB ' HG21 ' A' ' 7' ' ' VAL . 6.3 m -136.49 168.15 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 113.01 -1.905 . . . . 0.0 113.908 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.31 147.34 22.16 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 7.2 t -47.37 122.6 4.79 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.936 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.06 16.94 24.16 Favored Glycine 0 N--CA 1.514 3.835 0 O-C-N 121.353 -0.842 . . . . 0.0 114.96 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -107.02 97.03 6.86 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.796 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.22 87.64 7.19 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 123.592 1.663 . . . . 0.0 112.575 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' C ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -112.4 -26.54 3.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.952 -1.931 . . . . 0.0 116.046 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 5' ' ' VAL . 11.3 ttp -100.56 153.99 18.93 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.605 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.2 126.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 124.957 2.313 . . . . 0.0 115.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD1' HG21 ' A' ' 5' ' ' VAL . 17.8 m-30 -114.5 158.52 21.5 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.475 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -140.4 135.75 32.4 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.298 -1.65 0 CA-C-O 122.074 0.94 . . . . 0.0 113.199 -179.581 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 80.4 t . . . . . 0 N--CA 1.518 2.928 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -129.91 162.14 29.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.973 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 2.4 pm0 -105.12 153.34 21.64 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 74' ' ' PHE . 46.6 t -133.18 97.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.951 1.358 . . . . 0.0 113.716 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.7 p-10 -103.51 177.46 4.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 65' ' ' VAL . 79.0 t -104.29 142.02 23.73 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 7' ' ' VAL . 10.9 Cg_endo . . . . . 0 N--CA 1.493 1.493 0 C-N-CA 123.114 2.543 . . . . 0.0 113.633 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.505 2.296 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 89.9 mt-10 -87.21 -179.43 6.43 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 61' ' ' VAL . 97.7 t -109.69 115.73 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -46.15 9.53 Favored 'General case' 0 N--CA 1.522 3.161 0 CA-C-N 120.343 1.428 . . . . 0.0 110.24 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.68 100.72 4.71 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.058 1.409 . . . . 0.0 113.516 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 61' ' ' VAL . 13.8 p -82.14 58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 122.234 1.016 . . . . 0.0 111.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.1 mmt -22.08 -52.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.09 171.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 120.663 3.579 . . . . 0.0 120.663 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 51.5 mmtt -134.28 -162.17 1.22 Allowed 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 120.541 3.534 . . . . 0.0 120.541 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.12 92.96 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.984 0 O-C-N 119.938 -1.726 . . . . 0.0 113.898 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.39 12.37 13.56 Favored Glycine 1 N--CA 1.517 4.038 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.93 178.08 7.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.016 -1.592 . . . . 0.0 115.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -95.72 142.77 27.62 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 74' ' ' PHE . 1.8 t -145.93 113.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.706 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -132.24 151.92 51.59 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.98 79.12 0.22 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 124.035 1.874 . . . . 0.0 114.945 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CD ' ' N ' ' A' ' 32' ' ' GLN . 2.9 pp20? 166.77 -35.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 109.443 -3.526 . . . . 0.0 108.962 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 4.4 tt0 -58.99 80.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.254 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -31.66 70.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -24.27 -67.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.6 pt -151.43 141.87 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.292 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.5 m -99.09 139.94 33.99 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.79 146.08 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.514 2.765 0 N-CA-C 118.678 2.844 . . . . 0.0 118.678 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.516 2.874 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.8 mmt -125.76 150.6 47.61 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 122.363 0.265 . . . . 0.0 111.663 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -125.15 152.06 44.96 Favored 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -134.7 124.21 16.69 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.267 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -88.43 176.95 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.966 1.777 . . . . 0.0 111.592 171.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -53.31 117.35 11.52 Favored Pre-proline 0 CA--C 1.584 2.285 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 36.4 Cg_endo -48.85 -21.43 3.71 Favored 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 122.391 2.061 . . . . 0.0 114.235 174.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 11.4 p90 -169.92 -174.23 1.76 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.586 -2.097 . . . . 0.0 109.871 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -101.6 163.82 12.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.18 -152.13 19.89 Favored Glycine 0 N--CA 1.512 3.754 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.042 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.86 164.13 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.442 HG22 ' CE1' ' A' ' 74' ' ' PHE . 44.9 t -94.56 145.79 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.836 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 19.0 tttp -112.83 -73.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.58 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 47.7 tt0 -142.42 128.73 19.95 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.8 pt? -122.31 124.81 44.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.58 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.7 mptt -104.86 43.33 1.11 Allowed 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.21 157.41 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-N 114.095 -1.411 . . . . 0.0 114.453 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -144.45 171.44 14.35 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.521 ' CG2' HG12 ' A' ' 20' ' ' VAL . 33.5 t -88.74 103.63 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 101.782 -3.414 . . . . 0.0 101.782 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.98 12.91 2.81 Favored Glycine 1 N--CA 1.519 4.18 0 CA-C-N 108.657 -3.883 . . . . 0.0 111.958 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 26.1 t70 -120.39 163.49 17.8 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 111.682 -2.259 . . . . 0.0 107.283 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.22 152.67 22.57 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -136.39 170.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 110.632 -2.985 . . . . 0.0 110.029 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 67' ' ' THR . 15.4 ptmt -171.63 160.55 5.82 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.49 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 9.2 t -56.53 127.46 31.33 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 114.724 -2.79 . . . . 0.0 110.897 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.33 -41.22 2.27 Favored Glycine 0 N--CA 1.509 3.519 0 N-CA-C 117.439 1.736 . . . . 0.0 117.439 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 58.8 m -60.02 127.73 33.34 Favored 'General case' 0 N--CA 1.524 3.228 0 CA-C-N 119.627 1.713 . . . . 0.0 114.225 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 70' ' ' LEU . 8.4 mp -79.13 65.13 4.22 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-O 122.645 1.212 . . . . 0.0 111.649 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.513 HG22 ' SD ' ' A' ' 72' ' ' MET . 40.0 mm -33.49 -54.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.513 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -148.6 175.91 10.78 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.52 134.05 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.685 0.755 . . . . 0.0 110.665 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.592 ' CD2' HG11 ' A' ' 28' ' ' VAL . 14.6 m-30 -113.48 165.97 11.96 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.894 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 16.9 tp10 -130.81 80.91 1.97 Allowed 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 123.964 1.84 . . . . 0.0 109.426 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 118.029 2.604 . . . . 0.0 118.029 179.354 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' A' ' 4' ' ' GLU . 2.3 mmtt -114.65 161.88 17.52 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.988 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 1.2 pm0 -107.31 156.21 19.13 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 123.362 1.553 . . . . 0.0 114.257 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 74.6 t -137.5 111.64 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 124.655 2.169 . . . . 0.0 113.275 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.4 p-10 -97.53 166.16 11.64 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 111.981 -2.372 . . . . 0.0 106.28 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.16 135.95 29.32 Favored Pre-proline 0 C--N 1.29 -1.99 0 C-N-CA 117.607 -1.637 . . . . 0.0 109.413 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 C--N 1.312 -1.346 0 C-N-CA 121.903 1.736 . . . . 0.0 110.961 -172.491 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.564 HG23 HG23 ' A' ' 65' ' ' VAL . 2.5 m . . . . . 0 N--CA 1.509 2.482 0 CA-C-O 120.976 0.417 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -120.98 172.1 8.17 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.306 -0.871 . . . . 0.0 109.212 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 60' ' ' ASN . 2.8 t -107.12 140.75 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.067 0 CA-C-O 123.195 1.474 . . . . 0.0 112.529 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 76.1 p -116.96 -45.94 2.75 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.411 ' H ' ' HB ' ' A' ' 36' ' ' THR . 28.3 mt-10 -126.97 112.94 15.84 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.8 65.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 124.193 1.949 . . . . 0.0 110.874 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' A' ' 21' ' ' MET . 24.1 mmt -26.92 -44.85 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.379 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.35 162.94 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -128.63 -165.59 1.52 Allowed 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.8 t -70.23 111.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 O-C-N 120.75 -1.219 . . . . 0.0 108.998 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.32 -0.41 35.05 Favored Glycine 1 N--CA 1.52 4.298 0 O-C-N 124.113 0.883 . . . . 0.0 113.0 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.75 145.42 24.42 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.67 114.11 10.44 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 6.6 t -107.82 110.4 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.072 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.673 -1.267 . . . . 0.0 110.954 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -41.77 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.319 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.924 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -18.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 1.2 tm0? -84.71 108.76 17.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.7 p -40.13 118.21 0.87 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 120.182 3.401 . . . . 0.0 120.182 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 48' ' ' ALA . 4.8 mt -86.01 -60.98 1.86 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.5 pt -145.82 150.2 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 19' ' ' GLU . 55.2 m -102.05 131.22 48.63 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.4 m -121.66 137.31 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 122.09 0.947 . . . . 0.0 112.262 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.516 2.833 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.1 mtt -145.12 152.66 40.41 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -112.14 138.7 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.969 1.842 . . . . 0.0 113.865 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.5 t -112.28 112.57 52.0 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.24 177.06 4.69 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 122.08 1.854 . . . . 0.0 110.167 172.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.645 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -62.85 98.25 0.14 Allowed Pre-proline 0 C--N 1.286 -2.162 1 N-CA-C 123.17 4.507 . . . . 0.0 123.17 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.7 Cg_exo -34.51 -42.04 0.28 Allowed 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.827 2.351 . . . . 0.0 113.388 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -146.36 -173.9 4.31 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 109.916 -3.311 . . . . 0.0 111.389 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -103.8 154.44 19.58 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.5 -174.02 22.22 Favored Glycine 1 N--CA 1.523 4.451 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.734 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.96 162.01 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 CA-C-N 121.29 2.545 . . . . 0.0 113.307 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.58 121.07 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' CG ' ' HB2' ' A' ' 75' ' ' GLU . 2.5 tmtp? -93.24 -49.82 5.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.682 0.674 . . . . 0.0 111.722 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.462 ' OE2' ' CE ' ' A' ' 58' ' ' LYS . 45.9 tt0 -153.69 162.78 40.94 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.211 0.529 . . . . 0.0 112.086 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 57' ' ' LEU . 1.8 pt? -171.44 146.64 2.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.074 -1.016 . . . . 0.0 109.783 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' CE ' ' OE2' ' A' ' 56' ' ' GLU . 83.4 mttt -123.46 52.59 1.4 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 p -121.33 164.47 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.317 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -137.54 163.32 31.47 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -95.11 73.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-O 126.833 3.206 . . . . 0.0 109.519 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.92 39.16 0.12 Allowed Glycine 0 N--CA 1.509 3.508 1 CA-C-N 106.196 -5.002 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -120.31 174.39 6.55 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -114.19 136.74 52.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 -179.575 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.564 HG23 HG23 ' A' ' 15' ' ' VAL . 1.3 m -117.61 165.81 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.682 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -147.94 139.32 23.61 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 116.66 -1.638 . . . . 0.0 107.095 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -53.98 125.89 20.45 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.637 -2.425 . . . . 0.0 110.279 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.7 -39.54 2.76 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 112.962 -1.926 . . . . 0.0 114.142 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.4 t -52.03 120.73 5.69 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 1.2 mp -75.08 64.22 1.35 Allowed 'General case' 0 N--CA 1.525 3.294 0 CA-C-O 124.161 1.934 . . . . 0.0 111.975 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.496 ' CD1' HG12 ' A' ' 65' ' ' VAL . 18.8 mm -46.37 -44.55 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 120.858 3.651 . . . . 0.0 120.858 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 14.6 ptm -141.21 157.71 44.88 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.808 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.36 129.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 122.275 1.036 . . . . 0.0 110.882 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CZ ' HG21 ' A' ' 5' ' ' VAL . 13.1 m-30 -97.61 -171.44 2.19 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 6.0 tp10 -157.04 80.77 0.92 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.556 1.179 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.238 179.734 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.505 2.312 0 N-CA-C 120.274 3.435 . . . . 0.0 120.274 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -126.39 107.17 10.04 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.332 -2.213 . . . . 0.0 109.988 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.89 148.13 40.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.316 -0.865 . . . . 0.0 111.068 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.638 HG21 ' CD1' ' A' ' 74' ' ' PHE . 20.4 t -110.73 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 CA-C-O 123.014 1.387 . . . . 0.0 113.918 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.4 p-10 -89.83 161.76 15.83 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.503 HG21 ' CG2' ' A' ' 65' ' ' VAL . 89.9 t -97.9 128.91 32.47 Favored Pre-proline 0 C--N 1.292 -1.909 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.792 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 N--CA 1.501 1.957 0 C-N-CA 121.203 1.269 . . . . 0.0 115.131 169.486 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.505 2.324 0 CA-C-O 120.837 0.351 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.684 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 11.9 pt-20 -123.36 166.86 14.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.5 t -89.75 128.78 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 55.5 p -102.03 -44.59 5.43 Favored 'General case' 0 N--CA 1.512 2.656 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.786 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -134.84 103.53 5.65 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.0 p -82.4 79.59 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 124.172 1.939 . . . . 0.0 110.46 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 mmt -43.9 -45.42 7.58 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 111.708 -2.496 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.24 158.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.8 mptt -130.91 -177.79 4.53 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-O 125.106 2.384 . . . . 0.0 117.434 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.77 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 112.708 -2.042 . . . . 0.0 114.341 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 118.49 17.18 5.3 Favored Glycine 1 N--CA 1.52 4.248 0 CA-C-N 114.701 -1.136 . . . . 0.0 114.635 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -96.97 141.48 30.09 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 122.656 1.217 . . . . 0.0 113.799 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.558 ' HD3' HG13 ' A' ' 53' ' ' VAL . 52.6 mmtt -71.35 97.62 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.122 1.439 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 74' ' ' PHE . 65.1 t -102.18 107.23 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 113.62 -1.627 . . . . 0.0 115.335 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -120.49 163.39 18.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.048 -1.033 . . . . 0.0 110.32 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.96 166.24 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.967 0.792 . . . . 0.0 112.795 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 62.17 -26.27 0.06 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -74.5 96.8 2.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.231 -1.543 . . . . 0.0 110.132 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 t -40.7 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -27.13 -67.61 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.0 pt -147.57 143.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 111.902 -2.408 . . . . 0.0 112.526 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.1 m -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.53 158.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.524 3.23 0 CA-C-O 122.599 1.19 . . . . 0.0 110.51 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 27.3 t . . . . . 0 N--CA 1.519 2.977 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -116.39 160.18 20.91 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 122.629 0.372 . . . . 0.0 110.537 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -125.31 152.92 44.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.242 -0.912 . . . . 0.0 113.03 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 39.5 t -122.25 113.66 30.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -85.53 177.0 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.249 1.299 . . . . 0.0 112.499 170.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -62.47 95.53 0.06 OUTLIER Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 11.4 Cg_endo -38.52 -35.29 0.45 Allowed 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 122.512 2.141 . . . . 0.0 114.073 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -154.76 -174.93 5.18 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 112.117 -2.31 . . . . 0.0 108.758 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -104.2 155.1 19.0 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.5 -138.61 7.29 Favored Glycine 0 N--CA 1.511 3.638 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.289 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.558 HG13 ' HD3' ' A' ' 27' ' ' LYS . 1.9 t -140.55 165.14 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 74' ' ' PHE . 14.4 t -90.93 137.26 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 118.83 -1.148 . . . . 0.0 107.934 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 19.7 tptt -108.12 -59.6 1.83 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.705 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 27.3 tt0 -149.66 160.85 43.18 Favored 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.705 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -163.21 156.34 19.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.181 -0.95 . . . . 0.0 108.448 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.3 48.75 1.98 Allowed 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.985 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.22 152.35 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.044 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.491 ' H ' ' HB2' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -134.23 -175.38 3.84 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 124.745 2.212 . . . . 0.0 116.277 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -86.72 114.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 113.07 4.95 23.82 Favored Glycine 0 N--CA 1.511 3.699 0 CA-C-N 108.721 -3.854 . . . . 0.0 110.028 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.491 ' HB2' ' H ' ' A' ' 60' ' ' ASN . 1.5 t0 -79.78 177.55 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.824 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.684 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 28.2 mmtm -114.15 132.92 55.91 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 118.576 2.806 . . . . 0.0 118.576 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.503 ' CG2' HG21 ' A' ' 7' ' ' VAL . 1.3 p -132.86 169.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' N ' ' CG2' ' A' ' 65' ' ' VAL . 6.4 ptpp? -173.99 134.99 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.434 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.3 t -33.42 116.34 0.25 Allowed 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 124.741 2.21 . . . . 0.0 113.646 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.87 -35.47 4.68 Favored Glycine 0 N--CA 1.507 3.409 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.941 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 66.6 m -64.86 136.76 57.22 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.61 72.23 10.7 Favored 'General case' 0 N--CA 1.522 3.138 0 CA-C-O 122.209 1.004 . . . . 0.0 109.621 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.615 HD11 ' SD ' ' A' ' 72' ' ' MET . 1.6 pp -58.11 -46.12 88.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.615 ' SD ' HD11 ' A' ' 71' ' ' ILE . 11.4 ptm -132.83 171.89 13.31 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 118.617 -1.233 . . . . 0.0 114.116 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.24 123.58 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.594 -1.316 . . . . 0.0 112.595 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.638 ' CD1' HG21 ' A' ' 5' ' ' VAL . 14.8 m-30 -111.96 167.68 10.19 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.292 1.52 . . . . 0.0 113.726 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.589 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 32.7 tt0 -145.89 155.85 43.15 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.296 -1.735 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 -179.587 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 24.9 t . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -125.59 152.98 44.39 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.122 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -109.92 149.46 29.87 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.642 1.687 . . . . 0.0 114.731 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.541 HG21 ' CE1' ' A' ' 74' ' ' PHE . 70.2 t -122.86 114.29 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.565 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -109.9 -178.41 3.52 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.438 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.634 HG21 ' HB ' ' A' ' 65' ' ' VAL . 59.5 t -102.19 128.63 28.0 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.016 -1.074 . . . . 0.0 113.486 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.99 179.387 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 23.0 m . . . . . 0 N--CA 1.514 2.733 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 29.3 mt-10 -93.29 163.28 13.67 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.033 1.458 . . . . 0.0 112.302 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.06 112.61 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 19' ' ' GLU . 14.2 t -98.71 -37.41 9.5 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 18' ' ' THR . 21.6 mm-40 -129.92 127.65 40.55 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.55 65.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 124.526 2.108 . . . . 0.0 113.359 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.425 ' H ' ' HG2' ' A' ' 21' ' ' MET . 7.4 mmt -24.49 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 110.925 -2.852 . . . . 0.0 117.839 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.9 t -122.67 155.82 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.1 tttt -127.51 178.66 5.95 Favored 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 120.797 3.629 . . . . 0.0 120.797 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.21 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 113.716 -1.584 . . . . 0.0 113.576 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.63 1.39 19.79 Favored Glycine 1 N--CA 1.517 4.037 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.891 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.478 ' HB2' HG12 ' A' ' 22' ' ' VAL . 77.7 m-20 -90.32 150.54 21.87 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.651 1.215 . . . . 0.0 113.092 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -75.94 112.6 12.52 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.892 0.853 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -106.61 101.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.437 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -105.89 151.13 24.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.306 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.19 157.85 0.42 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.564 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 69.5 -26.24 0.15 Allowed 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 122.658 1.218 . . . . 0.0 112.961 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.468 HE22 ' CG2' ' A' ' 22' ' ' VAL . 4.5 tm0? -80.15 102.13 9.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.223 -1.548 . . . . 0.0 109.471 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.2 t -33.25 124.99 0.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.8 mt -93.6 -52.71 4.35 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 110.711 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.46 HG13 ' HB ' ' A' ' 46' ' ' VAL . 32.3 pt -144.26 134.69 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.9 m -92.1 120.68 32.94 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 102.789 -3.041 . . . . 0.0 102.789 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.1 m -109.02 147.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 N--CA 1.512 2.637 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -179.724 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.513 2.709 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ttm -143.22 171.04 14.63 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -130.32 153.02 49.1 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HB ' HG13 ' A' ' 35' ' ' ILE . 3.9 t -130.45 105.31 15.97 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.48 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -81.73 178.73 6.28 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 CA-C-O 123.612 1.421 . . . . 0.0 112.276 177.39 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -66.0 117.08 38.97 Favored Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 37.4 Cg_endo -49.63 -22.31 6.5 Favored 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 123.186 2.591 . . . . 0.0 114.968 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -171.52 -174.06 1.33 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 113.232 -1.804 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -102.56 119.1 38.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 -165.37 32.62 Favored Glycine 0 N--CA 1.513 3.769 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.44 154.37 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 CA-C-N 118.205 1.003 . . . . 0.0 109.204 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.492 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 24.3 t -78.8 121.18 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -97.37 -56.72 2.45 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.754 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 31.0 tt0 -149.08 150.53 32.9 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.997 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -146.23 163.77 34.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.075 -1.641 . . . . 0.0 108.869 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.465 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 8.4 mmtp -133.89 42.6 2.92 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.24 154.02 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-N 113.969 -1.468 . . . . 0.0 114.071 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -130.78 -175.93 3.83 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-O 125.542 2.592 . . . . 0.0 116.089 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.14 109.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 1 N-CA-C 99.135 -4.394 . . . . 0.0 99.135 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.47 -27.26 3.12 Favored Glycine 0 N--CA 1.508 3.443 0 CA-C-N 111.518 -2.583 . . . . 0.0 107.532 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -72.95 159.18 34.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.341 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -115.27 143.65 44.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.634 ' HB ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -131.62 161.7 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -156.02 158.27 37.55 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -27.72 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.19 -42.14 1.96 Allowed Glycine 0 N--CA 1.515 3.943 0 CA-C-N 112.944 -1.934 . . . . 0.0 114.923 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.7 m -36.0 118.39 0.51 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 mp -67.72 64.95 0.08 Allowed 'General case' 0 N--CA 1.513 2.699 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.545 HD11 HG22 ' A' ' 7' ' ' VAL . 3.9 mt -23.6 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptp -167.93 -176.85 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 111.361 -2.654 . . . . 0.0 115.586 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.26 122.67 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 123.495 1.617 . . . . 0.0 114.829 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 5' ' ' VAL . 10.7 m-30 -102.76 175.74 5.39 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 113.435 -1.711 . . . . 0.0 109.543 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.28 22.3 tp10 -144.97 109.71 5.01 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 121.398 3.851 . . . . 0.0 121.398 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.501 2.118 1 N-CA-C 122.858 4.392 . . . . 0.0 122.858 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -127.61 160.38 31.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.428 -2.623 . . . . 0.0 106.449 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -105.29 169.16 8.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.476 1.131 . . . . 0.0 110.437 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.54 HG21 ' CD1' ' A' ' 74' ' ' PHE . 73.2 t -125.82 102.27 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 114.343 -1.298 . . . . 0.0 113.804 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 13.7 p-10 -99.43 163.52 12.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 71' ' ' ILE . 55.1 t -75.4 138.09 71.3 Favored Pre-proline 0 N--CA 1.502 2.127 0 C-N-CA 116.862 -1.935 . . . . 0.0 110.503 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.493 1.464 0 C-N-CA 122.098 1.866 . . . . 0.0 112.675 177.21 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.507 2.399 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.0 pt-20 -113.56 167.46 10.58 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 t -84.42 119.43 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 t -100.77 -36.76 8.98 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.81 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.03 117.5 16.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.41 59.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 14.0 mmt -18.98 -45.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.1 t -124.8 155.77 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 22.3 mttt -140.72 -169.34 2.78 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 121.666 3.95 . . . . 0.0 121.666 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -51.49 84.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.08 -0.25 14.69 Favored Glycine 1 N--CA 1.519 4.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HB2' HG12 ' A' ' 22' ' ' VAL . 69.9 m-20 -89.1 139.83 30.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.883 1.801 . . . . 0.0 113.018 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -62.77 74.22 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 112.534 -2.121 . . . . 0.0 116.459 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -74.0 97.77 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -101.73 156.88 17.23 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.337 -1.477 . . . . 0.0 108.958 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -58.27 168.81 0.97 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.999 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.71 -24.66 0.08 Allowed 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 30' ' ' ALA . 3.7 tm0? -82.42 109.07 16.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 123.231 1.491 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 10.1 m -35.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 120.927 3.677 . . . . 0.0 120.927 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -24.77 -58.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 pt -146.14 150.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.92 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.425 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 96.7 m -102.52 124.93 48.96 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.4 m -110.8 154.0 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.51 2.572 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.511 2.583 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 mtm -132.81 164.33 27.08 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -122.19 148.73 44.58 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.062 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.0 t -122.76 116.21 29.18 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.16 172.32 13.97 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 CA-C-O 124.455 1.773 . . . . 0.0 110.347 176.5 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -76.34 117.05 61.59 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 111.84 -2.436 . . . . 0.0 115.377 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HG2' HG13 ' A' ' 5' ' ' VAL . 73.4 Cg_exo -39.34 -37.45 1.14 Allowed 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.008 2.472 . . . . 0.0 113.632 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.34 -174.16 4.55 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 110.963 -2.835 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -95.14 152.39 18.39 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.69 -150.14 22.33 Favored Glycine 1 N--CA 1.517 4.085 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.843 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.11 157.5 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 O-C-N 121.768 -0.842 . . . . 0.0 112.15 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 30.4 t -83.02 128.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 C-N-CA 118.091 -1.444 . . . . 0.0 107.662 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -106.26 -72.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 38.4 tt0 -127.36 123.28 35.86 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 123.368 1.556 . . . . 0.0 111.314 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.573 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.0 pt? -129.07 146.49 51.01 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.548 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 87.8 mttt -127.95 53.16 1.81 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.82 137.58 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 110.204 -3.18 . . . . 0.0 111.051 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.633 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.3 m120 -120.37 -171.33 2.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.741 2.21 . . . . 0.0 114.683 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.65 87.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 125.978 2.799 . . . . 0.0 106.422 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.07 24.35 0.23 Allowed Glycine 0 N--CA 1.516 3.97 1 CA-C-N 106.715 -4.766 . . . . 0.0 112.809 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.633 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -106.22 152.15 23.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -102.6 145.27 29.89 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.15 163.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.989 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -166.0 145.89 6.32 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.037 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -36.74 116.14 0.41 Allowed 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.403 1.573 . . . . 0.0 112.426 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.28 -52.18 0.73 Allowed Glycine 0 N--CA 1.511 3.665 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.951 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 16.4 t -45.74 128.18 8.44 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -73.39 60.24 0.62 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.513 HD11 HG22 ' A' ' 7' ' ' VAL . 2.7 mt -18.94 -60.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 119.031 2.974 . . . . 0.0 119.031 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.407 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -167.42 -172.51 1.97 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 112.321 -2.218 . . . . 0.0 115.238 -179.24 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.08 130.42 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 124.414 2.054 . . . . 0.0 112.691 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.2 m-30 -117.49 145.88 43.9 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 111.804 -2.453 . . . . 0.0 113.202 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.2 162.58 23.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 119.733 3.234 . . . . 0.0 119.733 -179.273 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m . . . . . 0 N--CA 1.512 2.655 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.62 149.06 33.83 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 111.549 -2.569 . . . . 0.0 111.376 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -97.4 104.2 16.2 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.492 1.139 . . . . 0.0 113.773 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 77.1 t -71.22 99.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 CA-C-O 124.8 2.238 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' SER . 5.8 p30 -96.05 177.4 5.75 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.631 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 67' ' ' THR . 78.2 t -98.01 131.82 25.85 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 C--N 1.311 -1.41 0 C-N-CA 120.708 0.939 . . . . 0.0 114.048 179.266 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.533 3.712 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.9 pt-20 -111.3 169.55 8.72 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.17 114.11 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -93.67 -44.79 8.0 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 112.84 -1.982 . . . . 0.0 114.859 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.571 ' HG3' HG22 ' A' ' 18' ' ' THR . 36.0 mt-10 -131.16 102.77 6.14 Favored 'General case' 0 N--CA 1.52 3.036 0 CA-C-N 119.866 1.212 . . . . 0.0 111.452 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.28 72.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 O-C-N 119.284 -2.135 . . . . 0.0 113.498 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 57.1 mmm -34.65 -52.28 0.51 Allowed 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.413 ' C ' ' HE2' ' A' ' 23' ' ' LYS . 15.8 m -98.65 150.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 CA-C-N 119.574 1.079 . . . . 0.0 113.55 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -123.33 169.28 11.48 Favored 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -54.59 87.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.292 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.506 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 127.32 9.62 4.03 Favored Glycine 1 N--CA 1.517 4.046 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -92.24 140.22 29.83 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.69 1.234 . . . . 0.0 111.91 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.66 86.2 2.71 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 126.839 2.056 . . . . 0.0 109.162 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.64 149.3 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -140.59 154.6 46.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 50' ' ' PHE . . . -69.11 99.19 1.08 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 139.81 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 127.784 3.177 . . . . 0.0 108.185 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -71.3 105.8 3.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 112.708 -2.042 . . . . 0.0 113.665 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 16.6 t -39.03 96.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 112.569 -2.105 . . . . 0.0 115.554 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 21' ' ' MET . 4.2 mt -53.52 -62.8 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.522 ' H ' HG23 ' A' ' 46' ' ' VAL . 25.6 pt -147.91 128.8 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.906 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 19' ' ' GLU . 5.2 m -67.87 129.79 40.99 Favored 'General case' 0 N--CA 1.517 2.917 0 O-C-N 119.965 -1.709 . . . . 0.0 111.066 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 65' ' ' VAL . 31.6 m -119.67 151.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.707 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 43' ' ' SER . 3.4 tt0 . . . . . 0 N--CA 1.515 2.781 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 92.7 p . . . . . 0 N--CA 1.51 2.554 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.0 mtm -139.55 164.71 29.17 Favored 'General case' 0 N--CA 1.516 2.872 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -120.3 168.52 11.18 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 123.148 1.451 . . . . 0.0 114.19 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -115.74 129.42 25.17 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.64 168.74 11.04 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-O 123.384 1.327 . . . . 0.0 109.935 168.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -74.98 117.19 60.83 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 112.859 -1.973 . . . . 0.0 115.065 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 35.9 Cg_endo -48.62 -25.75 8.33 Favored 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.011 1.807 . . . . 0.0 114.016 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -158.08 -173.37 4.31 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.896 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.71 165.86 10.83 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.1 -153.61 21.01 Favored Glycine 1 N--CA 1.522 4.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 113.538 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.07 153.51 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.544 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 41.3 t -77.14 84.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -61.83 -44.64 96.43 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.644 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 28.3 tt0 -176.46 159.23 1.91 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 124.005 0.815 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.7 pt? -154.76 159.77 40.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.323 -0.861 . . . . 0.0 109.703 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 29.8 mmtt -126.33 45.82 2.58 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.16 161.93 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.69 171.4 9.62 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 125.367 2.508 . . . . 0.0 116.952 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.86 100.15 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 1 N-CA-C 99.784 -4.154 . . . . 0.0 99.784 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.14 19.97 0.95 Allowed Glycine 0 N--CA 1.51 3.576 1 CA-C-N 107.305 -4.498 . . . . 0.0 111.84 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.18 170.43 8.1 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.482 0.713 . . . . 0.0 109.278 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -103.43 143.65 32.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.778 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG21 HG11 ' A' ' 37' ' ' VAL . 3.5 m -132.52 127.49 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HG2' ' N ' ' A' ' 67' ' ' THR . 26.1 ttmt -139.98 151.54 45.59 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.533 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 7.6 t -42.21 118.5 1.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 117.271 -1.772 . . . . 0.0 111.495 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.23 -51.36 0.78 Allowed Glycine 0 N--CA 1.513 3.793 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m -39.51 119.55 0.96 Allowed 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.62 65.47 1.82 Allowed 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 123.065 1.412 . . . . 0.0 111.346 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 mm -48.78 -57.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 120.729 3.604 . . . . 0.0 120.729 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.406 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 14.9 ptp -135.49 166.89 22.15 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.346 -0.846 . . . . 0.0 112.519 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -110.47 122.51 65.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.811 1.291 . . . . 0.0 112.253 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 7.5 m-30 -117.07 149.27 40.58 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.96 127.48 36.43 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.469 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 76' ' ' VAL . 28.8 m . . . . . 0 C--N 1.302 -1.483 1 N-CA-C 122.142 4.127 . . . . 0.0 122.142 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.509 2.485 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.498 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 3.1 mmmp? -134.17 166.5 22.62 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.129 1.443 . . . . 0.0 110.886 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' NZ ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -107.56 157.32 18.14 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.296 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 74' ' ' PHE . 58.9 t -126.08 106.98 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 CA-C-O 121.883 0.849 . . . . 0.0 111.504 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -101.87 152.85 20.41 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' HB ' ' A' ' 65' ' ' VAL . 99.2 t -71.33 132.29 86.06 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 116.877 -1.929 . . . . 0.0 112.197 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 CA--C 1.557 1.643 0 C-N-CA 122.616 2.211 . . . . 0.0 115.329 172.813 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.504 2.235 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.31 164.19 12.76 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 35' ' ' ILE . 20.0 t -103.4 116.25 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.099 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 2.1 t -96.8 -41.96 8.2 Favored 'General case' 0 N--CA 1.524 3.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.765 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -131.99 105.21 7.27 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.947 0.879 . . . . 0.0 110.855 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.45 63.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 O-C-N 119.087 -2.258 . . . . 0.0 115.261 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 55.6 mmm -23.17 -42.44 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 119.403 3.112 . . . . 0.0 119.403 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.7 t -119.74 155.26 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.6 tttm -131.46 175.33 9.24 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 120.551 3.537 . . . . 0.0 120.551 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.47 91.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.28 0.38 12.76 Favored Glycine 1 N--CA 1.516 4.03 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.775 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 22' ' ' VAL . 52.5 m-20 -93.27 143.65 26.07 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.58 1.181 . . . . 0.0 112.706 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -66.33 121.77 16.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.15 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 15.6 t -116.04 115.19 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -122.91 151.42 41.78 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.696 -0.628 . . . . 0.0 111.282 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -48.02 158.26 0.24 Allowed 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 69.51 -28.42 0.16 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 122.541 1.162 . . . . 0.0 112.753 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.429 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 6.4 tt0 -77.35 105.13 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.316 -1.49 . . . . 0.0 111.575 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 19.8 t -37.92 120.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.8 mt -85.78 -51.03 6.69 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.412 ' HB ' HG13 ' A' ' 17' ' ' VAL . 29.1 pt -146.79 137.35 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.958 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -84.32 128.26 34.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.35 160.77 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 N--CA 1.513 2.708 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.8 mtt -129.74 174.29 9.85 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -124.81 153.81 41.93 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 122.115 0.96 . . . . 0.0 113.512 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.1 t -121.03 104.42 41.44 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.525 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.5 OUTLIER -80.18 177.63 8.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 CA-C-O 123.779 1.491 . . . . 0.0 111.087 179.085 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -71.89 111.49 10.79 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -46.11 -28.52 5.48 Favored 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 121.884 1.723 . . . . 0.0 113.049 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -163.05 -173.51 3.47 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.112 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -103.89 160.78 14.51 Favored 'General case' 0 CA--C 1.579 2.07 1 N-CA-C 121.879 4.029 . . . . 0.0 121.879 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.95 -124.26 3.06 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 114.577 -1.192 . . . . 0.0 114.096 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.48 159.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.206 0 O-C-N 121.996 -0.708 . . . . 0.0 111.305 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.558 HG13 ' SD ' ' A' ' 72' ' ' MET . 67.6 t -80.85 112.0 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 28.3 tttm -89.94 -64.55 1.12 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.431 -1.308 . . . . 0.0 110.045 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' HG13 ' A' ' 73' ' ' ILE . 42.4 tt0 -145.07 133.77 22.2 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.3 pt? -130.53 163.13 27.72 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.532 -1.98 . . . . 0.0 109.314 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 14.1 mmtp -133.64 42.02 3.0 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 p -132.26 159.61 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.942 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -126.19 177.65 6.27 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -94.03 108.81 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 1 N-CA-C 97.752 -4.907 . . . . 0.0 97.752 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.2 6.05 6.45 Favored Glycine 0 N--CA 1.515 3.908 0 CA-C-N 109.898 -3.319 . . . . 0.0 109.784 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.71 156.84 16.17 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.72 144.38 41.11 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HB ' HG21 ' A' ' 7' ' ' VAL . 14.2 m -138.4 172.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -178.0 156.63 1.07 Allowed 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.2 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -26.73 101.4 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 118.644 2.831 . . . . 0.0 118.644 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.79 -53.02 0.69 Allowed Glycine 0 N--CA 1.511 3.697 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.073 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.1 m -21.85 117.2 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.36 59.49 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.496 HG22 ' HG2' ' A' ' 72' ' ' MET . 4.3 mm -34.5 -58.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.558 ' SD ' HG13 ' A' ' 54' ' ' VAL . 5.1 ptp -174.43 -170.81 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.261 -1.79 . . . . 0.0 113.757 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -116.7 130.28 71.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-O 124.026 1.87 . . . . 0.0 107.883 178.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 8.9 m-30 -112.69 161.65 16.62 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.835 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -134.36 137.19 43.95 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 C--N 1.294 -1.822 0 CA-C-O 124.552 2.12 . . . . 0.0 116.047 -179.727 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.518 2.928 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.68 160.65 26.74 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 123.826 0.704 . . . . 0.0 110.008 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -108.4 169.32 8.72 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.546 HG21 ' CE1' ' A' ' 74' ' ' PHE . 39.5 t -134.91 117.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 10.1 p-10 -106.33 166.67 10.37 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 71' ' ' ILE . 48.1 t -85.73 140.53 35.6 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 121.38 1.387 . . . . 0.0 112.879 171.511 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.515 2.822 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -110.85 171.33 7.53 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 124.207 0.942 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 35' ' ' ILE . 28.2 t -107.04 115.11 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.541 -0.724 . . . . 0.0 111.758 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 27.7 p -97.01 -50.38 4.64 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 124.065 0.946 . . . . 0.0 112.597 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' H ' ' HB ' ' A' ' 36' ' ' THR . 12.8 mp0 -121.63 105.22 10.23 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 123.594 1.664 . . . . 0.0 113.241 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.36 70.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 123.672 1.701 . . . . 0.0 114.367 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 12.9 mmt -30.36 -47.93 0.09 Allowed 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.477 ' CG2' HD23 ' A' ' 34' ' ' LEU . 15.8 m -128.71 154.35 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-O 122.853 1.311 . . . . 0.0 112.751 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.5 mtmt -129.3 -170.2 2.24 Favored 'General case' 0 N--CA 1.522 3.174 0 N-CA-C 119.066 2.987 . . . . 0.0 119.066 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.22 93.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.33 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.87 11.28 8.55 Favored Glycine 1 N--CA 1.516 4.003 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.553 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.5 m-20 -101.85 130.6 48.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 123.765 1.745 . . . . 0.0 112.649 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -57.0 91.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 111.648 -2.524 . . . . 0.0 111.642 179.156 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 22' ' ' VAL . 91.8 t -100.45 120.98 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -134.75 155.69 50.14 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.7 -1.25 . . . . 0.0 112.561 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.33 156.25 4.48 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.464 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 81.37 -20.29 0.38 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.715 1.884 . . . . 0.0 111.251 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.539 ' HG2' ' N ' ' A' ' 33' ' ' SER . 1.6 tt0 -95.15 155.4 16.75 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.579 1.181 . . . . 0.0 109.425 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.539 ' N ' ' HG2' ' A' ' 32' ' ' GLN . 62.6 p -76.13 134.16 40.05 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.213 1.482 . . . . 0.0 112.57 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.477 HD23 ' CG2' ' A' ' 22' ' ' VAL . 4.2 mt -96.13 -58.77 1.99 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.921 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.437 ' HB ' HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -147.74 148.38 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.576 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.472 ' HB ' ' H ' ' A' ' 19' ' ' GLU . 64.9 m -94.81 135.34 36.42 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.1 m -125.98 147.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.512 2.651 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 122.488 1.137 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.1 mtp -133.04 168.64 18.11 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.529 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 36' ' ' THR . 27.9 mt-10 -129.64 156.09 44.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.1 t -119.15 114.36 35.03 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.299 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.91 177.77 7.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 CA-C-O 123.698 1.458 . . . . 0.0 111.873 171.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -75.09 103.52 0.99 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 119.447 3.129 . . . . 0.0 119.447 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 19.5 Cg_endo -41.41 -34.36 1.89 Allowed 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.664 2.242 . . . . 0.0 113.908 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.56 -169.25 3.06 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 113.34 -1.754 . . . . 0.0 110.159 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.1 163.25 13.32 Favored 'General case' 0 CA--C 1.574 1.869 1 N-CA-C 123.135 4.494 . . . . 0.0 123.135 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.96 -142.93 14.51 Favored Glycine 1 N--CA 1.517 4.039 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.394 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.42 165.76 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 O-C-N 121.813 -0.816 . . . . 0.0 108.955 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 22.5 t -89.72 128.08 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.212 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HD2' ' HB2' ' A' ' 75' ' ' GLU . 39.6 tttm -103.62 -58.75 1.83 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 22.4 tt0 -141.95 151.2 42.35 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.949 0.795 . . . . 0.0 111.825 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -148.92 154.01 38.82 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 119.499 -2.001 . . . . 0.0 110.397 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 76.9 mttt -131.87 49.26 2.34 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-O 125.224 2.44 . . . . 0.0 109.582 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.0 m -137.5 151.9 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 1 CA-C-N 108.345 -4.025 . . . . 0.0 108.537 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -134.14 176.9 8.17 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 122.94 1.352 . . . . 0.0 111.585 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 18' ' ' THR . 1.6 t -88.29 114.1 26.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 1 N-CA-C 95.713 -5.662 . . . . 0.0 95.713 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.52 7.88 6.65 Favored Glycine 0 N--CA 1.513 3.822 0 CA-C-N 109.271 -3.604 . . . . 0.0 110.785 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 19.1 t70 -113.19 167.66 10.36 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.931 0.872 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.766 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.67 157.86 16.17 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.75 165.81 9.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 112.842 -1.981 . . . . 0.0 112.596 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -172.61 146.19 1.65 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 123.31 0.381 . . . . 0.0 110.951 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -42.12 113.32 0.42 Allowed 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 125.416 2.532 . . . . 0.0 115.952 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 -40.81 2.31 Favored Glycine 0 N--CA 1.515 3.932 0 CA-C-N 112.92 -1.945 . . . . 0.0 113.089 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.2 m -53.33 128.45 28.38 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 3.8 mm? -68.77 66.17 0.13 Allowed 'General case' 0 N--CA 1.521 3.097 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' HB ' ' SD ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -27.48 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -157.46 -173.23 4.31 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 110.773 -2.921 . . . . 0.0 115.147 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.412 HD11 ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -118.75 132.25 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 123.229 1.49 . . . . 0.0 110.432 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.546 ' CE1' HG21 ' A' ' 5' ' ' VAL . 18.2 m-30 -114.12 169.17 9.21 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-N 113.734 -1.576 . . . . 0.0 115.23 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 61.4 tt0 -138.46 127.08 23.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 123.467 1.603 . . . . 0.0 109.173 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 76' ' ' VAL . 16.8 m . . . . . 0 C--N 1.291 -1.965 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.506 2.37 0 N-CA-C 119.986 3.328 . . . . 0.0 119.986 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HE3' ' OE1' ' A' ' 4' ' ' GLU . 24.7 mmmt -119.8 158.71 26.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.366 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -96.18 145.92 25.12 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 123.424 1.583 . . . . 0.0 114.581 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -121.56 91.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-O 123.864 1.792 . . . . 0.0 111.223 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.66 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.5 p30 -101.91 -179.49 4.02 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 111.635 -2.529 . . . . 0.0 107.799 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 65' ' ' VAL . 79.8 t -104.51 133.54 20.14 Favored Pre-proline 0 N--CA 1.503 2.213 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.501 1.944 0 C-N-CA 123.875 3.05 . . . . 0.0 111.458 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.572 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 pt-20 -119.67 170.3 9.32 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.756 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.95 130.48 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.896 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 11.8 t -108.91 -44.91 3.89 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.059 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 3.3 mm-40 -130.55 112.76 13.48 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.801 1.286 . . . . 0.0 108.517 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 7.4 p -90.49 70.34 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 124.506 2.098 . . . . 0.0 114.083 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mmm -32.39 -60.87 0.28 Allowed 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 119.536 3.162 . . . . 0.0 119.536 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.703 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.3 t -103.81 150.22 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.703 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -129.56 -179.1 4.97 Favored 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 120.386 3.476 . . . . 0.0 120.386 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -53.07 115.5 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.226 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.09 10.88 31.11 Favored Glycine 1 N--CA 1.518 4.153 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.227 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' HB3' ' CG1' ' A' ' 22' ' ' VAL . 2.6 m-20 -114.45 131.85 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.732 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -58.41 75.72 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 108.696 -3.865 . . . . 0.0 110.614 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 2.3 t -82.5 151.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 CA-C-O 124.525 2.107 . . . . 0.0 114.049 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -152.26 153.41 33.7 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.953 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.54 163.43 0.28 Allowed 'General case' 0 N--CA 1.512 2.647 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.918 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 69.85 -27.79 0.16 Allowed 'General case' 0 N--CA 1.52 3.03 0 CA-C-O 122.018 0.913 . . . . 0.0 112.486 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -84.44 97.55 9.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.784 1.278 . . . . 0.0 112.261 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.0 m -31.86 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -70.98 -52.16 21.33 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.538 HG13 ' HB ' ' A' ' 46' ' ' VAL . 30.4 pt -143.11 151.76 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.909 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 51.9 m -105.31 127.97 53.23 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 28.4 m -120.45 154.17 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 N--CA 1.507 2.423 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -179.275 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.509 2.495 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 35.8 tpp -134.83 158.61 43.76 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.458 0.646 . . . . 0.0 111.714 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.37 153.67 30.59 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.904 1.812 . . . . 0.0 114.247 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.538 ' HB ' HG13 ' A' ' 35' ' ' ILE . 60.1 t -123.87 102.67 34.65 Favored Pre-proline 0 N--CA 1.495 1.824 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.413 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -79.01 169.37 19.41 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 CA-C-O 124.394 1.747 . . . . 0.0 109.743 173.603 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -61.26 115.48 14.72 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 111.441 -2.618 . . . . 0.0 117.528 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 28.0 Cg_endo -46.85 -26.66 4.91 Favored 'Trans proline' 0 N--CA 1.509 2.436 0 C-N-CA 122.144 1.896 . . . . 0.0 113.295 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -171.73 -174.26 1.32 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.532 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.51 166.97 11.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.83 -172.17 21.44 Favored Glycine 0 N--CA 1.514 3.84 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.369 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 t -106.65 149.87 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 C-N-CA 117.549 -1.661 . . . . 0.0 113.14 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG13 ' SD ' ' A' ' 72' ' ' MET . 58.4 t -67.29 102.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.592 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -82.44 -62.81 1.51 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.559 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 1.5 tt0 -147.24 151.28 36.42 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.96 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -143.55 135.81 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.502 -0.749 . . . . 0.0 110.58 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 41.9 mttm -114.45 42.87 2.01 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.11 161.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.072 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -132.78 170.78 14.79 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 121.489 3.885 . . . . 0.0 121.489 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.6 t -96.11 101.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 101.17 -3.641 . . . . 0.0 101.17 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.92 32.4 1.56 Allowed Glycine 0 N--CA 1.502 3.04 1 CA-C-N 107.826 -4.261 . . . . 0.0 106.816 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -113.95 174.07 6.12 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 16' ' ' GLU . 29.6 mmmt -101.37 132.39 46.96 Favored 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 121.233 3.79 . . . . 0.0 121.233 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -130.57 165.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 113.35 -1.75 . . . . 0.0 111.146 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 167.72 150.66 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 124.59 1.156 . . . . 0.0 110.021 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.76 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.34 -41.98 1.99 Allowed Glycine 1 N--CA 1.518 4.104 0 N-CA-C 116.699 1.44 . . . . 0.0 116.699 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.4 t -35.48 139.25 0.12 Allowed 'General case' 0 N--CA 1.531 3.617 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.966 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.3 mt -94.55 63.51 2.94 Favored 'General case' 0 N--CA 1.52 3.053 0 CA-C-N 120.358 1.435 . . . . 0.0 113.189 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.8 mm -40.52 -58.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.623 ' SD ' HG13 ' A' ' 54' ' ' VAL . 4.6 ptp -155.9 -172.92 4.3 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.27 122.0 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 122.998 1.38 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.618 ' CD1' HG21 ' A' ' 5' ' ' VAL . 5.6 m-30 -98.89 156.95 16.63 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.817 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.453 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 17.4 tt0 -147.6 98.15 2.94 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 123.952 1.834 . . . . 0.0 111.444 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.565 1.548 0 CA-C-N 114.053 -1.43 . . . . 0.0 114.616 179.547 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.0 t . . . . . 0 N--CA 1.513 2.705 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 73.3 mmtt -136.73 154.22 50.65 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.769 -1.559 . . . . 0.0 113.013 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.8 152.23 20.75 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.933 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 ' CE1' ' A' ' 74' ' ' PHE . 74.1 t -118.24 107.9 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -107.82 141.26 39.67 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.037 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 48.9 t -51.37 121.86 17.99 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 113.019 -1.9 . . . . 0.0 113.162 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 67' ' ' THR . 83.0 Cg_endo . . . . . 0 N--CA 1.505 2.148 0 C-N-CA 123.182 2.588 . . . . 0.0 114.623 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.521 3.107 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 10.2 pt-20 -106.73 179.12 4.36 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.524 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.69 115.61 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 38' ' ' GLU . 18.7 p -96.86 -41.22 8.54 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.2 126.02 46.18 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 119.679 1.127 . . . . 0.0 112.038 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.7 53.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 125.549 2.595 . . . . 0.0 116.547 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.7 mmm -20.05 -54.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 110.509 -3.042 . . . . 0.0 114.152 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' ' HZ3' ' A' ' 23' ' ' LYS . 1.4 m -114.88 159.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 O-C-N 120.778 -1.201 . . . . 0.0 108.699 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HZ3' ' HA ' ' A' ' 22' ' ' VAL . 3.8 mtmm -143.37 -176.9 5.12 Favored 'General case' 0 N--CA 1.522 3.13 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -49.15 106.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.775 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.99 -48.94 0.91 Allowed Glycine 0 N--CA 1.508 3.496 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -36.51 130.0 0.73 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-O 123.987 1.851 . . . . 0.0 115.39 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HD3' HG12 ' A' ' 53' ' ' VAL . 70.9 mmtt -70.5 76.88 0.57 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.141 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 74' ' ' PHE . 37.6 t -79.34 156.97 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 125.413 2.53 . . . . 0.0 116.981 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -164.81 154.93 13.85 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.833 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.48 166.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.332 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 65.05 -21.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' ALA . 1.3 tm0? -93.34 152.68 18.99 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 p -68.34 146.66 53.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 123.223 1.487 . . . . 0.0 110.716 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' HD2' ' A' ' 49' ' ' PRO . 4.9 mt -109.08 -65.6 1.13 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 123.748 1.737 . . . . 0.0 109.032 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.8 pt -142.53 160.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 111.351 -2.659 . . . . 0.0 110.013 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.6 m -107.3 129.04 54.94 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.7 m -118.39 151.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 118.116 2.636 . . . . 0.0 118.116 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.417 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.7 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.0 p . . . . . 0 N--CA 1.515 2.785 0 CA-C-O 121.581 0.705 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 30.5 mtp -142.92 163.3 33.17 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.909 -0.495 . . . . 0.0 112.185 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.01 149.23 42.49 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.777 1.275 . . . . 0.0 113.911 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.05 127.38 26.39 Favored Pre-proline 0 N--CA 1.503 2.202 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.958 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -92.67 178.59 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.148 1.899 . . . . 0.0 114.295 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -67.7 110.44 5.42 Favored Pre-proline 0 CA--C 1.578 2.056 0 N-CA-C 117.595 2.443 . . . . 0.0 117.595 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD2' HD11 ' A' ' 34' ' ' LEU . 40.2 Cg_endo -53.38 -21.41 17.88 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 122.905 2.404 . . . . 0.0 113.384 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -164.74 -169.65 1.78 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.401 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -108.82 158.77 17.34 Favored 'General case' 0 C--N 1.3 -1.56 1 N-CA-C 121.838 4.014 . . . . 0.0 121.838 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . 132.91 179.85 16.68 Favored Glycine 1 N--CA 1.519 4.212 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.548 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' HD3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -92.53 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.27 -1.723 . . . . 0.0 113.978 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 74' ' ' PHE . 35.6 t -83.87 112.23 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.07 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -93.16 -55.04 3.47 Favored 'General case' 0 N--CA 1.516 2.837 0 CA-C-N 120.42 1.464 . . . . 0.0 112.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 4.5 tt0 -147.91 162.08 40.0 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 121.135 0.493 . . . . 0.0 109.918 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -162.72 150.78 14.02 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.943 -1.098 . . . . 0.0 108.36 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 41.2 mtmt -125.16 53.01 1.55 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.896 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 71' ' ' ILE . 34.2 m -138.35 157.3 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 126.183 2.177 . . . . 0.0 112.279 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 3.6 m120 -124.78 173.83 8.31 Favored 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.79 83.05 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 127.298 3.428 . . . . 0.0 104.458 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.25 41.9 0.08 OUTLIER Glycine 0 N--CA 1.505 3.273 1 CA-C-N 104.699 -5.682 . . . . 0.0 107.058 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.499 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 11.3 t0 -122.49 168.67 11.83 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -113.24 144.91 41.9 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 121.786 3.995 . . . . 0.0 121.786 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 m -125.44 130.49 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 118.251 2.685 . . . . 0.0 118.251 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -130.18 120.28 24.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 8' ' ' PRO . 24.5 p -28.47 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 124.571 2.129 . . . . 0.0 112.501 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.46 42.0 1.67 Allowed Glycine 0 N--CA 1.508 3.485 0 CA-C-N 109.983 -3.281 . . . . 0.0 113.635 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -115.51 131.88 56.8 Favored 'General case' 0 N--CA 1.529 3.493 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.504 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.08 63.99 0.71 Allowed 'General case' 0 N--CA 1.519 2.981 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.463 HG23 HG11 ' A' ' 59' ' ' VAL . 24.0 mm -53.68 -63.47 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.592 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 18.2 ptt? -138.81 168.82 18.98 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.43 119.79 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 123.365 1.555 . . . . 0.0 110.388 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 28' ' ' VAL . 8.8 m-30 -99.87 163.87 12.27 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.435 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -144.34 106.14 4.3 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.851 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HA ' ' CA ' ' A' ' 52' ' ' GLY . 34.2 m . . . . . 0 N--CA 1.494 1.742 1 N-CA-C 122.784 4.364 . . . . 0.0 122.784 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 3' ' ' LYS . 3.5 t . . . . . 0 N--CA 1.516 2.833 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.612 ' H ' HG12 ' A' ' 2' ' ' VAL . 33.1 mmtm -141.79 131.51 24.17 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -88.25 151.1 22.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.698 -1.251 . . . . 0.0 109.236 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 79.7 t -108.14 115.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 CA-C-O 121.569 0.7 . . . . 0.0 111.851 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.6 p30 -106.18 -179.18 3.86 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 123.0 1.381 . . . . 0.0 111.383 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.547 HG22 HD11 ' A' ' 71' ' ' ILE . 34.7 t -101.19 117.86 61.39 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.907 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 85.0 Cg_endo . . . . . 0 N--CA 1.493 1.463 0 C-N-CA 121.643 1.562 . . . . 0.0 113.0 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.506 2.374 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.631 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 9.9 pt-20 -123.8 167.91 13.44 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -95.42 122.51 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 m -92.38 -52.02 4.86 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 126.424 1.89 . . . . 0.0 108.597 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -131.89 120.74 22.97 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.7 0.762 . . . . 0.0 111.407 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.5 p -95.29 61.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 123.573 1.654 . . . . 0.0 110.444 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 mtt -27.73 -32.77 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 118.584 2.809 . . . . 0.0 118.584 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG12 HE21 ' A' ' 32' ' ' GLN . 19.5 m -115.85 145.72 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -129.88 176.13 8.29 Favored 'General case' 0 N--CA 1.517 2.884 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.15 102.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.85 0 CA-C-N 114.174 -1.375 . . . . 0.0 114.406 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.02 -36.21 3.03 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.256 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -49.36 171.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HD3' HG12 ' A' ' 53' ' ' VAL . 74.3 mmtt -105.44 105.13 15.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 111.629 -2.532 . . . . 0.0 108.841 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 74' ' ' PHE . 21.8 t -115.2 106.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -117.29 158.74 23.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.827 -1.171 . . . . 0.0 110.52 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -42.5 157.83 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.702 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.027 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 2.7 tm-20 79.55 -48.88 0.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.828 1.299 . . . . 0.0 107.845 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' LEU . 43.0 tt0 -47.37 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 m -32.19 61.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -19.45 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 pt -147.61 146.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 110.628 -2.987 . . . . 0.0 112.89 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 45' ' ' GLU . 9.0 m -105.15 124.73 50.03 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.09 158.41 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 117.849 2.536 . . . . 0.0 117.849 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.621 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.794 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 N--CA 1.511 2.579 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 44' ' ' MET . 2.1 mpp? -121.71 159.2 27.09 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 36' ' ' THR . 19.8 mt-10 -117.18 146.41 43.24 Favored 'General case' 0 N--CA 1.506 2.342 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.481 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.7 127.04 25.92 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.838 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.48 171.86 7.22 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.794 1.662 . . . . 0.0 111.326 174.228 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -58.62 103.86 0.39 Allowed Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HG2' HG13 ' A' ' 5' ' ' VAL . 72.9 Cg_exo -35.48 -40.17 0.31 Allowed 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 123.409 2.739 . . . . 0.0 113.199 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.05 -172.4 4.01 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 109.981 -3.281 . . . . 0.0 108.109 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.45 162.15 14.18 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.706 3.224 . . . . 0.0 119.706 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.3 -154.25 21.58 Favored Glycine 1 N--CA 1.519 4.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.572 HG12 ' HD3' ' A' ' 27' ' ' LYS . 17.6 m -114.66 174.82 2.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.321 1.534 . . . . 0.0 113.001 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 74' ' ' PHE . 20.6 t -102.73 108.58 24.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.976 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 14.0 tttm -88.57 -45.42 9.9 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.179 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 60.3 tt0 -165.45 163.83 19.61 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.696 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -160.37 164.29 32.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.106 . . . . 0.0 110.447 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -130.88 51.07 2.16 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -143.7 155.35 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 125.633 1.833 . . . . 0.0 113.504 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.535 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -127.44 -177.36 4.05 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 125.521 2.581 . . . . 0.0 115.321 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.91 104.61 16.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 101.123 -3.658 . . . . 0.0 101.123 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 136.85 -10.72 3.95 Favored Glycine 0 N--CA 1.514 3.864 1 CA-C-N 107.783 -4.281 . . . . 0.0 110.188 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -69.73 174.01 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.959 0.904 . . . . 0.0 110.268 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.631 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 30.4 mmtm -115.85 142.18 47.12 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.8 164.65 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.14 0.576 . . . . 0.0 112.397 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.55 153.74 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 2.9 t -39.45 118.5 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 122.579 1.18 . . . . 0.0 113.426 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.45 -29.17 7.11 Favored Glycine 1 N--CA 1.518 4.127 0 CA-C-N 114.574 -1.194 . . . . 0.0 115.607 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 24.5 t -75.7 161.25 29.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 117.92 -1.512 . . . . 0.0 112.933 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.3 mt -97.91 64.79 1.75 Allowed 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.547 HD11 HG22 ' A' ' 7' ' ' VAL . 5.6 mt -21.82 -67.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.424 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 13.4 ptp -149.93 179.39 8.09 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.519 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.5 118.25 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 123.351 1.548 . . . . 0.0 111.835 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.501 ' CE1' HG22 ' A' ' 54' ' ' VAL . 10.5 m-30 -106.99 162.9 13.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 123.43 1.586 . . . . 0.0 112.086 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' O ' HG22 ' A' ' 53' ' ' VAL . 1.4 tt0 -142.57 133.09 25.09 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.345 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.295 -1.767 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.664 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.498 1.945 0 CA-C-O 124.14 1.924 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -126.98 145.23 50.78 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.503 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -81.79 155.58 25.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.19 0.995 . . . . 0.0 110.809 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 74' ' ' PHE . 48.2 t -122.71 91.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 123.73 1.729 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -96.32 146.5 24.68 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.23 137.84 81.52 Favored Pre-proline 0 N--CA 1.501 2.084 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.789 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.174 1.916 . . . . 0.0 112.699 -177.774 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.505 2.286 0 N-CA-C 110.87 -0.048 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 2.0 pm0 -118.64 179.03 4.25 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.73 1.252 . . . . 0.0 110.274 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -94.3 115.64 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.302 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 m -90.45 -34.98 15.4 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -143.62 134.74 25.66 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.19 64.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 124.73 2.205 . . . . 0.0 114.972 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.2 mmm -25.17 -48.74 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 109.875 -3.329 . . . . 0.0 118.019 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.82 164.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -130.52 -174.86 3.47 Favored 'General case' 0 N--CA 1.522 3.145 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.1 107.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.875 0 O-C-N 120.831 -1.168 . . . . 0.0 111.472 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.87 -25.83 9.82 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-O 122.172 0.873 . . . . 0.0 111.915 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.85 156.62 13.91 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -86.51 127.84 34.91 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.918 1.342 . . . . 0.0 110.65 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 35.7 t -127.41 93.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 112.369 -2.196 . . . . 0.0 113.599 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -99.79 158.7 15.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.726 -1.234 . . . . 0.0 108.617 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -54.08 163.68 0.75 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.142 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 75.55 -35.63 0.28 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.763 1.268 . . . . 0.0 110.562 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -67.31 127.22 31.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 123.146 1.45 . . . . 0.0 112.34 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.5 p -57.77 97.71 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -61.13 -63.31 1.34 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.81 150.17 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 112.187 -2.279 . . . . 0.0 110.038 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 87.2 m -97.77 114.95 27.09 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.74 148.57 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.511 2.596 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.4 ptp -148.98 174.59 12.12 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -122.88 157.95 31.4 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.9 t -121.54 126.18 26.56 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.582 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -88.94 171.84 4.64 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.485 1.369 . . . . 0.0 110.073 174.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -70.81 119.85 75.56 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 118.581 2.808 . . . . 0.0 118.581 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HD2' HD11 ' A' ' 34' ' ' LEU . 30.3 Cg_endo -50.1 -29.26 21.6 Favored 'Trans proline' 0 N--CA 1.511 2.544 0 C-N-CA 122.947 2.431 . . . . 0.0 112.953 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.71 -175.19 5.01 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 112.214 -2.266 . . . . 0.0 108.536 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.47 161.53 13.64 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.76 -167.88 23.81 Favored Glycine 1 N--CA 1.524 4.516 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.102 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.69 165.03 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 118.613 1.206 . . . . 0.0 113.171 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CE1' ' A' ' 74' ' ' PHE . 25.0 t -89.84 120.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 75' ' ' GLU . 6.3 tttp -103.98 -62.6 1.29 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG2' HD11 ' A' ' 73' ' ' ILE . 2.2 tp10 -130.62 137.19 49.5 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 118.326 0.512 . . . . 0.0 110.803 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.4 pt? -149.69 114.7 5.4 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 123.466 1.603 . . . . 0.0 108.425 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.437 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 93.3 mttt -94.48 50.74 1.37 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.28 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.11 143.36 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.431 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -130.94 -172.56 2.86 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.793 2.235 . . . . 0.0 113.58 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.54 108.27 19.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.37 -15.81 4.68 Favored Glycine 0 N--CA 1.513 3.798 0 CA-C-N 108.913 -3.767 . . . . 0.0 113.144 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -70.28 157.08 38.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.0 mmmt -91.56 136.69 32.94 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.98 152.3 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.999 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -162.98 148.29 11.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.4 t -55.32 120.59 7.32 Favored 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.241 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.14 6.42 39.43 Favored Glycine 1 N--CA 1.523 4.452 0 CA-C-N 114.408 -1.269 . . . . 0.0 114.985 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -93.84 112.69 24.58 Favored 'General case' 0 N--CA 1.517 2.919 0 O-C-N 120.95 -1.324 . . . . 0.0 111.491 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 70' ' ' LEU . 1.4 mp -61.94 56.59 0.01 OUTLIER 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mm -42.61 -51.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 4.9 ptp -151.18 -175.05 5.01 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.487 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -123.24 120.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 123.814 1.768 . . . . 0.0 114.494 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 5' ' ' VAL . 19.7 m-30 -108.82 164.61 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.313 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 4.7 tp10 -138.13 131.03 29.84 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 76' ' ' VAL . 27.1 m . . . . . 0 C--N 1.29 -1.979 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.503 2.219 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' HG22 ' A' ' 73' ' ' ILE . 4.1 mmmm -137.98 154.12 49.38 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 2.7 pp20? -101.35 172.08 7.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.761 -0.587 . . . . 0.0 110.103 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 74' ' ' PHE . 58.4 t -133.53 97.53 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.142 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 69' ' ' SER . 2.5 p-10 -94.56 168.66 10.71 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.572 HG23 HG13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -98.73 125.44 42.4 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 118.104 -1.438 . . . . 0.0 111.346 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 67' ' ' THR . 60.5 Cg_endo . . . . . 0 N--CA 1.502 2.005 0 C-N-CA 123.619 2.879 . . . . 0.0 109.961 -163.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.5 m . . . . . 0 N--CA 1.513 2.692 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.72 165.3 20.05 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -112.53 120.08 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 118.944 -1.102 . . . . 0.0 108.578 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -94.9 -48.18 6.12 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.081 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.83 102.94 5.42 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 123.2 1.476 . . . . 0.0 113.283 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.96 64.64 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 O-C-N 119.83 -1.794 . . . . 0.0 113.441 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 mtt -32.78 -36.12 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 N-CA-C 121.253 3.797 . . . . 0.0 121.253 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.91 142.68 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 6.8 mtpm? -134.94 179.94 6.0 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 119.148 3.018 . . . . 0.0 119.148 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.8 t -45.04 91.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.456 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 2.63 12.51 Favored Glycine 1 N--CA 1.523 4.454 0 CA-C-O 121.91 0.728 . . . . 0.0 113.555 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 59.4 m-20 -97.51 120.42 37.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 124.903 2.287 . . . . 0.0 113.731 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.715 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -65.52 95.24 0.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.649 -2.523 . . . . 0.0 110.933 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 34' ' ' LEU . 7.3 t -91.15 157.56 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.734 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.21 167.77 2.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.321 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.33 162.09 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 O-C-N 124.582 1.176 . . . . 0.0 113.638 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.85 -10.37 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.655 1.217 . . . . 0.0 113.923 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 30' ' ' ALA . 34.7 tt0 -90.15 87.68 6.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.203 -1.561 . . . . 0.0 106.809 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 70.7 m -35.99 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -24.63 -66.4 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 pt -147.42 146.02 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 111.387 -2.642 . . . . 0.0 111.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 45' ' ' GLU . 96.6 m -93.17 131.01 38.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.82 160.55 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.72 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.521 3.082 0 CA-C-O 120.778 0.323 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 45.2 mtm -109.72 161.28 15.56 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.832 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' A' ' 36' ' ' THR . 27.6 mt-10 -122.14 158.59 28.99 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.05 121.45 19.76 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.51 171.28 2.43 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.28 1.32 . . . . 0.0 111.217 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -45.28 96.7 0.12 Allowed Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HG ' ' A' ' 34' ' ' LEU . 18.2 Cg_endo -44.55 -28.39 2.69 Favored 'Trans proline' 0 N--CA 1.511 2.551 0 C-N-CA 121.968 1.779 . . . . 0.0 112.973 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -163.8 -179.35 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.322 -2.217 . . . . 0.0 107.016 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.16 156.54 18.71 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 120.035 3.346 . . . . 0.0 120.035 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.33 -173.65 22.14 Favored Glycine 1 N--CA 1.529 4.863 0 CA-C-N 112.772 -2.013 . . . . 0.0 114.185 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 26' ' ' ASP . 1.4 t -95.8 167.83 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 CA-C-N 120.405 2.103 . . . . 0.0 112.209 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 ' CE1' ' A' ' 74' ' ' PHE . 11.7 t -91.9 126.82 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.115 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 9.6 tttp -99.64 -60.44 1.53 Allowed 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 12.4 tt0 -144.6 159.71 42.35 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.285 0.564 . . . . 0.0 112.471 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.6 pt? -154.7 161.34 41.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.48 -2.013 . . . . 0.0 110.417 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.588 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.9 mptt -133.1 45.79 2.68 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 122.369 1.081 . . . . 0.0 108.962 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.91 149.2 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -129.89 177.69 7.08 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 125.504 2.574 . . . . 0.0 113.446 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.43 109.71 20.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.53 -27.95 3.04 Favored Glycine 0 N--CA 1.511 3.659 0 CA-C-N 111.929 -2.396 . . . . 0.0 108.393 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.78 169.86 17.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -123.32 164.39 18.89 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.909 1.337 . . . . 0.0 108.799 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.52 168.2 18.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -150.01 156.2 41.28 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 119.186 -1.006 . . . . 0.0 113.161 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -34.13 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.3 -5.69 45.38 Favored Glycine 1 N--CA 1.517 4.075 0 CA-C-N 113.785 -1.552 . . . . 0.0 115.8 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 8.5 m -63.7 133.52 53.73 Favored 'General case' 0 N--CA 1.524 3.226 0 CA-C-O 117.621 -1.18 . . . . 0.0 112.879 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.72 59.17 0.21 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 HG23 ' A' ' 7' ' ' VAL . 6.0 mm -30.68 -64.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 124.847 2.26 . . . . 0.0 116.528 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -152.27 177.25 10.75 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 111.357 -2.656 . . . . 0.0 112.856 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -118.42 127.89 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 123.384 1.564 . . . . 0.0 107.019 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.558 ' CD1' HG21 ' A' ' 5' ' ' VAL . 8.9 m-30 -105.51 160.76 14.91 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 113.316 -1.766 . . . . 0.0 115.005 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 14.0 tt0 -141.04 109.69 6.0 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 124.618 2.151 . . . . 0.0 111.362 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 CA--C 1.58 2.13 0 N-CA-C 121.362 3.838 . . . . 0.0 121.362 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 118.572 2.804 . . . . 0.0 118.572 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -118.83 146.63 44.7 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 124.225 1.964 . . . . 0.0 112.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 7.5 mp0 -91.15 132.17 36.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.438 -2.619 . . . . 0.0 114.258 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 92.2 t -104.26 111.75 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.726 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 69' ' ' SER . 16.3 p-10 -108.9 172.79 6.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.34 1.543 . . . . 0.0 112.273 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.556 HG22 ' CG1' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -101.39 117.82 61.26 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 112.832 -1.986 . . . . 0.0 113.65 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.506 2.257 0 C-N-CA 123.87 3.047 . . . . 0.0 112.724 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 35.4 m . . . . . 0 N--CA 1.517 2.904 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.613 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 1.6 pm0 -118.11 174.66 6.09 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.223 1.011 . . . . 0.0 113.315 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.43 127.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.221 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 81.4 p -98.82 -50.36 4.24 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -131.12 100.31 5.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 123.254 1.502 . . . . 0.0 112.9 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG22 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -73.89 65.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 O-C-N 120.295 -1.503 . . . . 0.0 114.06 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 34.3 mmm -30.39 -52.43 0.16 Allowed 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.9 m -89.01 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HZ3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -130.7 161.88 30.68 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.47 114.97 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.849 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.76 -29.15 6.16 Favored Glycine 0 N--CA 1.515 3.966 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.414 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 11.7 t70 -89.02 168.39 12.39 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -83.98 109.21 17.45 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 34' ' ' LEU . 6.7 t -111.04 102.77 14.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.612 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -120.25 159.02 25.78 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.316 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.48 160.92 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 74.27 -40.16 0.44 Allowed 'General case' 0 N--CA 1.516 2.843 0 CA-C-O 121.963 0.887 . . . . 0.0 110.475 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 47.0 tp60 -58.39 83.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 50.4 m -28.86 70.15 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.094 2.998 . . . . 0.0 119.094 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD21 HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -23.32 -67.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.29 155.44 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.525 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -99.16 136.63 38.84 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 25.0 m -124.85 148.71 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 18' ' ' THR . 3.4 tt0 . . . . . 0 N--CA 1.508 2.461 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.517 2.916 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.0 mtt -132.27 168.23 18.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.483 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.85 152.69 49.06 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 43.5 t -129.79 125.86 22.35 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.0 173.37 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.414 1.409 . . . . 0.0 110.544 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -54.36 98.81 0.18 Allowed Pre-proline 0 C--N 1.287 -2.145 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 19.0 Cg_endo -44.31 -29.3 2.94 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 C-N-CA 122.402 2.068 . . . . 0.0 113.679 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -158.76 -175.3 5.22 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.093 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -107.57 155.93 19.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.16 -168.61 26.53 Favored Glycine 1 N--CA 1.518 4.153 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 75' ' ' GLU . 5.6 m -109.95 154.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.435 -1.626 . . . . 0.0 112.268 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.56 108.9 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 1.9 tmtp? -94.24 -50.15 5.4 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.226 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.518 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.7 tt0 -155.88 162.89 40.35 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.518 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -167.85 156.77 9.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.085 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -131.76 53.27 2.01 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.39 153.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 126.079 2.112 . . . . 0.0 113.735 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.7 m120 -121.76 178.62 4.78 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 124.809 2.243 . . . . 0.0 115.576 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.37 108.9 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.96 -23.76 3.34 Favored Glycine 0 N--CA 1.507 3.378 1 CA-C-N 108.282 -4.054 . . . . 0.0 108.501 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -54.39 154.11 4.91 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.945 0.879 . . . . 0.0 111.58 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.613 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.6 mmmt -95.81 148.32 22.71 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.43 147.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.667 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -148.56 155.65 41.4 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -30.28 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.052 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.46 -32.5 5.53 Favored Glycine 0 N--CA 1.511 3.698 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.327 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 21.2 m -37.84 122.87 1.02 Allowed 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 70' ' ' LEU . 7.4 mp -70.39 58.96 0.19 Allowed 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.556 ' CG1' HG22 ' A' ' 7' ' ' VAL . 5.1 mt -20.07 -61.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.448 ' SD ' ' HE1' ' A' ' 74' ' ' PHE . 7.9 ptp -156.85 176.77 12.31 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 112.573 -2.103 . . . . 0.0 114.509 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 114.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 123.845 1.783 . . . . 0.0 112.42 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.448 ' HE1' ' SD ' ' A' ' 72' ' ' MET . 17.0 m-30 -106.96 154.88 20.43 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.632 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 2.5 tp10 -127.01 123.35 36.86 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 CA--C 1.582 2.189 1 N-CA-C 124.577 5.029 . . . . 0.0 124.577 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -128.54 84.0 2.2 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.227 2.677 . . . . 0.0 118.227 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.08 143.85 1.06 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 74' ' ' PHE . 26.5 t -118.01 120.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.0 p-10 -117.48 172.78 7.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.457 ' CG2' HD11 ' A' ' 71' ' ' ILE . 5.8 t -101.95 137.3 19.47 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 118.299 -1.361 . . . . 0.0 109.563 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' O ' HG22 ' A' ' 67' ' ' THR . 42.4 Cg_endo . . . . . 0 N--CA 1.505 2.195 0 C-N-CA 123.605 2.87 . . . . 0.0 111.327 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.503 2.212 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 49.5 mt-10 -92.33 169.98 10.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.544 -0.723 . . . . 0.0 109.558 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 35' ' ' ILE . 60.0 t -106.89 116.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -94.49 -43.43 8.35 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.633 1.173 . . . . 0.0 113.787 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -136.49 102.06 4.83 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.678 1.228 . . . . 0.0 110.342 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.7 p -75.18 63.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 O-C-N 119.562 -1.962 . . . . 0.0 116.1 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 28.9 mmm -29.57 -33.6 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 26' ' ' ASP . 2.1 t -125.57 154.32 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -134.41 -176.93 4.37 Favored 'General case' 0 N--CA 1.521 3.078 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.54 87.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.101 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.91 26.01 3.71 Favored Glycine 0 N--CA 1.514 3.869 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.576 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' HB3' ' CG1' ' A' ' 22' ' ' VAL . 1.3 m-20 -116.37 141.09 48.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.36 115.02 4.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.798 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.19 98.23 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -105.04 149.43 25.81 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.232 -1.543 . . . . 0.0 114.782 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.2 73.03 0.3 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 177.2 -24.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.001 -3.272 . . . . 0.0 110.131 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -89.87 119.08 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.877 -1.14 . . . . 0.0 112.74 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 29.5 t -48.78 123.87 7.6 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 48' ' ' ALA . 1.5 mt -81.78 -55.46 4.61 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.477 1.132 . . . . 0.0 112.625 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' A' ' 17' ' ' VAL . 19.9 pt -146.7 129.75 8.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.481 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 m -73.17 137.68 45.23 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.1 m -124.77 154.54 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.518 2.928 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.505 2.308 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.0 mmm -116.79 166.72 11.82 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.064 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -130.81 156.93 44.17 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.25 105.83 14.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.311 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 1.4 Cg_endo -77.71 175.66 10.97 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.155 1.236 . . . . 0.0 110.212 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.643 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -72.3 107.49 3.07 Favored Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -38.3 -39.33 1.01 Allowed 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.42 2.747 . . . . 0.0 113.981 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -150.77 176.69 10.8 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.02 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -94.82 89.09 5.54 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.57 -164.46 10.18 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 114.48 -1.236 . . . . 0.0 113.603 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.47 156.5 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 ' CE1' ' A' ' 74' ' ' PHE . 2.7 t -87.11 135.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.372 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -110.97 -65.22 1.19 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.158 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.506 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 29.7 tt0 -137.85 148.86 45.8 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.637 0.732 . . . . 0.0 109.521 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 57' ' ' LEU . 2.1 pt? -157.64 154.76 28.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.506 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 86.6 mttt -131.1 51.55 2.13 Favored 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.11 154.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 CA-C-N 111.82 -2.446 . . . . 0.0 114.195 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -145.55 -176.19 5.02 Favored 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.0 t -84.65 113.22 22.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 1 N-CA-C 99.688 -4.19 . . . . 0.0 99.688 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.93 10.15 12.7 Favored Glycine 0 N--CA 1.513 3.769 0 CA-C-N 112.293 -2.23 . . . . 0.0 108.952 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -103.68 159.58 15.5 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 150.12 35.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -136.02 166.04 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.336 -179.225 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.596 ' HD2' ' N ' ' A' ' 67' ' ' THR . 4.5 tmmm? -159.72 160.54 34.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.076 -1.015 . . . . 0.0 109.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.596 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 6.5 p -43.4 112.93 0.43 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.8 -8.49 61.55 Favored Glycine 0 N--CA 1.515 3.964 0 CA-C-N 113.043 -1.89 . . . . 0.0 114.619 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 7.2 m -67.41 127.13 31.53 Favored 'General case' 0 N--CA 1.52 3.068 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.184 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 6' ' ' ASN . 0.8 OUTLIER -72.99 66.21 0.79 Allowed 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -36.46 -61.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 119.549 3.166 . . . . 0.0 119.549 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 ptp -144.89 175.18 10.39 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 113.987 -1.46 . . . . 0.0 114.812 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -113.72 121.94 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.932 1.349 . . . . 0.0 111.677 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.553 ' CD1' HG21 ' A' ' 5' ' ' VAL . 15.2 m-30 -106.0 -177.36 3.34 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.168 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -153.44 165.55 35.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 120.224 3.416 . . . . 0.0 120.224 -179.463 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.513 2.713 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 1.1 mptt -125.15 155.09 40.49 Favored 'General case' 0 N--CA 1.515 2.781 0 CA-C-O 122.015 0.912 . . . . 0.0 112.477 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -107.35 149.35 27.94 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.298 1.523 . . . . 0.0 113.375 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 59.5 t -102.97 102.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-O 124.102 1.906 . . . . 0.0 112.074 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -95.94 130.12 43.0 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 111.094 -2.775 . . . . 0.0 105.563 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 67' ' ' THR . 69.7 t -55.64 132.51 71.79 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HD3' ' A' ' 49' ' ' PRO . 62.6 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 C-N-CA 121.578 1.519 . . . . 0.0 114.119 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.517 2.892 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.6 pt-20 -100.27 167.73 10.23 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.245 -0.909 . . . . 0.0 109.818 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' A' ' 35' ' ' ILE . 22.0 t -105.35 113.44 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.394 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.3 p -90.5 -40.98 11.67 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 93.8 mt-10 -133.99 101.76 5.17 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 123.297 1.522 . . . . 0.0 111.682 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.37 73.64 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-O 125.981 2.801 . . . . 0.0 113.047 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.449 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 mtp -38.39 -45.66 1.04 Allowed 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' C ' ' HD3' ' A' ' 23' ' ' LYS . 10.4 m -103.31 153.44 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 CA-C-N 119.486 1.039 . . . . 0.0 113.349 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.615 ' HD3' ' C ' ' A' ' 22' ' ' VAL . 3.7 mppt? -129.58 175.16 9.02 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.0 107.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.745 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.87 -28.11 5.5 Favored Glycine 1 N--CA 1.519 4.176 0 N-CA-C 114.598 0.599 . . . . 0.0 114.598 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -59.66 157.54 11.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -107.85 103.32 12.55 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 123.513 1.625 . . . . 0.0 106.982 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.644 HG11 HD21 ' A' ' 34' ' ' LEU . 66.1 t -103.78 117.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 120.327 3.454 . . . . 0.0 120.327 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -112.86 154.32 26.5 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 119.803 -1.81 . . . . 0.0 113.897 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.79 92.66 2.52 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 160.59 -20.51 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 109.994 -3.275 . . . . 0.0 109.284 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.58 165.86 14.0 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.023 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.3 p -85.56 106.19 16.7 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.644 HD21 HG11 ' A' ' 28' ' ' VAL . 3.4 mt -69.13 -63.78 1.0 Allowed 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 17' ' ' VAL . 33.9 pt -143.11 157.88 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.128 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 9.9 m -104.7 134.26 48.15 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.7 m -127.12 165.62 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.094 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 13.7 t . . . . . 0 N--CA 1.518 2.959 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 mmt -139.02 168.42 19.87 Favored 'General case' 0 N--CA 1.513 2.72 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -111.3 151.89 27.84 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 122.177 0.989 . . . . 0.0 111.627 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.2 t -122.66 119.59 28.11 Favored Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.616 -0.677 . . . . 0.0 109.708 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -85.17 175.9 6.19 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 CA-C-O 122.581 0.992 . . . . 0.0 111.67 175.503 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -75.6 108.41 5.77 Favored Pre-proline 0 CA--C 1.58 2.111 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD3' ' HD3' ' A' ' 8' ' ' PRO . 29.8 Cg_endo -48.62 -30.46 16.46 Favored 'Trans proline' 0 N--CA 1.512 2.584 0 C-N-CA 123.084 2.523 . . . . 0.0 114.122 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 178.38 10.15 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.498 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.29 20.85 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.04 -175.79 35.19 Favored Glycine 0 N--CA 1.507 3.413 0 CA-C-O 121.812 0.673 . . . . 0.0 111.985 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.6 151.12 19.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.199 -1.177 . . . . 0.0 111.379 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 10.7 t -74.69 80.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.633 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HE2' ' CB ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -68.54 -41.36 79.99 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.528 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CB ' ' HE2' ' A' ' 55' ' ' LYS . 39.7 tt0 -167.74 166.32 13.8 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 57' ' ' LEU . 1.6 pt? -166.56 159.34 14.19 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.046 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -132.24 49.14 2.34 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 122.715 1.245 . . . . 0.0 108.958 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.43 157.03 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 112.524 -2.125 . . . . 0.0 113.279 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -129.94 178.42 6.54 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 125.829 2.728 . . . . 0.0 115.065 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -90.24 112.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 100.536 -3.876 . . . . 0.0 100.536 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.02 -29.41 3.52 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 109.636 -3.438 . . . . 0.0 109.363 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -62.07 159.18 14.96 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.886 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -104.75 142.88 33.91 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HB ' HG21 ' A' ' 7' ' ' VAL . 28.6 m -123.71 158.19 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -153.03 145.7 24.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 118.088 -0.958 . . . . 0.0 108.934 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 14.3 t -47.78 121.74 4.35 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.851 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.98 35.06 Favored Glycine 0 N--CA 1.513 3.825 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.733 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.8 t -78.36 121.45 24.49 Favored 'General case' 0 N--CA 1.52 3.06 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.15 66.54 0.63 Allowed 'General case' 0 N--CA 1.516 2.827 0 CA-C-O 122.032 0.92 . . . . 0.0 113.158 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.478 HG13 ' HG2' ' A' ' 72' ' ' MET . 35.9 pt -58.98 -45.78 91.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.517 ' HE1' HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -137.24 165.11 26.92 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 112.888 -1.96 . . . . 0.0 115.974 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.06 125.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.943 1.354 . . . . 0.0 113.448 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.488 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 7.3 m-30 -117.14 150.35 38.85 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.24 160.11 30.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 -179.175 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.503 2.179 0 CA-C-O 121.437 0.637 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 2.3 mmtt -131.97 127.41 36.24 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.331 1.063 . . . . 0.0 112.961 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.661 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -68.97 122.68 19.17 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.892 -1.503 . . . . 0.0 110.595 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.697 HG21 ' CD1' ' A' ' 74' ' ' PHE . 10.6 t -101.49 96.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 CA-C-O 124.573 2.13 . . . . 0.0 114.999 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.421 ' HB2' ' HA2' ' A' ' 68' ' ' GLY . 12.2 p-10 -89.13 128.15 35.76 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 110.058 -3.246 . . . . 0.0 106.986 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 65' ' ' VAL . 12.5 t -68.49 130.79 91.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.502 1.995 0 C-N-CA 122.951 2.434 . . . . 0.0 115.635 -172.064 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.522 3.143 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -102.48 176.14 5.27 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 120.584 1.538 . . . . 0.0 113.728 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 t -108.35 119.4 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-O 122.921 1.344 . . . . 0.0 113.251 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.1 m -93.04 -52.67 4.47 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.368 -1.742 . . . . 0.0 111.305 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 16.5 mm-40 -126.32 126.87 44.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.485 0.659 . . . . 0.0 109.499 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.453 HG22 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -105.73 61.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 123.045 1.403 . . . . 0.0 111.646 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmt -21.22 -46.7 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 110.622 -2.99 . . . . 0.0 116.671 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.436 HG11 HG22 ' A' ' 28' ' ' VAL . 2.4 t -112.79 159.7 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HZ3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -133.7 178.42 6.95 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 179.851 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.6 99.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.782 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.69 13.51 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.679 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 22' ' ' VAL . 58.7 m-20 -75.76 147.22 39.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.641 ' HD2' HG13 ' A' ' 53' ' ' VAL . 27.8 mmmt -73.84 108.61 6.77 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.705 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -109.29 124.16 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.956 0.884 . . . . 0.0 109.95 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -137.3 159.88 40.65 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.08 161.06 0.08 Allowed 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.25 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 56.93 -1.7 0.05 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.07 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 1.4 tm0? -96.07 107.67 20.0 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.5 m -48.33 121.72 4.66 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -88.23 -59.38 2.25 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -144.79 152.95 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.702 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 16.7 m -110.44 125.42 53.25 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 179.169 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.97 157.8 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.514 2.754 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.28 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.516 2.86 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.5 ttt -144.85 161.05 40.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.079 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.28 155.16 20.81 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 123.265 1.507 . . . . 0.0 114.493 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.88 126.07 23.75 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.48 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -91.18 177.83 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 CA-C-O 124.51 1.796 . . . . 0.0 113.367 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.707 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -70.25 103.71 0.66 Allowed Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 111.699 -2.501 . . . . 0.0 117.613 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 23.7 Cg_endo -46.69 -26.21 4.28 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 121.718 1.612 . . . . 0.0 114.067 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -162.14 -172.62 3.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.683 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.71 166.81 10.52 Favored 'General case' 0 CA--C 1.568 1.669 1 N-CA-C 122.747 4.351 . . . . 0.0 122.747 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.62 -134.68 7.26 Favored Glycine 1 N--CA 1.526 4.645 0 CA-C-N 113.173 -1.831 . . . . 0.0 113.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG13 ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -134.91 160.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 O-C-N 121.512 -0.993 . . . . 0.0 109.915 179.317 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 39.7 t -84.44 133.63 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 C-N-CA 117.604 -1.638 . . . . 0.0 106.912 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 45.5 tptt -102.73 -62.52 1.26 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 25.6 tt0 -150.53 158.79 44.55 Favored 'General case' 0 N--CA 1.511 2.624 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.539 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.1 pt? -166.02 149.66 7.71 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.395 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -125.03 50.06 1.8 Allowed 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.8 162.9 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 126.33 2.269 . . . . 0.0 113.967 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.425 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -135.27 -177.51 4.68 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 120.625 3.565 . . . . 0.0 120.625 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -94.4 67.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 127.458 3.504 . . . . 0.0 109.575 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.15 37.33 0.02 OUTLIER Glycine 0 N--CA 1.506 3.354 1 CA-C-N 105.395 -5.366 . . . . 0.0 109.602 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 9.8 t0 -121.53 173.9 7.11 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 111.568 -2.316 . . . . 0.0 104.912 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' C ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -121.79 160.67 24.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 120.356 3.465 . . . . 0.0 120.356 -179.517 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG12 HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.27 147.8 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 119.992 3.33 . . . . 0.0 119.992 -179.213 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.95 163.23 40.0 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.724 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -50.58 106.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 123.358 1.551 . . . . 0.0 114.763 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 6' ' ' ASN . . . 95.05 11.69 56.09 Favored Glycine 0 N--CA 1.513 3.767 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.671 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 t -76.12 116.9 17.27 Favored 'General case' 0 N--CA 1.507 2.423 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.551 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -83.45 77.09 9.87 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.81 1.767 . . . . 0.0 109.831 -179.599 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.535 HG21 HG12 ' A' ' 65' ' ' VAL . 1.7 pp -77.95 -44.13 28.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.164 -1.835 . . . . 0.0 112.915 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 71' ' ' ILE . 9.3 ptm -130.36 175.34 9.04 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.674 -1.21 . . . . 0.0 113.259 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HA ' HG23 ' A' ' 5' ' ' VAL . 5.3 mp -128.49 128.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.697 ' CD1' HG21 ' A' ' 5' ' ' VAL . 16.4 m-30 -109.8 164.05 12.93 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.0 tt0 -137.88 131.11 30.5 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.303 -1.417 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -179.558 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.03 150.38 51.33 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.262 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -95.07 160.11 14.71 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.48 HG21 ' CE1' ' A' ' 74' ' ' PHE . 89.9 t -118.36 114.69 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.154 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.9 p-10 -105.79 173.67 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 71' ' ' ILE . 38.4 t -95.18 131.04 30.8 Favored Pre-proline 0 N--CA 1.495 1.781 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.61 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.501 1.927 0 C-N-CA 121.343 1.362 . . . . 0.0 111.99 172.022 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 18.0 m . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.672 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 12.2 pt-20 -118.16 164.71 14.75 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.266 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 62' ' ' GLY . 10.2 t -83.6 123.91 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.418 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.1 t -102.39 -45.8 4.98 Favored 'General case' 0 N--CA 1.522 3.155 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.798 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 24.3 mt-10 -130.97 123.1 28.08 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.893 0.854 . . . . 0.0 109.594 178.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -102.99 71.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 125.957 2.789 . . . . 0.0 110.538 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 mtt -34.07 -59.45 0.43 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 110.59 -3.004 . . . . 0.0 115.101 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.641 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.8 t -100.63 151.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 CA-C-O 122.161 0.981 . . . . 0.0 112.809 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.641 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -138.54 177.18 8.08 Favored 'General case' 0 N--CA 1.518 2.962 0 N-CA-C 121.574 3.916 . . . . 0.0 121.574 -178.74 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -42.5 97.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.88 11.8 25.58 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.634 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 t0 -110.32 142.23 42.25 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -59.39 107.17 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.707 -2.042 . . . . 0.0 116.145 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.529 HG11 ' CE2' ' A' ' 74' ' ' PHE . 94.6 t -114.97 118.22 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 122.271 1.034 . . . . 0.0 111.807 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -133.56 149.34 51.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.544 -1.348 . . . . 0.0 113.69 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -50.67 140.46 14.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 41.1 mm-40 93.73 -21.28 0.07 Allowed 'General case' 0 N--CA 1.513 2.707 0 O-C-N 126.703 2.502 . . . . 0.0 110.405 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -88.1 140.27 29.66 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.782 -1.199 . . . . 0.0 109.573 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.6 m -73.69 128.23 34.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 112.257 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.2 mt -95.38 -61.95 1.38 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 pt -137.66 146.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-O 122.551 1.167 . . . . 0.0 113.03 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 45' ' ' GLU . 88.1 m -101.87 116.89 33.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.4 m -113.25 160.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.513 2.702 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.514 2.753 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -118.94 156.07 30.2 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.477 0.581 . . . . 0.0 111.465 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HG2' HG23 ' A' ' 36' ' ' THR . 47.6 mt-10 -111.64 158.48 19.21 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.14 123.09 22.42 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 112.644 -2.071 . . . . 0.0 112.164 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -84.52 -179.7 3.97 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 CA-C-O 123.55 1.396 . . . . 0.0 112.636 168.937 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -66.02 101.24 0.27 Allowed Pre-proline 0 C--N 1.282 -2.356 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' HD12 ' A' ' 34' ' ' LEU . 9.4 Cg_endo -36.61 -35.98 0.22 Allowed 'Trans proline' 0 N--CA 1.51 2.476 0 C-N-CA 122.71 2.273 . . . . 0.0 113.986 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -154.24 -177.49 6.47 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 112.078 -2.328 . . . . 0.0 107.006 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -100.31 168.79 9.55 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.97 -147.53 19.29 Favored Glycine 1 N--CA 1.517 4.035 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.075 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.37 148.16 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 47.6 t -68.94 92.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.142 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 17.5 tttm -69.82 -58.9 3.33 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.954 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' CD ' ' NZ ' ' A' ' 55' ' ' LYS 0.319 37.3 tt0 -149.52 144.07 26.03 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.52 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -130.73 155.15 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -128.54 37.58 4.1 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.106 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.43 161.98 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-N 113.09 -1.868 . . . . 0.0 114.562 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -122.83 173.96 7.44 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 124.819 2.247 . . . . 0.0 115.677 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 18' ' ' THR . 3.4 t -98.97 100.69 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 101.305 -3.591 . . . . 0.0 101.305 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' VAL . . . 120.86 30.58 1.33 Allowed Glycine 0 N--CA 1.511 3.678 1 CA-C-N 106.973 -4.649 . . . . 0.0 107.8 -179.336 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -107.28 155.34 20.06 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 114.133 -1.034 . . . . 0.0 109.995 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.672 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 31.4 mmtm -89.22 140.15 29.76 Favored 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.27 166.75 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.97 0.891 . . . . 0.0 111.035 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -165.98 153.5 10.27 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 t -47.9 127.04 11.46 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 117.304 -1.758 . . . . 0.0 111.858 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.66 -40.5 2.41 Favored Glycine 0 N--CA 1.513 3.824 0 CA-C-N 114.902 -1.044 . . . . 0.0 114.464 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 32.3 t -57.0 146.25 27.69 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.289 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.99 63.89 7.56 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.682 1.23 . . . . 0.0 114.28 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.58 HG22 ' SD ' ' A' ' 72' ' ' MET . 1.4 mt -17.0 -57.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.58 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -168.84 -176.81 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 111.767 -2.469 . . . . 0.0 114.92 -179.596 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.96 125.45 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 124.092 1.901 . . . . 0.0 112.767 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 28' ' ' VAL . 17.3 m-30 -112.9 156.23 23.33 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.885 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -130.46 139.61 50.55 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 103.571 -2.752 . . . . 0.0 103.571 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 76' ' ' VAL . 16.2 m . . . . . 0 C--N 1.294 -1.822 1 N-CA-C 123.075 4.472 . . . . 0.0 123.075 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.521 3.078 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.574 ' HG3' HG13 ' A' ' 76' ' ' VAL . 70.7 mmtt -133.31 148.64 51.91 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.07 155.42 18.4 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.58 -1.325 . . . . 0.0 114.246 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 74' ' ' PHE . 40.1 t -121.97 88.36 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 124.753 2.216 . . . . 0.0 113.852 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.8 p30 -95.05 170.36 9.47 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 111.291 -2.686 . . . . 0.0 105.802 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.539 HG21 HG11 ' A' ' 65' ' ' VAL . 96.0 t -104.6 136.02 19.23 Favored Pre-proline 0 N--CA 1.504 2.246 0 C-N-CA 118.135 -1.426 . . . . 0.0 113.39 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 53.1 Cg_exo . . . . . 0 N--CA 1.5 1.9 0 C-N-CA 122.842 2.361 . . . . 0.0 115.509 168.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.5 2.066 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 8.7 pt-20 -124.42 172.63 9.01 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.68 122.84 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.995 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 p -101.56 -42.56 6.19 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.48 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.87 109.32 11.17 Favored 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' HG22 ' A' ' 61' ' ' VAL . 13.4 p -92.09 72.9 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 125.361 2.505 . . . . 0.0 110.279 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.9 mtt -35.27 -56.87 0.61 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 111.694 -2.503 . . . . 0.0 112.951 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.563 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 10.3 p -105.67 164.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 CA-C-O 123.29 1.519 . . . . 0.0 114.145 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.632 ' HD2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -145.96 174.69 11.04 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 119.409 3.114 . . . . 0.0 119.409 -179.424 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.2 t -47.62 111.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.13 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.69 -27.87 6.99 Favored Glycine 1 N--CA 1.516 4.027 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.117 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -81.93 173.17 12.47 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 124.256 1.979 . . . . 0.0 115.947 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.06 136.36 50.21 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.944 -1.934 . . . . 0.0 112.586 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG11 HD21 ' A' ' 34' ' ' LEU . 9.4 t -126.41 160.65 33.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.993 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.03 156.05 28.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.516 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.72 168.86 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 125.071 1.482 . . . . 0.0 111.171 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 5.9 mp0 55.17 -7.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.156 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -101.89 110.0 21.88 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.51 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -40.16 133.57 1.73 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 9.4 mt -100.86 -61.76 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.47 HG13 ' HB ' ' A' ' 46' ' ' VAL . 36.6 pt -141.85 151.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.243 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.9 m -101.84 138.27 39.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.9 m -129.67 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -179.303 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.516 2.851 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.6 ttm -167.81 164.09 14.13 Favored 'General case' 0 N--CA 1.517 2.883 0 CA-C-O 122.45 1.119 . . . . 0.0 112.927 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.6 mp0 -103.71 141.68 35.65 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 124.368 2.032 . . . . 0.0 114.659 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 22.7 t -121.56 98.97 45.58 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -81.94 -178.72 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 CA-C-O 124.25 1.688 . . . . 0.0 113.618 171.225 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -68.24 102.21 0.37 Allowed Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.7 Cg_endo -41.11 -25.01 0.2 Allowed 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 121.945 1.763 . . . . 0.0 115.453 170.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.45 -167.09 0.75 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.37 163.9 12.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.96 -175.72 19.34 Favored Glycine 1 N--CA 1.522 4.428 0 CA-C-N 113.58 -1.645 . . . . 0.0 113.443 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 75' ' ' GLU . 35.7 m -100.24 166.23 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.307 . . . . 0.0 114.287 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 74' ' ' PHE . 20.0 t -89.43 106.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 113.983 -1.462 . . . . 0.0 112.047 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -64.18 1.09 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 13.8 tt0 -140.39 155.71 46.65 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 118.506 0.594 . . . . 0.0 111.825 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.565 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.0 pt? -161.61 153.69 19.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.545 -0.722 . . . . 0.0 110.114 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.507 ' HD2' ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -129.05 55.87 1.71 Allowed 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.51 151.46 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 112.277 -2.238 . . . . 0.0 111.622 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -130.57 170.99 13.53 Favored 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.451 HG22 ' HB ' ' A' ' 20' ' ' VAL . 3.2 t -87.77 111.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 1 N-CA-C 98.202 -4.74 . . . . 0.0 98.202 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.36 21.64 5.1 Favored Glycine 0 N--CA 1.514 3.886 0 CA-C-N 109.667 -3.424 . . . . 0.0 111.716 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.297 36.1 t0 -114.56 175.27 5.56 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.648 1.179 . . . . 0.0 111.537 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 25.8 mmtp -98.56 149.55 22.63 Favored 'General case' 0 N--CA 1.526 3.351 1 N-CA-C 122.395 4.22 . . . . 0.0 122.395 -179.049 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 7' ' ' VAL . 4.4 t -144.77 168.36 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 67' ' ' THR . 10.4 ptmm? 174.93 139.0 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.6 t -31.51 122.55 0.26 Allowed 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.72 -24.77 26.17 Favored Glycine 0 N--CA 1.509 3.561 0 CA-C-N 114.285 -1.325 . . . . 0.0 114.624 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.1 m -75.21 123.22 24.89 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 70' ' ' LEU . 7.2 mp -75.46 72.32 2.46 Favored 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 125.338 1.455 . . . . 0.0 114.694 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.423 HD11 ' SD ' ' A' ' 72' ' ' MET . 1.7 pp -56.03 -52.49 49.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.445 ' SD ' ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -127.95 174.95 8.75 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -123.79 129.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.677 0.751 . . . . 0.0 110.602 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.7 m-30 -114.77 158.79 21.39 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.465 1.602 . . . . 0.0 111.732 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 53' ' ' VAL 0.355 11.6 tt0 -136.28 124.25 22.8 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 179.52 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 3' ' ' LYS . 23.3 m . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 121.047 3.721 . . . . 0.0 121.047 -179.281 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 3' ' ' LYS . 20.5 t . . . . . 0 N--CA 1.511 2.575 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 1.1 mmpt? -131.8 164.05 26.89 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.2 mp0 -107.78 140.4 40.91 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.606 HG21 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -115.08 100.84 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 CA-C-O 122.907 1.337 . . . . 0.0 112.483 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 69' ' ' SER . 3.3 p30 -91.84 173.87 7.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.806 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.594 HG22 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -112.71 137.2 21.66 Favored Pre-proline 0 N--CA 1.499 2.006 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.687 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 CA--C 1.56 1.778 0 C-N-CA 122.161 1.907 . . . . 0.0 116.437 175.69 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.527 3.387 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.6 pt-20 -113.79 178.9 4.12 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.424 HG13 ' HB ' ' A' ' 35' ' ' ILE . 96.0 t -110.76 111.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.99 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.9 t -91.51 -42.97 9.96 Favored 'General case' 0 N--CA 1.526 3.349 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -130.67 100.39 5.29 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 123.597 1.665 . . . . 0.0 109.327 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 61' ' ' VAL . 7.8 p -75.79 64.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 119.188 -2.195 . . . . 0.0 115.826 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -29.93 -27.4 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.537 HG22 ' N ' ' A' ' 23' ' ' LYS . 13.0 p -112.02 170.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' N ' HG22 ' A' ' 22' ' ' VAL . 33.3 mmtp -139.02 164.46 29.69 Favored 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.459 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 59.0 t -72.38 115.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 O-C-N 121.597 -0.69 . . . . 0.0 111.331 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . 116.01 -29.13 7.28 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.546 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.51 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 2.0 m-20 -63.9 -176.32 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 25' ' ' GLY . 36.7 mmtm -109.93 123.14 49.1 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.826 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 48' ' ' ALA . 2.2 t -123.35 102.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -91.9 162.5 14.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.05 -1.656 . . . . 0.0 111.434 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -61.72 164.94 5.57 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.617 -1.233 . . . . 0.0 107.75 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 70.62 -22.04 0.18 Allowed 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 123.6 1.666 . . . . 0.0 111.158 -179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 30' ' ' ALA . 37.7 tt0 -80.34 110.77 16.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.765 -1.209 . . . . 0.0 109.069 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 27.7 t -47.91 139.88 7.32 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.332 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -103.61 -55.95 2.3 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.458 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -148.33 141.76 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.475 1.131 . . . . 0.0 111.947 179.935 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.6 m -86.37 122.75 30.78 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.97 152.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.507 2.405 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.949 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 53.2 m . . . . . 0 N--CA 1.514 2.767 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtp -122.02 176.05 6.01 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -125.8 157.98 36.14 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 6.2 t -129.41 110.71 17.82 Favored Pre-proline 0 N--CA 1.498 1.946 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.629 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -83.36 -179.36 4.24 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.44 1.426 . . . . 0.0 113.829 173.314 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -64.14 105.79 0.79 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 120.484 3.513 . . . . 0.0 120.484 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 2.8 Cg_endo -29.09 -39.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.474 0 C-N-CA 122.165 1.91 . . . . 0.0 115.098 171.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.42 177.82 10.83 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.381 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -89.18 101.03 13.7 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.7 -178.9 29.5 Favored Glycine 1 N--CA 1.528 4.787 0 O-C-N 121.71 -0.619 . . . . 0.0 114.606 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 1.4 m -100.58 171.55 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.315 -1.697 . . . . 0.0 107.878 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' SD ' ' A' ' 72' ' ' MET . 96.3 t -94.04 121.99 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.237 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -86.05 -58.68 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 1.7 tp10 -167.2 150.79 6.53 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.843 1.964 . . . . 0.0 112.652 178.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -130.86 -178.61 4.88 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.194 -1.567 . . . . 0.0 110.856 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 1.5 mptp? -150.57 32.34 0.64 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.912 -1.117 . . . . 0.0 108.673 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.22 156.29 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-N 114.267 -1.333 . . . . 0.0 114.031 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -127.37 176.64 7.28 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -92.83 105.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.97 29.05 2.48 Favored Glycine 0 N--CA 1.51 3.617 1 CA-C-N 108.392 -4.004 . . . . 0.0 107.992 -178.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -113.73 163.24 15.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 1.7 pptp? -115.43 143.26 45.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.42 171.61 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.401 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -165.53 151.29 9.36 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 117.93 -1.033 . . . . 0.0 108.68 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 3.8 t -42.06 116.39 0.81 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-O 121.975 0.893 . . . . 0.0 112.841 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.68 -30.0 9.68 Favored Glycine 0 N--CA 1.514 3.834 0 CA-C-N 114.925 -1.034 . . . . 0.0 114.021 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 1.8 t -52.13 162.03 0.54 Allowed 'General case' 0 N--CA 1.52 3.05 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -96.79 64.17 2.05 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.598 HG22 ' HG2' ' A' ' 72' ' ' MET . 0.8 OUTLIER -30.54 -49.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 179.64 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.598 ' HG2' HG22 ' A' ' 71' ' ' ILE . 1.1 ptp 178.38 -179.25 0.3 Allowed 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -107.81 133.63 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 123.617 1.675 . . . . 0.0 108.548 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.606 ' CD1' HG21 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -101.88 168.3 9.51 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.403 -179.604 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' VAL . 18.7 tt0 -146.69 99.45 3.2 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 123.782 1.753 . . . . 0.0 107.729 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.572 1.788 1 N-CA-C 123.287 4.551 . . . . 0.0 123.287 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 9.5 p . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 119.854 3.279 . . . . 0.0 119.854 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 45.5 mmtt -138.24 165.12 27.51 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 118.822 2.897 . . . . 0.0 118.822 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.433 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -99.85 142.39 31.39 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 111.255 -2.702 . . . . 0.0 113.532 -179.39 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.611 HG21 ' CD1' ' A' ' 74' ' ' PHE . 43.4 t -118.79 98.43 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.168 0 O-C-N 121.212 -0.93 . . . . 0.0 112.447 179.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' SER . 23.6 p30 -110.82 174.89 5.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.381 1.086 . . . . 0.0 111.375 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 71' ' ' ILE . 70.1 t -108.78 130.34 22.85 Favored Pre-proline 0 N--CA 1.5 2.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.644 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 76.5 Cg_exo . . . . . 0 N--CA 1.509 2.423 0 C-N-CA 123.654 2.903 . . . . 0.0 114.463 164.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.513 2.722 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 11.7 pt-20 -116.85 169.29 9.5 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 122.0 -0.438 . . . . 0.0 111.442 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.08 118.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 O-C-N 120.907 -1.12 . . . . 0.0 112.422 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 3.7 t -98.47 -34.8 10.48 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.204 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 43.5 mt-10 -134.58 105.48 6.54 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.581 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.2 p -89.44 89.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 126.084 2.849 . . . . 0.0 111.811 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -59.93 -54.34 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 111.311 -2.677 . . . . 0.0 114.771 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG11 HD22 ' A' ' 34' ' ' LEU . 34.5 m -66.58 149.78 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 N-CA-C 118.009 2.596 . . . . 0.0 118.009 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 22' ' ' VAL . 13.0 mmtp -131.65 171.86 12.96 Favored 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 121.366 0.603 . . . . 0.0 112.339 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -75.75 98.19 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.47 14.85 7.3 Favored Glycine 1 N--CA 1.52 4.263 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.703 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.11 136.69 36.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -76.48 111.54 12.05 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 125.042 2.353 . . . . 0.0 106.812 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 96.7 t -111.22 108.31 25.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 109.857 -3.338 . . . . 0.0 112.719 -179.141 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.49 158.56 28.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.978 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.23 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.953 1.408 . . . . 0.0 113.037 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 72.61 -41.22 0.5 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.755 0.788 . . . . 0.0 110.823 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 13.2 tt0 -57.8 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.853 -1.155 . . . . 0.0 112.078 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 49.0 m -40.6 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.477 HD22 HG11 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -18.06 -67.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -151.31 149.38 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.236 -2.711 . . . . 0.0 109.294 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 1.2 m -106.75 133.6 51.17 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.36 146.66 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 N-CA-C 118.578 2.806 . . . . 0.0 118.578 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.811 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.514 2.73 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.4 mmt -137.77 146.47 43.66 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 17.1 mp0 -118.77 159.62 23.37 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -129.39 124.89 22.3 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.792 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.06 172.43 2.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.958 1.772 . . . . 0.0 112.025 171.438 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -53.17 100.55 0.23 Allowed Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.1 Cg_endo -42.44 -31.39 1.83 Allowed 'Trans proline' 0 N--CA 1.51 2.442 0 C-N-CA 122.816 2.344 . . . . 0.0 113.603 -178.471 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -160.0 -174.71 4.7 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.752 -2.476 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -107.25 159.87 16.03 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 120.509 3.522 . . . . 0.0 120.509 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.11 -144.87 15.9 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.395 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.44 161.97 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 CA-C-N 117.937 0.868 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.46 HG22 ' CE1' ' A' ' 74' ' ' PHE . 31.3 t -85.96 116.6 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -90.58 -67.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 41.7 tt0 -143.43 152.1 41.15 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.335 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.7 pt? -145.94 146.18 30.95 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 30.6 mmtt -119.17 46.1 1.96 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.86 152.12 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -134.04 -178.73 5.16 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.971 2.32 . . . . 0.0 114.222 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -87.89 112.24 23.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.71 -19.28 5.59 Favored Glycine 0 N--CA 1.509 3.565 0 CA-C-N 109.893 -3.321 . . . . 0.0 110.779 -179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.12 168.91 12.97 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.573 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.66 145.21 33.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -179.69 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -126.85 176.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 112.876 -1.965 . . . . 0.0 111.249 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 67' ' ' THR . 37.8 tttt 166.19 144.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.48 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 4.5 t -39.47 119.49 0.95 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.48 -32.58 5.99 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.725 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.0 t -56.92 128.65 37.91 Favored 'General case' 0 N--CA 1.512 2.656 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.406 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.8 tt -87.59 64.21 7.96 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 124.842 2.258 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.444 ' CG1' HG23 ' A' ' 7' ' ' VAL . 5.1 mm -24.26 -56.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 111.717 -2.492 . . . . 0.0 117.375 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 4.0 ptp -161.19 -174.17 4.21 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.033 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.15 123.97 72.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 124.504 2.097 . . . . 0.0 112.207 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.611 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.0 m-30 -113.05 165.26 12.53 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.733 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 2' ' ' VAL . 2.0 tt0 -142.3 122.71 14.01 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 CA--C 1.568 1.662 0 CA-C-O 122.736 1.255 . . . . 0.0 113.631 179.793 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.781 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -142.98 154.38 43.96 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 124.233 1.968 . . . . 0.0 111.395 178.789 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.781 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 13.4 pm0 -112.96 149.94 32.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.82 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.536 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 87.8 t -120.14 113.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.598 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.734 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 15.9 p-10 -109.86 177.18 4.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.329 1.062 . . . . 0.0 109.533 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.64 HG22 HD11 ' A' ' 71' ' ' ILE . 44.5 t -97.35 130.59 29.13 Favored Pre-proline 0 C--N 1.291 -1.958 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.088 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.681 0 C-N-CA 122.331 2.021 . . . . 0.0 110.565 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.519 2.99 0 CA-C-O 120.326 0.108 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.9 pt-20 -110.24 174.15 6.0 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.591 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.04 123.39 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.845 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.81 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.529 HG23 ' HG3' ' A' ' 19' ' ' GLU . 11.5 t -101.31 -43.83 5.84 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.529 ' HG3' HG23 ' A' ' 18' ' ' THR . 28.9 mt-10 -128.25 99.06 5.29 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.757 0.789 . . . . 0.0 112.685 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.423 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 7.4 p -75.65 70.59 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.091 -2.255 . . . . 0.0 114.281 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.4 mmm -33.83 -45.9 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.89 167.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 36.6 mmtm -137.43 175.5 9.55 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -74.6 99.2 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.777 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.71 -23.08 5.4 Favored Glycine 1 N--CA 1.518 4.15 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.309 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.53 168.32 16.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 123.482 1.61 . . . . 0.0 114.326 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -98.9 132.94 43.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' CG1' HD21 ' A' ' 34' ' ' LEU . 88.7 t -128.12 122.62 58.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.209 -179.399 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -128.59 152.66 48.07 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 112.908 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.96 68.74 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.776 0 CA-C-O 124.135 1.921 . . . . 0.0 115.131 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.609 ' HG3' ' N ' ' A' ' 32' ' ' GLN . 15.6 pt-20 -177.05 -37.66 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 110.124 -3.216 . . . . 0.0 111.565 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.609 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -71.58 110.49 6.2 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.945 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 7.2 p -51.26 67.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 ' CG1' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -14.03 -64.73 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 120.518 3.525 . . . . 0.0 120.518 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 pt -150.52 148.86 14.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.186 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.4 m -95.27 133.8 38.76 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 178.781 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.7 m -118.13 157.1 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.041 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.511 2.607 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -131.69 162.69 29.84 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 123.638 0.586 . . . . 0.0 110.328 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -115.12 159.51 20.78 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.022 -1.674 . . . . 0.0 114.186 179.665 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.3 t -121.42 133.44 24.22 Favored Pre-proline 0 N--CA 1.503 2.208 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.84 171.79 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.683 1.589 . . . . 0.0 111.899 173.52 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -54.79 100.43 0.22 Allowed Pre-proline 0 C--N 1.286 -2.192 0 CA-C-N 112.316 -2.22 . . . . 0.0 116.332 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -39.89 -33.72 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 122.151 1.901 . . . . 0.0 113.582 179.405 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CZ ' ' HD2' ' A' ' 3' ' ' LYS . 3.3 p90 -156.1 176.98 11.95 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-N 112.692 -2.049 . . . . 0.0 108.466 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.1 159.57 15.26 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.63 -142.13 10.4 Favored Glycine 0 N--CA 1.51 3.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.94 169.62 21.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 124.762 1.225 . . . . 0.0 108.757 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG22 ' CE1' ' A' ' 74' ' ' PHE . 38.5 t -95.61 127.7 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.439 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 44.8 tttp -102.72 -56.72 2.18 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.178 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 6.1 tp10 -154.72 157.13 37.59 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -149.9 147.45 27.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 118.871 -2.393 . . . . 0.0 113.995 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 53.42 1.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.46 154.49 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.978 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 9.9 m-80 -131.83 -174.38 3.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 124.299 2.0 . . . . 0.0 115.227 179.141 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.01 88.94 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-O 126.262 2.934 . . . . 0.0 110.05 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.37 15.72 0.41 Allowed Glycine 0 N--CA 1.515 3.917 1 CA-C-N 105.702 -5.227 . . . . 0.0 111.192 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -95.01 152.69 18.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.465 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 2.2 pptp? -106.95 142.03 37.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HB ' HG21 ' A' ' 7' ' ' VAL . 1.5 m -126.32 175.87 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 112.0 -2.363 . . . . 0.0 111.257 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.668 ' C ' ' HD3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 177.51 157.45 0.37 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.594 179.796 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -29.1 103.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 178.681 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . 109.74 -47.01 1.09 Allowed Glycine 1 N--CA 1.518 4.102 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.89 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 t -26.84 117.72 0.08 Allowed 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 61.18 0.2 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 7' ' ' VAL . 2.6 mt -23.79 -68.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 124.748 2.214 . . . . 0.0 115.575 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.7 ptp -154.58 -175.41 5.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.523 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -113.62 122.83 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 124.359 2.028 . . . . 0.0 110.948 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 8.9 m-30 -107.97 174.65 5.79 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.571 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 21.0 tt0 -151.45 166.37 31.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.517 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -179.316 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.504 2.236 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.51 139.82 51.44 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.714 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -85.57 155.92 20.96 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 119.242 -2.161 . . . . 0.0 113.651 179.374 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' CE1' ' A' ' 74' ' ' PHE . 90.4 t -116.56 119.79 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.809 0 C-N-CA 124.602 1.161 . . . . 0.0 113.92 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -111.05 174.78 5.7 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.744 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.515 HG23 ' CG1' ' A' ' 71' ' ' ILE . 60.7 t -96.86 130.4 30.24 Favored Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' HG23 ' A' ' 67' ' ' THR . 53.6 Cg_endo . . . . . 0 N--CA 1.508 2.348 0 C-N-CA 124.468 3.445 . . . . 0.0 120.913 -173.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 37' ' ' VAL . 1.4 m . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 121.806 0.812 . . . . 0.0 108.948 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.583 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 6.9 pt-20 -113.36 169.25 9.09 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 t -93.97 130.0 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.128 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -179.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.484 ' C ' ' HG3' ' A' ' 19' ' ' GLU . 63.9 p -105.8 -47.15 3.95 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.801 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 18' ' ' THR . 2.8 mt-10 -130.49 106.04 8.26 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 123.126 1.441 . . . . 0.0 112.822 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.88 70.49 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-O 123.709 1.718 . . . . 0.0 111.162 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 14.2 mmt -25.37 -52.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 111.786 -2.461 . . . . 0.0 116.982 179.612 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 m -102.59 179.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.787 0 N-CA-C 118.514 2.783 . . . . 0.0 118.514 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.3 mmtm -140.18 168.69 19.22 Favored 'General case' 0 N--CA 1.522 3.131 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.12 89.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.525 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.063 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.87 4.6 5.58 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.748 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.6 141.24 31.68 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.411 1.101 . . . . 0.0 113.474 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -64.99 135.32 55.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.983 179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.523 HG12 ' CB ' ' A' ' 48' ' ' ALA . 19.0 t -131.96 115.82 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -179.335 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -118.26 152.46 35.69 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.181 -1.575 . . . . 0.0 113.97 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.94 72.91 0.42 Allowed 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.494 1.616 . . . . 0.0 114.545 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 175.98 -22.44 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 110.315 -3.13 . . . . 0.0 110.299 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -92.94 117.04 29.61 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -179.105 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 14.7 m -48.27 126.8 11.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.331 1.063 . . . . 0.0 112.981 179.277 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -89.02 -55.26 3.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 125.003 1.321 . . . . 0.0 113.711 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -148.4 152.18 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.566 179.724 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -99.48 136.41 39.45 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.268 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 21.4 m -123.68 146.71 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.501 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.418 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 37.9 t . . . . . 0 N--CA 1.51 2.53 0 CA-C-O 121.008 0.432 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.0 mtm -132.22 172.31 12.58 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.786 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -122.88 156.69 34.13 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 122.178 0.989 . . . . 0.0 113.397 179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.2 122.24 19.04 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.753 179.468 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -85.86 178.7 4.13 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.008 1.805 . . . . 0.0 113.02 169.144 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -67.27 106.75 1.31 Allowed Pre-proline 0 C--N 1.287 -2.121 1 N-CA-C 122.188 4.144 . . . . 0.0 122.188 -179.903 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 78.5 Cg_exo -29.7 -40.69 0.06 OUTLIER 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.665 2.243 . . . . 0.0 115.61 174.236 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -154.11 -176.42 5.85 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 112.8 -2.0 . . . . 0.0 111.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -99.22 116.66 31.92 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.7 -169.7 34.84 Favored Glycine 1 N--CA 1.526 4.636 0 CA-C-O 119.276 -0.735 . . . . 0.0 112.556 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -109.91 157.31 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.34 0 CA-C-N 119.804 1.802 . . . . 0.0 107.847 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 20.8 t -76.43 113.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 6.5 tmtt? -91.74 -41.81 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.457 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 51.2 tt0 -164.92 161.28 19.99 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.155 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -162.71 152.16 15.53 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.164 -1.585 . . . . 0.0 109.243 178.587 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 54.0 mttt -126.29 49.48 2.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.761 1.267 . . . . 0.0 109.164 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.03 137.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 111.828 -2.442 . . . . 0.0 112.707 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.82 177.75 4.59 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 124.619 2.152 . . . . 0.0 113.621 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -85.06 115.8 27.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 1 N-CA-C 99.967 -4.086 . . . . 0.0 99.967 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.55 -24.74 5.49 Favored Glycine 0 N--CA 1.514 3.882 0 CA-C-N 110.156 -3.202 . . . . 0.0 109.905 -179.139 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.06 174.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.583 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 25.2 mmtm -104.13 136.13 44.33 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.558 HG12 HD12 ' A' ' 71' ' ' ILE . 19.9 m -132.15 142.87 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 123.218 1.485 . . . . 0.0 110.107 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 67' ' ' THR . 11.9 ttmt -141.01 123.44 15.86 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.69 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 8' ' ' PRO . 1.4 m -22.72 103.64 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.32 -42.49 1.72 Allowed Glycine 0 N--CA 1.511 3.695 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.542 -179.644 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 13.8 t -38.45 140.22 0.34 Allowed 'General case' 0 N--CA 1.53 3.526 0 CA-C-O 118.028 -0.987 . . . . 0.0 113.611 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.7 tt -80.78 57.33 2.96 Favored 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 124.527 2.108 . . . . 0.0 115.871 -179.565 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 65' ' ' VAL . 14.4 mm -30.05 -67.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 120.498 3.518 . . . . 0.0 120.498 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.505 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptm -143.26 172.15 13.14 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 111.784 -2.462 . . . . 0.0 113.397 -179.349 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.38 122.74 69.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 120.731 -1.231 . . . . 0.0 109.681 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.545 ' CE1' HG21 ' A' ' 5' ' ' VAL . 16.2 m-30 -105.02 144.69 31.47 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tp10 -120.73 99.2 6.39 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 124.551 2.12 . . . . 0.0 111.293 179.578 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.295 -1.761 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.598 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.514 2.736 1 N-CA-C 124.099 4.852 . . . . 0.0 124.099 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 74' ' ' PHE . 3.2 mttp -164.16 171.89 14.42 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.222 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 11.3 pt-20 -116.65 161.21 19.54 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.358 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.454 HG21 ' CE1' ' A' ' 74' ' ' PHE . 43.8 t -128.48 96.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 124.943 2.306 . . . . 0.0 108.143 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.9 p-10 -86.72 168.79 13.23 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.484 HG21 ' CG1' ' A' ' 65' ' ' VAL . 33.1 t -98.69 143.71 26.83 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 116.598 -2.041 . . . . 0.0 112.879 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' A' ' 7' ' ' VAL . 23.1 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.181 1.921 . . . . 0.0 114.633 177.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.508 2.471 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.57 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 28.8 mt-10 -112.19 128.67 56.3 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.49 119.01 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.109 0 C-N-CA 115.71 -2.396 . . . . 0.0 109.835 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -94.11 -51.24 4.93 Favored 'General case' 0 N--CA 1.519 2.98 0 C-N-CA 123.755 0.822 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.13 119.05 20.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.61 1.195 . . . . 0.0 112.726 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -92.33 63.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 123.594 1.664 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 67.3 mmm -24.33 -46.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.75 160.34 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -153.96 0.57 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 120.606 3.558 . . . . 0.0 120.606 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 55' ' ' LYS . 65.4 t -73.92 97.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.898 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.78 6.18 26.8 Favored Glycine 0 N--CA 1.516 3.977 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.722 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -92.85 152.77 19.23 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -82.09 124.84 30.2 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.55 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.451 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 t -123.47 148.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.054 -179.685 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -147.39 151.12 35.96 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.384 -0.822 . . . . 0.0 109.018 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 48' ' ' ALA . . . -48.72 158.96 0.27 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 124.172 0.92 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 74.12 -41.54 0.48 Allowed 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 123.901 1.81 . . . . 0.0 112.007 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 119.565 -1.959 . . . . 0.0 114.656 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -34.0 82.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 179.154 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -50.79 -51.48 50.19 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.2 pt -142.1 144.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.001 179.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 m -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 24.7 m -130.82 162.4 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 . . . . . 0 N--CA 1.511 2.601 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.745 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.507 2.408 0 CA-C-O 122.044 0.926 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 30.7 mmt -124.1 152.58 42.57 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.601 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -124.41 152.94 42.63 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 t -121.76 112.75 32.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.911 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.97 171.12 14.54 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 CA-C-O 124.282 1.701 . . . . 0.0 108.933 172.439 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -64.27 106.83 1.06 Allowed Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.089 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 3.8 Cg_endo -34.45 -37.04 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 121.808 1.672 . . . . 0.0 114.321 175.87 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -156.16 -175.74 5.59 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.61 164.83 12.43 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 126.49 -152.69 18.45 Favored Glycine 1 N--CA 1.524 4.567 0 O-C-N 121.415 -0.803 . . . . 0.0 114.78 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.38 165.46 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 121.429 0.633 . . . . 0.0 112.143 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 ' CE1' ' A' ' 74' ' ' PHE . 15.3 t -96.09 145.33 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.103 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' HG13 ' A' ' 24' ' ' VAL . 18.8 tptt -107.65 -60.59 1.68 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.631 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.9 tt0 -161.17 169.79 21.6 Favored 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.689 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt? -164.61 155.97 15.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.655 -1.278 . . . . 0.0 109.645 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -131.11 51.55 2.13 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.387 1.089 . . . . 0.0 108.368 179.714 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 71' ' ' ILE . 19.4 m -126.28 170.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 CA-C-N 114.121 -1.4 . . . . 0.0 114.719 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -138.65 165.95 25.62 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 120.692 3.59 . . . . 0.0 120.692 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.03 101.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 100.849 -3.76 . . . . 0.0 100.849 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.35 29.17 2.18 Favored Glycine 0 N--CA 1.508 3.481 0 CA-C-N 109.572 -3.467 . . . . 0.0 108.01 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.285 0.0 OUTLIER -112.12 178.79 4.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 179.44 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HE2' ' CD ' ' A' ' 16' ' ' GLU . 29.6 mmtp -109.77 130.35 55.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' CG1' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -113.01 147.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 113.492 -1.685 . . . . 0.0 112.918 -179.838 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -146.76 140.97 26.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 15.1 t -50.97 124.44 11.32 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.699 178.786 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.8 -47.11 1.05 Allowed Glycine 0 N--CA 1.508 3.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.659 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.9 t -36.32 118.78 0.56 Allowed 'General case' 0 N--CA 1.523 3.222 0 CA-C-O 117.316 -1.326 . . . . 0.0 113.606 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.92 62.15 1.09 Allowed 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 123.198 1.475 . . . . 0.0 110.527 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.433 ' HA ' HG11 ' A' ' 59' ' ' VAL . 21.2 mm -45.11 -58.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' VAL . 8.0 ptm -142.06 160.7 39.69 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -107.13 131.79 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 123.532 1.634 . . . . 0.0 112.54 179.549 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 3' ' ' LYS . 3.6 m-30 -110.35 165.27 11.91 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.956 -2.384 . . . . 0.0 116.919 -179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 21.6 tt0 -151.36 101.89 2.87 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.605 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 32.1 m . . . . . 0 CA--C 1.566 1.588 0 C-N-CA 127.297 2.239 . . . . 0.0 116.245 179.467 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG21 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 65' ' ' VAL . 33.3 m . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.649 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.639 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.639 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 26' ' ' ASP . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 3' ' ' LYS . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.649 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 15' ' ' VAL . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CE1' HG21 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG21 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 65' ' ' VAL . 33.3 m . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.649 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.639 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.639 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 26' ' ' ASP . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 3' ' ' LYS . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.649 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 15' ' ' VAL . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CE1' HG21 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.517 2.913 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 m -56.17 158.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 123.968 1.842 . . . . 0.0 115.926 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.643 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 6.1 mmmt -139.83 149.93 44.07 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.863 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -96.27 154.97 16.96 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 74' ' ' PHE . 43.3 t -116.52 117.27 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.586 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.2 p-10 -108.5 169.4 8.67 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.154 1.454 . . . . 0.0 109.767 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.591 HG12 HD12 ' A' ' 10' ' ' ILE . 1.4 t -94.94 115.0 64.94 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 112.546 -2.115 . . . . 0.0 106.468 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.483 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 52.8 Cg_endo -66.58 -90.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.513 2.142 . . . . 0.0 113.471 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 21.2 p-10 -123.82 116.54 23.13 Favored 'General case' 0 CA--C 1.578 2.027 0 CA-C-O 124.341 2.02 . . . . 0.0 113.875 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.591 HD12 HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -123.03 43.37 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.85 0 CA-C-O 124.416 2.055 . . . . 0.0 111.047 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.82 -64.25 0.03 OUTLIER Glycine 1 N--CA 1.518 4.129 0 CA-C-N 112.585 -2.098 . . . . 0.0 117.427 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.81 -163.07 9.64 Favored Glycine 1 N--CA 1.518 4.121 0 N-CA-C 118.016 1.966 . . . . 0.0 118.016 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -9.95 -106.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 120.572 3.545 . . . . 0.0 120.572 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.9 140.42 52.65 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-N 112.496 -2.138 . . . . 0.0 113.946 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 65' ' ' VAL . 24.7 m -139.13 162.34 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 122.693 1.235 . . . . 0.0 110.586 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 2.5 pt-20 -120.58 170.32 9.52 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.43 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 t -97.62 120.75 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' HB ' ' A' ' 36' ' ' THR . 12.2 t -96.47 -46.17 6.47 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.68 98.51 4.51 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 122.437 1.113 . . . . 0.0 113.362 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.8 p -81.62 68.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 124.599 2.142 . . . . 0.0 108.498 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -32.49 -56.15 0.34 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.729 2.862 . . . . 0.0 118.729 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.2 m -87.71 164.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.617 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 16.3 mmtp -131.79 -166.38 1.71 Allowed 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 124.25 1.976 . . . . 0.0 115.91 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.7 t -74.42 86.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-N 113.294 -1.775 . . . . 0.0 113.654 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.62 -11.49 7.07 Favored Glycine 1 N--CA 1.517 4.065 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.097 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -54.97 163.94 0.92 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD2' HG12 ' A' ' 53' ' ' VAL . 8.4 mmmm -100.2 102.29 13.54 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 112.263 -2.244 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.79 148.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 CA-C-O 124.217 1.96 . . . . 0.0 114.804 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -141.04 154.67 46.09 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.548 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -55.03 163.85 0.96 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 60.49 -16.54 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 30' ' ' ALA . 3.4 tm0? -88.81 106.97 18.72 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 4.0 t -36.57 138.44 0.23 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.3 mt -102.14 -59.43 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.8 pt -140.26 130.89 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.198 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 45' ' ' GLU . 6.7 m -83.55 123.06 29.38 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.8 m -115.66 141.59 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.64 -171.6 2.31 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.33 -39.1 0.59 Allowed Glycine 1 N--CA 1.524 4.502 0 N-CA-C 118.104 2.002 . . . . 0.0 118.104 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 10.6 p-10 -111.02 -106.25 0.37 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 124.296 1.998 . . . . 0.0 115.598 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.579 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 21.6 mmmt -117.78 -11.61 10.32 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 127.708 2.403 . . . . 0.0 108.401 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.09 168.08 10.0 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -116.63 124.71 50.43 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.565 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 32.6 mtt -121.97 164.86 16.89 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.64 -1.288 . . . . 0.0 112.117 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' HG2' HG23 ' A' ' 36' ' ' THR . 36.7 mt-10 -129.81 153.49 48.19 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.44 1.114 . . . . 0.0 112.361 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.8 t -124.74 112.97 27.16 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.698 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.56 177.52 5.6 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.741 1.627 . . . . 0.0 113.214 178.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -69.27 114.75 25.98 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 29.2 Cg_endo -46.79 -27.71 5.94 Favored 'Trans proline' 0 N--CA 1.512 2.609 0 C-N-CA 122.371 2.048 . . . . 0.0 112.609 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.643 ' CZ ' ' HE3' ' A' ' 3' ' ' LYS . 47.0 p90 -167.13 -175.28 2.92 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.26 164.12 12.61 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.85 -144.65 15.53 Favored Glycine 1 N--CA 1.52 4.293 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.545 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG12 ' HD2' ' A' ' 27' ' ' LYS . 3.4 m -121.87 166.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.062 0.934 . . . . 0.0 112.318 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' CE1' ' A' ' 74' ' ' PHE . 13.8 t -98.33 142.08 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.487 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 69.2 tttt -115.93 -63.88 1.39 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.645 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -135.82 158.5 44.24 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -155.97 115.8 3.63 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.077 -1.639 . . . . 0.0 113.203 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -90.65 52.54 2.21 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.237 -1.539 . . . . 0.0 109.466 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.18 149.09 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -122.67 172.02 8.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 124.355 2.026 . . . . 0.0 116.123 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -95.06 111.41 25.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 100.992 -3.707 . . . . 0.0 100.992 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.03 8.71 11.38 Favored Glycine 1 N--CA 1.518 4.15 1 CA-C-N 107.741 -4.3 . . . . 0.0 108.855 -179.218 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' A' ' 64' ' ' LYS . 43.9 t0 -94.82 177.49 5.89 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.611 -1.295 . . . . 0.0 110.264 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' CE ' ' HB3' ' A' ' 16' ' ' GLU . 2.6 mmtp -108.73 144.46 36.5 Favored 'General case' 0 N--CA 1.511 2.595 1 N-CA-C 123.369 4.581 . . . . 0.0 123.369 -179.174 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 15' ' ' VAL . 2.8 m -142.26 150.22 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.757 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -161.74 162.52 29.71 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 16.6 p -41.49 113.75 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.99 -35.88 4.78 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 111.641 -2.527 . . . . 0.0 115.314 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.6 t -38.31 132.92 1.02 Allowed 'General case' 0 N--CA 1.53 3.567 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.59 56.96 0.18 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.509 ' CG1' HG22 ' A' ' 7' ' ' VAL . 3.1 mt -23.12 -63.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CG2' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -159.23 171.94 18.95 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 112.529 -2.123 . . . . 0.0 114.123 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.77 120.51 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 123.635 1.683 . . . . 0.0 110.842 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' HG21 ' A' ' 5' ' ' VAL . 6.8 m-30 -99.05 176.01 5.71 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 112.083 -2.326 . . . . 0.0 109.136 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS 0.264 26.5 tt0 -156.39 115.87 3.52 Favored 'General case' 0 C--N 1.285 -2.23 1 N-CA-C 98.965 -4.457 . . . . 0.0 98.965 178.712 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 21.8 m -60.3 73.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 5.7 mt-10 83.22 -155.3 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 125.686 1.866 . . . . 0.0 109.79 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.09 58.34 0.06 OUTLIER Glycine 0 N--CA 1.512 3.734 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 4.31 50.91 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.072 1 N-CA-C 122.997 4.443 . . . . 0.0 122.997 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 120.014 3.338 . . . . 0.0 120.014 179.338 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mmm . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 115.588 -2.148 . . . . 0.0 107.147 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m -48.91 161.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.692 0 CA-C-N 120.06 1.3 . . . . 0.0 108.177 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.498 ' HE3' ' OE2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -112.19 127.12 55.86 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -66.84 142.86 57.19 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.717 1.246 . . . . 0.0 110.732 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 74' ' ' PHE . 26.2 t -116.49 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.9 p-10 -101.61 168.78 9.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.748 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.87 140.06 21.7 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.721 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -74.07 -171.31 0.86 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.327 2.684 . . . . 0.0 114.803 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.73 101.81 3.79 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 125.798 2.713 . . . . 0.0 113.355 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.568 HG21 ' CG2' ' A' ' 46' ' ' VAL . 2.1 pt -119.91 36.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.97 -145.55 17.03 Favored Glycine 1 N--CA 1.524 4.526 0 CA-C-N 114.255 -1.339 . . . . 0.0 116.217 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.19 -41.7 0.74 Allowed Glycine 1 N--CA 1.519 4.215 0 CA-C-N 114.574 -0.813 . . . . 0.0 111.253 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.49 ' OD2' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -72.25 173.61 8.39 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' OE2' ' NZ ' ' A' ' 64' ' ' LYS . 5.6 pt-20 -104.11 155.46 18.67 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 101.616 -3.476 . . . . 0.0 101.616 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 29.5 m -124.0 169.88 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 pm0 -113.13 164.96 12.85 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.488 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 t -101.48 117.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.221 -0.924 . . . . 0.0 110.118 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.61 -50.57 4.44 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.285 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.3 mt-10 -128.69 95.28 4.07 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 123.555 1.645 . . . . 0.0 111.305 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.5 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.8 p -70.23 66.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.5 mtt -30.24 -57.35 0.19 Allowed 'General case' 0 N--CA 1.512 2.631 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 18.8 m -87.16 171.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -134.33 169.37 17.31 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.63 110.26 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.704 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 10.91 21.62 Favored Glycine 0 N--CA 1.508 3.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.694 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.38 159.34 16.46 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 123.731 1.729 . . . . 0.0 110.045 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -78.58 122.74 26.29 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 125.151 2.405 . . . . 0.0 113.49 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 74' ' ' PHE . 92.7 t -125.25 97.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 110.455 -3.066 . . . . 0.0 114.56 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -107.44 160.01 15.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 173.83 0.24 Allowed 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.454 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 62.79 -18.67 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -94.97 139.51 31.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.132 -1.605 . . . . 0.0 107.789 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t -63.48 128.48 36.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -92.77 -64.52 1.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.8 pt -138.61 140.04 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 113.424 -1.717 . . . . 0.0 112.306 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 3.4 m -93.35 130.13 39.23 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.985 -3.339 . . . . 0.0 101.985 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.49 164.8 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.197 0.936 . . . . 0.0 112.473 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 11.6 tt0 -131.49 -142.96 0.23 Allowed 'General case' 0 N--CA 1.505 2.293 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.253 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 41' ' ' LYS . . . 158.2 67.12 0.01 OUTLIER Glycine 0 N--CA 1.512 3.724 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 t0 28.61 58.06 0.12 Allowed 'General case' 0 CA--C 1.586 2.336 0 O-C-N 128.258 2.975 . . . . 0.0 117.45 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 159.02 -6.39 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -179.27 140.73 0.16 Allowed 'General case' 0 N--CA 1.515 2.807 0 CA-C-N 120.431 1.469 . . . . 0.0 113.95 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.7 p -86.2 138.3 31.98 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.992 0.901 . . . . 0.0 112.953 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.39 124.72 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.842 -1.526 . . . . 0.0 107.413 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 22.7 mp0 -95.65 142.55 27.83 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 123.825 1.774 . . . . 0.0 113.557 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.568 ' CG2' HG21 ' A' ' 10' ' ' ILE . 7.1 t -113.48 118.47 43.45 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.582 -1.644 . . . . 0.0 115.092 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -82.14 178.11 6.65 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.875 1.717 . . . . 0.0 112.356 174.167 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -67.51 103.1 0.44 Allowed Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 118.793 2.886 . . . . 0.0 118.793 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.8 Cg_endo -42.93 -29.59 1.56 Allowed 'Trans proline' 0 N--CA 1.508 2.349 0 C-N-CA 122.416 2.077 . . . . 0.0 114.105 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -159.2 -179.44 7.99 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.24 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.53 17.08 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 120.097 3.369 . . . . 0.0 120.097 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.37 -147.82 18.56 Favored Glycine 1 N--CA 1.519 4.221 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.98 160.89 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.93 83.74 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -67.47 -42.48 82.94 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -163.84 130.19 3.16 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 1.9 pt? -126.95 151.27 48.73 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 119.78 -1.825 . . . . 0.0 108.362 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -121.05 45.08 2.35 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.899 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 p -141.11 154.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.953 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -124.26 171.78 9.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -87.0 114.76 26.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 100.9 -3.741 . . . . 0.0 100.9 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.35 -0.77 16.41 Favored Glycine 0 N--CA 1.503 3.147 0 CA-C-N 110.145 -3.207 . . . . 0.0 109.216 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.8 170.48 9.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.334 0.667 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' NZ ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -118.68 145.73 45.26 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 121.13 3.752 . . . . 0.0 121.13 -179.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.471 HG12 ' CD1' ' A' ' 71' ' ' ILE . 17.1 m -130.62 164.79 32.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.218 -1.81 . . . . 0.0 113.557 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 140.82 18.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 t -43.72 120.42 2.0 Allowed 'General case' 0 N--CA 1.514 2.773 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.242 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.13 -23.72 10.46 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 117.285 1.674 . . . . 0.0 117.285 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.4 t -79.25 143.26 35.46 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 118.664 -1.214 . . . . 0.0 112.602 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 70' ' ' LEU . 9.3 mp -87.99 62.49 6.87 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 124.369 2.033 . . . . 0.0 113.338 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CD1' HG12 ' A' ' 65' ' ' VAL . 12.9 mm -44.65 -45.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -133.85 -177.47 4.58 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.743 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -138.63 117.29 13.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 5' ' ' VAL . 22.6 m-30 -109.75 159.51 17.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.273 3.1 tt0 -126.02 150.9 47.76 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.23 71.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -58.19 82.25 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.7 -59.81 0.08 OUTLIER Glycine 0 N--CA 1.512 3.751 0 N-CA-C 106.053 -2.819 . . . . 0.0 106.053 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 114.16 153.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 1 CA-C-N 108.185 -4.007 . . . . 0.0 106.83 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.519 0 CA-C-O 116.52 -1.705 . . . . 0.0 108.858 -179.803 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.506 2.371 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 m 10.67 103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.682 0 N-CA-C 121.218 3.784 . . . . 0.0 121.218 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.606 ' HZ2' ' CD ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -99.13 158.77 15.44 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 113.011 -1.904 . . . . 0.0 114.131 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.606 ' CD ' ' HZ2' ' A' ' 3' ' ' LYS . 4.5 mp0 -100.27 149.79 23.23 Favored 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 74' ' ' PHE . 85.2 t -130.89 91.54 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.092 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 15.3 p-10 -104.93 174.28 5.94 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.576 HG13 HD12 ' A' ' 10' ' ' ILE . 56.4 t -90.81 126.23 56.45 Favored Pre-proline 0 N--CA 1.504 2.255 0 C-N-CA 117.128 -1.829 . . . . 0.0 106.527 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 20.3 Cg_endo -86.61 -63.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.5 0 N-CA-C 120.606 3.272 . . . . 0.0 120.606 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -96.59 -42.88 7.83 Favored 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 126.207 1.803 . . . . 0.0 112.805 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.576 HD12 HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -53.49 64.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 C-N-CA 129.718 3.207 . . . . 0.0 108.182 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . -108.62 -168.05 20.97 Favored Glycine 0 N--CA 1.504 3.184 0 CA-C-N 113.31 -1.768 . . . . 0.0 114.806 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.62 -157.52 15.2 Favored Glycine 0 N--CA 1.514 3.846 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.882 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.93 58.42 2.38 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 123.535 1.635 . . . . 0.0 112.518 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 41.4 149.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 N-CA-C 119.11 3.004 . . . . 0.0 119.11 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.87 165.46 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 O-C-N 119.773 -1.83 . . . . 0.0 115.379 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.1 pt-20 -120.36 171.08 8.78 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -101.52 120.93 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.181 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 p -97.8 -52.84 3.6 Favored 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.837 -1.529 . . . . 0.0 111.279 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -123.27 104.98 9.47 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 122.978 1.37 . . . . 0.0 113.882 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.63 93.29 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.175 -1.578 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -38.23 90.12 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 26' ' ' ASP . 3.4 t -126.49 160.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -134.51 -175.63 3.94 Favored 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.37 91.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 113.83 -1.532 . . . . 0.0 112.114 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.36 -4.23 13.61 Favored Glycine 1 N--CA 1.52 4.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.326 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.548 ' HB2' HG12 ' A' ' 22' ' ' VAL . 23.8 m-20 -93.07 143.32 26.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.242 1.02 . . . . 0.0 111.697 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 80' ' ' ALA . 45.8 pttt -76.4 122.9 25.15 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 124.71 2.195 . . . . 0.0 115.935 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 59.1 t -110.81 125.26 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.593 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -132.23 150.7 52.1 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 111.925 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -44.05 157.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.49 -20.05 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.529 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 30.0 tt0 -74.42 148.11 41.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -84.89 124.14 31.28 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.483 1.135 . . . . 0.0 108.592 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.9 mt -85.35 -57.57 3.02 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 122.652 1.215 . . . . 0.0 110.191 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -143.98 151.61 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -102.4 138.94 38.67 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.3 m -129.96 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 3.4 tt0 -134.72 -161.91 1.2 Allowed 'General case' 0 N--CA 1.512 2.669 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' A' ' 38' ' ' GLU . . . 172.95 -67.11 0.11 Allowed Glycine 1 N--CA 1.524 4.542 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -123.88 171.6 9.55 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -24.31 -6.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.442 1 N-CA-C 124.576 5.028 . . . . 0.0 124.576 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.18 116.44 17.68 Favored 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 120.171 1.35 . . . . 0.0 111.071 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.2 p -74.99 163.37 27.69 Favored 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.17 148.26 33.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.039 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 14.0 mp0 -114.64 151.57 33.33 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 123.511 1.624 . . . . 0.0 114.457 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG22 HG21 ' A' ' 10' ' ' ILE . 31.0 t -112.7 105.88 55.72 Favored Pre-proline 0 N--CA 1.506 2.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -86.33 179.81 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.87 1.529 . . . . 0.0 112.276 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -71.31 107.36 2.62 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 42.2 Cg_endo -49.52 -26.4 12.36 Favored 'Trans proline' 0 N--CA 1.514 2.697 0 C-N-CA 122.22 1.947 . . . . 0.0 113.757 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -164.97 -175.7 3.85 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 163.97 12.4 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 129.2 -144.83 15.78 Favored Glycine 1 N--CA 1.528 4.778 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.879 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.03 169.76 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 CA-C-N 118.879 1.339 . . . . 0.0 111.389 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 27.0 t -88.2 133.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.4 -53.8 3.63 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.032 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.29 159.42 19.9 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 124.672 1.233 . . . . 0.0 110.726 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -155.31 130.3 9.41 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -100.76 29.97 4.25 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.935 -1.103 . . . . 0.0 109.768 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -119.4 157.33 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 112.71 -2.041 . . . . 0.0 114.005 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.94 -178.42 4.88 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.5 t -90.19 106.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 1 N-CA-C 99.059 -4.423 . . . . 0.0 99.059 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.22 28.59 2.15 Favored Glycine 0 N--CA 1.515 3.919 0 CA-C-N 108.991 -3.731 . . . . 0.0 110.591 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 67.3 t0 -119.71 164.9 15.23 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -106.08 141.31 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 119.857 3.28 . . . . 0.0 119.857 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -139.19 -179.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.92 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 65' ' ' VAL . 7.2 pttt 149.94 154.59 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.923 0 C-N-CA 125.715 1.606 . . . . 0.0 111.656 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.1 p -25.09 103.59 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 118.515 2.784 . . . . 0.0 118.515 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.14 -47.8 1.0 Allowed Glycine 0 N--CA 1.507 3.415 0 CA-C-N 111.711 -2.495 . . . . 0.0 112.491 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.1 t -50.12 123.9 9.19 Favored 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.953 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 25.7 mt -72.56 67.39 0.76 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 7' ' ' VAL . 2.0 mt -22.75 -58.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 8.8 ptp -169.66 -173.67 1.69 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.414 -2.176 . . . . 0.0 115.488 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.52 133.51 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.501 1.143 . . . . 0.0 110.731 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 5' ' ' VAL . 12.1 m-30 -112.64 176.2 5.12 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.271 7.3 tp10 -144.37 99.54 3.39 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 29.8 m -54.39 33.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.693 1 N-CA-C 126.853 5.872 . . . . 0.0 126.853 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -134.88 -176.01 4.09 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 118.068 0.394 . . . . 0.0 111.956 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.549 ' H ' ' CD ' ' A' ' 77' ' ' GLU . . . 134.69 -32.32 2.63 Favored Glycine 1 N--CA 1.52 4.251 0 O-C-N 120.145 -1.597 . . . . 0.0 110.191 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 78' ' ' GLY . . . 97.43 -90.41 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.152 0 CA-C-N 109.667 -3.267 . . . . 0.0 118.08 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.564 1.501 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 9.8 ttm . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.503 -0.761 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 t 85.48 119.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 126.713 2.508 . . . . 0.0 114.091 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -118.74 122.62 42.89 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.778 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -68.4 155.65 39.4 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.977 0.894 . . . . 0.0 110.267 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 74' ' ' PHE . 36.9 t -122.87 100.18 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.45 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 10.9 p-10 -98.24 96.56 8.16 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.421 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' THR . 89.6 t -20.75 122.71 0.1 Allowed Pre-proline 0 N--CA 1.511 2.58 0 CA-C-N 113.093 -1.867 . . . . 0.0 114.858 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.36 -172.1 0.22 Allowed 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 122.262 1.975 . . . . 0.0 116.346 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -65.66 45.08 0.02 OUTLIER 'General case' 0 CA--C 1.585 2.294 0 C-N-CA 127.017 2.127 . . . . 0.0 115.837 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.501 HG21 HG22 ' A' ' 46' ' ' VAL . 30.8 pt -80.25 48.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 O-C-N 120.049 -1.657 . . . . 0.0 114.161 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.57 -162.84 12.83 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.739 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.54 -45.29 0.67 Allowed Glycine 1 N--CA 1.521 4.341 0 CA-C-O 122.042 0.801 . . . . 0.0 112.365 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.03 -176.96 4.78 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 112.686 -1.757 . . . . 0.0 110.545 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -96.2 139.78 31.86 Favored 'General case' 0 N--CA 1.509 2.511 0 CA-C-O 122.436 1.112 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.16 159.7 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.672 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.9 pt-20 -107.32 166.52 10.58 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 t -94.86 116.29 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.226 1.012 . . . . 0.0 112.456 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -94.65 -32.23 13.48 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 113.78 -1.555 . . . . 0.0 111.726 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 0.4 OUTLIER -138.54 107.64 6.05 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.828 0.705 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.3 p -86.74 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 118.43 -2.669 . . . . 0.0 117.088 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.3 mmt -20.3 -51.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.55 HG21 HE22 ' A' ' 32' ' ' GLN . 2.9 t -111.97 151.54 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 23' ' ' LYS . 23.4 mtmt -134.07 -177.62 4.66 Favored 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.24 94.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.246 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.9 -7.1 17.36 Favored Glycine 1 N--CA 1.516 4.021 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -92.48 142.54 27.3 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.251 1.024 . . . . 0.0 110.477 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -69.82 127.25 32.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.653 2.644 . . . . 0.0 117.193 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 1.5 t -112.66 98.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 109.86 -3.336 . . . . 0.0 113.906 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.473 ' H ' ' HG2' ' A' ' 32' ' ' GLN . . . -112.85 146.96 37.97 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.75 -1.219 . . . . 0.0 112.42 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.02 124.16 20.04 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 118.89 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 128.358 3.536 . . . . 0.0 110.62 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.55 HE22 HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.09 147.38 22.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.417 -1.427 . . . . 0.0 108.997 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 2.2 t -80.48 80.94 6.85 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.0 mt -29.99 -57.25 0.18 Allowed 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.8 pt -149.41 156.76 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 112.591 -2.095 . . . . 0.0 110.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 87.2 m -106.15 131.75 53.03 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.96 154.88 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.537 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 27.7 tt0 -130.18 169.58 15.18 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 123.721 1.725 . . . . 0.0 113.372 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.537 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . -171.79 174.78 45.26 Favored Glycine 0 N--CA 1.512 3.744 0 N-CA-C 105.011 -3.236 . . . . 0.0 105.011 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -3.94 59.78 0.0 OUTLIER 'General case' 0 CA--C 1.588 2.426 0 N-CA-C 121.176 3.769 . . . . 0.0 121.176 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' GLY . 33.3 mmtp 59.61 27.25 16.42 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.624 1.202 . . . . 0.0 113.145 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.45 76.78 1.65 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -66.34 107.47 2.02 Favored 'General case' 0 N--CA 1.513 2.682 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.961 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.3 mtm -106.34 165.81 10.98 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -102.12 145.28 29.58 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.54 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG22 HG21 ' A' ' 10' ' ' ILE . 90.5 t -117.81 97.2 50.55 Favored Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.861 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 7.1 Cg_endo -73.95 175.02 11.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-O 125.154 2.064 . . . . 0.0 111.584 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.633 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -77.04 109.06 7.9 Favored Pre-proline 0 C--N 1.284 -2.276 0 CA-C-N 111.527 -2.578 . . . . 0.0 117.262 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 27.6 Cg_endo -47.08 -32.03 12.67 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.794 2.329 . . . . 0.0 111.707 -170.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -155.73 -178.35 7.23 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 111.932 -2.395 . . . . 0.0 107.318 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -97.97 159.68 14.78 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.51 -147.68 19.39 Favored Glycine 1 N--CA 1.531 4.971 0 C-N-CA 123.828 0.728 . . . . 0.0 112.663 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 162.16 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 CA-C-N 119.029 1.415 . . . . 0.0 109.521 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 24.9 t -82.25 102.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.844 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HZ1' ' C ' ' A' ' 80' ' ' ALA . 11.8 tptm -76.79 -47.8 20.51 Favored 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.482 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 5.4 tt0 -161.33 152.58 18.71 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.7 pt? -149.69 150.67 32.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.592 -1.942 . . . . 0.0 108.489 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 6.0 mttp -115.34 47.28 1.33 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 121.785 0.802 . . . . 0.0 111.246 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -139.49 140.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 113.688 -1.597 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -125.45 -170.44 2.18 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.132 1.444 . . . . 0.0 110.49 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.43 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.78 9.05 4.98 Favored Glycine 1 N--CA 1.517 4.097 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.577 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -101.57 157.3 16.92 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -111.45 146.49 37.12 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HB ' HG21 ' A' ' 7' ' ' VAL . 6.3 m -136.49 168.15 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 113.01 -1.905 . . . . 0.0 113.908 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.31 147.34 22.16 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 7.2 t -47.37 122.6 4.79 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.936 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.06 16.94 24.16 Favored Glycine 0 N--CA 1.514 3.835 0 O-C-N 121.353 -0.842 . . . . 0.0 114.96 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -107.02 97.03 6.86 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.796 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.22 87.64 7.19 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 123.592 1.663 . . . . 0.0 112.575 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' C ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -112.4 -26.54 3.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.952 -1.931 . . . . 0.0 116.046 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 5' ' ' VAL . 11.3 ttp -100.56 153.99 18.93 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.605 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.2 126.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 124.957 2.313 . . . . 0.0 115.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD1' HG21 ' A' ' 5' ' ' VAL . 17.8 m-30 -114.5 158.52 21.5 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.475 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' OE2' ' N ' ' A' ' 1' ' ' MET . 3.4 tp10 -140.4 135.75 32.4 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -91.15 56.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 122.074 0.94 . . . . 0.0 113.199 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 66.26 -173.27 0.19 Allowed 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 113.486 -1.688 . . . . 0.0 110.324 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.59 -64.49 0.59 Allowed Glycine 0 N--CA 1.505 3.3 1 N-CA-C 102.25 -4.34 . . . . 0.0 102.25 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -156.73 -102.02 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' C ' ' HZ1' ' A' ' 55' ' ' LYS . . . . . . . . 0 CA--C 1.567 1.623 0 C-N-CA 125.139 1.376 . . . . 0.0 110.622 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mmt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 80.4 t -11.73 123.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.928 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -129.91 162.14 29.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.973 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 2.4 pm0 -105.12 153.34 21.64 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 74' ' ' PHE . 46.6 t -133.18 97.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.951 1.358 . . . . 0.0 113.716 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.7 p-10 -103.51 177.46 4.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 65' ' ' VAL . 79.0 t -104.29 142.02 23.73 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 7' ' ' VAL . 10.9 Cg_endo -79.04 -174.36 2.26 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.114 2.543 . . . . 0.0 113.633 176.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -69.2 53.77 0.1 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 112.574 -2.103 . . . . 0.0 114.228 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG21 ' CG2' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -70.87 21.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.104 0 O-C-N 119.776 -1.827 . . . . 0.0 115.805 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 86.61 169.57 46.04 Favored Glycine 0 N--CA 1.506 3.327 0 CA-C-N 112.785 -2.007 . . . . 0.0 113.86 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 38.29 -163.86 0.01 OUTLIER Glycine 1 N--CA 1.525 4.578 0 N-CA-C 120.968 3.147 . . . . 0.0 120.968 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.89 -74.02 0.28 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 112.096 -2.052 . . . . 0.0 112.302 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.68 163.8 28.95 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 123.241 1.496 . . . . 0.0 114.75 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m -152.22 154.57 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.868 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 89.9 mt-10 -87.21 -179.43 6.43 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 61' ' ' VAL . 97.7 t -109.69 115.73 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -46.15 9.53 Favored 'General case' 0 N--CA 1.522 3.161 0 CA-C-N 120.343 1.428 . . . . 0.0 110.24 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.68 100.72 4.71 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.058 1.409 . . . . 0.0 113.516 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 61' ' ' VAL . 13.8 p -82.14 58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 122.234 1.016 . . . . 0.0 111.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.1 mmt -22.08 -52.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.09 171.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 120.663 3.579 . . . . 0.0 120.663 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 51.5 mmtt -134.28 -162.17 1.22 Allowed 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 120.541 3.534 . . . . 0.0 120.541 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.12 92.96 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.984 0 O-C-N 119.938 -1.726 . . . . 0.0 113.898 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.39 12.37 13.56 Favored Glycine 1 N--CA 1.517 4.038 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.93 178.08 7.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.016 -1.592 . . . . 0.0 115.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -95.72 142.77 27.62 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 74' ' ' PHE . 1.8 t -145.93 113.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.706 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -132.24 151.92 51.59 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.98 79.12 0.22 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 124.035 1.874 . . . . 0.0 114.945 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CD ' ' N ' ' A' ' 32' ' ' GLN . 2.9 pp20? 166.77 -35.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 109.443 -3.526 . . . . 0.0 108.962 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 4.4 tt0 -58.99 80.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.254 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -31.66 70.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -24.27 -67.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.6 pt -151.43 141.87 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.292 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.5 m -99.09 139.94 33.99 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.79 146.08 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.6 -162.36 1.18 Allowed 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 118.678 2.844 . . . . 0.0 118.678 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.75 -89.95 0.12 Allowed Glycine 1 N--CA 1.524 4.528 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.974 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 42' ' ' ALA . 2.1 m-20 -93.45 -172.9 3.05 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.954 0.883 . . . . 0.0 111.745 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -43.14 7.16 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 121.692 3.96 . . . . 0.0 121.692 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -151.93 107.27 3.3 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 120.277 1.399 . . . . 0.0 114.145 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -65.85 152.59 44.07 Favored 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.8 mmt -125.76 150.6 47.61 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 122.363 0.265 . . . . 0.0 111.663 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -125.15 152.06 44.96 Favored 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.48 ' CG2' HG21 ' A' ' 10' ' ' ILE . 24.9 t -134.7 124.21 16.69 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.267 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -88.43 176.95 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.966 1.777 . . . . 0.0 111.592 171.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -53.31 117.35 11.52 Favored Pre-proline 0 CA--C 1.584 2.285 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 36.4 Cg_endo -48.85 -21.43 3.71 Favored 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 122.391 2.061 . . . . 0.0 114.235 174.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 11.4 p90 -169.92 -174.23 1.76 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.586 -2.097 . . . . 0.0 109.871 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -101.6 163.82 12.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.18 -152.13 19.89 Favored Glycine 0 N--CA 1.512 3.754 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.042 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.86 164.13 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.442 HG22 ' CE1' ' A' ' 74' ' ' PHE . 44.9 t -94.56 145.79 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.836 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 19.0 tttp -112.83 -73.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.58 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 47.7 tt0 -142.42 128.73 19.95 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.8 pt? -122.31 124.81 44.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.58 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.7 mptt -104.86 43.33 1.11 Allowed 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.21 157.41 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-N 114.095 -1.411 . . . . 0.0 114.453 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -144.45 171.44 14.35 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.521 ' CG2' HG12 ' A' ' 20' ' ' VAL . 33.5 t -88.74 103.63 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 101.782 -3.414 . . . . 0.0 101.782 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.98 12.91 2.81 Favored Glycine 1 N--CA 1.519 4.18 0 CA-C-N 108.657 -3.883 . . . . 0.0 111.958 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 26.1 t70 -120.39 163.49 17.8 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 111.682 -2.259 . . . . 0.0 107.283 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.22 152.67 22.57 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -136.39 170.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 110.632 -2.985 . . . . 0.0 110.029 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 67' ' ' THR . 15.4 ptmt -171.63 160.55 5.82 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.49 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 9.2 t -56.53 127.46 31.33 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 114.724 -2.79 . . . . 0.0 110.897 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.33 -41.22 2.27 Favored Glycine 0 N--CA 1.509 3.519 0 N-CA-C 117.439 1.736 . . . . 0.0 117.439 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 58.8 m -60.02 127.73 33.34 Favored 'General case' 0 N--CA 1.524 3.228 0 CA-C-N 119.627 1.713 . . . . 0.0 114.225 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 70' ' ' LEU . 8.4 mp -79.13 65.13 4.22 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-O 122.645 1.212 . . . . 0.0 111.649 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.513 HG22 ' SD ' ' A' ' 72' ' ' MET . 40.0 mm -33.49 -54.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.513 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -148.6 175.91 10.78 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.52 134.05 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.685 0.755 . . . . 0.0 110.665 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.592 ' CD2' HG11 ' A' ' 28' ' ' VAL . 14.6 m-30 -113.48 165.97 11.96 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.894 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 16.9 tp10 -130.81 80.91 1.97 Allowed 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 123.964 1.84 . . . . 0.0 109.426 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.4 m -34.82 61.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 118.029 2.604 . . . . 0.0 118.029 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -125.26 173.1 9.03 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 120.099 3.37 . . . . 0.0 120.099 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.81 -28.24 3.57 Favored Glycine 1 N--CA 1.517 4.085 0 N-CA-C 104.483 -3.447 . . . . 0.0 104.483 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 80.76 160.82 0.16 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 109.417 -3.391 . . . . 0.0 117.137 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.522 0 C-N-CA 128.998 2.919 . . . . 0.0 104.621 179.763 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' OE1' ' A' ' 75' ' ' GLU . 9.5 mtt . . . . . 0 N--CA 1.505 2.291 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.5 t -53.67 118.72 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' A' ' 4' ' ' GLU . 2.3 mmtt -114.65 161.88 17.52 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.988 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 1.2 pm0 -107.31 156.21 19.13 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 123.362 1.553 . . . . 0.0 114.257 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 74.6 t -137.5 111.64 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 124.655 2.169 . . . . 0.0 113.275 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.4 p-10 -97.53 166.16 11.64 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 111.981 -2.372 . . . . 0.0 106.28 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.4 HG12 HD12 ' A' ' 10' ' ' ILE . 83.6 t -90.16 135.95 29.32 Favored Pre-proline 0 C--N 1.29 -1.99 0 C-N-CA 117.607 -1.637 . . . . 0.0 109.413 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.47 -169.2 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.903 1.736 . . . . 0.0 110.961 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -70.28 56.07 0.15 Allowed 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 123.845 1.783 . . . . 0.0 113.458 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.4 HD12 HG12 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -77.98 42.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 O-C-N 119.672 -1.893 . . . . 0.0 113.511 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.18 -138.4 14.93 Favored Glycine 1 N--CA 1.52 4.296 0 CA-C-N 115.184 -0.916 . . . . 0.0 114.739 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.58 79.98 0.28 Allowed Glycine 1 N--CA 1.517 4.068 0 N-CA-C 105.973 -2.851 . . . . 0.0 105.973 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' HB3' ' HG3' ' A' ' 66' ' ' LYS . 76.6 m-20 44.87 -129.12 1.03 Allowed 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 121.332 3.827 . . . . 0.0 121.332 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 64' ' ' LYS . 1.1 mm-40 -2.08 78.49 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 1 N-CA-C 122.686 4.328 . . . . 0.0 122.686 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.564 HG23 HG23 ' A' ' 65' ' ' VAL . 2.5 m -126.72 158.8 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-N 113.521 -1.672 . . . . 0.0 110.628 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -120.98 172.1 8.17 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.306 -0.871 . . . . 0.0 109.212 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 60' ' ' ASN . 2.8 t -107.12 140.75 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.067 0 CA-C-O 123.195 1.474 . . . . 0.0 112.529 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 76.1 p -116.96 -45.94 2.75 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.411 ' H ' ' HB ' ' A' ' 36' ' ' THR . 28.3 mt-10 -126.97 112.94 15.84 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.8 65.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 124.193 1.949 . . . . 0.0 110.874 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' A' ' 21' ' ' MET . 24.1 mmt -26.92 -44.85 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.379 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.35 162.94 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -128.63 -165.59 1.52 Allowed 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.8 t -70.23 111.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 O-C-N 120.75 -1.219 . . . . 0.0 108.998 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.32 -0.41 35.05 Favored Glycine 1 N--CA 1.52 4.298 0 O-C-N 124.113 0.883 . . . . 0.0 113.0 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.75 145.42 24.42 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.67 114.11 10.44 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 6.6 t -107.82 110.4 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.072 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.673 -1.267 . . . . 0.0 110.954 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -41.77 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.319 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.924 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -18.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 1.2 tm0? -84.71 108.76 17.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.7 p -40.13 118.21 0.87 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 120.182 3.401 . . . . 0.0 120.182 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 48' ' ' ALA . 4.8 mt -86.01 -60.98 1.86 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.5 pt -145.82 150.2 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 19' ' ' GLU . 55.2 m -102.05 131.22 48.63 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.4 m -121.66 137.31 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.01 150.71 25.46 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 122.09 0.947 . . . . 0.0 112.262 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 40' ' ' ASP . . . -138.16 176.88 20.45 Favored Glycine 1 N--CA 1.524 4.513 0 CA-C-O 117.028 -1.985 . . . . 0.0 109.793 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' OD1' ' HE3' ' A' ' 41' ' ' LYS . 24.1 t0 -53.81 128.39 29.69 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-N 121.853 2.827 . . . . 0.0 106.888 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.457 ' HE3' ' OD1' ' A' ' 40' ' ' ASP . 22.3 mmtp 41.77 3.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -120.27 140.16 51.64 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 119.748 1.158 . . . . 0.0 113.361 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 p -113.98 137.45 51.68 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 123.63 0.772 . . . . 0.0 110.112 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.1 mtt -145.12 152.66 40.41 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -112.14 138.7 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.969 1.842 . . . . 0.0 113.865 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.5 t -112.28 112.57 52.0 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.24 177.06 4.69 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 122.08 1.854 . . . . 0.0 110.167 172.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.645 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -62.85 98.25 0.14 Allowed Pre-proline 0 C--N 1.286 -2.162 1 N-CA-C 123.17 4.507 . . . . 0.0 123.17 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.7 Cg_exo -34.51 -42.04 0.28 Allowed 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.827 2.351 . . . . 0.0 113.388 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -146.36 -173.9 4.31 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 109.916 -3.311 . . . . 0.0 111.389 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -103.8 154.44 19.58 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.5 -174.02 22.22 Favored Glycine 1 N--CA 1.523 4.451 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.734 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.96 162.01 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 CA-C-N 121.29 2.545 . . . . 0.0 113.307 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.58 121.07 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' CG ' ' HB2' ' A' ' 75' ' ' GLU . 2.5 tmtp? -93.24 -49.82 5.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.682 0.674 . . . . 0.0 111.722 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' OE2' ' CE ' ' A' ' 58' ' ' LYS . 45.9 tt0 -153.69 162.78 40.94 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.211 0.529 . . . . 0.0 112.086 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 57' ' ' LEU . 1.8 pt? -171.44 146.64 2.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.074 -1.016 . . . . 0.0 109.783 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' CE ' ' OE2' ' A' ' 56' ' ' GLU . 83.4 mttt -123.46 52.59 1.4 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 p -121.33 164.47 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.317 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -137.54 163.32 31.47 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -95.11 73.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-O 126.833 3.206 . . . . 0.0 109.519 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.92 39.16 0.12 Allowed Glycine 0 N--CA 1.509 3.508 1 CA-C-N 106.196 -5.002 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -120.31 174.39 6.55 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' NZ ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -114.19 136.74 52.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 -179.575 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.564 HG23 HG23 ' A' ' 15' ' ' VAL . 1.3 m -117.61 165.81 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.682 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 48.5 tttm -147.94 139.32 23.61 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 116.66 -1.638 . . . . 0.0 107.095 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -53.98 125.89 20.45 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.637 -2.425 . . . . 0.0 110.279 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.7 -39.54 2.76 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 112.962 -1.926 . . . . 0.0 114.142 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.4 t -52.03 120.73 5.69 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 1.2 mp -75.08 64.22 1.35 Allowed 'General case' 0 N--CA 1.525 3.294 0 CA-C-O 124.161 1.934 . . . . 0.0 111.975 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.496 ' CD1' HG12 ' A' ' 65' ' ' VAL . 18.8 mm -46.37 -44.55 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 120.858 3.651 . . . . 0.0 120.858 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 14.6 ptm -141.21 157.71 44.88 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.808 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.36 129.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 122.275 1.036 . . . . 0.0 110.882 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CZ ' HG21 ' A' ' 5' ' ' VAL . 13.1 m-30 -97.61 -171.44 2.19 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 6.0 tp10 -157.04 80.77 0.92 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.7 m -38.42 90.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.238 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 35.7 67.03 0.31 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -115.72 -63.54 0.37 Allowed Glycine 1 N--CA 1.521 4.306 1 N-CA-C 99.777 -5.329 . . . . 0.0 99.777 178.931 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 78' ' ' GLY . . . 99.81 165.7 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.079 1 N-CA-C 123.215 4.524 . . . . 0.0 123.215 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.071 0 C-N-CA 129.887 3.275 . . . . 0.0 107.65 179.85 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 N--CA 1.503 2.187 0 CA-C-O 114.229 -2.796 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.5 m 13.23 121.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 120.274 3.435 . . . . 0.0 120.274 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -126.39 107.17 10.04 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.332 -2.213 . . . . 0.0 109.988 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.89 148.13 40.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.316 -0.865 . . . . 0.0 111.068 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.638 HG21 ' CD1' ' A' ' 74' ' ' PHE . 20.4 t -110.73 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 CA-C-O 123.014 1.387 . . . . 0.0 113.918 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.4 p-10 -89.83 161.76 15.83 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.503 HG21 ' CG2' ' A' ' 65' ' ' VAL . 89.9 t -97.9 128.91 32.47 Favored Pre-proline 0 C--N 1.292 -1.909 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.792 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' C ' HD12 ' A' ' 10' ' ' ILE . 53.1 Cg_exo -59.88 -169.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.203 1.269 . . . . 0.0 115.131 169.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.39 40.84 0.01 OUTLIER 'General case' 0 CA--C 1.591 2.555 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.555 HG21 HG23 ' A' ' 46' ' ' VAL . 3.9 mp -85.3 61.92 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 119.03 -2.294 . . . . 0.0 115.658 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.83 -164.28 13.31 Favored Glycine 0 N--CA 1.495 2.622 0 CA-C-N 112.495 -2.139 . . . . 0.0 117.769 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.37 -158.0 11.62 Favored Glycine 1 N--CA 1.52 4.273 0 CA-C-N 113.782 -1.209 . . . . 0.0 113.016 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 10.4 -102.16 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 125.496 1.351 . . . . 0.0 113.939 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.75 ' HB3' ' HE3' ' A' ' 66' ' ' LYS . 18.7 pt-20 -157.15 134.95 10.84 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 124.433 2.063 . . . . 0.0 112.339 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.45 175.06 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-N 112.876 -1.966 . . . . 0.0 110.888 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.684 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 11.9 pt-20 -123.36 166.86 14.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.5 t -89.75 128.78 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 55.5 p -102.03 -44.59 5.43 Favored 'General case' 0 N--CA 1.512 2.656 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.786 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -134.84 103.53 5.65 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.0 p -82.4 79.59 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 124.172 1.939 . . . . 0.0 110.46 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 mmt -43.9 -45.42 7.58 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 111.708 -2.496 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.24 158.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.8 mptt -130.91 -177.79 4.53 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-O 125.106 2.384 . . . . 0.0 117.434 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.77 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 112.708 -2.042 . . . . 0.0 114.341 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 118.49 17.18 5.3 Favored Glycine 1 N--CA 1.52 4.248 0 CA-C-N 114.701 -1.136 . . . . 0.0 114.635 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -96.97 141.48 30.09 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 122.656 1.217 . . . . 0.0 113.799 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.558 ' HD3' HG13 ' A' ' 53' ' ' VAL . 52.6 mmtt -71.35 97.62 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.122 1.439 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 74' ' ' PHE . 65.1 t -102.18 107.23 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 113.62 -1.627 . . . . 0.0 115.335 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -120.49 163.39 18.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.048 -1.033 . . . . 0.0 110.32 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.96 166.24 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.967 0.792 . . . . 0.0 112.795 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 62.17 -26.27 0.06 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -74.5 96.8 2.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.231 -1.543 . . . . 0.0 110.132 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 t -40.7 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -27.13 -67.61 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.0 pt -147.57 143.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 111.902 -2.408 . . . . 0.0 112.526 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.1 m -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.53 158.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -135.67 156.76 48.33 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-O 122.599 1.19 . . . . 0.0 110.51 178.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.71 -88.45 0.56 Allowed Glycine 1 N--CA 1.523 4.477 0 C-N-CA 126.907 2.194 . . . . 0.0 109.441 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.555 ' O ' ' HD2' ' A' ' 41' ' ' LYS . 1.3 p-10 -129.34 94.71 3.85 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 125.416 2.532 . . . . 0.0 107.391 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.555 ' HD2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER 51.42 25.41 2.61 Favored 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.794 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.18 83.1 2.13 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.237 2.68 . . . . 0.0 118.237 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 27.3 t -62.27 113.46 2.9 Favored 'General case' 0 N--CA 1.519 2.977 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -116.39 160.18 20.91 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 122.629 0.372 . . . . 0.0 110.537 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -125.31 152.92 44.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.242 -0.912 . . . . 0.0 113.03 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.555 HG23 HG21 ' A' ' 10' ' ' ILE . 39.5 t -122.25 113.66 30.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -85.53 177.0 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.249 1.299 . . . . 0.0 112.499 170.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -62.47 95.53 0.06 OUTLIER Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 11.4 Cg_endo -38.52 -35.29 0.45 Allowed 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 122.512 2.141 . . . . 0.0 114.073 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -154.76 -174.93 5.18 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 112.117 -2.31 . . . . 0.0 108.758 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -104.2 155.1 19.0 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.5 -138.61 7.29 Favored Glycine 0 N--CA 1.511 3.638 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.289 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.558 HG13 ' HD3' ' A' ' 27' ' ' LYS . 1.9 t -140.55 165.14 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 74' ' ' PHE . 14.4 t -90.93 137.26 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 118.83 -1.148 . . . . 0.0 107.934 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 19.7 tptt -108.12 -59.6 1.83 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.705 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 27.3 tt0 -149.66 160.85 43.18 Favored 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.705 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -163.21 156.34 19.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.181 -0.95 . . . . 0.0 108.448 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.3 48.75 1.98 Allowed 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.985 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.22 152.35 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.044 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' H ' ' HB2' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -134.23 -175.38 3.84 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 124.745 2.212 . . . . 0.0 116.277 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -86.72 114.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 113.07 4.95 23.82 Favored Glycine 0 N--CA 1.511 3.699 0 CA-C-N 108.721 -3.854 . . . . 0.0 110.028 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.491 ' HB2' ' H ' ' A' ' 60' ' ' ASN . 1.5 t0 -79.78 177.55 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.824 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.684 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 28.2 mmtm -114.15 132.92 55.91 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 118.576 2.806 . . . . 0.0 118.576 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.503 ' CG2' HG21 ' A' ' 7' ' ' VAL . 1.3 p -132.86 169.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.75 ' HE3' ' HB3' ' A' ' 14' ' ' GLU . 6.4 ptpp? -173.99 134.99 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.434 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.3 t -33.42 116.34 0.25 Allowed 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 124.741 2.21 . . . . 0.0 113.646 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.87 -35.47 4.68 Favored Glycine 0 N--CA 1.507 3.409 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.941 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 66.6 m -64.86 136.76 57.22 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.61 72.23 10.7 Favored 'General case' 0 N--CA 1.522 3.138 0 CA-C-O 122.209 1.004 . . . . 0.0 109.621 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.615 HD11 ' SD ' ' A' ' 72' ' ' MET . 1.6 pp -58.11 -46.12 88.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.615 ' SD ' HD11 ' A' ' 71' ' ' ILE . 11.4 ptm -132.83 171.89 13.31 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 118.617 -1.233 . . . . 0.0 114.116 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.24 123.58 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.594 -1.316 . . . . 0.0 112.595 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.638 ' CD1' HG21 ' A' ' 5' ' ' VAL . 14.8 m-30 -111.96 167.68 10.19 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.292 1.52 . . . . 0.0 113.726 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.589 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 32.7 tt0 -145.89 155.85 43.15 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.36 42.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -11.05 -61.23 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.517 0 CA-C-O 124.433 2.063 . . . . 0.0 115.486 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.59 101.55 0.2 Allowed Glycine 0 N--CA 1.499 2.885 1 N-CA-C 98.147 -5.981 . . . . 0.0 98.147 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.69 31.63 2.27 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 117.189 -1.805 . . . . 0.0 113.179 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.841 0 O-C-N 127.859 3.224 . . . . 0.0 106.152 -179.577 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 2.3 ttp . . . . . 0 N--CA 1.509 2.509 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 24.9 t -22.02 120.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -125.59 152.98 44.39 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.122 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -109.92 149.46 29.87 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.642 1.687 . . . . 0.0 114.731 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.541 HG21 ' CE1' ' A' ' 74' ' ' PHE . 70.2 t -122.86 114.29 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.565 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -109.9 -178.41 3.52 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.438 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.634 HG21 ' HB ' ' A' ' 65' ' ' VAL . 59.5 t -102.19 128.63 28.0 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.016 -1.074 . . . . 0.0 113.486 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -77.87 -164.11 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.99 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.27 64.61 2.7 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.634 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -75.82 56.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.316 0 O-C-N 119.908 -1.745 . . . . 0.0 111.296 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.61 -54.69 1.07 Allowed Glycine 1 N--CA 1.519 4.184 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.21 -34.85 1.8 Allowed Glycine 0 N--CA 1.514 3.884 0 CA-C-N 112.406 -1.897 . . . . 0.0 113.791 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.72 -167.35 0.45 Allowed 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.61 ' HG3' ' HB3' ' A' ' 66' ' ' LYS . 3.4 mt-10 -108.03 129.14 55.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 120.796 -1.19 . . . . 0.0 108.774 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 23.0 m -125.08 168.71 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 29.3 mt-10 -93.29 163.28 13.67 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.033 1.458 . . . . 0.0 112.302 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.06 112.61 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 19' ' ' GLU . 14.2 t -98.71 -37.41 9.5 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 18' ' ' THR . 21.6 mm-40 -129.92 127.65 40.55 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.55 65.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 124.526 2.108 . . . . 0.0 113.359 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.425 ' H ' ' HG2' ' A' ' 21' ' ' MET . 7.4 mmt -24.49 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 110.925 -2.852 . . . . 0.0 117.839 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.9 t -122.67 155.82 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.1 tttt -127.51 178.66 5.95 Favored 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 120.797 3.629 . . . . 0.0 120.797 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.21 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 113.716 -1.584 . . . . 0.0 113.576 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.63 1.39 19.79 Favored Glycine 1 N--CA 1.517 4.037 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.891 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.478 ' HB2' HG12 ' A' ' 22' ' ' VAL . 77.7 m-20 -90.32 150.54 21.87 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.651 1.215 . . . . 0.0 113.092 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -75.94 112.6 12.52 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.892 0.853 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -106.61 101.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.437 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -105.89 151.13 24.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.306 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.19 157.85 0.42 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.564 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 69.5 -26.24 0.15 Allowed 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 122.658 1.218 . . . . 0.0 112.961 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.468 HE22 ' CG2' ' A' ' 22' ' ' VAL . 4.5 tm0? -80.15 102.13 9.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.223 -1.548 . . . . 0.0 109.471 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.2 t -33.25 124.99 0.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.8 mt -93.6 -52.71 4.35 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 110.711 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.46 HG13 ' HB ' ' A' ' 46' ' ' VAL . 32.3 pt -144.26 134.69 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.9 m -92.1 120.68 32.94 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 102.789 -3.041 . . . . 0.0 102.789 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.1 m -109.02 147.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -127.52 -146.49 0.33 Allowed 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.73 -116.94 1.26 Allowed Glycine 1 N--CA 1.525 4.59 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -88.14 83.36 6.99 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 126.594 3.092 . . . . 0.0 116.393 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 68.36 -20.44 0.14 Allowed 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 111.97 -2.377 . . . . 0.0 115.292 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.21 139.8 32.65 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -116.84 141.25 48.46 Favored 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ttm -143.22 171.04 14.63 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -130.32 153.02 49.1 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HB ' HG13 ' A' ' 35' ' ' ILE . 3.9 t -130.45 105.31 15.97 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.48 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -81.73 178.73 6.28 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 CA-C-O 123.612 1.421 . . . . 0.0 112.276 177.39 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -66.0 117.08 38.97 Favored Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 37.4 Cg_endo -49.63 -22.31 6.5 Favored 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 123.186 2.591 . . . . 0.0 114.968 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -171.52 -174.06 1.33 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 113.232 -1.804 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -102.56 119.1 38.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 -165.37 32.62 Favored Glycine 0 N--CA 1.513 3.769 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.44 154.37 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 CA-C-N 118.205 1.003 . . . . 0.0 109.204 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.492 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 24.3 t -78.8 121.18 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -97.37 -56.72 2.45 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.754 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 31.0 tt0 -149.08 150.53 32.9 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.997 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -146.23 163.77 34.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.075 -1.641 . . . . 0.0 108.869 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.465 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 8.4 mmtp -133.89 42.6 2.92 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.24 154.02 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-N 113.969 -1.468 . . . . 0.0 114.071 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -130.78 -175.93 3.83 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-O 125.542 2.592 . . . . 0.0 116.089 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.14 109.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 1 N-CA-C 99.135 -4.394 . . . . 0.0 99.135 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.47 -27.26 3.12 Favored Glycine 0 N--CA 1.508 3.443 0 CA-C-N 111.518 -2.583 . . . . 0.0 107.532 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -72.95 159.18 34.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.341 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' NZ ' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -115.27 143.65 44.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.634 ' HB ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -131.62 161.7 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.61 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 1.2 pttp -156.02 158.27 37.55 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -27.72 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.19 -42.14 1.96 Allowed Glycine 0 N--CA 1.515 3.943 0 CA-C-N 112.944 -1.934 . . . . 0.0 114.923 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.7 m -36.0 118.39 0.51 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 mp -67.72 64.95 0.08 Allowed 'General case' 0 N--CA 1.513 2.699 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.545 HD11 HG22 ' A' ' 7' ' ' VAL . 3.9 mt -23.6 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptp -167.93 -176.85 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 111.361 -2.654 . . . . 0.0 115.586 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.26 122.67 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 123.495 1.617 . . . . 0.0 114.829 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 5' ' ' VAL . 10.7 m-30 -102.76 175.74 5.39 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 113.435 -1.711 . . . . 0.0 109.543 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.414 ' OE2' ' N ' ' A' ' 1' ' ' MET 0.28 22.3 tp10 -144.97 109.71 5.01 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.47 72.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 121.398 3.851 . . . . 0.0 121.398 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -121.6 149.73 42.72 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.4 -47.85 0.04 OUTLIER Glycine 1 N--CA 1.526 4.656 0 CA-C-O 122.01 0.783 . . . . 0.0 112.526 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' H ' ' H ' ' A' ' 80' ' ' ALA . . . 146.48 32.87 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.953 0 CA-C-N 109.2 -3.5 . . . . 0.0 109.495 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.447 ' H ' ' H ' ' A' ' 79' ' ' ALA . . . . . . . . 0 CA--C 1.572 1.826 3 N-CA-C 98.242 -4.725 . . . . 0.0 98.242 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.633 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 m -15.03 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 1 N-CA-C 122.858 4.392 . . . . 0.0 122.858 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -127.61 160.38 31.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.428 -2.623 . . . . 0.0 106.449 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -105.29 169.16 8.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.476 1.131 . . . . 0.0 110.437 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.54 HG21 ' CD1' ' A' ' 74' ' ' PHE . 73.2 t -125.82 102.27 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 114.343 -1.298 . . . . 0.0 113.804 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 13.7 p-10 -99.43 163.52 12.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 71' ' ' ILE . 55.1 t -75.4 138.09 71.3 Favored Pre-proline 0 N--CA 1.502 2.127 0 C-N-CA 116.862 -1.935 . . . . 0.0 110.503 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HG2' HG23 ' A' ' 10' ' ' ILE . 38.5 Cg_endo -71.3 -174.98 1.35 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.098 1.866 . . . . 0.0 112.675 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.73 49.07 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.515 HG21 HG22 ' A' ' 46' ' ' VAL . 37.8 pt -79.78 58.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 O-C-N 119.366 -2.084 . . . . 0.0 111.893 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -20.04 69.77 0.0 OUTLIER Glycine 1 N--CA 1.524 4.539 0 N-CA-C 122.975 3.95 . . . . 0.0 122.975 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.46 -155.95 9.23 Favored Glycine 1 N--CA 1.524 4.552 0 N-CA-C 118.845 2.298 . . . . 0.0 118.845 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -56.89 -120.18 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.626 0 CA-C-N 112.895 -1.653 . . . . 0.0 109.359 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 8.6 tt0 -151.61 122.12 7.38 Favored 'General case' 0 N--CA 1.497 1.889 1 N-CA-C 99.44 -4.282 . . . . 0.0 99.44 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.92 169.37 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.0 pt-20 -113.56 167.46 10.58 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 t -84.42 119.43 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 t -100.77 -36.76 8.98 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.81 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.03 117.5 16.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.41 59.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 14.0 mmt -18.98 -45.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.1 t -124.8 155.77 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 22.3 mttt -140.72 -169.34 2.78 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 121.666 3.95 . . . . 0.0 121.666 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -51.49 84.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.08 -0.25 14.69 Favored Glycine 1 N--CA 1.519 4.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HB2' HG12 ' A' ' 22' ' ' VAL . 69.9 m-20 -89.1 139.83 30.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.883 1.801 . . . . 0.0 113.018 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HZ2' ' CD ' ' A' ' 77' ' ' GLU . 49.8 mmtt -62.77 74.22 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 112.534 -2.121 . . . . 0.0 116.459 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -74.0 97.77 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -101.73 156.88 17.23 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.337 -1.477 . . . . 0.0 108.958 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -58.27 168.81 0.97 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.999 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.71 -24.66 0.08 Allowed 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 30' ' ' ALA . 3.7 tm0? -82.42 109.07 16.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 123.231 1.491 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 10.1 m -35.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 120.927 3.677 . . . . 0.0 120.927 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -24.77 -58.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 pt -146.14 150.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.92 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.425 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 96.7 m -102.52 124.93 48.96 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.4 m -110.8 154.0 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -140.73 -161.95 1.29 Allowed 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' A' ' 38' ' ' GLU . . . 148.87 -84.84 0.17 Allowed Glycine 1 N--CA 1.525 4.588 0 N-CA-C 115.673 1.029 . . . . 0.0 115.673 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 42' ' ' ALA . 1.8 m-20 -115.37 -131.36 0.32 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 123.175 1.464 . . . . 0.0 109.193 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' NZ ' ' OD2' ' A' ' 13' ' ' ASP . 27.5 pttt -8.84 -32.99 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 121.576 3.917 . . . . 0.0 121.576 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . 178.48 178.05 0.42 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.739 0.78 . . . . 0.0 110.935 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.7 t -99.97 150.26 22.6 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.472 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 mtm -132.81 164.33 27.08 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -122.19 148.73 44.58 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.062 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG22 HG21 ' A' ' 10' ' ' ILE . 76.0 t -122.76 116.21 29.18 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.16 172.32 13.97 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 CA-C-O 124.455 1.773 . . . . 0.0 110.347 176.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -76.34 117.05 61.59 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 111.84 -2.436 . . . . 0.0 115.377 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HG2' HG13 ' A' ' 5' ' ' VAL . 73.4 Cg_exo -39.34 -37.45 1.14 Allowed 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.008 2.472 . . . . 0.0 113.632 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.34 -174.16 4.55 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 110.963 -2.835 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -95.14 152.39 18.39 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.69 -150.14 22.33 Favored Glycine 1 N--CA 1.517 4.085 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.843 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG21 ' CD ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -130.11 157.5 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 O-C-N 121.768 -0.842 . . . . 0.0 112.15 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 30.4 t -83.02 128.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 C-N-CA 118.091 -1.444 . . . . 0.0 107.662 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -106.26 -72.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 38.4 tt0 -127.36 123.28 35.86 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 123.368 1.556 . . . . 0.0 111.314 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.573 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.0 pt? -129.07 146.49 51.01 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.548 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 87.8 mttt -127.95 53.16 1.81 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.82 137.58 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 110.204 -3.18 . . . . 0.0 111.051 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.633 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.3 m120 -120.37 -171.33 2.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.741 2.21 . . . . 0.0 114.683 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.65 87.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 125.978 2.799 . . . . 0.0 106.422 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.07 24.35 0.23 Allowed Glycine 0 N--CA 1.516 3.97 1 CA-C-N 106.715 -4.766 . . . . 0.0 112.809 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.633 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -106.22 152.15 23.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -102.6 145.27 29.89 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.15 163.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.989 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 13' ' ' ASP . 53.4 tttt -166.0 145.89 6.32 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.037 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -36.74 116.14 0.41 Allowed 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.403 1.573 . . . . 0.0 112.426 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.28 -52.18 0.73 Allowed Glycine 0 N--CA 1.511 3.665 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.951 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 16.4 t -45.74 128.18 8.44 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -73.39 60.24 0.62 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.513 HD11 HG22 ' A' ' 7' ' ' VAL . 2.7 mt -18.94 -60.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 119.031 2.974 . . . . 0.0 119.031 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.407 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -167.42 -172.51 1.97 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 112.321 -2.218 . . . . 0.0 115.238 -179.24 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.08 130.42 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 124.414 2.054 . . . . 0.0 112.691 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.2 m-30 -117.49 145.88 43.9 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 111.804 -2.453 . . . . 0.0 113.202 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.2 162.58 23.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 78' ' ' GLY . 28.1 m -111.52 120.53 62.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 119.733 3.234 . . . . 0.0 119.733 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.55 ' CD ' ' HZ2' ' A' ' 27' ' ' LYS . 58.7 mt-10 -65.35 76.31 0.06 Allowed 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 124.19 1.948 . . . . 0.0 109.685 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . 161.93 78.1 0.03 OUTLIER Glycine 0 N--CA 1.507 3.371 1 N-CA-C 99.505 -5.438 . . . . 0.0 99.505 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.99 62.09 4.8 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 C-N-CA 127.252 2.221 . . . . 0.0 108.88 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.497 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 5.8 ptp . . . . . 0 N--CA 1.506 2.374 0 CA-C-O 117.477 -1.249 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m -76.6 155.0 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -145.62 149.06 33.83 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 111.549 -2.569 . . . . 0.0 111.376 178.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -97.4 104.2 16.2 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.492 1.139 . . . . 0.0 113.773 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 77.1 t -71.22 99.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 CA-C-O 124.8 2.238 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' SER . 5.8 p30 -96.05 177.4 5.75 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.631 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 67' ' ' THR . 78.2 t -98.01 131.82 25.85 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.26 -176.29 1.58 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 120.708 0.939 . . . . 0.0 114.048 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -68.42 46.55 0.05 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 112.605 -2.089 . . . . 0.0 114.382 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.403 HG21 HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.35 45.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 O-C-N 119.59 -1.944 . . . . 0.0 113.33 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.12 -163.93 12.16 Favored Glycine 0 N--CA 1.513 3.815 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.053 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.62 -35.65 1.53 Allowed Glycine 1 N--CA 1.522 4.423 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -41.43 162.55 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.934 0 CA-C-N 109.324 -3.438 . . . . 0.0 113.276 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 2.7 tp10 -117.7 112.29 20.27 Favored 'General case' 0 N--CA 1.52 3.063 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.99 177.29 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.712 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.9 pt-20 -111.3 169.55 8.72 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.17 114.11 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -93.67 -44.79 8.0 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 112.84 -1.982 . . . . 0.0 114.859 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.571 ' HG3' HG22 ' A' ' 18' ' ' THR . 36.0 mt-10 -131.16 102.77 6.14 Favored 'General case' 0 N--CA 1.52 3.036 0 CA-C-N 119.866 1.212 . . . . 0.0 111.452 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.28 72.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 O-C-N 119.284 -2.135 . . . . 0.0 113.498 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 57.1 mmm -34.65 -52.28 0.51 Allowed 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.413 ' C ' ' HE2' ' A' ' 23' ' ' LYS . 15.8 m -98.65 150.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 CA-C-N 119.574 1.079 . . . . 0.0 113.55 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -123.33 169.28 11.48 Favored 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -54.59 87.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.292 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.506 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 127.32 9.62 4.03 Favored Glycine 1 N--CA 1.517 4.046 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -92.24 140.22 29.83 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.69 1.234 . . . . 0.0 111.91 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.563 ' HZ1' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -75.66 86.2 2.71 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 126.839 2.056 . . . . 0.0 109.162 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.64 149.3 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -140.59 154.6 46.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 50' ' ' PHE . . . -69.11 99.19 1.08 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 139.81 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 127.784 3.177 . . . . 0.0 108.185 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -71.3 105.8 3.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 112.708 -2.042 . . . . 0.0 113.665 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 16.6 t -39.03 96.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 112.569 -2.105 . . . . 0.0 115.554 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 21' ' ' MET . 4.2 mt -53.52 -62.8 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.522 ' H ' HG23 ' A' ' 46' ' ' VAL . 25.6 pt -147.91 128.8 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.906 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 19' ' ' GLU . 5.2 m -67.87 129.79 40.99 Favored 'General case' 0 N--CA 1.517 2.917 0 O-C-N 119.965 -1.709 . . . . 0.0 111.066 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 65' ' ' VAL . 31.6 m -119.67 151.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.707 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 43' ' ' SER . 3.4 tt0 -142.51 -152.04 0.39 Allowed 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.57 -69.93 0.31 Allowed Glycine 1 N--CA 1.526 4.65 0 C-N-CA 124.936 1.255 . . . . 0.0 112.759 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -116.09 -165.69 1.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 117.828 0.814 . . . . 0.0 110.795 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -56.36 25.96 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 121.474 3.879 . . . . 0.0 121.474 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.13 76.32 1.5 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 123.456 1.598 . . . . 0.0 114.831 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 92.7 p -59.52 127.86 34.16 Favored 'General case' 0 N--CA 1.51 2.554 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.99 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.0 mtm -139.55 164.71 29.17 Favored 'General case' 0 N--CA 1.516 2.872 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -120.3 168.52 11.18 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 123.148 1.451 . . . . 0.0 114.19 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -115.74 129.42 25.17 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.64 168.74 11.04 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-O 123.384 1.327 . . . . 0.0 109.935 168.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -74.98 117.19 60.83 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 112.859 -1.973 . . . . 0.0 115.065 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 35.9 Cg_endo -48.62 -25.75 8.33 Favored 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.011 1.807 . . . . 0.0 114.016 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -158.08 -173.37 4.31 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.896 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.71 165.86 10.83 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.1 -153.61 21.01 Favored Glycine 1 N--CA 1.522 4.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 113.538 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.07 153.51 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.544 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 41.3 t -77.14 84.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -61.83 -44.64 96.43 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.644 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 28.3 tt0 -176.46 159.23 1.91 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 124.005 0.815 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.7 pt? -154.76 159.77 40.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.323 -0.861 . . . . 0.0 109.703 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 29.8 mmtt -126.33 45.82 2.58 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.16 161.93 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.69 171.4 9.62 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 125.367 2.508 . . . . 0.0 116.952 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.86 100.15 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 1 N-CA-C 99.784 -4.154 . . . . 0.0 99.784 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.14 19.97 0.95 Allowed Glycine 0 N--CA 1.51 3.576 1 CA-C-N 107.305 -4.498 . . . . 0.0 111.84 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.18 170.43 8.1 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.482 0.713 . . . . 0.0 109.278 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -103.43 143.65 32.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.778 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG21 HG11 ' A' ' 37' ' ' VAL . 3.5 m -132.52 127.49 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HG2' ' N ' ' A' ' 67' ' ' THR . 26.1 ttmt -139.98 151.54 45.59 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.533 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 7.6 t -42.21 118.5 1.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 117.271 -1.772 . . . . 0.0 111.495 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.23 -51.36 0.78 Allowed Glycine 0 N--CA 1.513 3.793 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m -39.51 119.55 0.96 Allowed 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.62 65.47 1.82 Allowed 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 123.065 1.412 . . . . 0.0 111.346 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 mm -48.78 -57.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 120.729 3.604 . . . . 0.0 120.729 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.406 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 14.9 ptp -135.49 166.89 22.15 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.346 -0.846 . . . . 0.0 112.519 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -110.47 122.51 65.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.811 1.291 . . . . 0.0 112.253 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 7.5 m-30 -117.07 149.27 40.58 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.497 ' OE2' ' N ' ' A' ' 1' ' ' MET . 3.4 tt0 -131.96 127.48 36.43 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.469 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 76' ' ' VAL . 28.8 m -68.82 49.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.483 1 N-CA-C 122.142 4.127 . . . . 0.0 122.142 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 3.82 -68.23 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 121.004 3.705 . . . . 0.0 121.004 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.74 43.07 0.23 Allowed Glycine 0 N--CA 1.516 3.981 0 CA-C-N 110.568 -3.015 . . . . 0.0 105.9 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 30.19 77.9 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 1 N-CA-C 121.844 4.016 . . . . 0.0 121.844 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.563 ' C ' ' HZ1' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.574 1.901 0 CA-C-N 111.685 -2.507 . . . . 0.0 113.765 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.653 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.244 -1.836 . . . . 0.0 107.168 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.2 t -21.28 136.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.498 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 3.1 mmmp? -134.17 166.5 22.62 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.129 1.443 . . . . 0.0 110.886 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' NZ ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -107.56 157.32 18.14 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.296 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 74' ' ' PHE . 58.9 t -126.08 106.98 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 CA-C-O 121.883 0.849 . . . . 0.0 111.504 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -101.87 152.85 20.41 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' HB ' ' A' ' 65' ' ' VAL . 99.2 t -71.33 132.29 86.06 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 116.877 -1.929 . . . . 0.0 112.197 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -71.91 -175.17 1.56 Allowed 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 122.616 2.211 . . . . 0.0 115.329 172.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.34 46.52 0.02 OUTLIER 'General case' 0 CA--C 1.583 2.217 0 C-N-CA 127.452 2.301 . . . . 0.0 116.224 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.534 HG21 HG22 ' A' ' 46' ' ' VAL . 36.2 pt -75.23 53.66 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -23.58 92.41 0.01 OUTLIER Glycine 1 N--CA 1.53 4.905 0 N-CA-C 118.515 2.166 . . . . 0.0 118.515 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.26 37.32 0.02 OUTLIER Glycine 1 N--CA 1.535 5.255 0 CA-C-O 124.826 2.348 . . . . 0.0 111.782 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.282 30.2 m-20 -1.54 68.28 0.0 OUTLIER 'General case' 0 CA--C 1.597 2.772 2 N-CA-C 127.928 6.27 . . . . 0.0 127.928 -179.516 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 109.64 78.54 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.848 0 C-N-CA 128.66 2.784 . . . . 0.0 108.113 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.0 m -106.58 156.12 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-N 113.348 -1.751 . . . . 0.0 115.358 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.31 164.19 12.76 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 35' ' ' ILE . 20.0 t -103.4 116.25 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.099 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 2.1 t -96.8 -41.96 8.2 Favored 'General case' 0 N--CA 1.524 3.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.765 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -131.99 105.21 7.27 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.947 0.879 . . . . 0.0 110.855 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.45 63.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 O-C-N 119.087 -2.258 . . . . 0.0 115.261 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 55.6 mmm -23.17 -42.44 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 119.403 3.112 . . . . 0.0 119.403 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.7 t -119.74 155.26 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.6 tttm -131.46 175.33 9.24 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 120.551 3.537 . . . . 0.0 120.551 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.47 91.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.28 0.38 12.76 Favored Glycine 1 N--CA 1.516 4.03 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.775 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 22' ' ' VAL . 52.5 m-20 -93.27 143.65 26.07 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.58 1.181 . . . . 0.0 112.706 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HE3' ' CD ' ' A' ' 77' ' ' GLU . 14.0 mmmm -66.33 121.77 16.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.15 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 15.6 t -116.04 115.19 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -122.91 151.42 41.78 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.696 -0.628 . . . . 0.0 111.282 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -48.02 158.26 0.24 Allowed 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 69.51 -28.42 0.16 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 122.541 1.162 . . . . 0.0 112.753 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.429 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 6.4 tt0 -77.35 105.13 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.316 -1.49 . . . . 0.0 111.575 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 19.8 t -37.92 120.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.8 mt -85.78 -51.03 6.69 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.412 ' HB ' HG13 ' A' ' 17' ' ' VAL . 29.1 pt -146.79 137.35 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.958 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -84.32 128.26 34.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.35 160.77 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -138.13 -143.02 0.16 Allowed 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.48 -104.83 0.32 Allowed Glycine 1 N--CA 1.524 4.54 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . 0.314 0.3 OUTLIER -90.45 -89.22 0.16 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 118.474 1.137 . . . . 0.0 113.651 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.19 43.06 1.94 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.55 149.51 1.67 Allowed 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 93.5 p -106.02 126.94 52.8 Favored 'General case' 0 N--CA 1.513 2.708 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.95 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.8 mtt -129.74 174.29 9.85 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -124.81 153.81 41.93 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 122.115 0.96 . . . . 0.0 113.512 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.534 HG22 HG21 ' A' ' 10' ' ' ILE . 53.1 t -121.03 104.42 41.44 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.525 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.5 OUTLIER -80.18 177.63 8.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 CA-C-O 123.779 1.491 . . . . 0.0 111.087 179.085 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -71.89 111.49 10.79 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -46.11 -28.52 5.48 Favored 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 121.884 1.723 . . . . 0.0 113.049 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -163.05 -173.51 3.47 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.112 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -103.89 160.78 14.51 Favored 'General case' 0 CA--C 1.579 2.07 1 N-CA-C 121.879 4.029 . . . . 0.0 121.879 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.95 -124.26 3.06 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 114.577 -1.192 . . . . 0.0 114.096 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -141.48 159.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.206 0 O-C-N 121.996 -0.708 . . . . 0.0 111.305 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG13 ' SD ' ' A' ' 72' ' ' MET . 67.6 t -80.85 112.0 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 28.3 tttm -89.94 -64.55 1.12 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.431 -1.308 . . . . 0.0 110.045 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' HG13 ' A' ' 73' ' ' ILE . 42.4 tt0 -145.07 133.77 22.2 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.3 pt? -130.53 163.13 27.72 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.532 -1.98 . . . . 0.0 109.314 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 14.1 mmtp -133.64 42.02 3.0 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 p -132.26 159.61 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.942 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -126.19 177.65 6.27 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -94.03 108.81 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 1 N-CA-C 97.752 -4.907 . . . . 0.0 97.752 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.2 6.05 6.45 Favored Glycine 0 N--CA 1.515 3.908 0 CA-C-N 109.898 -3.319 . . . . 0.0 109.784 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.71 156.84 16.17 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.72 144.38 41.11 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HB ' HG21 ' A' ' 7' ' ' VAL . 14.2 m -138.4 172.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -178.0 156.63 1.07 Allowed 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.2 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -26.73 101.4 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 118.644 2.831 . . . . 0.0 118.644 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.79 -53.02 0.69 Allowed Glycine 0 N--CA 1.511 3.697 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.073 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.1 m -21.85 117.2 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.36 59.49 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.496 HG22 ' HG2' ' A' ' 72' ' ' MET . 4.3 mm -34.5 -58.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.558 ' SD ' HG13 ' A' ' 54' ' ' VAL . 5.1 ptp -174.43 -170.81 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.261 -1.79 . . . . 0.0 113.757 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -116.7 130.28 71.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-O 124.026 1.87 . . . . 0.0 107.883 178.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 8.9 m-30 -112.69 161.65 16.62 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.835 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -134.36 137.19 43.95 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 m -76.53 74.15 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 124.552 2.12 . . . . 0.0 116.047 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.513 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 3.5 mt-10 76.13 -97.57 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 108.598 -3.91 . . . . 0.0 118.18 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.0 77.0 0.11 Allowed Glycine 0 N--CA 1.513 3.83 1 N-CA-C 100.97 -4.852 . . . . 0.0 100.97 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.44 34.79 0.64 Allowed 'General case' 0 CA--C 1.573 1.855 0 CA-C-N 112.83 -1.685 . . . . 0.0 114.577 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.721 0 C-N-CA 128.34 2.656 . . . . 0.0 106.978 -179.527 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mtp . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.927 -1.035 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.82 -178.89 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.928 0 CA-C-N 119.888 1.222 . . . . 0.0 109.911 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.68 160.65 26.74 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 123.826 0.704 . . . . 0.0 110.008 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -108.4 169.32 8.72 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.546 HG21 ' CE1' ' A' ' 74' ' ' PHE . 39.5 t -134.91 117.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 10.1 p-10 -106.33 166.67 10.37 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 71' ' ' ILE . 48.1 t -85.73 140.53 35.6 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.89 178.9 6.05 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.38 1.387 . . . . 0.0 112.879 171.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -64.48 56.18 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.541 HG21 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -82.45 41.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.039 0 O-C-N 119.439 -2.038 . . . . 0.0 111.974 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 7.1 53.42 0.0 OUTLIER Glycine 1 N--CA 1.524 4.552 0 N-CA-C 119.957 2.743 . . . . 0.0 119.957 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.3 -28.26 0.24 Allowed Glycine 1 N--CA 1.522 4.387 0 CA-C-N 113.79 -1.205 . . . . 0.0 112.152 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.301 20.5 m-20 15.0 16.02 0.0 OUTLIER 'General case' 0 CA--C 1.586 2.351 2 N-CA-C 124.922 5.156 . . . . 0.0 124.922 -179.78 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -146.94 69.76 1.18 Allowed 'General case' 0 N--CA 1.501 2.114 1 N-CA-C 97.233 -5.099 . . . . 0.0 97.233 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.7 168.32 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.822 0 C-N-CA 117.497 -1.681 . . . . 0.0 115.034 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -110.85 171.33 7.53 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 124.207 0.942 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 35' ' ' ILE . 28.2 t -107.04 115.11 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.541 -0.724 . . . . 0.0 111.758 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 27.7 p -97.01 -50.38 4.64 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 124.065 0.946 . . . . 0.0 112.597 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' H ' ' HB ' ' A' ' 36' ' ' THR . 12.8 mp0 -121.63 105.22 10.23 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 123.594 1.664 . . . . 0.0 113.241 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.36 70.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 123.672 1.701 . . . . 0.0 114.367 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 12.9 mmt -30.36 -47.93 0.09 Allowed 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.477 ' CG2' HD23 ' A' ' 34' ' ' LEU . 15.8 m -128.71 154.35 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-O 122.853 1.311 . . . . 0.0 112.751 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.5 mtmt -129.3 -170.2 2.24 Favored 'General case' 0 N--CA 1.522 3.174 0 N-CA-C 119.066 2.987 . . . . 0.0 119.066 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.22 93.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.33 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.87 11.28 8.55 Favored Glycine 1 N--CA 1.516 4.003 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.553 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.5 m-20 -101.85 130.6 48.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 123.765 1.745 . . . . 0.0 112.649 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -57.0 91.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 111.648 -2.524 . . . . 0.0 111.642 179.156 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 22' ' ' VAL . 91.8 t -100.45 120.98 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -134.75 155.69 50.14 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.7 -1.25 . . . . 0.0 112.561 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.33 156.25 4.48 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.464 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 81.37 -20.29 0.38 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.715 1.884 . . . . 0.0 111.251 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.539 ' HG2' ' N ' ' A' ' 33' ' ' SER . 1.6 tt0 -95.15 155.4 16.75 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.579 1.181 . . . . 0.0 109.425 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.539 ' N ' ' HG2' ' A' ' 32' ' ' GLN . 62.6 p -76.13 134.16 40.05 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.213 1.482 . . . . 0.0 112.57 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.477 HD23 ' CG2' ' A' ' 22' ' ' VAL . 4.2 mt -96.13 -58.77 1.99 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.921 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.437 ' HB ' HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -147.74 148.38 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.576 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.472 ' HB ' ' H ' ' A' ' 19' ' ' GLU . 64.9 m -94.81 135.34 36.42 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.1 m -125.98 147.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.526 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -132.84 -165.6 1.63 Allowed 'General case' 0 N--CA 1.512 2.651 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . 163.14 -83.91 0.11 Allowed Glycine 1 N--CA 1.521 4.304 0 CA-C-N 114.46 -1.245 . . . . 0.0 115.316 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.517 ' OD2' ' HE2' ' A' ' 41' ' ' LYS . 25.0 t70 -120.86 -122.79 0.28 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 117.705 0.752 . . . . 0.0 111.422 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.517 ' HE2' ' OD2' ' A' ' 40' ' ' ASP . 65.3 mmtt -6.67 -46.23 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 119.768 3.248 . . . . 0.0 119.768 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -178.59 179.42 0.74 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 123.602 0.761 . . . . 0.0 112.016 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.7 145.01 26.85 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.049 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.1 mtp -133.04 168.64 18.11 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.529 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 36' ' ' THR . 27.9 mt-10 -129.64 156.09 44.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.541 HG22 HG21 ' A' ' 10' ' ' ILE . 71.1 t -119.15 114.36 35.03 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.299 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.91 177.77 7.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 CA-C-O 123.698 1.458 . . . . 0.0 111.873 171.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -75.09 103.52 0.99 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 119.447 3.129 . . . . 0.0 119.447 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 19.5 Cg_endo -41.41 -34.36 1.89 Allowed 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.664 2.242 . . . . 0.0 113.908 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.56 -169.25 3.06 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 113.34 -1.754 . . . . 0.0 110.159 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.1 163.25 13.32 Favored 'General case' 0 CA--C 1.574 1.869 1 N-CA-C 123.135 4.494 . . . . 0.0 123.135 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.96 -142.93 14.51 Favored Glycine 1 N--CA 1.517 4.039 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.394 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.42 165.76 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 O-C-N 121.813 -0.816 . . . . 0.0 108.955 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 22.5 t -89.72 128.08 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.212 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HD2' ' HB2' ' A' ' 75' ' ' GLU . 39.6 tttm -103.62 -58.75 1.83 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 22.4 tt0 -141.95 151.2 42.35 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.949 0.795 . . . . 0.0 111.825 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -148.92 154.01 38.82 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 119.499 -2.001 . . . . 0.0 110.397 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 76.9 mttt -131.87 49.26 2.34 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-O 125.224 2.44 . . . . 0.0 109.582 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.0 m -137.5 151.9 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 1 CA-C-N 108.345 -4.025 . . . . 0.0 108.537 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -134.14 176.9 8.17 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 122.94 1.352 . . . . 0.0 111.585 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 18' ' ' THR . 1.6 t -88.29 114.1 26.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 1 N-CA-C 95.713 -5.662 . . . . 0.0 95.713 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.52 7.88 6.65 Favored Glycine 0 N--CA 1.513 3.822 0 CA-C-N 109.271 -3.604 . . . . 0.0 110.785 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 19.1 t70 -113.19 167.66 10.36 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.931 0.872 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.766 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.67 157.86 16.17 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.75 165.81 9.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 112.842 -1.981 . . . . 0.0 112.596 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -172.61 146.19 1.65 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 123.31 0.381 . . . . 0.0 110.951 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -42.12 113.32 0.42 Allowed 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 125.416 2.532 . . . . 0.0 115.952 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 -40.81 2.31 Favored Glycine 0 N--CA 1.515 3.932 0 CA-C-N 112.92 -1.945 . . . . 0.0 113.089 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.2 m -53.33 128.45 28.38 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 3.8 mm? -68.77 66.17 0.13 Allowed 'General case' 0 N--CA 1.521 3.097 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' HB ' ' SD ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -27.48 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -157.46 -173.23 4.31 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 110.773 -2.921 . . . . 0.0 115.147 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.412 HD11 ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -118.75 132.25 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 123.229 1.49 . . . . 0.0 110.432 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.546 ' CE1' HG21 ' A' ' 5' ' ' VAL . 18.2 m-30 -114.12 169.17 9.21 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-N 113.734 -1.576 . . . . 0.0 115.23 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 61.4 tt0 -138.46 127.08 23.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 123.467 1.603 . . . . 0.0 109.173 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 76' ' ' VAL . 16.8 m -77.94 86.31 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -3.32 72.72 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 N-CA-C 121.552 3.908 . . . . 0.0 121.552 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -140.44 26.11 2.57 Favored Glycine 0 N--CA 1.507 3.402 0 N-CA-C 106.072 -2.811 . . . . 0.0 106.072 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -31.73 102.34 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 118.586 2.81 . . . . 0.0 118.586 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.61 0 O-C-N 124.655 1.222 . . . . 0.0 110.194 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mtp . . . . . 0 N--CA 1.51 2.56 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.9 m 0.17 119.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 N-CA-C 119.986 3.328 . . . . 0.0 119.986 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HE3' ' OE1' ' A' ' 4' ' ' GLU . 24.7 mmmt -119.8 158.71 26.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.366 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -96.18 145.92 25.12 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 123.424 1.583 . . . . 0.0 114.581 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -121.56 91.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-O 123.864 1.792 . . . . 0.0 111.223 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.66 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.5 p30 -101.91 -179.49 4.02 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 111.635 -2.529 . . . . 0.0 107.799 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 65' ' ' VAL . 79.8 t -104.51 133.54 20.14 Favored Pre-proline 0 N--CA 1.503 2.213 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -82.77 -170.05 0.85 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 123.875 3.05 . . . . 0.0 111.458 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -72.98 66.97 0.82 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 124.764 2.221 . . . . 0.0 112.535 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -76.57 52.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.773 0 O-C-N 119.808 -1.807 . . . . 0.0 114.886 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.13 -37.38 0.11 Allowed Glycine 1 N--CA 1.522 4.381 0 N-CA-C 120.43 2.932 . . . . 0.0 120.43 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.51 179.8 16.19 Favored Glycine 1 N--CA 1.531 5.025 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 10.7 t70 -86.41 -72.73 0.49 Allowed 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 121.624 0.726 . . . . 0.0 111.559 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -114.47 124.81 52.84 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 m -148.71 158.54 6.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.002 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.572 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 pt-20 -119.67 170.3 9.32 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.756 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.95 130.48 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.896 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 11.8 t -108.91 -44.91 3.89 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.059 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 3.3 mm-40 -130.55 112.76 13.48 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.801 1.286 . . . . 0.0 108.517 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 7.4 p -90.49 70.34 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 124.506 2.098 . . . . 0.0 114.083 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mmm -32.39 -60.87 0.28 Allowed 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 119.536 3.162 . . . . 0.0 119.536 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.703 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.3 t -103.81 150.22 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.703 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -129.56 -179.1 4.97 Favored 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 120.386 3.476 . . . . 0.0 120.386 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -53.07 115.5 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.226 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.09 10.88 31.11 Favored Glycine 1 N--CA 1.518 4.153 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.227 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' HB3' ' CG1' ' A' ' 22' ' ' VAL . 2.6 m-20 -114.45 131.85 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.732 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -58.41 75.72 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 108.696 -3.865 . . . . 0.0 110.614 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 2.3 t -82.5 151.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 CA-C-O 124.525 2.107 . . . . 0.0 114.049 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -152.26 153.41 33.7 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.953 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.54 163.43 0.28 Allowed 'General case' 0 N--CA 1.512 2.647 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.918 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 69.85 -27.79 0.16 Allowed 'General case' 0 N--CA 1.52 3.03 0 CA-C-O 122.018 0.913 . . . . 0.0 112.486 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -84.44 97.55 9.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.784 1.278 . . . . 0.0 112.261 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.0 m -31.86 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -70.98 -52.16 21.33 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.538 HG13 ' HB ' ' A' ' 46' ' ' VAL . 30.4 pt -143.11 151.76 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.909 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 51.9 m -105.31 127.97 53.23 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 28.4 m -120.45 154.17 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -125.0 172.65 9.25 Favored 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.57 -65.04 0.01 OUTLIER Glycine 1 N--CA 1.53 4.911 0 N-CA-C 122.663 3.825 . . . . 0.0 122.663 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.603 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 9.5 p-10 -112.56 -83.16 0.59 Allowed 'General case' 0 N--CA 1.522 3.154 0 N-CA-C 120.51 3.522 . . . . 0.0 120.51 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.603 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 66.3 mmtt -119.56 -28.18 5.36 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 129.664 3.186 . . . . 0.0 111.238 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.43 167.36 10.79 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.99 1.376 . . . . 0.0 112.786 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -111.78 156.39 22.02 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.957 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 35.8 tpp -134.83 158.61 43.76 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.458 0.646 . . . . 0.0 111.714 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.37 153.67 30.59 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.904 1.812 . . . . 0.0 114.247 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.538 ' HB ' HG13 ' A' ' 35' ' ' ILE . 60.1 t -123.87 102.67 34.65 Favored Pre-proline 0 N--CA 1.495 1.824 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.413 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -79.01 169.37 19.41 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 CA-C-O 124.394 1.747 . . . . 0.0 109.743 173.603 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -61.26 115.48 14.72 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 111.441 -2.618 . . . . 0.0 117.528 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 28.0 Cg_endo -46.85 -26.66 4.91 Favored 'Trans proline' 0 N--CA 1.509 2.436 0 C-N-CA 122.144 1.896 . . . . 0.0 113.295 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -171.73 -174.26 1.32 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.532 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.51 166.97 11.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.83 -172.17 21.44 Favored Glycine 0 N--CA 1.514 3.84 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.369 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 t -106.65 149.87 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 C-N-CA 117.549 -1.661 . . . . 0.0 113.14 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG13 ' SD ' ' A' ' 72' ' ' MET . 58.4 t -67.29 102.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.592 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -82.44 -62.81 1.51 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.559 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 1.5 tt0 -147.24 151.28 36.42 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.96 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -143.55 135.81 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.502 -0.749 . . . . 0.0 110.58 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 41.9 mttm -114.45 42.87 2.01 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.11 161.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.072 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -132.78 170.78 14.79 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 121.489 3.885 . . . . 0.0 121.489 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.6 t -96.11 101.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 101.17 -3.641 . . . . 0.0 101.17 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.92 32.4 1.56 Allowed Glycine 0 N--CA 1.502 3.04 1 CA-C-N 107.826 -4.261 . . . . 0.0 106.816 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -113.95 174.07 6.12 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 16' ' ' GLU . 29.6 mmmt -101.37 132.39 46.96 Favored 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 121.233 3.79 . . . . 0.0 121.233 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -130.57 165.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 113.35 -1.75 . . . . 0.0 111.146 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 167.72 150.66 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 124.59 1.156 . . . . 0.0 110.021 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.76 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.34 -41.98 1.99 Allowed Glycine 1 N--CA 1.518 4.104 0 N-CA-C 116.699 1.44 . . . . 0.0 116.699 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.4 t -35.48 139.25 0.12 Allowed 'General case' 0 N--CA 1.531 3.617 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.966 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.3 mt -94.55 63.51 2.94 Favored 'General case' 0 N--CA 1.52 3.053 0 CA-C-N 120.358 1.435 . . . . 0.0 113.189 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.8 mm -40.52 -58.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.623 ' SD ' HG13 ' A' ' 54' ' ' VAL . 4.6 ptp -155.9 -172.92 4.3 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.27 122.0 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 122.998 1.38 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.618 ' CD1' HG21 ' A' ' 5' ' ' VAL . 5.6 m-30 -98.89 156.95 16.63 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.817 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.453 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 17.4 tt0 -147.6 98.15 2.94 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 123.952 1.834 . . . . 0.0 111.444 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 78' ' ' GLY . 34.3 m -58.49 69.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-N 114.053 -1.43 . . . . 0.0 114.616 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 52.82 -69.83 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.87 0 CA-C-O 122.202 1.001 . . . . 0.0 112.816 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . 164.03 33.1 0.02 OUTLIER Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -22.5 -83.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.315 0 C-N-CA 130.683 3.593 . . . . 0.0 108.709 179.505 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttm . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.0 t -42.45 164.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 73.3 mmtt -136.73 154.22 50.65 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.769 -1.559 . . . . 0.0 113.013 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.8 152.23 20.75 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.933 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 ' CE1' ' A' ' 74' ' ' PHE . 74.1 t -118.24 107.9 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -107.82 141.26 39.67 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.037 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 48.9 t -51.37 121.86 17.99 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 113.019 -1.9 . . . . 0.0 113.162 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 67' ' ' THR . 83.0 Cg_endo -63.49 -168.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.505 2.148 0 C-N-CA 123.182 2.588 . . . . 0.0 114.623 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -70.01 48.88 0.1 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 124.377 2.037 . . . . 0.0 115.126 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.508 HG21 HG22 ' A' ' 46' ' ' VAL . 29.8 pt -80.64 47.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.761 0 O-C-N 119.798 -1.814 . . . . 0.0 114.039 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -10.11 57.87 0.0 OUTLIER Glycine 1 N--CA 1.524 4.566 0 N-CA-C 120.505 2.962 . . . . 0.0 120.505 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -130.93 160.31 23.25 Favored Glycine 1 N--CA 1.519 4.196 0 N-CA-C 114.461 0.544 . . . . 0.0 114.461 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -82.23 58.8 4.19 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 124.787 1.235 . . . . 0.0 112.721 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 66' ' ' LYS . 4.8 mm-40 65.19 97.25 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.221 0 CA-C-O 122.239 1.018 . . . . 0.0 112.249 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.69 169.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 10.2 pt-20 -106.73 179.12 4.36 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.524 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.69 115.61 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 38' ' ' GLU . 18.7 p -96.86 -41.22 8.54 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.2 126.02 46.18 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 119.679 1.127 . . . . 0.0 112.038 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.7 53.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 125.549 2.595 . . . . 0.0 116.547 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.7 mmm -20.05 -54.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 110.509 -3.042 . . . . 0.0 114.152 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' ' HZ3' ' A' ' 23' ' ' LYS . 1.4 m -114.88 159.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 O-C-N 120.778 -1.201 . . . . 0.0 108.699 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HZ3' ' HA ' ' A' ' 22' ' ' VAL . 3.8 mtmm -143.37 -176.9 5.12 Favored 'General case' 0 N--CA 1.522 3.13 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -49.15 106.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.775 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.99 -48.94 0.91 Allowed Glycine 0 N--CA 1.508 3.496 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -36.51 130.0 0.73 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-O 123.987 1.851 . . . . 0.0 115.39 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' NZ ' ' CD ' ' A' ' 77' ' ' GLU . 70.9 mmtt -70.5 76.88 0.57 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.141 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 74' ' ' PHE . 37.6 t -79.34 156.97 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 125.413 2.53 . . . . 0.0 116.981 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -164.81 154.93 13.85 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.833 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.48 166.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.332 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 65.05 -21.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' ALA . 1.3 tm0? -93.34 152.68 18.99 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 p -68.34 146.66 53.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 123.223 1.487 . . . . 0.0 110.716 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' HD2' ' A' ' 49' ' ' PRO . 4.9 mt -109.08 -65.6 1.13 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 123.748 1.737 . . . . 0.0 109.032 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.8 pt -142.53 160.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 111.351 -2.659 . . . . 0.0 110.013 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.6 m -107.3 129.04 54.94 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.7 m -118.39 151.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 118.116 2.636 . . . . 0.0 118.116 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.417 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER -133.35 -167.25 1.89 Allowed 'General case' 0 N--CA 1.513 2.7 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -179.106 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.59 -101.84 0.24 Allowed Glycine 1 N--CA 1.527 4.714 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.495 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 42' ' ' ALA . 23.3 m-20 -90.81 -133.48 0.12 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 122.258 1.028 . . . . 0.0 112.89 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.564 ' NZ ' ' SD ' ' A' ' 44' ' ' MET . 10.8 ptmm? 4.14 -43.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.487 1 N-CA-C 122.811 4.375 . . . . 0.0 122.811 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . 167.03 163.96 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 O-C-N 124.778 1.299 . . . . 0.0 110.386 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.0 p -69.21 153.28 43.93 Favored 'General case' 0 N--CA 1.515 2.785 0 CA-C-O 121.581 0.705 . . . . 0.0 112.872 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.564 ' SD ' ' NZ ' ' A' ' 41' ' ' LYS . 30.5 mtp -142.92 163.3 33.17 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.909 -0.495 . . . . 0.0 112.185 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.01 149.23 42.49 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.777 1.275 . . . . 0.0 113.911 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG22 HG21 ' A' ' 10' ' ' ILE . 54.6 t -120.05 127.38 26.39 Favored Pre-proline 0 N--CA 1.503 2.202 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -92.67 178.59 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.148 1.899 . . . . 0.0 114.295 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -67.7 110.44 5.42 Favored Pre-proline 0 CA--C 1.578 2.056 0 N-CA-C 117.595 2.443 . . . . 0.0 117.595 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD2' HD11 ' A' ' 34' ' ' LEU . 40.2 Cg_endo -53.38 -21.41 17.88 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 122.905 2.404 . . . . 0.0 113.384 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -164.74 -169.65 1.78 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.401 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -108.82 158.77 17.34 Favored 'General case' 0 C--N 1.3 -1.56 1 N-CA-C 121.838 4.014 . . . . 0.0 121.838 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . 132.91 179.85 16.68 Favored Glycine 1 N--CA 1.519 4.212 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.548 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' HD3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -92.53 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.27 -1.723 . . . . 0.0 113.978 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 74' ' ' PHE . 35.6 t -83.87 112.23 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.07 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -93.16 -55.04 3.47 Favored 'General case' 0 N--CA 1.516 2.837 0 CA-C-N 120.42 1.464 . . . . 0.0 112.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 4.5 tt0 -147.91 162.08 40.0 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 121.135 0.493 . . . . 0.0 109.918 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -162.72 150.78 14.02 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.943 -1.098 . . . . 0.0 108.36 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 41.2 mtmt -125.16 53.01 1.55 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.896 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 71' ' ' ILE . 34.2 m -138.35 157.3 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 126.183 2.177 . . . . 0.0 112.279 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 3.6 m120 -124.78 173.83 8.31 Favored 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.79 83.05 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 127.298 3.428 . . . . 0.0 104.458 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.25 41.9 0.08 OUTLIER Glycine 0 N--CA 1.505 3.273 1 CA-C-N 104.699 -5.682 . . . . 0.0 107.058 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.499 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 11.3 t0 -122.49 168.67 11.83 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -113.24 144.91 41.9 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 121.786 3.995 . . . . 0.0 121.786 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 m -125.44 130.49 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 118.251 2.685 . . . . 0.0 118.251 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HB3' ' CD ' ' A' ' 14' ' ' GLU . 4.4 ptmm? -130.18 120.28 24.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 8' ' ' PRO . 24.5 p -28.47 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 124.571 2.129 . . . . 0.0 112.501 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.46 42.0 1.67 Allowed Glycine 0 N--CA 1.508 3.485 0 CA-C-N 109.983 -3.281 . . . . 0.0 113.635 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -115.51 131.88 56.8 Favored 'General case' 0 N--CA 1.529 3.493 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.504 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.08 63.99 0.71 Allowed 'General case' 0 N--CA 1.519 2.981 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.463 HG23 HG11 ' A' ' 59' ' ' VAL . 24.0 mm -53.68 -63.47 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.592 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 18.2 ptt? -138.81 168.82 18.98 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.43 119.79 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 123.365 1.555 . . . . 0.0 110.388 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 28' ' ' VAL . 8.8 m-30 -99.87 163.87 12.27 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.435 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -144.34 106.14 4.3 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.851 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HA ' ' CA ' ' A' ' 52' ' ' GLY . 34.2 m -43.69 48.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 1 N-CA-C 122.784 4.364 . . . . 0.0 122.784 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.523 ' CD ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.52 104.4 16.42 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.98 -51.95 0.08 OUTLIER Glycine 1 N--CA 1.517 4.035 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 122.15 100.38 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 109.48 -3.36 . . . . 0.0 106.479 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.694 0 C-N-CA 127.82 2.448 . . . . 0.0 106.57 -179.587 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 117.199 -1.381 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 3' ' ' LYS . 3.5 t 62.12 -178.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.833 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.612 ' H ' HG12 ' A' ' 2' ' ' VAL . 33.1 mmtm -141.79 131.51 24.17 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -88.25 151.1 22.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.698 -1.251 . . . . 0.0 109.236 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 79.7 t -108.14 115.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 CA-C-O 121.569 0.7 . . . . 0.0 111.851 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.6 p30 -106.18 -179.18 3.86 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 123.0 1.381 . . . . 0.0 111.383 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.547 HG22 HD11 ' A' ' 71' ' ' ILE . 34.7 t -101.19 117.86 61.39 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.907 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 85.0 Cg_endo -61.92 -174.35 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.643 1.562 . . . . 0.0 113.0 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -68.75 51.66 0.08 Allowed 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 124.729 2.204 . . . . 0.0 114.171 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.533 HG21 HG22 ' A' ' 46' ' ' VAL . 29.6 pt -78.03 46.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 O-C-N 119.066 -2.271 . . . . 0.0 114.611 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.14 -66.42 0.35 Allowed Glycine 1 N--CA 1.519 4.224 0 N-CA-C 116.276 1.27 . . . . 0.0 116.276 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.13 -59.65 0.46 Allowed Glycine 1 N--CA 1.517 4.035 0 CA-C-N 113.698 -1.251 . . . . 0.0 110.015 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -27.09 143.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 117.886 2.551 . . . . 0.0 117.886 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' CD ' ' HZ3' ' A' ' 66' ' ' LYS . 3.2 mm-40 -85.56 87.47 7.4 Favored 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 101.775 -3.417 . . . . 0.0 101.775 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 m -95.67 175.56 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 114.295 -1.321 . . . . 0.0 114.226 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.631 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 9.9 pt-20 -123.8 167.91 13.44 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -95.42 122.51 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 m -92.38 -52.02 4.86 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 126.424 1.89 . . . . 0.0 108.597 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -131.89 120.74 22.97 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.7 0.762 . . . . 0.0 111.407 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.5 p -95.29 61.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 123.573 1.654 . . . . 0.0 110.444 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 mtt -27.73 -32.77 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 118.584 2.809 . . . . 0.0 118.584 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG12 HE21 ' A' ' 32' ' ' GLN . 19.5 m -115.85 145.72 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -129.88 176.13 8.29 Favored 'General case' 0 N--CA 1.517 2.884 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.15 102.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.85 0 CA-C-N 114.174 -1.375 . . . . 0.0 114.406 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.02 -36.21 3.03 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.256 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -49.36 171.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HD3' HG12 ' A' ' 53' ' ' VAL . 74.3 mmtt -105.44 105.13 15.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 111.629 -2.532 . . . . 0.0 108.841 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 74' ' ' PHE . 21.8 t -115.2 106.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -117.29 158.74 23.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.827 -1.171 . . . . 0.0 110.52 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -42.5 157.83 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.702 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.027 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 2.7 tm-20 79.55 -48.88 0.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.828 1.299 . . . . 0.0 107.845 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' LEU . 43.0 tt0 -47.37 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 m -32.19 61.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -19.45 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 pt -147.61 146.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 110.628 -2.987 . . . . 0.0 112.89 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 45' ' ' GLU . 9.0 m -105.15 124.73 50.03 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.09 158.41 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 117.849 2.536 . . . . 0.0 117.849 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.05 -177.42 4.13 Favored 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.794 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.09 -75.01 0.13 Allowed Glycine 0 N--CA 1.514 3.878 0 N-CA-C 118.833 2.293 . . . . 0.0 118.833 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.775 ' HB2' ' CE ' ' A' ' 41' ' ' LYS . 49.3 m-20 -127.79 -102.11 0.34 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 125.67 2.653 . . . . 0.0 115.793 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.775 ' CE ' ' HB2' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -33.2 -47.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 129.245 3.018 . . . . 0.0 115.907 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' O ' ' SD ' ' A' ' 44' ' ' MET . . . 179.01 173.26 0.77 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.1 p -90.78 148.86 22.26 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 123.525 0.516 . . . . 0.0 111.949 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 42' ' ' ALA . 2.1 mpp? -121.71 159.2 27.09 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 36' ' ' THR . 19.8 mt-10 -117.18 146.41 43.24 Favored 'General case' 0 N--CA 1.506 2.342 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.481 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.533 HG22 HG21 ' A' ' 10' ' ' ILE . 66.5 t -122.7 127.04 25.92 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.838 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.48 171.86 7.22 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.794 1.662 . . . . 0.0 111.326 174.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -58.62 103.86 0.39 Allowed Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HG2' HG13 ' A' ' 5' ' ' VAL . 72.9 Cg_exo -35.48 -40.17 0.31 Allowed 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 123.409 2.739 . . . . 0.0 113.199 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.05 -172.4 4.01 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 109.981 -3.281 . . . . 0.0 108.109 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.45 162.15 14.18 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.706 3.224 . . . . 0.0 119.706 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.3 -154.25 21.58 Favored Glycine 1 N--CA 1.519 4.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.572 HG12 ' HD3' ' A' ' 27' ' ' LYS . 17.6 m -114.66 174.82 2.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.321 1.534 . . . . 0.0 113.001 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 74' ' ' PHE . 20.6 t -102.73 108.58 24.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.976 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 14.0 tttm -88.57 -45.42 9.9 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.179 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 60.3 tt0 -165.45 163.83 19.61 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.696 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -160.37 164.29 32.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.106 . . . . 0.0 110.447 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -130.88 51.07 2.16 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -143.7 155.35 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 125.633 1.833 . . . . 0.0 113.504 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.535 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -127.44 -177.36 4.05 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 125.521 2.581 . . . . 0.0 115.321 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.91 104.61 16.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 101.123 -3.658 . . . . 0.0 101.123 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 136.85 -10.72 3.95 Favored Glycine 0 N--CA 1.514 3.864 1 CA-C-N 107.783 -4.281 . . . . 0.0 110.188 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -69.73 174.01 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.959 0.904 . . . . 0.0 110.268 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.631 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 30.4 mmtm -115.85 142.18 47.12 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.8 164.65 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.14 0.576 . . . . 0.0 112.397 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' HZ3' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -175.55 153.74 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 2.9 t -39.45 118.5 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 122.579 1.18 . . . . 0.0 113.426 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.45 -29.17 7.11 Favored Glycine 1 N--CA 1.518 4.127 0 CA-C-N 114.574 -1.194 . . . . 0.0 115.607 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 24.5 t -75.7 161.25 29.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 117.92 -1.512 . . . . 0.0 112.933 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.3 mt -97.91 64.79 1.75 Allowed 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.547 HD11 HG22 ' A' ' 7' ' ' VAL . 5.6 mt -21.82 -67.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.424 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 13.4 ptp -149.93 179.39 8.09 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.519 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.5 118.25 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 123.351 1.548 . . . . 0.0 111.835 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.501 ' CE1' HG22 ' A' ' 54' ' ' VAL . 10.5 m-30 -106.99 162.9 13.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 123.43 1.586 . . . . 0.0 112.086 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' O ' HG22 ' A' ' 53' ' ' VAL . 1.4 tt0 -142.57 133.09 25.09 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.345 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 79' ' ' ALA . 14.6 m -83.65 73.87 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.569 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 61.61 -17.67 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.144 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 76' ' ' VAL . . . 153.6 -54.75 0.44 Allowed Glycine 1 N--CA 1.524 4.536 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 76' ' ' VAL . . . 92.76 104.99 0.02 OUTLIER 'General case' 0 CA--C 1.582 2.181 0 CA-C-N 110.167 -3.017 . . . . 0.0 118.42 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 2.795 0 C-N-CA 128.565 2.746 . . . . 0.0 106.937 179.557 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 mtm . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 115.495 -2.193 . . . . 0.0 106.426 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.405 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 22.6 t 63.48 136.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 124.14 1.924 . . . . 0.0 113.48 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -126.98 145.23 50.78 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.503 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -81.79 155.58 25.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.19 0.995 . . . . 0.0 110.809 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 74' ' ' PHE . 48.2 t -122.71 91.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 123.73 1.729 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -96.32 146.5 24.68 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG12 HD12 ' A' ' 10' ' ' ILE . 53.9 t -72.23 137.84 81.52 Favored Pre-proline 0 N--CA 1.501 2.084 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.789 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -76.44 -175.33 2.51 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.174 1.916 . . . . 0.0 112.699 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.13 57.83 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 124.595 2.141 . . . . 0.0 115.631 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.594 HG21 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -80.4 51.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.93 0 O-C-N 119.232 -2.167 . . . . 0.0 109.758 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.55 -60.39 0.67 Allowed Glycine 1 N--CA 1.518 4.152 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.771 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.79 -59.21 0.54 Allowed Glycine 0 N--CA 1.511 3.653 0 CA-C-N 113.059 -1.571 . . . . 0.0 110.213 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -22.87 176.25 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.0 1 N-CA-C 123.244 4.535 . . . . 0.0 123.244 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -99.38 88.02 3.78 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 112.045 -2.343 . . . . 0.0 113.694 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.8 m -118.63 161.99 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.87 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 2.0 pm0 -118.64 179.03 4.25 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.73 1.252 . . . . 0.0 110.274 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -94.3 115.64 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.302 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 m -90.45 -34.98 15.4 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -143.62 134.74 25.66 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.19 64.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 124.73 2.205 . . . . 0.0 114.972 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.2 mmm -25.17 -48.74 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 109.875 -3.329 . . . . 0.0 118.019 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.82 164.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -130.52 -174.86 3.47 Favored 'General case' 0 N--CA 1.522 3.145 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.1 107.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.875 0 O-C-N 120.831 -1.168 . . . . 0.0 111.472 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.87 -25.83 9.82 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-O 122.172 0.873 . . . . 0.0 111.915 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.85 156.62 13.91 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -86.51 127.84 34.91 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.918 1.342 . . . . 0.0 110.65 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 35.7 t -127.41 93.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 112.369 -2.196 . . . . 0.0 113.599 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -99.79 158.7 15.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.726 -1.234 . . . . 0.0 108.617 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -54.08 163.68 0.75 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.142 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 75.55 -35.63 0.28 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.763 1.268 . . . . 0.0 110.562 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -67.31 127.22 31.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 123.146 1.45 . . . . 0.0 112.34 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.5 p -57.77 97.71 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -61.13 -63.31 1.34 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.81 150.17 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 112.187 -2.279 . . . . 0.0 110.038 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 87.2 m -97.77 114.95 27.09 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.74 148.57 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -129.3 178.07 6.71 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.4 -72.02 0.02 OUTLIER Glycine 1 N--CA 1.519 4.217 0 N-CA-C 116.883 1.513 . . . . 0.0 116.883 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.674 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 10.9 p-10 -114.55 -73.21 0.66 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 123.038 1.399 . . . . 0.0 113.216 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.674 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -125.78 -14.34 6.22 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 126.864 2.065 . . . . 0.0 110.68 179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.89 132.79 53.83 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 t -102.57 143.22 32.55 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.717 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.4 ptp -148.98 174.59 12.12 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -122.88 157.95 31.4 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG22 HG21 ' A' ' 10' ' ' ILE . 74.9 t -121.54 126.18 26.56 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.582 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -88.94 171.84 4.64 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.485 1.369 . . . . 0.0 110.073 174.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -70.81 119.85 75.56 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 118.581 2.808 . . . . 0.0 118.581 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HD2' HD11 ' A' ' 34' ' ' LEU . 30.3 Cg_endo -50.1 -29.26 21.6 Favored 'Trans proline' 0 N--CA 1.511 2.544 0 C-N-CA 122.947 2.431 . . . . 0.0 112.953 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.71 -175.19 5.01 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 112.214 -2.266 . . . . 0.0 108.536 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.47 161.53 13.64 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.76 -167.88 23.81 Favored Glycine 1 N--CA 1.524 4.516 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.102 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.69 165.03 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 118.613 1.206 . . . . 0.0 113.171 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CE1' ' A' ' 74' ' ' PHE . 25.0 t -89.84 120.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 75' ' ' GLU . 6.3 tttp -103.98 -62.6 1.29 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG2' HD11 ' A' ' 73' ' ' ILE . 2.2 tp10 -130.62 137.19 49.5 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 118.326 0.512 . . . . 0.0 110.803 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.4 pt? -149.69 114.7 5.4 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 123.466 1.603 . . . . 0.0 108.425 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 93.3 mttt -94.48 50.74 1.37 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.28 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.11 143.36 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.431 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -130.94 -172.56 2.86 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.793 2.235 . . . . 0.0 113.58 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.54 108.27 19.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.37 -15.81 4.68 Favored Glycine 0 N--CA 1.513 3.798 0 CA-C-N 108.913 -3.767 . . . . 0.0 113.144 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -70.28 157.08 38.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.0 mmmt -91.56 136.69 32.94 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.98 152.3 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.999 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -162.98 148.29 11.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.4 t -55.32 120.59 7.32 Favored 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.241 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.14 6.42 39.43 Favored Glycine 1 N--CA 1.523 4.452 0 CA-C-N 114.408 -1.269 . . . . 0.0 114.985 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -93.84 112.69 24.58 Favored 'General case' 0 N--CA 1.517 2.919 0 O-C-N 120.95 -1.324 . . . . 0.0 111.491 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 70' ' ' LEU . 1.4 mp -61.94 56.59 0.01 OUTLIER 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mm -42.61 -51.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 4.9 ptp -151.18 -175.05 5.01 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.487 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -123.24 120.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 123.814 1.768 . . . . 0.0 114.494 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 5' ' ' VAL . 19.7 m-30 -108.82 164.61 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.313 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 4.7 tp10 -138.13 131.03 29.84 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 76' ' ' VAL . 27.1 m -70.93 59.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 68.51 101.76 0.05 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-O 123.71 1.719 . . . . 0.0 112.972 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.18 45.52 0.8 Allowed Glycine 1 N--CA 1.522 4.4 0 N-CA-C 107.334 -2.306 . . . . 0.0 107.334 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 37.02 50.27 0.88 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 110.531 -2.834 . . . . 0.0 115.528 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.463 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.663 0 C-N-CA 129.926 3.29 . . . . 0.0 107.264 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.41 0 CA-C-O 120.669 0.271 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 m -88.68 146.15 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' HG22 ' A' ' 73' ' ' ILE . 4.1 mmmm -137.98 154.12 49.38 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 2.7 pp20? -101.35 172.08 7.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.761 -0.587 . . . . 0.0 110.103 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 74' ' ' PHE . 58.4 t -133.53 97.53 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.142 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 69' ' ' SER . 2.5 p-10 -94.56 168.66 10.71 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.572 HG23 HG13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -98.73 125.44 42.4 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 118.104 -1.438 . . . . 0.0 111.346 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 60.5 Cg_endo -67.74 -91.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 123.619 2.879 . . . . 0.0 109.961 -163.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.527 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 4.6 p-10 -130.53 147.43 52.21 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.53 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -151.49 37.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.553 0 CA-C-O 123.831 1.777 . . . . 0.0 109.554 179.227 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.45 -55.61 3.7 Favored Glycine 1 N--CA 1.52 4.275 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.791 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -125.58 -144.74 6.3 Favored Glycine 0 N--CA 1.506 3.313 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.551 ' CG ' ' NZ ' ' A' ' 66' ' ' LYS . 0.6 OUTLIER -105.33 -75.38 0.63 Allowed 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 102.87 3.72 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 119.376 3.102 . . . . 0.0 119.376 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.5 m -129.88 141.93 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.692 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.72 165.3 20.05 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -112.53 120.08 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 118.944 -1.102 . . . . 0.0 108.578 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -94.9 -48.18 6.12 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.081 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.83 102.94 5.42 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 123.2 1.476 . . . . 0.0 113.283 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.96 64.64 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 O-C-N 119.83 -1.794 . . . . 0.0 113.441 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 mtt -32.78 -36.12 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 N-CA-C 121.253 3.797 . . . . 0.0 121.253 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.91 142.68 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 6.8 mtpm? -134.94 179.94 6.0 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 119.148 3.018 . . . . 0.0 119.148 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.8 t -45.04 91.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.456 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 2.63 12.51 Favored Glycine 1 N--CA 1.523 4.454 0 CA-C-O 121.91 0.728 . . . . 0.0 113.555 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 59.4 m-20 -97.51 120.42 37.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 124.903 2.287 . . . . 0.0 113.731 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.715 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -65.52 95.24 0.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.649 -2.523 . . . . 0.0 110.933 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 34' ' ' LEU . 7.3 t -91.15 157.56 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.734 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.21 167.77 2.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.321 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.33 162.09 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 O-C-N 124.582 1.176 . . . . 0.0 113.638 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.85 -10.37 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.655 1.217 . . . . 0.0 113.923 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 30' ' ' ALA . 34.7 tt0 -90.15 87.68 6.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.203 -1.561 . . . . 0.0 106.809 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 70.7 m -35.99 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -24.63 -66.4 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 pt -147.42 146.02 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 111.387 -2.642 . . . . 0.0 111.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 45' ' ' GLU . 96.6 m -93.17 131.01 38.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.82 160.55 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -128.5 -157.89 0.85 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 129.7 172.28 13.12 Favored Glycine 0 N--CA 1.51 3.597 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 54.05 -83.42 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 CA-C-O 122.989 1.375 . . . . 0.0 113.095 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 39' ' ' GLY . 1.5 pptp? 170.69 35.71 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 128.615 2.766 . . . . 0.0 108.615 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.11 104.57 5.97 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.114 -1.403 . . . . 0.0 114.561 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t -70.52 109.07 4.62 Favored 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.529 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 45.2 mtm -109.72 161.28 15.56 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.832 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' A' ' 36' ' ' THR . 27.6 mt-10 -122.14 158.59 28.99 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 37.3 t -130.05 121.45 19.76 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.51 171.28 2.43 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.28 1.32 . . . . 0.0 111.217 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -45.28 96.7 0.12 Allowed Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HG ' ' A' ' 34' ' ' LEU . 18.2 Cg_endo -44.55 -28.39 2.69 Favored 'Trans proline' 0 N--CA 1.511 2.551 0 C-N-CA 121.968 1.779 . . . . 0.0 112.973 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -163.8 -179.35 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.322 -2.217 . . . . 0.0 107.016 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.16 156.54 18.71 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 120.035 3.346 . . . . 0.0 120.035 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.33 -173.65 22.14 Favored Glycine 1 N--CA 1.529 4.863 0 CA-C-N 112.772 -2.013 . . . . 0.0 114.185 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 26' ' ' ASP . 1.4 t -95.8 167.83 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 CA-C-N 120.405 2.103 . . . . 0.0 112.209 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 ' CE1' ' A' ' 74' ' ' PHE . 11.7 t -91.9 126.82 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.115 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 9.6 tttp -99.64 -60.44 1.53 Allowed 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 12.4 tt0 -144.6 159.71 42.35 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.285 0.564 . . . . 0.0 112.471 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.6 pt? -154.7 161.34 41.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.48 -2.013 . . . . 0.0 110.417 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.588 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.9 mptt -133.1 45.79 2.68 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 122.369 1.081 . . . . 0.0 108.962 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.91 149.2 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -129.89 177.69 7.08 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 125.504 2.574 . . . . 0.0 113.446 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.43 109.71 20.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.53 -27.95 3.04 Favored Glycine 0 N--CA 1.511 3.659 0 CA-C-N 111.929 -2.396 . . . . 0.0 108.393 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.78 169.86 17.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -123.32 164.39 18.89 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.909 1.337 . . . . 0.0 108.799 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.52 168.2 18.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.551 ' NZ ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -150.01 156.2 41.28 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 119.186 -1.006 . . . . 0.0 113.161 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -34.13 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.3 -5.69 45.38 Favored Glycine 1 N--CA 1.517 4.075 0 CA-C-N 113.785 -1.552 . . . . 0.0 115.8 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 8.5 m -63.7 133.52 53.73 Favored 'General case' 0 N--CA 1.524 3.226 0 CA-C-O 117.621 -1.18 . . . . 0.0 112.879 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.72 59.17 0.21 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 HG23 ' A' ' 7' ' ' VAL . 6.0 mm -30.68 -64.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 124.847 2.26 . . . . 0.0 116.528 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -152.27 177.25 10.75 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 111.357 -2.656 . . . . 0.0 112.856 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -118.42 127.89 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 123.384 1.564 . . . . 0.0 107.019 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.558 ' CD1' HG21 ' A' ' 5' ' ' VAL . 8.9 m-30 -105.51 160.76 14.91 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 113.316 -1.766 . . . . 0.0 115.005 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 14.0 tt0 -141.04 109.69 6.0 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 124.618 2.151 . . . . 0.0 111.362 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 m -53.5 44.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.13 0 N-CA-C 121.362 3.838 . . . . 0.0 121.362 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 22.42 -94.69 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -140.41 40.42 1.38 Allowed Glycine 1 N--CA 1.52 4.283 0 N-CA-C 105.031 -3.228 . . . . 0.0 105.031 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 17.9 58.65 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 110.114 -3.043 . . . . 0.0 119.009 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 1.732 0 CA-C-N 111.363 -2.653 . . . . 0.0 105.613 179.769 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 3.3 mpp? . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -9.53 130.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 118.572 2.804 . . . . 0.0 118.572 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -118.83 146.63 44.7 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 124.225 1.964 . . . . 0.0 112.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 7.5 mp0 -91.15 132.17 36.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.438 -2.619 . . . . 0.0 114.258 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 92.2 t -104.26 111.75 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.726 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 69' ' ' SER . 16.3 p-10 -108.9 172.79 6.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.34 1.543 . . . . 0.0 112.273 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.608 HG12 HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -101.39 117.82 61.26 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 112.832 -1.986 . . . . 0.0 113.65 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -85.24 172.31 8.47 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 123.87 3.047 . . . . 0.0 112.724 172.132 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -1.5 37.74 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.604 1 N-CA-C 123.346 4.572 . . . . 0.0 123.346 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -76.8 61.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 O-C-N 119.226 -2.171 . . . . 0.0 114.496 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -41.12 141.28 1.08 Allowed Glycine 0 N--CA 1.515 3.905 0 CA-C-N 112.868 -1.969 . . . . 0.0 114.165 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . 126.2 -45.88 1.13 Allowed Glycine 1 N--CA 1.521 4.318 0 N-CA-C 106.453 -2.659 . . . . 0.0 106.453 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' HB3' ' HZ1' ' A' ' 66' ' ' LYS . 1.0 OUTLIER 75.46 163.88 0.26 Allowed 'General case' 0 CA--C 1.573 1.863 0 O-C-N 128.418 3.07 . . . . 0.0 114.545 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' CD ' ' NZ ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER 36.37 52.98 0.97 Allowed 'General case' 0 N--CA 1.51 2.554 0 CA-C-O 122.534 1.159 . . . . 0.0 110.589 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 35.4 m -97.41 160.92 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.783 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.613 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 1.6 pm0 -118.11 174.66 6.09 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.223 1.011 . . . . 0.0 113.315 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.43 127.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.221 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 81.4 p -98.82 -50.36 4.24 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -131.12 100.31 5.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 123.254 1.502 . . . . 0.0 112.9 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG22 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -73.89 65.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 O-C-N 120.295 -1.503 . . . . 0.0 114.06 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 34.3 mmm -30.39 -52.43 0.16 Allowed 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.9 m -89.01 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HZ3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -130.7 161.88 30.68 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.47 114.97 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.849 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.76 -29.15 6.16 Favored Glycine 0 N--CA 1.515 3.966 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.414 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 11.7 t70 -89.02 168.39 12.39 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -83.98 109.21 17.45 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 34' ' ' LEU . 6.7 t -111.04 102.77 14.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.612 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -120.25 159.02 25.78 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.316 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.48 160.92 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 74.27 -40.16 0.44 Allowed 'General case' 0 N--CA 1.516 2.843 0 CA-C-O 121.963 0.887 . . . . 0.0 110.475 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 47.0 tp60 -58.39 83.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 50.4 m -28.86 70.15 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.094 2.998 . . . . 0.0 119.094 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD21 HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -23.32 -67.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.29 155.44 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.525 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -99.16 136.63 38.84 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 25.0 m -124.85 148.71 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 18' ' ' THR . 3.4 tt0 -118.98 174.25 6.41 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.14 -68.96 0.07 OUTLIER Glycine 1 N--CA 1.518 4.135 0 CA-C-N 114.792 -1.095 . . . . 0.0 113.28 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.92 -177.73 3.73 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.896 1.331 . . . . 0.0 110.936 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.51 -15.02 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.36 150.69 48.95 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.211 0.529 . . . . 0.0 111.764 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -89.68 164.17 14.82 Favored 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.0 mtt -132.27 168.23 18.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.483 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.85 152.69 49.06 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG21 ' CG2' ' A' ' 10' ' ' ILE . 43.5 t -129.79 125.86 22.35 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.0 173.37 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.414 1.409 . . . . 0.0 110.544 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -54.36 98.81 0.18 Allowed Pre-proline 0 C--N 1.287 -2.145 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 19.0 Cg_endo -44.31 -29.3 2.94 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 C-N-CA 122.402 2.068 . . . . 0.0 113.679 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -158.76 -175.3 5.22 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.093 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -107.57 155.93 19.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.16 -168.61 26.53 Favored Glycine 1 N--CA 1.518 4.153 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 75' ' ' GLU . 5.6 m -109.95 154.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.435 -1.626 . . . . 0.0 112.268 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.56 108.9 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 1.9 tmtp? -94.24 -50.15 5.4 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.226 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.7 tt0 -155.88 162.89 40.35 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.518 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -167.85 156.77 9.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.085 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -131.76 53.27 2.01 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.39 153.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 126.079 2.112 . . . . 0.0 113.735 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.7 m120 -121.76 178.62 4.78 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 124.809 2.243 . . . . 0.0 115.576 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.37 108.9 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.96 -23.76 3.34 Favored Glycine 0 N--CA 1.507 3.378 1 CA-C-N 108.282 -4.054 . . . . 0.0 108.501 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -54.39 154.11 4.91 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.945 0.879 . . . . 0.0 111.58 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.613 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.6 mmmt -95.81 148.32 22.71 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.43 147.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.667 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HZ1' ' HB3' ' A' ' 13' ' ' ASP . 20.2 tttp -148.56 155.65 41.4 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.556 ' N ' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -30.28 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.052 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.46 -32.5 5.53 Favored Glycine 0 N--CA 1.511 3.698 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.327 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 21.2 m -37.84 122.87 1.02 Allowed 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 70' ' ' LEU . 7.4 mp -70.39 58.96 0.19 Allowed 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.556 ' CG1' HG22 ' A' ' 7' ' ' VAL . 5.1 mt -20.07 -61.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.448 ' SD ' ' HE1' ' A' ' 74' ' ' PHE . 7.9 ptp -156.85 176.77 12.31 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 112.573 -2.103 . . . . 0.0 114.509 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 114.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 123.845 1.783 . . . . 0.0 112.42 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.448 ' HE1' ' SD ' ' A' ' 72' ' ' MET . 17.0 m-30 -106.96 154.88 20.43 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.632 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 2.5 tp10 -127.01 123.35 36.86 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.3 m -51.9 33.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.582 2.189 1 N-CA-C 124.577 5.029 . . . . 0.0 124.577 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -90.82 63.89 5.4 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 123.604 1.669 . . . . 0.0 112.891 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.23 67.88 0.03 OUTLIER Glycine 0 N--CA 1.506 3.348 0 N-CA-C 104.971 -3.251 . . . . 0.0 104.971 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.28 138.39 36.76 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 112.268 -1.966 . . . . 0.0 109.143 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 O-C-N 126.658 2.474 . . . . 0.0 115.868 -179.844 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.551 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 9.0 ttt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 100.847 -3.76 . . . . 0.0 100.847 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.551 ' H ' ' HG2' ' A' ' 1' ' ' MET . 7.2 p -163.9 134.79 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -128.54 84.0 2.2 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.227 2.677 . . . . 0.0 118.227 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.08 143.85 1.06 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 74' ' ' PHE . 26.5 t -118.01 120.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.0 p-10 -117.48 172.78 7.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.552 ' CG1' HD12 ' A' ' 10' ' ' ILE . 5.8 t -101.95 137.3 19.47 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 118.299 -1.361 . . . . 0.0 109.563 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 42.4 Cg_endo -70.39 -92.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.195 0 C-N-CA 123.605 2.87 . . . . 0.0 111.327 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 10.1 p-10 -116.97 145.09 43.87 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 123.654 1.692 . . . . 0.0 109.491 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -155.93 48.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 CA-C-O 123.292 1.52 . . . . 0.0 111.496 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.24 -63.27 3.43 Favored Glycine 1 N--CA 1.522 4.406 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.342 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.81 -49.54 0.52 Allowed Glycine 1 N--CA 1.526 4.694 0 O-C-N 123.902 0.413 . . . . 0.0 112.154 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.29 -174.11 1.52 Allowed 'General case' 0 CA--C 1.585 2.321 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 8.3 pt-20 -102.29 151.89 21.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 119.387 -2.071 . . . . 0.0 107.239 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.83 158.43 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 49.5 mt-10 -92.33 169.98 10.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.544 -0.723 . . . . 0.0 109.558 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 35' ' ' ILE . 60.0 t -106.89 116.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -94.49 -43.43 8.35 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.633 1.173 . . . . 0.0 113.787 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -136.49 102.06 4.83 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.678 1.228 . . . . 0.0 110.342 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.7 p -75.18 63.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 O-C-N 119.562 -1.962 . . . . 0.0 116.1 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 28.9 mmm -29.57 -33.6 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 26' ' ' ASP . 2.1 t -125.57 154.32 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -134.41 -176.93 4.37 Favored 'General case' 0 N--CA 1.521 3.078 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.54 87.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.101 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.91 26.01 3.71 Favored Glycine 0 N--CA 1.514 3.869 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.576 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' HB3' ' CG1' ' A' ' 22' ' ' VAL . 1.3 m-20 -116.37 141.09 48.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.36 115.02 4.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.798 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.19 98.23 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -105.04 149.43 25.81 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.232 -1.543 . . . . 0.0 114.782 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.2 73.03 0.3 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 177.2 -24.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.001 -3.272 . . . . 0.0 110.131 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -89.87 119.08 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.877 -1.14 . . . . 0.0 112.74 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 29.5 t -48.78 123.87 7.6 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 48' ' ' ALA . 1.5 mt -81.78 -55.46 4.61 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.477 1.132 . . . . 0.0 112.625 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' A' ' 17' ' ' VAL . 19.9 pt -146.7 129.75 8.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.481 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 m -73.17 137.68 45.23 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.1 m -124.77 154.54 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.1 OUTLIER -140.42 -164.41 1.71 Allowed 'General case' 0 N--CA 1.518 2.928 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.7 -51.26 0.49 Allowed Glycine 0 N--CA 1.513 3.809 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 42' ' ' ALA . 45.0 t0 -155.51 -118.12 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.636 0.732 . . . . 0.0 112.341 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.451 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -10.76 -44.2 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.888 2.922 . . . . 0.0 118.888 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . 171.92 157.15 0.09 Allowed 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 123.637 0.775 . . . . 0.0 111.571 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.7 m -58.81 127.64 33.23 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.0 mmm -116.79 166.72 11.82 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.064 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -130.81 156.93 44.17 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 6.1 t -131.25 105.83 14.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.311 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 1.4 Cg_endo -77.71 175.66 10.97 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.155 1.236 . . . . 0.0 110.212 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.643 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -72.3 107.49 3.07 Favored Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -38.3 -39.33 1.01 Allowed 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.42 2.747 . . . . 0.0 113.981 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -150.77 176.69 10.8 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.02 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -94.82 89.09 5.54 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.57 -164.46 10.18 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 114.48 -1.236 . . . . 0.0 113.603 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.47 156.5 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 ' CE1' ' A' ' 74' ' ' PHE . 2.7 t -87.11 135.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.372 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 10.2 tptt -110.97 -65.22 1.19 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.158 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.506 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 29.7 tt0 -137.85 148.86 45.8 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.637 0.732 . . . . 0.0 109.521 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 57' ' ' LEU . 2.1 pt? -157.64 154.76 28.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 86.6 mttt -131.1 51.55 2.13 Favored 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.11 154.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 CA-C-N 111.82 -2.446 . . . . 0.0 114.195 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -145.55 -176.19 5.02 Favored 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.0 t -84.65 113.22 22.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 1 N-CA-C 99.688 -4.19 . . . . 0.0 99.688 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.93 10.15 12.7 Favored Glycine 0 N--CA 1.513 3.769 0 CA-C-N 112.293 -2.23 . . . . 0.0 108.952 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -103.68 159.58 15.5 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HZ3' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -114.51 150.12 35.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -179.373 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -136.02 166.04 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.336 -179.225 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.596 ' HD2' ' N ' ' A' ' 67' ' ' THR . 4.5 tmmm? -159.72 160.54 34.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.076 -1.015 . . . . 0.0 109.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.596 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 6.5 p -43.4 112.93 0.43 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.8 -8.49 61.55 Favored Glycine 0 N--CA 1.515 3.964 0 CA-C-N 113.043 -1.89 . . . . 0.0 114.619 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 7.2 m -67.41 127.13 31.53 Favored 'General case' 0 N--CA 1.52 3.068 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.184 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 6' ' ' ASN . 0.8 OUTLIER -72.99 66.21 0.79 Allowed 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -36.46 -61.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 119.549 3.166 . . . . 0.0 119.549 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 ptp -144.89 175.18 10.39 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 113.987 -1.46 . . . . 0.0 114.812 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -113.72 121.94 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.932 1.349 . . . . 0.0 111.677 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.553 ' CD1' HG21 ' A' ' 5' ' ' VAL . 15.2 m-30 -106.0 -177.36 3.34 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.168 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -153.44 165.55 35.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m -115.57 70.04 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 120.224 3.416 . . . . 0.0 120.224 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.496 ' OE2' ' NZ ' ' A' ' 55' ' ' LYS . 52.2 mt-10 -61.0 -71.62 0.14 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 119.116 3.006 . . . . 0.0 119.116 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.81 9.27 0.87 Allowed Glycine 1 N--CA 1.533 5.142 0 O-C-N 119.924 -1.735 . . . . 0.0 114.491 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.5 31.29 3.95 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 112.319 -1.941 . . . . 0.0 115.451 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.62 0 C-N-CA 127.874 2.469 . . . . 0.0 104.972 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.339 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 m -55.92 -174.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 1.1 mptt -125.15 155.09 40.49 Favored 'General case' 0 N--CA 1.515 2.781 0 CA-C-O 122.015 0.912 . . . . 0.0 112.477 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -107.35 149.35 27.94 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.298 1.523 . . . . 0.0 113.375 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 59.5 t -102.97 102.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-O 124.102 1.906 . . . . 0.0 112.074 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -95.94 130.12 43.0 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 111.094 -2.775 . . . . 0.0 105.563 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 67' ' ' THR . 69.7 t -55.64 132.51 71.79 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HD3' ' A' ' 49' ' ' PRO . 62.6 Cg_endo -69.36 -176.41 1.36 Allowed 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.578 1.519 . . . . 0.0 114.119 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -62.02 46.57 0.01 OUTLIER 'General case' 0 CA--C 1.58 2.101 0 C-N-CA 127.905 2.482 . . . . 0.0 115.912 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.57 HG21 HG22 ' A' ' 46' ' ' VAL . 40.3 pt -79.11 59.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 O-C-N 119.79 -1.819 . . . . 0.0 113.017 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -33.13 140.16 0.08 OUTLIER Glycine 1 N--CA 1.521 4.362 0 CA-C-N 113.635 -1.621 . . . . 0.0 116.261 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.97 88.58 0.66 Allowed Glycine 1 N--CA 1.52 4.238 0 CA-C-O 121.881 0.712 . . . . 0.0 112.042 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.255 17.9 m-20 -2.36 60.39 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 121.086 3.736 . . . . 0.0 121.086 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' OE1' ' HB3' ' A' ' 66' ' ' LYS . 27.1 mm-40 69.07 118.36 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.032 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.846 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 m -119.5 158.83 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.892 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.6 pt-20 -100.27 167.73 10.23 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.245 -0.909 . . . . 0.0 109.818 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' A' ' 35' ' ' ILE . 22.0 t -105.35 113.44 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.394 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.3 p -90.5 -40.98 11.67 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 93.8 mt-10 -133.99 101.76 5.17 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 123.297 1.522 . . . . 0.0 111.682 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.37 73.64 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-O 125.981 2.801 . . . . 0.0 113.047 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.449 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 mtp -38.39 -45.66 1.04 Allowed 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' C ' ' HD3' ' A' ' 23' ' ' LYS . 10.4 m -103.31 153.44 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 CA-C-N 119.486 1.039 . . . . 0.0 113.349 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.615 ' HD3' ' C ' ' A' ' 22' ' ' VAL . 3.7 mppt? -129.58 175.16 9.02 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.0 107.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.745 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.87 -28.11 5.5 Favored Glycine 1 N--CA 1.519 4.176 0 N-CA-C 114.598 0.599 . . . . 0.0 114.598 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -59.66 157.54 11.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 17.6 mmtp -107.85 103.32 12.55 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 123.513 1.625 . . . . 0.0 106.982 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.644 HG11 HD21 ' A' ' 34' ' ' LEU . 66.1 t -103.78 117.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 120.327 3.454 . . . . 0.0 120.327 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -112.86 154.32 26.5 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 119.803 -1.81 . . . . 0.0 113.897 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.79 92.66 2.52 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 160.59 -20.51 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 109.994 -3.275 . . . . 0.0 109.284 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.58 165.86 14.0 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.023 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.3 p -85.56 106.19 16.7 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.644 HD21 HG11 ' A' ' 28' ' ' VAL . 3.4 mt -69.13 -63.78 1.0 Allowed 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 17' ' ' VAL . 33.9 pt -143.11 157.88 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.128 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 9.9 m -104.7 134.26 48.15 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.7 m -127.12 165.62 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -131.63 151.13 51.86 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.82 -161.41 9.22 Favored Glycine 0 N--CA 1.511 3.646 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 25.3 t70 -63.38 96.15 0.11 Allowed 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 117.634 -1.626 . . . . 0.0 109.104 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER 46.57 39.61 7.11 Favored 'General case' 0 N--CA 1.511 2.616 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.374 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.82 65.72 1.34 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 13.7 t -51.82 131.38 30.64 Favored 'General case' 0 N--CA 1.518 2.959 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 mmt -139.02 168.42 19.87 Favored 'General case' 0 N--CA 1.513 2.72 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -111.3 151.89 27.84 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 122.177 0.989 . . . . 0.0 111.627 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 10' ' ' ILE . 70.2 t -122.66 119.59 28.11 Favored Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.616 -0.677 . . . . 0.0 109.708 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -85.17 175.9 6.19 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 CA-C-O 122.581 0.992 . . . . 0.0 111.67 175.503 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -75.6 108.41 5.77 Favored Pre-proline 0 CA--C 1.58 2.111 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD3' ' HD3' ' A' ' 8' ' ' PRO . 29.8 Cg_endo -48.62 -30.46 16.46 Favored 'Trans proline' 0 N--CA 1.512 2.584 0 C-N-CA 123.084 2.523 . . . . 0.0 114.122 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 178.38 10.15 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.498 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.29 20.85 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.04 -175.79 35.19 Favored Glycine 0 N--CA 1.507 3.413 0 CA-C-O 121.812 0.673 . . . . 0.0 111.985 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.6 151.12 19.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.199 -1.177 . . . . 0.0 111.379 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 10.7 t -74.69 80.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.633 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HE2' ' CB ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -68.54 -41.36 79.99 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.528 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CB ' ' HE2' ' A' ' 55' ' ' LYS . 39.7 tt0 -167.74 166.32 13.8 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 57' ' ' LEU . 1.6 pt? -166.56 159.34 14.19 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.046 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -132.24 49.14 2.34 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 122.715 1.245 . . . . 0.0 108.958 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.43 157.03 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 112.524 -2.125 . . . . 0.0 113.279 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -129.94 178.42 6.54 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 125.829 2.728 . . . . 0.0 115.065 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -90.24 112.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 100.536 -3.876 . . . . 0.0 100.536 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.02 -29.41 3.52 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 109.636 -3.438 . . . . 0.0 109.363 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -62.07 159.18 14.96 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.886 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -104.75 142.88 33.91 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HB ' HG21 ' A' ' 7' ' ' VAL . 28.6 m -123.71 158.19 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HB3' ' OE1' ' A' ' 14' ' ' GLU . 14.4 ptmm? -153.03 145.7 24.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 118.088 -0.958 . . . . 0.0 108.934 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 14.3 t -47.78 121.74 4.35 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.851 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.98 35.06 Favored Glycine 0 N--CA 1.513 3.825 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.733 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.8 t -78.36 121.45 24.49 Favored 'General case' 0 N--CA 1.52 3.06 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.15 66.54 0.63 Allowed 'General case' 0 N--CA 1.516 2.827 0 CA-C-O 122.032 0.92 . . . . 0.0 113.158 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.478 HG13 ' HG2' ' A' ' 72' ' ' MET . 35.9 pt -58.98 -45.78 91.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.517 ' HE1' HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -137.24 165.11 26.92 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 112.888 -1.96 . . . . 0.0 115.974 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.06 125.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.943 1.354 . . . . 0.0 113.448 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.488 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 7.3 m-30 -117.14 150.35 38.85 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.24 160.11 30.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 78' ' ' GLY . 27.2 m -106.07 67.7 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 2.2 mm-40 -13.59 62.61 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.785 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . -177.24 91.41 0.08 OUTLIER Glycine 0 N--CA 1.505 3.297 1 N-CA-C 99.87 -5.292 . . . . 0.0 99.87 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.29 55.9 1.31 Allowed 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 C-N-CA 127.173 2.189 . . . . 0.0 107.701 -179.967 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 117.232 -1.366 . . . . 0.0 107.792 . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 m -87.74 -177.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 124.813 1.321 . . . . 0.0 110.361 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 2.3 mmtt -131.97 127.41 36.24 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.331 1.063 . . . . 0.0 112.961 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.661 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -68.97 122.68 19.17 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.892 -1.503 . . . . 0.0 110.595 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.697 HG21 ' CD1' ' A' ' 74' ' ' PHE . 10.6 t -101.49 96.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 CA-C-O 124.573 2.13 . . . . 0.0 114.999 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' HB2' ' HA2' ' A' ' 68' ' ' GLY . 12.2 p-10 -89.13 128.15 35.76 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 110.058 -3.246 . . . . 0.0 106.986 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.557 HG12 HD12 ' A' ' 10' ' ' ILE . 12.5 t -68.49 130.79 91.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 28.2 Cg_endo -72.28 -92.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.951 2.434 . . . . 0.0 115.635 -172.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.474 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 9.8 p-10 -108.58 106.57 16.69 Favored 'General case' 0 CA--C 1.577 1.983 0 CA-C-O 125.865 2.745 . . . . 0.0 114.487 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.557 HD12 HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.43 50.13 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.254 -1.529 . . . . 0.0 111.156 179.836 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.33 -59.17 4.67 Favored Glycine 1 N--CA 1.519 4.211 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.897 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.33 -53.83 0.32 Allowed Glycine 1 N--CA 1.523 4.494 0 CA-C-N 114.272 -0.964 . . . . 0.0 114.084 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.46 -149.33 0.14 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 124.1 0.96 . . . . 0.0 110.591 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -120.19 145.45 46.96 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.392 -1.443 . . . . 0.0 110.307 179.253 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.59 177.59 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -178.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -102.48 176.14 5.27 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 120.584 1.538 . . . . 0.0 113.728 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 t -108.35 119.4 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-O 122.921 1.344 . . . . 0.0 113.251 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.1 m -93.04 -52.67 4.47 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.368 -1.742 . . . . 0.0 111.305 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 16.5 mm-40 -126.32 126.87 44.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.485 0.659 . . . . 0.0 109.499 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.453 HG22 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -105.73 61.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 123.045 1.403 . . . . 0.0 111.646 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmt -21.22 -46.7 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 110.622 -2.99 . . . . 0.0 116.671 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.436 HG11 HG22 ' A' ' 28' ' ' VAL . 2.4 t -112.79 159.7 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HZ3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -133.7 178.42 6.95 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 179.851 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.6 99.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.782 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.69 13.51 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.679 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 22' ' ' VAL . 58.7 m-20 -75.76 147.22 39.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.641 ' HD2' HG13 ' A' ' 53' ' ' VAL . 27.8 mmmt -73.84 108.61 6.77 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.705 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -109.29 124.16 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.956 0.884 . . . . 0.0 109.95 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -137.3 159.88 40.65 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.08 161.06 0.08 Allowed 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.25 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 56.93 -1.7 0.05 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.07 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 1.4 tm0? -96.07 107.67 20.0 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.5 m -48.33 121.72 4.66 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -88.23 -59.38 2.25 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -144.79 152.95 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.702 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 16.7 m -110.44 125.42 53.25 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 179.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.97 157.8 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.76 -175.01 3.82 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.28 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.4 -72.1 0.28 Allowed Glycine 1 N--CA 1.521 4.363 0 CA-C-O 119.181 -0.788 . . . . 0.0 114.925 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -118.63 -121.76 0.29 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 124.242 1.972 . . . . 0.0 114.421 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 41' ' ' LYS . 2.7 mmmp? -19.57 -40.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 119.842 3.275 . . . . 0.0 119.842 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 167.91 164.55 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 O-C-N 126.682 2.488 . . . . 0.0 111.906 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -74.71 152.8 39.07 Favored 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.94 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.5 ttt -144.85 161.05 40.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.079 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.28 155.16 20.81 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 123.265 1.507 . . . . 0.0 114.493 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.493 HG21 ' CG2' ' A' ' 10' ' ' ILE . 21.0 t -127.88 126.07 23.75 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.48 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -91.18 177.83 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 CA-C-O 124.51 1.796 . . . . 0.0 113.367 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.707 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -70.25 103.71 0.66 Allowed Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 111.699 -2.501 . . . . 0.0 117.613 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 23.7 Cg_endo -46.69 -26.21 4.28 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 121.718 1.612 . . . . 0.0 114.067 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -162.14 -172.62 3.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.683 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.71 166.81 10.52 Favored 'General case' 0 CA--C 1.568 1.669 1 N-CA-C 122.747 4.351 . . . . 0.0 122.747 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.62 -134.68 7.26 Favored Glycine 1 N--CA 1.526 4.645 0 CA-C-N 113.173 -1.831 . . . . 0.0 113.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG13 ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -134.91 160.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 O-C-N 121.512 -0.993 . . . . 0.0 109.915 179.317 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 39.7 t -84.44 133.63 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 C-N-CA 117.604 -1.638 . . . . 0.0 106.912 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 45.5 tptt -102.73 -62.52 1.26 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 25.6 tt0 -150.53 158.79 44.55 Favored 'General case' 0 N--CA 1.511 2.624 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.539 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.1 pt? -166.02 149.66 7.71 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.395 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -125.03 50.06 1.8 Allowed 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.8 162.9 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 126.33 2.269 . . . . 0.0 113.967 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.425 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -135.27 -177.51 4.68 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 120.625 3.565 . . . . 0.0 120.625 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -94.4 67.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 127.458 3.504 . . . . 0.0 109.575 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.15 37.33 0.02 OUTLIER Glycine 0 N--CA 1.506 3.354 1 CA-C-N 105.395 -5.366 . . . . 0.0 109.602 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 9.8 t0 -121.53 173.9 7.11 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 111.568 -2.316 . . . . 0.0 104.912 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' C ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -121.79 160.67 24.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 120.356 3.465 . . . . 0.0 120.356 -179.517 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG12 HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.27 147.8 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 119.992 3.33 . . . . 0.0 119.992 -179.213 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.606 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -155.95 163.23 40.0 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.724 179.733 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -50.58 106.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 123.358 1.551 . . . . 0.0 114.763 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 6' ' ' ASN . . . 95.05 11.69 56.09 Favored Glycine 0 N--CA 1.513 3.767 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.671 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 t -76.12 116.9 17.27 Favored 'General case' 0 N--CA 1.507 2.423 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.551 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -83.45 77.09 9.87 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.81 1.767 . . . . 0.0 109.831 -179.599 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.535 HG21 HG12 ' A' ' 65' ' ' VAL . 1.7 pp -77.95 -44.13 28.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.164 -1.835 . . . . 0.0 112.915 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 71' ' ' ILE . 9.3 ptm -130.36 175.34 9.04 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.674 -1.21 . . . . 0.0 113.259 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HA ' HG23 ' A' ' 5' ' ' VAL . 5.3 mp -128.49 128.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.697 ' CD1' HG21 ' A' ' 5' ' ' VAL . 16.4 m-30 -109.8 164.05 12.93 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.0 tt0 -137.88 131.11 30.5 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.39 56.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.53 147.52 26.67 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 118.928 2.936 . . . . 0.0 118.928 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 164.83 73.64 0.03 OUTLIER Glycine 0 N--CA 1.506 3.327 1 N-CA-C 101.876 -4.49 . . . . 0.0 101.876 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.94 48.56 0.72 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.932 0 C-N-CA 128.764 2.826 . . . . 0.0 107.848 -179.825 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.49 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 18.6 mtp . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.6 m -51.95 138.8 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.03 150.38 51.33 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.262 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -95.07 160.11 14.71 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG21 ' CE1' ' A' ' 74' ' ' PHE . 89.9 t -118.36 114.69 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.154 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.9 p-10 -105.79 173.67 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.481 HG11 HD11 ' A' ' 10' ' ' ILE . 38.4 t -95.18 131.04 30.8 Favored Pre-proline 0 N--CA 1.495 1.781 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.61 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -64.1 -176.38 0.37 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.343 1.362 . . . . 0.0 111.99 172.022 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -57.77 39.46 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 119.76 3.244 . . . . 0.0 119.76 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.61 HG21 ' CG2' ' A' ' 46' ' ' VAL . 27.6 pt -81.02 69.34 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 119.066 -2.271 . . . . 0.0 111.973 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.06 168.45 1.55 Allowed Glycine 1 N--CA 1.52 4.268 0 CA-C-N 112.663 -2.062 . . . . 0.0 112.562 179.316 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.34 170.4 12.74 Favored Glycine 1 N--CA 1.526 4.636 0 CA-C-O 121.482 0.49 . . . . 0.0 113.406 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.8 67.59 4.56 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 123.709 1.719 . . . . 0.0 114.194 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 68.82 100.61 0.06 Allowed 'General case' 0 N--CA 1.513 2.701 0 CA-C-N 111.859 -2.428 . . . . 0.0 111.039 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 10' ' ' ILE . 18.0 m -96.35 141.7 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 117.302 -1.759 . . . . 0.0 106.843 -179.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.672 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 12.2 pt-20 -118.16 164.71 14.75 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.266 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 62' ' ' GLY . 10.2 t -83.6 123.91 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.418 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.1 t -102.39 -45.8 4.98 Favored 'General case' 0 N--CA 1.522 3.155 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.798 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 24.3 mt-10 -130.97 123.1 28.08 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.893 0.854 . . . . 0.0 109.594 178.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -102.99 71.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 125.957 2.789 . . . . 0.0 110.538 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 mtt -34.07 -59.45 0.43 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 110.59 -3.004 . . . . 0.0 115.101 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.641 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.8 t -100.63 151.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 CA-C-O 122.161 0.981 . . . . 0.0 112.809 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.641 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -138.54 177.18 8.08 Favored 'General case' 0 N--CA 1.518 2.962 0 N-CA-C 121.574 3.916 . . . . 0.0 121.574 -178.74 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -42.5 97.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.88 11.8 25.58 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.634 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 t0 -110.32 142.23 42.25 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -59.39 107.17 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.707 -2.042 . . . . 0.0 116.145 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.529 HG11 ' CE2' ' A' ' 74' ' ' PHE . 94.6 t -114.97 118.22 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 122.271 1.034 . . . . 0.0 111.807 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -133.56 149.34 51.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.544 -1.348 . . . . 0.0 113.69 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -50.67 140.46 14.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 41.1 mm-40 93.73 -21.28 0.07 Allowed 'General case' 0 N--CA 1.513 2.707 0 O-C-N 126.703 2.502 . . . . 0.0 110.405 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -88.1 140.27 29.66 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.782 -1.199 . . . . 0.0 109.573 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.6 m -73.69 128.23 34.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 112.257 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.2 mt -95.38 -61.95 1.38 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 pt -137.66 146.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-O 122.551 1.167 . . . . 0.0 113.03 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 45' ' ' GLU . 88.1 m -101.87 116.89 33.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.4 m -113.25 160.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -127.08 -165.31 1.45 Allowed 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.942 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.14 -53.89 0.78 Allowed Glycine 1 N--CA 1.529 4.881 0 CA-C-N 119.052 0.842 . . . . 0.0 114.355 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -86.33 179.67 6.85 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.162 0.982 . . . . 0.0 109.709 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -46.0 -7.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -154.58 162.11 41.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.2 t -83.13 138.65 33.59 Favored 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.98 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -118.94 156.07 30.2 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.477 0.581 . . . . 0.0 111.465 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HG2' HG23 ' A' ' 36' ' ' THR . 47.6 mt-10 -111.64 158.48 19.21 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.61 ' CG2' HG21 ' A' ' 10' ' ' ILE . 2.9 t -128.14 123.09 22.42 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 112.644 -2.071 . . . . 0.0 112.164 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -84.52 -179.7 3.97 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 CA-C-O 123.55 1.396 . . . . 0.0 112.636 168.937 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -66.02 101.24 0.27 Allowed Pre-proline 0 C--N 1.282 -2.356 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' HD12 ' A' ' 34' ' ' LEU . 9.4 Cg_endo -36.61 -35.98 0.22 Allowed 'Trans proline' 0 N--CA 1.51 2.476 0 C-N-CA 122.71 2.273 . . . . 0.0 113.986 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -154.24 -177.49 6.47 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 112.078 -2.328 . . . . 0.0 107.006 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -100.31 168.79 9.55 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.97 -147.53 19.29 Favored Glycine 1 N--CA 1.517 4.035 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.075 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.37 148.16 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 47.6 t -68.94 92.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.142 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 17.5 tttm -69.82 -58.9 3.33 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.954 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' CD ' ' NZ ' ' A' ' 55' ' ' LYS 0.319 37.3 tt0 -149.52 144.07 26.03 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.52 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -130.73 155.15 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -128.54 37.58 4.1 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.106 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.43 161.98 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-N 113.09 -1.868 . . . . 0.0 114.562 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -122.83 173.96 7.44 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 124.819 2.247 . . . . 0.0 115.677 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 18' ' ' THR . 3.4 t -98.97 100.69 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 101.305 -3.591 . . . . 0.0 101.305 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' VAL . . . 120.86 30.58 1.33 Allowed Glycine 0 N--CA 1.511 3.678 1 CA-C-N 106.973 -4.649 . . . . 0.0 107.8 -179.336 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -107.28 155.34 20.06 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 114.133 -1.034 . . . . 0.0 109.995 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.672 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 31.4 mmtm -89.22 140.15 29.76 Favored 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.27 166.75 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.97 0.891 . . . . 0.0 111.035 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -165.98 153.5 10.27 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 t -47.9 127.04 11.46 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 117.304 -1.758 . . . . 0.0 111.858 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.66 -40.5 2.41 Favored Glycine 0 N--CA 1.513 3.824 0 CA-C-N 114.902 -1.044 . . . . 0.0 114.464 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 32.3 t -57.0 146.25 27.69 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.289 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.99 63.89 7.56 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.682 1.23 . . . . 0.0 114.28 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.58 HG22 ' SD ' ' A' ' 72' ' ' MET . 1.4 mt -17.0 -57.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.58 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -168.84 -176.81 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 111.767 -2.469 . . . . 0.0 114.92 -179.596 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.96 125.45 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 124.092 1.901 . . . . 0.0 112.767 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 28' ' ' VAL . 17.3 m-30 -112.9 156.23 23.33 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.885 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' OE2' ' N ' ' A' ' 1' ' ' MET . 6.1 tp10 -130.46 139.61 50.55 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 103.571 -2.752 . . . . 0.0 103.571 179.041 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 76' ' ' VAL . 16.2 m -86.26 23.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 1 N-CA-C 123.075 4.472 . . . . 0.0 123.075 -179.187 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 76' ' ' VAL . 17.4 mm-40 6.78 -86.06 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.98 51.8 0.63 Allowed Glycine 0 N--CA 1.509 3.534 0 N-CA-C 103.287 -3.925 . . . . 0.0 103.287 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.49 82.68 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -179.418 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.565 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.12 179.63 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.677 ' H3 ' ' CA ' ' A' ' 80' ' ' ALA . 3.6 tmm? . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 101.886 -3.376 . . . . 0.0 101.886 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m -126.56 159.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.078 0 CA-C-N 123.694 2.952 . . . . 0.0 113.467 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.574 ' HG3' HG13 ' A' ' 76' ' ' VAL . 70.7 mmtt -133.31 148.64 51.91 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.07 155.42 18.4 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.58 -1.325 . . . . 0.0 114.246 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 74' ' ' PHE . 40.1 t -121.97 88.36 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 124.753 2.216 . . . . 0.0 113.852 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.8 p30 -95.05 170.36 9.47 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 111.291 -2.686 . . . . 0.0 105.802 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.539 HG21 HG11 ' A' ' 65' ' ' VAL . 96.0 t -104.6 136.02 19.23 Favored Pre-proline 0 N--CA 1.504 2.246 0 C-N-CA 118.135 -1.426 . . . . 0.0 113.39 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 53.1 Cg_exo -60.41 -166.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.842 2.361 . . . . 0.0 115.509 168.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.23 32.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.638 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.4 mp -83.75 64.31 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 CA-C-O 126.198 2.904 . . . . 0.0 111.982 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.51 -113.28 4.38 Favored Glycine 0 C--N 1.292 -1.87 0 CA-C-N 109.863 -3.335 . . . . 0.0 110.859 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.99 -31.55 1.97 Allowed Glycine 0 N--CA 1.514 3.846 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.98 84.07 0.22 Allowed 'General case' 0 CA--C 1.58 2.123 0 CA-C-N 111.754 -2.223 . . . . 0.0 105.339 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' CD ' ' NZ ' ' A' ' 64' ' ' LYS . 12.9 tt0 -2.67 86.27 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.106 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -179.381 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -99.23 168.92 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.651 -179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 8.7 pt-20 -124.42 172.63 9.01 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.68 122.84 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.995 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 p -101.56 -42.56 6.19 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.48 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.87 109.32 11.17 Favored 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' HG22 ' A' ' 61' ' ' VAL . 13.4 p -92.09 72.9 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 125.361 2.505 . . . . 0.0 110.279 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.9 mtt -35.27 -56.87 0.61 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 111.694 -2.503 . . . . 0.0 112.951 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.563 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 10.3 p -105.67 164.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 CA-C-O 123.29 1.519 . . . . 0.0 114.145 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.632 ' HD2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -145.96 174.69 11.04 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 119.409 3.114 . . . . 0.0 119.409 -179.424 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.2 t -47.62 111.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.13 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.69 -27.87 6.99 Favored Glycine 1 N--CA 1.516 4.027 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.117 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -81.93 173.17 12.47 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 124.256 1.979 . . . . 0.0 115.947 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.06 136.36 50.21 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.944 -1.934 . . . . 0.0 112.586 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG11 HD21 ' A' ' 34' ' ' LEU . 9.4 t -126.41 160.65 33.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.993 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.03 156.05 28.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.516 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.72 168.86 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 125.071 1.482 . . . . 0.0 111.171 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 5.9 mp0 55.17 -7.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.156 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -101.89 110.0 21.88 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.51 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -40.16 133.57 1.73 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 9.4 mt -100.86 -61.76 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.47 HG13 ' HB ' ' A' ' 46' ' ' VAL . 36.6 pt -141.85 151.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.243 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.9 m -101.84 138.27 39.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.9 m -129.67 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -123.01 162.74 21.78 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.04 148.06 19.49 Favored Glycine 1 N--CA 1.516 4.029 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.648 ' CB ' ' HD3' ' A' ' 41' ' ' LYS . 11.8 m-20 6.69 -67.16 0.0 OUTLIER 'General case' 0 CA--C 1.59 2.482 0 N-CA-C 120.533 3.531 . . . . 0.0 120.533 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.648 ' HD3' ' CB ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -136.29 35.94 2.75 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 126.605 1.962 . . . . 0.0 113.324 -179.515 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.65 136.7 4.52 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.7 t -108.74 169.01 8.93 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.991 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.486 ' SD ' HG23 ' A' ' 10' ' ' ILE . 51.6 ttm -167.81 164.09 14.13 Favored 'General case' 0 N--CA 1.517 2.883 0 CA-C-O 122.45 1.119 . . . . 0.0 112.927 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.6 mp0 -103.71 141.68 35.65 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 124.368 2.032 . . . . 0.0 114.659 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.561 ' CG2' HG21 ' A' ' 10' ' ' ILE . 22.7 t -121.56 98.97 45.58 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -81.94 -178.72 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 CA-C-O 124.25 1.688 . . . . 0.0 113.618 171.225 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -68.24 102.21 0.37 Allowed Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.7 Cg_endo -41.11 -25.01 0.2 Allowed 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 121.945 1.763 . . . . 0.0 115.453 170.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.45 -167.09 0.75 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.37 163.9 12.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.96 -175.72 19.34 Favored Glycine 1 N--CA 1.522 4.428 0 CA-C-N 113.58 -1.645 . . . . 0.0 113.443 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 75' ' ' GLU . 35.7 m -100.24 166.23 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.307 . . . . 0.0 114.287 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 74' ' ' PHE . 20.0 t -89.43 106.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 113.983 -1.462 . . . . 0.0 112.047 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -64.18 1.09 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 13.8 tt0 -140.39 155.71 46.65 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 118.506 0.594 . . . . 0.0 111.825 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.565 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.0 pt? -161.61 153.69 19.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.545 -0.722 . . . . 0.0 110.114 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.507 ' HD2' ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -129.05 55.87 1.71 Allowed 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.51 151.46 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 112.277 -2.238 . . . . 0.0 111.622 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -130.57 170.99 13.53 Favored 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.451 HG22 ' HB ' ' A' ' 20' ' ' VAL . 3.2 t -87.77 111.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 1 N-CA-C 98.202 -4.74 . . . . 0.0 98.202 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.36 21.64 5.1 Favored Glycine 0 N--CA 1.514 3.886 0 CA-C-N 109.667 -3.424 . . . . 0.0 111.716 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.297 36.1 t0 -114.56 175.27 5.56 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.648 1.179 . . . . 0.0 111.537 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 25.8 mmtp -98.56 149.55 22.63 Favored 'General case' 0 N--CA 1.526 3.351 1 N-CA-C 122.395 4.22 . . . . 0.0 122.395 -179.049 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 7' ' ' VAL . 4.4 t -144.77 168.36 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 67' ' ' THR . 10.4 ptmm? 174.93 139.0 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.6 t -31.51 122.55 0.26 Allowed 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.72 -24.77 26.17 Favored Glycine 0 N--CA 1.509 3.561 0 CA-C-N 114.285 -1.325 . . . . 0.0 114.624 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.1 m -75.21 123.22 24.89 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 70' ' ' LEU . 7.2 mp -75.46 72.32 2.46 Favored 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 125.338 1.455 . . . . 0.0 114.694 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.423 HD11 ' SD ' ' A' ' 72' ' ' MET . 1.7 pp -56.03 -52.49 49.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.445 ' SD ' ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -127.95 174.95 8.75 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -123.79 129.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.677 0.751 . . . . 0.0 110.602 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.7 m-30 -114.77 158.79 21.39 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.465 1.602 . . . . 0.0 111.732 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 53' ' ' VAL 0.355 11.6 tt0 -136.28 124.25 22.8 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 179.52 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 3' ' ' LYS . 23.3 m -68.56 54.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 121.047 3.721 . . . . 0.0 121.047 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' HG2' HG21 ' A' ' 53' ' ' VAL . 22.8 mm-40 -13.81 74.1 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.287 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . -138.62 -63.22 0.04 OUTLIER Glycine 0 N--CA 1.508 3.494 0 N-CA-C 104.751 -3.34 . . . . 0.0 104.751 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . 176.88 29.73 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.677 ' CA ' ' H3 ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 114.709 -2.567 . . . . 0.0 111.66 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.514 2.733 0 CA-C-O 116.07 -1.919 . . . . 0.0 106.107 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 3' ' ' LYS . 20.5 t -122.02 175.37 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.575 0 O-C-N 124.544 1.153 . . . . 0.0 112.419 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 1.1 mmpt? -131.8 164.05 26.89 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.2 mp0 -107.78 140.4 40.91 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG21 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -115.08 100.84 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 CA-C-O 122.907 1.337 . . . . 0.0 112.483 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 69' ' ' SER . 3.3 p30 -91.84 173.87 7.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.806 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.594 HG22 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -112.71 137.2 21.66 Favored Pre-proline 0 N--CA 1.499 2.006 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.687 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.91 -173.25 0.57 Allowed 'Trans proline' 0 CA--C 1.56 1.778 0 C-N-CA 122.161 1.907 . . . . 0.0 116.437 175.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -57.96 42.74 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 119.282 3.067 . . . . 0.0 119.282 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.547 HG21 ' CG2' ' A' ' 46' ' ' VAL . 10.8 pt -80.42 48.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 O-C-N 119.639 -1.913 . . . . 0.0 113.746 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.86 173.33 20.61 Favored Glycine 1 N--CA 1.524 4.54 0 N-CA-C 116.699 1.44 . . . . 0.0 116.699 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . -105.98 -25.33 6.52 Favored Glycine 1 N--CA 1.525 4.617 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.922 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.35 -137.4 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 129.555 3.142 . . . . 0.0 107.714 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' CD ' ' HD3' ' A' ' 64' ' ' LYS . 19.6 tt0 -133.54 148.31 51.63 Favored 'General case' 0 N--CA 1.522 3.157 0 CA-C-N 119.052 0.842 . . . . 0.0 112.302 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 m -142.67 163.24 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 O-C-N 120.709 -1.244 . . . . 0.0 113.123 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.6 pt-20 -113.79 178.9 4.12 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.424 HG13 ' HB ' ' A' ' 35' ' ' ILE . 96.0 t -110.76 111.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.99 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.9 t -91.51 -42.97 9.96 Favored 'General case' 0 N--CA 1.526 3.349 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -130.67 100.39 5.29 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 123.597 1.665 . . . . 0.0 109.327 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 61' ' ' VAL . 7.8 p -75.79 64.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 119.188 -2.195 . . . . 0.0 115.826 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -29.93 -27.4 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.537 HG22 ' N ' ' A' ' 23' ' ' LYS . 13.0 p -112.02 170.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' N ' HG22 ' A' ' 22' ' ' VAL . 33.3 mmtp -139.02 164.46 29.69 Favored 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.459 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 59.0 t -72.38 115.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 O-C-N 121.597 -0.69 . . . . 0.0 111.331 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . 116.01 -29.13 7.28 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.546 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.51 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 2.0 m-20 -63.9 -176.32 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 25' ' ' GLY . 36.7 mmtm -109.93 123.14 49.1 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.826 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 48' ' ' ALA . 2.2 t -123.35 102.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -91.9 162.5 14.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.05 -1.656 . . . . 0.0 111.434 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -61.72 164.94 5.57 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.617 -1.233 . . . . 0.0 107.75 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 70.62 -22.04 0.18 Allowed 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 123.6 1.666 . . . . 0.0 111.158 -179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 30' ' ' ALA . 37.7 tt0 -80.34 110.77 16.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.765 -1.209 . . . . 0.0 109.069 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 27.7 t -47.91 139.88 7.32 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.332 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -103.61 -55.95 2.3 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.458 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -148.33 141.76 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.475 1.131 . . . . 0.0 111.947 179.935 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.6 m -86.37 122.75 30.78 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.97 152.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -137.15 148.66 46.77 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.949 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.73 3.46 8.64 Favored Glycine 1 N--CA 1.526 4.692 0 O-C-N 120.839 -1.163 . . . . 0.0 110.412 179.312 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.453 ' OD2' ' NZ ' ' A' ' 41' ' ' LYS . 47.1 t0 105.86 132.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 131.377 3.871 . . . . 0.0 104.257 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 18.2 mmtm 48.39 17.24 0.12 Allowed 'General case' 0 N--CA 1.52 3.066 0 O-C-N 121.488 -0.757 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -128.56 53.18 1.86 Allowed 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 -179.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 53.2 m -54.44 86.01 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtp -122.02 176.05 6.01 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -125.8 157.98 36.14 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.547 ' CG2' HG21 ' A' ' 10' ' ' ILE . 6.2 t -129.41 110.71 17.82 Favored Pre-proline 0 N--CA 1.498 1.946 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.629 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -83.36 -179.36 4.24 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.44 1.426 . . . . 0.0 113.829 173.314 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -64.14 105.79 0.79 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 120.484 3.513 . . . . 0.0 120.484 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 2.8 Cg_endo -29.09 -39.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.474 0 C-N-CA 122.165 1.91 . . . . 0.0 115.098 171.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.42 177.82 10.83 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.381 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -89.18 101.03 13.7 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.7 -178.9 29.5 Favored Glycine 1 N--CA 1.528 4.787 0 O-C-N 121.71 -0.619 . . . . 0.0 114.606 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 1.4 m -100.58 171.55 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.315 -1.697 . . . . 0.0 107.878 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' SD ' ' A' ' 72' ' ' MET . 96.3 t -94.04 121.99 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.237 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -86.05 -58.68 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 1.7 tp10 -167.2 150.79 6.53 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.843 1.964 . . . . 0.0 112.652 178.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -130.86 -178.61 4.88 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.194 -1.567 . . . . 0.0 110.856 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 1.5 mptp? -150.57 32.34 0.64 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.912 -1.117 . . . . 0.0 108.673 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.22 156.29 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-N 114.267 -1.333 . . . . 0.0 114.031 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -127.37 176.64 7.28 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -92.83 105.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.97 29.05 2.48 Favored Glycine 0 N--CA 1.51 3.617 1 CA-C-N 108.392 -4.004 . . . . 0.0 107.992 -178.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -113.73 163.24 15.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 1.7 pptp? -115.43 143.26 45.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.42 171.61 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.401 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 12' ' ' GLY . 1.6 tmtp? -165.53 151.29 9.36 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 117.93 -1.033 . . . . 0.0 108.68 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 3.8 t -42.06 116.39 0.81 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-O 121.975 0.893 . . . . 0.0 112.841 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.68 -30.0 9.68 Favored Glycine 0 N--CA 1.514 3.834 0 CA-C-N 114.925 -1.034 . . . . 0.0 114.021 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 1.8 t -52.13 162.03 0.54 Allowed 'General case' 0 N--CA 1.52 3.05 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -96.79 64.17 2.05 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.598 HG22 ' HG2' ' A' ' 72' ' ' MET . 0.8 OUTLIER -30.54 -49.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 179.64 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.598 ' HG2' HG22 ' A' ' 71' ' ' ILE . 1.1 ptp 178.38 -179.25 0.3 Allowed 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -107.81 133.63 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 123.617 1.675 . . . . 0.0 108.548 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.606 ' CD1' HG21 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -101.88 168.3 9.51 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.403 -179.604 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' VAL . 18.7 tt0 -146.69 99.45 3.2 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 123.782 1.753 . . . . 0.0 107.729 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m -54.64 49.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.788 1 N-CA-C 123.287 4.551 . . . . 0.0 123.287 -179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.63 -173.93 2.85 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 123.636 1.684 . . . . 0.0 111.773 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.17 -52.44 0.04 OUTLIER Glycine 0 N--CA 1.503 3.144 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 126.72 -43.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 O-C-N 129.491 3.701 . . . . 0.0 109.182 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.306 0 C-N-CA 129.861 3.265 . . . . 0.0 107.596 179.688 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpt . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 9.5 p -19.13 137.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 119.854 3.279 . . . . 0.0 119.854 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 45.5 mmtt -138.24 165.12 27.51 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 118.822 2.897 . . . . 0.0 118.822 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -99.85 142.39 31.39 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 111.255 -2.702 . . . . 0.0 113.532 -179.39 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.611 HG21 ' CD1' ' A' ' 74' ' ' PHE . 43.4 t -118.79 98.43 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.168 0 O-C-N 121.212 -0.93 . . . . 0.0 112.447 179.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' SER . 23.6 p30 -110.82 174.89 5.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.381 1.086 . . . . 0.0 111.375 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 71' ' ' ILE . 70.1 t -108.78 130.34 22.85 Favored Pre-proline 0 N--CA 1.5 2.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.644 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 76.5 Cg_exo -57.01 -169.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.423 0 C-N-CA 123.654 2.903 . . . . 0.0 114.463 164.185 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -43.58 7.53 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.533 0 N-CA-C 120.377 3.473 . . . . 0.0 120.377 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 10' ' ' ILE . 4.3 mp -73.21 73.67 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 125.245 2.45 . . . . 0.0 113.411 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.93 103.36 1.27 Allowed Glycine 0 N--CA 1.5 2.902 0 N-CA-C 121.095 3.198 . . . . 0.0 121.095 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' HE3' ' A' ' 66' ' ' LYS . . . -70.11 -48.41 39.71 Favored Glycine 1 N--CA 1.523 4.454 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.593 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.96 -91.53 0.19 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 110.935 -2.633 . . . . 0.0 106.869 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -160.7 169.36 22.98 Favored 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.64 166.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.478 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 11.7 pt-20 -116.85 169.29 9.5 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 122.0 -0.438 . . . . 0.0 111.442 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.08 118.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 O-C-N 120.907 -1.12 . . . . 0.0 112.422 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 3.7 t -98.47 -34.8 10.48 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.204 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 43.5 mt-10 -134.58 105.48 6.54 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.581 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.2 p -89.44 89.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 126.084 2.849 . . . . 0.0 111.811 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -59.93 -54.34 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 111.311 -2.677 . . . . 0.0 114.771 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG11 HD22 ' A' ' 34' ' ' LEU . 34.5 m -66.58 149.78 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 N-CA-C 118.009 2.596 . . . . 0.0 118.009 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 22' ' ' VAL . 13.0 mmtp -131.65 171.86 12.96 Favored 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 121.366 0.603 . . . . 0.0 112.339 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -75.75 98.19 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.47 14.85 7.3 Favored Glycine 1 N--CA 1.52 4.263 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.703 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.11 136.69 36.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -76.48 111.54 12.05 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 125.042 2.353 . . . . 0.0 106.812 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 96.7 t -111.22 108.31 25.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 109.857 -3.338 . . . . 0.0 112.719 -179.141 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.49 158.56 28.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.978 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.23 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.953 1.408 . . . . 0.0 113.037 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 72.61 -41.22 0.5 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.755 0.788 . . . . 0.0 110.823 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 13.2 tt0 -57.8 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.853 -1.155 . . . . 0.0 112.078 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 49.0 m -40.6 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.477 HD22 HG11 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -18.06 -67.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -151.31 149.38 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.236 -2.711 . . . . 0.0 109.294 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 1.2 m -106.75 133.6 51.17 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.36 146.66 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 N-CA-C 118.578 2.806 . . . . 0.0 118.578 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -136.4 -153.39 0.5 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.35 -63.82 0.55 Allowed Glycine 1 N--CA 1.519 4.226 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.966 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.39 -171.16 2.02 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 123.775 1.75 . . . . 0.0 113.919 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -73.81 40.87 0.12 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.423 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.06 103.6 1.85 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.466 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.3 p -74.16 142.54 45.46 Favored 'General case' 0 N--CA 1.514 2.73 0 O-C-N 121.922 -0.486 . . . . 0.0 111.701 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.4 mmt -137.77 146.47 43.66 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 17.1 mp0 -118.77 159.62 23.37 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.517 ' CG2' HG21 ' A' ' 10' ' ' ILE . 12.3 t -129.39 124.89 22.3 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.792 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.06 172.43 2.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.958 1.772 . . . . 0.0 112.025 171.438 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -53.17 100.55 0.23 Allowed Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.1 Cg_endo -42.44 -31.39 1.83 Allowed 'Trans proline' 0 N--CA 1.51 2.442 0 C-N-CA 122.816 2.344 . . . . 0.0 113.603 -178.471 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -160.0 -174.71 4.7 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.752 -2.476 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -107.25 159.87 16.03 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 120.509 3.522 . . . . 0.0 120.509 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.11 -144.87 15.9 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.395 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.44 161.97 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 CA-C-N 117.937 0.868 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.46 HG22 ' CE1' ' A' ' 74' ' ' PHE . 31.3 t -85.96 116.6 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -90.58 -67.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 41.7 tt0 -143.43 152.1 41.15 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.335 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.7 pt? -145.94 146.18 30.95 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 30.6 mmtt -119.17 46.1 1.96 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.86 152.12 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -134.04 -178.73 5.16 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.971 2.32 . . . . 0.0 114.222 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -87.89 112.24 23.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.71 -19.28 5.59 Favored Glycine 0 N--CA 1.509 3.565 0 CA-C-N 109.893 -3.321 . . . . 0.0 110.779 -179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.12 168.91 12.97 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.573 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.66 145.21 33.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -179.69 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -126.85 176.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 112.876 -1.965 . . . . 0.0 111.249 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 67' ' ' THR . 37.8 tttt 166.19 144.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.48 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 4.5 t -39.47 119.49 0.95 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.48 -32.58 5.99 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.725 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.0 t -56.92 128.65 37.91 Favored 'General case' 0 N--CA 1.512 2.656 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.406 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.8 tt -87.59 64.21 7.96 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 124.842 2.258 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.444 ' CG1' HG23 ' A' ' 7' ' ' VAL . 5.1 mm -24.26 -56.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 111.717 -2.492 . . . . 0.0 117.375 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 4.0 ptp -161.19 -174.17 4.21 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.033 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.15 123.97 72.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 124.504 2.097 . . . . 0.0 112.207 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.611 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.0 m-30 -113.05 165.26 12.53 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.733 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 2' ' ' VAL . 2.0 tt0 -142.3 122.71 14.01 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.32 87.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 CA-C-O 122.736 1.255 . . . . 0.0 113.631 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 73.1 -87.86 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 111.889 -2.414 . . . . 0.0 114.061 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.13 -73.1 0.45 Allowed Glycine 1 N--CA 1.516 4.009 1 N-CA-C 99.674 -5.37 . . . . 0.0 99.674 179.761 . . . . . . . . 3 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -167.07 31.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 178.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 79' ' ' ALA . . . . . . . . 0 N--CA 1.496 1.839 0 C-N-CA 128.86 2.864 . . . . 0.0 108.57 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.8 mtp . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m -161.96 169.27 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 124.962 1.414 . . . . 0.0 108.735 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.781 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -142.98 154.38 43.96 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 124.233 1.968 . . . . 0.0 111.395 178.789 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.781 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 13.4 pm0 -112.96 149.94 32.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.82 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.536 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 87.8 t -120.14 113.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.598 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.734 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 15.9 p-10 -109.86 177.18 4.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.329 1.062 . . . . 0.0 109.533 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.64 HG22 HD11 ' A' ' 71' ' ' ILE . 44.5 t -97.35 130.59 29.13 Favored Pre-proline 0 C--N 1.291 -1.958 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.088 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -83.93 -157.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.331 2.021 . . . . 0.0 110.565 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -84.05 65.65 8.82 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 124.556 2.122 . . . . 0.0 109.871 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.542 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -74.88 54.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 CA-C-O 123.238 1.494 . . . . 0.0 114.622 -179.894 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 32.19 39.83 0.07 OUTLIER Glycine 1 N--CA 1.524 4.534 0 N-CA-C 117.11 1.604 . . . . 0.0 117.11 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.49 173.73 46.49 Favored Glycine 0 N--CA 1.506 3.342 0 CA-C-N 113.516 -1.342 . . . . 0.0 111.727 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.299 16.9 m-20 -93.33 -84.15 0.3 Allowed 'General case' 0 CA--C 1.577 1.984 0 CA-C-O 116.429 -1.748 . . . . 0.0 111.12 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -110.03 135.93 50.08 Favored 'General case' 0 N--CA 1.517 2.903 0 CA-C-N 123.123 2.692 . . . . 0.0 112.722 179.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 m -142.06 160.99 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.99 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.776 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.9 pt-20 -110.24 174.15 6.0 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.591 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.04 123.39 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.845 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.81 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.529 HG23 ' HG3' ' A' ' 19' ' ' GLU . 11.5 t -101.31 -43.83 5.84 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.529 ' HG3' HG23 ' A' ' 18' ' ' THR . 28.9 mt-10 -128.25 99.06 5.29 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.757 0.789 . . . . 0.0 112.685 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.423 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 7.4 p -75.65 70.59 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.091 -2.255 . . . . 0.0 114.281 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.4 mmm -33.83 -45.9 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.89 167.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 36.6 mmtm -137.43 175.5 9.55 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -74.6 99.2 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.777 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.71 -23.08 5.4 Favored Glycine 1 N--CA 1.518 4.15 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.309 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.53 168.32 16.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 123.482 1.61 . . . . 0.0 114.326 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -98.9 132.94 43.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' CG1' HD21 ' A' ' 34' ' ' LEU . 88.7 t -128.12 122.62 58.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.209 -179.399 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -128.59 152.66 48.07 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 112.908 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.96 68.74 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.776 0 CA-C-O 124.135 1.921 . . . . 0.0 115.131 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.609 ' HG3' ' N ' ' A' ' 32' ' ' GLN . 15.6 pt-20 -177.05 -37.66 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 110.124 -3.216 . . . . 0.0 111.565 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.609 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -71.58 110.49 6.2 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.945 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 7.2 p -51.26 67.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 ' CG1' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -14.03 -64.73 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 120.518 3.525 . . . . 0.0 120.518 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 pt -150.52 148.86 14.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.186 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.4 m -95.27 133.8 38.76 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 178.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.7 m -118.13 157.1 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.97 167.44 13.59 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.79 94.98 0.16 Allowed Glycine 0 N--CA 1.511 3.653 0 CA-C-N 111.944 -2.389 . . . . 0.0 114.668 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.552 ' HB2' ' CE ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER 60.18 -68.8 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.666 0 CA-C-O 124.093 1.902 . . . . 0.0 115.492 179.696 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' CE ' ' HB2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -144.8 23.88 1.54 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 112.331 -2.213 . . . . 0.0 111.158 -179.82 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.56 122.87 19.41 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m -105.87 124.66 49.93 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.351 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -131.69 162.69 29.84 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 123.638 0.586 . . . . 0.0 110.328 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -115.12 159.51 20.78 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.022 -1.674 . . . . 0.0 114.186 179.665 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG22 ' CG2' ' A' ' 10' ' ' ILE . 71.3 t -121.42 133.44 24.22 Favored Pre-proline 0 N--CA 1.503 2.208 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.84 171.79 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.683 1.589 . . . . 0.0 111.899 173.52 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -54.79 100.43 0.22 Allowed Pre-proline 0 C--N 1.286 -2.192 0 CA-C-N 112.316 -2.22 . . . . 0.0 116.332 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -39.89 -33.72 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 122.151 1.901 . . . . 0.0 113.582 179.405 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CZ ' ' HD2' ' A' ' 3' ' ' LYS . 3.3 p90 -156.1 176.98 11.95 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-N 112.692 -2.049 . . . . 0.0 108.466 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.1 159.57 15.26 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.63 -142.13 10.4 Favored Glycine 0 N--CA 1.51 3.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.94 169.62 21.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 124.762 1.225 . . . . 0.0 108.757 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG22 ' CE1' ' A' ' 74' ' ' PHE . 38.5 t -95.61 127.7 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.439 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 44.8 tttp -102.72 -56.72 2.18 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.178 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 6.1 tp10 -154.72 157.13 37.59 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -149.9 147.45 27.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 118.871 -2.393 . . . . 0.0 113.995 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 53.42 1.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.46 154.49 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.978 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 9.9 m-80 -131.83 -174.38 3.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 124.299 2.0 . . . . 0.0 115.227 179.141 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.01 88.94 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-O 126.262 2.934 . . . . 0.0 110.05 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.37 15.72 0.41 Allowed Glycine 0 N--CA 1.515 3.917 1 CA-C-N 105.702 -5.227 . . . . 0.0 111.192 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -95.01 152.69 18.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.465 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 2.2 pptp? -106.95 142.03 37.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HB ' HG21 ' A' ' 7' ' ' VAL . 1.5 m -126.32 175.87 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 112.0 -2.363 . . . . 0.0 111.257 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.668 ' C ' ' HD3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 177.51 157.45 0.37 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.594 179.796 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -29.1 103.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 178.681 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . 109.74 -47.01 1.09 Allowed Glycine 1 N--CA 1.518 4.102 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.89 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 t -26.84 117.72 0.08 Allowed 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 61.18 0.2 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 7' ' ' VAL . 2.6 mt -23.79 -68.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 124.748 2.214 . . . . 0.0 115.575 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.7 ptp -154.58 -175.41 5.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.523 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -113.62 122.83 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 124.359 2.028 . . . . 0.0 110.948 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 8.9 m-30 -107.97 174.65 5.79 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.571 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 21.0 tt0 -151.45 166.37 31.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.517 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.35 56.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -179.316 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -64.1 -72.75 0.13 Allowed 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.52 50.01 0.07 OUTLIER Glycine 1 N--CA 1.521 4.344 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 17.37 64.32 0.02 OUTLIER 'General case' 0 CA--C 1.579 2.061 0 N-CA-C 119.797 3.258 . . . . 0.0 119.797 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.619 0 C-N-CA 128.074 2.55 . . . . 0.0 105.905 179.831 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 5.5 ttp . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.32 121.03 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.51 139.82 51.44 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.714 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -85.57 155.92 20.96 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 119.242 -2.161 . . . . 0.0 113.651 179.374 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' CE1' ' A' ' 74' ' ' PHE . 90.4 t -116.56 119.79 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.809 0 C-N-CA 124.602 1.161 . . . . 0.0 113.92 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -111.05 174.78 5.7 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.744 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.515 HG23 ' CG1' ' A' ' 71' ' ' ILE . 60.7 t -96.86 130.4 30.24 Favored Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' HG23 ' A' ' 67' ' ' THR . 53.6 Cg_endo -64.33 -100.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.348 0 C-N-CA 124.468 3.445 . . . . 0.0 120.913 -173.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 p30 -123.86 39.72 3.9 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 116.458 2.022 . . . . 0.0 116.458 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.551 HG21 ' CG2' ' A' ' 46' ' ' VAL . 5.6 pt -84.92 58.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 CA-C-O 124.859 2.266 . . . . 0.0 114.754 -179.536 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.72 111.1 0.97 Allowed Glycine 1 N--CA 1.516 4.001 0 CA-C-N 111.454 -2.612 . . . . 0.0 114.089 179.235 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 14' ' ' GLU . . . 160.51 82.83 0.04 OUTLIER Glycine 0 N--CA 1.508 3.496 0 O-C-N 121.676 -0.896 . . . . 0.0 112.187 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.287 4.5 m-20 13.11 23.38 0.0 OUTLIER 'General case' 0 CA--C 1.594 2.635 0 C-N-CA 131.572 3.949 . . . . 0.0 121.643 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' GLY . 42.5 tt0 118.52 137.5 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.878 0 C-N-CA 130.381 3.472 . . . . 0.0 112.368 179.7 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.454 HG21 HD12 ' A' ' 10' ' ' ILE . 1.4 m -137.41 146.12 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.948 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.583 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 6.9 pt-20 -113.36 169.25 9.09 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 t -93.97 130.0 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.128 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -179.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.484 ' C ' ' HG3' ' A' ' 19' ' ' GLU . 63.9 p -105.8 -47.15 3.95 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.801 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 18' ' ' THR . 2.8 mt-10 -130.49 106.04 8.26 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 123.126 1.441 . . . . 0.0 112.822 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.88 70.49 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-O 123.709 1.718 . . . . 0.0 111.162 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 14.2 mmt -25.37 -52.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 111.786 -2.461 . . . . 0.0 116.982 179.612 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 m -102.59 179.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.787 0 N-CA-C 118.514 2.783 . . . . 0.0 118.514 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.3 mmtm -140.18 168.69 19.22 Favored 'General case' 0 N--CA 1.522 3.131 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.12 89.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.525 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.063 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.87 4.6 5.58 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.748 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.6 141.24 31.68 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.411 1.101 . . . . 0.0 113.474 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 28.4 mttp -64.99 135.32 55.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.983 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.523 HG12 ' CB ' ' A' ' 48' ' ' ALA . 19.0 t -131.96 115.82 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -179.335 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -118.26 152.46 35.69 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.181 -1.575 . . . . 0.0 113.97 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.94 72.91 0.42 Allowed 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.494 1.616 . . . . 0.0 114.545 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 175.98 -22.44 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 110.315 -3.13 . . . . 0.0 110.299 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -92.94 117.04 29.61 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -179.105 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 14.7 m -48.27 126.8 11.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.331 1.063 . . . . 0.0 112.981 179.277 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -89.02 -55.26 3.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 125.003 1.321 . . . . 0.0 113.711 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -148.4 152.18 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.566 179.724 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -99.48 136.41 39.45 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.268 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 21.4 m -123.68 146.71 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 43' ' ' SER . 0.0 OUTLIER -124.84 -173.69 2.86 Favored 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 179.8 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.23 145.36 4.93 Favored Glycine 1 N--CA 1.519 4.177 0 O-C-N 124.419 1.074 . . . . 0.0 113.061 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 1.0 -73.0 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -179.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -35.65 -54.68 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 160.84 172.13 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.294 0 O-C-N 126.109 2.131 . . . . 0.0 107.851 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.418 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 37.9 t -89.79 141.41 28.65 Favored 'General case' 0 N--CA 1.51 2.53 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.679 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.0 mtm -132.22 172.31 12.58 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.786 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -122.88 156.69 34.13 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 122.178 0.989 . . . . 0.0 113.397 179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.551 ' CG2' HG21 ' A' ' 10' ' ' ILE . 5.8 t -131.2 122.24 19.04 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.753 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -85.86 178.7 4.13 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.008 1.805 . . . . 0.0 113.02 169.144 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -67.27 106.75 1.31 Allowed Pre-proline 0 C--N 1.287 -2.121 1 N-CA-C 122.188 4.144 . . . . 0.0 122.188 -179.903 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 78.5 Cg_exo -29.7 -40.69 0.06 OUTLIER 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.665 2.243 . . . . 0.0 115.61 174.236 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -154.11 -176.42 5.85 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 112.8 -2.0 . . . . 0.0 111.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -99.22 116.66 31.92 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.7 -169.7 34.84 Favored Glycine 1 N--CA 1.526 4.636 0 CA-C-O 119.276 -0.735 . . . . 0.0 112.556 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.485 ' CG2' ' HG3' ' A' ' 77' ' ' GLU . 2.1 t -109.91 157.31 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.34 0 CA-C-N 119.804 1.802 . . . . 0.0 107.847 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 20.8 t -76.43 113.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 6.5 tmtt? -91.74 -41.81 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.457 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 51.2 tt0 -164.92 161.28 19.99 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.155 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -162.71 152.16 15.53 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.164 -1.585 . . . . 0.0 109.243 178.587 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 54.0 mttt -126.29 49.48 2.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.761 1.267 . . . . 0.0 109.164 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.03 137.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 111.828 -2.442 . . . . 0.0 112.707 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.82 177.75 4.59 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 124.619 2.152 . . . . 0.0 113.621 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -85.06 115.8 27.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 1 N-CA-C 99.967 -4.086 . . . . 0.0 99.967 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.55 -24.74 5.49 Favored Glycine 0 N--CA 1.514 3.882 0 CA-C-N 110.156 -3.202 . . . . 0.0 109.905 -179.139 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.06 174.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.583 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 25.2 mmtm -104.13 136.13 44.33 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.558 HG12 HD12 ' A' ' 71' ' ' ILE . 19.9 m -132.15 142.87 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 123.218 1.485 . . . . 0.0 110.107 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 67' ' ' THR . 11.9 ttmt -141.01 123.44 15.86 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.69 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 8' ' ' PRO . 1.4 m -22.72 103.64 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.32 -42.49 1.72 Allowed Glycine 0 N--CA 1.511 3.695 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.542 -179.644 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 13.8 t -38.45 140.22 0.34 Allowed 'General case' 0 N--CA 1.53 3.526 0 CA-C-O 118.028 -0.987 . . . . 0.0 113.611 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.7 tt -80.78 57.33 2.96 Favored 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 124.527 2.108 . . . . 0.0 115.871 -179.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 65' ' ' VAL . 14.4 mm -30.05 -67.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 120.498 3.518 . . . . 0.0 120.498 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.505 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptm -143.26 172.15 13.14 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 111.784 -2.462 . . . . 0.0 113.397 -179.349 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.38 122.74 69.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 120.731 -1.231 . . . . 0.0 109.681 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.545 ' CE1' HG21 ' A' ' 5' ' ' VAL . 16.2 m-30 -105.02 144.69 31.47 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tp10 -120.73 99.2 6.39 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 124.551 2.12 . . . . 0.0 111.293 179.578 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 m -49.26 90.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HG3' ' CG2' ' A' ' 53' ' ' VAL . 83.4 mt-10 -26.77 -50.01 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.853 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.91 -67.76 0.16 Allowed Glycine 0 N--CA 1.516 3.967 0 N-CA-C 103.171 -3.972 . . . . 0.0 103.171 179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 175.88 33.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 111.15 -2.525 . . . . 0.0 109.111 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.807 3 N-CA-C 97.479 -5.008 . . . . 0.0 97.479 -179.291 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.587 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.2 m -19.36 154.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 1 N-CA-C 124.099 4.852 . . . . 0.0 124.099 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 74' ' ' PHE . 3.2 mttp -164.16 171.89 14.42 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.222 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 11.3 pt-20 -116.65 161.21 19.54 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.358 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.454 HG21 ' CE1' ' A' ' 74' ' ' PHE . 43.8 t -128.48 96.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 124.943 2.306 . . . . 0.0 108.143 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.9 p-10 -86.72 168.79 13.23 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.484 HG21 ' CG1' ' A' ' 65' ' ' VAL . 33.1 t -98.69 143.71 26.83 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 116.598 -2.041 . . . . 0.0 112.879 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' A' ' 7' ' ' VAL . 23.1 Cg_endo -72.05 -178.98 3.51 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.181 1.921 . . . . 0.0 114.633 177.555 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -53.99 40.82 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 118.757 2.873 . . . . 0.0 118.757 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.573 HG21 ' CG2' ' A' ' 46' ' ' VAL . 9.6 pt -79.53 46.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 O-C-N 118.842 -2.411 . . . . 0.0 116.368 -179.406 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.0 175.74 18.58 Favored Glycine 1 N--CA 1.526 4.664 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HE3' ' A' ' 66' ' ' LYS . . . -97.75 -29.31 7.8 Favored Glycine 1 N--CA 1.525 4.569 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' O ' ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -89.35 -167.87 2.0 Allowed 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 131.263 3.825 . . . . 0.0 110.54 -179.885 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -112.03 149.76 31.59 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 122.554 1.169 . . . . 0.0 112.041 179.782 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG21 HD12 ' A' ' 10' ' ' ILE . 34.2 m -123.47 167.22 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.275 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.57 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 28.8 mt-10 -112.19 128.67 56.3 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.49 119.01 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.109 0 C-N-CA 115.71 -2.396 . . . . 0.0 109.835 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -94.11 -51.24 4.93 Favored 'General case' 0 N--CA 1.519 2.98 0 C-N-CA 123.755 0.822 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.13 119.05 20.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.61 1.195 . . . . 0.0 112.726 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -92.33 63.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 123.594 1.664 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 67.3 mmm -24.33 -46.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.75 160.34 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -153.96 0.57 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 120.606 3.558 . . . . 0.0 120.606 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 55' ' ' LYS . 65.4 t -73.92 97.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.898 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.78 6.18 26.8 Favored Glycine 0 N--CA 1.516 3.977 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.722 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -92.85 152.77 19.23 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -82.09 124.84 30.2 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.55 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.451 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 t -123.47 148.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.054 -179.685 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -147.39 151.12 35.96 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.384 -0.822 . . . . 0.0 109.018 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 48' ' ' ALA . . . -48.72 158.96 0.27 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 124.172 0.92 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 74.12 -41.54 0.48 Allowed 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 123.901 1.81 . . . . 0.0 112.007 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 119.565 -1.959 . . . . 0.0 114.656 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -34.0 82.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 179.154 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -50.79 -51.48 50.19 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.2 pt -142.1 144.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.001 179.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 m -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 24.7 m -130.82 162.4 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 17.7 tt0 -121.57 -144.61 0.35 Allowed 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' H ' ' HG2' ' A' ' 38' ' ' GLU . . . 129.67 -141.21 12.38 Favored Glycine 1 N--CA 1.517 4.096 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.224 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -48.26 86.19 0.0 OUTLIER 'General case' 0 CA--C 1.6 2.872 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 0.3 OUTLIER 33.49 32.1 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.149 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -179.532 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.58 150.34 38.69 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.823 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.5 p -106.46 130.22 54.3 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 122.044 0.926 . . . . 0.0 111.63 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 30.7 mmt -124.1 152.58 42.57 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.601 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -124.41 152.94 42.63 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.573 ' CG2' HG21 ' A' ' 10' ' ' ILE . 5.4 t -121.76 112.75 32.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.911 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.97 171.12 14.54 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 CA-C-O 124.282 1.701 . . . . 0.0 108.933 172.439 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -64.27 106.83 1.06 Allowed Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.089 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 3.8 Cg_endo -34.45 -37.04 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 121.808 1.672 . . . . 0.0 114.321 175.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -156.16 -175.74 5.59 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.61 164.83 12.43 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 126.49 -152.69 18.45 Favored Glycine 1 N--CA 1.524 4.567 0 O-C-N 121.415 -0.803 . . . . 0.0 114.78 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.38 165.46 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 121.429 0.633 . . . . 0.0 112.143 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 ' CE1' ' A' ' 74' ' ' PHE . 15.3 t -96.09 145.33 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.103 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' HG13 ' A' ' 24' ' ' VAL . 18.8 tptt -107.65 -60.59 1.68 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.631 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.9 tt0 -161.17 169.79 21.6 Favored 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.689 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt? -164.61 155.97 15.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.655 -1.278 . . . . 0.0 109.645 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -131.11 51.55 2.13 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.387 1.089 . . . . 0.0 108.368 179.714 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 71' ' ' ILE . 19.4 m -126.28 170.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 CA-C-N 114.121 -1.4 . . . . 0.0 114.719 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -138.65 165.95 25.62 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 120.692 3.59 . . . . 0.0 120.692 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.03 101.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 100.849 -3.76 . . . . 0.0 100.849 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.35 29.17 2.18 Favored Glycine 0 N--CA 1.508 3.481 0 CA-C-N 109.572 -3.467 . . . . 0.0 108.01 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.285 0.0 OUTLIER -112.12 178.79 4.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 179.44 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HE2' ' CD ' ' A' ' 16' ' ' GLU . 29.6 mmtp -109.77 130.35 55.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' CG1' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -113.01 147.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 113.492 -1.685 . . . . 0.0 112.918 -179.838 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' CE ' ' O ' ' A' ' 13' ' ' ASP . 4.3 tptm -146.76 140.97 26.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 15.1 t -50.97 124.44 11.32 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.699 178.786 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.8 -47.11 1.05 Allowed Glycine 0 N--CA 1.508 3.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.659 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.9 t -36.32 118.78 0.56 Allowed 'General case' 0 N--CA 1.523 3.222 0 CA-C-O 117.316 -1.326 . . . . 0.0 113.606 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.92 62.15 1.09 Allowed 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 123.198 1.475 . . . . 0.0 110.527 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.433 ' HA ' HG11 ' A' ' 59' ' ' VAL . 21.2 mm -45.11 -58.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' VAL . 8.0 ptm -142.06 160.7 39.69 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -107.13 131.79 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 123.532 1.634 . . . . 0.0 112.54 179.549 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 3' ' ' LYS . 3.6 m-30 -110.35 165.27 11.91 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.956 -2.384 . . . . 0.0 116.919 -179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 21.6 tt0 -151.36 101.89 2.87 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.605 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 32.1 m -48.66 60.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 C-N-CA 127.297 2.239 . . . . 0.0 116.245 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 85.94 144.9 0.06 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 -179.189 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.56 9.52 4.63 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 2.89 -80.03 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.697 0 O-C-N 127.668 2.628 . . . . 0.0 115.393 -179.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.209 0 O-C-N 127.652 3.095 . . . . 0.0 113.785 179.61 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' O ' HG22 ' A' ' 76' ' ' VAL . 57.2 mtm . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -34.35 137.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.595 HG21 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -76.12 177.37 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 11' ' ' GLY . 10.1 p30 -70.63 60.52 0.22 Allowed 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 125.264 2.459 . . . . 0.0 114.778 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.523 HG21 HG12 ' A' ' 46' ' ' VAL . 10.8 pt -79.22 39.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 CA-C-O 123.687 1.708 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 46.48 -79.99 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.89 95.47 0.01 OUTLIER Glycine 1 N--CA 1.52 4.242 0 N-CA-C 117.869 1.907 . . . . 0.0 117.869 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -17.68 -66.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.17 139.01 35.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.466 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 65' ' ' VAL . 33.3 m -144.79 155.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.724 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.639 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.639 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 26' ' ' ASP . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.86 -166.74 1.66 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.6 174.3 16.73 Favored Glycine 0 N--CA 1.514 3.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -14.07 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt 66.98 -3.9 0.88 Allowed 'General case' 0 N--CA 1.518 2.942 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.27 118.14 34.44 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -103.44 125.75 50.21 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.523 HG12 HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 3' ' ' LYS . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.724 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 15' ' ' VAL . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CE1' HG21 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 1' ' ' MET . 27.5 m -62.96 74.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.47 146.64 40.41 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.384 179.589 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.16 -36.53 2.38 Favored Glycine 0 N--CA 1.511 3.676 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 158.35 -170.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 110.981 -2.609 . . . . 0.0 111.923 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.699 0 C-N-CA 125.611 1.564 . . . . 0.0 108.714 179.926 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' O ' HG22 ' A' ' 76' ' ' VAL . 57.2 mtm . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -34.35 137.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.595 HG21 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -76.12 177.37 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 11' ' ' GLY . 10.1 p30 -70.63 60.52 0.22 Allowed 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 125.264 2.459 . . . . 0.0 114.778 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.523 HG21 HG12 ' A' ' 46' ' ' VAL . 10.8 pt -79.22 39.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 CA-C-O 123.687 1.708 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 46.48 -79.99 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.89 95.47 0.01 OUTLIER Glycine 1 N--CA 1.52 4.242 0 N-CA-C 117.869 1.907 . . . . 0.0 117.869 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -17.68 -66.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 179.849 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.17 139.01 35.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 65' ' ' VAL . 33.3 m -144.79 155.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.724 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.639 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.639 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 26' ' ' ASP . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.86 -166.74 1.66 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.6 174.3 16.73 Favored Glycine 0 N--CA 1.514 3.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -14.07 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt 66.98 -3.9 0.88 Allowed 'General case' 0 N--CA 1.518 2.942 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.27 118.14 34.44 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.633 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -103.44 125.75 50.21 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.523 HG12 HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 3' ' ' LYS . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.724 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 15' ' ' VAL . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CE1' HG21 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 1' ' ' MET . 27.5 m -62.96 74.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.47 146.64 40.41 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.384 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.16 -36.53 2.38 Favored Glycine 0 N--CA 1.511 3.676 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 158.35 -170.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 110.981 -2.609 . . . . 0.0 111.923 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.699 0 C-N-CA 125.611 1.564 . . . . 0.0 108.714 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 123.968 1.842 . . . . 0.0 115.926 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.643 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 6.1 mmmt -139.83 149.93 44.07 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.863 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -96.27 154.97 16.96 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 74' ' ' PHE . 43.3 t -116.52 117.27 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.586 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.2 p-10 -108.5 169.4 8.67 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.154 1.454 . . . . 0.0 109.767 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.509 HG22 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -94.94 115.0 64.94 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 112.546 -2.115 . . . . 0.0 106.468 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.413 ' O ' HG22 ' A' ' 67' ' ' THR . 52.8 Cg_endo . . . . . 0 N--CA 1.506 2.235 0 C-N-CA 122.513 2.142 . . . . 0.0 113.471 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 65' ' ' VAL . 24.7 m . . . . . 0 N--CA 1.502 2.146 0 CA-C-O 122.693 1.235 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 2.5 pt-20 -120.58 170.32 9.52 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.43 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 t -97.62 120.75 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' HB ' ' A' ' 36' ' ' THR . 12.2 t -96.47 -46.17 6.47 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.68 98.51 4.51 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 122.437 1.113 . . . . 0.0 113.362 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.8 p -81.62 68.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 124.599 2.142 . . . . 0.0 108.498 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -32.49 -56.15 0.34 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.729 2.862 . . . . 0.0 118.729 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.2 m -87.71 164.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.617 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 16.3 mmtp -131.79 -166.38 1.71 Allowed 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 124.25 1.976 . . . . 0.0 115.91 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.7 t -74.42 86.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-N 113.294 -1.775 . . . . 0.0 113.654 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.62 -11.49 7.07 Favored Glycine 1 N--CA 1.517 4.065 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.097 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -54.97 163.94 0.92 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD2' HG12 ' A' ' 53' ' ' VAL . 8.4 mmmm -100.2 102.29 13.54 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 112.263 -2.244 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.79 148.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 CA-C-O 124.217 1.96 . . . . 0.0 114.804 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -141.04 154.67 46.09 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.548 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -55.03 163.85 0.96 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 60.49 -16.54 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -88.81 106.97 18.72 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 4.0 t -36.57 138.44 0.23 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.3 mt -102.14 -59.43 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.8 pt -140.26 130.89 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.198 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 45' ' ' GLU . 6.7 m -83.55 123.06 29.38 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.8 m -115.66 141.59 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.512 2.666 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 N--CA 1.508 2.464 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 32.6 mtt -121.97 164.86 16.89 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.64 -1.288 . . . . 0.0 112.117 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' HG2' HG23 ' A' ' 36' ' ' THR . 36.7 mt-10 -129.81 153.49 48.19 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.44 1.114 . . . . 0.0 112.361 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.8 t -124.74 112.97 27.16 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.698 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.56 177.52 5.6 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.741 1.627 . . . . 0.0 113.214 178.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -69.27 114.75 25.98 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 29.2 Cg_endo -46.79 -27.71 5.94 Favored 'Trans proline' 0 N--CA 1.512 2.609 0 C-N-CA 122.371 2.048 . . . . 0.0 112.609 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.643 ' CZ ' ' HE3' ' A' ' 3' ' ' LYS . 47.0 p90 -167.13 -175.28 2.92 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.26 164.12 12.61 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.85 -144.65 15.53 Favored Glycine 1 N--CA 1.52 4.293 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.545 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG12 ' HD2' ' A' ' 27' ' ' LYS . 3.4 m -121.87 166.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.062 0.934 . . . . 0.0 112.318 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' CE1' ' A' ' 74' ' ' PHE . 13.8 t -98.33 142.08 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.487 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 69.2 tttt -115.93 -63.88 1.39 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.645 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -135.82 158.5 44.24 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -155.97 115.8 3.63 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.077 -1.639 . . . . 0.0 113.203 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -90.65 52.54 2.21 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.237 -1.539 . . . . 0.0 109.466 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.18 149.09 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -122.67 172.02 8.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 124.355 2.026 . . . . 0.0 116.123 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -95.06 111.41 25.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 100.992 -3.707 . . . . 0.0 100.992 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.03 8.71 11.38 Favored Glycine 1 N--CA 1.518 4.15 1 CA-C-N 107.741 -4.3 . . . . 0.0 108.855 -179.218 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' A' ' 64' ' ' LYS . 43.9 t0 -94.82 177.49 5.89 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.611 -1.295 . . . . 0.0 110.264 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' CE ' ' HB3' ' A' ' 16' ' ' GLU . 2.6 mmtp -108.73 144.46 36.5 Favored 'General case' 0 N--CA 1.511 2.595 1 N-CA-C 123.369 4.581 . . . . 0.0 123.369 -179.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 15' ' ' VAL . 2.8 m -142.26 150.22 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.757 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -161.74 162.52 29.71 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 16.6 p -41.49 113.75 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.99 -35.88 4.78 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 111.641 -2.527 . . . . 0.0 115.314 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.6 t -38.31 132.92 1.02 Allowed 'General case' 0 N--CA 1.53 3.567 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.59 56.96 0.18 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.509 ' CG1' HG22 ' A' ' 7' ' ' VAL . 3.1 mt -23.12 -63.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CG2' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -159.23 171.94 18.95 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 112.529 -2.123 . . . . 0.0 114.123 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.77 120.51 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 123.635 1.683 . . . . 0.0 110.842 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' HG21 ' A' ' 5' ' ' VAL . 6.8 m-30 -99.05 176.01 5.71 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 112.083 -2.326 . . . . 0.0 109.136 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS 0.264 26.5 tt0 -156.39 115.87 3.52 Favored 'General case' 0 C--N 1.285 -2.23 1 N-CA-C 98.965 -4.457 . . . . 0.0 98.965 178.712 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.783 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.513 2.692 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.498 ' HE3' ' OE2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -112.19 127.12 55.86 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -66.84 142.86 57.19 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.717 1.246 . . . . 0.0 110.732 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 74' ' ' PHE . 26.2 t -116.49 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.9 p-10 -101.61 168.78 9.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.748 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.87 140.06 21.7 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.721 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 N--CA 1.496 1.674 0 C-N-CA 123.327 2.684 . . . . 0.0 114.803 -179.239 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.502 2.159 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 pm0 -113.13 164.96 12.85 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.488 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 t -101.48 117.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.221 -0.924 . . . . 0.0 110.118 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.61 -50.57 4.44 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.285 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.3 mt-10 -128.69 95.28 4.07 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 123.555 1.645 . . . . 0.0 111.305 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.5 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.8 p -70.23 66.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.5 mtt -30.24 -57.35 0.19 Allowed 'General case' 0 N--CA 1.512 2.631 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.422 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 18.8 m -87.16 171.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -134.33 169.37 17.31 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.63 110.26 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.704 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 10.91 21.62 Favored Glycine 0 N--CA 1.508 3.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.694 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.38 159.34 16.46 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 123.731 1.729 . . . . 0.0 110.045 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -78.58 122.74 26.29 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 125.151 2.405 . . . . 0.0 113.49 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 74' ' ' PHE . 92.7 t -125.25 97.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 110.455 -3.066 . . . . 0.0 114.56 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -107.44 160.01 15.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 173.83 0.24 Allowed 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.454 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 62.79 -18.67 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 1.6 pp0? -94.97 139.51 31.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.132 -1.605 . . . . 0.0 107.789 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t -63.48 128.48 36.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -92.77 -64.52 1.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.8 pt -138.61 140.04 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 113.424 -1.717 . . . . 0.0 112.306 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 3.4 m -93.35 130.13 39.23 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.985 -3.339 . . . . 0.0 101.985 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.49 164.8 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.197 0.936 . . . . 0.0 112.473 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 11.6 tt0 . . . . . 0 N--CA 1.505 2.293 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.253 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.505 2.302 0 CA-C-O 121.992 0.901 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.39 124.72 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.842 -1.526 . . . . 0.0 107.413 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 22.7 mp0 -95.65 142.55 27.83 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 123.825 1.774 . . . . 0.0 113.557 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 t -113.48 118.47 43.45 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.582 -1.644 . . . . 0.0 115.092 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -82.14 178.11 6.65 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.875 1.717 . . . . 0.0 112.356 174.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -67.51 103.1 0.44 Allowed Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 118.793 2.886 . . . . 0.0 118.793 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.8 Cg_endo -42.93 -29.59 1.56 Allowed 'Trans proline' 0 N--CA 1.508 2.349 0 C-N-CA 122.416 2.077 . . . . 0.0 114.105 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -159.2 -179.44 7.99 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.24 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.53 17.08 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 120.097 3.369 . . . . 0.0 120.097 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.37 -147.82 18.56 Favored Glycine 1 N--CA 1.519 4.221 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.98 160.89 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.93 83.74 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -67.47 -42.48 82.94 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -163.84 130.19 3.16 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 1.9 pt? -126.95 151.27 48.73 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 119.78 -1.825 . . . . 0.0 108.362 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -121.05 45.08 2.35 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.899 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 p -141.11 154.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.953 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -124.26 171.78 9.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -87.0 114.76 26.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 100.9 -3.741 . . . . 0.0 100.9 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.35 -0.77 16.41 Favored Glycine 0 N--CA 1.503 3.147 0 CA-C-N 110.145 -3.207 . . . . 0.0 109.216 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.8 170.48 9.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.334 0.667 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -118.68 145.73 45.26 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 121.13 3.752 . . . . 0.0 121.13 -179.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.471 HG12 ' CD1' ' A' ' 71' ' ' ILE . 17.1 m -130.62 164.79 32.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.218 -1.81 . . . . 0.0 113.557 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 140.82 18.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 t -43.72 120.42 2.0 Allowed 'General case' 0 N--CA 1.514 2.773 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.242 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.13 -23.72 10.46 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 117.285 1.674 . . . . 0.0 117.285 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.4 t -79.25 143.26 35.46 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 118.664 -1.214 . . . . 0.0 112.602 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 70' ' ' LEU . 9.3 mp -87.99 62.49 6.87 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 124.369 2.033 . . . . 0.0 113.338 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CD1' HG12 ' A' ' 65' ' ' VAL . 12.9 mm -44.65 -45.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -133.85 -177.47 4.58 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.743 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -138.63 117.29 13.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 5' ' ' VAL . 22.6 m-30 -109.75 159.51 17.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.273 3.1 tt0 -126.02 150.9 47.76 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 -179.472 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.513 2.682 0 N-CA-C 121.218 3.784 . . . . 0.0 121.218 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.606 ' HZ2' ' CD ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -99.13 158.77 15.44 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 113.011 -1.904 . . . . 0.0 114.131 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.606 ' CD ' ' HZ2' ' A' ' 3' ' ' LYS . 4.5 mp0 -100.27 149.79 23.23 Favored 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 74' ' ' PHE . 85.2 t -130.89 91.54 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.092 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 15.3 p-10 -104.93 174.28 5.94 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.508 HG22 HD11 ' A' ' 71' ' ' ILE . 56.4 t -90.81 126.23 56.45 Favored Pre-proline 0 N--CA 1.504 2.255 0 C-N-CA 117.128 -1.829 . . . . 0.0 106.527 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 N--CA 1.51 2.5 0 N-CA-C 120.606 3.272 . . . . 0.0 120.606 175.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.511 2.607 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.1 pt-20 -120.36 171.08 8.78 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -101.52 120.93 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.181 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 p -97.8 -52.84 3.6 Favored 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.837 -1.529 . . . . 0.0 111.279 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -123.27 104.98 9.47 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 122.978 1.37 . . . . 0.0 113.882 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.63 93.29 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.175 -1.578 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -38.23 90.12 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 26' ' ' ASP . 3.4 t -126.49 160.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -134.51 -175.63 3.94 Favored 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.37 91.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 113.83 -1.532 . . . . 0.0 112.114 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.36 -4.23 13.61 Favored Glycine 1 N--CA 1.52 4.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.326 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.548 ' HB2' HG12 ' A' ' 22' ' ' VAL . 23.8 m-20 -93.07 143.32 26.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.242 1.02 . . . . 0.0 111.697 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -76.4 122.9 25.15 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 124.71 2.195 . . . . 0.0 115.935 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 59.1 t -110.81 125.26 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.593 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -132.23 150.7 52.1 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 111.925 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -44.05 157.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.49 -20.05 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.529 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 30.0 tt0 -74.42 148.11 41.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -84.89 124.14 31.28 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.483 1.135 . . . . 0.0 108.592 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.9 mt -85.35 -57.57 3.02 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 122.652 1.215 . . . . 0.0 110.191 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -143.98 151.61 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -102.4 138.94 38.67 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.3 m -129.96 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 N--CA 1.512 2.669 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 N--CA 1.515 2.799 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.17 148.26 33.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.039 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 14.0 mp0 -114.64 151.57 33.33 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 123.511 1.624 . . . . 0.0 114.457 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.0 t -112.7 105.88 55.72 Favored Pre-proline 0 N--CA 1.506 2.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -86.33 179.81 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.87 1.529 . . . . 0.0 112.276 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -71.31 107.36 2.62 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 42.2 Cg_endo -49.52 -26.4 12.36 Favored 'Trans proline' 0 N--CA 1.514 2.697 0 C-N-CA 122.22 1.947 . . . . 0.0 113.757 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -164.97 -175.7 3.85 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 163.97 12.4 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 129.2 -144.83 15.78 Favored Glycine 1 N--CA 1.528 4.778 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.879 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.03 169.76 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 CA-C-N 118.879 1.339 . . . . 0.0 111.389 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 27.0 t -88.2 133.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.4 -53.8 3.63 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.032 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.29 159.42 19.9 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 124.672 1.233 . . . . 0.0 110.726 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -155.31 130.3 9.41 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -100.76 29.97 4.25 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.935 -1.103 . . . . 0.0 109.768 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.467 ' C ' HD22 ' A' ' 60' ' ' ASN . 29.4 m -119.4 157.33 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 112.71 -2.041 . . . . 0.0 114.005 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.467 HD22 ' C ' ' A' ' 59' ' ' VAL . 1.6 m-80 -131.94 -178.42 4.88 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.5 t -90.19 106.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 1 N-CA-C 99.059 -4.423 . . . . 0.0 99.059 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.22 28.59 2.15 Favored Glycine 0 N--CA 1.515 3.919 0 CA-C-N 108.991 -3.731 . . . . 0.0 110.591 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 67.3 t0 -119.71 164.9 15.23 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -106.08 141.31 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 119.857 3.28 . . . . 0.0 119.857 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -139.19 -179.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.92 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 65' ' ' VAL . 7.2 pttt 149.94 154.59 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.923 0 C-N-CA 125.715 1.606 . . . . 0.0 111.656 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.1 p -25.09 103.59 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 118.515 2.784 . . . . 0.0 118.515 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.14 -47.8 1.0 Allowed Glycine 0 N--CA 1.507 3.415 0 CA-C-N 111.711 -2.495 . . . . 0.0 112.491 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.1 t -50.12 123.9 9.19 Favored 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.953 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 25.7 mt -72.56 67.39 0.76 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 7' ' ' VAL . 2.0 mt -22.75 -58.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 8.8 ptp -169.66 -173.67 1.69 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.414 -2.176 . . . . 0.0 115.488 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.52 133.51 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.501 1.143 . . . . 0.0 110.731 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 5' ' ' VAL . 12.1 m-30 -112.64 176.2 5.12 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.271 7.3 tp10 -144.37 99.54 3.39 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 29.8 m . . . . . 0 CA--C 1.569 1.693 1 N-CA-C 126.853 5.872 . . . . 0.0 126.853 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 124.03 1.872 . . . . 0.0 114.091 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -118.74 122.62 42.89 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.778 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -68.4 155.65 39.4 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.977 0.894 . . . . 0.0 110.267 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 74' ' ' PHE . 36.9 t -122.87 100.18 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.45 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 10.9 p-10 -98.24 96.56 8.16 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.421 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' THR . 89.6 t -20.75 122.71 0.1 Allowed Pre-proline 0 N--CA 1.511 2.58 0 CA-C-N 113.093 -1.867 . . . . 0.0 114.858 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.504 2.127 0 C-N-CA 122.262 1.975 . . . . 0.0 116.346 -178.227 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.512 2.672 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.9 pt-20 -107.32 166.52 10.58 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 t -94.86 116.29 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.226 1.012 . . . . 0.0 112.456 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -94.65 -32.23 13.48 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 113.78 -1.555 . . . . 0.0 111.726 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 0.4 OUTLIER -138.54 107.64 6.05 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.828 0.705 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.3 p -86.74 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 118.43 -2.669 . . . . 0.0 117.088 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.3 mmt -20.3 -51.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.55 HG21 HE22 ' A' ' 32' ' ' GLN . 2.9 t -111.97 151.54 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 23' ' ' LYS . 23.4 mtmt -134.07 -177.62 4.66 Favored 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.24 94.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.246 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.9 -7.1 17.36 Favored Glycine 1 N--CA 1.516 4.021 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -92.48 142.54 27.3 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.251 1.024 . . . . 0.0 110.477 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -69.82 127.25 32.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.653 2.644 . . . . 0.0 117.193 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 1.5 t -112.66 98.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 109.86 -3.336 . . . . 0.0 113.906 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.473 ' H ' ' HG2' ' A' ' 32' ' ' GLN . . . -112.85 146.96 37.97 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.75 -1.219 . . . . 0.0 112.42 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.02 124.16 20.04 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 118.89 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 128.358 3.536 . . . . 0.0 110.62 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.55 HE22 HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.09 147.38 22.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.417 -1.427 . . . . 0.0 108.997 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 2.2 t -80.48 80.94 6.85 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.0 mt -29.99 -57.25 0.18 Allowed 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.8 pt -149.41 156.76 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 112.591 -2.095 . . . . 0.0 110.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 87.2 m -106.15 131.75 53.03 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.96 154.88 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 N--CA 1.505 2.29 0 CA-C-O 123.721 1.725 . . . . 0.0 113.372 179.464 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.513 2.682 0 CA-C-O 121.13 0.49 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.3 mtm -106.34 165.81 10.98 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -102.12 145.28 29.58 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.54 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.5 t -117.81 97.2 50.55 Favored Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.861 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 7.1 Cg_endo -73.95 175.02 11.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-O 125.154 2.064 . . . . 0.0 111.584 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.633 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -77.04 109.06 7.9 Favored Pre-proline 0 C--N 1.284 -2.276 0 CA-C-N 111.527 -2.578 . . . . 0.0 117.262 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 27.6 Cg_endo -47.08 -32.03 12.67 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.794 2.329 . . . . 0.0 111.707 -170.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -155.73 -178.35 7.23 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 111.932 -2.395 . . . . 0.0 107.318 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -97.97 159.68 14.78 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.51 -147.68 19.39 Favored Glycine 1 N--CA 1.531 4.971 0 C-N-CA 123.828 0.728 . . . . 0.0 112.663 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 162.16 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 CA-C-N 119.029 1.415 . . . . 0.0 109.521 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 24.9 t -82.25 102.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.844 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -76.79 -47.8 20.51 Favored 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.482 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 5.4 tt0 -161.33 152.58 18.71 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.7 pt? -149.69 150.67 32.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.592 -1.942 . . . . 0.0 108.489 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 6.0 mttp -115.34 47.28 1.33 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 121.785 0.802 . . . . 0.0 111.246 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -139.49 140.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 113.688 -1.597 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -125.45 -170.44 2.18 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.132 1.444 . . . . 0.0 110.49 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.43 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.78 9.05 4.98 Favored Glycine 1 N--CA 1.517 4.097 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.577 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -101.57 157.3 16.92 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -111.45 146.49 37.12 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HB ' HG21 ' A' ' 7' ' ' VAL . 6.3 m -136.49 168.15 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 113.01 -1.905 . . . . 0.0 113.908 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.31 147.34 22.16 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 7.2 t -47.37 122.6 4.79 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.936 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.06 16.94 24.16 Favored Glycine 0 N--CA 1.514 3.835 0 O-C-N 121.353 -0.842 . . . . 0.0 114.96 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -107.02 97.03 6.86 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.796 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.22 87.64 7.19 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 123.592 1.663 . . . . 0.0 112.575 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' C ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -112.4 -26.54 3.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.952 -1.931 . . . . 0.0 116.046 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 5' ' ' VAL . 11.3 ttp -100.56 153.99 18.93 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.605 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.2 126.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 124.957 2.313 . . . . 0.0 115.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD1' HG21 ' A' ' 5' ' ' VAL . 17.8 m-30 -114.5 158.52 21.5 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.475 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -140.4 135.75 32.4 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.298 -1.65 0 CA-C-O 122.074 0.94 . . . . 0.0 113.199 -179.581 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 80.4 t . . . . . 0 N--CA 1.518 2.928 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -129.91 162.14 29.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.973 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 2.4 pm0 -105.12 153.34 21.64 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 74' ' ' PHE . 46.6 t -133.18 97.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.951 1.358 . . . . 0.0 113.716 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.7 p-10 -103.51 177.46 4.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 65' ' ' VAL . 79.0 t -104.29 142.02 23.73 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 7' ' ' VAL . 10.9 Cg_endo . . . . . 0 N--CA 1.493 1.493 0 C-N-CA 123.114 2.543 . . . . 0.0 113.633 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.505 2.296 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 89.9 mt-10 -87.21 -179.43 6.43 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 61' ' ' VAL . 97.7 t -109.69 115.73 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -46.15 9.53 Favored 'General case' 0 N--CA 1.522 3.161 0 CA-C-N 120.343 1.428 . . . . 0.0 110.24 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.68 100.72 4.71 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.058 1.409 . . . . 0.0 113.516 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 61' ' ' VAL . 13.8 p -82.14 58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 122.234 1.016 . . . . 0.0 111.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.1 mmt -22.08 -52.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.09 171.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 120.663 3.579 . . . . 0.0 120.663 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 51.5 mmtt -134.28 -162.17 1.22 Allowed 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 120.541 3.534 . . . . 0.0 120.541 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.12 92.96 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.984 0 O-C-N 119.938 -1.726 . . . . 0.0 113.898 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.39 12.37 13.56 Favored Glycine 1 N--CA 1.517 4.038 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.93 178.08 7.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.016 -1.592 . . . . 0.0 115.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -95.72 142.77 27.62 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 74' ' ' PHE . 1.8 t -145.93 113.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.706 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -132.24 151.92 51.59 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.98 79.12 0.22 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 124.035 1.874 . . . . 0.0 114.945 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CD ' ' N ' ' A' ' 32' ' ' GLN . 2.9 pp20? 166.77 -35.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 109.443 -3.526 . . . . 0.0 108.962 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 4.4 tt0 -58.99 80.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.254 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -31.66 70.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -24.27 -67.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.6 pt -151.43 141.87 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.292 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.5 m -99.09 139.94 33.99 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.79 146.08 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.514 2.765 0 N-CA-C 118.678 2.844 . . . . 0.0 118.678 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.516 2.874 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.8 mmt -125.76 150.6 47.61 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 122.363 0.265 . . . . 0.0 111.663 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -125.15 152.06 44.96 Favored 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -134.7 124.21 16.69 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.267 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -88.43 176.95 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.966 1.777 . . . . 0.0 111.592 171.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -53.31 117.35 11.52 Favored Pre-proline 0 CA--C 1.584 2.285 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 36.4 Cg_endo -48.85 -21.43 3.71 Favored 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 122.391 2.061 . . . . 0.0 114.235 174.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 11.4 p90 -169.92 -174.23 1.76 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.586 -2.097 . . . . 0.0 109.871 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -101.6 163.82 12.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.18 -152.13 19.89 Favored Glycine 0 N--CA 1.512 3.754 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.042 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.86 164.13 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.442 HG22 ' CE1' ' A' ' 74' ' ' PHE . 44.9 t -94.56 145.79 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.836 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 19.0 tttp -112.83 -73.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.58 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 47.7 tt0 -142.42 128.73 19.95 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.8 pt? -122.31 124.81 44.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.58 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.7 mptt -104.86 43.33 1.11 Allowed 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.21 157.41 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-N 114.095 -1.411 . . . . 0.0 114.453 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -144.45 171.44 14.35 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.521 ' CG2' HG12 ' A' ' 20' ' ' VAL . 33.5 t -88.74 103.63 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 101.782 -3.414 . . . . 0.0 101.782 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.98 12.91 2.81 Favored Glycine 1 N--CA 1.519 4.18 0 CA-C-N 108.657 -3.883 . . . . 0.0 111.958 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 26.1 t70 -120.39 163.49 17.8 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 111.682 -2.259 . . . . 0.0 107.283 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.22 152.67 22.57 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -136.39 170.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 110.632 -2.985 . . . . 0.0 110.029 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 67' ' ' THR . 15.4 ptmt -171.63 160.55 5.82 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.49 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 9.2 t -56.53 127.46 31.33 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 114.724 -2.79 . . . . 0.0 110.897 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.33 -41.22 2.27 Favored Glycine 0 N--CA 1.509 3.519 0 N-CA-C 117.439 1.736 . . . . 0.0 117.439 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 58.8 m -60.02 127.73 33.34 Favored 'General case' 0 N--CA 1.524 3.228 0 CA-C-N 119.627 1.713 . . . . 0.0 114.225 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 70' ' ' LEU . 8.4 mp -79.13 65.13 4.22 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-O 122.645 1.212 . . . . 0.0 111.649 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.513 HG22 ' SD ' ' A' ' 72' ' ' MET . 40.0 mm -33.49 -54.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.513 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -148.6 175.91 10.78 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.52 134.05 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.685 0.755 . . . . 0.0 110.665 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.592 ' CD2' HG11 ' A' ' 28' ' ' VAL . 14.6 m-30 -113.48 165.97 11.96 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.894 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 16.9 tp10 -130.81 80.91 1.97 Allowed 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 123.964 1.84 . . . . 0.0 109.426 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 118.029 2.604 . . . . 0.0 118.029 179.354 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' A' ' 4' ' ' GLU . 2.3 mmtt -114.65 161.88 17.52 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.988 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 1.2 pm0 -107.31 156.21 19.13 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 123.362 1.553 . . . . 0.0 114.257 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 74.6 t -137.5 111.64 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 124.655 2.169 . . . . 0.0 113.275 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.4 p-10 -97.53 166.16 11.64 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 111.981 -2.372 . . . . 0.0 106.28 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.16 135.95 29.32 Favored Pre-proline 0 C--N 1.29 -1.99 0 C-N-CA 117.607 -1.637 . . . . 0.0 109.413 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 C--N 1.312 -1.346 0 C-N-CA 121.903 1.736 . . . . 0.0 110.961 -172.491 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.564 HG23 HG23 ' A' ' 65' ' ' VAL . 2.5 m . . . . . 0 N--CA 1.509 2.482 0 CA-C-O 120.976 0.417 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -120.98 172.1 8.17 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.306 -0.871 . . . . 0.0 109.212 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 60' ' ' ASN . 2.8 t -107.12 140.75 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.067 0 CA-C-O 123.195 1.474 . . . . 0.0 112.529 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 76.1 p -116.96 -45.94 2.75 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.411 ' H ' ' HB ' ' A' ' 36' ' ' THR . 28.3 mt-10 -126.97 112.94 15.84 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.8 65.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 124.193 1.949 . . . . 0.0 110.874 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' A' ' 21' ' ' MET . 24.1 mmt -26.92 -44.85 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.379 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.35 162.94 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -128.63 -165.59 1.52 Allowed 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.8 t -70.23 111.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 O-C-N 120.75 -1.219 . . . . 0.0 108.998 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.32 -0.41 35.05 Favored Glycine 1 N--CA 1.52 4.298 0 O-C-N 124.113 0.883 . . . . 0.0 113.0 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.75 145.42 24.42 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.67 114.11 10.44 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 6.6 t -107.82 110.4 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.072 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.673 -1.267 . . . . 0.0 110.954 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -41.77 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.319 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.924 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -18.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 1.2 tm0? -84.71 108.76 17.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.7 p -40.13 118.21 0.87 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 120.182 3.401 . . . . 0.0 120.182 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 48' ' ' ALA . 4.8 mt -86.01 -60.98 1.86 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.5 pt -145.82 150.2 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 19' ' ' GLU . 55.2 m -102.05 131.22 48.63 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.4 m -121.66 137.31 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 122.09 0.947 . . . . 0.0 112.262 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.516 2.833 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.1 mtt -145.12 152.66 40.41 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -112.14 138.7 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.969 1.842 . . . . 0.0 113.865 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.5 t -112.28 112.57 52.0 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.24 177.06 4.69 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 122.08 1.854 . . . . 0.0 110.167 172.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.645 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -62.85 98.25 0.14 Allowed Pre-proline 0 C--N 1.286 -2.162 1 N-CA-C 123.17 4.507 . . . . 0.0 123.17 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.7 Cg_exo -34.51 -42.04 0.28 Allowed 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.827 2.351 . . . . 0.0 113.388 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -146.36 -173.9 4.31 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 109.916 -3.311 . . . . 0.0 111.389 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -103.8 154.44 19.58 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.5 -174.02 22.22 Favored Glycine 1 N--CA 1.523 4.451 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.734 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.96 162.01 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 CA-C-N 121.29 2.545 . . . . 0.0 113.307 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.58 121.07 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' CG ' ' HB2' ' A' ' 75' ' ' GLU . 2.5 tmtp? -93.24 -49.82 5.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.682 0.674 . . . . 0.0 111.722 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.462 ' OE2' ' CE ' ' A' ' 58' ' ' LYS . 45.9 tt0 -153.69 162.78 40.94 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.211 0.529 . . . . 0.0 112.086 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 57' ' ' LEU . 1.8 pt? -171.44 146.64 2.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.074 -1.016 . . . . 0.0 109.783 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' CE ' ' OE2' ' A' ' 56' ' ' GLU . 83.4 mttt -123.46 52.59 1.4 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 p -121.33 164.47 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.317 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -137.54 163.32 31.47 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -95.11 73.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-O 126.833 3.206 . . . . 0.0 109.519 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.92 39.16 0.12 Allowed Glycine 0 N--CA 1.509 3.508 1 CA-C-N 106.196 -5.002 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -120.31 174.39 6.55 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -114.19 136.74 52.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 -179.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.564 HG23 HG23 ' A' ' 15' ' ' VAL . 1.3 m -117.61 165.81 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.682 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -147.94 139.32 23.61 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 116.66 -1.638 . . . . 0.0 107.095 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -53.98 125.89 20.45 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.637 -2.425 . . . . 0.0 110.279 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.7 -39.54 2.76 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 112.962 -1.926 . . . . 0.0 114.142 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.4 t -52.03 120.73 5.69 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 1.2 mp -75.08 64.22 1.35 Allowed 'General case' 0 N--CA 1.525 3.294 0 CA-C-O 124.161 1.934 . . . . 0.0 111.975 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.496 ' CD1' HG12 ' A' ' 65' ' ' VAL . 18.8 mm -46.37 -44.55 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 120.858 3.651 . . . . 0.0 120.858 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 14.6 ptm -141.21 157.71 44.88 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.808 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.36 129.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 122.275 1.036 . . . . 0.0 110.882 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CZ ' HG21 ' A' ' 5' ' ' VAL . 13.1 m-30 -97.61 -171.44 2.19 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 6.0 tp10 -157.04 80.77 0.92 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.556 1.179 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.238 179.734 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.505 2.312 0 N-CA-C 120.274 3.435 . . . . 0.0 120.274 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -126.39 107.17 10.04 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.332 -2.213 . . . . 0.0 109.988 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.89 148.13 40.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.316 -0.865 . . . . 0.0 111.068 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.638 HG21 ' CD1' ' A' ' 74' ' ' PHE . 20.4 t -110.73 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 CA-C-O 123.014 1.387 . . . . 0.0 113.918 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.4 p-10 -89.83 161.76 15.83 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.503 HG21 ' CG2' ' A' ' 65' ' ' VAL . 89.9 t -97.9 128.91 32.47 Favored Pre-proline 0 C--N 1.292 -1.909 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.792 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 N--CA 1.501 1.957 0 C-N-CA 121.203 1.269 . . . . 0.0 115.131 169.486 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.505 2.324 0 CA-C-O 120.837 0.351 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.684 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 11.9 pt-20 -123.36 166.86 14.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.5 t -89.75 128.78 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 55.5 p -102.03 -44.59 5.43 Favored 'General case' 0 N--CA 1.512 2.656 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.786 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -134.84 103.53 5.65 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.0 p -82.4 79.59 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 124.172 1.939 . . . . 0.0 110.46 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 mmt -43.9 -45.42 7.58 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 111.708 -2.496 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.24 158.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.8 mptt -130.91 -177.79 4.53 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-O 125.106 2.384 . . . . 0.0 117.434 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.77 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 112.708 -2.042 . . . . 0.0 114.341 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 118.49 17.18 5.3 Favored Glycine 1 N--CA 1.52 4.248 0 CA-C-N 114.701 -1.136 . . . . 0.0 114.635 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -96.97 141.48 30.09 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 122.656 1.217 . . . . 0.0 113.799 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.558 ' HD3' HG13 ' A' ' 53' ' ' VAL . 52.6 mmtt -71.35 97.62 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.122 1.439 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 74' ' ' PHE . 65.1 t -102.18 107.23 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 113.62 -1.627 . . . . 0.0 115.335 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -120.49 163.39 18.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.048 -1.033 . . . . 0.0 110.32 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.96 166.24 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.967 0.792 . . . . 0.0 112.795 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 62.17 -26.27 0.06 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -74.5 96.8 2.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.231 -1.543 . . . . 0.0 110.132 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 t -40.7 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -27.13 -67.61 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.0 pt -147.57 143.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 111.902 -2.408 . . . . 0.0 112.526 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.1 m -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.53 158.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.524 3.23 0 CA-C-O 122.599 1.19 . . . . 0.0 110.51 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 27.3 t . . . . . 0 N--CA 1.519 2.977 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -116.39 160.18 20.91 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 122.629 0.372 . . . . 0.0 110.537 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -125.31 152.92 44.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.242 -0.912 . . . . 0.0 113.03 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 39.5 t -122.25 113.66 30.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -85.53 177.0 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.249 1.299 . . . . 0.0 112.499 170.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -62.47 95.53 0.06 OUTLIER Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 11.4 Cg_endo -38.52 -35.29 0.45 Allowed 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 122.512 2.141 . . . . 0.0 114.073 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -154.76 -174.93 5.18 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 112.117 -2.31 . . . . 0.0 108.758 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -104.2 155.1 19.0 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.5 -138.61 7.29 Favored Glycine 0 N--CA 1.511 3.638 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.289 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.558 HG13 ' HD3' ' A' ' 27' ' ' LYS . 1.9 t -140.55 165.14 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 74' ' ' PHE . 14.4 t -90.93 137.26 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 118.83 -1.148 . . . . 0.0 107.934 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 19.7 tptt -108.12 -59.6 1.83 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.705 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 27.3 tt0 -149.66 160.85 43.18 Favored 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.705 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -163.21 156.34 19.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.181 -0.95 . . . . 0.0 108.448 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.3 48.75 1.98 Allowed 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.985 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.22 152.35 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.044 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.491 ' H ' ' HB2' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -134.23 -175.38 3.84 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 124.745 2.212 . . . . 0.0 116.277 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -86.72 114.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 113.07 4.95 23.82 Favored Glycine 0 N--CA 1.511 3.699 0 CA-C-N 108.721 -3.854 . . . . 0.0 110.028 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.491 ' HB2' ' H ' ' A' ' 60' ' ' ASN . 1.5 t0 -79.78 177.55 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.824 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.684 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 28.2 mmtm -114.15 132.92 55.91 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 118.576 2.806 . . . . 0.0 118.576 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.503 ' CG2' HG21 ' A' ' 7' ' ' VAL . 1.3 p -132.86 169.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' N ' ' CG2' ' A' ' 65' ' ' VAL . 6.4 ptpp? -173.99 134.99 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.434 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.3 t -33.42 116.34 0.25 Allowed 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 124.741 2.21 . . . . 0.0 113.646 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.87 -35.47 4.68 Favored Glycine 0 N--CA 1.507 3.409 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.941 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 66.6 m -64.86 136.76 57.22 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.61 72.23 10.7 Favored 'General case' 0 N--CA 1.522 3.138 0 CA-C-O 122.209 1.004 . . . . 0.0 109.621 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.615 HD11 ' SD ' ' A' ' 72' ' ' MET . 1.6 pp -58.11 -46.12 88.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.615 ' SD ' HD11 ' A' ' 71' ' ' ILE . 11.4 ptm -132.83 171.89 13.31 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 118.617 -1.233 . . . . 0.0 114.116 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.24 123.58 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.594 -1.316 . . . . 0.0 112.595 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.638 ' CD1' HG21 ' A' ' 5' ' ' VAL . 14.8 m-30 -111.96 167.68 10.19 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.292 1.52 . . . . 0.0 113.726 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.589 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 32.7 tt0 -145.89 155.85 43.15 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.296 -1.735 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 -179.587 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 24.9 t . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -125.59 152.98 44.39 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.122 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -109.92 149.46 29.87 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.642 1.687 . . . . 0.0 114.731 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.541 HG21 ' CE1' ' A' ' 74' ' ' PHE . 70.2 t -122.86 114.29 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.565 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -109.9 -178.41 3.52 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.438 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.634 HG21 ' HB ' ' A' ' 65' ' ' VAL . 59.5 t -102.19 128.63 28.0 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.016 -1.074 . . . . 0.0 113.486 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.99 179.387 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 23.0 m . . . . . 0 N--CA 1.514 2.733 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 29.3 mt-10 -93.29 163.28 13.67 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.033 1.458 . . . . 0.0 112.302 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.06 112.61 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 19' ' ' GLU . 14.2 t -98.71 -37.41 9.5 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 18' ' ' THR . 21.6 mm-40 -129.92 127.65 40.55 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.55 65.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 124.526 2.108 . . . . 0.0 113.359 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.425 ' H ' ' HG2' ' A' ' 21' ' ' MET . 7.4 mmt -24.49 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 110.925 -2.852 . . . . 0.0 117.839 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.9 t -122.67 155.82 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.1 tttt -127.51 178.66 5.95 Favored 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 120.797 3.629 . . . . 0.0 120.797 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.21 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 113.716 -1.584 . . . . 0.0 113.576 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.63 1.39 19.79 Favored Glycine 1 N--CA 1.517 4.037 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.891 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.478 ' HB2' HG12 ' A' ' 22' ' ' VAL . 77.7 m-20 -90.32 150.54 21.87 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.651 1.215 . . . . 0.0 113.092 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -75.94 112.6 12.52 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.892 0.853 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -106.61 101.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.437 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -105.89 151.13 24.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.306 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.19 157.85 0.42 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.564 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 69.5 -26.24 0.15 Allowed 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 122.658 1.218 . . . . 0.0 112.961 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.468 HE22 ' CG2' ' A' ' 22' ' ' VAL . 4.5 tm0? -80.15 102.13 9.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.223 -1.548 . . . . 0.0 109.471 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.2 t -33.25 124.99 0.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.8 mt -93.6 -52.71 4.35 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 110.711 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.46 HG13 ' HB ' ' A' ' 46' ' ' VAL . 32.3 pt -144.26 134.69 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.9 m -92.1 120.68 32.94 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 102.789 -3.041 . . . . 0.0 102.789 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.1 m -109.02 147.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 N--CA 1.512 2.637 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -179.724 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.513 2.709 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ttm -143.22 171.04 14.63 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -130.32 153.02 49.1 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HB ' HG13 ' A' ' 35' ' ' ILE . 3.9 t -130.45 105.31 15.97 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.48 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -81.73 178.73 6.28 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 CA-C-O 123.612 1.421 . . . . 0.0 112.276 177.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -66.0 117.08 38.97 Favored Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 37.4 Cg_endo -49.63 -22.31 6.5 Favored 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 123.186 2.591 . . . . 0.0 114.968 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -171.52 -174.06 1.33 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 113.232 -1.804 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -102.56 119.1 38.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 -165.37 32.62 Favored Glycine 0 N--CA 1.513 3.769 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.44 154.37 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 CA-C-N 118.205 1.003 . . . . 0.0 109.204 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.492 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 24.3 t -78.8 121.18 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -97.37 -56.72 2.45 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.754 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 31.0 tt0 -149.08 150.53 32.9 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.997 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -146.23 163.77 34.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.075 -1.641 . . . . 0.0 108.869 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.465 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 8.4 mmtp -133.89 42.6 2.92 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.24 154.02 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-N 113.969 -1.468 . . . . 0.0 114.071 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -130.78 -175.93 3.83 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-O 125.542 2.592 . . . . 0.0 116.089 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.14 109.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 1 N-CA-C 99.135 -4.394 . . . . 0.0 99.135 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.47 -27.26 3.12 Favored Glycine 0 N--CA 1.508 3.443 0 CA-C-N 111.518 -2.583 . . . . 0.0 107.532 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -72.95 159.18 34.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.341 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -115.27 143.65 44.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.634 ' HB ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -131.62 161.7 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -156.02 158.27 37.55 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -27.72 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.19 -42.14 1.96 Allowed Glycine 0 N--CA 1.515 3.943 0 CA-C-N 112.944 -1.934 . . . . 0.0 114.923 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.7 m -36.0 118.39 0.51 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 mp -67.72 64.95 0.08 Allowed 'General case' 0 N--CA 1.513 2.699 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.545 HD11 HG22 ' A' ' 7' ' ' VAL . 3.9 mt -23.6 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptp -167.93 -176.85 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 111.361 -2.654 . . . . 0.0 115.586 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.26 122.67 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 123.495 1.617 . . . . 0.0 114.829 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 5' ' ' VAL . 10.7 m-30 -102.76 175.74 5.39 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 113.435 -1.711 . . . . 0.0 109.543 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.28 22.3 tp10 -144.97 109.71 5.01 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 121.398 3.851 . . . . 0.0 121.398 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.501 2.118 1 N-CA-C 122.858 4.392 . . . . 0.0 122.858 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -127.61 160.38 31.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.428 -2.623 . . . . 0.0 106.449 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -105.29 169.16 8.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.476 1.131 . . . . 0.0 110.437 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.54 HG21 ' CD1' ' A' ' 74' ' ' PHE . 73.2 t -125.82 102.27 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 114.343 -1.298 . . . . 0.0 113.804 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 13.7 p-10 -99.43 163.52 12.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 71' ' ' ILE . 55.1 t -75.4 138.09 71.3 Favored Pre-proline 0 N--CA 1.502 2.127 0 C-N-CA 116.862 -1.935 . . . . 0.0 110.503 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.493 1.464 0 C-N-CA 122.098 1.866 . . . . 0.0 112.675 177.21 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.507 2.399 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.0 pt-20 -113.56 167.46 10.58 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 t -84.42 119.43 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 t -100.77 -36.76 8.98 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.81 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.03 117.5 16.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.41 59.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 14.0 mmt -18.98 -45.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.1 t -124.8 155.77 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 22.3 mttt -140.72 -169.34 2.78 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 121.666 3.95 . . . . 0.0 121.666 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -51.49 84.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.08 -0.25 14.69 Favored Glycine 1 N--CA 1.519 4.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HB2' HG12 ' A' ' 22' ' ' VAL . 69.9 m-20 -89.1 139.83 30.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.883 1.801 . . . . 0.0 113.018 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -62.77 74.22 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 112.534 -2.121 . . . . 0.0 116.459 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -74.0 97.77 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -101.73 156.88 17.23 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.337 -1.477 . . . . 0.0 108.958 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -58.27 168.81 0.97 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.999 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.71 -24.66 0.08 Allowed 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 30' ' ' ALA . 3.7 tm0? -82.42 109.07 16.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 123.231 1.491 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 10.1 m -35.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 120.927 3.677 . . . . 0.0 120.927 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -24.77 -58.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 pt -146.14 150.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.92 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.425 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 96.7 m -102.52 124.93 48.96 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.4 m -110.8 154.0 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.51 2.572 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.511 2.583 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 mtm -132.81 164.33 27.08 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -122.19 148.73 44.58 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.062 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.0 t -122.76 116.21 29.18 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.16 172.32 13.97 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 CA-C-O 124.455 1.773 . . . . 0.0 110.347 176.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -76.34 117.05 61.59 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 111.84 -2.436 . . . . 0.0 115.377 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HG2' HG13 ' A' ' 5' ' ' VAL . 73.4 Cg_exo -39.34 -37.45 1.14 Allowed 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.008 2.472 . . . . 0.0 113.632 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.34 -174.16 4.55 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 110.963 -2.835 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -95.14 152.39 18.39 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.69 -150.14 22.33 Favored Glycine 1 N--CA 1.517 4.085 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.843 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.11 157.5 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 O-C-N 121.768 -0.842 . . . . 0.0 112.15 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 30.4 t -83.02 128.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 C-N-CA 118.091 -1.444 . . . . 0.0 107.662 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -106.26 -72.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 38.4 tt0 -127.36 123.28 35.86 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 123.368 1.556 . . . . 0.0 111.314 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.573 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.0 pt? -129.07 146.49 51.01 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.548 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 87.8 mttt -127.95 53.16 1.81 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.82 137.58 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 110.204 -3.18 . . . . 0.0 111.051 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.633 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.3 m120 -120.37 -171.33 2.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.741 2.21 . . . . 0.0 114.683 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.65 87.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 125.978 2.799 . . . . 0.0 106.422 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.07 24.35 0.23 Allowed Glycine 0 N--CA 1.516 3.97 1 CA-C-N 106.715 -4.766 . . . . 0.0 112.809 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.633 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -106.22 152.15 23.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -102.6 145.27 29.89 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.15 163.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.989 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -166.0 145.89 6.32 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.037 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -36.74 116.14 0.41 Allowed 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.403 1.573 . . . . 0.0 112.426 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.28 -52.18 0.73 Allowed Glycine 0 N--CA 1.511 3.665 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.951 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 16.4 t -45.74 128.18 8.44 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -73.39 60.24 0.62 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.513 HD11 HG22 ' A' ' 7' ' ' VAL . 2.7 mt -18.94 -60.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 119.031 2.974 . . . . 0.0 119.031 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.407 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -167.42 -172.51 1.97 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 112.321 -2.218 . . . . 0.0 115.238 -179.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.08 130.42 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 124.414 2.054 . . . . 0.0 112.691 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.2 m-30 -117.49 145.88 43.9 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 111.804 -2.453 . . . . 0.0 113.202 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.2 162.58 23.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 119.733 3.234 . . . . 0.0 119.733 -179.273 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m . . . . . 0 N--CA 1.512 2.655 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.62 149.06 33.83 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 111.549 -2.569 . . . . 0.0 111.376 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -97.4 104.2 16.2 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.492 1.139 . . . . 0.0 113.773 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 77.1 t -71.22 99.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 CA-C-O 124.8 2.238 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' SER . 5.8 p30 -96.05 177.4 5.75 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.631 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 67' ' ' THR . 78.2 t -98.01 131.82 25.85 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 C--N 1.311 -1.41 0 C-N-CA 120.708 0.939 . . . . 0.0 114.048 179.266 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.533 3.712 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.9 pt-20 -111.3 169.55 8.72 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.17 114.11 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -93.67 -44.79 8.0 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 112.84 -1.982 . . . . 0.0 114.859 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.571 ' HG3' HG22 ' A' ' 18' ' ' THR . 36.0 mt-10 -131.16 102.77 6.14 Favored 'General case' 0 N--CA 1.52 3.036 0 CA-C-N 119.866 1.212 . . . . 0.0 111.452 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.28 72.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 O-C-N 119.284 -2.135 . . . . 0.0 113.498 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 57.1 mmm -34.65 -52.28 0.51 Allowed 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.413 ' C ' ' HE2' ' A' ' 23' ' ' LYS . 15.8 m -98.65 150.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 CA-C-N 119.574 1.079 . . . . 0.0 113.55 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -123.33 169.28 11.48 Favored 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -54.59 87.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.292 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.506 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 127.32 9.62 4.03 Favored Glycine 1 N--CA 1.517 4.046 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -92.24 140.22 29.83 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.69 1.234 . . . . 0.0 111.91 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.66 86.2 2.71 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 126.839 2.056 . . . . 0.0 109.162 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.64 149.3 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -140.59 154.6 46.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 50' ' ' PHE . . . -69.11 99.19 1.08 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 139.81 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 127.784 3.177 . . . . 0.0 108.185 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -71.3 105.8 3.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 112.708 -2.042 . . . . 0.0 113.665 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 16.6 t -39.03 96.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 112.569 -2.105 . . . . 0.0 115.554 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 21' ' ' MET . 4.2 mt -53.52 -62.8 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.522 ' H ' HG23 ' A' ' 46' ' ' VAL . 25.6 pt -147.91 128.8 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.906 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 19' ' ' GLU . 5.2 m -67.87 129.79 40.99 Favored 'General case' 0 N--CA 1.517 2.917 0 O-C-N 119.965 -1.709 . . . . 0.0 111.066 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 65' ' ' VAL . 31.6 m -119.67 151.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.707 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 43' ' ' SER . 3.4 tt0 . . . . . 0 N--CA 1.515 2.781 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 92.7 p . . . . . 0 N--CA 1.51 2.554 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.0 mtm -139.55 164.71 29.17 Favored 'General case' 0 N--CA 1.516 2.872 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -120.3 168.52 11.18 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 123.148 1.451 . . . . 0.0 114.19 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -115.74 129.42 25.17 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.64 168.74 11.04 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-O 123.384 1.327 . . . . 0.0 109.935 168.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -74.98 117.19 60.83 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 112.859 -1.973 . . . . 0.0 115.065 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 35.9 Cg_endo -48.62 -25.75 8.33 Favored 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.011 1.807 . . . . 0.0 114.016 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -158.08 -173.37 4.31 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.896 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.71 165.86 10.83 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.1 -153.61 21.01 Favored Glycine 1 N--CA 1.522 4.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 113.538 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.07 153.51 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.544 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 41.3 t -77.14 84.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -61.83 -44.64 96.43 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.644 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 28.3 tt0 -176.46 159.23 1.91 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 124.005 0.815 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.7 pt? -154.76 159.77 40.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.323 -0.861 . . . . 0.0 109.703 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 29.8 mmtt -126.33 45.82 2.58 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.16 161.93 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.69 171.4 9.62 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 125.367 2.508 . . . . 0.0 116.952 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.86 100.15 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 1 N-CA-C 99.784 -4.154 . . . . 0.0 99.784 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.14 19.97 0.95 Allowed Glycine 0 N--CA 1.51 3.576 1 CA-C-N 107.305 -4.498 . . . . 0.0 111.84 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.18 170.43 8.1 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.482 0.713 . . . . 0.0 109.278 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -103.43 143.65 32.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.778 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG21 HG11 ' A' ' 37' ' ' VAL . 3.5 m -132.52 127.49 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HG2' ' N ' ' A' ' 67' ' ' THR . 26.1 ttmt -139.98 151.54 45.59 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.533 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 7.6 t -42.21 118.5 1.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 117.271 -1.772 . . . . 0.0 111.495 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.23 -51.36 0.78 Allowed Glycine 0 N--CA 1.513 3.793 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m -39.51 119.55 0.96 Allowed 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.62 65.47 1.82 Allowed 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 123.065 1.412 . . . . 0.0 111.346 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 mm -48.78 -57.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 120.729 3.604 . . . . 0.0 120.729 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.406 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 14.9 ptp -135.49 166.89 22.15 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.346 -0.846 . . . . 0.0 112.519 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -110.47 122.51 65.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.811 1.291 . . . . 0.0 112.253 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 7.5 m-30 -117.07 149.27 40.58 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -131.96 127.48 36.43 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.469 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 76' ' ' VAL . 28.8 m . . . . . 0 C--N 1.302 -1.483 1 N-CA-C 122.142 4.127 . . . . 0.0 122.142 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.509 2.485 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.498 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 3.1 mmmp? -134.17 166.5 22.62 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.129 1.443 . . . . 0.0 110.886 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' NZ ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -107.56 157.32 18.14 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.296 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 74' ' ' PHE . 58.9 t -126.08 106.98 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 CA-C-O 121.883 0.849 . . . . 0.0 111.504 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -101.87 152.85 20.41 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' HB ' ' A' ' 65' ' ' VAL . 99.2 t -71.33 132.29 86.06 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 116.877 -1.929 . . . . 0.0 112.197 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 CA--C 1.557 1.643 0 C-N-CA 122.616 2.211 . . . . 0.0 115.329 172.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.504 2.235 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.31 164.19 12.76 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 35' ' ' ILE . 20.0 t -103.4 116.25 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.099 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 2.1 t -96.8 -41.96 8.2 Favored 'General case' 0 N--CA 1.524 3.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.765 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -131.99 105.21 7.27 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.947 0.879 . . . . 0.0 110.855 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.45 63.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 O-C-N 119.087 -2.258 . . . . 0.0 115.261 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 55.6 mmm -23.17 -42.44 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 119.403 3.112 . . . . 0.0 119.403 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.7 t -119.74 155.26 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.6 tttm -131.46 175.33 9.24 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 120.551 3.537 . . . . 0.0 120.551 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.47 91.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.28 0.38 12.76 Favored Glycine 1 N--CA 1.516 4.03 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.775 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 22' ' ' VAL . 52.5 m-20 -93.27 143.65 26.07 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.58 1.181 . . . . 0.0 112.706 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -66.33 121.77 16.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.15 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 15.6 t -116.04 115.19 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -122.91 151.42 41.78 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.696 -0.628 . . . . 0.0 111.282 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -48.02 158.26 0.24 Allowed 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 69.51 -28.42 0.16 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 122.541 1.162 . . . . 0.0 112.753 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.429 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 6.4 tt0 -77.35 105.13 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.316 -1.49 . . . . 0.0 111.575 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 19.8 t -37.92 120.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.8 mt -85.78 -51.03 6.69 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.412 ' HB ' HG13 ' A' ' 17' ' ' VAL . 29.1 pt -146.79 137.35 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.958 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -84.32 128.26 34.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.35 160.77 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 N--CA 1.513 2.708 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.8 mtt -129.74 174.29 9.85 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -124.81 153.81 41.93 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 122.115 0.96 . . . . 0.0 113.512 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.1 t -121.03 104.42 41.44 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.525 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.5 OUTLIER -80.18 177.63 8.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 CA-C-O 123.779 1.491 . . . . 0.0 111.087 179.085 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -71.89 111.49 10.79 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -46.11 -28.52 5.48 Favored 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 121.884 1.723 . . . . 0.0 113.049 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -163.05 -173.51 3.47 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.112 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -103.89 160.78 14.51 Favored 'General case' 0 CA--C 1.579 2.07 1 N-CA-C 121.879 4.029 . . . . 0.0 121.879 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.95 -124.26 3.06 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 114.577 -1.192 . . . . 0.0 114.096 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.48 159.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.206 0 O-C-N 121.996 -0.708 . . . . 0.0 111.305 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.558 HG13 ' SD ' ' A' ' 72' ' ' MET . 67.6 t -80.85 112.0 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 28.3 tttm -89.94 -64.55 1.12 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.431 -1.308 . . . . 0.0 110.045 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' HG13 ' A' ' 73' ' ' ILE . 42.4 tt0 -145.07 133.77 22.2 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.3 pt? -130.53 163.13 27.72 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.532 -1.98 . . . . 0.0 109.314 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 14.1 mmtp -133.64 42.02 3.0 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 p -132.26 159.61 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.942 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -126.19 177.65 6.27 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -94.03 108.81 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 1 N-CA-C 97.752 -4.907 . . . . 0.0 97.752 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.2 6.05 6.45 Favored Glycine 0 N--CA 1.515 3.908 0 CA-C-N 109.898 -3.319 . . . . 0.0 109.784 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.71 156.84 16.17 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.72 144.38 41.11 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HB ' HG21 ' A' ' 7' ' ' VAL . 14.2 m -138.4 172.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -178.0 156.63 1.07 Allowed 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.2 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -26.73 101.4 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 118.644 2.831 . . . . 0.0 118.644 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.79 -53.02 0.69 Allowed Glycine 0 N--CA 1.511 3.697 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.073 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.1 m -21.85 117.2 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.36 59.49 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.496 HG22 ' HG2' ' A' ' 72' ' ' MET . 4.3 mm -34.5 -58.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.558 ' SD ' HG13 ' A' ' 54' ' ' VAL . 5.1 ptp -174.43 -170.81 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.261 -1.79 . . . . 0.0 113.757 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -116.7 130.28 71.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-O 124.026 1.87 . . . . 0.0 107.883 178.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 8.9 m-30 -112.69 161.65 16.62 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.835 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -134.36 137.19 43.95 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 C--N 1.294 -1.822 0 CA-C-O 124.552 2.12 . . . . 0.0 116.047 -179.727 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.518 2.928 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.68 160.65 26.74 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 123.826 0.704 . . . . 0.0 110.008 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -108.4 169.32 8.72 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.546 HG21 ' CE1' ' A' ' 74' ' ' PHE . 39.5 t -134.91 117.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 10.1 p-10 -106.33 166.67 10.37 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 71' ' ' ILE . 48.1 t -85.73 140.53 35.6 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 121.38 1.387 . . . . 0.0 112.879 171.511 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.515 2.822 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -110.85 171.33 7.53 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 124.207 0.942 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 35' ' ' ILE . 28.2 t -107.04 115.11 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.541 -0.724 . . . . 0.0 111.758 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 27.7 p -97.01 -50.38 4.64 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 124.065 0.946 . . . . 0.0 112.597 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' H ' ' HB ' ' A' ' 36' ' ' THR . 12.8 mp0 -121.63 105.22 10.23 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 123.594 1.664 . . . . 0.0 113.241 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.36 70.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 123.672 1.701 . . . . 0.0 114.367 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 12.9 mmt -30.36 -47.93 0.09 Allowed 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.477 ' CG2' HD23 ' A' ' 34' ' ' LEU . 15.8 m -128.71 154.35 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-O 122.853 1.311 . . . . 0.0 112.751 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.5 mtmt -129.3 -170.2 2.24 Favored 'General case' 0 N--CA 1.522 3.174 0 N-CA-C 119.066 2.987 . . . . 0.0 119.066 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.22 93.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.33 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.87 11.28 8.55 Favored Glycine 1 N--CA 1.516 4.003 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.553 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.5 m-20 -101.85 130.6 48.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 123.765 1.745 . . . . 0.0 112.649 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -57.0 91.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 111.648 -2.524 . . . . 0.0 111.642 179.156 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 22' ' ' VAL . 91.8 t -100.45 120.98 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -134.75 155.69 50.14 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.7 -1.25 . . . . 0.0 112.561 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.33 156.25 4.48 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.464 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 81.37 -20.29 0.38 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.715 1.884 . . . . 0.0 111.251 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.539 ' HG2' ' N ' ' A' ' 33' ' ' SER . 3.6 tt0 -95.15 155.4 16.75 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.579 1.181 . . . . 0.0 109.425 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.539 ' N ' ' HG2' ' A' ' 32' ' ' GLN . 62.6 p -76.13 134.16 40.05 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.213 1.482 . . . . 0.0 112.57 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.477 HD23 ' CG2' ' A' ' 22' ' ' VAL . 4.2 mt -96.13 -58.77 1.99 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.921 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.437 ' HB ' HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -147.74 148.38 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.576 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.472 ' HB ' ' H ' ' A' ' 19' ' ' GLU . 64.9 m -94.81 135.34 36.42 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.1 m -125.98 147.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.512 2.651 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 122.488 1.137 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.1 mtp -133.04 168.64 18.11 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.529 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 36' ' ' THR . 27.9 mt-10 -129.64 156.09 44.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.1 t -119.15 114.36 35.03 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.299 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.91 177.77 7.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 CA-C-O 123.698 1.458 . . . . 0.0 111.873 171.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -75.09 103.52 0.99 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 119.447 3.129 . . . . 0.0 119.447 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 19.5 Cg_endo -41.41 -34.36 1.89 Allowed 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.664 2.242 . . . . 0.0 113.908 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.56 -169.25 3.06 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 113.34 -1.754 . . . . 0.0 110.159 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.1 163.25 13.32 Favored 'General case' 0 CA--C 1.574 1.869 1 N-CA-C 123.135 4.494 . . . . 0.0 123.135 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.96 -142.93 14.51 Favored Glycine 1 N--CA 1.517 4.039 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.394 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.42 165.76 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 O-C-N 121.813 -0.816 . . . . 0.0 108.955 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 22.5 t -89.72 128.08 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.212 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HD2' ' HB2' ' A' ' 75' ' ' GLU . 39.6 tttm -103.62 -58.75 1.83 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 22.4 tt0 -141.95 151.2 42.35 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.949 0.795 . . . . 0.0 111.825 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -148.92 154.01 38.82 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 119.499 -2.001 . . . . 0.0 110.397 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 76.9 mttt -131.87 49.26 2.34 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-O 125.224 2.44 . . . . 0.0 109.582 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.0 m -137.5 151.9 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 1 CA-C-N 108.345 -4.025 . . . . 0.0 108.537 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -134.14 176.9 8.17 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 122.94 1.352 . . . . 0.0 111.585 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 18' ' ' THR . 1.6 t -88.29 114.1 26.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 1 N-CA-C 95.713 -5.662 . . . . 0.0 95.713 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.52 7.88 6.65 Favored Glycine 0 N--CA 1.513 3.822 0 CA-C-N 109.271 -3.604 . . . . 0.0 110.785 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 19.1 t70 -113.19 167.66 10.36 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.931 0.872 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.766 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.67 157.86 16.17 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.75 165.81 9.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 112.842 -1.981 . . . . 0.0 112.596 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -172.61 146.19 1.65 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 123.31 0.381 . . . . 0.0 110.951 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -42.12 113.32 0.42 Allowed 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 125.416 2.532 . . . . 0.0 115.952 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 -40.81 2.31 Favored Glycine 0 N--CA 1.515 3.932 0 CA-C-N 112.92 -1.945 . . . . 0.0 113.089 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.2 m -53.33 128.45 28.38 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 3.8 mm? -68.77 66.17 0.13 Allowed 'General case' 0 N--CA 1.521 3.097 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' HB ' ' SD ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -27.48 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -157.46 -173.23 4.31 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 110.773 -2.921 . . . . 0.0 115.147 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.412 HD11 ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -118.75 132.25 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 123.229 1.49 . . . . 0.0 110.432 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.546 ' CE1' HG21 ' A' ' 5' ' ' VAL . 18.2 m-30 -114.12 169.17 9.21 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-N 113.734 -1.576 . . . . 0.0 115.23 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 61.4 tt0 -138.46 127.08 23.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 123.467 1.603 . . . . 0.0 109.173 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 76' ' ' VAL . 16.8 m . . . . . 0 C--N 1.291 -1.965 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.506 2.37 0 N-CA-C 119.986 3.328 . . . . 0.0 119.986 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HE3' ' OE1' ' A' ' 4' ' ' GLU . 24.7 mmmt -119.8 158.71 26.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.366 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -96.18 145.92 25.12 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 123.424 1.583 . . . . 0.0 114.581 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -121.56 91.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-O 123.864 1.792 . . . . 0.0 111.223 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.66 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.5 p30 -101.91 -179.49 4.02 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 111.635 -2.529 . . . . 0.0 107.799 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 65' ' ' VAL . 79.8 t -104.51 133.54 20.14 Favored Pre-proline 0 N--CA 1.503 2.213 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.501 1.944 0 C-N-CA 123.875 3.05 . . . . 0.0 111.458 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.572 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 pt-20 -119.67 170.3 9.32 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.756 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.95 130.48 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.896 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 11.8 t -108.91 -44.91 3.89 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.059 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 3.3 mm-40 -130.55 112.76 13.48 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.801 1.286 . . . . 0.0 108.517 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 7.4 p -90.49 70.34 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 124.506 2.098 . . . . 0.0 114.083 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mmm -32.39 -60.87 0.28 Allowed 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 119.536 3.162 . . . . 0.0 119.536 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.703 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.3 t -103.81 150.22 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.703 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -129.56 -179.1 4.97 Favored 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 120.386 3.476 . . . . 0.0 120.386 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -53.07 115.5 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.226 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.09 10.88 31.11 Favored Glycine 1 N--CA 1.518 4.153 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.227 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' HB3' ' CG1' ' A' ' 22' ' ' VAL . 2.6 m-20 -114.45 131.85 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.732 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -58.41 75.72 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 108.696 -3.865 . . . . 0.0 110.614 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 2.3 t -82.5 151.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 CA-C-O 124.525 2.107 . . . . 0.0 114.049 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -152.26 153.41 33.7 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.953 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.54 163.43 0.28 Allowed 'General case' 0 N--CA 1.512 2.647 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.918 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 69.85 -27.79 0.16 Allowed 'General case' 0 N--CA 1.52 3.03 0 CA-C-O 122.018 0.913 . . . . 0.0 112.486 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -84.44 97.55 9.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.784 1.278 . . . . 0.0 112.261 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.0 m -31.86 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -70.98 -52.16 21.33 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.538 HG13 ' HB ' ' A' ' 46' ' ' VAL . 30.4 pt -143.11 151.76 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.909 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 51.9 m -105.31 127.97 53.23 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 28.4 m -120.45 154.17 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 N--CA 1.507 2.423 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -179.275 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.509 2.495 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 35.8 tpp -134.83 158.61 43.76 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.458 0.646 . . . . 0.0 111.714 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.37 153.67 30.59 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.904 1.812 . . . . 0.0 114.247 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.538 ' HB ' HG13 ' A' ' 35' ' ' ILE . 60.1 t -123.87 102.67 34.65 Favored Pre-proline 0 N--CA 1.495 1.824 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.413 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -79.01 169.37 19.41 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 CA-C-O 124.394 1.747 . . . . 0.0 109.743 173.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -61.26 115.48 14.72 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 111.441 -2.618 . . . . 0.0 117.528 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 28.0 Cg_endo -46.85 -26.66 4.91 Favored 'Trans proline' 0 N--CA 1.509 2.436 0 C-N-CA 122.144 1.896 . . . . 0.0 113.295 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -171.73 -174.26 1.32 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.532 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.51 166.97 11.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.83 -172.17 21.44 Favored Glycine 0 N--CA 1.514 3.84 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.369 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 t -106.65 149.87 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 C-N-CA 117.549 -1.661 . . . . 0.0 113.14 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG13 ' SD ' ' A' ' 72' ' ' MET . 58.4 t -67.29 102.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.592 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -82.44 -62.81 1.51 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.559 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 1.5 tt0 -147.24 151.28 36.42 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.96 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -143.55 135.81 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.502 -0.749 . . . . 0.0 110.58 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 41.9 mttm -114.45 42.87 2.01 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.11 161.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.072 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -132.78 170.78 14.79 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 121.489 3.885 . . . . 0.0 121.489 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.6 t -96.11 101.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 101.17 -3.641 . . . . 0.0 101.17 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.92 32.4 1.56 Allowed Glycine 0 N--CA 1.502 3.04 1 CA-C-N 107.826 -4.261 . . . . 0.0 106.816 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -113.95 174.07 6.12 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 16' ' ' GLU . 29.6 mmmt -101.37 132.39 46.96 Favored 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 121.233 3.79 . . . . 0.0 121.233 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -130.57 165.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 113.35 -1.75 . . . . 0.0 111.146 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 167.72 150.66 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 124.59 1.156 . . . . 0.0 110.021 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.76 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.34 -41.98 1.99 Allowed Glycine 1 N--CA 1.518 4.104 0 N-CA-C 116.699 1.44 . . . . 0.0 116.699 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.4 t -35.48 139.25 0.12 Allowed 'General case' 0 N--CA 1.531 3.617 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.966 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.3 mt -94.55 63.51 2.94 Favored 'General case' 0 N--CA 1.52 3.053 0 CA-C-N 120.358 1.435 . . . . 0.0 113.189 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.8 mm -40.52 -58.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.623 ' SD ' HG13 ' A' ' 54' ' ' VAL . 4.6 ptp -155.9 -172.92 4.3 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.27 122.0 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 122.998 1.38 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.618 ' CD1' HG21 ' A' ' 5' ' ' VAL . 5.6 m-30 -98.89 156.95 16.63 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.817 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.453 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 17.4 tt0 -147.6 98.15 2.94 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 123.952 1.834 . . . . 0.0 111.444 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.565 1.548 0 CA-C-N 114.053 -1.43 . . . . 0.0 114.616 179.547 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.0 t . . . . . 0 N--CA 1.513 2.705 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 73.3 mmtt -136.73 154.22 50.65 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.769 -1.559 . . . . 0.0 113.013 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.8 152.23 20.75 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.933 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 ' CE1' ' A' ' 74' ' ' PHE . 74.1 t -118.24 107.9 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -107.82 141.26 39.67 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.037 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 48.9 t -51.37 121.86 17.99 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 113.019 -1.9 . . . . 0.0 113.162 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 67' ' ' THR . 83.0 Cg_endo . . . . . 0 N--CA 1.505 2.148 0 C-N-CA 123.182 2.588 . . . . 0.0 114.623 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.521 3.107 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 10.2 pt-20 -106.73 179.12 4.36 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.524 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.69 115.61 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 38' ' ' GLU . 18.7 p -96.86 -41.22 8.54 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.2 126.02 46.18 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 119.679 1.127 . . . . 0.0 112.038 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.7 53.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 125.549 2.595 . . . . 0.0 116.547 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.7 mmm -20.05 -54.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 110.509 -3.042 . . . . 0.0 114.152 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' ' HZ3' ' A' ' 23' ' ' LYS . 1.4 m -114.88 159.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 O-C-N 120.778 -1.201 . . . . 0.0 108.699 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HZ3' ' HA ' ' A' ' 22' ' ' VAL . 3.8 mtmm -143.37 -176.9 5.12 Favored 'General case' 0 N--CA 1.522 3.13 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -49.15 106.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.775 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.99 -48.94 0.91 Allowed Glycine 0 N--CA 1.508 3.496 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -36.51 130.0 0.73 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-O 123.987 1.851 . . . . 0.0 115.39 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HD3' HG12 ' A' ' 53' ' ' VAL . 70.9 mmtt -70.5 76.88 0.57 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.141 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 74' ' ' PHE . 37.6 t -79.34 156.97 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 125.413 2.53 . . . . 0.0 116.981 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -164.81 154.93 13.85 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.833 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.48 166.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.332 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 65.05 -21.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -93.34 152.68 18.99 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.532 ' N ' ' NE2' ' A' ' 32' ' ' GLN . 8.6 p -68.34 146.66 53.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 123.223 1.487 . . . . 0.0 110.716 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' HD2' ' A' ' 49' ' ' PRO . 4.9 mt -109.08 -65.6 1.13 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 123.748 1.737 . . . . 0.0 109.032 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.8 pt -142.53 160.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 111.351 -2.659 . . . . 0.0 110.013 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.6 m -107.3 129.04 54.94 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.7 m -118.39 151.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 118.116 2.636 . . . . 0.0 118.116 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.417 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.7 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.0 p . . . . . 0 N--CA 1.515 2.785 0 CA-C-O 121.581 0.705 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 30.5 mtp -142.92 163.3 33.17 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.909 -0.495 . . . . 0.0 112.185 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.01 149.23 42.49 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.777 1.275 . . . . 0.0 113.911 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.05 127.38 26.39 Favored Pre-proline 0 N--CA 1.503 2.202 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.958 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -92.67 178.59 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.148 1.899 . . . . 0.0 114.295 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -67.7 110.44 5.42 Favored Pre-proline 0 CA--C 1.578 2.056 0 N-CA-C 117.595 2.443 . . . . 0.0 117.595 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD2' HD11 ' A' ' 34' ' ' LEU . 40.2 Cg_endo -53.38 -21.41 17.88 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 122.905 2.404 . . . . 0.0 113.384 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -164.74 -169.65 1.78 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.401 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -108.82 158.77 17.34 Favored 'General case' 0 C--N 1.3 -1.56 1 N-CA-C 121.838 4.014 . . . . 0.0 121.838 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . 132.91 179.85 16.68 Favored Glycine 1 N--CA 1.519 4.212 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.548 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' HD3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -92.53 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.27 -1.723 . . . . 0.0 113.978 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 74' ' ' PHE . 35.6 t -83.87 112.23 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.07 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -93.16 -55.04 3.47 Favored 'General case' 0 N--CA 1.516 2.837 0 CA-C-N 120.42 1.464 . . . . 0.0 112.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 4.5 tt0 -147.91 162.08 40.0 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 121.135 0.493 . . . . 0.0 109.918 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -162.72 150.78 14.02 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.943 -1.098 . . . . 0.0 108.36 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 41.2 mtmt -125.16 53.01 1.55 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.896 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 71' ' ' ILE . 34.2 m -138.35 157.3 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 126.183 2.177 . . . . 0.0 112.279 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 3.6 m120 -124.78 173.83 8.31 Favored 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.79 83.05 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 127.298 3.428 . . . . 0.0 104.458 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.25 41.9 0.08 OUTLIER Glycine 0 N--CA 1.505 3.273 1 CA-C-N 104.699 -5.682 . . . . 0.0 107.058 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.499 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 11.3 t0 -122.49 168.67 11.83 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -113.24 144.91 41.9 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 121.786 3.995 . . . . 0.0 121.786 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 m -125.44 130.49 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 118.251 2.685 . . . . 0.0 118.251 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -130.18 120.28 24.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 8' ' ' PRO . 24.5 p -28.47 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 124.571 2.129 . . . . 0.0 112.501 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.46 42.0 1.67 Allowed Glycine 0 N--CA 1.508 3.485 0 CA-C-N 109.983 -3.281 . . . . 0.0 113.635 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -115.51 131.88 56.8 Favored 'General case' 0 N--CA 1.529 3.493 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.504 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.08 63.99 0.71 Allowed 'General case' 0 N--CA 1.519 2.981 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.463 HG23 HG11 ' A' ' 59' ' ' VAL . 24.0 mm -53.68 -63.47 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.592 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 18.2 ptt? -138.81 168.82 18.98 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.43 119.79 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 123.365 1.555 . . . . 0.0 110.388 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 28' ' ' VAL . 8.8 m-30 -99.87 163.87 12.27 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.435 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -144.34 106.14 4.3 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.851 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HA ' ' CA ' ' A' ' 52' ' ' GLY . 34.2 m . . . . . 0 N--CA 1.494 1.742 1 N-CA-C 122.784 4.364 . . . . 0.0 122.784 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 3' ' ' LYS . 3.5 t . . . . . 0 N--CA 1.516 2.833 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.612 ' H ' HG12 ' A' ' 2' ' ' VAL . 33.1 mmtm -141.79 131.51 24.17 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -88.25 151.1 22.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.698 -1.251 . . . . 0.0 109.236 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 79.7 t -108.14 115.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 CA-C-O 121.569 0.7 . . . . 0.0 111.851 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.6 p30 -106.18 -179.18 3.86 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 123.0 1.381 . . . . 0.0 111.383 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.547 HG22 HD11 ' A' ' 71' ' ' ILE . 34.7 t -101.19 117.86 61.39 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.907 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 85.0 Cg_endo . . . . . 0 N--CA 1.493 1.463 0 C-N-CA 121.643 1.562 . . . . 0.0 113.0 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.506 2.374 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.631 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 9.9 pt-20 -123.8 167.91 13.44 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -95.42 122.51 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 m -92.38 -52.02 4.86 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 126.424 1.89 . . . . 0.0 108.597 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -131.89 120.74 22.97 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.7 0.762 . . . . 0.0 111.407 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.5 p -95.29 61.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 123.573 1.654 . . . . 0.0 110.444 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 mtt -27.73 -32.77 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 118.584 2.809 . . . . 0.0 118.584 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG12 HE21 ' A' ' 32' ' ' GLN . 19.5 m -115.85 145.72 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -129.88 176.13 8.29 Favored 'General case' 0 N--CA 1.517 2.884 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.15 102.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.85 0 CA-C-N 114.174 -1.375 . . . . 0.0 114.406 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.02 -36.21 3.03 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.256 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -49.36 171.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HD3' HG12 ' A' ' 53' ' ' VAL . 74.3 mmtt -105.44 105.13 15.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 111.629 -2.532 . . . . 0.0 108.841 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 74' ' ' PHE . 21.8 t -115.2 106.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -117.29 158.74 23.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.827 -1.171 . . . . 0.0 110.52 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -42.5 157.83 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.702 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.027 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 2.7 tm-20 79.55 -48.88 0.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.828 1.299 . . . . 0.0 107.845 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' LEU . 43.0 tt0 -47.37 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 m -32.19 61.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -19.45 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 pt -147.61 146.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 110.628 -2.987 . . . . 0.0 112.89 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 45' ' ' GLU . 9.0 m -105.15 124.73 50.03 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.09 158.41 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 117.849 2.536 . . . . 0.0 117.849 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.621 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.794 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 N--CA 1.511 2.579 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 44' ' ' MET . 2.1 mpp? -121.71 159.2 27.09 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 36' ' ' THR . 19.8 mt-10 -117.18 146.41 43.24 Favored 'General case' 0 N--CA 1.506 2.342 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.481 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.7 127.04 25.92 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.838 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.48 171.86 7.22 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.794 1.662 . . . . 0.0 111.326 174.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -58.62 103.86 0.39 Allowed Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HG2' HG13 ' A' ' 5' ' ' VAL . 72.9 Cg_exo -35.48 -40.17 0.31 Allowed 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 123.409 2.739 . . . . 0.0 113.199 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.05 -172.4 4.01 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 109.981 -3.281 . . . . 0.0 108.109 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.45 162.15 14.18 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.706 3.224 . . . . 0.0 119.706 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.3 -154.25 21.58 Favored Glycine 1 N--CA 1.519 4.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.572 HG12 ' HD3' ' A' ' 27' ' ' LYS . 17.6 m -114.66 174.82 2.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.321 1.534 . . . . 0.0 113.001 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 74' ' ' PHE . 20.6 t -102.73 108.58 24.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.976 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 14.0 tttm -88.57 -45.42 9.9 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.179 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 60.3 tt0 -165.45 163.83 19.61 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.696 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -160.37 164.29 32.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.106 . . . . 0.0 110.447 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -130.88 51.07 2.16 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -143.7 155.35 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 125.633 1.833 . . . . 0.0 113.504 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.535 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -127.44 -177.36 4.05 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 125.521 2.581 . . . . 0.0 115.321 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.91 104.61 16.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 101.123 -3.658 . . . . 0.0 101.123 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 136.85 -10.72 3.95 Favored Glycine 0 N--CA 1.514 3.864 1 CA-C-N 107.783 -4.281 . . . . 0.0 110.188 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -69.73 174.01 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.959 0.904 . . . . 0.0 110.268 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.631 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 30.4 mmtm -115.85 142.18 47.12 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.8 164.65 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.14 0.576 . . . . 0.0 112.397 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.55 153.74 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 2.9 t -39.45 118.5 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 122.579 1.18 . . . . 0.0 113.426 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.45 -29.17 7.11 Favored Glycine 1 N--CA 1.518 4.127 0 CA-C-N 114.574 -1.194 . . . . 0.0 115.607 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 24.5 t -75.7 161.25 29.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 117.92 -1.512 . . . . 0.0 112.933 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.3 mt -97.91 64.79 1.75 Allowed 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.547 HD11 HG22 ' A' ' 7' ' ' VAL . 5.6 mt -21.82 -67.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.424 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 13.4 ptp -149.93 179.39 8.09 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.519 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.5 118.25 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 123.351 1.548 . . . . 0.0 111.835 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.501 ' CE1' HG22 ' A' ' 54' ' ' VAL . 10.5 m-30 -106.99 162.9 13.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 123.43 1.586 . . . . 0.0 112.086 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' O ' HG22 ' A' ' 53' ' ' VAL . 1.4 tt0 -142.57 133.09 25.09 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.345 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.295 -1.767 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.664 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.498 1.945 0 CA-C-O 124.14 1.924 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -126.98 145.23 50.78 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.503 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -81.79 155.58 25.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.19 0.995 . . . . 0.0 110.809 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 74' ' ' PHE . 48.2 t -122.71 91.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 123.73 1.729 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -96.32 146.5 24.68 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.23 137.84 81.52 Favored Pre-proline 0 N--CA 1.501 2.084 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.789 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.174 1.916 . . . . 0.0 112.699 -177.774 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.505 2.286 0 N-CA-C 110.87 -0.048 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 2.0 pm0 -118.64 179.03 4.25 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.73 1.252 . . . . 0.0 110.274 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -94.3 115.64 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.302 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 m -90.45 -34.98 15.4 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -143.62 134.74 25.66 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.19 64.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 124.73 2.205 . . . . 0.0 114.972 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.2 mmm -25.17 -48.74 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 109.875 -3.329 . . . . 0.0 118.019 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.82 164.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -130.52 -174.86 3.47 Favored 'General case' 0 N--CA 1.522 3.145 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.1 107.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.875 0 O-C-N 120.831 -1.168 . . . . 0.0 111.472 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.87 -25.83 9.82 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-O 122.172 0.873 . . . . 0.0 111.915 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.85 156.62 13.91 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -86.51 127.84 34.91 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.918 1.342 . . . . 0.0 110.65 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 35.7 t -127.41 93.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 112.369 -2.196 . . . . 0.0 113.599 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -99.79 158.7 15.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.726 -1.234 . . . . 0.0 108.617 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -54.08 163.68 0.75 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.142 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 75.55 -35.63 0.28 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.763 1.268 . . . . 0.0 110.562 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -67.31 127.22 31.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 123.146 1.45 . . . . 0.0 112.34 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.5 p -57.77 97.71 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -61.13 -63.31 1.34 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.81 150.17 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 112.187 -2.279 . . . . 0.0 110.038 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 87.2 m -97.77 114.95 27.09 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.74 148.57 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.511 2.596 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.4 ptp -148.98 174.59 12.12 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -122.88 157.95 31.4 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.9 t -121.54 126.18 26.56 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.582 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -88.94 171.84 4.64 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.485 1.369 . . . . 0.0 110.073 174.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -70.81 119.85 75.56 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 118.581 2.808 . . . . 0.0 118.581 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HD2' HD11 ' A' ' 34' ' ' LEU . 30.3 Cg_endo -50.1 -29.26 21.6 Favored 'Trans proline' 0 N--CA 1.511 2.544 0 C-N-CA 122.947 2.431 . . . . 0.0 112.953 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.71 -175.19 5.01 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 112.214 -2.266 . . . . 0.0 108.536 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.47 161.53 13.64 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.76 -167.88 23.81 Favored Glycine 1 N--CA 1.524 4.516 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.102 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.69 165.03 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 118.613 1.206 . . . . 0.0 113.171 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CE1' ' A' ' 74' ' ' PHE . 25.0 t -89.84 120.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 75' ' ' GLU . 6.3 tttp -103.98 -62.6 1.29 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG2' HD11 ' A' ' 73' ' ' ILE . 2.2 tp10 -130.62 137.19 49.5 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 118.326 0.512 . . . . 0.0 110.803 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.4 pt? -149.69 114.7 5.4 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 123.466 1.603 . . . . 0.0 108.425 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.437 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 93.3 mttt -94.48 50.74 1.37 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.28 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.11 143.36 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.431 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -130.94 -172.56 2.86 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.793 2.235 . . . . 0.0 113.58 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.54 108.27 19.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.37 -15.81 4.68 Favored Glycine 0 N--CA 1.513 3.798 0 CA-C-N 108.913 -3.767 . . . . 0.0 113.144 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -70.28 157.08 38.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.0 mmmt -91.56 136.69 32.94 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.98 152.3 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.999 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -162.98 148.29 11.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.4 t -55.32 120.59 7.32 Favored 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.241 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.14 6.42 39.43 Favored Glycine 1 N--CA 1.523 4.452 0 CA-C-N 114.408 -1.269 . . . . 0.0 114.985 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -93.84 112.69 24.58 Favored 'General case' 0 N--CA 1.517 2.919 0 O-C-N 120.95 -1.324 . . . . 0.0 111.491 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 70' ' ' LEU . 1.4 mp -61.94 56.59 0.01 OUTLIER 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mm -42.61 -51.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 4.9 ptp -151.18 -175.05 5.01 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.487 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -123.24 120.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 123.814 1.768 . . . . 0.0 114.494 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 5' ' ' VAL . 19.7 m-30 -108.82 164.61 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.313 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 4.7 tp10 -138.13 131.03 29.84 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 76' ' ' VAL . 27.1 m . . . . . 0 C--N 1.29 -1.979 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.503 2.219 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' HG22 ' A' ' 73' ' ' ILE . 4.1 mmmm -137.98 154.12 49.38 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 2.7 pp20? -101.35 172.08 7.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.761 -0.587 . . . . 0.0 110.103 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 74' ' ' PHE . 58.4 t -133.53 97.53 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.142 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.0 p30 -94.56 168.66 10.71 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.572 HG23 HG13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -98.73 125.44 42.4 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 118.104 -1.438 . . . . 0.0 111.346 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 67' ' ' THR . 60.5 Cg_endo . . . . . 0 N--CA 1.502 2.005 0 C-N-CA 123.619 2.879 . . . . 0.0 109.961 -163.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.5 m . . . . . 0 N--CA 1.513 2.692 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.72 165.3 20.05 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -112.53 120.08 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 118.944 -1.102 . . . . 0.0 108.578 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -94.9 -48.18 6.12 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.081 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.83 102.94 5.42 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 123.2 1.476 . . . . 0.0 113.283 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.96 64.64 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 O-C-N 119.83 -1.794 . . . . 0.0 113.441 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 mtt -32.78 -36.12 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 N-CA-C 121.253 3.797 . . . . 0.0 121.253 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.91 142.68 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 6.8 mtpm? -134.94 179.94 6.0 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 119.148 3.018 . . . . 0.0 119.148 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.8 t -45.04 91.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.456 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 2.63 12.51 Favored Glycine 1 N--CA 1.523 4.454 0 CA-C-O 121.91 0.728 . . . . 0.0 113.555 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 59.4 m-20 -97.51 120.42 37.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 124.903 2.287 . . . . 0.0 113.731 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.715 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -65.52 95.24 0.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.649 -2.523 . . . . 0.0 110.933 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 34' ' ' LEU . 7.3 t -91.15 157.56 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.734 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.21 167.77 2.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.321 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.33 162.09 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 O-C-N 124.582 1.176 . . . . 0.0 113.638 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.85 -10.37 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.655 1.217 . . . . 0.0 113.923 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 30' ' ' ALA . 34.7 tt0 -90.15 87.68 6.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.203 -1.561 . . . . 0.0 106.809 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 70.7 m -35.99 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -24.63 -66.4 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 pt -147.42 146.02 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 111.387 -2.642 . . . . 0.0 111.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 45' ' ' GLU . 96.6 m -93.17 131.01 38.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.82 160.55 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.72 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.521 3.082 0 CA-C-O 120.778 0.323 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 45.2 mtm -109.72 161.28 15.56 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.832 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' A' ' 36' ' ' THR . 27.6 mt-10 -122.14 158.59 28.99 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.05 121.45 19.76 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.51 171.28 2.43 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.28 1.32 . . . . 0.0 111.217 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -45.28 96.7 0.12 Allowed Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HG ' ' A' ' 34' ' ' LEU . 18.2 Cg_endo -44.55 -28.39 2.69 Favored 'Trans proline' 0 N--CA 1.511 2.551 0 C-N-CA 121.968 1.779 . . . . 0.0 112.973 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -163.8 -179.35 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.322 -2.217 . . . . 0.0 107.016 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.16 156.54 18.71 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 120.035 3.346 . . . . 0.0 120.035 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.33 -173.65 22.14 Favored Glycine 1 N--CA 1.529 4.863 0 CA-C-N 112.772 -2.013 . . . . 0.0 114.185 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 26' ' ' ASP . 1.4 t -95.8 167.83 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 CA-C-N 120.405 2.103 . . . . 0.0 112.209 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 ' CE1' ' A' ' 74' ' ' PHE . 11.7 t -91.9 126.82 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.115 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 9.6 tttp -99.64 -60.44 1.53 Allowed 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 12.4 tt0 -144.6 159.71 42.35 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.285 0.564 . . . . 0.0 112.471 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.6 pt? -154.7 161.34 41.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.48 -2.013 . . . . 0.0 110.417 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.588 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.9 mptt -133.1 45.79 2.68 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 122.369 1.081 . . . . 0.0 108.962 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.91 149.2 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -129.89 177.69 7.08 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 125.504 2.574 . . . . 0.0 113.446 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.43 109.71 20.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.53 -27.95 3.04 Favored Glycine 0 N--CA 1.511 3.659 0 CA-C-N 111.929 -2.396 . . . . 0.0 108.393 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.78 169.86 17.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -123.32 164.39 18.89 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.909 1.337 . . . . 0.0 108.799 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.52 168.2 18.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -150.01 156.2 41.28 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 119.186 -1.006 . . . . 0.0 113.161 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -34.13 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.3 -5.69 45.38 Favored Glycine 1 N--CA 1.517 4.075 0 CA-C-N 113.785 -1.552 . . . . 0.0 115.8 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 8.5 m -63.7 133.52 53.73 Favored 'General case' 0 N--CA 1.524 3.226 0 CA-C-O 117.621 -1.18 . . . . 0.0 112.879 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.72 59.17 0.21 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 HG23 ' A' ' 7' ' ' VAL . 6.0 mm -30.68 -64.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 124.847 2.26 . . . . 0.0 116.528 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -152.27 177.25 10.75 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 111.357 -2.656 . . . . 0.0 112.856 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -118.42 127.89 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 123.384 1.564 . . . . 0.0 107.019 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.558 ' CD1' HG21 ' A' ' 5' ' ' VAL . 8.9 m-30 -105.51 160.76 14.91 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 113.316 -1.766 . . . . 0.0 115.005 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 14.0 tt0 -141.04 109.69 6.0 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 124.618 2.151 . . . . 0.0 111.362 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 CA--C 1.58 2.13 0 N-CA-C 121.362 3.838 . . . . 0.0 121.362 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 118.572 2.804 . . . . 0.0 118.572 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -118.83 146.63 44.7 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 124.225 1.964 . . . . 0.0 112.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 7.5 mp0 -91.15 132.17 36.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.438 -2.619 . . . . 0.0 114.258 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 92.2 t -104.26 111.75 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.726 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 69' ' ' SER . 16.3 p-10 -108.9 172.79 6.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.34 1.543 . . . . 0.0 112.273 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.556 HG22 ' CG1' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -101.39 117.82 61.26 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 112.832 -1.986 . . . . 0.0 113.65 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.506 2.257 0 C-N-CA 123.87 3.047 . . . . 0.0 112.724 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 35.4 m . . . . . 0 N--CA 1.517 2.904 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.613 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 1.6 pm0 -118.11 174.66 6.09 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.223 1.011 . . . . 0.0 113.315 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.43 127.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.221 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 81.4 p -98.82 -50.36 4.24 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -131.12 100.31 5.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 123.254 1.502 . . . . 0.0 112.9 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG22 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -73.89 65.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 O-C-N 120.295 -1.503 . . . . 0.0 114.06 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 34.3 mmm -30.39 -52.43 0.16 Allowed 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.9 m -89.01 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HZ3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -130.7 161.88 30.68 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.47 114.97 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.849 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.76 -29.15 6.16 Favored Glycine 0 N--CA 1.515 3.966 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.414 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 11.7 t70 -89.02 168.39 12.39 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -83.98 109.21 17.45 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 34' ' ' LEU . 6.7 t -111.04 102.77 14.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.612 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -120.25 159.02 25.78 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.316 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.48 160.92 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 74.27 -40.16 0.44 Allowed 'General case' 0 N--CA 1.516 2.843 0 CA-C-O 121.963 0.887 . . . . 0.0 110.475 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 47.0 tp60 -58.39 83.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 50.4 m -28.86 70.15 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.094 2.998 . . . . 0.0 119.094 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD21 HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -23.32 -67.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.29 155.44 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.525 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -99.16 136.63 38.84 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 25.0 m -124.85 148.71 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 18' ' ' THR . 3.4 tt0 . . . . . 0 N--CA 1.508 2.461 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.517 2.916 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.0 mtt -132.27 168.23 18.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.483 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.85 152.69 49.06 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 43.5 t -129.79 125.86 22.35 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.0 173.37 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.414 1.409 . . . . 0.0 110.544 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -54.36 98.81 0.18 Allowed Pre-proline 0 C--N 1.287 -2.145 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 19.0 Cg_endo -44.31 -29.3 2.94 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 C-N-CA 122.402 2.068 . . . . 0.0 113.679 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -158.76 -175.3 5.22 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.093 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -107.57 155.93 19.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.16 -168.61 26.53 Favored Glycine 1 N--CA 1.518 4.153 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 75' ' ' GLU . 5.6 m -109.95 154.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.435 -1.626 . . . . 0.0 112.268 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.56 108.9 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 1.9 tmtp? -94.24 -50.15 5.4 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.226 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.518 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.7 tt0 -155.88 162.89 40.35 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.518 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -167.85 156.77 9.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.085 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -131.76 53.27 2.01 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.39 153.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 126.079 2.112 . . . . 0.0 113.735 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.7 m120 -121.76 178.62 4.78 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 124.809 2.243 . . . . 0.0 115.576 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.37 108.9 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.96 -23.76 3.34 Favored Glycine 0 N--CA 1.507 3.378 1 CA-C-N 108.282 -4.054 . . . . 0.0 108.501 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -54.39 154.11 4.91 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.945 0.879 . . . . 0.0 111.58 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.613 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.6 mmmt -95.81 148.32 22.71 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.43 147.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.667 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -148.56 155.65 41.4 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -30.28 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.052 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.46 -32.5 5.53 Favored Glycine 0 N--CA 1.511 3.698 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.327 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 21.2 m -37.84 122.87 1.02 Allowed 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 70' ' ' LEU . 7.4 mp -70.39 58.96 0.19 Allowed 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.556 ' CG1' HG22 ' A' ' 7' ' ' VAL . 5.1 mt -20.07 -61.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.448 ' SD ' ' HE1' ' A' ' 74' ' ' PHE . 7.9 ptp -156.85 176.77 12.31 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 112.573 -2.103 . . . . 0.0 114.509 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 114.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 123.845 1.783 . . . . 0.0 112.42 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.448 ' HE1' ' SD ' ' A' ' 72' ' ' MET . 17.0 m-30 -106.96 154.88 20.43 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.632 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 2.5 tp10 -127.01 123.35 36.86 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 CA--C 1.582 2.189 1 N-CA-C 124.577 5.029 . . . . 0.0 124.577 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -128.54 84.0 2.2 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.227 2.677 . . . . 0.0 118.227 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.08 143.85 1.06 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 74' ' ' PHE . 26.5 t -118.01 120.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.0 p-10 -117.48 172.78 7.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.457 ' CG2' HD11 ' A' ' 71' ' ' ILE . 5.8 t -101.95 137.3 19.47 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 118.299 -1.361 . . . . 0.0 109.563 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' O ' HG22 ' A' ' 67' ' ' THR . 42.4 Cg_endo . . . . . 0 N--CA 1.505 2.195 0 C-N-CA 123.605 2.87 . . . . 0.0 111.327 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.503 2.212 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 49.5 mt-10 -92.33 169.98 10.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.544 -0.723 . . . . 0.0 109.558 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 35' ' ' ILE . 60.0 t -106.89 116.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -94.49 -43.43 8.35 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.633 1.173 . . . . 0.0 113.787 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -136.49 102.06 4.83 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.678 1.228 . . . . 0.0 110.342 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.7 p -75.18 63.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 O-C-N 119.562 -1.962 . . . . 0.0 116.1 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 28.9 mmm -29.57 -33.6 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 26' ' ' ASP . 2.1 t -125.57 154.32 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -134.41 -176.93 4.37 Favored 'General case' 0 N--CA 1.521 3.078 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.54 87.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.101 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.91 26.01 3.71 Favored Glycine 0 N--CA 1.514 3.869 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.576 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.431 ' HB3' ' CG1' ' A' ' 22' ' ' VAL . 1.3 m-20 -116.37 141.09 48.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.36 115.02 4.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.798 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.19 98.23 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -105.04 149.43 25.81 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.232 -1.543 . . . . 0.0 114.782 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.2 73.03 0.3 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 177.2 -24.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.001 -3.272 . . . . 0.0 110.131 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -89.87 119.08 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.877 -1.14 . . . . 0.0 112.74 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 29.5 t -48.78 123.87 7.6 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 48' ' ' ALA . 1.5 mt -81.78 -55.46 4.61 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.477 1.132 . . . . 0.0 112.625 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' A' ' 17' ' ' VAL . 19.9 pt -146.7 129.75 8.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.481 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 m -73.17 137.68 45.23 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.1 m -124.77 154.54 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.518 2.928 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.505 2.308 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.0 mmm -116.79 166.72 11.82 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.064 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -130.81 156.93 44.17 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.25 105.83 14.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.311 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 1.4 Cg_endo -77.71 175.66 10.97 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.155 1.236 . . . . 0.0 110.212 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.643 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -72.3 107.49 3.07 Favored Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -38.3 -39.33 1.01 Allowed 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.42 2.747 . . . . 0.0 113.981 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -150.77 176.69 10.8 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.02 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -94.82 89.09 5.54 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.57 -164.46 10.18 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 114.48 -1.236 . . . . 0.0 113.603 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.47 156.5 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 ' CE1' ' A' ' 74' ' ' PHE . 2.7 t -87.11 135.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.372 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -110.97 -65.22 1.19 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.158 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.506 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 29.7 tt0 -137.85 148.86 45.8 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.637 0.732 . . . . 0.0 109.521 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 57' ' ' LEU . 2.1 pt? -157.64 154.76 28.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.506 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 86.6 mttt -131.1 51.55 2.13 Favored 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.11 154.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 CA-C-N 111.82 -2.446 . . . . 0.0 114.195 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -145.55 -176.19 5.02 Favored 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.0 t -84.65 113.22 22.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 1 N-CA-C 99.688 -4.19 . . . . 0.0 99.688 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.93 10.15 12.7 Favored Glycine 0 N--CA 1.513 3.769 0 CA-C-N 112.293 -2.23 . . . . 0.0 108.952 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -103.68 159.58 15.5 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 150.12 35.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -136.02 166.04 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.336 -179.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.596 ' HD2' ' N ' ' A' ' 67' ' ' THR . 4.5 tmmm? -159.72 160.54 34.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.076 -1.015 . . . . 0.0 109.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.596 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 6.5 p -43.4 112.93 0.43 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.8 -8.49 61.55 Favored Glycine 0 N--CA 1.515 3.964 0 CA-C-N 113.043 -1.89 . . . . 0.0 114.619 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 7.2 m -67.41 127.13 31.53 Favored 'General case' 0 N--CA 1.52 3.068 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.184 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 6' ' ' ASN . 0.8 OUTLIER -72.99 66.21 0.79 Allowed 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -36.46 -61.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 119.549 3.166 . . . . 0.0 119.549 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 ptp -144.89 175.18 10.39 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 113.987 -1.46 . . . . 0.0 114.812 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -113.72 121.94 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.932 1.349 . . . . 0.0 111.677 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.553 ' CD1' HG21 ' A' ' 5' ' ' VAL . 15.2 m-30 -106.0 -177.36 3.34 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.168 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -153.44 165.55 35.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 120.224 3.416 . . . . 0.0 120.224 -179.463 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.513 2.713 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 1.1 mptt -125.15 155.09 40.49 Favored 'General case' 0 N--CA 1.515 2.781 0 CA-C-O 122.015 0.912 . . . . 0.0 112.477 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -107.35 149.35 27.94 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.298 1.523 . . . . 0.0 113.375 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 59.5 t -102.97 102.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-O 124.102 1.906 . . . . 0.0 112.074 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.453 ' H ' ' ND2' ' A' ' 6' ' ' ASN . 2.1 p30 -95.94 130.12 43.0 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 111.094 -2.775 . . . . 0.0 105.563 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 67' ' ' THR . 69.7 t -55.64 132.51 71.79 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HD3' ' A' ' 49' ' ' PRO . 62.6 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 C-N-CA 121.578 1.519 . . . . 0.0 114.119 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.517 2.892 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.6 pt-20 -100.27 167.73 10.23 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.245 -0.909 . . . . 0.0 109.818 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' A' ' 35' ' ' ILE . 22.0 t -105.35 113.44 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.394 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.3 p -90.5 -40.98 11.67 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 93.8 mt-10 -133.99 101.76 5.17 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 123.297 1.522 . . . . 0.0 111.682 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.37 73.64 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-O 125.981 2.801 . . . . 0.0 113.047 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.449 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 mtp -38.39 -45.66 1.04 Allowed 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' C ' ' HD3' ' A' ' 23' ' ' LYS . 10.4 m -103.31 153.44 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 CA-C-N 119.486 1.039 . . . . 0.0 113.349 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.615 ' HD3' ' C ' ' A' ' 22' ' ' VAL . 3.7 mppt? -129.58 175.16 9.02 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.0 107.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.745 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.87 -28.11 5.5 Favored Glycine 1 N--CA 1.519 4.176 0 N-CA-C 114.598 0.599 . . . . 0.0 114.598 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -59.66 157.54 11.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -107.85 103.32 12.55 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 123.513 1.625 . . . . 0.0 106.982 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.644 HG11 HD21 ' A' ' 34' ' ' LEU . 66.1 t -103.78 117.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 120.327 3.454 . . . . 0.0 120.327 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -112.86 154.32 26.5 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 119.803 -1.81 . . . . 0.0 113.897 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.79 92.66 2.52 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 160.59 -20.51 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 109.994 -3.275 . . . . 0.0 109.284 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.58 165.86 14.0 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.023 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.3 p -85.56 106.19 16.7 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.644 HD21 HG11 ' A' ' 28' ' ' VAL . 3.4 mt -69.13 -63.78 1.0 Allowed 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 17' ' ' VAL . 33.9 pt -143.11 157.88 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.128 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 9.9 m -104.7 134.26 48.15 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.7 m -127.12 165.62 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.094 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 13.7 t . . . . . 0 N--CA 1.518 2.959 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 mmt -139.02 168.42 19.87 Favored 'General case' 0 N--CA 1.513 2.72 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -111.3 151.89 27.84 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 122.177 0.989 . . . . 0.0 111.627 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.2 t -122.66 119.59 28.11 Favored Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.616 -0.677 . . . . 0.0 109.708 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -85.17 175.9 6.19 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 CA-C-O 122.581 0.992 . . . . 0.0 111.67 175.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -75.6 108.41 5.77 Favored Pre-proline 0 CA--C 1.58 2.111 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD3' ' HD3' ' A' ' 8' ' ' PRO . 29.8 Cg_endo -48.62 -30.46 16.46 Favored 'Trans proline' 0 N--CA 1.512 2.584 0 C-N-CA 123.084 2.523 . . . . 0.0 114.122 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 178.38 10.15 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.498 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.29 20.85 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.04 -175.79 35.19 Favored Glycine 0 N--CA 1.507 3.413 0 CA-C-O 121.812 0.673 . . . . 0.0 111.985 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.6 151.12 19.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.199 -1.177 . . . . 0.0 111.379 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 10.7 t -74.69 80.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.633 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HE2' ' CB ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -68.54 -41.36 79.99 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.528 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CB ' ' HE2' ' A' ' 55' ' ' LYS . 39.7 tt0 -167.74 166.32 13.8 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 57' ' ' LEU . 1.6 pt? -166.56 159.34 14.19 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.046 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -132.24 49.14 2.34 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 122.715 1.245 . . . . 0.0 108.958 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.43 157.03 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 112.524 -2.125 . . . . 0.0 113.279 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -129.94 178.42 6.54 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 125.829 2.728 . . . . 0.0 115.065 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -90.24 112.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 100.536 -3.876 . . . . 0.0 100.536 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.02 -29.41 3.52 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 109.636 -3.438 . . . . 0.0 109.363 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -62.07 159.18 14.96 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.886 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -104.75 142.88 33.91 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HB ' HG21 ' A' ' 7' ' ' VAL . 28.6 m -123.71 158.19 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -153.03 145.7 24.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 118.088 -0.958 . . . . 0.0 108.934 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 14.3 t -47.78 121.74 4.35 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.851 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.98 35.06 Favored Glycine 0 N--CA 1.513 3.825 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.733 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.8 t -78.36 121.45 24.49 Favored 'General case' 0 N--CA 1.52 3.06 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.15 66.54 0.63 Allowed 'General case' 0 N--CA 1.516 2.827 0 CA-C-O 122.032 0.92 . . . . 0.0 113.158 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.478 HG13 ' HG2' ' A' ' 72' ' ' MET . 35.9 pt -58.98 -45.78 91.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.517 ' HE1' HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -137.24 165.11 26.92 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 112.888 -1.96 . . . . 0.0 115.974 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.06 125.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.943 1.354 . . . . 0.0 113.448 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.488 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 7.3 m-30 -117.14 150.35 38.85 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.24 160.11 30.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 -179.175 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.503 2.179 0 CA-C-O 121.437 0.637 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 2.3 mmtt -131.97 127.41 36.24 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.331 1.063 . . . . 0.0 112.961 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.661 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -68.97 122.68 19.17 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.892 -1.503 . . . . 0.0 110.595 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.697 HG21 ' CD1' ' A' ' 74' ' ' PHE . 10.6 t -101.49 96.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 CA-C-O 124.573 2.13 . . . . 0.0 114.999 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.421 ' HB2' ' HA2' ' A' ' 68' ' ' GLY . 12.2 p-10 -89.13 128.15 35.76 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 110.058 -3.246 . . . . 0.0 106.986 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 65' ' ' VAL . 12.5 t -68.49 130.79 91.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.502 1.995 0 C-N-CA 122.951 2.434 . . . . 0.0 115.635 -172.064 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.522 3.143 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -102.48 176.14 5.27 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 120.584 1.538 . . . . 0.0 113.728 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 t -108.35 119.4 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-O 122.921 1.344 . . . . 0.0 113.251 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.1 m -93.04 -52.67 4.47 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.368 -1.742 . . . . 0.0 111.305 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 16.5 mm-40 -126.32 126.87 44.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.485 0.659 . . . . 0.0 109.499 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.453 HG22 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -105.73 61.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 123.045 1.403 . . . . 0.0 111.646 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmt -21.22 -46.7 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 110.622 -2.99 . . . . 0.0 116.671 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.436 HG11 HG22 ' A' ' 28' ' ' VAL . 2.4 t -112.79 159.7 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HZ3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -133.7 178.42 6.95 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 179.851 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.6 99.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.782 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.69 13.51 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.679 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 22' ' ' VAL . 58.7 m-20 -75.76 147.22 39.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.641 ' HD2' HG13 ' A' ' 53' ' ' VAL . 27.8 mmmt -73.84 108.61 6.77 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.705 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -109.29 124.16 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.956 0.884 . . . . 0.0 109.95 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -137.3 159.88 40.65 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.08 161.06 0.08 Allowed 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.25 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 56.93 -1.7 0.05 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.07 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 1.4 tm0? -96.07 107.67 20.0 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.5 m -48.33 121.72 4.66 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -88.23 -59.38 2.25 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -144.79 152.95 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.702 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 16.7 m -110.44 125.42 53.25 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 179.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.97 157.8 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.514 2.754 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.28 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.516 2.86 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.5 ttt -144.85 161.05 40.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.079 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.28 155.16 20.81 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 123.265 1.507 . . . . 0.0 114.493 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.88 126.07 23.75 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.48 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -91.18 177.83 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 CA-C-O 124.51 1.796 . . . . 0.0 113.367 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.707 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -70.25 103.71 0.66 Allowed Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 111.699 -2.501 . . . . 0.0 117.613 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 23.7 Cg_endo -46.69 -26.21 4.28 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 121.718 1.612 . . . . 0.0 114.067 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -162.14 -172.62 3.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.683 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.71 166.81 10.52 Favored 'General case' 0 CA--C 1.568 1.669 1 N-CA-C 122.747 4.351 . . . . 0.0 122.747 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.62 -134.68 7.26 Favored Glycine 1 N--CA 1.526 4.645 0 CA-C-N 113.173 -1.831 . . . . 0.0 113.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG13 ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -134.91 160.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 O-C-N 121.512 -0.993 . . . . 0.0 109.915 179.317 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 39.7 t -84.44 133.63 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 C-N-CA 117.604 -1.638 . . . . 0.0 106.912 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 45.5 tptt -102.73 -62.52 1.26 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 25.6 tt0 -150.53 158.79 44.55 Favored 'General case' 0 N--CA 1.511 2.624 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.539 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.1 pt? -166.02 149.66 7.71 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -125.03 50.06 1.8 Allowed 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.8 162.9 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 126.33 2.269 . . . . 0.0 113.967 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.425 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -135.27 -177.51 4.68 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 120.625 3.565 . . . . 0.0 120.625 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -94.4 67.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 127.458 3.504 . . . . 0.0 109.575 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.15 37.33 0.02 OUTLIER Glycine 0 N--CA 1.506 3.354 1 CA-C-N 105.395 -5.366 . . . . 0.0 109.602 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 9.8 t0 -121.53 173.9 7.11 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 111.568 -2.316 . . . . 0.0 104.912 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' C ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -121.79 160.67 24.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 120.356 3.465 . . . . 0.0 120.356 -179.517 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG12 HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.27 147.8 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 119.992 3.33 . . . . 0.0 119.992 -179.213 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.95 163.23 40.0 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.724 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -50.58 106.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 123.358 1.551 . . . . 0.0 114.763 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 6' ' ' ASN . . . 95.05 11.69 56.09 Favored Glycine 0 N--CA 1.513 3.767 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.671 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 t -76.12 116.9 17.27 Favored 'General case' 0 N--CA 1.507 2.423 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.551 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -83.45 77.09 9.87 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.81 1.767 . . . . 0.0 109.831 -179.599 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.535 HG21 HG12 ' A' ' 65' ' ' VAL . 1.7 pp -77.95 -44.13 28.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.164 -1.835 . . . . 0.0 112.915 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 71' ' ' ILE . 9.3 ptm -130.36 175.34 9.04 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.674 -1.21 . . . . 0.0 113.259 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HA ' HG23 ' A' ' 5' ' ' VAL . 5.3 mp -128.49 128.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.697 ' CD1' HG21 ' A' ' 5' ' ' VAL . 16.4 m-30 -109.8 164.05 12.93 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.0 tt0 -137.88 131.11 30.5 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.303 -1.417 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -179.558 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.03 150.38 51.33 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.262 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -95.07 160.11 14.71 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.48 HG21 ' CE1' ' A' ' 74' ' ' PHE . 89.9 t -118.36 114.69 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.154 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.9 p-10 -105.79 173.67 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 71' ' ' ILE . 38.4 t -95.18 131.04 30.8 Favored Pre-proline 0 N--CA 1.495 1.781 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.61 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.501 1.927 0 C-N-CA 121.343 1.362 . . . . 0.0 111.99 172.022 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 18.0 m . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.672 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 12.2 pt-20 -118.16 164.71 14.75 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.266 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 62' ' ' GLY . 10.2 t -83.6 123.91 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.418 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.1 t -102.39 -45.8 4.98 Favored 'General case' 0 N--CA 1.522 3.155 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.798 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 24.3 mt-10 -130.97 123.1 28.08 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.893 0.854 . . . . 0.0 109.594 178.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -102.99 71.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 125.957 2.789 . . . . 0.0 110.538 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 mtt -34.07 -59.45 0.43 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 110.59 -3.004 . . . . 0.0 115.101 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.641 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.8 t -100.63 151.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 CA-C-O 122.161 0.981 . . . . 0.0 112.809 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.641 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -138.54 177.18 8.08 Favored 'General case' 0 N--CA 1.518 2.962 0 N-CA-C 121.574 3.916 . . . . 0.0 121.574 -178.74 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -42.5 97.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.88 11.8 25.58 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.634 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 t0 -110.32 142.23 42.25 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -59.39 107.17 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.707 -2.042 . . . . 0.0 116.145 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.529 HG11 ' CE2' ' A' ' 74' ' ' PHE . 94.6 t -114.97 118.22 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 122.271 1.034 . . . . 0.0 111.807 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -133.56 149.34 51.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.544 -1.348 . . . . 0.0 113.69 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -50.67 140.46 14.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 41.1 mm-40 93.73 -21.28 0.07 Allowed 'General case' 0 N--CA 1.513 2.707 0 O-C-N 126.703 2.502 . . . . 0.0 110.405 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -88.1 140.27 29.66 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.782 -1.199 . . . . 0.0 109.573 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.6 m -73.69 128.23 34.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 112.257 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.2 mt -95.38 -61.95 1.38 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 pt -137.66 146.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-O 122.551 1.167 . . . . 0.0 113.03 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 45' ' ' GLU . 88.1 m -101.87 116.89 33.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.4 m -113.25 160.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.513 2.702 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.514 2.753 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -118.94 156.07 30.2 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.477 0.581 . . . . 0.0 111.465 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HG2' HG23 ' A' ' 36' ' ' THR . 47.6 mt-10 -111.64 158.48 19.21 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.14 123.09 22.42 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 112.644 -2.071 . . . . 0.0 112.164 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -84.52 -179.7 3.97 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 CA-C-O 123.55 1.396 . . . . 0.0 112.636 168.937 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -66.02 101.24 0.27 Allowed Pre-proline 0 C--N 1.282 -2.356 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' HD12 ' A' ' 34' ' ' LEU . 9.4 Cg_endo -36.61 -35.98 0.22 Allowed 'Trans proline' 0 N--CA 1.51 2.476 0 C-N-CA 122.71 2.273 . . . . 0.0 113.986 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -154.24 -177.49 6.47 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 112.078 -2.328 . . . . 0.0 107.006 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -100.31 168.79 9.55 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.97 -147.53 19.29 Favored Glycine 1 N--CA 1.517 4.035 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.075 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.37 148.16 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 47.6 t -68.94 92.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.142 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 17.5 tttm -69.82 -58.9 3.33 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.954 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' CD ' ' NZ ' ' A' ' 55' ' ' LYS 0.319 37.3 tt0 -149.52 144.07 26.03 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.52 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -130.73 155.15 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -128.54 37.58 4.1 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.106 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.43 161.98 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-N 113.09 -1.868 . . . . 0.0 114.562 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -122.83 173.96 7.44 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 124.819 2.247 . . . . 0.0 115.677 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 18' ' ' THR . 3.4 t -98.97 100.69 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 101.305 -3.591 . . . . 0.0 101.305 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' VAL . . . 120.86 30.58 1.33 Allowed Glycine 0 N--CA 1.511 3.678 1 CA-C-N 106.973 -4.649 . . . . 0.0 107.8 -179.336 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -107.28 155.34 20.06 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 114.133 -1.034 . . . . 0.0 109.995 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.672 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 31.4 mmtm -89.22 140.15 29.76 Favored 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.27 166.75 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.97 0.891 . . . . 0.0 111.035 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -165.98 153.5 10.27 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 t -47.9 127.04 11.46 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 117.304 -1.758 . . . . 0.0 111.858 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.66 -40.5 2.41 Favored Glycine 0 N--CA 1.513 3.824 0 CA-C-N 114.902 -1.044 . . . . 0.0 114.464 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 32.3 t -57.0 146.25 27.69 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.289 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.99 63.89 7.56 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.682 1.23 . . . . 0.0 114.28 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.58 HG22 ' SD ' ' A' ' 72' ' ' MET . 1.4 mt -17.0 -57.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.58 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -168.84 -176.81 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 111.767 -2.469 . . . . 0.0 114.92 -179.596 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.96 125.45 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 124.092 1.901 . . . . 0.0 112.767 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 28' ' ' VAL . 17.3 m-30 -112.9 156.23 23.33 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.885 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -130.46 139.61 50.55 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 103.571 -2.752 . . . . 0.0 103.571 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 76' ' ' VAL . 16.2 m . . . . . 0 C--N 1.294 -1.822 1 N-CA-C 123.075 4.472 . . . . 0.0 123.075 -179.187 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.521 3.078 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.574 ' HG3' HG13 ' A' ' 76' ' ' VAL . 70.7 mmtt -133.31 148.64 51.91 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.07 155.42 18.4 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.58 -1.325 . . . . 0.0 114.246 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 74' ' ' PHE . 40.1 t -121.97 88.36 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 124.753 2.216 . . . . 0.0 113.852 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.8 p30 -95.05 170.36 9.47 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 111.291 -2.686 . . . . 0.0 105.802 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.539 HG21 HG11 ' A' ' 65' ' ' VAL . 96.0 t -104.6 136.02 19.23 Favored Pre-proline 0 N--CA 1.504 2.246 0 C-N-CA 118.135 -1.426 . . . . 0.0 113.39 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 53.1 Cg_exo . . . . . 0 N--CA 1.5 1.9 0 C-N-CA 122.842 2.361 . . . . 0.0 115.509 168.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.5 2.066 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 8.7 pt-20 -124.42 172.63 9.01 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.68 122.84 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.995 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 p -101.56 -42.56 6.19 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.48 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.87 109.32 11.17 Favored 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' HG22 ' A' ' 61' ' ' VAL . 13.4 p -92.09 72.9 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 125.361 2.505 . . . . 0.0 110.279 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.9 mtt -35.27 -56.87 0.61 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 111.694 -2.503 . . . . 0.0 112.951 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.563 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 10.3 p -105.67 164.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 CA-C-O 123.29 1.519 . . . . 0.0 114.145 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.632 ' HD2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -145.96 174.69 11.04 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 119.409 3.114 . . . . 0.0 119.409 -179.424 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.2 t -47.62 111.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.13 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.69 -27.87 6.99 Favored Glycine 1 N--CA 1.516 4.027 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.117 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -81.93 173.17 12.47 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 124.256 1.979 . . . . 0.0 115.947 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.06 136.36 50.21 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.944 -1.934 . . . . 0.0 112.586 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG11 HD21 ' A' ' 34' ' ' LEU . 9.4 t -126.41 160.65 33.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.993 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.03 156.05 28.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.516 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.72 168.86 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 125.071 1.482 . . . . 0.0 111.171 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 5.9 mp0 55.17 -7.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.156 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -101.89 110.0 21.88 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.51 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -40.16 133.57 1.73 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 9.4 mt -100.86 -61.76 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.47 HG13 ' HB ' ' A' ' 46' ' ' VAL . 36.6 pt -141.85 151.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.243 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.9 m -101.84 138.27 39.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.9 m -129.67 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 N--CA 1.503 2.187 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -179.303 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.516 2.851 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.6 ttm -167.81 164.09 14.13 Favored 'General case' 0 N--CA 1.517 2.883 0 CA-C-O 122.45 1.119 . . . . 0.0 112.927 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.6 mp0 -103.71 141.68 35.65 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 124.368 2.032 . . . . 0.0 114.659 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 22.7 t -121.56 98.97 45.58 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -81.94 -178.72 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 CA-C-O 124.25 1.688 . . . . 0.0 113.618 171.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -68.24 102.21 0.37 Allowed Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.7 Cg_endo -41.11 -25.01 0.2 Allowed 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 121.945 1.763 . . . . 0.0 115.453 170.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.45 -167.09 0.75 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.37 163.9 12.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.96 -175.72 19.34 Favored Glycine 1 N--CA 1.522 4.428 0 CA-C-N 113.58 -1.645 . . . . 0.0 113.443 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 75' ' ' GLU . 35.7 m -100.24 166.23 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.307 . . . . 0.0 114.287 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 74' ' ' PHE . 20.0 t -89.43 106.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 113.983 -1.462 . . . . 0.0 112.047 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -64.18 1.09 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 13.8 tt0 -140.39 155.71 46.65 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 118.506 0.594 . . . . 0.0 111.825 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.565 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.0 pt? -161.61 153.69 19.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.545 -0.722 . . . . 0.0 110.114 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.507 ' HD2' ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -129.05 55.87 1.71 Allowed 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.51 151.46 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 112.277 -2.238 . . . . 0.0 111.622 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -130.57 170.99 13.53 Favored 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.451 HG22 ' HB ' ' A' ' 20' ' ' VAL . 3.2 t -87.77 111.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 1 N-CA-C 98.202 -4.74 . . . . 0.0 98.202 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.36 21.64 5.1 Favored Glycine 0 N--CA 1.514 3.886 0 CA-C-N 109.667 -3.424 . . . . 0.0 111.716 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.297 36.1 t0 -114.56 175.27 5.56 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.648 1.179 . . . . 0.0 111.537 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 25.8 mmtp -98.56 149.55 22.63 Favored 'General case' 0 N--CA 1.526 3.351 1 N-CA-C 122.395 4.22 . . . . 0.0 122.395 -179.049 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 7' ' ' VAL . 4.4 t -144.77 168.36 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 67' ' ' THR . 10.4 ptmm? 174.93 139.0 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.6 t -31.51 122.55 0.26 Allowed 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.72 -24.77 26.17 Favored Glycine 0 N--CA 1.509 3.561 0 CA-C-N 114.285 -1.325 . . . . 0.0 114.624 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.1 m -75.21 123.22 24.89 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 70' ' ' LEU . 7.2 mp -75.46 72.32 2.46 Favored 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 125.338 1.455 . . . . 0.0 114.694 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.423 HD11 ' SD ' ' A' ' 72' ' ' MET . 1.7 pp -56.03 -52.49 49.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.445 ' SD ' ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -127.95 174.95 8.75 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -123.79 129.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.677 0.751 . . . . 0.0 110.602 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.7 m-30 -114.77 158.79 21.39 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.465 1.602 . . . . 0.0 111.732 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 53' ' ' VAL 0.355 11.6 tt0 -136.28 124.25 22.8 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 179.52 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 3' ' ' LYS . 23.3 m . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 121.047 3.721 . . . . 0.0 121.047 -179.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 3' ' ' LYS . 20.5 t . . . . . 0 N--CA 1.511 2.575 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 1.1 mmpt? -131.8 164.05 26.89 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.2 mp0 -107.78 140.4 40.91 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.606 HG21 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -115.08 100.84 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 CA-C-O 122.907 1.337 . . . . 0.0 112.483 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 69' ' ' SER . 3.3 p30 -91.84 173.87 7.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.806 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.594 HG22 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -112.71 137.2 21.66 Favored Pre-proline 0 N--CA 1.499 2.006 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.687 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 CA--C 1.56 1.778 0 C-N-CA 122.161 1.907 . . . . 0.0 116.437 175.69 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.527 3.387 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.6 pt-20 -113.79 178.9 4.12 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.424 HG13 ' HB ' ' A' ' 35' ' ' ILE . 96.0 t -110.76 111.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.99 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.9 t -91.51 -42.97 9.96 Favored 'General case' 0 N--CA 1.526 3.349 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -130.67 100.39 5.29 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 123.597 1.665 . . . . 0.0 109.327 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 61' ' ' VAL . 7.8 p -75.79 64.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 119.188 -2.195 . . . . 0.0 115.826 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -29.93 -27.4 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.537 HG22 ' N ' ' A' ' 23' ' ' LYS . 13.0 p -112.02 170.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' N ' HG22 ' A' ' 22' ' ' VAL . 33.3 mmtp -139.02 164.46 29.69 Favored 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.459 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 59.0 t -72.38 115.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 O-C-N 121.597 -0.69 . . . . 0.0 111.331 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . 116.01 -29.13 7.28 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.546 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.51 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 2.0 m-20 -63.9 -176.32 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 25' ' ' GLY . 36.7 mmtm -109.93 123.14 49.1 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.826 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 48' ' ' ALA . 2.2 t -123.35 102.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -91.9 162.5 14.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.05 -1.656 . . . . 0.0 111.434 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -61.72 164.94 5.57 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.617 -1.233 . . . . 0.0 107.75 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 70.62 -22.04 0.18 Allowed 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 123.6 1.666 . . . . 0.0 111.158 -179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 30' ' ' ALA . 37.7 tt0 -80.34 110.77 16.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.765 -1.209 . . . . 0.0 109.069 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 27.7 t -47.91 139.88 7.32 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.332 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -103.61 -55.95 2.3 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.458 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -148.33 141.76 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.475 1.131 . . . . 0.0 111.947 179.935 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.6 m -86.37 122.75 30.78 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.97 152.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.507 2.405 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.949 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 53.2 m . . . . . 0 N--CA 1.514 2.767 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtp -122.02 176.05 6.01 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -125.8 157.98 36.14 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 6.2 t -129.41 110.71 17.82 Favored Pre-proline 0 N--CA 1.498 1.946 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.629 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -83.36 -179.36 4.24 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.44 1.426 . . . . 0.0 113.829 173.314 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -64.14 105.79 0.79 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 120.484 3.513 . . . . 0.0 120.484 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 2.8 Cg_endo -29.09 -39.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.474 0 C-N-CA 122.165 1.91 . . . . 0.0 115.098 171.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.42 177.82 10.83 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.381 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -89.18 101.03 13.7 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.7 -178.9 29.5 Favored Glycine 1 N--CA 1.528 4.787 0 O-C-N 121.71 -0.619 . . . . 0.0 114.606 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 1.4 m -100.58 171.55 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.315 -1.697 . . . . 0.0 107.878 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' SD ' ' A' ' 72' ' ' MET . 96.3 t -94.04 121.99 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.237 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -86.05 -58.68 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 1.7 tp10 -167.2 150.79 6.53 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.843 1.964 . . . . 0.0 112.652 178.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -130.86 -178.61 4.88 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.194 -1.567 . . . . 0.0 110.856 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 1.5 mptp? -150.57 32.34 0.64 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.912 -1.117 . . . . 0.0 108.673 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.22 156.29 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-N 114.267 -1.333 . . . . 0.0 114.031 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -127.37 176.64 7.28 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -92.83 105.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.97 29.05 2.48 Favored Glycine 0 N--CA 1.51 3.617 1 CA-C-N 108.392 -4.004 . . . . 0.0 107.992 -178.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -113.73 163.24 15.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 1.7 pptp? -115.43 143.26 45.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.42 171.61 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.401 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -165.53 151.29 9.36 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 117.93 -1.033 . . . . 0.0 108.68 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 3.8 t -42.06 116.39 0.81 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-O 121.975 0.893 . . . . 0.0 112.841 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.68 -30.0 9.68 Favored Glycine 0 N--CA 1.514 3.834 0 CA-C-N 114.925 -1.034 . . . . 0.0 114.021 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 1.8 t -52.13 162.03 0.54 Allowed 'General case' 0 N--CA 1.52 3.05 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -96.79 64.17 2.05 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.598 HG22 ' HG2' ' A' ' 72' ' ' MET . 0.8 OUTLIER -30.54 -49.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 179.64 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.598 ' HG2' HG22 ' A' ' 71' ' ' ILE . 1.1 ptp 178.38 -179.25 0.3 Allowed 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -107.81 133.63 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 123.617 1.675 . . . . 0.0 108.548 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.606 ' CD1' HG21 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -101.88 168.3 9.51 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.403 -179.604 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' VAL . 18.7 tt0 -146.69 99.45 3.2 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 123.782 1.753 . . . . 0.0 107.729 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.572 1.788 1 N-CA-C 123.287 4.551 . . . . 0.0 123.287 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 9.5 p . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 119.854 3.279 . . . . 0.0 119.854 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 45.5 mmtt -138.24 165.12 27.51 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 118.822 2.897 . . . . 0.0 118.822 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.433 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -99.85 142.39 31.39 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 111.255 -2.702 . . . . 0.0 113.532 -179.39 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.611 HG21 ' CD1' ' A' ' 74' ' ' PHE . 43.4 t -118.79 98.43 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.168 0 O-C-N 121.212 -0.93 . . . . 0.0 112.447 179.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' SER . 23.6 p30 -110.82 174.89 5.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.381 1.086 . . . . 0.0 111.375 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 71' ' ' ILE . 70.1 t -108.78 130.34 22.85 Favored Pre-proline 0 N--CA 1.5 2.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.644 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 76.5 Cg_exo . . . . . 0 N--CA 1.509 2.423 0 C-N-CA 123.654 2.903 . . . . 0.0 114.463 164.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.513 2.722 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 11.7 pt-20 -116.85 169.29 9.5 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 122.0 -0.438 . . . . 0.0 111.442 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.08 118.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 O-C-N 120.907 -1.12 . . . . 0.0 112.422 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 3.7 t -98.47 -34.8 10.48 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.204 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 43.5 mt-10 -134.58 105.48 6.54 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.581 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.2 p -89.44 89.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 126.084 2.849 . . . . 0.0 111.811 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -59.93 -54.34 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 111.311 -2.677 . . . . 0.0 114.771 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG11 HD22 ' A' ' 34' ' ' LEU . 34.5 m -66.58 149.78 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 N-CA-C 118.009 2.596 . . . . 0.0 118.009 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 22' ' ' VAL . 13.0 mmtp -131.65 171.86 12.96 Favored 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 121.366 0.603 . . . . 0.0 112.339 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -75.75 98.19 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.47 14.85 7.3 Favored Glycine 1 N--CA 1.52 4.263 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.703 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.11 136.69 36.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -76.48 111.54 12.05 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 125.042 2.353 . . . . 0.0 106.812 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 96.7 t -111.22 108.31 25.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 109.857 -3.338 . . . . 0.0 112.719 -179.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.49 158.56 28.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.978 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.23 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.953 1.408 . . . . 0.0 113.037 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 72.61 -41.22 0.5 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.755 0.788 . . . . 0.0 110.823 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 13.2 tt0 -57.8 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.853 -1.155 . . . . 0.0 112.078 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 49.0 m -40.6 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.477 HD22 HG11 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -18.06 -67.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -151.31 149.38 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.236 -2.711 . . . . 0.0 109.294 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 1.2 m -106.75 133.6 51.17 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.36 146.66 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 N-CA-C 118.578 2.806 . . . . 0.0 118.578 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.811 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.514 2.73 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.4 mmt -137.77 146.47 43.66 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 17.1 mp0 -118.77 159.62 23.37 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -129.39 124.89 22.3 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.792 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.06 172.43 2.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.958 1.772 . . . . 0.0 112.025 171.438 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -53.17 100.55 0.23 Allowed Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.1 Cg_endo -42.44 -31.39 1.83 Allowed 'Trans proline' 0 N--CA 1.51 2.442 0 C-N-CA 122.816 2.344 . . . . 0.0 113.603 -178.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -160.0 -174.71 4.7 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.752 -2.476 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -107.25 159.87 16.03 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 120.509 3.522 . . . . 0.0 120.509 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.11 -144.87 15.9 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.395 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.44 161.97 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 CA-C-N 117.937 0.868 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.46 HG22 ' CE1' ' A' ' 74' ' ' PHE . 31.3 t -85.96 116.6 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -90.58 -67.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 41.7 tt0 -143.43 152.1 41.15 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.335 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.7 pt? -145.94 146.18 30.95 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 30.6 mmtt -119.17 46.1 1.96 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.86 152.12 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -134.04 -178.73 5.16 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.971 2.32 . . . . 0.0 114.222 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -87.89 112.24 23.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.71 -19.28 5.59 Favored Glycine 0 N--CA 1.509 3.565 0 CA-C-N 109.893 -3.321 . . . . 0.0 110.779 -179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.12 168.91 12.97 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.573 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.66 145.21 33.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -179.69 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -126.85 176.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 112.876 -1.965 . . . . 0.0 111.249 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 67' ' ' THR . 37.8 tttt 166.19 144.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.48 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 4.5 t -39.47 119.49 0.95 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.48 -32.58 5.99 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.725 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.0 t -56.92 128.65 37.91 Favored 'General case' 0 N--CA 1.512 2.656 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.406 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.8 tt -87.59 64.21 7.96 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 124.842 2.258 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.444 ' CG1' HG23 ' A' ' 7' ' ' VAL . 5.1 mm -24.26 -56.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 111.717 -2.492 . . . . 0.0 117.375 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 4.0 ptp -161.19 -174.17 4.21 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.033 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.15 123.97 72.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 124.504 2.097 . . . . 0.0 112.207 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.611 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.0 m-30 -113.05 165.26 12.53 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.733 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 2' ' ' VAL . 2.0 tt0 -142.3 122.71 14.01 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 CA--C 1.568 1.662 0 CA-C-O 122.736 1.255 . . . . 0.0 113.631 179.793 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.781 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -142.98 154.38 43.96 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 124.233 1.968 . . . . 0.0 111.395 178.789 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.781 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 13.4 pm0 -112.96 149.94 32.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.82 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.536 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 87.8 t -120.14 113.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.598 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.734 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 15.9 p-10 -109.86 177.18 4.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.329 1.062 . . . . 0.0 109.533 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.64 HG22 HD11 ' A' ' 71' ' ' ILE . 44.5 t -97.35 130.59 29.13 Favored Pre-proline 0 C--N 1.291 -1.958 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.088 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.681 0 C-N-CA 122.331 2.021 . . . . 0.0 110.565 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.519 2.99 0 CA-C-O 120.326 0.108 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.9 pt-20 -110.24 174.15 6.0 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.591 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.04 123.39 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.845 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.81 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.529 HG23 ' HG3' ' A' ' 19' ' ' GLU . 11.5 t -101.31 -43.83 5.84 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.529 ' HG3' HG23 ' A' ' 18' ' ' THR . 28.9 mt-10 -128.25 99.06 5.29 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.757 0.789 . . . . 0.0 112.685 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.423 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 7.4 p -75.65 70.59 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.091 -2.255 . . . . 0.0 114.281 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.4 mmm -33.83 -45.9 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.89 167.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 36.6 mmtm -137.43 175.5 9.55 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -74.6 99.2 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.777 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.71 -23.08 5.4 Favored Glycine 1 N--CA 1.518 4.15 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.309 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.53 168.32 16.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 123.482 1.61 . . . . 0.0 114.326 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -98.9 132.94 43.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' CG1' HD21 ' A' ' 34' ' ' LEU . 88.7 t -128.12 122.62 58.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.209 -179.399 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -128.59 152.66 48.07 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 112.908 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.96 68.74 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.776 0 CA-C-O 124.135 1.921 . . . . 0.0 115.131 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.609 ' HG3' ' N ' ' A' ' 32' ' ' GLN . 15.6 pt-20 -177.05 -37.66 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 110.124 -3.216 . . . . 0.0 111.565 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.609 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -71.58 110.49 6.2 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.945 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 7.2 p -51.26 67.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 ' CG1' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -14.03 -64.73 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 120.518 3.525 . . . . 0.0 120.518 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 pt -150.52 148.86 14.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.186 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.4 m -95.27 133.8 38.76 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 178.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.7 m -118.13 157.1 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.041 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.511 2.607 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -131.69 162.69 29.84 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 123.638 0.586 . . . . 0.0 110.328 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -115.12 159.51 20.78 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.022 -1.674 . . . . 0.0 114.186 179.665 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.3 t -121.42 133.44 24.22 Favored Pre-proline 0 N--CA 1.503 2.208 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.84 171.79 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.683 1.589 . . . . 0.0 111.899 173.52 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -54.79 100.43 0.22 Allowed Pre-proline 0 C--N 1.286 -2.192 0 CA-C-N 112.316 -2.22 . . . . 0.0 116.332 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -39.89 -33.72 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 122.151 1.901 . . . . 0.0 113.582 179.405 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CZ ' ' HD2' ' A' ' 3' ' ' LYS . 3.3 p90 -156.1 176.98 11.95 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-N 112.692 -2.049 . . . . 0.0 108.466 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.1 159.57 15.26 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.63 -142.13 10.4 Favored Glycine 0 N--CA 1.51 3.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.94 169.62 21.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 124.762 1.225 . . . . 0.0 108.757 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG22 ' CE1' ' A' ' 74' ' ' PHE . 38.5 t -95.61 127.7 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.439 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 44.8 tttp -102.72 -56.72 2.18 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.178 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 6.1 tp10 -154.72 157.13 37.59 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -149.9 147.45 27.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 118.871 -2.393 . . . . 0.0 113.995 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 53.42 1.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.46 154.49 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.978 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 9.9 m-80 -131.83 -174.38 3.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 124.299 2.0 . . . . 0.0 115.227 179.141 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.01 88.94 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-O 126.262 2.934 . . . . 0.0 110.05 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.37 15.72 0.41 Allowed Glycine 0 N--CA 1.515 3.917 1 CA-C-N 105.702 -5.227 . . . . 0.0 111.192 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -95.01 152.69 18.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.465 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 2.2 pptp? -106.95 142.03 37.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HB ' HG21 ' A' ' 7' ' ' VAL . 1.5 m -126.32 175.87 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 112.0 -2.363 . . . . 0.0 111.257 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.668 ' C ' ' HD3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 177.51 157.45 0.37 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.594 179.796 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -29.1 103.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 178.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . 109.74 -47.01 1.09 Allowed Glycine 1 N--CA 1.518 4.102 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.89 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 t -26.84 117.72 0.08 Allowed 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 61.18 0.2 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 7' ' ' VAL . 2.6 mt -23.79 -68.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 124.748 2.214 . . . . 0.0 115.575 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.7 ptp -154.58 -175.41 5.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.523 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -113.62 122.83 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 124.359 2.028 . . . . 0.0 110.948 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 8.9 m-30 -107.97 174.65 5.79 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.571 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 21.0 tt0 -151.45 166.37 31.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -179.316 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.504 2.236 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.51 139.82 51.44 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.714 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -85.57 155.92 20.96 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 119.242 -2.161 . . . . 0.0 113.651 179.374 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' CE1' ' A' ' 74' ' ' PHE . 90.4 t -116.56 119.79 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.809 0 C-N-CA 124.602 1.161 . . . . 0.0 113.92 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -111.05 174.78 5.7 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.744 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.515 HG23 ' CG1' ' A' ' 71' ' ' ILE . 60.7 t -96.86 130.4 30.24 Favored Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' HG23 ' A' ' 67' ' ' THR . 53.6 Cg_endo . . . . . 0 N--CA 1.508 2.348 0 C-N-CA 124.468 3.445 . . . . 0.0 120.913 -173.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 37' ' ' VAL . 1.4 m . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 121.806 0.812 . . . . 0.0 108.948 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.583 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 6.9 pt-20 -113.36 169.25 9.09 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 t -93.97 130.0 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.128 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -179.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.484 ' C ' ' HG3' ' A' ' 19' ' ' GLU . 63.9 p -105.8 -47.15 3.95 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.801 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 18' ' ' THR . 2.8 mt-10 -130.49 106.04 8.26 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 123.126 1.441 . . . . 0.0 112.822 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.88 70.49 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-O 123.709 1.718 . . . . 0.0 111.162 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 14.2 mmt -25.37 -52.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 111.786 -2.461 . . . . 0.0 116.982 179.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 m -102.59 179.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.787 0 N-CA-C 118.514 2.783 . . . . 0.0 118.514 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.3 mmtm -140.18 168.69 19.22 Favored 'General case' 0 N--CA 1.522 3.131 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.12 89.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.525 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.063 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.87 4.6 5.58 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.748 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.6 141.24 31.68 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.411 1.101 . . . . 0.0 113.474 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -64.99 135.32 55.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.983 179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.523 HG12 ' CB ' ' A' ' 48' ' ' ALA . 19.0 t -131.96 115.82 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -179.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -118.26 152.46 35.69 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.181 -1.575 . . . . 0.0 113.97 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.94 72.91 0.42 Allowed 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.494 1.616 . . . . 0.0 114.545 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 175.98 -22.44 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 110.315 -3.13 . . . . 0.0 110.299 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -92.94 117.04 29.61 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -179.105 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 14.7 m -48.27 126.8 11.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.331 1.063 . . . . 0.0 112.981 179.277 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -89.02 -55.26 3.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 125.003 1.321 . . . . 0.0 113.711 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -148.4 152.18 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.566 179.724 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -99.48 136.41 39.45 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 21.4 m -123.68 146.71 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.501 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.418 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 37.9 t . . . . . 0 N--CA 1.51 2.53 0 CA-C-O 121.008 0.432 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.0 mtm -132.22 172.31 12.58 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -122.88 156.69 34.13 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 122.178 0.989 . . . . 0.0 113.397 179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.2 122.24 19.04 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.753 179.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -85.86 178.7 4.13 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.008 1.805 . . . . 0.0 113.02 169.144 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -67.27 106.75 1.31 Allowed Pre-proline 0 C--N 1.287 -2.121 1 N-CA-C 122.188 4.144 . . . . 0.0 122.188 -179.903 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 78.5 Cg_exo -29.7 -40.69 0.06 OUTLIER 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.665 2.243 . . . . 0.0 115.61 174.236 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -154.11 -176.42 5.85 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 112.8 -2.0 . . . . 0.0 111.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -99.22 116.66 31.92 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.7 -169.7 34.84 Favored Glycine 1 N--CA 1.526 4.636 0 CA-C-O 119.276 -0.735 . . . . 0.0 112.556 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -109.91 157.31 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.34 0 CA-C-N 119.804 1.802 . . . . 0.0 107.847 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 20.8 t -76.43 113.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 6.5 tmtt? -91.74 -41.81 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 51.2 tt0 -164.92 161.28 19.99 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.155 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -162.71 152.16 15.53 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.164 -1.585 . . . . 0.0 109.243 178.587 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 54.0 mttt -126.29 49.48 2.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.761 1.267 . . . . 0.0 109.164 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.03 137.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 111.828 -2.442 . . . . 0.0 112.707 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.82 177.75 4.59 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 124.619 2.152 . . . . 0.0 113.621 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -85.06 115.8 27.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 1 N-CA-C 99.967 -4.086 . . . . 0.0 99.967 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.55 -24.74 5.49 Favored Glycine 0 N--CA 1.514 3.882 0 CA-C-N 110.156 -3.202 . . . . 0.0 109.905 -179.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.06 174.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.583 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 25.2 mmtm -104.13 136.13 44.33 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.558 HG12 HD12 ' A' ' 71' ' ' ILE . 19.9 m -132.15 142.87 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 123.218 1.485 . . . . 0.0 110.107 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 67' ' ' THR . 11.9 ttmt -141.01 123.44 15.86 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.69 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 8' ' ' PRO . 1.4 m -22.72 103.64 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.32 -42.49 1.72 Allowed Glycine 0 N--CA 1.511 3.695 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.542 -179.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 13.8 t -38.45 140.22 0.34 Allowed 'General case' 0 N--CA 1.53 3.526 0 CA-C-O 118.028 -0.987 . . . . 0.0 113.611 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.7 tt -80.78 57.33 2.96 Favored 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 124.527 2.108 . . . . 0.0 115.871 -179.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 65' ' ' VAL . 14.4 mm -30.05 -67.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 120.498 3.518 . . . . 0.0 120.498 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.505 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptm -143.26 172.15 13.14 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 111.784 -2.462 . . . . 0.0 113.397 -179.349 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.38 122.74 69.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 120.731 -1.231 . . . . 0.0 109.681 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.545 ' CE1' HG21 ' A' ' 5' ' ' VAL . 16.2 m-30 -105.02 144.69 31.47 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tp10 -120.73 99.2 6.39 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 124.551 2.12 . . . . 0.0 111.293 179.578 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.295 -1.761 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.598 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.514 2.736 1 N-CA-C 124.099 4.852 . . . . 0.0 124.099 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 74' ' ' PHE . 3.2 mttp -164.16 171.89 14.42 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.222 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 11.3 pt-20 -116.65 161.21 19.54 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.358 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.454 HG21 ' CE1' ' A' ' 74' ' ' PHE . 43.8 t -128.48 96.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 124.943 2.306 . . . . 0.0 108.143 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.9 p-10 -86.72 168.79 13.23 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.484 HG21 ' CG1' ' A' ' 65' ' ' VAL . 33.1 t -98.69 143.71 26.83 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 116.598 -2.041 . . . . 0.0 112.879 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' A' ' 7' ' ' VAL . 23.1 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.181 1.921 . . . . 0.0 114.633 177.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.508 2.471 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.57 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 28.8 mt-10 -112.19 128.67 56.3 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.49 119.01 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.109 0 C-N-CA 115.71 -2.396 . . . . 0.0 109.835 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -94.11 -51.24 4.93 Favored 'General case' 0 N--CA 1.519 2.98 0 C-N-CA 123.755 0.822 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.13 119.05 20.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.61 1.195 . . . . 0.0 112.726 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -92.33 63.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 123.594 1.664 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 67.3 mmm -24.33 -46.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.75 160.34 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -153.96 0.57 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 120.606 3.558 . . . . 0.0 120.606 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 55' ' ' LYS . 65.4 t -73.92 97.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.898 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.78 6.18 26.8 Favored Glycine 0 N--CA 1.516 3.977 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.722 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -92.85 152.77 19.23 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -82.09 124.84 30.2 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.55 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.451 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 t -123.47 148.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.054 -179.685 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -147.39 151.12 35.96 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.384 -0.822 . . . . 0.0 109.018 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 48' ' ' ALA . . . -48.72 158.96 0.27 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 124.172 0.92 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 74.12 -41.54 0.48 Allowed 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 123.901 1.81 . . . . 0.0 112.007 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 119.565 -1.959 . . . . 0.0 114.656 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -34.0 82.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 179.154 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -50.79 -51.48 50.19 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.2 pt -142.1 144.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.001 179.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 m -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 24.7 m -130.82 162.4 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 . . . . . 0 N--CA 1.511 2.601 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.745 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.507 2.408 0 CA-C-O 122.044 0.926 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 30.7 mmt -124.1 152.58 42.57 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.601 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -124.41 152.94 42.63 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 t -121.76 112.75 32.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.911 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.97 171.12 14.54 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 CA-C-O 124.282 1.701 . . . . 0.0 108.933 172.439 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -64.27 106.83 1.06 Allowed Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.089 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 3.8 Cg_endo -34.45 -37.04 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 121.808 1.672 . . . . 0.0 114.321 175.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -156.16 -175.74 5.59 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.61 164.83 12.43 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 126.49 -152.69 18.45 Favored Glycine 1 N--CA 1.524 4.567 0 O-C-N 121.415 -0.803 . . . . 0.0 114.78 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.38 165.46 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 121.429 0.633 . . . . 0.0 112.143 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 ' CE1' ' A' ' 74' ' ' PHE . 15.3 t -96.09 145.33 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.103 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' HG13 ' A' ' 24' ' ' VAL . 18.8 tptt -107.65 -60.59 1.68 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.631 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.9 tt0 -161.17 169.79 21.6 Favored 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.689 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt? -164.61 155.97 15.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.655 -1.278 . . . . 0.0 109.645 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -131.11 51.55 2.13 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.387 1.089 . . . . 0.0 108.368 179.714 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 71' ' ' ILE . 19.4 m -126.28 170.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 CA-C-N 114.121 -1.4 . . . . 0.0 114.719 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -138.65 165.95 25.62 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 120.692 3.59 . . . . 0.0 120.692 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.03 101.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 100.849 -3.76 . . . . 0.0 100.849 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.35 29.17 2.18 Favored Glycine 0 N--CA 1.508 3.481 0 CA-C-N 109.572 -3.467 . . . . 0.0 108.01 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.285 0.0 OUTLIER -112.12 178.79 4.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 179.44 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HE2' ' CD ' ' A' ' 16' ' ' GLU . 29.6 mmtp -109.77 130.35 55.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' CG1' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -113.01 147.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 113.492 -1.685 . . . . 0.0 112.918 -179.838 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -146.76 140.97 26.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 15.1 t -50.97 124.44 11.32 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.699 178.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.8 -47.11 1.05 Allowed Glycine 0 N--CA 1.508 3.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.659 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.9 t -36.32 118.78 0.56 Allowed 'General case' 0 N--CA 1.523 3.222 0 CA-C-O 117.316 -1.326 . . . . 0.0 113.606 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.92 62.15 1.09 Allowed 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 123.198 1.475 . . . . 0.0 110.527 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.433 ' HA ' HG11 ' A' ' 59' ' ' VAL . 21.2 mm -45.11 -58.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' VAL . 8.0 ptm -142.06 160.7 39.69 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -107.13 131.79 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 123.532 1.634 . . . . 0.0 112.54 179.549 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 3' ' ' LYS . 3.6 m-30 -110.35 165.27 11.91 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.956 -2.384 . . . . 0.0 116.919 -179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 21.6 tt0 -151.36 101.89 2.87 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 32.1 m . . . . . 0 CA--C 1.566 1.588 0 C-N-CA 127.297 2.239 . . . . 0.0 116.245 179.467 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG21 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 65' ' ' VAL . 33.3 m . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.649 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.639 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.639 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 26' ' ' ASP . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 3' ' ' LYS . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.649 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 15' ' ' VAL . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CE1' HG21 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG21 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 65' ' ' VAL . 33.3 m . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.649 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.639 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.639 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 26' ' ' ASP . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 3' ' ' LYS . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.649 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 15' ' ' VAL . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CE1' HG21 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.517 2.913 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 m -56.17 158.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 123.968 1.842 . . . . 0.0 115.926 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.643 ' HE3' ' CZ ' ' A' ' 50' ' ' PHE . 6.1 mmmt -139.83 149.93 44.07 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.863 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -96.27 154.97 16.96 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 74' ' ' PHE . 43.3 t -116.52 117.27 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.586 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.2 p-10 -108.5 169.4 8.67 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.154 1.454 . . . . 0.0 109.767 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.591 HG12 HD12 ' A' ' 10' ' ' ILE . 1.4 t -94.94 115.0 64.94 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 112.546 -2.115 . . . . 0.0 106.468 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.483 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 52.8 Cg_endo -66.58 -90.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.513 2.142 . . . . 0.0 113.471 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 21.2 p-10 -123.82 116.54 23.13 Favored 'General case' 0 CA--C 1.578 2.027 0 CA-C-O 124.341 2.02 . . . . 0.0 113.875 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.591 HD12 HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -123.03 43.37 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.85 0 CA-C-O 124.416 2.055 . . . . 0.0 111.047 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.82 -64.25 0.03 OUTLIER Glycine 1 N--CA 1.518 4.129 0 CA-C-N 112.585 -2.098 . . . . 0.0 117.427 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.81 -163.07 9.64 Favored Glycine 1 N--CA 1.518 4.121 0 N-CA-C 118.016 1.966 . . . . 0.0 118.016 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -9.95 -106.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 120.572 3.545 . . . . 0.0 120.572 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.9 140.42 52.65 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-N 112.496 -2.138 . . . . 0.0 113.946 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 65' ' ' VAL . 24.7 m -139.13 162.34 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 122.693 1.235 . . . . 0.0 110.586 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 2.5 pt-20 -120.58 170.32 9.52 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.43 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 t -97.62 120.75 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' HB ' ' A' ' 36' ' ' THR . 12.2 t -96.47 -46.17 6.47 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.68 98.51 4.51 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 122.437 1.113 . . . . 0.0 113.362 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.8 p -81.62 68.74 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 124.599 2.142 . . . . 0.0 108.498 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -32.49 -56.15 0.34 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.729 2.862 . . . . 0.0 118.729 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.2 m -87.71 164.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.617 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 16.3 mmtp -131.79 -166.38 1.71 Allowed 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 124.25 1.976 . . . . 0.0 115.91 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.7 t -74.42 86.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-N 113.294 -1.775 . . . . 0.0 113.654 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.62 -11.49 7.07 Favored Glycine 1 N--CA 1.517 4.065 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.097 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -54.97 163.94 0.92 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD2' HG12 ' A' ' 53' ' ' VAL . 8.4 mmmm -100.2 102.29 13.54 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 112.263 -2.244 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.79 148.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 CA-C-O 124.217 1.96 . . . . 0.0 114.804 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -141.04 154.67 46.09 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.792 -1.549 . . . . 0.0 109.548 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -55.03 163.85 0.96 Allowed 'General case' 0 N--CA 1.505 2.286 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 60.49 -16.54 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -88.81 106.97 18.72 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 4.0 t -36.57 138.44 0.23 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.3 mt -102.14 -59.43 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.8 pt -140.26 130.89 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-N 112.895 -1.957 . . . . 0.0 114.198 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 45' ' ' GLU . 6.7 m -83.55 123.06 29.38 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.8 m -115.66 141.59 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.64 -171.6 2.31 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.33 -39.1 0.59 Allowed Glycine 1 N--CA 1.524 4.502 0 N-CA-C 118.104 2.002 . . . . 0.0 118.104 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 10.6 p-10 -111.02 -106.25 0.37 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 124.296 1.998 . . . . 0.0 115.598 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.579 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 21.6 mmmt -117.78 -11.61 10.32 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 127.708 2.403 . . . . 0.0 108.401 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.09 168.08 10.0 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -116.63 124.71 50.43 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.565 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 32.6 mtt -121.97 164.86 16.89 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.64 -1.288 . . . . 0.0 112.117 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' HG2' HG23 ' A' ' 36' ' ' THR . 36.7 mt-10 -129.81 153.49 48.19 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.44 1.114 . . . . 0.0 112.361 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.8 t -124.74 112.97 27.16 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.698 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.56 177.52 5.6 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.741 1.627 . . . . 0.0 113.214 178.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -69.27 114.75 25.98 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 29.2 Cg_endo -46.79 -27.71 5.94 Favored 'Trans proline' 0 N--CA 1.512 2.609 0 C-N-CA 122.371 2.048 . . . . 0.0 112.609 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.643 ' CZ ' ' HE3' ' A' ' 3' ' ' LYS . 47.0 p90 -167.13 -175.28 2.92 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.26 164.12 12.61 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.85 -144.65 15.53 Favored Glycine 1 N--CA 1.52 4.293 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.545 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG12 ' HD2' ' A' ' 27' ' ' LYS . 3.4 m -121.87 166.56 16.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.062 0.934 . . . . 0.0 112.318 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' CE1' ' A' ' 74' ' ' PHE . 13.8 t -98.33 142.08 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.487 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 69.2 tttt -115.93 -63.88 1.39 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.645 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -135.82 158.5 44.24 Favored 'General case' 0 N--CA 1.524 3.257 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -155.97 115.8 3.63 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.077 -1.639 . . . . 0.0 113.203 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -90.65 52.54 2.21 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.237 -1.539 . . . . 0.0 109.466 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.18 149.09 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -122.67 172.02 8.72 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 124.355 2.026 . . . . 0.0 116.123 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -95.06 111.41 25.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 100.992 -3.707 . . . . 0.0 100.992 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.03 8.71 11.38 Favored Glycine 1 N--CA 1.518 4.15 1 CA-C-N 107.741 -4.3 . . . . 0.0 108.855 -179.218 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' A' ' 64' ' ' LYS . 43.9 t0 -94.82 177.49 5.89 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.611 -1.295 . . . . 0.0 110.264 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' CE ' ' HB3' ' A' ' 16' ' ' GLU . 2.6 mmtp -108.73 144.46 36.5 Favored 'General case' 0 N--CA 1.511 2.595 1 N-CA-C 123.369 4.581 . . . . 0.0 123.369 -179.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 15' ' ' VAL . 2.8 m -142.26 150.22 18.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.153 -2.294 . . . . 0.0 110.757 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -161.74 162.52 29.71 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 16.6 p -41.49 113.75 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.99 -35.88 4.78 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 111.641 -2.527 . . . . 0.0 115.314 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.6 t -38.31 132.92 1.02 Allowed 'General case' 0 N--CA 1.53 3.567 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.59 56.96 0.18 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.509 ' CG1' HG22 ' A' ' 7' ' ' VAL . 3.1 mt -23.12 -63.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' CG2' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -159.23 171.94 18.95 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 112.529 -2.123 . . . . 0.0 114.123 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.77 120.51 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 123.635 1.683 . . . . 0.0 110.842 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' HG21 ' A' ' 5' ' ' VAL . 6.8 m-30 -99.05 176.01 5.71 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 112.083 -2.326 . . . . 0.0 109.136 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS 0.264 26.5 tt0 -156.39 115.87 3.52 Favored 'General case' 0 C--N 1.285 -2.23 1 N-CA-C 98.965 -4.457 . . . . 0.0 98.965 178.712 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 21.8 m -60.3 73.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 5.7 mt-10 83.22 -155.3 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 125.686 1.866 . . . . 0.0 109.79 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.09 58.34 0.06 OUTLIER Glycine 0 N--CA 1.512 3.734 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 4.31 50.91 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.072 1 N-CA-C 122.997 4.443 . . . . 0.0 122.997 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 120.014 3.338 . . . . 0.0 120.014 179.338 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mmm . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 115.588 -2.148 . . . . 0.0 107.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m -48.91 161.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.692 0 CA-C-N 120.06 1.3 . . . . 0.0 108.177 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.498 ' HE3' ' OE2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -112.19 127.12 55.86 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.656 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -66.84 142.86 57.19 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.717 1.246 . . . . 0.0 110.732 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 74' ' ' PHE . 26.2 t -116.49 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.9 p-10 -101.61 168.78 9.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.748 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.87 140.06 21.7 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.721 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -74.07 -171.31 0.86 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.327 2.684 . . . . 0.0 114.803 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.73 101.81 3.79 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 125.798 2.713 . . . . 0.0 113.355 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.568 HG21 ' CG2' ' A' ' 46' ' ' VAL . 2.1 pt -119.91 36.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.97 -145.55 17.03 Favored Glycine 1 N--CA 1.524 4.526 0 CA-C-N 114.255 -1.339 . . . . 0.0 116.217 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.19 -41.7 0.74 Allowed Glycine 1 N--CA 1.519 4.215 0 CA-C-N 114.574 -0.813 . . . . 0.0 111.253 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.49 ' OD2' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -72.25 173.61 8.39 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' OE2' ' NZ ' ' A' ' 64' ' ' LYS . 5.6 pt-20 -104.11 155.46 18.67 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 101.616 -3.476 . . . . 0.0 101.616 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 29.5 m -124.0 169.88 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.4 pm0 -113.13 164.96 12.85 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.488 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 t -101.48 117.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.221 -0.924 . . . . 0.0 110.118 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.61 -50.57 4.44 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.285 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.3 mt-10 -128.69 95.28 4.07 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 123.555 1.645 . . . . 0.0 111.305 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.5 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.8 p -70.23 66.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.5 mtt -30.24 -57.35 0.19 Allowed 'General case' 0 N--CA 1.512 2.631 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 18.8 m -87.16 171.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -134.33 169.37 17.31 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.63 110.26 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.704 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.08 10.91 21.62 Favored Glycine 0 N--CA 1.508 3.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.694 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -107.38 159.34 16.46 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 123.731 1.729 . . . . 0.0 110.045 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -78.58 122.74 26.29 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 125.151 2.405 . . . . 0.0 113.49 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 74' ' ' PHE . 92.7 t -125.25 97.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 110.455 -3.066 . . . . 0.0 114.56 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -107.44 160.01 15.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 173.83 0.24 Allowed 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.454 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 62.79 -18.67 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 1.6 pp0? -94.97 139.51 31.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.132 -1.605 . . . . 0.0 107.789 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 5.5 t -63.48 128.48 36.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -92.77 -64.52 1.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.8 pt -138.61 140.04 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 113.424 -1.717 . . . . 0.0 112.306 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 3.4 m -93.35 130.13 39.23 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.985 -3.339 . . . . 0.0 101.985 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.49 164.8 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 124.197 0.936 . . . . 0.0 112.473 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 11.6 tt0 -131.49 -142.96 0.23 Allowed 'General case' 0 N--CA 1.505 2.293 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.253 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 41' ' ' LYS . . . 158.2 67.12 0.01 OUTLIER Glycine 0 N--CA 1.512 3.724 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 t0 28.61 58.06 0.12 Allowed 'General case' 0 CA--C 1.586 2.336 0 O-C-N 128.258 2.975 . . . . 0.0 117.45 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 159.02 -6.39 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -179.27 140.73 0.16 Allowed 'General case' 0 N--CA 1.515 2.807 0 CA-C-N 120.431 1.469 . . . . 0.0 113.95 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.7 p -86.2 138.3 31.98 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.992 0.901 . . . . 0.0 112.953 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.39 124.72 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.842 -1.526 . . . . 0.0 107.413 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 22.7 mp0 -95.65 142.55 27.83 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 123.825 1.774 . . . . 0.0 113.557 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.568 ' CG2' HG21 ' A' ' 10' ' ' ILE . 7.1 t -113.48 118.47 43.45 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.582 -1.644 . . . . 0.0 115.092 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -82.14 178.11 6.65 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.875 1.717 . . . . 0.0 112.356 174.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -67.51 103.1 0.44 Allowed Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 118.793 2.886 . . . . 0.0 118.793 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.8 Cg_endo -42.93 -29.59 1.56 Allowed 'Trans proline' 0 N--CA 1.508 2.349 0 C-N-CA 122.416 2.077 . . . . 0.0 114.105 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -159.2 -179.44 7.99 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.24 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 156.53 17.08 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 120.097 3.369 . . . . 0.0 120.097 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.37 -147.82 18.56 Favored Glycine 1 N--CA 1.519 4.221 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.98 160.89 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.93 83.74 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.146 -0.971 . . . . 0.0 110.082 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -67.47 -42.48 82.94 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -163.84 130.19 3.16 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 1.9 pt? -126.95 151.27 48.73 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 119.78 -1.825 . . . . 0.0 108.362 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -121.05 45.08 2.35 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-O 121.626 0.727 . . . . 0.0 109.899 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 p -141.11 154.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.953 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -124.26 171.78 9.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -87.0 114.76 26.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 100.9 -3.741 . . . . 0.0 100.9 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.35 -0.77 16.41 Favored Glycine 0 N--CA 1.503 3.147 0 CA-C-N 110.145 -3.207 . . . . 0.0 109.216 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.8 170.48 9.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.334 0.667 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' NZ ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -118.68 145.73 45.26 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 121.13 3.752 . . . . 0.0 121.13 -179.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.471 HG12 ' CD1' ' A' ' 71' ' ' ILE . 17.1 m -130.62 164.79 32.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.218 -1.81 . . . . 0.0 113.557 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 140.82 18.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 t -43.72 120.42 2.0 Allowed 'General case' 0 N--CA 1.514 2.773 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.242 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.13 -23.72 10.46 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 117.285 1.674 . . . . 0.0 117.285 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.4 t -79.25 143.26 35.46 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 118.664 -1.214 . . . . 0.0 112.602 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 70' ' ' LEU . 9.3 mp -87.99 62.49 6.87 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 124.369 2.033 . . . . 0.0 113.338 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CD1' HG12 ' A' ' 65' ' ' VAL . 12.9 mm -44.65 -45.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -133.85 -177.47 4.58 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.743 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -138.63 117.29 13.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 5' ' ' VAL . 22.6 m-30 -109.75 159.51 17.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.273 3.1 tt0 -126.02 150.9 47.76 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.23 71.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -58.19 82.25 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.7 -59.81 0.08 OUTLIER Glycine 0 N--CA 1.512 3.751 0 N-CA-C 106.053 -2.819 . . . . 0.0 106.053 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 114.16 153.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 1 CA-C-N 108.185 -4.007 . . . . 0.0 106.83 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.519 0 CA-C-O 116.52 -1.705 . . . . 0.0 108.858 -179.803 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.506 2.371 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 m 10.67 103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.682 0 N-CA-C 121.218 3.784 . . . . 0.0 121.218 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.606 ' HZ2' ' CD ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -99.13 158.77 15.44 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 113.011 -1.904 . . . . 0.0 114.131 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.606 ' CD ' ' HZ2' ' A' ' 3' ' ' LYS . 4.5 mp0 -100.27 149.79 23.23 Favored 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 74' ' ' PHE . 85.2 t -130.89 91.54 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.092 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 15.3 p-10 -104.93 174.28 5.94 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.576 HG13 HD12 ' A' ' 10' ' ' ILE . 56.4 t -90.81 126.23 56.45 Favored Pre-proline 0 N--CA 1.504 2.255 0 C-N-CA 117.128 -1.829 . . . . 0.0 106.527 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 20.3 Cg_endo -86.61 -63.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.5 0 N-CA-C 120.606 3.272 . . . . 0.0 120.606 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -96.59 -42.88 7.83 Favored 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 126.207 1.803 . . . . 0.0 112.805 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.576 HD12 HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -53.49 64.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.537 3.915 0 C-N-CA 129.718 3.207 . . . . 0.0 108.182 179.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' ASP . . . -108.62 -168.05 20.97 Favored Glycine 0 N--CA 1.504 3.184 0 CA-C-N 113.31 -1.768 . . . . 0.0 114.806 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.62 -157.52 15.2 Favored Glycine 0 N--CA 1.514 3.846 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.882 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.93 58.42 2.38 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 123.535 1.635 . . . . 0.0 112.518 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 41.4 149.17 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 N-CA-C 119.11 3.004 . . . . 0.0 119.11 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.87 165.46 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 O-C-N 119.773 -1.83 . . . . 0.0 115.379 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.1 pt-20 -120.36 171.08 8.78 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -101.52 120.93 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.181 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 p -97.8 -52.84 3.6 Favored 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.837 -1.529 . . . . 0.0 111.279 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -123.27 104.98 9.47 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 122.978 1.37 . . . . 0.0 113.882 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.63 93.29 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.175 -1.578 . . . . 0.0 109.547 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -38.23 90.12 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 26' ' ' ASP . 3.4 t -126.49 160.23 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -134.51 -175.63 3.94 Favored 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.37 91.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 113.83 -1.532 . . . . 0.0 112.114 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.36 -4.23 13.61 Favored Glycine 1 N--CA 1.52 4.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.326 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.548 ' HB2' HG12 ' A' ' 22' ' ' VAL . 23.8 m-20 -93.07 143.32 26.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.242 1.02 . . . . 0.0 111.697 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 80' ' ' ALA . 45.8 pttt -76.4 122.9 25.15 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 124.71 2.195 . . . . 0.0 115.935 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 59.1 t -110.81 125.26 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 109.609 -3.451 . . . . 0.0 113.593 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -132.23 150.7 52.1 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 111.925 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -44.05 157.58 0.05 Allowed 'General case' 0 N--CA 1.516 2.86 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.49 -20.05 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.529 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 30.0 tt0 -74.42 148.11 41.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -84.89 124.14 31.28 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.483 1.135 . . . . 0.0 108.592 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.9 mt -85.35 -57.57 3.02 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 122.652 1.215 . . . . 0.0 110.191 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -143.98 151.61 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.2 m -102.4 138.94 38.67 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.3 m -129.96 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 3.4 tt0 -134.72 -161.91 1.2 Allowed 'General case' 0 N--CA 1.512 2.669 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' A' ' 38' ' ' GLU . . . 172.95 -67.11 0.11 Allowed Glycine 1 N--CA 1.524 4.542 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -123.88 171.6 9.55 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -24.31 -6.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.442 1 N-CA-C 124.576 5.028 . . . . 0.0 124.576 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.18 116.44 17.68 Favored 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 120.171 1.35 . . . . 0.0 111.071 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.2 p -74.99 163.37 27.69 Favored 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.17 148.26 33.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.039 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 14.0 mp0 -114.64 151.57 33.33 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 123.511 1.624 . . . . 0.0 114.457 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG22 HG21 ' A' ' 10' ' ' ILE . 31.0 t -112.7 105.88 55.72 Favored Pre-proline 0 N--CA 1.506 2.375 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -86.33 179.81 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.87 1.529 . . . . 0.0 112.276 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -71.31 107.36 2.62 Favored Pre-proline 0 C--N 1.285 -2.209 0 N-CA-C 119.966 3.321 . . . . 0.0 119.966 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 42.2 Cg_endo -49.52 -26.4 12.36 Favored 'Trans proline' 0 N--CA 1.514 2.697 0 C-N-CA 122.22 1.947 . . . . 0.0 113.757 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -164.97 -175.7 3.85 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 112.55 -2.114 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 163.97 12.4 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 129.2 -144.83 15.78 Favored Glycine 1 N--CA 1.528 4.778 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.879 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.03 169.76 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 CA-C-N 118.879 1.339 . . . . 0.0 111.389 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 27.0 t -88.2 133.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.4 -53.8 3.63 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.032 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.29 159.42 19.9 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 124.672 1.233 . . . . 0.0 110.726 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -155.31 130.3 9.41 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -100.76 29.97 4.25 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.935 -1.103 . . . . 0.0 109.768 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.467 ' C ' HD22 ' A' ' 60' ' ' ASN . 29.4 m -119.4 157.33 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 112.71 -2.041 . . . . 0.0 114.005 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.467 HD22 ' C ' ' A' ' 59' ' ' VAL . 1.6 m-80 -131.94 -178.42 4.88 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.5 t -90.19 106.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 1 N-CA-C 99.059 -4.423 . . . . 0.0 99.059 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.22 28.59 2.15 Favored Glycine 0 N--CA 1.515 3.919 0 CA-C-N 108.991 -3.731 . . . . 0.0 110.591 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 67.3 t0 -119.71 164.9 15.23 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -106.08 141.31 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 119.857 3.28 . . . . 0.0 119.857 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -139.19 -179.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.92 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 65' ' ' VAL . 7.2 pttt 149.94 154.59 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.923 0 C-N-CA 125.715 1.606 . . . . 0.0 111.656 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.1 p -25.09 103.59 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 118.515 2.784 . . . . 0.0 118.515 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.14 -47.8 1.0 Allowed Glycine 0 N--CA 1.507 3.415 0 CA-C-N 111.711 -2.495 . . . . 0.0 112.491 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.1 t -50.12 123.9 9.19 Favored 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.953 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 25.7 mt -72.56 67.39 0.76 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 7' ' ' VAL . 2.0 mt -22.75 -58.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 8.8 ptp -169.66 -173.67 1.69 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 112.414 -2.176 . . . . 0.0 115.488 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.52 133.51 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 122.501 1.143 . . . . 0.0 110.731 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 5' ' ' VAL . 12.1 m-30 -112.64 176.2 5.12 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.271 7.3 tp10 -144.37 99.54 3.39 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 29.8 m -54.39 33.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.693 1 N-CA-C 126.853 5.872 . . . . 0.0 126.853 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -134.88 -176.01 4.09 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 118.068 0.394 . . . . 0.0 111.956 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.549 ' H ' ' CD ' ' A' ' 77' ' ' GLU . . . 134.69 -32.32 2.63 Favored Glycine 1 N--CA 1.52 4.251 0 O-C-N 120.145 -1.597 . . . . 0.0 110.191 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 78' ' ' GLY . . . 97.43 -90.41 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.152 0 CA-C-N 109.667 -3.267 . . . . 0.0 118.08 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.564 1.501 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 9.8 ttm . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.503 -0.761 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 t 85.48 119.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 126.713 2.508 . . . . 0.0 114.091 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -118.74 122.62 42.89 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.778 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -68.4 155.65 39.4 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.977 0.894 . . . . 0.0 110.267 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 74' ' ' PHE . 36.9 t -122.87 100.18 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.45 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 10.9 p-10 -98.24 96.56 8.16 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.421 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' THR . 89.6 t -20.75 122.71 0.1 Allowed Pre-proline 0 N--CA 1.511 2.58 0 CA-C-N 113.093 -1.867 . . . . 0.0 114.858 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.36 -172.1 0.22 Allowed 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 122.262 1.975 . . . . 0.0 116.346 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -65.66 45.08 0.02 OUTLIER 'General case' 0 CA--C 1.585 2.294 0 C-N-CA 127.017 2.127 . . . . 0.0 115.837 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.501 HG21 HG22 ' A' ' 46' ' ' VAL . 30.8 pt -80.25 48.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 O-C-N 120.049 -1.657 . . . . 0.0 114.161 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.57 -162.84 12.83 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.739 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.54 -45.29 0.67 Allowed Glycine 1 N--CA 1.521 4.341 0 CA-C-O 122.042 0.801 . . . . 0.0 112.365 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.03 -176.96 4.78 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 112.686 -1.757 . . . . 0.0 110.545 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -96.2 139.78 31.86 Favored 'General case' 0 N--CA 1.509 2.511 0 CA-C-O 122.436 1.112 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.16 159.7 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.672 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.9 pt-20 -107.32 166.52 10.58 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 t -94.86 116.29 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.226 1.012 . . . . 0.0 112.456 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -94.65 -32.23 13.48 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 113.78 -1.555 . . . . 0.0 111.726 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 0.4 OUTLIER -138.54 107.64 6.05 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.828 0.705 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.3 p -86.74 57.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 118.43 -2.669 . . . . 0.0 117.088 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.3 mmt -20.3 -51.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.55 HG21 HE22 ' A' ' 32' ' ' GLN . 2.9 t -111.97 151.54 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 23' ' ' LYS . 23.4 mtmt -134.07 -177.62 4.66 Favored 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.24 94.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.246 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.9 -7.1 17.36 Favored Glycine 1 N--CA 1.516 4.021 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -92.48 142.54 27.3 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.251 1.024 . . . . 0.0 110.477 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -69.82 127.25 32.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 125.653 2.644 . . . . 0.0 117.193 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 1.5 t -112.66 98.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 109.86 -3.336 . . . . 0.0 113.906 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.473 ' H ' ' HG2' ' A' ' 32' ' ' GLN . . . -112.85 146.96 37.97 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.75 -1.219 . . . . 0.0 112.42 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.02 124.16 20.04 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 118.89 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 128.358 3.536 . . . . 0.0 110.62 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.55 HE22 HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -92.09 147.38 22.99 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.417 -1.427 . . . . 0.0 108.997 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 2.2 t -80.48 80.94 6.85 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.0 mt -29.99 -57.25 0.18 Allowed 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.8 pt -149.41 156.76 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 112.591 -2.095 . . . . 0.0 110.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 87.2 m -106.15 131.75 53.03 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.96 154.88 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.537 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 27.7 tt0 -130.18 169.58 15.18 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 123.721 1.725 . . . . 0.0 113.372 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.537 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . -171.79 174.78 45.26 Favored Glycine 0 N--CA 1.512 3.744 0 N-CA-C 105.011 -3.236 . . . . 0.0 105.011 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -3.94 59.78 0.0 OUTLIER 'General case' 0 CA--C 1.588 2.426 0 N-CA-C 121.176 3.769 . . . . 0.0 121.176 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' GLY . 33.3 mmtp 59.61 27.25 16.42 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.624 1.202 . . . . 0.0 113.145 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.45 76.78 1.65 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -66.34 107.47 2.02 Favored 'General case' 0 N--CA 1.513 2.682 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.961 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.3 mtm -106.34 165.81 10.98 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -102.12 145.28 29.58 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.54 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG22 HG21 ' A' ' 10' ' ' ILE . 90.5 t -117.81 97.2 50.55 Favored Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.861 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 7.1 Cg_endo -73.95 175.02 11.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-O 125.154 2.064 . . . . 0.0 111.584 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.633 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -77.04 109.06 7.9 Favored Pre-proline 0 C--N 1.284 -2.276 0 CA-C-N 111.527 -2.578 . . . . 0.0 117.262 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 27.6 Cg_endo -47.08 -32.03 12.67 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.794 2.329 . . . . 0.0 111.707 -170.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -155.73 -178.35 7.23 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 111.932 -2.395 . . . . 0.0 107.318 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -97.97 159.68 14.78 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 119.152 3.019 . . . . 0.0 119.152 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.51 -147.68 19.39 Favored Glycine 1 N--CA 1.531 4.971 0 C-N-CA 123.828 0.728 . . . . 0.0 112.663 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 162.16 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 CA-C-N 119.029 1.415 . . . . 0.0 109.521 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 24.9 t -82.25 102.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.844 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HZ1' ' C ' ' A' ' 80' ' ' ALA . 11.8 tptm -76.79 -47.8 20.51 Favored 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.482 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 5.4 tt0 -161.33 152.58 18.71 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.7 pt? -149.69 150.67 32.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.592 -1.942 . . . . 0.0 108.489 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 6.0 mttp -115.34 47.28 1.33 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 121.785 0.802 . . . . 0.0 111.246 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -139.49 140.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 113.688 -1.597 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -125.45 -170.44 2.18 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 123.132 1.444 . . . . 0.0 110.49 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.43 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 102.226 -3.25 . . . . 0.0 102.226 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.78 9.05 4.98 Favored Glycine 1 N--CA 1.517 4.097 0 CA-C-N 109.098 -3.683 . . . . 0.0 113.577 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -101.57 157.3 16.92 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -111.45 146.49 37.12 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HB ' HG21 ' A' ' 7' ' ' VAL . 6.3 m -136.49 168.15 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 113.01 -1.905 . . . . 0.0 113.908 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.31 147.34 22.16 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 7.2 t -47.37 122.6 4.79 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.936 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.06 16.94 24.16 Favored Glycine 0 N--CA 1.514 3.835 0 O-C-N 121.353 -0.842 . . . . 0.0 114.96 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -107.02 97.03 6.86 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.796 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.22 87.64 7.19 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 123.592 1.663 . . . . 0.0 112.575 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' C ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -112.4 -26.54 3.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.952 -1.931 . . . . 0.0 116.046 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 5' ' ' VAL . 11.3 ttp -100.56 153.99 18.93 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.605 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.2 126.82 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 124.957 2.313 . . . . 0.0 115.834 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD1' HG21 ' A' ' 5' ' ' VAL . 17.8 m-30 -114.5 158.52 21.5 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.475 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' OE2' ' N ' ' A' ' 1' ' ' MET . 3.4 tp10 -140.4 135.75 32.4 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -91.15 56.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 122.074 0.94 . . . . 0.0 113.199 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 66.26 -173.27 0.19 Allowed 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 113.486 -1.688 . . . . 0.0 110.324 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.59 -64.49 0.59 Allowed Glycine 0 N--CA 1.505 3.3 1 N-CA-C 102.25 -4.34 . . . . 0.0 102.25 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -156.73 -102.02 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' C ' ' HZ1' ' A' ' 55' ' ' LYS . . . . . . . . 0 CA--C 1.567 1.623 0 C-N-CA 125.139 1.376 . . . . 0.0 110.622 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mmt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 80.4 t -11.73 123.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.928 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -129.91 162.14 29.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.973 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 2.4 pm0 -105.12 153.34 21.64 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 74' ' ' PHE . 46.6 t -133.18 97.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.951 1.358 . . . . 0.0 113.716 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.7 p-10 -103.51 177.46 4.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 65' ' ' VAL . 79.0 t -104.29 142.02 23.73 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 7' ' ' VAL . 10.9 Cg_endo -79.04 -174.36 2.26 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.114 2.543 . . . . 0.0 113.633 176.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -69.2 53.77 0.1 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 112.574 -2.103 . . . . 0.0 114.228 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG21 ' CG2' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -70.87 21.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.104 0 O-C-N 119.776 -1.827 . . . . 0.0 115.805 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 86.61 169.57 46.04 Favored Glycine 0 N--CA 1.506 3.327 0 CA-C-N 112.785 -2.007 . . . . 0.0 113.86 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 38.29 -163.86 0.01 OUTLIER Glycine 1 N--CA 1.525 4.578 0 N-CA-C 120.968 3.147 . . . . 0.0 120.968 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.89 -74.02 0.28 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 112.096 -2.052 . . . . 0.0 112.302 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.68 163.8 28.95 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 123.241 1.496 . . . . 0.0 114.75 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m -152.22 154.57 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.868 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 89.9 mt-10 -87.21 -179.43 6.43 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 61' ' ' VAL . 97.7 t -109.69 115.73 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -46.15 9.53 Favored 'General case' 0 N--CA 1.522 3.161 0 CA-C-N 120.343 1.428 . . . . 0.0 110.24 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.68 100.72 4.71 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.058 1.409 . . . . 0.0 113.516 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 61' ' ' VAL . 13.8 p -82.14 58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 122.234 1.016 . . . . 0.0 111.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.1 mmt -22.08 -52.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.343 2.72 . . . . 0.0 118.343 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.09 171.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 120.663 3.579 . . . . 0.0 120.663 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 51.5 mmtt -134.28 -162.17 1.22 Allowed 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 120.541 3.534 . . . . 0.0 120.541 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.12 92.96 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.984 0 O-C-N 119.938 -1.726 . . . . 0.0 113.898 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.39 12.37 13.56 Favored Glycine 1 N--CA 1.517 4.038 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.93 178.08 7.74 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.016 -1.592 . . . . 0.0 115.162 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -95.72 142.77 27.62 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 74' ' ' PHE . 1.8 t -145.93 113.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.622 -1.626 . . . . 0.0 113.706 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -132.24 151.92 51.59 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.98 79.12 0.22 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 124.035 1.874 . . . . 0.0 114.945 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CD ' ' N ' ' A' ' 32' ' ' GLN . 2.9 pp20? 166.77 -35.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 109.443 -3.526 . . . . 0.0 108.962 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.527 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 4.4 tt0 -58.99 80.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.254 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -31.66 70.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -24.27 -67.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.6 pt -151.43 141.87 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 CA-C-N 111.104 -2.771 . . . . 0.0 113.292 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.5 m -99.09 139.94 33.99 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.79 146.08 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.6 -162.36 1.18 Allowed 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 118.678 2.844 . . . . 0.0 118.678 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.75 -89.95 0.12 Allowed Glycine 1 N--CA 1.524 4.528 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.974 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 42' ' ' ALA . 2.1 m-20 -93.45 -172.9 3.05 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.954 0.883 . . . . 0.0 111.745 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -43.14 7.16 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 121.692 3.96 . . . . 0.0 121.692 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -151.93 107.27 3.3 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 120.277 1.399 . . . . 0.0 114.145 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -65.85 152.59 44.07 Favored 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.8 mmt -125.76 150.6 47.61 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 122.363 0.265 . . . . 0.0 111.663 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -125.15 152.06 44.96 Favored 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.48 ' CG2' HG21 ' A' ' 10' ' ' ILE . 24.9 t -134.7 124.21 16.69 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.267 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -88.43 176.95 3.41 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.966 1.777 . . . . 0.0 111.592 171.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -53.31 117.35 11.52 Favored Pre-proline 0 CA--C 1.584 2.285 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 36.4 Cg_endo -48.85 -21.43 3.71 Favored 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 122.391 2.061 . . . . 0.0 114.235 174.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 11.4 p90 -169.92 -174.23 1.76 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 112.586 -2.097 . . . . 0.0 109.871 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -101.6 163.82 12.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.18 -152.13 19.89 Favored Glycine 0 N--CA 1.512 3.754 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.042 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.86 164.13 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.442 HG22 ' CE1' ' A' ' 74' ' ' PHE . 44.9 t -94.56 145.79 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.836 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 19.0 tttp -112.83 -73.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.58 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 47.7 tt0 -142.42 128.73 19.95 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.8 pt? -122.31 124.81 44.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.58 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.7 mptt -104.86 43.33 1.11 Allowed 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.21 157.41 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-N 114.095 -1.411 . . . . 0.0 114.453 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -144.45 171.44 14.35 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.521 ' CG2' HG12 ' A' ' 20' ' ' VAL . 33.5 t -88.74 103.63 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 101.782 -3.414 . . . . 0.0 101.782 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.98 12.91 2.81 Favored Glycine 1 N--CA 1.519 4.18 0 CA-C-N 108.657 -3.883 . . . . 0.0 111.958 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 26.1 t70 -120.39 163.49 17.8 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 111.682 -2.259 . . . . 0.0 107.283 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HD2' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.22 152.67 22.57 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -136.39 170.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 110.632 -2.985 . . . . 0.0 110.029 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 67' ' ' THR . 15.4 ptmt -171.63 160.55 5.82 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.49 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 9.2 t -56.53 127.46 31.33 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 114.724 -2.79 . . . . 0.0 110.897 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.33 -41.22 2.27 Favored Glycine 0 N--CA 1.509 3.519 0 N-CA-C 117.439 1.736 . . . . 0.0 117.439 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 58.8 m -60.02 127.73 33.34 Favored 'General case' 0 N--CA 1.524 3.228 0 CA-C-N 119.627 1.713 . . . . 0.0 114.225 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 70' ' ' LEU . 8.4 mp -79.13 65.13 4.22 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-O 122.645 1.212 . . . . 0.0 111.649 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.513 HG22 ' SD ' ' A' ' 72' ' ' MET . 40.0 mm -33.49 -54.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.513 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -148.6 175.91 10.78 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.52 134.05 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.685 0.755 . . . . 0.0 110.665 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.592 ' CD2' HG11 ' A' ' 28' ' ' VAL . 14.6 m-30 -113.48 165.97 11.96 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.894 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 16.9 tp10 -130.81 80.91 1.97 Allowed 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 123.964 1.84 . . . . 0.0 109.426 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.4 m -34.82 61.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 118.029 2.604 . . . . 0.0 118.029 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -125.26 173.1 9.03 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 120.099 3.37 . . . . 0.0 120.099 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.81 -28.24 3.57 Favored Glycine 1 N--CA 1.517 4.085 0 N-CA-C 104.483 -3.447 . . . . 0.0 104.483 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 80.76 160.82 0.16 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 109.417 -3.391 . . . . 0.0 117.137 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.522 0 C-N-CA 128.998 2.919 . . . . 0.0 104.621 179.763 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' OE1' ' A' ' 75' ' ' GLU . 9.5 mtt . . . . . 0 N--CA 1.505 2.291 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.5 t -53.67 118.72 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' A' ' 4' ' ' GLU . 2.3 mmtt -114.65 161.88 17.52 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.988 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 1.2 pm0 -107.31 156.21 19.13 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 123.362 1.553 . . . . 0.0 114.257 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 74.6 t -137.5 111.64 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 124.655 2.169 . . . . 0.0 113.275 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' SER . 12.4 p-10 -97.53 166.16 11.64 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 111.981 -2.372 . . . . 0.0 106.28 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.4 HG12 HD12 ' A' ' 10' ' ' ILE . 83.6 t -90.16 135.95 29.32 Favored Pre-proline 0 C--N 1.29 -1.99 0 C-N-CA 117.607 -1.637 . . . . 0.0 109.413 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.47 -169.2 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.903 1.736 . . . . 0.0 110.961 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -70.28 56.07 0.15 Allowed 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 123.845 1.783 . . . . 0.0 113.458 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.4 HD12 HG12 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -77.98 42.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 O-C-N 119.672 -1.893 . . . . 0.0 113.511 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.18 -138.4 14.93 Favored Glycine 1 N--CA 1.52 4.296 0 CA-C-N 115.184 -0.916 . . . . 0.0 114.739 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.58 79.98 0.28 Allowed Glycine 1 N--CA 1.517 4.068 0 N-CA-C 105.973 -2.851 . . . . 0.0 105.973 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' HB3' ' HG3' ' A' ' 66' ' ' LYS . 76.6 m-20 44.87 -129.12 1.03 Allowed 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 121.332 3.827 . . . . 0.0 121.332 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 64' ' ' LYS . 1.1 mm-40 -2.08 78.49 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 1 N-CA-C 122.686 4.328 . . . . 0.0 122.686 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.564 HG23 HG23 ' A' ' 65' ' ' VAL . 2.5 m -126.72 158.8 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-N 113.521 -1.672 . . . . 0.0 110.628 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -120.98 172.1 8.17 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.306 -0.871 . . . . 0.0 109.212 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 60' ' ' ASN . 2.8 t -107.12 140.75 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.067 0 CA-C-O 123.195 1.474 . . . . 0.0 112.529 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 76.1 p -116.96 -45.94 2.75 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.411 ' H ' ' HB ' ' A' ' 36' ' ' THR . 28.3 mt-10 -126.97 112.94 15.84 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.8 65.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 124.193 1.949 . . . . 0.0 110.874 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' A' ' 21' ' ' MET . 24.1 mmt -26.92 -44.85 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.379 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.35 162.94 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -128.63 -165.59 1.52 Allowed 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.8 t -70.23 111.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 O-C-N 120.75 -1.219 . . . . 0.0 108.998 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.32 -0.41 35.05 Favored Glycine 1 N--CA 1.52 4.298 0 O-C-N 124.113 0.883 . . . . 0.0 113.0 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.75 145.42 24.42 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.67 114.11 10.44 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 6.6 t -107.82 110.4 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.072 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.673 -1.267 . . . . 0.0 110.954 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -41.77 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.319 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.924 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -18.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 1.2 tm0? -84.71 108.76 17.58 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.7 p -40.13 118.21 0.87 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 120.182 3.401 . . . . 0.0 120.182 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 48' ' ' ALA . 4.8 mt -86.01 -60.98 1.86 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.5 pt -145.82 150.2 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 19' ' ' GLU . 55.2 m -102.05 131.22 48.63 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.4 m -121.66 137.31 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.01 150.71 25.46 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 122.09 0.947 . . . . 0.0 112.262 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 40' ' ' ASP . . . -138.16 176.88 20.45 Favored Glycine 1 N--CA 1.524 4.513 0 CA-C-O 117.028 -1.985 . . . . 0.0 109.793 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' OD1' ' HE3' ' A' ' 41' ' ' LYS . 24.1 t0 -53.81 128.39 29.69 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-N 121.853 2.827 . . . . 0.0 106.888 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.457 ' HE3' ' OD1' ' A' ' 40' ' ' ASP . 22.3 mmtp 41.77 3.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -120.27 140.16 51.64 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-N 119.748 1.158 . . . . 0.0 113.361 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 p -113.98 137.45 51.68 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 123.63 0.772 . . . . 0.0 110.112 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.1 mtt -145.12 152.66 40.41 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -112.14 138.7 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.969 1.842 . . . . 0.0 113.865 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.5 t -112.28 112.57 52.0 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.297 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.24 177.06 4.69 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 122.08 1.854 . . . . 0.0 110.167 172.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.645 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -62.85 98.25 0.14 Allowed Pre-proline 0 C--N 1.286 -2.162 1 N-CA-C 123.17 4.507 . . . . 0.0 123.17 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.7 Cg_exo -34.51 -42.04 0.28 Allowed 'Trans proline' 0 N--CA 1.511 2.531 0 C-N-CA 122.827 2.351 . . . . 0.0 113.388 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -146.36 -173.9 4.31 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 109.916 -3.311 . . . . 0.0 111.389 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -103.8 154.44 19.58 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.5 -174.02 22.22 Favored Glycine 1 N--CA 1.523 4.451 0 CA-C-O 118.676 -1.069 . . . . 0.0 113.734 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.96 162.01 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.642 0 CA-C-N 121.29 2.545 . . . . 0.0 113.307 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.5 t -83.58 121.07 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' CG ' ' HB2' ' A' ' 75' ' ' GLU . 2.5 tmtp? -93.24 -49.82 5.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.682 0.674 . . . . 0.0 111.722 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' OE2' ' CE ' ' A' ' 58' ' ' LYS . 45.9 tt0 -153.69 162.78 40.94 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.211 0.529 . . . . 0.0 112.086 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 57' ' ' LEU . 1.8 pt? -171.44 146.64 2.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.074 -1.016 . . . . 0.0 109.783 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' CE ' ' OE2' ' A' ' 56' ' ' GLU . 83.4 mttt -123.46 52.59 1.4 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 p -121.33 164.47 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.317 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -137.54 163.32 31.47 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -95.11 73.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-O 126.833 3.206 . . . . 0.0 109.519 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.92 39.16 0.12 Allowed Glycine 0 N--CA 1.509 3.508 1 CA-C-N 106.196 -5.002 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -120.31 174.39 6.55 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' NZ ' ' OE2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -114.19 136.74 52.62 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 120.07 3.359 . . . . 0.0 120.07 -179.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.564 HG23 HG23 ' A' ' 15' ' ' VAL . 1.3 m -117.61 165.81 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 112.943 -1.935 . . . . 0.0 112.682 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HG3' ' HB3' ' A' ' 13' ' ' ASP . 48.5 tttm -147.94 139.32 23.61 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 116.66 -1.638 . . . . 0.0 107.095 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -53.98 125.89 20.45 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.637 -2.425 . . . . 0.0 110.279 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.7 -39.54 2.76 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 112.962 -1.926 . . . . 0.0 114.142 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.4 t -52.03 120.73 5.69 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 1.2 mp -75.08 64.22 1.35 Allowed 'General case' 0 N--CA 1.525 3.294 0 CA-C-O 124.161 1.934 . . . . 0.0 111.975 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.496 ' CD1' HG12 ' A' ' 65' ' ' VAL . 18.8 mm -46.37 -44.55 6.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 120.858 3.651 . . . . 0.0 120.858 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 14.6 ptm -141.21 157.71 44.88 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.808 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.36 129.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 122.275 1.036 . . . . 0.0 110.882 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CZ ' HG21 ' A' ' 5' ' ' VAL . 13.1 m-30 -97.61 -171.44 2.19 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 6.0 tp10 -157.04 80.77 0.92 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.7 m -38.42 90.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.238 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 35.7 67.03 0.31 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -115.72 -63.54 0.37 Allowed Glycine 1 N--CA 1.521 4.306 1 N-CA-C 99.777 -5.329 . . . . 0.0 99.777 178.931 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 78' ' ' GLY . . . 99.81 165.7 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.079 1 N-CA-C 123.215 4.524 . . . . 0.0 123.215 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.071 0 C-N-CA 129.887 3.275 . . . . 0.0 107.65 179.85 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 N--CA 1.503 2.187 0 CA-C-O 114.229 -2.796 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.5 m 13.23 121.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 120.274 3.435 . . . . 0.0 120.274 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -126.39 107.17 10.04 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 112.332 -2.213 . . . . 0.0 109.988 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.89 148.13 40.64 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.316 -0.865 . . . . 0.0 111.068 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.638 HG21 ' CD1' ' A' ' 74' ' ' PHE . 20.4 t -110.73 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 CA-C-O 123.014 1.387 . . . . 0.0 113.918 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.4 p-10 -89.83 161.76 15.83 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.503 HG21 ' CG2' ' A' ' 65' ' ' VAL . 89.9 t -97.9 128.91 32.47 Favored Pre-proline 0 C--N 1.292 -1.909 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.792 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' C ' HD12 ' A' ' 10' ' ' ILE . 53.1 Cg_exo -59.88 -169.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.203 1.269 . . . . 0.0 115.131 169.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.39 40.84 0.01 OUTLIER 'General case' 0 CA--C 1.591 2.555 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.555 HG21 HG23 ' A' ' 46' ' ' VAL . 3.9 mp -85.3 61.92 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 119.03 -2.294 . . . . 0.0 115.658 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.83 -164.28 13.31 Favored Glycine 0 N--CA 1.495 2.622 0 CA-C-N 112.495 -2.139 . . . . 0.0 117.769 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.37 -158.0 11.62 Favored Glycine 1 N--CA 1.52 4.273 0 CA-C-N 113.782 -1.209 . . . . 0.0 113.016 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 10.4 -102.16 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 125.496 1.351 . . . . 0.0 113.939 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.75 ' HB3' ' HE3' ' A' ' 66' ' ' LYS . 18.7 pt-20 -157.15 134.95 10.84 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 124.433 2.063 . . . . 0.0 112.339 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.45 175.06 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-N 112.876 -1.966 . . . . 0.0 110.888 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.684 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 11.9 pt-20 -123.36 166.86 14.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.5 t -89.75 128.78 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 55.5 p -102.03 -44.59 5.43 Favored 'General case' 0 N--CA 1.512 2.656 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.786 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -134.84 103.53 5.65 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.0 p -82.4 79.59 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 124.172 1.939 . . . . 0.0 110.46 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 mmt -43.9 -45.42 7.58 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 111.708 -2.496 . . . . 0.0 115.552 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.24 158.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.8 mptt -130.91 -177.79 4.53 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-O 125.106 2.384 . . . . 0.0 117.434 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.77 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 112.708 -2.042 . . . . 0.0 114.341 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 118.49 17.18 5.3 Favored Glycine 1 N--CA 1.52 4.248 0 CA-C-N 114.701 -1.136 . . . . 0.0 114.635 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -96.97 141.48 30.09 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 122.656 1.217 . . . . 0.0 113.799 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.558 ' HD3' HG13 ' A' ' 53' ' ' VAL . 52.6 mmtt -71.35 97.62 1.63 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.122 1.439 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 74' ' ' PHE . 65.1 t -102.18 107.23 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 113.62 -1.627 . . . . 0.0 115.335 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -120.49 163.39 18.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.048 -1.033 . . . . 0.0 110.32 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.96 166.24 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.967 0.792 . . . . 0.0 112.795 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 62.17 -26.27 0.06 Allowed 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -74.5 96.8 2.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.231 -1.543 . . . . 0.0 110.132 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 t -40.7 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -27.13 -67.61 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.0 pt -147.57 143.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 111.902 -2.408 . . . . 0.0 112.526 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.1 m -93.1 140.72 29.2 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.53 158.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 117.53 2.418 . . . . 0.0 117.53 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -135.67 156.76 48.33 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-O 122.599 1.19 . . . . 0.0 110.51 178.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.71 -88.45 0.56 Allowed Glycine 1 N--CA 1.523 4.477 0 C-N-CA 126.907 2.194 . . . . 0.0 109.441 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.555 ' O ' ' HD2' ' A' ' 41' ' ' LYS . 1.3 p-10 -129.34 94.71 3.85 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 125.416 2.532 . . . . 0.0 107.391 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.555 ' HD2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER 51.42 25.41 2.61 Favored 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.794 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.18 83.1 2.13 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.237 2.68 . . . . 0.0 118.237 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 27.3 t -62.27 113.46 2.9 Favored 'General case' 0 N--CA 1.519 2.977 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -116.39 160.18 20.91 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 122.629 0.372 . . . . 0.0 110.537 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -125.31 152.92 44.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.242 -0.912 . . . . 0.0 113.03 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.555 HG23 HG21 ' A' ' 10' ' ' ILE . 39.5 t -122.25 113.66 30.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -85.53 177.0 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.249 1.299 . . . . 0.0 112.499 170.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -62.47 95.53 0.06 OUTLIER Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 11.4 Cg_endo -38.52 -35.29 0.45 Allowed 'Trans proline' 0 N--CA 1.511 2.554 0 C-N-CA 122.512 2.141 . . . . 0.0 114.073 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -154.76 -174.93 5.18 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 112.117 -2.31 . . . . 0.0 108.758 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -104.2 155.1 19.0 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.5 -138.61 7.29 Favored Glycine 0 N--CA 1.511 3.638 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.289 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.558 HG13 ' HD3' ' A' ' 27' ' ' LYS . 1.9 t -140.55 165.14 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 74' ' ' PHE . 14.4 t -90.93 137.26 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 118.83 -1.148 . . . . 0.0 107.934 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 19.7 tptt -108.12 -59.6 1.83 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.705 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 27.3 tt0 -149.66 160.85 43.18 Favored 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.705 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -163.21 156.34 19.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.181 -0.95 . . . . 0.0 108.448 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -125.3 48.75 1.98 Allowed 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.985 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.22 152.35 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.044 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' H ' ' HB2' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -134.23 -175.38 3.84 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 124.745 2.212 . . . . 0.0 116.277 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -86.72 114.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 113.07 4.95 23.82 Favored Glycine 0 N--CA 1.511 3.699 0 CA-C-N 108.721 -3.854 . . . . 0.0 110.028 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.491 ' HB2' ' H ' ' A' ' 60' ' ' ASN . 1.5 t0 -79.78 177.55 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.824 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.684 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 28.2 mmtm -114.15 132.92 55.91 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 118.576 2.806 . . . . 0.0 118.576 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.503 ' CG2' HG21 ' A' ' 7' ' ' VAL . 1.3 p -132.86 169.92 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.75 ' HE3' ' HB3' ' A' ' 14' ' ' GLU . 6.4 ptpp? -173.99 134.99 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.434 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.3 t -33.42 116.34 0.25 Allowed 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 124.741 2.21 . . . . 0.0 113.646 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.87 -35.47 4.68 Favored Glycine 0 N--CA 1.507 3.409 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.941 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 66.6 m -64.86 136.76 57.22 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.61 72.23 10.7 Favored 'General case' 0 N--CA 1.522 3.138 0 CA-C-O 122.209 1.004 . . . . 0.0 109.621 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.615 HD11 ' SD ' ' A' ' 72' ' ' MET . 1.6 pp -58.11 -46.12 88.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.615 ' SD ' HD11 ' A' ' 71' ' ' ILE . 11.4 ptm -132.83 171.89 13.31 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 118.617 -1.233 . . . . 0.0 114.116 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.24 123.58 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.594 -1.316 . . . . 0.0 112.595 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.638 ' CD1' HG21 ' A' ' 5' ' ' VAL . 14.8 m-30 -111.96 167.68 10.19 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 123.292 1.52 . . . . 0.0 113.726 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.589 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 32.7 tt0 -145.89 155.85 43.15 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.36 42.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -11.05 -61.23 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.517 0 CA-C-O 124.433 2.063 . . . . 0.0 115.486 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.59 101.55 0.2 Allowed Glycine 0 N--CA 1.499 2.885 1 N-CA-C 98.147 -5.981 . . . . 0.0 98.147 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.69 31.63 2.27 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 117.189 -1.805 . . . . 0.0 113.179 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.841 0 O-C-N 127.859 3.224 . . . . 0.0 106.152 -179.577 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 2.3 ttp . . . . . 0 N--CA 1.509 2.509 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 3' ' ' LYS . 24.9 t -22.02 120.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -125.59 152.98 44.39 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.122 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -109.92 149.46 29.87 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.642 1.687 . . . . 0.0 114.731 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.541 HG21 ' CE1' ' A' ' 74' ' ' PHE . 70.2 t -122.86 114.29 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.565 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -109.9 -178.41 3.52 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.438 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.634 HG21 ' HB ' ' A' ' 65' ' ' VAL . 59.5 t -102.19 128.63 28.0 Favored Pre-proline 0 N--CA 1.498 1.954 0 C-N-CA 119.016 -1.074 . . . . 0.0 113.486 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -77.87 -164.11 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.99 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.27 64.61 2.7 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.634 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -75.82 56.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.316 0 O-C-N 119.908 -1.745 . . . . 0.0 111.296 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.61 -54.69 1.07 Allowed Glycine 1 N--CA 1.519 4.184 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.21 -34.85 1.8 Allowed Glycine 0 N--CA 1.514 3.884 0 CA-C-N 112.406 -1.897 . . . . 0.0 113.791 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.72 -167.35 0.45 Allowed 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.61 ' HG3' ' HB3' ' A' ' 66' ' ' LYS . 3.4 mt-10 -108.03 129.14 55.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 120.796 -1.19 . . . . 0.0 108.774 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 23.0 m -125.08 168.71 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 29.3 mt-10 -93.29 163.28 13.67 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.033 1.458 . . . . 0.0 112.302 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.06 112.61 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 19' ' ' GLU . 14.2 t -98.71 -37.41 9.5 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 18' ' ' THR . 21.6 mm-40 -129.92 127.65 40.55 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.55 65.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 124.526 2.108 . . . . 0.0 113.359 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.425 ' H ' ' HG2' ' A' ' 21' ' ' MET . 7.4 mmt -24.49 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 110.925 -2.852 . . . . 0.0 117.839 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.9 t -122.67 155.82 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 8.1 tttt -127.51 178.66 5.95 Favored 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 120.797 3.629 . . . . 0.0 120.797 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.21 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 113.716 -1.584 . . . . 0.0 113.576 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.63 1.39 19.79 Favored Glycine 1 N--CA 1.517 4.037 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.891 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.478 ' HB2' HG12 ' A' ' 22' ' ' VAL . 77.7 m-20 -90.32 150.54 21.87 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.651 1.215 . . . . 0.0 113.092 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -75.94 112.6 12.52 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.892 0.853 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -106.61 101.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.437 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -105.89 151.13 24.94 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.306 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.19 157.85 0.42 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.564 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 69.5 -26.24 0.15 Allowed 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 122.658 1.218 . . . . 0.0 112.961 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.468 HE22 ' CG2' ' A' ' 22' ' ' VAL . 4.5 tm0? -80.15 102.13 9.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.223 -1.548 . . . . 0.0 109.471 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 32.2 t -33.25 124.99 0.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.8 mt -93.6 -52.71 4.35 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.779 0.8 . . . . 0.0 110.711 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.46 HG13 ' HB ' ' A' ' 46' ' ' VAL . 32.3 pt -144.26 134.69 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.9 m -92.1 120.68 32.94 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 102.789 -3.041 . . . . 0.0 102.789 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 27.1 m -109.02 147.53 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -127.52 -146.49 0.33 Allowed 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.73 -116.94 1.26 Allowed Glycine 1 N--CA 1.525 4.59 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -88.14 83.36 6.99 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 126.594 3.092 . . . . 0.0 116.393 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 68.36 -20.44 0.14 Allowed 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 111.97 -2.377 . . . . 0.0 115.292 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.21 139.8 32.65 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -116.84 141.25 48.46 Favored 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ttm -143.22 171.04 14.63 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -130.32 153.02 49.1 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HB ' HG13 ' A' ' 35' ' ' ILE . 3.9 t -130.45 105.31 15.97 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.48 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -81.73 178.73 6.28 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 CA-C-O 123.612 1.421 . . . . 0.0 112.276 177.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -66.0 117.08 38.97 Favored Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 119.918 3.303 . . . . 0.0 119.918 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 37.4 Cg_endo -49.63 -22.31 6.5 Favored 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 123.186 2.591 . . . . 0.0 114.968 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -171.52 -174.06 1.33 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 113.232 -1.804 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -102.56 119.1 38.25 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 -165.37 32.62 Favored Glycine 0 N--CA 1.513 3.769 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.44 154.37 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 CA-C-N 118.205 1.003 . . . . 0.0 109.204 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.492 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 24.3 t -78.8 121.18 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -97.37 -56.72 2.45 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.754 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 31.0 tt0 -149.08 150.53 32.9 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.997 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -146.23 163.77 34.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.075 -1.641 . . . . 0.0 108.869 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.465 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 8.4 mmtp -133.89 42.6 2.92 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.24 154.02 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-N 113.969 -1.468 . . . . 0.0 114.071 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -130.78 -175.93 3.83 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-O 125.542 2.592 . . . . 0.0 116.089 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.14 109.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 1 N-CA-C 99.135 -4.394 . . . . 0.0 99.135 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.47 -27.26 3.12 Favored Glycine 0 N--CA 1.508 3.443 0 CA-C-N 111.518 -2.583 . . . . 0.0 107.532 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -72.95 159.18 34.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.341 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' NZ ' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -115.27 143.65 44.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.634 ' HB ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -131.62 161.7 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.61 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 1.2 pttp -156.02 158.27 37.55 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -27.72 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.19 -42.14 1.96 Allowed Glycine 0 N--CA 1.515 3.943 0 CA-C-N 112.944 -1.934 . . . . 0.0 114.923 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.7 m -36.0 118.39 0.51 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 mp -67.72 64.95 0.08 Allowed 'General case' 0 N--CA 1.513 2.699 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.545 HD11 HG22 ' A' ' 7' ' ' VAL . 3.9 mt -23.6 -56.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptp -167.93 -176.85 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 111.361 -2.654 . . . . 0.0 115.586 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.26 122.67 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 123.495 1.617 . . . . 0.0 114.829 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 5' ' ' VAL . 10.7 m-30 -102.76 175.74 5.39 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 113.435 -1.711 . . . . 0.0 109.543 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.414 ' OE2' ' N ' ' A' ' 1' ' ' MET 0.28 22.3 tp10 -144.97 109.71 5.01 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.47 72.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 121.398 3.851 . . . . 0.0 121.398 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -121.6 149.73 42.72 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.4 -47.85 0.04 OUTLIER Glycine 1 N--CA 1.526 4.656 0 CA-C-O 122.01 0.783 . . . . 0.0 112.526 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' H ' ' H ' ' A' ' 80' ' ' ALA . . . 146.48 32.87 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.953 0 CA-C-N 109.2 -3.5 . . . . 0.0 109.495 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.447 ' H ' ' H ' ' A' ' 79' ' ' ALA . . . . . . . . 0 CA--C 1.572 1.826 3 N-CA-C 98.242 -4.725 . . . . 0.0 98.242 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.633 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 m -15.03 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 1 N-CA-C 122.858 4.392 . . . . 0.0 122.858 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -127.61 160.38 31.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.428 -2.623 . . . . 0.0 106.449 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -105.29 169.16 8.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.476 1.131 . . . . 0.0 110.437 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.54 HG21 ' CD1' ' A' ' 74' ' ' PHE . 73.2 t -125.82 102.27 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 114.343 -1.298 . . . . 0.0 113.804 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 13.7 p-10 -99.43 163.52 12.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 71' ' ' ILE . 55.1 t -75.4 138.09 71.3 Favored Pre-proline 0 N--CA 1.502 2.127 0 C-N-CA 116.862 -1.935 . . . . 0.0 110.503 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HG2' HG23 ' A' ' 10' ' ' ILE . 38.5 Cg_endo -71.3 -174.98 1.35 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.098 1.866 . . . . 0.0 112.675 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.73 49.07 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.515 HG21 HG22 ' A' ' 46' ' ' VAL . 37.8 pt -79.78 58.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 O-C-N 119.366 -2.084 . . . . 0.0 111.893 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -20.04 69.77 0.0 OUTLIER Glycine 1 N--CA 1.524 4.539 0 N-CA-C 122.975 3.95 . . . . 0.0 122.975 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.46 -155.95 9.23 Favored Glycine 1 N--CA 1.524 4.552 0 N-CA-C 118.845 2.298 . . . . 0.0 118.845 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -56.89 -120.18 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.626 0 CA-C-N 112.895 -1.653 . . . . 0.0 109.359 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 8.6 tt0 -151.61 122.12 7.38 Favored 'General case' 0 N--CA 1.497 1.889 1 N-CA-C 99.44 -4.282 . . . . 0.0 99.44 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.92 169.37 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.0 pt-20 -113.56 167.46 10.58 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 t -84.42 119.43 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 t -100.77 -36.76 8.98 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.81 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.03 117.5 16.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -95.41 59.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 14.0 mmt -18.98 -45.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.1 t -124.8 155.77 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 22.3 mttt -140.72 -169.34 2.78 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 121.666 3.95 . . . . 0.0 121.666 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -51.49 84.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.924 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.08 -0.25 14.69 Favored Glycine 1 N--CA 1.519 4.198 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HB2' HG12 ' A' ' 22' ' ' VAL . 69.9 m-20 -89.1 139.83 30.06 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 123.883 1.801 . . . . 0.0 113.018 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HZ2' ' CD ' ' A' ' 77' ' ' GLU . 49.8 mmtt -62.77 74.22 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 112.534 -2.121 . . . . 0.0 116.459 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 t -74.0 97.77 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -101.73 156.88 17.23 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.337 -1.477 . . . . 0.0 108.958 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -58.27 168.81 0.97 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.999 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.71 -24.66 0.08 Allowed 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 30' ' ' ALA . 3.7 tm0? -82.42 109.07 16.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 123.231 1.491 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 10.1 m -35.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 120.927 3.677 . . . . 0.0 120.927 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -24.77 -58.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 pt -146.14 150.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 112.503 -2.135 . . . . 0.0 109.92 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.425 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 96.7 m -102.52 124.93 48.96 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 35.4 m -110.8 154.0 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -140.73 -161.95 1.29 Allowed 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' A' ' 38' ' ' GLU . . . 148.87 -84.84 0.17 Allowed Glycine 1 N--CA 1.525 4.588 0 N-CA-C 115.673 1.029 . . . . 0.0 115.673 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 42' ' ' ALA . 1.8 m-20 -115.37 -131.36 0.32 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 123.175 1.464 . . . . 0.0 109.193 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' NZ ' ' OD2' ' A' ' 13' ' ' ASP . 27.5 pttt -8.84 -32.99 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 121.576 3.917 . . . . 0.0 121.576 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . 178.48 178.05 0.42 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.739 0.78 . . . . 0.0 110.935 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.7 t -99.97 150.26 22.6 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.472 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 mtm -132.81 164.33 27.08 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -122.19 148.73 44.58 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.062 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG22 HG21 ' A' ' 10' ' ' ILE . 76.0 t -122.76 116.21 29.18 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.16 172.32 13.97 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 CA-C-O 124.455 1.773 . . . . 0.0 110.347 176.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -76.34 117.05 61.59 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 111.84 -2.436 . . . . 0.0 115.377 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HG2' HG13 ' A' ' 5' ' ' VAL . 73.4 Cg_exo -39.34 -37.45 1.14 Allowed 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.008 2.472 . . . . 0.0 113.632 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.34 -174.16 4.55 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 110.963 -2.835 . . . . 0.0 109.865 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -95.14 152.39 18.39 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.69 -150.14 22.33 Favored Glycine 1 N--CA 1.517 4.085 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.843 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG21 ' CD ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -130.11 157.5 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 O-C-N 121.768 -0.842 . . . . 0.0 112.15 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 30.4 t -83.02 128.91 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 C-N-CA 118.091 -1.444 . . . . 0.0 107.662 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -106.26 -72.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 38.4 tt0 -127.36 123.28 35.86 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 123.368 1.556 . . . . 0.0 111.314 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.573 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.0 pt? -129.07 146.49 51.01 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.548 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 87.8 mttt -127.95 53.16 1.81 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.82 137.58 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 110.204 -3.18 . . . . 0.0 111.051 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.633 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.3 m120 -120.37 -171.33 2.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 124.741 2.21 . . . . 0.0 114.683 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.65 87.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 125.978 2.799 . . . . 0.0 106.422 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.07 24.35 0.23 Allowed Glycine 0 N--CA 1.516 3.97 1 CA-C-N 106.715 -4.766 . . . . 0.0 112.809 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.633 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -106.22 152.15 23.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -102.6 145.27 29.89 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.15 163.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.989 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 13' ' ' ASP . 53.4 tttt -166.0 145.89 6.32 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.037 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -36.74 116.14 0.41 Allowed 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.403 1.573 . . . . 0.0 112.426 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.28 -52.18 0.73 Allowed Glycine 0 N--CA 1.511 3.665 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.951 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 16.4 t -45.74 128.18 8.44 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -73.39 60.24 0.62 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.513 HD11 HG22 ' A' ' 7' ' ' VAL . 2.7 mt -18.94 -60.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 119.031 2.974 . . . . 0.0 119.031 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.407 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -167.42 -172.51 1.97 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 112.321 -2.218 . . . . 0.0 115.238 -179.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.08 130.42 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 124.414 2.054 . . . . 0.0 112.691 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.2 m-30 -117.49 145.88 43.9 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 111.804 -2.453 . . . . 0.0 113.202 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -124.2 162.58 23.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 100.994 -3.706 . . . . 0.0 100.994 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 78' ' ' GLY . 28.1 m -111.52 120.53 62.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 119.733 3.234 . . . . 0.0 119.733 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.55 ' CD ' ' HZ2' ' A' ' 27' ' ' LYS . 58.7 mt-10 -65.35 76.31 0.06 Allowed 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 124.19 1.948 . . . . 0.0 109.685 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . 161.93 78.1 0.03 OUTLIER Glycine 0 N--CA 1.507 3.371 1 N-CA-C 99.505 -5.438 . . . . 0.0 99.505 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.99 62.09 4.8 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 C-N-CA 127.252 2.221 . . . . 0.0 108.88 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.497 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 5.8 ptp . . . . . 0 N--CA 1.506 2.374 0 CA-C-O 117.477 -1.249 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m -76.6 155.0 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -145.62 149.06 33.83 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 111.549 -2.569 . . . . 0.0 111.376 178.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -97.4 104.2 16.2 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.492 1.139 . . . . 0.0 113.773 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 77.1 t -71.22 99.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 CA-C-O 124.8 2.238 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' SER . 5.8 p30 -96.05 177.4 5.75 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.631 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 67' ' ' THR . 78.2 t -98.01 131.82 25.85 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.26 -176.29 1.58 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 120.708 0.939 . . . . 0.0 114.048 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -68.42 46.55 0.05 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 112.605 -2.089 . . . . 0.0 114.382 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.403 HG21 HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.35 45.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 O-C-N 119.59 -1.944 . . . . 0.0 113.33 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.12 -163.93 12.16 Favored Glycine 0 N--CA 1.513 3.815 0 CA-C-N 113.717 -1.583 . . . . 0.0 112.053 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.62 -35.65 1.53 Allowed Glycine 1 N--CA 1.522 4.423 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -41.43 162.55 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.934 0 CA-C-N 109.324 -3.438 . . . . 0.0 113.276 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 2.7 tp10 -117.7 112.29 20.27 Favored 'General case' 0 N--CA 1.52 3.063 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.99 177.29 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.712 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.9 pt-20 -111.3 169.55 8.72 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 t -104.17 114.11 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.326 0 CA-C-O 122.253 1.025 . . . . 0.0 113.411 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -93.67 -44.79 8.0 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 112.84 -1.982 . . . . 0.0 114.859 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.571 ' HG3' HG22 ' A' ' 18' ' ' THR . 36.0 mt-10 -131.16 102.77 6.14 Favored 'General case' 0 N--CA 1.52 3.036 0 CA-C-N 119.866 1.212 . . . . 0.0 111.452 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.28 72.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 O-C-N 119.284 -2.135 . . . . 0.0 113.498 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 57.1 mmm -34.65 -52.28 0.51 Allowed 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.413 ' C ' ' HE2' ' A' ' 23' ' ' LYS . 15.8 m -98.65 150.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 CA-C-N 119.574 1.079 . . . . 0.0 113.55 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -123.33 169.28 11.48 Favored 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -54.59 87.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.292 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.506 ' H ' ' HB ' ' A' ' 54' ' ' VAL . . . 127.32 9.62 4.03 Favored Glycine 1 N--CA 1.517 4.046 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -92.24 140.22 29.83 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.69 1.234 . . . . 0.0 111.91 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.563 ' HZ1' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -75.66 86.2 2.71 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 126.839 2.056 . . . . 0.0 109.162 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.64 149.3 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -140.59 154.6 46.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 50' ' ' PHE . . . -69.11 99.19 1.08 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 139.81 -28.19 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 127.784 3.177 . . . . 0.0 108.185 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -71.3 105.8 3.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 112.708 -2.042 . . . . 0.0 113.665 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 16.6 t -39.03 96.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 112.569 -2.105 . . . . 0.0 115.554 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 21' ' ' MET . 4.2 mt -53.52 -62.8 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.522 ' H ' HG23 ' A' ' 46' ' ' VAL . 25.6 pt -147.91 128.8 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.906 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 19' ' ' GLU . 5.2 m -67.87 129.79 40.99 Favored 'General case' 0 N--CA 1.517 2.917 0 O-C-N 119.965 -1.709 . . . . 0.0 111.066 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 65' ' ' VAL . 31.6 m -119.67 151.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.707 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 43' ' ' SER . 3.4 tt0 -142.51 -152.04 0.39 Allowed 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.57 -69.93 0.31 Allowed Glycine 1 N--CA 1.526 4.65 0 C-N-CA 124.936 1.255 . . . . 0.0 112.759 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -116.09 -165.69 1.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 117.828 0.814 . . . . 0.0 110.795 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -56.36 25.96 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 121.474 3.879 . . . . 0.0 121.474 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.13 76.32 1.5 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 123.456 1.598 . . . . 0.0 114.831 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 92.7 p -59.52 127.86 34.16 Favored 'General case' 0 N--CA 1.51 2.554 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.99 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.0 mtm -139.55 164.71 29.17 Favored 'General case' 0 N--CA 1.516 2.872 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -120.3 168.52 11.18 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 123.148 1.451 . . . . 0.0 114.19 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -115.74 129.42 25.17 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.64 168.74 11.04 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-O 123.384 1.327 . . . . 0.0 109.935 168.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -74.98 117.19 60.83 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 112.859 -1.973 . . . . 0.0 115.065 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 35.9 Cg_endo -48.62 -25.75 8.33 Favored 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.011 1.807 . . . . 0.0 114.016 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -158.08 -173.37 4.31 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.896 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.71 165.86 10.83 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.1 -153.61 21.01 Favored Glycine 1 N--CA 1.522 4.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 113.538 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.07 153.51 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.544 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 41.3 t -77.14 84.32 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -61.83 -44.64 96.43 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.644 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 28.3 tt0 -176.46 159.23 1.91 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 124.005 0.815 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.7 pt? -154.76 159.77 40.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.323 -0.861 . . . . 0.0 109.703 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 29.8 mmtt -126.33 45.82 2.58 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.16 161.93 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.69 171.4 9.62 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 125.367 2.508 . . . . 0.0 116.952 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.86 100.15 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 1 N-CA-C 99.784 -4.154 . . . . 0.0 99.784 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.14 19.97 0.95 Allowed Glycine 0 N--CA 1.51 3.576 1 CA-C-N 107.305 -4.498 . . . . 0.0 111.84 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.18 170.43 8.1 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.482 0.713 . . . . 0.0 109.278 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -103.43 143.65 32.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.778 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG21 HG11 ' A' ' 37' ' ' VAL . 3.5 m -132.52 127.49 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HG2' ' N ' ' A' ' 67' ' ' THR . 26.1 ttmt -139.98 151.54 45.59 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.533 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 7.6 t -42.21 118.5 1.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 117.271 -1.772 . . . . 0.0 111.495 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.23 -51.36 0.78 Allowed Glycine 0 N--CA 1.513 3.793 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m -39.51 119.55 0.96 Allowed 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.62 65.47 1.82 Allowed 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 123.065 1.412 . . . . 0.0 111.346 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 mm -48.78 -57.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 120.729 3.604 . . . . 0.0 120.729 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.406 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 14.9 ptp -135.49 166.89 22.15 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.346 -0.846 . . . . 0.0 112.519 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -110.47 122.51 65.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.811 1.291 . . . . 0.0 112.253 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 7.5 m-30 -117.07 149.27 40.58 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.497 ' OE2' ' N ' ' A' ' 1' ' ' MET . 3.4 tt0 -131.96 127.48 36.43 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.469 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 76' ' ' VAL . 28.8 m -68.82 49.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.483 1 N-CA-C 122.142 4.127 . . . . 0.0 122.142 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 3.82 -68.23 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 121.004 3.705 . . . . 0.0 121.004 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.74 43.07 0.23 Allowed Glycine 0 N--CA 1.516 3.981 0 CA-C-N 110.568 -3.015 . . . . 0.0 105.9 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 30.19 77.9 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 1 N-CA-C 121.844 4.016 . . . . 0.0 121.844 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.563 ' C ' ' HZ1' ' A' ' 27' ' ' LYS . . . . . . . . 0 CA--C 1.574 1.901 0 CA-C-N 111.685 -2.507 . . . . 0.0 113.765 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.653 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.244 -1.836 . . . . 0.0 107.168 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.2 t -21.28 136.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.498 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 3.1 mmmp? -134.17 166.5 22.62 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.129 1.443 . . . . 0.0 110.886 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' NZ ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -107.56 157.32 18.14 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.296 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 74' ' ' PHE . 58.9 t -126.08 106.98 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 CA-C-O 121.883 0.849 . . . . 0.0 111.504 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -101.87 152.85 20.41 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' HB ' ' A' ' 65' ' ' VAL . 99.2 t -71.33 132.29 86.06 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 116.877 -1.929 . . . . 0.0 112.197 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -71.91 -175.17 1.56 Allowed 'Trans proline' 0 CA--C 1.557 1.643 0 C-N-CA 122.616 2.211 . . . . 0.0 115.329 172.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.34 46.52 0.02 OUTLIER 'General case' 0 CA--C 1.583 2.217 0 C-N-CA 127.452 2.301 . . . . 0.0 116.224 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.534 HG21 HG22 ' A' ' 46' ' ' VAL . 36.2 pt -75.23 53.66 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.606 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -23.58 92.41 0.01 OUTLIER Glycine 1 N--CA 1.53 4.905 0 N-CA-C 118.515 2.166 . . . . 0.0 118.515 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.26 37.32 0.02 OUTLIER Glycine 1 N--CA 1.535 5.255 0 CA-C-O 124.826 2.348 . . . . 0.0 111.782 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.282 30.2 m-20 -1.54 68.28 0.0 OUTLIER 'General case' 0 CA--C 1.597 2.772 2 N-CA-C 127.928 6.27 . . . . 0.0 127.928 -179.516 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 109.64 78.54 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.848 0 C-N-CA 128.66 2.784 . . . . 0.0 108.113 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.0 m -106.58 156.12 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-N 113.348 -1.751 . . . . 0.0 115.358 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.31 164.19 12.76 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 35' ' ' ILE . 20.0 t -103.4 116.25 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.099 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 2.1 t -96.8 -41.96 8.2 Favored 'General case' 0 N--CA 1.524 3.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.765 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -131.99 105.21 7.27 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.947 0.879 . . . . 0.0 110.855 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.45 63.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 O-C-N 119.087 -2.258 . . . . 0.0 115.261 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 55.6 mmm -23.17 -42.44 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 119.403 3.112 . . . . 0.0 119.403 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 26' ' ' ASP . 2.7 t -119.74 155.26 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.6 tttm -131.46 175.33 9.24 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 120.551 3.537 . . . . 0.0 120.551 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.47 91.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.28 0.38 12.76 Favored Glycine 1 N--CA 1.516 4.03 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.775 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 22' ' ' VAL . 52.5 m-20 -93.27 143.65 26.07 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.58 1.181 . . . . 0.0 112.706 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HE3' ' CD ' ' A' ' 77' ' ' GLU . 14.0 mmmm -66.33 121.77 16.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.15 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 15.6 t -116.04 115.19 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -122.91 151.42 41.78 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.696 -0.628 . . . . 0.0 111.282 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -48.02 158.26 0.24 Allowed 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 69.51 -28.42 0.16 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 122.541 1.162 . . . . 0.0 112.753 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.429 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 6.4 tt0 -77.35 105.13 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.316 -1.49 . . . . 0.0 111.575 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 19.8 t -37.92 120.05 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 48' ' ' ALA . 2.8 mt -85.78 -51.03 6.69 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.412 ' HB ' HG13 ' A' ' 17' ' ' VAL . 29.1 pt -146.79 137.35 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.958 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -84.32 128.26 34.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.35 160.77 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -138.13 -143.02 0.16 Allowed 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.48 -104.83 0.32 Allowed Glycine 1 N--CA 1.524 4.54 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . 0.314 0.3 OUTLIER -90.45 -89.22 0.16 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 118.474 1.137 . . . . 0.0 113.651 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.19 43.06 1.94 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.55 149.51 1.67 Allowed 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 93.5 p -106.02 126.94 52.8 Favored 'General case' 0 N--CA 1.513 2.708 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.95 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.8 mtt -129.74 174.29 9.85 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -124.81 153.81 41.93 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 122.115 0.96 . . . . 0.0 113.512 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.534 HG22 HG21 ' A' ' 10' ' ' ILE . 53.1 t -121.03 104.42 41.44 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.525 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.5 OUTLIER -80.18 177.63 8.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 CA-C-O 123.779 1.491 . . . . 0.0 111.087 179.085 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -71.89 111.49 10.79 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -46.11 -28.52 5.48 Favored 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 121.884 1.723 . . . . 0.0 113.049 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -163.05 -173.51 3.47 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.112 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -103.89 160.78 14.51 Favored 'General case' 0 CA--C 1.579 2.07 1 N-CA-C 121.879 4.029 . . . . 0.0 121.879 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.95 -124.26 3.06 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 114.577 -1.192 . . . . 0.0 114.096 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -141.48 159.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.206 0 O-C-N 121.996 -0.708 . . . . 0.0 111.305 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG13 ' SD ' ' A' ' 72' ' ' MET . 67.6 t -80.85 112.0 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 28.3 tttm -89.94 -64.55 1.12 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.431 -1.308 . . . . 0.0 110.045 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' HG13 ' A' ' 73' ' ' ILE . 42.4 tt0 -145.07 133.77 22.2 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.3 pt? -130.53 163.13 27.72 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.532 -1.98 . . . . 0.0 109.314 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 14.1 mmtp -133.64 42.02 3.0 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 p -132.26 159.61 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.942 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -126.19 177.65 6.27 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.2 t -94.03 108.81 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 1 N-CA-C 97.752 -4.907 . . . . 0.0 97.752 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.2 6.05 6.45 Favored Glycine 0 N--CA 1.515 3.908 0 CA-C-N 109.898 -3.319 . . . . 0.0 109.784 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.71 156.84 16.17 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.72 144.38 41.11 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HB ' HG21 ' A' ' 7' ' ' VAL . 14.2 m -138.4 172.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -178.0 156.63 1.07 Allowed 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.2 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -26.73 101.4 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 118.644 2.831 . . . . 0.0 118.644 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.79 -53.02 0.69 Allowed Glycine 0 N--CA 1.511 3.697 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.073 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.1 m -21.85 117.2 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.36 59.49 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.496 HG22 ' HG2' ' A' ' 72' ' ' MET . 4.3 mm -34.5 -58.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.558 ' SD ' HG13 ' A' ' 54' ' ' VAL . 5.1 ptp -174.43 -170.81 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 113.261 -1.79 . . . . 0.0 113.757 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -116.7 130.28 71.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-O 124.026 1.87 . . . . 0.0 107.883 178.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 8.9 m-30 -112.69 161.65 16.62 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.835 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -134.36 137.19 43.95 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 m -76.53 74.15 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 124.552 2.12 . . . . 0.0 116.047 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.513 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 3.5 mt-10 76.13 -97.57 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 108.598 -3.91 . . . . 0.0 118.18 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.0 77.0 0.11 Allowed Glycine 0 N--CA 1.513 3.83 1 N-CA-C 100.97 -4.852 . . . . 0.0 100.97 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.44 34.79 0.64 Allowed 'General case' 0 CA--C 1.573 1.855 0 CA-C-N 112.83 -1.685 . . . . 0.0 114.577 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.721 0 C-N-CA 128.34 2.656 . . . . 0.0 106.978 -179.527 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mtp . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.927 -1.035 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.82 -178.89 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.928 0 CA-C-N 119.888 1.222 . . . . 0.0 109.911 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -123.68 160.65 26.74 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 123.826 0.704 . . . . 0.0 110.008 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -108.4 169.32 8.72 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.546 HG21 ' CE1' ' A' ' 74' ' ' PHE . 39.5 t -134.91 117.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 10.1 p-10 -106.33 166.67 10.37 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.466 HG23 HG12 ' A' ' 71' ' ' ILE . 48.1 t -85.73 140.53 35.6 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.89 178.9 6.05 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.38 1.387 . . . . 0.0 112.879 171.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -64.48 56.18 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.541 HG21 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -82.45 41.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.039 0 O-C-N 119.439 -2.038 . . . . 0.0 111.974 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 7.1 53.42 0.0 OUTLIER Glycine 1 N--CA 1.524 4.552 0 N-CA-C 119.957 2.743 . . . . 0.0 119.957 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.3 -28.26 0.24 Allowed Glycine 1 N--CA 1.522 4.387 0 CA-C-N 113.79 -1.205 . . . . 0.0 112.152 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.301 20.5 m-20 15.0 16.02 0.0 OUTLIER 'General case' 0 CA--C 1.586 2.351 2 N-CA-C 124.922 5.156 . . . . 0.0 124.922 -179.78 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -146.94 69.76 1.18 Allowed 'General case' 0 N--CA 1.501 2.114 1 N-CA-C 97.233 -5.099 . . . . 0.0 97.233 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.7 168.32 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.822 0 C-N-CA 117.497 -1.681 . . . . 0.0 115.034 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.1 pt-20 -110.85 171.33 7.53 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 124.207 0.942 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 35' ' ' ILE . 28.2 t -107.04 115.11 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.541 -0.724 . . . . 0.0 111.758 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 27.7 p -97.01 -50.38 4.64 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 124.065 0.946 . . . . 0.0 112.597 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' H ' ' HB ' ' A' ' 36' ' ' THR . 12.8 mp0 -121.63 105.22 10.23 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-O 123.594 1.664 . . . . 0.0 113.241 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.36 70.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 123.672 1.701 . . . . 0.0 114.367 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 12.9 mmt -30.36 -47.93 0.09 Allowed 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.477 ' CG2' HD23 ' A' ' 34' ' ' LEU . 15.8 m -128.71 154.35 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-O 122.853 1.311 . . . . 0.0 112.751 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.5 mtmt -129.3 -170.2 2.24 Favored 'General case' 0 N--CA 1.522 3.174 0 N-CA-C 119.066 2.987 . . . . 0.0 119.066 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.22 93.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.33 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.87 11.28 8.55 Favored Glycine 1 N--CA 1.516 4.003 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.553 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.5 m-20 -101.85 130.6 48.35 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 123.765 1.745 . . . . 0.0 112.649 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -57.0 91.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 111.648 -2.524 . . . . 0.0 111.642 179.156 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 22' ' ' VAL . 91.8 t -100.45 120.98 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -134.75 155.69 50.14 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.7 -1.25 . . . . 0.0 112.561 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.33 156.25 4.48 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.464 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 81.37 -20.29 0.38 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.715 1.884 . . . . 0.0 111.251 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.539 ' HG2' ' N ' ' A' ' 33' ' ' SER . 3.6 tt0 -95.15 155.4 16.75 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.579 1.181 . . . . 0.0 109.425 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.539 ' N ' ' HG2' ' A' ' 32' ' ' GLN . 62.6 p -76.13 134.16 40.05 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.213 1.482 . . . . 0.0 112.57 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.477 HD23 ' CG2' ' A' ' 22' ' ' VAL . 4.2 mt -96.13 -58.77 1.99 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.921 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.437 ' HB ' HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -147.74 148.38 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.576 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.472 ' HB ' ' H ' ' A' ' 19' ' ' GLU . 64.9 m -94.81 135.34 36.42 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.1 m -125.98 147.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.526 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -132.84 -165.6 1.63 Allowed 'General case' 0 N--CA 1.512 2.651 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . 163.14 -83.91 0.11 Allowed Glycine 1 N--CA 1.521 4.304 0 CA-C-N 114.46 -1.245 . . . . 0.0 115.316 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.517 ' OD2' ' HE2' ' A' ' 41' ' ' LYS . 25.0 t70 -120.86 -122.79 0.28 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 117.705 0.752 . . . . 0.0 111.422 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.517 ' HE2' ' OD2' ' A' ' 40' ' ' ASP . 65.3 mmtt -6.67 -46.23 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 119.768 3.248 . . . . 0.0 119.768 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -178.59 179.42 0.74 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 123.602 0.761 . . . . 0.0 112.016 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.7 145.01 26.85 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.049 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.1 mtp -133.04 168.64 18.11 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.529 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 36' ' ' THR . 27.9 mt-10 -129.64 156.09 44.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.541 HG22 HG21 ' A' ' 10' ' ' ILE . 71.1 t -119.15 114.36 35.03 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.299 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -81.91 177.77 7.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 CA-C-O 123.698 1.458 . . . . 0.0 111.873 171.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -75.09 103.52 0.99 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 119.447 3.129 . . . . 0.0 119.447 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 19.5 Cg_endo -41.41 -34.36 1.89 Allowed 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 122.664 2.242 . . . . 0.0 113.908 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.56 -169.25 3.06 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 113.34 -1.754 . . . . 0.0 110.159 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.1 163.25 13.32 Favored 'General case' 0 CA--C 1.574 1.869 1 N-CA-C 123.135 4.494 . . . . 0.0 123.135 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.96 -142.93 14.51 Favored Glycine 1 N--CA 1.517 4.039 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.394 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.42 165.76 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.651 0 O-C-N 121.813 -0.816 . . . . 0.0 108.955 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 22.5 t -89.72 128.08 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.212 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HD2' ' HB2' ' A' ' 75' ' ' GLU . 39.6 tttm -103.62 -58.75 1.83 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 22.4 tt0 -141.95 151.2 42.35 Favored 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.949 0.795 . . . . 0.0 111.825 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -148.92 154.01 38.82 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 119.499 -2.001 . . . . 0.0 110.397 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 76.9 mttt -131.87 49.26 2.34 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-O 125.224 2.44 . . . . 0.0 109.582 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.0 m -137.5 151.9 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 1 CA-C-N 108.345 -4.025 . . . . 0.0 108.537 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -134.14 176.9 8.17 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 122.94 1.352 . . . . 0.0 111.585 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 18' ' ' THR . 1.6 t -88.29 114.1 26.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 1 N-CA-C 95.713 -5.662 . . . . 0.0 95.713 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.52 7.88 6.65 Favored Glycine 0 N--CA 1.513 3.822 0 CA-C-N 109.271 -3.604 . . . . 0.0 110.785 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 64' ' ' LYS . 19.1 t70 -113.19 167.66 10.36 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.931 0.872 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.766 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.67 157.86 16.17 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.75 165.81 9.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 112.842 -1.981 . . . . 0.0 112.596 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -172.61 146.19 1.65 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 123.31 0.381 . . . . 0.0 110.951 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 t -42.12 113.32 0.42 Allowed 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 125.416 2.532 . . . . 0.0 115.952 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.81 -40.81 2.31 Favored Glycine 0 N--CA 1.515 3.932 0 CA-C-N 112.92 -1.945 . . . . 0.0 113.089 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.2 m -53.33 128.45 28.38 Favored 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 3.8 mm? -68.77 66.17 0.13 Allowed 'General case' 0 N--CA 1.521 3.097 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' HB ' ' SD ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -27.48 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 118.328 2.714 . . . . 0.0 118.328 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -157.46 -173.23 4.31 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 110.773 -2.921 . . . . 0.0 115.147 -179.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.412 HD11 ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -118.75 132.25 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 123.229 1.49 . . . . 0.0 110.432 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.546 ' CE1' HG21 ' A' ' 5' ' ' VAL . 18.2 m-30 -114.12 169.17 9.21 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-N 113.734 -1.576 . . . . 0.0 115.23 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 61.4 tt0 -138.46 127.08 23.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 123.467 1.603 . . . . 0.0 109.173 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 76' ' ' VAL . 16.8 m -77.94 86.31 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -3.32 72.72 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 N-CA-C 121.552 3.908 . . . . 0.0 121.552 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -140.44 26.11 2.57 Favored Glycine 0 N--CA 1.507 3.402 0 N-CA-C 106.072 -2.811 . . . . 0.0 106.072 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -31.73 102.34 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 118.586 2.81 . . . . 0.0 118.586 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.61 0 O-C-N 124.655 1.222 . . . . 0.0 110.194 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mtp . . . . . 0 N--CA 1.51 2.56 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.9 m 0.17 119.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 N-CA-C 119.986 3.328 . . . . 0.0 119.986 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HE3' ' OE1' ' A' ' 4' ' ' GLU . 24.7 mmmt -119.8 158.71 26.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.366 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -96.18 145.92 25.12 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 123.424 1.583 . . . . 0.0 114.581 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -121.56 91.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-O 123.864 1.792 . . . . 0.0 111.223 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.66 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.5 p30 -101.91 -179.49 4.02 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 111.635 -2.529 . . . . 0.0 107.799 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 65' ' ' VAL . 79.8 t -104.51 133.54 20.14 Favored Pre-proline 0 N--CA 1.503 2.213 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -82.77 -170.05 0.85 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 123.875 3.05 . . . . 0.0 111.458 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -72.98 66.97 0.82 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 124.764 2.221 . . . . 0.0 112.535 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -76.57 52.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.773 0 O-C-N 119.808 -1.807 . . . . 0.0 114.886 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.13 -37.38 0.11 Allowed Glycine 1 N--CA 1.522 4.381 0 N-CA-C 120.43 2.932 . . . . 0.0 120.43 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.51 179.8 16.19 Favored Glycine 1 N--CA 1.531 5.025 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' O ' ' CB ' ' A' ' 66' ' ' LYS . 10.7 t70 -86.41 -72.73 0.49 Allowed 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 121.624 0.726 . . . . 0.0 111.559 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -114.47 124.81 52.84 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 m -148.71 158.54 6.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.002 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.572 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 pt-20 -119.67 170.3 9.32 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.756 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.95 130.48 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.896 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 11.8 t -108.91 -44.91 3.89 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.059 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 3.3 mm-40 -130.55 112.76 13.48 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.801 1.286 . . . . 0.0 108.517 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 7.4 p -90.49 70.34 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 124.506 2.098 . . . . 0.0 114.083 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mmm -32.39 -60.87 0.28 Allowed 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 119.536 3.162 . . . . 0.0 119.536 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.703 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.3 t -103.81 150.22 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.703 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -129.56 -179.1 4.97 Favored 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 120.386 3.476 . . . . 0.0 120.386 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -53.07 115.5 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.226 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.09 10.88 31.11 Favored Glycine 1 N--CA 1.518 4.153 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.227 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' HB3' ' CG1' ' A' ' 22' ' ' VAL . 2.6 m-20 -114.45 131.85 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.732 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -58.41 75.72 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 108.696 -3.865 . . . . 0.0 110.614 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 2.3 t -82.5 151.66 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 CA-C-O 124.525 2.107 . . . . 0.0 114.049 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -152.26 153.41 33.7 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.953 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.54 163.43 0.28 Allowed 'General case' 0 N--CA 1.512 2.647 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.918 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 69.85 -27.79 0.16 Allowed 'General case' 0 N--CA 1.52 3.03 0 CA-C-O 122.018 0.913 . . . . 0.0 112.486 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -84.44 97.55 9.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.784 1.278 . . . . 0.0 112.261 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.0 m -31.86 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -70.98 -52.16 21.33 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.538 HG13 ' HB ' ' A' ' 46' ' ' VAL . 30.4 pt -143.11 151.76 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.909 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 51.9 m -105.31 127.97 53.23 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 28.4 m -120.45 154.17 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -125.0 172.65 9.25 Favored 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 118.16 2.652 . . . . 0.0 118.16 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.57 -65.04 0.01 OUTLIER Glycine 1 N--CA 1.53 4.911 0 N-CA-C 122.663 3.825 . . . . 0.0 122.663 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.603 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 9.5 p-10 -112.56 -83.16 0.59 Allowed 'General case' 0 N--CA 1.522 3.154 0 N-CA-C 120.51 3.522 . . . . 0.0 120.51 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.603 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 66.3 mmtt -119.56 -28.18 5.36 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 129.664 3.186 . . . . 0.0 111.238 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.43 167.36 10.79 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.99 1.376 . . . . 0.0 112.786 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -111.78 156.39 22.02 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.957 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 35.8 tpp -134.83 158.61 43.76 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.458 0.646 . . . . 0.0 111.714 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.37 153.67 30.59 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.904 1.812 . . . . 0.0 114.247 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.538 ' HB ' HG13 ' A' ' 35' ' ' ILE . 60.1 t -123.87 102.67 34.65 Favored Pre-proline 0 N--CA 1.495 1.824 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.413 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -79.01 169.37 19.41 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 CA-C-O 124.394 1.747 . . . . 0.0 109.743 173.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -61.26 115.48 14.72 Favored Pre-proline 0 C--N 1.28 -2.434 0 CA-C-N 111.441 -2.618 . . . . 0.0 117.528 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 28.0 Cg_endo -46.85 -26.66 4.91 Favored 'Trans proline' 0 N--CA 1.509 2.436 0 C-N-CA 122.144 1.896 . . . . 0.0 113.295 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -171.73 -174.26 1.32 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.532 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.51 166.97 11.43 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.83 -172.17 21.44 Favored Glycine 0 N--CA 1.514 3.84 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.369 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 t -106.65 149.87 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 C-N-CA 117.549 -1.661 . . . . 0.0 113.14 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG13 ' SD ' ' A' ' 72' ' ' MET . 58.4 t -67.29 102.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.592 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -82.44 -62.81 1.51 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.559 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 1.5 tt0 -147.24 151.28 36.42 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.96 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -143.55 135.81 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.502 -0.749 . . . . 0.0 110.58 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 41.9 mttm -114.45 42.87 2.01 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.11 161.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.765 0 CA-C-N 114.169 -1.378 . . . . 0.0 114.072 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -132.78 170.78 14.79 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 121.489 3.885 . . . . 0.0 121.489 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.6 t -96.11 101.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 101.17 -3.641 . . . . 0.0 101.17 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.92 32.4 1.56 Allowed Glycine 0 N--CA 1.502 3.04 1 CA-C-N 107.826 -4.261 . . . . 0.0 106.816 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -113.95 174.07 6.12 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 16' ' ' GLU . 29.6 mmmt -101.37 132.39 46.96 Favored 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 121.233 3.79 . . . . 0.0 121.233 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -130.57 165.22 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 113.35 -1.75 . . . . 0.0 111.146 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 167.72 150.66 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 124.59 1.156 . . . . 0.0 110.021 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.76 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.34 -41.98 1.99 Allowed Glycine 1 N--CA 1.518 4.104 0 N-CA-C 116.699 1.44 . . . . 0.0 116.699 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.4 t -35.48 139.25 0.12 Allowed 'General case' 0 N--CA 1.531 3.617 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.966 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.3 mt -94.55 63.51 2.94 Favored 'General case' 0 N--CA 1.52 3.053 0 CA-C-N 120.358 1.435 . . . . 0.0 113.189 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.8 mm -40.52 -58.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.623 ' SD ' HG13 ' A' ' 54' ' ' VAL . 4.6 ptp -155.9 -172.92 4.3 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.27 122.0 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 122.998 1.38 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.618 ' CD1' HG21 ' A' ' 5' ' ' VAL . 5.6 m-30 -98.89 156.95 16.63 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.817 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.453 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 17.4 tt0 -147.6 98.15 2.94 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 123.952 1.834 . . . . 0.0 111.444 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 78' ' ' GLY . 34.3 m -58.49 69.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 CA-C-N 114.053 -1.43 . . . . 0.0 114.616 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 52.82 -69.83 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.87 0 CA-C-O 122.202 1.001 . . . . 0.0 112.816 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . 164.03 33.1 0.02 OUTLIER Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -22.5 -83.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.315 0 C-N-CA 130.683 3.593 . . . . 0.0 108.709 179.505 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttm . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.0 t -42.45 164.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 73.3 mmtt -136.73 154.22 50.65 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.769 -1.559 . . . . 0.0 113.013 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.8 152.23 20.75 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.933 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 ' CE1' ' A' ' 74' ' ' PHE . 74.1 t -118.24 107.9 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -107.82 141.26 39.67 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.037 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 48.9 t -51.37 121.86 17.99 Favored Pre-proline 0 N--CA 1.5 2.049 0 CA-C-N 113.019 -1.9 . . . . 0.0 113.162 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 67' ' ' THR . 83.0 Cg_endo -63.49 -168.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.505 2.148 0 C-N-CA 123.182 2.588 . . . . 0.0 114.623 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -70.01 48.88 0.1 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 124.377 2.037 . . . . 0.0 115.126 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.508 HG21 HG22 ' A' ' 46' ' ' VAL . 29.8 pt -80.64 47.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.761 0 O-C-N 119.798 -1.814 . . . . 0.0 114.039 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -10.11 57.87 0.0 OUTLIER Glycine 1 N--CA 1.524 4.566 0 N-CA-C 120.505 2.962 . . . . 0.0 120.505 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -130.93 160.31 23.25 Favored Glycine 1 N--CA 1.519 4.196 0 N-CA-C 114.461 0.544 . . . . 0.0 114.461 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -82.23 58.8 4.19 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 124.787 1.235 . . . . 0.0 112.721 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 66' ' ' LYS . 4.8 mm-40 65.19 97.25 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.221 0 CA-C-O 122.239 1.018 . . . . 0.0 112.249 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.69 169.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 10.2 pt-20 -106.73 179.12 4.36 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.461 -1.296 . . . . 0.0 113.524 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.69 115.61 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 38' ' ' GLU . 18.7 p -96.86 -41.22 8.54 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 117.412 -1.28 . . . . 0.0 111.066 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.2 126.02 46.18 Favored 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 119.679 1.127 . . . . 0.0 112.038 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.7 53.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 125.549 2.595 . . . . 0.0 116.547 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.7 mmm -20.05 -54.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 110.509 -3.042 . . . . 0.0 114.152 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' ' HZ3' ' A' ' 23' ' ' LYS . 1.4 m -114.88 159.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 O-C-N 120.778 -1.201 . . . . 0.0 108.699 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HZ3' ' HA ' ' A' ' 22' ' ' VAL . 3.8 mtmm -143.37 -176.9 5.12 Favored 'General case' 0 N--CA 1.522 3.13 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -49.15 106.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.775 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.99 -48.94 0.91 Allowed Glycine 0 N--CA 1.508 3.496 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -36.51 130.0 0.73 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-O 123.987 1.851 . . . . 0.0 115.39 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' NZ ' ' CD ' ' A' ' 77' ' ' GLU . 70.9 mmtt -70.5 76.88 0.57 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.141 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 74' ' ' PHE . 37.6 t -79.34 156.97 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 125.413 2.53 . . . . 0.0 116.981 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -164.81 154.93 13.85 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 112.917 -1.947 . . . . 0.0 112.833 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -49.48 166.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.332 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 65.05 -21.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -93.34 152.68 18.99 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.532 ' N ' ' NE2' ' A' ' 32' ' ' GLN . 8.6 p -68.34 146.66 53.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 123.223 1.487 . . . . 0.0 110.716 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' HD2' ' A' ' 49' ' ' PRO . 4.9 mt -109.08 -65.6 1.13 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 123.748 1.737 . . . . 0.0 109.032 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.8 pt -142.53 160.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 111.351 -2.659 . . . . 0.0 110.013 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.6 m -107.3 129.04 54.94 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.7 m -118.39 151.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 118.116 2.636 . . . . 0.0 118.116 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.417 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER -133.35 -167.25 1.89 Allowed 'General case' 0 N--CA 1.513 2.7 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -179.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.59 -101.84 0.24 Allowed Glycine 1 N--CA 1.527 4.714 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.495 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 42' ' ' ALA . 23.3 m-20 -90.81 -133.48 0.12 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 122.258 1.028 . . . . 0.0 112.89 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.564 ' NZ ' ' SD ' ' A' ' 44' ' ' MET . 10.8 ptmm? 4.14 -43.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.487 1 N-CA-C 122.811 4.375 . . . . 0.0 122.811 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . 167.03 163.96 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 O-C-N 124.778 1.299 . . . . 0.0 110.386 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.0 p -69.21 153.28 43.93 Favored 'General case' 0 N--CA 1.515 2.785 0 CA-C-O 121.581 0.705 . . . . 0.0 112.872 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.564 ' SD ' ' NZ ' ' A' ' 41' ' ' LYS . 30.5 mtp -142.92 163.3 33.17 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.909 -0.495 . . . . 0.0 112.185 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.01 149.23 42.49 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.777 1.275 . . . . 0.0 113.911 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG22 HG21 ' A' ' 10' ' ' ILE . 54.6 t -120.05 127.38 26.39 Favored Pre-proline 0 N--CA 1.503 2.202 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -92.67 178.59 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.148 1.899 . . . . 0.0 114.295 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -67.7 110.44 5.42 Favored Pre-proline 0 CA--C 1.578 2.056 0 N-CA-C 117.595 2.443 . . . . 0.0 117.595 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD2' HD11 ' A' ' 34' ' ' LEU . 40.2 Cg_endo -53.38 -21.41 17.88 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 122.905 2.404 . . . . 0.0 113.384 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -164.74 -169.65 1.78 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.401 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -108.82 158.77 17.34 Favored 'General case' 0 C--N 1.3 -1.56 1 N-CA-C 121.838 4.014 . . . . 0.0 121.838 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . 132.91 179.85 16.68 Favored Glycine 1 N--CA 1.519 4.212 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.548 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' HD3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -92.53 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.27 -1.723 . . . . 0.0 113.978 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 74' ' ' PHE . 35.6 t -83.87 112.23 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.07 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -93.16 -55.04 3.47 Favored 'General case' 0 N--CA 1.516 2.837 0 CA-C-N 120.42 1.464 . . . . 0.0 112.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 4.5 tt0 -147.91 162.08 40.0 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 121.135 0.493 . . . . 0.0 109.918 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.1 pt? -162.72 150.78 14.02 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.943 -1.098 . . . . 0.0 108.36 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 41.2 mtmt -125.16 53.01 1.55 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.896 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 71' ' ' ILE . 34.2 m -138.35 157.3 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 126.183 2.177 . . . . 0.0 112.279 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 3.6 m120 -124.78 173.83 8.31 Favored 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.79 83.05 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 127.298 3.428 . . . . 0.0 104.458 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.25 41.9 0.08 OUTLIER Glycine 0 N--CA 1.505 3.273 1 CA-C-N 104.699 -5.682 . . . . 0.0 107.058 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.499 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 11.3 t0 -122.49 168.67 11.83 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -113.24 144.91 41.9 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 121.786 3.995 . . . . 0.0 121.786 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 m -125.44 130.49 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 118.251 2.685 . . . . 0.0 118.251 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HB3' ' CD ' ' A' ' 14' ' ' GLU . 4.4 ptmm? -130.18 120.28 24.27 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 8' ' ' PRO . 24.5 p -28.47 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 124.571 2.129 . . . . 0.0 112.501 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.46 42.0 1.67 Allowed Glycine 0 N--CA 1.508 3.485 0 CA-C-N 109.983 -3.281 . . . . 0.0 113.635 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -115.51 131.88 56.8 Favored 'General case' 0 N--CA 1.529 3.493 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.504 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.08 63.99 0.71 Allowed 'General case' 0 N--CA 1.519 2.981 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.463 HG23 HG11 ' A' ' 59' ' ' VAL . 24.0 mm -53.68 -63.47 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.592 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 18.2 ptt? -138.81 168.82 18.98 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.43 119.79 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-O 123.365 1.555 . . . . 0.0 110.388 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 28' ' ' VAL . 8.8 m-30 -99.87 163.87 12.27 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.435 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -144.34 106.14 4.3 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.851 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HA ' ' CA ' ' A' ' 52' ' ' GLY . 34.2 m -43.69 48.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 1 N-CA-C 122.784 4.364 . . . . 0.0 122.784 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.523 ' CD ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.52 104.4 16.42 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.98 -51.95 0.08 OUTLIER Glycine 1 N--CA 1.517 4.035 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 122.15 100.38 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 109.48 -3.36 . . . . 0.0 106.479 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.694 0 C-N-CA 127.82 2.448 . . . . 0.0 106.57 -179.587 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 117.199 -1.381 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 3' ' ' LYS . 3.5 t 62.12 -178.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.833 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.612 ' H ' HG12 ' A' ' 2' ' ' VAL . 33.1 mmtm -141.79 131.51 24.17 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -88.25 151.1 22.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.698 -1.251 . . . . 0.0 109.236 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 79.7 t -108.14 115.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 CA-C-O 121.569 0.7 . . . . 0.0 111.851 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.6 p30 -106.18 -179.18 3.86 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 123.0 1.381 . . . . 0.0 111.383 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.547 HG22 HD11 ' A' ' 71' ' ' ILE . 34.7 t -101.19 117.86 61.39 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 112.804 -1.998 . . . . 0.0 110.907 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 85.0 Cg_endo -61.92 -174.35 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.643 1.562 . . . . 0.0 113.0 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -68.75 51.66 0.08 Allowed 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 124.729 2.204 . . . . 0.0 114.171 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.533 HG21 HG22 ' A' ' 46' ' ' VAL . 29.6 pt -78.03 46.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 O-C-N 119.066 -2.271 . . . . 0.0 114.611 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.14 -66.42 0.35 Allowed Glycine 1 N--CA 1.519 4.224 0 N-CA-C 116.276 1.27 . . . . 0.0 116.276 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.13 -59.65 0.46 Allowed Glycine 1 N--CA 1.517 4.035 0 CA-C-N 113.698 -1.251 . . . . 0.0 110.015 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -27.09 143.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 117.886 2.551 . . . . 0.0 117.886 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' CD ' ' HZ3' ' A' ' 66' ' ' LYS . 3.2 mm-40 -85.56 87.47 7.4 Favored 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 101.775 -3.417 . . . . 0.0 101.775 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 m -95.67 175.56 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 114.295 -1.321 . . . . 0.0 114.226 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.631 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 9.9 pt-20 -123.8 167.91 13.44 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -95.42 122.51 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 m -92.38 -52.02 4.86 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 126.424 1.89 . . . . 0.0 108.597 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -131.89 120.74 22.97 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.7 0.762 . . . . 0.0 111.407 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.5 p -95.29 61.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 123.573 1.654 . . . . 0.0 110.444 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 mtt -27.73 -32.77 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 118.584 2.809 . . . . 0.0 118.584 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG12 HE21 ' A' ' 32' ' ' GLN . 19.5 m -115.85 145.72 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -129.88 176.13 8.29 Favored 'General case' 0 N--CA 1.517 2.884 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.15 102.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.85 0 CA-C-N 114.174 -1.375 . . . . 0.0 114.406 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.02 -36.21 3.03 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.256 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -49.36 171.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 119.237 3.051 . . . . 0.0 119.237 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HD3' HG12 ' A' ' 53' ' ' VAL . 74.3 mmtt -105.44 105.13 15.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 111.629 -2.532 . . . . 0.0 108.841 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 74' ' ' PHE . 21.8 t -115.2 106.77 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -117.29 158.74 23.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.827 -1.171 . . . . 0.0 110.52 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -42.5 157.83 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.702 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.027 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 2.7 tm-20 79.55 -48.88 0.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.828 1.299 . . . . 0.0 107.845 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' LEU . 43.0 tt0 -47.37 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 1.5 m -32.19 61.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -19.45 -67.39 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 pt -147.61 146.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 110.628 -2.987 . . . . 0.0 112.89 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 45' ' ' GLU . 9.0 m -105.15 124.73 50.03 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.09 158.41 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 117.849 2.536 . . . . 0.0 117.849 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.05 -177.42 4.13 Favored 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.794 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.09 -75.01 0.13 Allowed Glycine 0 N--CA 1.514 3.878 0 N-CA-C 118.833 2.293 . . . . 0.0 118.833 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.775 ' HB2' ' CE ' ' A' ' 41' ' ' LYS . 49.3 m-20 -127.79 -102.11 0.34 Allowed 'General case' 0 N--CA 1.514 2.743 0 CA-C-O 125.67 2.653 . . . . 0.0 115.793 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.775 ' CE ' ' HB2' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -33.2 -47.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 129.245 3.018 . . . . 0.0 115.907 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' O ' ' SD ' ' A' ' 44' ' ' MET . . . 179.01 173.26 0.77 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.1 p -90.78 148.86 22.26 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 123.525 0.516 . . . . 0.0 111.949 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 42' ' ' ALA . 2.1 mpp? -121.71 159.2 27.09 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 36' ' ' THR . 19.8 mt-10 -117.18 146.41 43.24 Favored 'General case' 0 N--CA 1.506 2.342 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.481 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.533 HG22 HG21 ' A' ' 10' ' ' ILE . 66.5 t -122.7 127.04 25.92 Favored Pre-proline 0 N--CA 1.5 2.055 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.838 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -86.48 171.86 7.22 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.794 1.662 . . . . 0.0 111.326 174.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -58.62 103.86 0.39 Allowed Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HG2' HG13 ' A' ' 5' ' ' VAL . 72.9 Cg_exo -35.48 -40.17 0.31 Allowed 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 123.409 2.739 . . . . 0.0 113.199 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -157.05 -172.4 4.01 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 109.981 -3.281 . . . . 0.0 108.109 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.45 162.15 14.18 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.706 3.224 . . . . 0.0 119.706 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.3 -154.25 21.58 Favored Glycine 1 N--CA 1.519 4.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.572 HG12 ' HD3' ' A' ' 27' ' ' LYS . 17.6 m -114.66 174.82 2.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 123.321 1.534 . . . . 0.0 113.001 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 74' ' ' PHE . 20.6 t -102.73 108.58 24.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.976 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 56' ' ' GLU . 14.0 tttm -88.57 -45.42 9.9 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.179 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 60.3 tt0 -165.45 163.83 19.61 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.696 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -160.37 164.29 32.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.931 -1.106 . . . . 0.0 110.447 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -130.88 51.07 2.16 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -143.7 155.35 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 125.633 1.833 . . . . 0.0 113.504 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.535 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -127.44 -177.36 4.05 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 125.521 2.581 . . . . 0.0 115.321 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.91 104.61 16.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 101.123 -3.658 . . . . 0.0 101.123 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . . . 136.85 -10.72 3.95 Favored Glycine 0 N--CA 1.514 3.864 1 CA-C-N 107.783 -4.281 . . . . 0.0 110.188 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -69.73 174.01 5.59 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.959 0.904 . . . . 0.0 110.268 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.631 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 30.4 mmtm -115.85 142.18 47.12 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.8 164.65 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 123.14 0.576 . . . . 0.0 112.397 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' HZ3' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -175.55 153.74 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 2.9 t -39.45 118.5 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 122.579 1.18 . . . . 0.0 113.426 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.45 -29.17 7.11 Favored Glycine 1 N--CA 1.518 4.127 0 CA-C-N 114.574 -1.194 . . . . 0.0 115.607 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 24.5 t -75.7 161.25 29.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 117.92 -1.512 . . . . 0.0 112.933 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.3 mt -97.91 64.79 1.75 Allowed 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.547 HD11 HG22 ' A' ' 7' ' ' VAL . 5.6 mt -21.82 -67.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.424 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 13.4 ptp -149.93 179.39 8.09 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 112.87 -1.968 . . . . 0.0 113.519 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.5 118.25 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 123.351 1.548 . . . . 0.0 111.835 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.501 ' CE1' HG22 ' A' ' 54' ' ' VAL . 10.5 m-30 -106.99 162.9 13.43 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 123.43 1.586 . . . . 0.0 112.086 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' O ' HG22 ' A' ' 53' ' ' VAL . 1.4 tt0 -142.57 133.09 25.09 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.345 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 79' ' ' ALA . 14.6 m -83.65 73.87 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.569 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 61.61 -17.67 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.144 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 76' ' ' VAL . . . 153.6 -54.75 0.44 Allowed Glycine 1 N--CA 1.524 4.536 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 76' ' ' VAL . . . 92.76 104.99 0.02 OUTLIER 'General case' 0 CA--C 1.582 2.181 0 CA-C-N 110.167 -3.017 . . . . 0.0 118.42 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 2.795 0 C-N-CA 128.565 2.746 . . . . 0.0 106.937 179.557 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 mtm . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 115.495 -2.193 . . . . 0.0 106.426 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.405 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 22.6 t 63.48 136.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 124.14 1.924 . . . . 0.0 113.48 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -126.98 145.23 50.78 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.503 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -81.79 155.58 25.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.19 0.995 . . . . 0.0 110.809 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 74' ' ' PHE . 48.2 t -122.71 91.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 123.73 1.729 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -96.32 146.5 24.68 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG12 HD12 ' A' ' 10' ' ' ILE . 53.9 t -72.23 137.84 81.52 Favored Pre-proline 0 N--CA 1.501 2.084 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.789 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -76.44 -175.33 2.51 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.174 1.916 . . . . 0.0 112.699 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.13 57.83 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 124.595 2.141 . . . . 0.0 115.631 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.594 HG21 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -80.4 51.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.93 0 O-C-N 119.232 -2.167 . . . . 0.0 109.758 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.55 -60.39 0.67 Allowed Glycine 1 N--CA 1.518 4.152 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.771 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.79 -59.21 0.54 Allowed Glycine 0 N--CA 1.511 3.653 0 CA-C-N 113.059 -1.571 . . . . 0.0 110.213 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -22.87 176.25 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.0 1 N-CA-C 123.244 4.535 . . . . 0.0 123.244 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -99.38 88.02 3.78 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 112.045 -2.343 . . . . 0.0 113.694 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.8 m -118.63 161.99 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.87 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 2.0 pm0 -118.64 179.03 4.25 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.73 1.252 . . . . 0.0 110.274 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -94.3 115.64 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.302 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 m -90.45 -34.98 15.4 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' CB ' ' HB ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -143.62 134.74 25.66 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.19 64.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 124.73 2.205 . . . . 0.0 114.972 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.2 mmm -25.17 -48.74 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 109.875 -3.329 . . . . 0.0 118.019 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.82 164.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.963 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -130.52 -174.86 3.47 Favored 'General case' 0 N--CA 1.522 3.145 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.1 107.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.875 0 O-C-N 120.831 -1.168 . . . . 0.0 111.472 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.87 -25.83 9.82 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-O 122.172 0.873 . . . . 0.0 111.915 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.85 156.62 13.91 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -86.51 127.84 34.91 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.918 1.342 . . . . 0.0 110.65 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ALA . 35.7 t -127.41 93.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 112.369 -2.196 . . . . 0.0 113.599 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -99.79 158.7 15.61 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.726 -1.234 . . . . 0.0 108.617 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -54.08 163.68 0.75 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.142 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 75.55 -35.63 0.28 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.763 1.268 . . . . 0.0 110.562 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 30' ' ' ALA . 39.4 tt0 -67.31 127.22 31.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 123.146 1.45 . . . . 0.0 112.34 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.5 p -57.77 97.71 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -61.13 -63.31 1.34 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 pt -142.81 150.17 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 112.187 -2.279 . . . . 0.0 110.038 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' A' ' 19' ' ' GLU . 87.2 m -97.77 114.95 27.09 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.74 148.57 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -129.3 178.07 6.71 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.4 -72.02 0.02 OUTLIER Glycine 1 N--CA 1.519 4.217 0 N-CA-C 116.883 1.513 . . . . 0.0 116.883 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.674 ' CG ' ' H ' ' A' ' 41' ' ' LYS . 10.9 p-10 -114.55 -73.21 0.66 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 123.038 1.399 . . . . 0.0 113.216 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.674 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -125.78 -14.34 6.22 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 126.864 2.065 . . . . 0.0 110.68 179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.89 132.79 53.83 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 t -102.57 143.22 32.55 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.717 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.4 ptp -148.98 174.59 12.12 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -122.88 157.95 31.4 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG22 HG21 ' A' ' 10' ' ' ILE . 74.9 t -121.54 126.18 26.56 Favored Pre-proline 0 N--CA 1.503 2.186 0 CA-C-N 113.562 -1.654 . . . . 0.0 109.582 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -88.94 171.84 4.64 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 CA-C-O 123.485 1.369 . . . . 0.0 110.073 174.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -70.81 119.85 75.56 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 118.581 2.808 . . . . 0.0 118.581 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HD2' HD11 ' A' ' 34' ' ' LEU . 30.3 Cg_endo -50.1 -29.26 21.6 Favored 'Trans proline' 0 N--CA 1.511 2.544 0 C-N-CA 122.947 2.431 . . . . 0.0 112.953 -174.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -159.71 -175.19 5.01 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 112.214 -2.266 . . . . 0.0 108.536 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.47 161.53 13.64 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.76 -167.88 23.81 Favored Glycine 1 N--CA 1.524 4.516 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.102 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.69 165.03 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 118.613 1.206 . . . . 0.0 113.171 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CE1' ' A' ' 74' ' ' PHE . 25.0 t -89.84 120.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.729 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 75' ' ' GLU . 6.3 tttp -103.98 -62.6 1.29 Allowed 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG2' HD11 ' A' ' 73' ' ' ILE . 2.2 tp10 -130.62 137.19 49.5 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 118.326 0.512 . . . . 0.0 110.803 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.4 pt? -149.69 114.7 5.4 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 123.466 1.603 . . . . 0.0 108.425 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 93.3 mttt -94.48 50.74 1.37 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.28 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.11 143.36 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.431 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -130.94 -172.56 2.86 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.793 2.235 . . . . 0.0 113.58 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.54 108.27 19.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.37 -15.81 4.68 Favored Glycine 0 N--CA 1.513 3.798 0 CA-C-N 108.913 -3.767 . . . . 0.0 113.144 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -70.28 157.08 38.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.0 mmmt -91.56 136.69 32.94 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.98 152.3 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.999 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -162.98 148.29 11.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.4 t -55.32 120.59 7.32 Favored 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 117.822 -1.551 . . . . 0.0 112.241 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.14 6.42 39.43 Favored Glycine 1 N--CA 1.523 4.452 0 CA-C-N 114.408 -1.269 . . . . 0.0 114.985 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -93.84 112.69 24.58 Favored 'General case' 0 N--CA 1.517 2.919 0 O-C-N 120.95 -1.324 . . . . 0.0 111.491 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 70' ' ' LEU . 1.4 mp -61.94 56.59 0.01 OUTLIER 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mm -42.61 -51.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 4.9 ptp -151.18 -175.05 5.01 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.487 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -123.24 120.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 123.814 1.768 . . . . 0.0 114.494 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 5' ' ' VAL . 19.7 m-30 -108.82 164.61 12.24 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.313 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 4.7 tp10 -138.13 131.03 29.84 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 76' ' ' VAL . 27.1 m -70.93 59.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 68.51 101.76 0.05 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-O 123.71 1.719 . . . . 0.0 112.972 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.18 45.52 0.8 Allowed Glycine 1 N--CA 1.522 4.4 0 N-CA-C 107.334 -2.306 . . . . 0.0 107.334 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 37.02 50.27 0.88 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 110.531 -2.834 . . . . 0.0 115.528 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.463 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.663 0 C-N-CA 129.926 3.29 . . . . 0.0 107.264 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.41 0 CA-C-O 120.669 0.271 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 m -88.68 146.15 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' O ' HG22 ' A' ' 73' ' ' ILE . 4.1 mmmm -137.98 154.12 49.38 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 2.7 pp20? -101.35 172.08 7.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.761 -0.587 . . . . 0.0 110.103 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 74' ' ' PHE . 58.4 t -133.53 97.53 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.142 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 69' ' ' SER . 6.0 p30 -94.56 168.66 10.71 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.572 HG23 HG13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -98.73 125.44 42.4 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 118.104 -1.438 . . . . 0.0 111.346 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 60.5 Cg_endo -67.74 -91.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 123.619 2.879 . . . . 0.0 109.961 -163.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.527 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 4.6 p-10 -130.53 147.43 52.21 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.53 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -151.49 37.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.553 0 CA-C-O 123.831 1.777 . . . . 0.0 109.554 179.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.45 -55.61 3.7 Favored Glycine 1 N--CA 1.52 4.275 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.791 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -125.58 -144.74 6.3 Favored Glycine 0 N--CA 1.506 3.313 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.551 ' CG ' ' NZ ' ' A' ' 66' ' ' LYS . 0.6 OUTLIER -105.33 -75.38 0.63 Allowed 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 102.87 3.72 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 119.376 3.102 . . . . 0.0 119.376 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 33.5 m -129.88 141.93 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.692 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.72 165.3 20.05 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -112.53 120.08 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 C-N-CA 118.944 -1.102 . . . . 0.0 108.578 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -94.9 -48.18 6.12 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.081 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.83 102.94 5.42 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 123.2 1.476 . . . . 0.0 113.283 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.96 64.64 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 O-C-N 119.83 -1.794 . . . . 0.0 113.441 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 mtt -32.78 -36.12 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 N-CA-C 121.253 3.797 . . . . 0.0 121.253 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -118.91 142.68 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.605 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 6.8 mtpm? -134.94 179.94 6.0 Favored 'General case' 0 N--CA 1.51 2.569 0 N-CA-C 119.148 3.018 . . . . 0.0 119.148 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.8 t -45.04 91.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.456 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 2.63 12.51 Favored Glycine 1 N--CA 1.523 4.454 0 CA-C-O 121.91 0.728 . . . . 0.0 113.555 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 59.4 m-20 -97.51 120.42 37.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 124.903 2.287 . . . . 0.0 113.731 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.715 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -65.52 95.24 0.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.649 -2.523 . . . . 0.0 110.933 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 34' ' ' LEU . 7.3 t -91.15 157.56 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.734 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.21 167.77 2.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.321 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -42.33 162.09 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 O-C-N 124.582 1.176 . . . . 0.0 113.638 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.85 -10.37 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.655 1.217 . . . . 0.0 113.923 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 30' ' ' ALA . 34.7 tt0 -90.15 87.68 6.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.203 -1.561 . . . . 0.0 106.809 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 70.7 m -35.99 76.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -24.63 -66.4 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 pt -147.42 146.02 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 111.387 -2.642 . . . . 0.0 111.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 45' ' ' GLU . 96.6 m -93.17 131.01 38.63 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.82 160.55 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -128.5 -157.89 0.85 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 129.7 172.28 13.12 Favored Glycine 0 N--CA 1.51 3.597 0 N-CA-C 106.217 -2.753 . . . . 0.0 106.217 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 54.05 -83.42 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 CA-C-O 122.989 1.375 . . . . 0.0 113.095 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 39' ' ' GLY . 1.5 pptp? 170.69 35.71 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 128.615 2.766 . . . . 0.0 108.615 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.11 104.57 5.97 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.114 -1.403 . . . . 0.0 114.561 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.4 t -70.52 109.07 4.62 Favored 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.529 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 45.2 mtm -109.72 161.28 15.56 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.832 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' A' ' 36' ' ' THR . 27.6 mt-10 -122.14 158.59 28.99 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 37.3 t -130.05 121.45 19.76 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.51 171.28 2.43 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.28 1.32 . . . . 0.0 111.217 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -45.28 96.7 0.12 Allowed Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HG ' ' A' ' 34' ' ' LEU . 18.2 Cg_endo -44.55 -28.39 2.69 Favored 'Trans proline' 0 N--CA 1.511 2.551 0 C-N-CA 121.968 1.779 . . . . 0.0 112.973 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -163.8 -179.35 6.27 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 112.322 -2.217 . . . . 0.0 107.016 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.16 156.54 18.71 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 120.035 3.346 . . . . 0.0 120.035 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.33 -173.65 22.14 Favored Glycine 1 N--CA 1.529 4.863 0 CA-C-N 112.772 -2.013 . . . . 0.0 114.185 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 26' ' ' ASP . 1.4 t -95.8 167.83 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 CA-C-N 120.405 2.103 . . . . 0.0 112.209 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.505 HG22 ' CE1' ' A' ' 74' ' ' PHE . 11.7 t -91.9 126.82 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.115 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 9.6 tttp -99.64 -60.44 1.53 Allowed 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' CD ' ' NZ ' ' A' ' 58' ' ' LYS . 12.4 tt0 -144.6 159.71 42.35 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.285 0.564 . . . . 0.0 112.471 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.6 pt? -154.7 161.34 41.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.48 -2.013 . . . . 0.0 110.417 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.588 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 1.9 mptt -133.1 45.79 2.68 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 122.369 1.081 . . . . 0.0 108.962 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.91 149.2 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -129.89 177.69 7.08 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 125.504 2.574 . . . . 0.0 113.446 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.43 109.71 20.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.53 -27.95 3.04 Favored Glycine 0 N--CA 1.511 3.659 0 CA-C-N 111.929 -2.396 . . . . 0.0 108.393 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.78 169.86 17.05 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -123.32 164.39 18.89 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.909 1.337 . . . . 0.0 108.799 179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.52 168.2 18.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.551 ' NZ ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -150.01 156.2 41.28 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 119.186 -1.006 . . . . 0.0 113.161 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -34.13 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.3 -5.69 45.38 Favored Glycine 1 N--CA 1.517 4.075 0 CA-C-N 113.785 -1.552 . . . . 0.0 115.8 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 8.5 m -63.7 133.52 53.73 Favored 'General case' 0 N--CA 1.524 3.226 0 CA-C-O 117.621 -1.18 . . . . 0.0 112.879 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.72 59.17 0.21 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 HG23 ' A' ' 7' ' ' VAL . 6.0 mm -30.68 -64.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 124.847 2.26 . . . . 0.0 116.528 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.54 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -152.27 177.25 10.75 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 111.357 -2.656 . . . . 0.0 112.856 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -118.42 127.89 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 123.384 1.564 . . . . 0.0 107.019 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.558 ' CD1' HG21 ' A' ' 5' ' ' VAL . 8.9 m-30 -105.51 160.76 14.91 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 113.316 -1.766 . . . . 0.0 115.005 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 14.0 tt0 -141.04 109.69 6.0 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 124.618 2.151 . . . . 0.0 111.362 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 m -53.5 44.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.13 0 N-CA-C 121.362 3.838 . . . . 0.0 121.362 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 22.42 -94.69 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.523 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -140.41 40.42 1.38 Allowed Glycine 1 N--CA 1.52 4.283 0 N-CA-C 105.031 -3.228 . . . . 0.0 105.031 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 17.9 58.65 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 110.114 -3.043 . . . . 0.0 119.009 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 1.732 0 CA-C-N 111.363 -2.653 . . . . 0.0 105.613 179.769 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 3.3 mpp? . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -9.53 130.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 118.572 2.804 . . . . 0.0 118.572 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -118.83 146.63 44.7 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 124.225 1.964 . . . . 0.0 112.498 179.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 7.5 mp0 -91.15 132.17 36.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.438 -2.619 . . . . 0.0 114.258 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 92.2 t -104.26 111.75 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.726 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 69' ' ' SER . 16.3 p-10 -108.9 172.79 6.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.34 1.543 . . . . 0.0 112.273 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.608 HG12 HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -101.39 117.82 61.26 Favored Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 112.832 -1.986 . . . . 0.0 113.65 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -85.24 172.31 8.47 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 123.87 3.047 . . . . 0.0 112.724 172.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -1.5 37.74 0.0 OUTLIER 'General case' 0 CA--C 1.593 2.604 1 N-CA-C 123.346 4.572 . . . . 0.0 123.346 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -76.8 61.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 O-C-N 119.226 -2.171 . . . . 0.0 114.496 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -41.12 141.28 1.08 Allowed Glycine 0 N--CA 1.515 3.905 0 CA-C-N 112.868 -1.969 . . . . 0.0 114.165 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . 126.2 -45.88 1.13 Allowed Glycine 1 N--CA 1.521 4.318 0 N-CA-C 106.453 -2.659 . . . . 0.0 106.453 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' HB3' ' HZ1' ' A' ' 66' ' ' LYS . 1.0 OUTLIER 75.46 163.88 0.26 Allowed 'General case' 0 CA--C 1.573 1.863 0 O-C-N 128.418 3.07 . . . . 0.0 114.545 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' CD ' ' NZ ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER 36.37 52.98 0.97 Allowed 'General case' 0 N--CA 1.51 2.554 0 CA-C-O 122.534 1.159 . . . . 0.0 110.589 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 38' ' ' GLU . 35.4 m -97.41 160.92 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.783 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.613 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 1.6 pm0 -118.11 174.66 6.09 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.223 1.011 . . . . 0.0 113.315 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.43 127.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.221 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 81.4 p -98.82 -50.36 4.24 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -131.12 100.31 5.17 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 123.254 1.502 . . . . 0.0 112.9 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG22 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -73.89 65.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 O-C-N 120.295 -1.503 . . . . 0.0 114.06 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 34.3 mmm -30.39 -52.43 0.16 Allowed 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.9 m -89.01 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HZ3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -130.7 161.88 30.68 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.9 t -53.47 114.97 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.849 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.76 -29.15 6.16 Favored Glycine 0 N--CA 1.515 3.966 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.414 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 11.7 t70 -89.02 168.39 12.39 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -83.98 109.21 17.45 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 34' ' ' LEU . 6.7 t -111.04 102.77 14.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.612 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -120.25 159.02 25.78 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.316 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.48 160.92 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 74.27 -40.16 0.44 Allowed 'General case' 0 N--CA 1.516 2.843 0 CA-C-O 121.963 0.887 . . . . 0.0 110.475 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 47.0 tp60 -58.39 83.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 50.4 m -28.86 70.15 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.094 2.998 . . . . 0.0 119.094 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD21 HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -23.32 -67.45 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.29 155.44 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.525 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -99.16 136.63 38.84 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 25.0 m -124.85 148.71 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 18' ' ' THR . 3.4 tt0 -118.98 174.25 6.41 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.14 -68.96 0.07 OUTLIER Glycine 1 N--CA 1.518 4.135 0 CA-C-N 114.792 -1.095 . . . . 0.0 113.28 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.92 -177.73 3.73 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.896 1.331 . . . . 0.0 110.936 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.51 -15.02 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.36 150.69 48.95 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.211 0.529 . . . . 0.0 111.764 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -89.68 164.17 14.82 Favored 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 51.0 mtt -132.27 168.23 18.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.483 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.85 152.69 49.06 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG21 ' CG2' ' A' ' 10' ' ' ILE . 43.5 t -129.79 125.86 22.35 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.0 173.37 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.414 1.409 . . . . 0.0 110.544 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -54.36 98.81 0.18 Allowed Pre-proline 0 C--N 1.287 -2.145 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 19.0 Cg_endo -44.31 -29.3 2.94 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 C-N-CA 122.402 2.068 . . . . 0.0 113.679 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -158.76 -175.3 5.22 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.093 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -107.57 155.93 19.58 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.16 -168.61 26.53 Favored Glycine 1 N--CA 1.518 4.153 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 75' ' ' GLU . 5.6 m -109.95 154.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.435 -1.626 . . . . 0.0 112.268 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -74.56 108.9 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 1.9 tmtp? -94.24 -50.15 5.4 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.226 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.7 tt0 -155.88 162.89 40.35 Favored 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.518 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.3 pt? -167.85 156.77 9.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.085 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -131.76 53.27 2.01 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.39 153.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 O-C-N 126.079 2.112 . . . . 0.0 113.735 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 2.7 m120 -121.76 178.62 4.78 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 124.809 2.243 . . . . 0.0 115.576 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.37 108.9 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.96 -23.76 3.34 Favored Glycine 0 N--CA 1.507 3.378 1 CA-C-N 108.282 -4.054 . . . . 0.0 108.501 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -54.39 154.11 4.91 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.945 0.879 . . . . 0.0 111.58 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.613 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 9.6 mmmt -95.81 148.32 22.71 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.43 147.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.667 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HZ1' ' HB3' ' A' ' 13' ' ' ASP . 20.2 tttp -148.56 155.65 41.4 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.556 ' N ' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -30.28 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.052 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.46 -32.5 5.53 Favored Glycine 0 N--CA 1.511 3.698 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.327 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 21.2 m -37.84 122.87 1.02 Allowed 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 70' ' ' LEU . 7.4 mp -70.39 58.96 0.19 Allowed 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.556 ' CG1' HG22 ' A' ' 7' ' ' VAL . 5.1 mt -20.07 -61.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.448 ' SD ' ' HE1' ' A' ' 74' ' ' PHE . 7.9 ptp -156.85 176.77 12.31 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 112.573 -2.103 . . . . 0.0 114.509 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 114.06 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 123.845 1.783 . . . . 0.0 112.42 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.448 ' HE1' ' SD ' ' A' ' 72' ' ' MET . 17.0 m-30 -106.96 154.88 20.43 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.632 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 2.5 tp10 -127.01 123.35 36.86 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.3 m -51.9 33.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.582 2.189 1 N-CA-C 124.577 5.029 . . . . 0.0 124.577 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -90.82 63.89 5.4 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 123.604 1.669 . . . . 0.0 112.891 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.23 67.88 0.03 OUTLIER Glycine 0 N--CA 1.506 3.348 0 N-CA-C 104.971 -3.251 . . . . 0.0 104.971 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.28 138.39 36.76 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 112.268 -1.966 . . . . 0.0 109.143 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 O-C-N 126.658 2.474 . . . . 0.0 115.868 -179.844 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.551 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 9.0 ttt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 100.847 -3.76 . . . . 0.0 100.847 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.551 ' H ' ' HG2' ' A' ' 1' ' ' MET . 7.2 p -163.9 134.79 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -128.54 84.0 2.2 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.227 2.677 . . . . 0.0 118.227 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.08 143.85 1.06 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 74' ' ' PHE . 26.5 t -118.01 120.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.0 p-10 -117.48 172.78 7.1 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.552 ' CG1' HD12 ' A' ' 10' ' ' ILE . 5.8 t -101.95 137.3 19.47 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 118.299 -1.361 . . . . 0.0 109.563 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 42.4 Cg_endo -70.39 -92.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.195 0 C-N-CA 123.605 2.87 . . . . 0.0 111.327 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 10.1 p-10 -116.97 145.09 43.87 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 123.654 1.692 . . . . 0.0 109.491 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -155.93 48.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 CA-C-O 123.292 1.52 . . . . 0.0 111.496 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.24 -63.27 3.43 Favored Glycine 1 N--CA 1.522 4.406 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.342 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.81 -49.54 0.52 Allowed Glycine 1 N--CA 1.526 4.694 0 O-C-N 123.902 0.413 . . . . 0.0 112.154 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.29 -174.11 1.52 Allowed 'General case' 0 CA--C 1.585 2.321 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 8.3 pt-20 -102.29 151.89 21.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 119.387 -2.071 . . . . 0.0 107.239 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.83 158.43 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 119.337 3.088 . . . . 0.0 119.337 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 49.5 mt-10 -92.33 169.98 10.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.544 -0.723 . . . . 0.0 109.558 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 35' ' ' ILE . 60.0 t -106.89 116.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -94.49 -43.43 8.35 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.633 1.173 . . . . 0.0 113.787 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -136.49 102.06 4.83 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.678 1.228 . . . . 0.0 110.342 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.7 p -75.18 63.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 O-C-N 119.562 -1.962 . . . . 0.0 116.1 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 28.9 mmm -29.57 -33.6 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 26' ' ' ASP . 2.1 t -125.57 154.32 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -134.41 -176.93 4.37 Favored 'General case' 0 N--CA 1.521 3.078 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.54 87.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.932 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.101 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.91 26.01 3.71 Favored Glycine 0 N--CA 1.514 3.869 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.576 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.431 ' HB3' ' CG1' ' A' ' 22' ' ' VAL . 1.3 m-20 -116.37 141.09 48.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -63.36 115.02 4.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.798 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.19 98.23 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -105.04 149.43 25.81 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.232 -1.543 . . . . 0.0 114.782 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.2 73.03 0.3 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 177.2 -24.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.001 -3.272 . . . . 0.0 110.131 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -89.87 119.08 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.877 -1.14 . . . . 0.0 112.74 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 29.5 t -48.78 123.87 7.6 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.674 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 48' ' ' ALA . 1.5 mt -81.78 -55.46 4.61 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.477 1.132 . . . . 0.0 112.625 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' A' ' 17' ' ' VAL . 19.9 pt -146.7 129.75 8.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.481 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 m -73.17 137.68 45.23 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.1 m -124.77 154.54 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.1 OUTLIER -140.42 -164.41 1.71 Allowed 'General case' 0 N--CA 1.518 2.928 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.7 -51.26 0.49 Allowed Glycine 0 N--CA 1.513 3.809 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 42' ' ' ALA . 45.0 t0 -155.51 -118.12 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.636 0.732 . . . . 0.0 112.341 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.451 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -10.76 -44.2 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.888 2.922 . . . . 0.0 118.888 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . 171.92 157.15 0.09 Allowed 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 123.637 0.775 . . . . 0.0 111.571 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.7 m -58.81 127.64 33.23 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 44.0 mmm -116.79 166.72 11.82 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.064 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -130.81 156.93 44.17 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 6.1 t -131.25 105.83 14.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.311 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 1.4 Cg_endo -77.71 175.66 10.97 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 C-N-CA 121.155 1.236 . . . . 0.0 110.212 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.643 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -72.3 107.49 3.07 Favored Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -38.3 -39.33 1.01 Allowed 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.42 2.747 . . . . 0.0 113.981 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -150.77 176.69 10.8 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.02 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -94.82 89.09 5.54 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.57 -164.46 10.18 Favored Glycine 1 N--CA 1.52 4.259 0 CA-C-N 114.48 -1.236 . . . . 0.0 113.603 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.47 156.5 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 ' CE1' ' A' ' 74' ' ' PHE . 2.7 t -87.11 135.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.372 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 10.2 tptt -110.97 -65.22 1.19 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.158 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.506 ' CD ' ' CE ' ' A' ' 58' ' ' LYS . 29.7 tt0 -137.85 148.86 45.8 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.637 0.732 . . . . 0.0 109.521 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 57' ' ' LEU . 2.1 pt? -157.64 154.76 28.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' CE ' ' CD ' ' A' ' 56' ' ' GLU . 86.6 mttt -131.1 51.55 2.13 Favored 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.11 154.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 CA-C-N 111.82 -2.446 . . . . 0.0 114.195 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -145.55 -176.19 5.02 Favored 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.0 t -84.65 113.22 22.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 1 N-CA-C 99.688 -4.19 . . . . 0.0 99.688 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.93 10.15 12.7 Favored Glycine 0 N--CA 1.513 3.769 0 CA-C-N 112.293 -2.23 . . . . 0.0 108.952 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -103.68 159.58 15.5 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HZ3' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -114.51 150.12 35.36 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -179.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -136.02 166.04 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.336 -179.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.596 ' HD2' ' N ' ' A' ' 67' ' ' THR . 4.5 tmmm? -159.72 160.54 34.16 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.076 -1.015 . . . . 0.0 109.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.596 ' N ' ' HD2' ' A' ' 66' ' ' LYS . 6.5 p -43.4 112.93 0.43 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.8 -8.49 61.55 Favored Glycine 0 N--CA 1.515 3.964 0 CA-C-N 113.043 -1.89 . . . . 0.0 114.619 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 7.2 m -67.41 127.13 31.53 Favored 'General case' 0 N--CA 1.52 3.068 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.184 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 6' ' ' ASN . 0.8 OUTLIER -72.99 66.21 0.79 Allowed 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -36.46 -61.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 119.549 3.166 . . . . 0.0 119.549 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 ptp -144.89 175.18 10.39 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 113.987 -1.46 . . . . 0.0 114.812 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mt -113.72 121.94 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.932 1.349 . . . . 0.0 111.677 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.553 ' CD1' HG21 ' A' ' 5' ' ' VAL . 15.2 m-30 -106.0 -177.36 3.34 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.168 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -153.44 165.55 35.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m -115.57 70.04 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 120.224 3.416 . . . . 0.0 120.224 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.496 ' OE2' ' NZ ' ' A' ' 55' ' ' LYS . 52.2 mt-10 -61.0 -71.62 0.14 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 119.116 3.006 . . . . 0.0 119.116 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.81 9.27 0.87 Allowed Glycine 1 N--CA 1.533 5.142 0 O-C-N 119.924 -1.735 . . . . 0.0 114.491 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 49.5 31.29 3.95 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 112.319 -1.941 . . . . 0.0 115.451 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.62 0 C-N-CA 127.874 2.469 . . . . 0.0 104.972 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.339 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 m -55.92 -174.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 1.1 mptt -125.15 155.09 40.49 Favored 'General case' 0 N--CA 1.515 2.781 0 CA-C-O 122.015 0.912 . . . . 0.0 112.477 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -107.35 149.35 27.94 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.298 1.523 . . . . 0.0 113.375 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 59.5 t -102.97 102.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-O 124.102 1.906 . . . . 0.0 112.074 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.453 ' H ' ' ND2' ' A' ' 6' ' ' ASN . 2.1 p30 -95.94 130.12 43.0 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 111.094 -2.775 . . . . 0.0 105.563 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 67' ' ' THR . 69.7 t -55.64 132.51 71.79 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HD3' ' A' ' 49' ' ' PRO . 62.6 Cg_endo -69.36 -176.41 1.36 Allowed 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.578 1.519 . . . . 0.0 114.119 176.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -62.02 46.57 0.01 OUTLIER 'General case' 0 CA--C 1.58 2.101 0 C-N-CA 127.905 2.482 . . . . 0.0 115.912 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.57 HG21 HG22 ' A' ' 46' ' ' VAL . 40.3 pt -79.11 59.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 O-C-N 119.79 -1.819 . . . . 0.0 113.017 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -33.13 140.16 0.08 OUTLIER Glycine 1 N--CA 1.521 4.362 0 CA-C-N 113.635 -1.621 . . . . 0.0 116.261 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.97 88.58 0.66 Allowed Glycine 1 N--CA 1.52 4.238 0 CA-C-O 121.881 0.712 . . . . 0.0 112.042 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.255 17.9 m-20 -2.36 60.39 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 121.086 3.736 . . . . 0.0 121.086 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' OE1' ' HB3' ' A' ' 66' ' ' LYS . 27.1 mm-40 69.07 118.36 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.032 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.846 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 m -119.5 158.83 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.892 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 7.6 pt-20 -100.27 167.73 10.23 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.245 -0.909 . . . . 0.0 109.818 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' A' ' 35' ' ' ILE . 22.0 t -105.35 113.44 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.394 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.3 p -90.5 -40.98 11.67 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 93.8 mt-10 -133.99 101.76 5.17 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 123.297 1.522 . . . . 0.0 111.682 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.37 73.64 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-O 125.981 2.801 . . . . 0.0 113.047 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.449 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 mtp -38.39 -45.66 1.04 Allowed 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' C ' ' HD3' ' A' ' 23' ' ' LYS . 10.4 m -103.31 153.44 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 CA-C-N 119.486 1.039 . . . . 0.0 113.349 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.615 ' HD3' ' C ' ' A' ' 22' ' ' VAL . 3.7 mppt? -129.58 175.16 9.02 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.0 107.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.745 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.87 -28.11 5.5 Favored Glycine 1 N--CA 1.519 4.176 0 N-CA-C 114.598 0.599 . . . . 0.0 114.598 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -59.66 157.54 11.64 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 17.6 mmtp -107.85 103.32 12.55 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 123.513 1.625 . . . . 0.0 106.982 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.644 HG11 HD21 ' A' ' 34' ' ' LEU . 66.1 t -103.78 117.88 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 120.327 3.454 . . . . 0.0 120.327 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -112.86 154.32 26.5 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 119.803 -1.81 . . . . 0.0 113.897 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.79 92.66 2.52 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 160.59 -20.51 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 109.994 -3.275 . . . . 0.0 109.284 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -89.58 165.86 14.0 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.023 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.3 p -85.56 106.19 16.7 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.644 HD21 HG11 ' A' ' 28' ' ' VAL . 3.4 mt -69.13 -63.78 1.0 Allowed 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 17' ' ' VAL . 33.9 pt -143.11 157.88 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.128 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 9.9 m -104.7 134.26 48.15 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.7 m -127.12 165.62 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -131.63 151.13 51.86 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.82 -161.41 9.22 Favored Glycine 0 N--CA 1.511 3.646 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 25.3 t70 -63.38 96.15 0.11 Allowed 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 117.634 -1.626 . . . . 0.0 109.104 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER 46.57 39.61 7.11 Favored 'General case' 0 N--CA 1.511 2.616 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.374 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.82 65.72 1.34 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 13.7 t -51.82 131.38 30.64 Favored 'General case' 0 N--CA 1.518 2.959 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 mmt -139.02 168.42 19.87 Favored 'General case' 0 N--CA 1.513 2.72 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -111.3 151.89 27.84 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 122.177 0.989 . . . . 0.0 111.627 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 10' ' ' ILE . 70.2 t -122.66 119.59 28.11 Favored Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.616 -0.677 . . . . 0.0 109.708 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -85.17 175.9 6.19 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 CA-C-O 122.581 0.992 . . . . 0.0 111.67 175.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -75.6 108.41 5.77 Favored Pre-proline 0 CA--C 1.58 2.111 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD3' ' HD3' ' A' ' 8' ' ' PRO . 29.8 Cg_endo -48.62 -30.46 16.46 Favored 'Trans proline' 0 N--CA 1.512 2.584 0 C-N-CA 123.084 2.523 . . . . 0.0 114.122 -170.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 178.38 10.15 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.498 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.29 20.85 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.04 -175.79 35.19 Favored Glycine 0 N--CA 1.507 3.413 0 CA-C-O 121.812 0.673 . . . . 0.0 111.985 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.6 151.12 19.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.199 -1.177 . . . . 0.0 111.379 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 10.7 t -74.69 80.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.633 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HE2' ' CB ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -68.54 -41.36 79.99 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.528 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CB ' ' HE2' ' A' ' 55' ' ' LYS . 39.7 tt0 -167.74 166.32 13.8 Favored 'General case' 0 N--CA 1.512 2.666 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 57' ' ' LEU . 1.6 pt? -166.56 159.34 14.19 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.02 0.438 . . . . 0.0 110.046 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -132.24 49.14 2.34 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 122.715 1.245 . . . . 0.0 108.958 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.43 157.03 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 112.524 -2.125 . . . . 0.0 113.279 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -129.94 178.42 6.54 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 125.829 2.728 . . . . 0.0 115.065 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -90.24 112.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 100.536 -3.876 . . . . 0.0 100.536 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.02 -29.41 3.52 Favored Glycine 0 N--CA 1.511 3.665 0 CA-C-N 109.636 -3.438 . . . . 0.0 109.363 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -62.07 159.18 14.96 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.886 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -104.75 142.88 33.91 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HB ' HG21 ' A' ' 7' ' ' VAL . 28.6 m -123.71 158.19 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HB3' ' OE1' ' A' ' 14' ' ' GLU . 14.4 ptmm? -153.03 145.7 24.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 118.088 -0.958 . . . . 0.0 108.934 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 14.3 t -47.78 121.74 4.35 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.851 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.98 35.06 Favored Glycine 0 N--CA 1.513 3.825 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.733 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.8 t -78.36 121.45 24.49 Favored 'General case' 0 N--CA 1.52 3.06 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.15 66.54 0.63 Allowed 'General case' 0 N--CA 1.516 2.827 0 CA-C-O 122.032 0.92 . . . . 0.0 113.158 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.478 HG13 ' HG2' ' A' ' 72' ' ' MET . 35.9 pt -58.98 -45.78 91.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.517 ' HE1' HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -137.24 165.11 26.92 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 112.888 -1.96 . . . . 0.0 115.974 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.06 125.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.943 1.354 . . . . 0.0 113.448 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.488 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 7.3 m-30 -117.14 150.35 38.85 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.24 160.11 30.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 78' ' ' GLY . 27.2 m -106.07 67.7 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 2.2 mm-40 -13.59 62.61 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.785 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . -177.24 91.41 0.08 OUTLIER Glycine 0 N--CA 1.505 3.297 1 N-CA-C 99.87 -5.292 . . . . 0.0 99.87 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.29 55.9 1.31 Allowed 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 C-N-CA 127.173 2.189 . . . . 0.0 107.701 -179.967 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 117.232 -1.366 . . . . 0.0 107.792 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 m -87.74 -177.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 124.813 1.321 . . . . 0.0 110.361 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 2.3 mmtt -131.97 127.41 36.24 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.331 1.063 . . . . 0.0 112.961 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.661 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -68.97 122.68 19.17 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.892 -1.503 . . . . 0.0 110.595 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.697 HG21 ' CD1' ' A' ' 74' ' ' PHE . 10.6 t -101.49 96.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 CA-C-O 124.573 2.13 . . . . 0.0 114.999 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' HB2' ' HA2' ' A' ' 68' ' ' GLY . 12.2 p-10 -89.13 128.15 35.76 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 110.058 -3.246 . . . . 0.0 106.986 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.557 HG12 HD12 ' A' ' 10' ' ' ILE . 12.5 t -68.49 130.79 91.89 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 28.2 Cg_endo -72.28 -92.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.951 2.434 . . . . 0.0 115.635 -172.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.474 ' H ' ' HG2' ' A' ' 8' ' ' PRO . 9.8 p-10 -108.58 106.57 16.69 Favored 'General case' 0 CA--C 1.577 1.983 0 CA-C-O 125.865 2.745 . . . . 0.0 114.487 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.557 HD12 HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.43 50.13 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.254 -1.529 . . . . 0.0 111.156 179.836 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.33 -59.17 4.67 Favored Glycine 1 N--CA 1.519 4.211 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.897 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 161.33 -53.83 0.32 Allowed Glycine 1 N--CA 1.523 4.494 0 CA-C-N 114.272 -0.964 . . . . 0.0 114.084 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.46 -149.33 0.14 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 124.1 0.96 . . . . 0.0 110.591 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -120.19 145.45 46.96 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.392 -1.443 . . . . 0.0 110.307 179.253 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.59 177.59 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -178.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -102.48 176.14 5.27 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 120.584 1.538 . . . . 0.0 113.728 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 t -108.35 119.4 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.033 0 CA-C-O 122.921 1.344 . . . . 0.0 113.251 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 1.1 m -93.04 -52.67 4.47 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.368 -1.742 . . . . 0.0 111.305 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 16.5 mm-40 -126.32 126.87 44.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.485 0.659 . . . . 0.0 109.499 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.453 HG22 ' HZ3' ' A' ' 23' ' ' LYS . 13.7 p -105.73 61.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 123.045 1.403 . . . . 0.0 111.646 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmt -21.22 -46.7 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 110.622 -2.99 . . . . 0.0 116.671 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.436 HG11 HG22 ' A' ' 28' ' ' VAL . 2.4 t -112.79 159.7 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HZ3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -133.7 178.42 6.95 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 179.851 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.6 99.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.782 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.65 -12.69 13.51 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.679 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 22' ' ' VAL . 58.7 m-20 -75.76 147.22 39.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.641 ' HD2' HG13 ' A' ' 53' ' ' VAL . 27.8 mmmt -73.84 108.61 6.77 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.705 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -109.29 124.16 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.956 0.884 . . . . 0.0 109.95 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -137.3 159.88 40.65 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.08 161.06 0.08 Allowed 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.25 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 56.93 -1.7 0.05 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.07 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 29' ' ' ALA . 1.4 tm0? -96.07 107.67 20.0 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.5 m -48.33 121.72 4.66 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.6 mt -88.23 -59.38 2.25 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -144.79 152.95 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.702 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 16.7 m -110.44 125.42 53.25 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 179.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.97 157.8 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.76 -175.01 3.82 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.28 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.4 -72.1 0.28 Allowed Glycine 1 N--CA 1.521 4.363 0 CA-C-O 119.181 -0.788 . . . . 0.0 114.925 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -118.63 -121.76 0.29 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 124.242 1.972 . . . . 0.0 114.421 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 41' ' ' LYS . 2.7 mmmp? -19.57 -40.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 119.842 3.275 . . . . 0.0 119.842 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 167.91 164.55 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 O-C-N 126.682 2.488 . . . . 0.0 111.906 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -74.71 152.8 39.07 Favored 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.94 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.5 ttt -144.85 161.05 40.26 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.079 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.28 155.16 20.81 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 123.265 1.507 . . . . 0.0 114.493 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.493 HG21 ' CG2' ' A' ' 10' ' ' ILE . 21.0 t -127.88 126.07 23.75 Favored Pre-proline 0 N--CA 1.499 1.979 0 CA-C-N 113.145 -1.843 . . . . 0.0 110.48 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -91.18 177.83 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 CA-C-O 124.51 1.796 . . . . 0.0 113.367 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.707 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -70.25 103.71 0.66 Allowed Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 111.699 -2.501 . . . . 0.0 117.613 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 23.7 Cg_endo -46.69 -26.21 4.28 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 121.718 1.612 . . . . 0.0 114.067 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -162.14 -172.62 3.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.683 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.71 166.81 10.52 Favored 'General case' 0 CA--C 1.568 1.669 1 N-CA-C 122.747 4.351 . . . . 0.0 122.747 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.62 -134.68 7.26 Favored Glycine 1 N--CA 1.526 4.645 0 CA-C-N 113.173 -1.831 . . . . 0.0 113.684 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG13 ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -134.91 160.52 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 O-C-N 121.512 -0.993 . . . . 0.0 109.915 179.317 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 39.7 t -84.44 133.63 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 C-N-CA 117.604 -1.638 . . . . 0.0 106.912 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 45.5 tptt -102.73 -62.52 1.26 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 25.6 tt0 -150.53 158.79 44.55 Favored 'General case' 0 N--CA 1.511 2.624 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.539 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.1 pt? -166.02 149.66 7.71 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -125.03 50.06 1.8 Allowed 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.67 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.8 162.9 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 126.33 2.269 . . . . 0.0 113.967 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.425 ' H ' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -135.27 -177.51 4.68 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 120.625 3.565 . . . . 0.0 120.625 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -94.4 67.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 127.458 3.504 . . . . 0.0 109.575 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.15 37.33 0.02 OUTLIER Glycine 0 N--CA 1.506 3.354 1 CA-C-N 105.395 -5.366 . . . . 0.0 109.602 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' H ' ' A' ' 60' ' ' ASN . 9.8 t0 -121.53 173.9 7.11 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 111.568 -2.316 . . . . 0.0 104.912 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' C ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -121.79 160.67 24.14 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 120.356 3.465 . . . . 0.0 120.356 -179.517 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG12 HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.27 147.8 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 119.992 3.33 . . . . 0.0 119.992 -179.213 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.606 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -155.95 163.23 40.0 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.724 179.733 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -50.58 106.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 123.358 1.551 . . . . 0.0 114.763 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 6' ' ' ASN . . . 95.05 11.69 56.09 Favored Glycine 0 N--CA 1.513 3.767 0 CA-C-N 113.39 -1.732 . . . . 0.0 112.671 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 t -76.12 116.9 17.27 Favored 'General case' 0 N--CA 1.507 2.423 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.551 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -83.45 77.09 9.87 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 123.81 1.767 . . . . 0.0 109.831 -179.599 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.535 HG21 HG12 ' A' ' 65' ' ' VAL . 1.7 pp -77.95 -44.13 28.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.164 -1.835 . . . . 0.0 112.915 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 71' ' ' ILE . 9.3 ptm -130.36 175.34 9.04 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.674 -1.21 . . . . 0.0 113.259 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HA ' HG23 ' A' ' 5' ' ' VAL . 5.3 mp -128.49 128.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.697 ' CD1' HG21 ' A' ' 5' ' ' VAL . 16.4 m-30 -109.8 164.05 12.93 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.0 tt0 -137.88 131.11 30.5 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.39 56.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.53 147.52 26.67 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 118.928 2.936 . . . . 0.0 118.928 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 164.83 73.64 0.03 OUTLIER Glycine 0 N--CA 1.506 3.327 1 N-CA-C 101.876 -4.49 . . . . 0.0 101.876 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.94 48.56 0.72 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.932 0 C-N-CA 128.764 2.826 . . . . 0.0 107.848 -179.825 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.49 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 18.6 mtp . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.6 m -51.95 138.8 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.03 150.38 51.33 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 112.921 -1.945 . . . . 0.0 112.262 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -95.07 160.11 14.71 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG21 ' CE1' ' A' ' 74' ' ' PHE . 89.9 t -118.36 114.69 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.154 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 69' ' ' SER . 13.9 p-10 -105.79 173.67 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.968 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.481 HG11 HD11 ' A' ' 10' ' ' ILE . 38.4 t -95.18 131.04 30.8 Favored Pre-proline 0 N--CA 1.495 1.781 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.61 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -64.1 -176.38 0.37 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.343 1.362 . . . . 0.0 111.99 172.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -57.77 39.46 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 119.76 3.244 . . . . 0.0 119.76 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.61 HG21 ' CG2' ' A' ' 46' ' ' VAL . 27.6 pt -81.02 69.34 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 119.066 -2.271 . . . . 0.0 111.973 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.06 168.45 1.55 Allowed Glycine 1 N--CA 1.52 4.268 0 CA-C-N 112.663 -2.062 . . . . 0.0 112.562 179.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.34 170.4 12.74 Favored Glycine 1 N--CA 1.526 4.636 0 CA-C-O 121.482 0.49 . . . . 0.0 113.406 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.8 67.59 4.56 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 123.709 1.719 . . . . 0.0 114.194 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 68.82 100.61 0.06 Allowed 'General case' 0 N--CA 1.513 2.701 0 CA-C-N 111.859 -2.428 . . . . 0.0 111.039 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.497 HG21 HD12 ' A' ' 10' ' ' ILE . 18.0 m -96.35 141.7 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 117.302 -1.759 . . . . 0.0 106.843 -179.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.672 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 12.2 pt-20 -118.16 164.71 14.75 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.2 -1.4 . . . . 0.0 113.266 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 62' ' ' GLY . 10.2 t -83.6 123.91 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.418 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.1 t -102.39 -45.8 4.98 Favored 'General case' 0 N--CA 1.522 3.155 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.798 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 24.3 mt-10 -130.97 123.1 28.08 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.893 0.854 . . . . 0.0 109.594 178.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -102.99 71.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 125.957 2.789 . . . . 0.0 110.538 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 mtt -34.07 -59.45 0.43 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 110.59 -3.004 . . . . 0.0 115.101 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.641 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 2.8 t -100.63 151.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 CA-C-O 122.161 0.981 . . . . 0.0 112.809 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.641 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -138.54 177.18 8.08 Favored 'General case' 0 N--CA 1.518 2.962 0 N-CA-C 121.574 3.916 . . . . 0.0 121.574 -178.74 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -42.5 97.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.88 11.8 25.58 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.634 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 t0 -110.32 142.23 42.25 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -59.39 107.17 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.707 -2.042 . . . . 0.0 116.145 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.529 HG11 ' CE2' ' A' ' 74' ' ' PHE . 94.6 t -114.97 118.22 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 122.271 1.034 . . . . 0.0 111.807 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -133.56 149.34 51.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.544 -1.348 . . . . 0.0 113.69 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -50.67 140.46 14.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 41.1 mm-40 93.73 -21.28 0.07 Allowed 'General case' 0 N--CA 1.513 2.707 0 O-C-N 126.703 2.502 . . . . 0.0 110.405 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -88.1 140.27 29.66 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.782 -1.199 . . . . 0.0 109.573 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 48.6 m -73.69 128.23 34.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 112.257 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.2 mt -95.38 -61.95 1.38 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 pt -137.66 146.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-O 122.551 1.167 . . . . 0.0 113.03 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 45' ' ' GLU . 88.1 m -101.87 116.89 33.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 33.4 m -113.25 160.6 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -127.08 -165.31 1.45 Allowed 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.942 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.14 -53.89 0.78 Allowed Glycine 1 N--CA 1.529 4.881 0 CA-C-N 119.052 0.842 . . . . 0.0 114.355 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -86.33 179.67 6.85 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.162 0.982 . . . . 0.0 109.709 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -46.0 -7.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -154.58 162.11 41.29 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.2 t -83.13 138.65 33.59 Favored 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.98 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -118.94 156.07 30.2 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.477 0.581 . . . . 0.0 111.465 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HG2' HG23 ' A' ' 36' ' ' THR . 47.6 mt-10 -111.64 158.48 19.21 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.61 ' CG2' HG21 ' A' ' 10' ' ' ILE . 2.9 t -128.14 123.09 22.42 Favored Pre-proline 0 N--CA 1.497 1.879 0 CA-C-N 112.644 -2.071 . . . . 0.0 112.164 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -84.52 -179.7 3.97 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 CA-C-O 123.55 1.396 . . . . 0.0 112.636 168.937 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -66.02 101.24 0.27 Allowed Pre-proline 0 C--N 1.282 -2.356 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' HD12 ' A' ' 34' ' ' LEU . 9.4 Cg_endo -36.61 -35.98 0.22 Allowed 'Trans proline' 0 N--CA 1.51 2.476 0 C-N-CA 122.71 2.273 . . . . 0.0 113.986 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -154.24 -177.49 6.47 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 112.078 -2.328 . . . . 0.0 107.006 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -100.31 168.79 9.55 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.97 -147.53 19.29 Favored Glycine 1 N--CA 1.517 4.035 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.075 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.37 148.16 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 47.6 t -68.94 92.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.142 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' NZ ' ' CD ' ' A' ' 56' ' ' GLU . 17.5 tttm -69.82 -58.9 3.33 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.954 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' CD ' ' NZ ' ' A' ' 55' ' ' LYS 0.319 37.3 tt0 -149.52 144.07 26.03 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.52 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.9 pt? -130.73 155.15 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -128.54 37.58 4.1 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.106 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.43 161.98 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-N 113.09 -1.868 . . . . 0.0 114.562 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -122.83 173.96 7.44 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 124.819 2.247 . . . . 0.0 115.677 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 18' ' ' THR . 3.4 t -98.97 100.69 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 101.305 -3.591 . . . . 0.0 101.305 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' VAL . . . 120.86 30.58 1.33 Allowed Glycine 0 N--CA 1.511 3.678 1 CA-C-N 106.973 -4.649 . . . . 0.0 107.8 -179.336 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -107.28 155.34 20.06 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 114.133 -1.034 . . . . 0.0 109.995 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.672 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 31.4 mmtm -89.22 140.15 29.76 Favored 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.27 166.75 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.97 0.891 . . . . 0.0 111.035 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -165.98 153.5 10.27 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 t -47.9 127.04 11.46 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 117.304 -1.758 . . . . 0.0 111.858 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.66 -40.5 2.41 Favored Glycine 0 N--CA 1.513 3.824 0 CA-C-N 114.902 -1.044 . . . . 0.0 114.464 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 32.3 t -57.0 146.25 27.69 Favored 'General case' 0 N--CA 1.518 2.927 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.289 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.99 63.89 7.56 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.682 1.23 . . . . 0.0 114.28 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.58 HG22 ' SD ' ' A' ' 72' ' ' MET . 1.4 mt -17.0 -57.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.58 ' SD ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -168.84 -176.81 2.81 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 111.767 -2.469 . . . . 0.0 114.92 -179.596 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.96 125.45 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 124.092 1.901 . . . . 0.0 112.767 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 28' ' ' VAL . 17.3 m-30 -112.9 156.23 23.33 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.885 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' OE2' ' N ' ' A' ' 1' ' ' MET . 6.1 tp10 -130.46 139.61 50.55 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 103.571 -2.752 . . . . 0.0 103.571 179.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 76' ' ' VAL . 16.2 m -86.26 23.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 1 N-CA-C 123.075 4.472 . . . . 0.0 123.075 -179.187 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 76' ' ' VAL . 17.4 mm-40 6.78 -86.06 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.98 51.8 0.63 Allowed Glycine 0 N--CA 1.509 3.534 0 N-CA-C 103.287 -3.925 . . . . 0.0 103.287 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.49 82.68 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -179.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.565 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.12 179.63 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.677 ' H3 ' ' CA ' ' A' ' 80' ' ' ALA . 3.6 tmm? . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 101.886 -3.376 . . . . 0.0 101.886 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 m -126.56 159.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.078 0 CA-C-N 123.694 2.952 . . . . 0.0 113.467 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.574 ' HG3' HG13 ' A' ' 76' ' ' VAL . 70.7 mmtt -133.31 148.64 51.91 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -103.07 155.42 18.4 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.58 -1.325 . . . . 0.0 114.246 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 74' ' ' PHE . 40.1 t -121.97 88.36 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 124.753 2.216 . . . . 0.0 113.852 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 14.8 p30 -95.05 170.36 9.47 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 111.291 -2.686 . . . . 0.0 105.802 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.539 HG21 HG11 ' A' ' 65' ' ' VAL . 96.0 t -104.6 136.02 19.23 Favored Pre-proline 0 N--CA 1.504 2.246 0 C-N-CA 118.135 -1.426 . . . . 0.0 113.39 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 53.1 Cg_exo -60.41 -166.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.842 2.361 . . . . 0.0 115.509 168.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.23 32.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.638 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.4 mp -83.75 64.31 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 CA-C-O 126.198 2.904 . . . . 0.0 111.982 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.51 -113.28 4.38 Favored Glycine 0 C--N 1.292 -1.87 0 CA-C-N 109.863 -3.335 . . . . 0.0 110.859 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.99 -31.55 1.97 Allowed Glycine 0 N--CA 1.514 3.846 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.98 84.07 0.22 Allowed 'General case' 0 CA--C 1.58 2.123 0 CA-C-N 111.754 -2.223 . . . . 0.0 105.339 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' CD ' ' NZ ' ' A' ' 64' ' ' LYS . 12.9 tt0 -2.67 86.27 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.106 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -179.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -99.23 168.92 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.651 -179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 64' ' ' LYS . 8.7 pt-20 -124.42 172.63 9.01 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.68 122.84 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.995 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 p -101.56 -42.56 6.19 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.48 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.87 109.32 11.17 Favored 'General case' 0 N--CA 1.511 2.605 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' HG22 ' A' ' 61' ' ' VAL . 13.4 p -92.09 72.9 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 125.361 2.505 . . . . 0.0 110.279 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.9 mtt -35.27 -56.87 0.61 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 111.694 -2.503 . . . . 0.0 112.951 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.563 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 10.3 p -105.67 164.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 CA-C-O 123.29 1.519 . . . . 0.0 114.145 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.632 ' HD2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -145.96 174.69 11.04 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 119.409 3.114 . . . . 0.0 119.409 -179.424 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.2 t -47.62 111.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.13 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.69 -27.87 6.99 Favored Glycine 1 N--CA 1.516 4.027 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.117 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -81.93 173.17 12.47 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 124.256 1.979 . . . . 0.0 115.947 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.06 136.36 50.21 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.944 -1.934 . . . . 0.0 112.586 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG11 HD21 ' A' ' 34' ' ' LEU . 9.4 t -126.41 160.65 33.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.993 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.03 156.05 28.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.516 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -51.72 168.86 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 125.071 1.482 . . . . 0.0 111.171 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 5.9 mp0 55.17 -7.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.156 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -101.89 110.0 21.88 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 179.51 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -40.16 133.57 1.73 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 9.4 mt -100.86 -61.76 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.47 HG13 ' HB ' ' A' ' 46' ' ' VAL . 36.6 pt -141.85 151.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.243 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.9 m -101.84 138.27 39.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 15.9 m -129.67 150.91 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -123.01 162.74 21.78 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.04 148.06 19.49 Favored Glycine 1 N--CA 1.516 4.029 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.648 ' CB ' ' HD3' ' A' ' 41' ' ' LYS . 11.8 m-20 6.69 -67.16 0.0 OUTLIER 'General case' 0 CA--C 1.59 2.482 0 N-CA-C 120.533 3.531 . . . . 0.0 120.533 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.648 ' HD3' ' CB ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -136.29 35.94 2.75 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 126.605 1.962 . . . . 0.0 113.324 -179.515 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.65 136.7 4.52 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.7 t -108.74 169.01 8.93 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.991 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.486 ' SD ' HG23 ' A' ' 10' ' ' ILE . 51.6 ttm -167.81 164.09 14.13 Favored 'General case' 0 N--CA 1.517 2.883 0 CA-C-O 122.45 1.119 . . . . 0.0 112.927 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.6 mp0 -103.71 141.68 35.65 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 124.368 2.032 . . . . 0.0 114.659 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.561 ' CG2' HG21 ' A' ' 10' ' ' ILE . 22.7 t -121.56 98.97 45.58 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -81.94 -178.72 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 CA-C-O 124.25 1.688 . . . . 0.0 113.618 171.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -68.24 102.21 0.37 Allowed Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.7 Cg_endo -41.11 -25.01 0.2 Allowed 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 121.945 1.763 . . . . 0.0 115.453 170.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.45 -167.09 0.75 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.37 163.9 12.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.96 -175.72 19.34 Favored Glycine 1 N--CA 1.522 4.428 0 CA-C-N 113.58 -1.645 . . . . 0.0 113.443 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 75' ' ' GLU . 35.7 m -100.24 166.23 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.307 . . . . 0.0 114.287 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 74' ' ' PHE . 20.0 t -89.43 106.87 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 113.983 -1.462 . . . . 0.0 112.047 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -64.18 1.09 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 13.8 tt0 -140.39 155.71 46.65 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 118.506 0.594 . . . . 0.0 111.825 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.565 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 2.0 pt? -161.61 153.69 19.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.545 -0.722 . . . . 0.0 110.114 178.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.507 ' HD2' ' OE2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -129.05 55.87 1.71 Allowed 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.51 151.46 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 112.277 -2.238 . . . . 0.0 111.622 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -130.57 170.99 13.53 Favored 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.451 HG22 ' HB ' ' A' ' 20' ' ' VAL . 3.2 t -87.77 111.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 1 N-CA-C 98.202 -4.74 . . . . 0.0 98.202 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.36 21.64 5.1 Favored Glycine 0 N--CA 1.514 3.886 0 CA-C-N 109.667 -3.424 . . . . 0.0 111.716 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.297 36.1 t0 -114.56 175.27 5.56 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.648 1.179 . . . . 0.0 111.537 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HD3' ' HB3' ' A' ' 16' ' ' GLU . 25.8 mmtp -98.56 149.55 22.63 Favored 'General case' 0 N--CA 1.526 3.351 1 N-CA-C 122.395 4.22 . . . . 0.0 122.395 -179.049 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 7' ' ' VAL . 4.4 t -144.77 168.36 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 67' ' ' THR . 10.4 ptmm? 174.93 139.0 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.6 t -31.51 122.55 0.26 Allowed 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.72 -24.77 26.17 Favored Glycine 0 N--CA 1.509 3.561 0 CA-C-N 114.285 -1.325 . . . . 0.0 114.624 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 20.1 m -75.21 123.22 24.89 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 70' ' ' LEU . 7.2 mp -75.46 72.32 2.46 Favored 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 125.338 1.455 . . . . 0.0 114.694 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.423 HD11 ' SD ' ' A' ' 72' ' ' MET . 1.7 pp -56.03 -52.49 49.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.445 ' SD ' ' CE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -127.95 174.95 8.75 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.8 mt -123.79 129.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.677 0.751 . . . . 0.0 110.602 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.7 m-30 -114.77 158.79 21.39 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.465 1.602 . . . . 0.0 111.732 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 53' ' ' VAL 0.355 11.6 tt0 -136.28 124.25 22.8 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 179.52 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 3' ' ' LYS . 23.3 m -68.56 54.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 121.047 3.721 . . . . 0.0 121.047 -179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' HG2' HG21 ' A' ' 53' ' ' VAL . 22.8 mm-40 -13.81 74.1 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.287 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 76' ' ' VAL . . . -138.62 -63.22 0.04 OUTLIER Glycine 0 N--CA 1.508 3.494 0 N-CA-C 104.751 -3.34 . . . . 0.0 104.751 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . 176.88 29.73 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.677 ' CA ' ' H3 ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 114.709 -2.567 . . . . 0.0 111.66 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.514 2.733 0 CA-C-O 116.07 -1.919 . . . . 0.0 106.107 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 3' ' ' LYS . 20.5 t -122.02 175.37 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.575 0 O-C-N 124.544 1.153 . . . . 0.0 112.419 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 1.1 mmpt? -131.8 164.05 26.89 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.2 mp0 -107.78 140.4 40.91 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG21 ' CD1' ' A' ' 74' ' ' PHE . 25.8 t -115.08 100.84 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 CA-C-O 122.907 1.337 . . . . 0.0 112.483 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 69' ' ' SER . 3.3 p30 -91.84 173.87 7.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.806 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.594 HG22 ' CG1' ' A' ' 71' ' ' ILE . 1.4 t -112.71 137.2 21.66 Favored Pre-proline 0 N--CA 1.499 2.006 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.687 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.91 -173.25 0.57 Allowed 'Trans proline' 0 CA--C 1.56 1.778 0 C-N-CA 122.161 1.907 . . . . 0.0 116.437 175.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -57.96 42.74 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 119.282 3.067 . . . . 0.0 119.282 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.547 HG21 ' CG2' ' A' ' 46' ' ' VAL . 10.8 pt -80.42 48.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 O-C-N 119.639 -1.913 . . . . 0.0 113.746 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.86 173.33 20.61 Favored Glycine 1 N--CA 1.524 4.54 0 N-CA-C 116.699 1.44 . . . . 0.0 116.699 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . -105.98 -25.33 6.52 Favored Glycine 1 N--CA 1.525 4.617 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.922 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.35 -137.4 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 129.555 3.142 . . . . 0.0 107.714 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' CD ' ' HD3' ' A' ' 64' ' ' LYS . 19.6 tt0 -133.54 148.31 51.63 Favored 'General case' 0 N--CA 1.522 3.157 0 CA-C-N 119.052 0.842 . . . . 0.0 112.302 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 m -142.67 163.24 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 O-C-N 120.709 -1.244 . . . . 0.0 113.123 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 8.6 pt-20 -113.79 178.9 4.12 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.424 HG13 ' HB ' ' A' ' 35' ' ' ILE . 96.0 t -110.76 111.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.99 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 4.9 t -91.51 -42.97 9.96 Favored 'General case' 0 N--CA 1.526 3.349 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -130.67 100.39 5.29 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 123.597 1.665 . . . . 0.0 109.327 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 61' ' ' VAL . 7.8 p -75.79 64.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 119.188 -2.195 . . . . 0.0 115.826 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -29.93 -27.4 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.537 HG22 ' N ' ' A' ' 23' ' ' LYS . 13.0 p -112.02 170.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' N ' HG22 ' A' ' 22' ' ' VAL . 33.3 mmtp -139.02 164.46 29.69 Favored 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.459 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 59.0 t -72.38 115.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 O-C-N 121.597 -0.69 . . . . 0.0 111.331 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . 116.01 -29.13 7.28 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.546 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.51 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 2.0 m-20 -63.9 -176.32 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 25' ' ' GLY . 36.7 mmtm -109.93 123.14 49.1 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.826 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 48' ' ' ALA . 2.2 t -123.35 102.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -91.9 162.5 14.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.05 -1.656 . . . . 0.0 111.434 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 32' ' ' GLN . . . -61.72 164.94 5.57 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.617 -1.233 . . . . 0.0 107.75 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 70.62 -22.04 0.18 Allowed 'General case' 0 N--CA 1.52 3.073 0 CA-C-O 123.6 1.666 . . . . 0.0 111.158 -179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 30' ' ' ALA . 37.7 tt0 -80.34 110.77 16.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.765 -1.209 . . . . 0.0 109.069 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 27.7 t -47.91 139.88 7.32 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.332 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.3 mt -103.61 -55.95 2.3 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.458 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -148.33 141.76 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.475 1.131 . . . . 0.0 111.947 179.935 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.6 m -86.37 122.75 30.78 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.97 152.05 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -137.15 148.66 46.77 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.949 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.73 3.46 8.64 Favored Glycine 1 N--CA 1.526 4.692 0 O-C-N 120.839 -1.163 . . . . 0.0 110.412 179.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.453 ' OD2' ' NZ ' ' A' ' 41' ' ' LYS . 47.1 t0 105.86 132.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 131.377 3.871 . . . . 0.0 104.257 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 18.2 mmtm 48.39 17.24 0.12 Allowed 'General case' 0 N--CA 1.52 3.066 0 O-C-N 121.488 -0.757 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -128.56 53.18 1.86 Allowed 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 -179.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 38' ' ' GLU . 53.2 m -54.44 86.01 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtp -122.02 176.05 6.01 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -125.8 157.98 36.14 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.547 ' CG2' HG21 ' A' ' 10' ' ' ILE . 6.2 t -129.41 110.71 17.82 Favored Pre-proline 0 N--CA 1.498 1.946 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.629 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -83.36 -179.36 4.24 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.44 1.426 . . . . 0.0 113.829 173.314 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -64.14 105.79 0.79 Allowed Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 120.484 3.513 . . . . 0.0 120.484 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 2.8 Cg_endo -29.09 -39.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.474 0 C-N-CA 122.165 1.91 . . . . 0.0 115.098 171.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.42 177.82 10.83 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.381 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -89.18 101.03 13.7 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.7 -178.9 29.5 Favored Glycine 1 N--CA 1.528 4.787 0 O-C-N 121.71 -0.619 . . . . 0.0 114.606 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 1.4 m -100.58 171.55 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.315 -1.697 . . . . 0.0 107.878 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' SD ' ' A' ' 72' ' ' MET . 96.3 t -94.04 121.99 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.237 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -86.05 -58.68 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 1.7 tp10 -167.2 150.79 6.53 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.843 1.964 . . . . 0.0 112.652 178.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -130.86 -178.61 4.88 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.194 -1.567 . . . . 0.0 110.856 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 1.5 mptp? -150.57 32.34 0.64 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.912 -1.117 . . . . 0.0 108.673 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.22 156.29 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-N 114.267 -1.333 . . . . 0.0 114.031 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -127.37 176.64 7.28 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.4 t -92.83 105.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 100.919 -3.734 . . . . 0.0 100.919 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.97 29.05 2.48 Favored Glycine 0 N--CA 1.51 3.617 1 CA-C-N 108.392 -4.004 . . . . 0.0 107.992 -178.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -113.73 163.24 15.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HD3' ' CD ' ' A' ' 14' ' ' GLU . 1.7 pptp? -115.43 143.26 45.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 -179.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.42 171.61 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 112.321 -2.218 . . . . 0.0 111.401 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 12' ' ' GLY . 1.6 tmtp? -165.53 151.29 9.36 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 117.93 -1.033 . . . . 0.0 108.68 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 3.8 t -42.06 116.39 0.81 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-O 121.975 0.893 . . . . 0.0 112.841 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.68 -30.0 9.68 Favored Glycine 0 N--CA 1.514 3.834 0 CA-C-N 114.925 -1.034 . . . . 0.0 114.021 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 1.8 t -52.13 162.03 0.54 Allowed 'General case' 0 N--CA 1.52 3.05 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -96.79 64.17 2.05 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.598 HG22 ' HG2' ' A' ' 72' ' ' MET . 0.8 OUTLIER -30.54 -49.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 179.64 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.598 ' HG2' HG22 ' A' ' 71' ' ' ILE . 1.1 ptp 178.38 -179.25 0.3 Allowed 'General case' 0 N--CA 1.511 2.622 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -107.81 133.63 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 123.617 1.675 . . . . 0.0 108.548 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.606 ' CD1' HG21 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -101.88 168.3 9.51 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.046 -1.888 . . . . 0.0 111.403 -179.604 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 53' ' ' VAL . 18.7 tt0 -146.69 99.45 3.2 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 123.782 1.753 . . . . 0.0 107.729 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.3 m -54.64 49.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.788 1 N-CA-C 123.287 4.551 . . . . 0.0 123.287 -179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.63 -173.93 2.85 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 123.636 1.684 . . . . 0.0 111.773 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.17 -52.44 0.04 OUTLIER Glycine 0 N--CA 1.503 3.144 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 126.72 -43.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 O-C-N 129.491 3.701 . . . . 0.0 109.182 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.306 0 C-N-CA 129.861 3.265 . . . . 0.0 107.596 179.688 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpt . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 9.5 p -19.13 137.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 119.854 3.279 . . . . 0.0 119.854 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 45.5 mmtt -138.24 165.12 27.51 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 118.822 2.897 . . . . 0.0 118.822 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -99.85 142.39 31.39 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 111.255 -2.702 . . . . 0.0 113.532 -179.39 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.611 HG21 ' CD1' ' A' ' 74' ' ' PHE . 43.4 t -118.79 98.43 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.168 0 O-C-N 121.212 -0.93 . . . . 0.0 112.447 179.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' SER . 23.6 p30 -110.82 174.89 5.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.381 1.086 . . . . 0.0 111.375 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 71' ' ' ILE . 70.1 t -108.78 130.34 22.85 Favored Pre-proline 0 N--CA 1.5 2.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.644 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 76.5 Cg_exo -57.01 -169.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.423 0 C-N-CA 123.654 2.903 . . . . 0.0 114.463 164.185 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -43.58 7.53 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.533 0 N-CA-C 120.377 3.473 . . . . 0.0 120.377 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 10' ' ' ILE . 4.3 mp -73.21 73.67 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 125.245 2.45 . . . . 0.0 113.411 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.93 103.36 1.27 Allowed Glycine 0 N--CA 1.5 2.902 0 N-CA-C 121.095 3.198 . . . . 0.0 121.095 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' HE3' ' A' ' 66' ' ' LYS . . . -70.11 -48.41 39.71 Favored Glycine 1 N--CA 1.523 4.454 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.593 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.96 -91.53 0.19 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 110.935 -2.633 . . . . 0.0 106.869 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -160.7 169.36 22.98 Favored 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.64 166.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.478 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 11.7 pt-20 -116.85 169.29 9.5 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 122.0 -0.438 . . . . 0.0 111.442 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.08 118.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 O-C-N 120.907 -1.12 . . . . 0.0 112.422 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 3.7 t -98.47 -34.8 10.48 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.204 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 43.5 mt-10 -134.58 105.48 6.54 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.581 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.2 p -89.44 89.94 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 126.084 2.849 . . . . 0.0 111.811 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mmt -59.93 -54.34 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 111.311 -2.677 . . . . 0.0 114.771 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG11 HD22 ' A' ' 34' ' ' LEU . 34.5 m -66.58 149.78 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 N-CA-C 118.009 2.596 . . . . 0.0 118.009 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 22' ' ' VAL . 13.0 mmtp -131.65 171.86 12.96 Favored 'General case' 0 N--CA 1.51 2.562 0 CA-C-O 121.366 0.603 . . . . 0.0 112.339 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -75.75 98.19 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.47 14.85 7.3 Favored Glycine 1 N--CA 1.52 4.263 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.703 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.11 136.69 36.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -76.48 111.54 12.05 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 125.042 2.353 . . . . 0.0 106.812 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 74' ' ' PHE . 96.7 t -111.22 108.31 25.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 109.857 -3.338 . . . . 0.0 112.719 -179.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.49 158.56 28.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.978 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -39.23 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.953 1.408 . . . . 0.0 113.037 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 72.61 -41.22 0.5 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.755 0.788 . . . . 0.0 110.823 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 13.2 tt0 -57.8 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.853 -1.155 . . . . 0.0 112.078 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 49.0 m -40.6 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.477 HD22 HG11 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -18.06 -67.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -151.31 149.38 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.236 -2.711 . . . . 0.0 109.294 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 19' ' ' GLU . 1.2 m -106.75 133.6 51.17 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.36 146.66 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 N-CA-C 118.578 2.806 . . . . 0.0 118.578 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -136.4 -153.39 0.5 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.35 -63.82 0.55 Allowed Glycine 1 N--CA 1.519 4.226 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.966 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.39 -171.16 2.02 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 123.775 1.75 . . . . 0.0 113.919 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -73.81 40.87 0.12 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.423 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.06 103.6 1.85 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.466 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.3 p -74.16 142.54 45.46 Favored 'General case' 0 N--CA 1.514 2.73 0 O-C-N 121.922 -0.486 . . . . 0.0 111.701 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.4 mmt -137.77 146.47 43.66 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 17.1 mp0 -118.77 159.62 23.37 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.517 ' CG2' HG21 ' A' ' 10' ' ' ILE . 12.3 t -129.39 124.89 22.3 Favored Pre-proline 0 N--CA 1.497 1.882 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.792 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.06 172.43 2.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.958 1.772 . . . . 0.0 112.025 171.438 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -53.17 100.55 0.23 Allowed Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 14.1 Cg_endo -42.44 -31.39 1.83 Allowed 'Trans proline' 0 N--CA 1.51 2.442 0 C-N-CA 122.816 2.344 . . . . 0.0 113.603 -178.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -160.0 -174.71 4.7 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.752 -2.476 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -107.25 159.87 16.03 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 120.509 3.522 . . . . 0.0 120.509 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.11 -144.87 15.9 Favored Glycine 1 N--CA 1.517 4.061 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.395 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.44 161.97 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 CA-C-N 117.937 0.868 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.46 HG22 ' CE1' ' A' ' 74' ' ' PHE . 31.3 t -85.96 116.6 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -90.58 -67.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 41.7 tt0 -143.43 152.1 41.15 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.335 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.7 pt? -145.94 146.18 30.95 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 30.6 mmtt -119.17 46.1 1.96 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.86 152.12 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -134.04 -178.73 5.16 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.971 2.32 . . . . 0.0 114.222 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.8 t -87.89 112.24 23.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.71 -19.28 5.59 Favored Glycine 0 N--CA 1.509 3.565 0 CA-C-N 109.893 -3.321 . . . . 0.0 110.779 -179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.12 168.91 12.97 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.573 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.66 145.21 33.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -179.69 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -126.85 176.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 112.876 -1.965 . . . . 0.0 111.249 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 67' ' ' THR . 37.8 tttt 166.19 144.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.48 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 4.5 t -39.47 119.49 0.95 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.48 -32.58 5.99 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.725 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 15.0 t -56.92 128.65 37.91 Favored 'General case' 0 N--CA 1.512 2.656 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.406 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.8 tt -87.59 64.21 7.96 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 124.842 2.258 . . . . 0.0 111.079 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.444 ' CG1' HG23 ' A' ' 7' ' ' VAL . 5.1 mm -24.26 -56.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 111.717 -2.492 . . . . 0.0 117.375 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 4.0 ptp -161.19 -174.17 4.21 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.033 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.15 123.97 72.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 124.504 2.097 . . . . 0.0 112.207 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.611 ' CD1' HG21 ' A' ' 5' ' ' VAL . 13.0 m-30 -113.05 165.26 12.53 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.733 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 2' ' ' VAL . 2.0 tt0 -142.3 122.71 14.01 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.32 87.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 CA-C-O 122.736 1.255 . . . . 0.0 113.631 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 73.1 -87.86 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 111.889 -2.414 . . . . 0.0 114.061 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.13 -73.1 0.45 Allowed Glycine 1 N--CA 1.516 4.009 1 N-CA-C 99.674 -5.37 . . . . 0.0 99.674 179.761 . . . . . . . . 3 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -167.07 31.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 178.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 79' ' ' ALA . . . . . . . . 0 N--CA 1.496 1.839 0 C-N-CA 128.86 2.864 . . . . 0.0 108.57 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.8 mtp . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m -161.96 169.27 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 124.962 1.414 . . . . 0.0 108.735 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.781 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -142.98 154.38 43.96 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 124.233 1.968 . . . . 0.0 111.395 178.789 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.781 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 13.4 pm0 -112.96 149.94 32.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.82 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.536 ' CG2' ' CG ' ' A' ' 74' ' ' PHE . 87.8 t -120.14 113.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.598 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.734 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 15.9 p-10 -109.86 177.18 4.8 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.329 1.062 . . . . 0.0 109.533 179.289 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.64 HG22 HD11 ' A' ' 71' ' ' ILE . 44.5 t -97.35 130.59 29.13 Favored Pre-proline 0 C--N 1.291 -1.958 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.088 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -83.93 -157.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.331 2.021 . . . . 0.0 110.565 -179.146 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -84.05 65.65 8.82 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 124.556 2.122 . . . . 0.0 109.871 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.542 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -74.88 54.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 CA-C-O 123.238 1.494 . . . . 0.0 114.622 -179.894 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 32.19 39.83 0.07 OUTLIER Glycine 1 N--CA 1.524 4.534 0 N-CA-C 117.11 1.604 . . . . 0.0 117.11 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.49 173.73 46.49 Favored Glycine 0 N--CA 1.506 3.342 0 CA-C-N 113.516 -1.342 . . . . 0.0 111.727 179.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.299 16.9 m-20 -93.33 -84.15 0.3 Allowed 'General case' 0 CA--C 1.577 1.984 0 CA-C-O 116.429 -1.748 . . . . 0.0 111.12 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -110.03 135.93 50.08 Favored 'General case' 0 N--CA 1.517 2.903 0 CA-C-N 123.123 2.692 . . . . 0.0 112.722 179.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 m -142.06 160.99 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.99 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.776 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 64' ' ' LYS . 12.9 pt-20 -110.24 174.15 6.0 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.591 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.04 123.39 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.845 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.81 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.529 HG23 ' HG3' ' A' ' 19' ' ' GLU . 11.5 t -101.31 -43.83 5.84 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.529 ' HG3' HG23 ' A' ' 18' ' ' THR . 28.9 mt-10 -128.25 99.06 5.29 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.757 0.789 . . . . 0.0 112.685 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.423 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 7.4 p -75.65 70.59 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 119.091 -2.255 . . . . 0.0 114.281 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 55.4 mmm -33.83 -45.9 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.89 167.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 20' ' ' VAL . 36.6 mmtm -137.43 175.5 9.55 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -74.6 99.2 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.875 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.777 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.71 -23.08 5.4 Favored Glycine 1 N--CA 1.518 4.15 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.309 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.53 168.32 16.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 123.482 1.61 . . . . 0.0 114.326 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -98.9 132.94 43.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' CG1' HD21 ' A' ' 34' ' ' LEU . 88.7 t -128.12 122.62 58.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.209 -179.399 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -128.59 152.66 48.07 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.991 . . . . 0.0 112.908 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.96 68.74 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.776 0 CA-C-O 124.135 1.921 . . . . 0.0 115.131 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.609 ' HG3' ' N ' ' A' ' 32' ' ' GLN . 15.6 pt-20 -177.05 -37.66 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 110.124 -3.216 . . . . 0.0 111.565 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.609 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -71.58 110.49 6.2 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.945 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 7.2 p -51.26 67.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 ' CG1' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -14.03 -64.73 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 120.518 3.525 . . . . 0.0 120.518 179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 pt -150.52 148.86 14.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.186 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.4 m -95.27 133.8 38.76 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 178.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 31.7 m -118.13 157.1 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.97 167.44 13.59 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.79 94.98 0.16 Allowed Glycine 0 N--CA 1.511 3.653 0 CA-C-N 111.944 -2.389 . . . . 0.0 114.668 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.552 ' HB2' ' CE ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER 60.18 -68.8 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.666 0 CA-C-O 124.093 1.902 . . . . 0.0 115.492 179.696 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' CE ' ' HB2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -144.8 23.88 1.54 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 112.331 -2.213 . . . . 0.0 111.158 -179.82 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.56 122.87 19.41 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m -105.87 124.66 49.93 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.351 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -131.69 162.69 29.84 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 123.638 0.586 . . . . 0.0 110.328 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -115.12 159.51 20.78 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.022 -1.674 . . . . 0.0 114.186 179.665 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG22 ' CG2' ' A' ' 10' ' ' ILE . 71.3 t -121.42 133.44 24.22 Favored Pre-proline 0 N--CA 1.503 2.208 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.84 171.79 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.683 1.589 . . . . 0.0 111.899 173.52 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -54.79 100.43 0.22 Allowed Pre-proline 0 C--N 1.286 -2.192 0 CA-C-N 112.316 -2.22 . . . . 0.0 116.332 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -39.89 -33.72 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 122.151 1.901 . . . . 0.0 113.582 179.405 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CZ ' ' HD2' ' A' ' 3' ' ' LYS . 3.3 p90 -156.1 176.98 11.95 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-N 112.692 -2.049 . . . . 0.0 108.466 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.1 159.57 15.26 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.63 -142.13 10.4 Favored Glycine 0 N--CA 1.51 3.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.94 169.62 21.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 124.762 1.225 . . . . 0.0 108.757 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG22 ' CE1' ' A' ' 74' ' ' PHE . 38.5 t -95.61 127.7 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.439 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 44.8 tttp -102.72 -56.72 2.18 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.178 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 6.1 tp10 -154.72 157.13 37.59 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -149.9 147.45 27.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 118.871 -2.393 . . . . 0.0 113.995 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 53.42 1.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.46 154.49 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.978 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 9.9 m-80 -131.83 -174.38 3.4 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 124.299 2.0 . . . . 0.0 115.227 179.141 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.01 88.94 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-O 126.262 2.934 . . . . 0.0 110.05 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.37 15.72 0.41 Allowed Glycine 0 N--CA 1.515 3.917 1 CA-C-N 105.702 -5.227 . . . . 0.0 111.192 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -95.01 152.69 18.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.465 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 2.2 pptp? -106.95 142.03 37.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HB ' HG21 ' A' ' 7' ' ' VAL . 1.5 m -126.32 175.87 7.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 112.0 -2.363 . . . . 0.0 111.257 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.668 ' C ' ' HD3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER 177.51 157.45 0.37 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.594 179.796 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -29.1 103.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 178.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 6' ' ' ASN . . . 109.74 -47.01 1.09 Allowed Glycine 1 N--CA 1.518 4.102 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.89 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 t -26.84 117.72 0.08 Allowed 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 61.18 0.2 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.64 HD11 HG22 ' A' ' 7' ' ' VAL . 2.6 mt -23.79 -68.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 124.748 2.214 . . . . 0.0 115.575 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.7 ptp -154.58 -175.41 5.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.523 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -113.62 122.83 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 124.359 2.028 . . . . 0.0 110.948 179.415 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.536 ' CG ' ' CG2' ' A' ' 5' ' ' VAL . 8.9 m-30 -107.97 174.65 5.79 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 111.408 -2.633 . . . . 0.0 109.571 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 21.0 tt0 -151.45 166.37 31.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.35 56.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -179.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -64.1 -72.75 0.13 Allowed 'General case' 0 N--CA 1.517 2.916 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.52 50.01 0.07 OUTLIER Glycine 1 N--CA 1.521 4.344 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 17.37 64.32 0.02 OUTLIER 'General case' 0 CA--C 1.579 2.061 0 N-CA-C 119.797 3.258 . . . . 0.0 119.797 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.619 0 C-N-CA 128.074 2.55 . . . . 0.0 105.905 179.831 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' OE2' ' A' ' 75' ' ' GLU . 5.5 ttp . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.32 121.03 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.51 139.82 51.44 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.714 179.18 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -85.57 155.92 20.96 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 119.242 -2.161 . . . . 0.0 113.651 179.374 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' CE1' ' A' ' 74' ' ' PHE . 90.4 t -116.56 119.79 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.809 0 C-N-CA 124.602 1.161 . . . . 0.0 113.92 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -111.05 174.78 5.7 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.744 179.547 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.515 HG23 ' CG1' ' A' ' 71' ' ' ILE . 60.7 t -96.86 130.4 30.24 Favored Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' HG23 ' A' ' 67' ' ' THR . 53.6 Cg_endo -64.33 -100.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.348 0 C-N-CA 124.468 3.445 . . . . 0.0 120.913 -173.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 p30 -123.86 39.72 3.9 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 116.458 2.022 . . . . 0.0 116.458 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.551 HG21 ' CG2' ' A' ' 46' ' ' VAL . 5.6 pt -84.92 58.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 CA-C-O 124.859 2.266 . . . . 0.0 114.754 -179.536 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.72 111.1 0.97 Allowed Glycine 1 N--CA 1.516 4.001 0 CA-C-N 111.454 -2.612 . . . . 0.0 114.089 179.235 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 14' ' ' GLU . . . 160.51 82.83 0.04 OUTLIER Glycine 0 N--CA 1.508 3.496 0 O-C-N 121.676 -0.896 . . . . 0.0 112.187 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.287 4.5 m-20 13.11 23.38 0.0 OUTLIER 'General case' 0 CA--C 1.594 2.635 0 C-N-CA 131.572 3.949 . . . . 0.0 121.643 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' GLY . 42.5 tt0 118.52 137.5 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.878 0 C-N-CA 130.381 3.472 . . . . 0.0 112.368 179.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.454 HG21 HD12 ' A' ' 10' ' ' ILE . 1.4 m -137.41 146.12 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.948 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.583 ' CD ' ' HZ1' ' A' ' 64' ' ' LYS . 6.9 pt-20 -113.36 169.25 9.09 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 t -93.97 130.0 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.128 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 -179.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.484 ' C ' ' HG3' ' A' ' 19' ' ' GLU . 63.9 p -105.8 -47.15 3.95 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.801 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' C ' ' A' ' 18' ' ' THR . 2.8 mt-10 -130.49 106.04 8.26 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 123.126 1.441 . . . . 0.0 112.822 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.88 70.49 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-O 123.709 1.718 . . . . 0.0 111.162 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 14.2 mmt -25.37 -52.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 111.786 -2.461 . . . . 0.0 116.982 179.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 m -102.59 179.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.787 0 N-CA-C 118.514 2.783 . . . . 0.0 118.514 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 40.3 mmtm -140.18 168.69 19.22 Favored 'General case' 0 N--CA 1.522 3.131 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.0 t -60.12 89.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.525 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.063 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.87 4.6 5.58 Favored Glycine 1 N--CA 1.517 4.08 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.748 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.6 141.24 31.68 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.411 1.101 . . . . 0.0 113.474 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 28.4 mttp -64.99 135.32 55.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.983 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.523 HG12 ' CB ' ' A' ' 48' ' ' ALA . 19.0 t -131.96 115.82 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -179.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -118.26 152.46 35.69 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.181 -1.575 . . . . 0.0 113.97 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.94 72.91 0.42 Allowed 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.494 1.616 . . . . 0.0 114.545 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 175.98 -22.44 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 110.315 -3.13 . . . . 0.0 110.299 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -92.94 117.04 29.61 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -179.105 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 14.7 m -48.27 126.8 11.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.331 1.063 . . . . 0.0 112.981 179.277 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 48' ' ' ALA . 3.2 mt -89.02 -55.26 3.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 125.003 1.321 . . . . 0.0 113.711 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -148.4 152.18 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.566 179.724 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -99.48 136.41 39.45 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 179.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 21.4 m -123.68 146.71 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 43' ' ' SER . 0.0 OUTLIER -124.84 -173.69 2.86 Favored 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 179.8 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.23 145.36 4.93 Favored Glycine 1 N--CA 1.519 4.177 0 O-C-N 124.419 1.074 . . . . 0.0 113.061 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 1.0 -73.0 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -179.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -35.65 -54.68 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 160.84 172.13 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.294 0 O-C-N 126.109 2.131 . . . . 0.0 107.851 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.418 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 37.9 t -89.79 141.41 28.65 Favored 'General case' 0 N--CA 1.51 2.53 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.679 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.0 mtm -132.22 172.31 12.58 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -122.88 156.69 34.13 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 122.178 0.989 . . . . 0.0 113.397 179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.551 ' CG2' HG21 ' A' ' 10' ' ' ILE . 5.8 t -131.2 122.24 19.04 Favored Pre-proline 0 N--CA 1.497 1.909 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.753 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -85.86 178.7 4.13 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.008 1.805 . . . . 0.0 113.02 169.144 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -67.27 106.75 1.31 Allowed Pre-proline 0 C--N 1.287 -2.121 1 N-CA-C 122.188 4.144 . . . . 0.0 122.188 -179.903 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 78.5 Cg_exo -29.7 -40.69 0.06 OUTLIER 'Trans proline' 0 N--CA 1.508 2.334 0 C-N-CA 122.665 2.243 . . . . 0.0 115.61 174.236 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -154.11 -176.42 5.85 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 112.8 -2.0 . . . . 0.0 111.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . . . -99.22 116.66 31.92 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.7 -169.7 34.84 Favored Glycine 1 N--CA 1.526 4.636 0 CA-C-O 119.276 -0.735 . . . . 0.0 112.556 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.485 ' CG2' ' HG3' ' A' ' 77' ' ' GLU . 2.1 t -109.91 157.31 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.34 0 CA-C-N 119.804 1.802 . . . . 0.0 107.847 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 23' ' ' LYS . 20.8 t -76.43 113.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 6.5 tmtt? -91.74 -41.81 10.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 51.2 tt0 -164.92 161.28 19.99 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.155 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 2.0 pt? -162.71 152.16 15.53 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.164 -1.585 . . . . 0.0 109.243 178.587 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' NZ ' ' OE2' ' A' ' 56' ' ' GLU . 54.0 mttt -126.29 49.48 2.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.761 1.267 . . . . 0.0 109.164 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.03 137.11 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 111.828 -2.442 . . . . 0.0 112.707 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.82 177.75 4.59 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 124.619 2.152 . . . . 0.0 113.621 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 18' ' ' THR . 2.5 t -85.06 115.8 27.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 1 N-CA-C 99.967 -4.086 . . . . 0.0 99.967 179.901 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.55 -24.74 5.49 Favored Glycine 0 N--CA 1.514 3.882 0 CA-C-N 110.156 -3.202 . . . . 0.0 109.905 -179.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.06 174.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.583 ' HZ1' ' CD ' ' A' ' 16' ' ' GLU . 25.2 mmtm -104.13 136.13 44.33 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.558 HG12 HD12 ' A' ' 71' ' ' ILE . 19.9 m -132.15 142.87 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 123.218 1.485 . . . . 0.0 110.107 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 67' ' ' THR . 11.9 ttmt -141.01 123.44 15.86 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.69 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 8' ' ' PRO . 1.4 m -22.72 103.64 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.401 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.32 -42.49 1.72 Allowed Glycine 0 N--CA 1.511 3.695 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.542 -179.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 13.8 t -38.45 140.22 0.34 Allowed 'General case' 0 N--CA 1.53 3.526 0 CA-C-O 118.028 -0.987 . . . . 0.0 113.611 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.7 tt -80.78 57.33 2.96 Favored 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 124.527 2.108 . . . . 0.0 115.871 -179.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 65' ' ' VAL . 14.4 mm -30.05 -67.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 120.498 3.518 . . . . 0.0 120.498 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.505 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 3.9 ptm -143.26 172.15 13.14 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 111.784 -2.462 . . . . 0.0 113.397 -179.349 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.38 122.74 69.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 120.731 -1.231 . . . . 0.0 109.681 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.545 ' CE1' HG21 ' A' ' 5' ' ' VAL . 16.2 m-30 -105.02 144.69 31.47 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tp10 -120.73 99.2 6.39 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 124.551 2.12 . . . . 0.0 111.293 179.578 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 m -49.26 90.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HG3' ' CG2' ' A' ' 53' ' ' VAL . 83.4 mt-10 -26.77 -50.01 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.853 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.91 -67.76 0.16 Allowed Glycine 0 N--CA 1.516 3.967 0 N-CA-C 103.171 -3.972 . . . . 0.0 103.171 179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 175.88 33.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 111.15 -2.525 . . . . 0.0 109.111 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.807 3 N-CA-C 97.479 -5.008 . . . . 0.0 97.479 -179.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.587 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.2 m -19.36 154.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 1 N-CA-C 124.099 4.852 . . . . 0.0 124.099 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 74' ' ' PHE . 3.2 mttp -164.16 171.89 14.42 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.222 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 11.3 pt-20 -116.65 161.21 19.54 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.358 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.454 HG21 ' CE1' ' A' ' 74' ' ' PHE . 43.8 t -128.48 96.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 124.943 2.306 . . . . 0.0 108.143 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 69' ' ' SER . 18.9 p-10 -86.72 168.79 13.23 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 179.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.484 HG21 ' CG1' ' A' ' 65' ' ' VAL . 33.1 t -98.69 143.71 26.83 Favored Pre-proline 0 C--N 1.288 -2.072 0 C-N-CA 116.598 -2.041 . . . . 0.0 112.879 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' A' ' 7' ' ' VAL . 23.1 Cg_endo -72.05 -178.98 3.51 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.181 1.921 . . . . 0.0 114.633 177.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -53.99 40.82 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 118.757 2.873 . . . . 0.0 118.757 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.573 HG21 ' CG2' ' A' ' 46' ' ' VAL . 9.6 pt -79.53 46.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 O-C-N 118.842 -2.411 . . . . 0.0 116.368 -179.406 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.0 175.74 18.58 Favored Glycine 1 N--CA 1.526 4.664 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HE3' ' A' ' 66' ' ' LYS . . . -97.75 -29.31 7.8 Favored Glycine 1 N--CA 1.525 4.569 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' O ' ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -89.35 -167.87 2.0 Allowed 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 131.263 3.825 . . . . 0.0 110.54 -179.885 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -112.03 149.76 31.59 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 122.554 1.169 . . . . 0.0 112.041 179.782 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG21 HD12 ' A' ' 10' ' ' ILE . 34.2 m -123.47 167.22 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.275 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.57 ' CD ' ' HE2' ' A' ' 64' ' ' LYS . 28.8 mt-10 -112.19 128.67 56.3 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.49 119.01 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.109 0 C-N-CA 115.71 -2.396 . . . . 0.0 109.835 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -94.11 -51.24 4.93 Favored 'General case' 0 N--CA 1.519 2.98 0 C-N-CA 123.755 0.822 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -132.13 119.05 20.41 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.61 1.195 . . . . 0.0 112.726 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -92.33 63.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 123.594 1.664 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 67.3 mmm -24.33 -46.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.75 160.34 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -153.96 0.57 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 120.606 3.558 . . . . 0.0 120.606 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 55' ' ' LYS . 65.4 t -73.92 97.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.898 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.78 6.18 26.8 Favored Glycine 0 N--CA 1.516 3.977 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.722 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -92.85 152.77 19.23 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -82.09 124.84 30.2 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.55 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.451 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 t -123.47 148.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.054 -179.685 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -147.39 151.12 35.96 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.384 -0.822 . . . . 0.0 109.018 179.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 48' ' ' ALA . . . -48.72 158.96 0.27 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 124.172 0.92 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 74.12 -41.54 0.48 Allowed 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 123.901 1.81 . . . . 0.0 112.007 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 119.565 -1.959 . . . . 0.0 114.656 -179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -34.0 82.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 179.154 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 48' ' ' ALA . 5.7 mt -50.79 -51.48 50.19 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.2 pt -142.1 144.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.001 179.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 m -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 24.7 m -130.82 162.4 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 17.7 tt0 -121.57 -144.61 0.35 Allowed 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' H ' ' HG2' ' A' ' 38' ' ' GLU . . . 129.67 -141.21 12.38 Favored Glycine 1 N--CA 1.517 4.096 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.224 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -48.26 86.19 0.0 OUTLIER 'General case' 0 CA--C 1.6 2.872 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 0.3 OUTLIER 33.49 32.1 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.149 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -179.532 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.58 150.34 38.69 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.823 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.5 p -106.46 130.22 54.3 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 122.044 0.926 . . . . 0.0 111.63 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 30.7 mmt -124.1 152.58 42.57 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.601 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -124.41 152.94 42.63 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.573 ' CG2' HG21 ' A' ' 10' ' ' ILE . 5.4 t -121.76 112.75 32.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.911 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -80.97 171.12 14.54 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 CA-C-O 124.282 1.701 . . . . 0.0 108.933 172.439 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -64.27 106.83 1.06 Allowed Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.089 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 3.8 Cg_endo -34.45 -37.04 0.12 Allowed 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 121.808 1.672 . . . . 0.0 114.321 175.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -156.16 -175.74 5.59 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.61 164.83 12.43 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 126.49 -152.69 18.45 Favored Glycine 1 N--CA 1.524 4.567 0 O-C-N 121.415 -0.803 . . . . 0.0 114.78 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.38 165.46 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 121.429 0.633 . . . . 0.0 112.143 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG22 ' CE1' ' A' ' 74' ' ' PHE . 15.3 t -96.09 145.33 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.103 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' HG13 ' A' ' 24' ' ' VAL . 18.8 tptt -107.65 -60.59 1.68 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.631 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HG2' ' N ' ' A' ' 57' ' ' LEU . 32.9 tt0 -161.17 169.79 21.6 Favored 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.689 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt? -164.61 155.97 15.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.655 -1.278 . . . . 0.0 109.645 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -131.11 51.55 2.13 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.387 1.089 . . . . 0.0 108.368 179.714 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 71' ' ' ILE . 19.4 m -126.28 170.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 CA-C-N 114.121 -1.4 . . . . 0.0 114.719 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -138.65 165.95 25.62 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 120.692 3.59 . . . . 0.0 120.692 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.9 t -96.03 101.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 100.849 -3.76 . . . . 0.0 100.849 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.35 29.17 2.18 Favored Glycine 0 N--CA 1.508 3.481 0 CA-C-N 109.572 -3.467 . . . . 0.0 108.01 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . 0.285 0.0 OUTLIER -112.12 178.79 4.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 179.44 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HE2' ' CD ' ' A' ' 16' ' ' GLU . 29.6 mmtp -109.77 130.35 55.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' CG1' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -113.01 147.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 113.492 -1.685 . . . . 0.0 112.918 -179.838 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' CE ' ' O ' ' A' ' 13' ' ' ASP . 4.3 tptm -146.76 140.97 26.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 15.1 t -50.97 124.44 11.32 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.699 178.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.8 -47.11 1.05 Allowed Glycine 0 N--CA 1.508 3.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.659 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 28.9 t -36.32 118.78 0.56 Allowed 'General case' 0 N--CA 1.523 3.222 0 CA-C-O 117.316 -1.326 . . . . 0.0 113.606 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.92 62.15 1.09 Allowed 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 123.198 1.475 . . . . 0.0 110.527 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.433 ' HA ' HG11 ' A' ' 59' ' ' VAL . 21.2 mm -45.11 -58.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' VAL . 8.0 ptm -142.06 160.7 39.69 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -107.13 131.79 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 123.532 1.634 . . . . 0.0 112.54 179.549 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 3' ' ' LYS . 3.6 m-30 -110.35 165.27 11.91 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.956 -2.384 . . . . 0.0 116.919 -179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 21.6 tt0 -151.36 101.89 2.87 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 32.1 m -48.66 60.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 C-N-CA 127.297 2.239 . . . . 0.0 116.245 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 85.94 144.9 0.06 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 -179.189 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.56 9.52 4.63 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 2.89 -80.03 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.697 0 O-C-N 127.668 2.628 . . . . 0.0 115.393 -179.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.209 0 O-C-N 127.652 3.095 . . . . 0.0 113.785 179.61 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' O ' HG22 ' A' ' 76' ' ' VAL . 57.2 mtm . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -34.35 137.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.595 HG21 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -76.12 177.37 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 11' ' ' GLY . 10.1 p30 -70.63 60.52 0.22 Allowed 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 125.264 2.459 . . . . 0.0 114.778 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.523 HG21 HG12 ' A' ' 46' ' ' VAL . 10.8 pt -79.22 39.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 CA-C-O 123.687 1.708 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 46.48 -79.99 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.89 95.47 0.01 OUTLIER Glycine 1 N--CA 1.52 4.242 0 N-CA-C 117.869 1.907 . . . . 0.0 117.869 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -17.68 -66.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.17 139.01 35.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.466 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 65' ' ' VAL . 33.3 m -144.79 155.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.724 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.639 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.639 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 26' ' ' ASP . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.86 -166.74 1.66 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.6 174.3 16.73 Favored Glycine 0 N--CA 1.514 3.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -14.07 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt 66.98 -3.9 0.88 Allowed 'General case' 0 N--CA 1.518 2.942 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.27 118.14 34.44 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -103.44 125.75 50.21 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.523 HG12 HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 3' ' ' LYS . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.724 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 15' ' ' VAL . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CE1' HG21 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 1' ' ' MET . 27.5 m -62.96 74.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.47 146.64 40.41 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.384 179.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.16 -36.53 2.38 Favored Glycine 0 N--CA 1.511 3.676 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 158.35 -170.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 110.981 -2.609 . . . . 0.0 111.923 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.699 0 C-N-CA 125.611 1.564 . . . . 0.0 108.714 179.926 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' O ' HG22 ' A' ' 76' ' ' VAL . 57.2 mtm . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -34.35 137.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 4' ' ' GLU . 14.4 mmtt -139.25 169.59 17.49 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.899 -1.5 . . . . 0.0 114.627 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -101.66 146.11 28.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.719 -179.64 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.595 HG21 ' CE1' ' A' ' 74' ' ' PHE . 63.8 t -120.5 101.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.787 1.279 . . . . 0.0 111.59 179.484 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 69' ' ' SER . 11.8 p-10 -108.48 166.94 10.4 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' A' ' 71' ' ' ILE . 46.8 t -91.93 140.68 24.86 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 117.658 -1.617 . . . . 0.0 107.198 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -76.12 177.37 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-O 123.87 1.529 . . . . 0.0 115.19 171.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 11' ' ' GLY . 10.1 p30 -70.63 60.52 0.22 Allowed 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 125.264 2.459 . . . . 0.0 114.778 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.523 HG21 HG12 ' A' ' 46' ' ' VAL . 10.8 pt -79.22 39.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 CA-C-O 123.687 1.708 . . . . 0.0 111.092 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . 46.48 -79.99 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.89 95.47 0.01 OUTLIER Glycine 1 N--CA 1.52 4.242 0 N-CA-C 117.869 1.907 . . . . 0.0 117.869 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -17.68 -66.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 179.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.17 139.01 35.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 65' ' ' VAL . 33.3 m -144.79 155.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.724 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -114.71 171.82 7.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.413 -1.429 . . . . 0.0 113.544 179.519 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.22 121.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.765 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 6.2 t -102.7 -40.08 6.75 Favored 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 13.6 tt0 -137.4 123.66 20.56 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 123.007 1.384 . . . . 0.0 111.156 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.44 75.67 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 125.141 2.4 . . . . 0.0 115.322 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mmt -39.15 -58.22 1.19 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.652 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.639 ' C ' ' HD2' ' A' ' 23' ' ' LYS . 15.2 m -88.77 154.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.639 ' HD2' ' C ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.28 169.57 17.01 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.15 96.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.858 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.43 19.84 9.04 Favored Glycine 0 N--CA 1.511 3.686 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.65 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 28' ' ' VAL . 5.6 t0 -104.24 138.55 40.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 123.411 1.577 . . . . 0.0 114.31 -179.667 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.25 98.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.365 -2.198 . . . . 0.0 112.509 179.249 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 26' ' ' ASP . 2.4 t -103.72 89.48 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . . . -102.02 153.24 20.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 111.457 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -55.13 138.34 44.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 6.5 mm-40 104.34 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 127.28 2.863 . . . . 0.0 108.872 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -84.55 93.01 8.25 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.072 -1.018 . . . . 0.0 111.476 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 74.1 m -33.61 67.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -9.94 -71.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.6 pt -144.23 127.66 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 CA-C-N 112.692 -2.049 . . . . 0.0 111.173 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 19' ' ' GLU . 1.7 m -73.07 125.42 27.63 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.94 160.32 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.86 -166.74 1.66 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.6 174.3 16.73 Favored Glycine 0 N--CA 1.514 3.837 0 CA-C-N 113.736 -1.575 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -14.07 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt 66.98 -3.9 0.88 Allowed 'General case' 0 N--CA 1.518 2.942 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.27 118.14 34.44 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -103.44 125.75 50.21 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.7 ttp -142.44 163.55 32.55 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 123.418 0.449 . . . . 0.0 111.498 -179.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -119.47 164.68 15.41 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 124.077 1.894 . . . . 0.0 114.636 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.523 HG12 HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -121.88 131.54 24.41 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.043 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -91.99 170.14 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 CA-C-O 124.241 1.684 . . . . 0.0 112.993 174.433 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . . . -55.88 104.72 0.45 Allowed Pre-proline 0 C--N 1.285 -2.202 0 CA-C-N 110.73 -2.941 . . . . 0.0 115.575 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 48' ' ' ALA . 12.9 Cg_endo -40.8 -34.04 1.23 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 122.812 2.341 . . . . 0.0 114.249 -174.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 3' ' ' LYS . 37.1 p90 -157.9 -174.82 5.03 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.726 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 29' ' ' ALA . . . -102.18 95.57 6.41 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.92 -163.35 11.45 Favored Glycine 1 N--CA 1.516 4.005 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.28 158.87 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.554 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.55 HG13 ' SD ' ' A' ' 72' ' ' MET . 47.2 t -79.51 131.44 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.02 -58.42 1.94 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -148.07 127.68 13.29 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 72' ' ' MET . 1.8 pt? -126.42 154.52 43.53 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 119.341 -2.099 . . . . 0.0 109.21 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -135.27 43.5 2.65 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.084 0.945 . . . . 0.0 110.253 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.57 164.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.236 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -128.12 175.35 8.49 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 18' ' ' THR . 4.3 t -94.66 104.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.23 26.3 2.27 Favored Glycine 0 N--CA 1.512 3.716 1 CA-C-N 107.764 -4.289 . . . . 0.0 109.669 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -98.23 167.84 10.61 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 113.515 -1.342 . . . . 0.0 109.054 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.724 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 48.9 mmtt -102.31 129.04 48.64 Favored 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -179.605 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 15' ' ' VAL . 6.4 m -128.88 137.95 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -144.93 152.78 40.74 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -46.91 117.65 1.76 Allowed 'General case' 0 N--CA 1.516 2.838 0 C-N-CA 118.077 -1.449 . . . . 0.0 109.432 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.77 -46.98 1.06 Allowed Glycine 0 N--CA 1.51 3.623 0 CA-C-N 113.931 -1.486 . . . . 0.0 112.99 -179.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 70.2 m -38.02 116.72 0.54 Allowed 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 55.73 0.12 Allowed 'General case' 0 N--CA 1.517 2.91 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 7' ' ' VAL . 29.4 mm -22.15 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 5.8 ptp -169.58 -175.36 2.13 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.424 -1.716 . . . . 0.0 114.8 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.41 134.32 58.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 124.858 2.266 . . . . 0.0 110.678 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CE1' HG21 ' A' ' 5' ' ' VAL . 4.3 m-30 -107.19 -171.03 1.8 Allowed 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 111.685 -2.507 . . . . 0.0 109.06 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -160.52 107.59 1.55 Allowed 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 1' ' ' MET . 27.5 m -62.96 74.48 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 118.775 2.88 . . . . 0.0 118.775 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.47 146.64 40.41 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.384 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.16 -36.53 2.38 Favored Glycine 0 N--CA 1.511 3.676 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 158.35 -170.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 110.981 -2.609 . . . . 0.0 111.923 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.699 0 C-N-CA 125.611 1.564 . . . . 0.0 108.714 179.926 . . . . . . . . 0 0 . 1 stop_ save_